@antibody_1_multiplicity_2_copy_1-1
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCAGAAACGCGATGCAAGTAATAACCACTATATCATAGTAATATGATCAGAATTGCACATTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAACATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCCTATATGTGCTACACCGCTATAAATAACTGAGACCCACTCCA
+
??=??BB>DDBBDDDBGG>EFGHHIFCBFH@I5FHHIGIE=DHIICFH?F9HEHF?<HEH5FG@HBIFHHHH+EHIGIHHFHDHGHHHC==EHHFAHDHE-EI.HGH6GGHHDHGHFFDHFE*+HEAGFGHG3GGFEFG(<EGEEE6#*EGEGGEG;GEGEEEGCAEGG<G8FGE1CF1E/G*GEEEGE8E:E?G)ECGEEGF?EAC/*EE8CE/7BG,((F9E*8FEEE?<C/E:C6AEG*G?F(E8GE
@antibody_1_multiplicity_2_copy_2-1
ATGTAGTAGTAGTAGTAGTCCAGAAACGCGATGCAAGTAATAACCACTATATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTCTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTATATGTGCTACACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGATCCTGGCGGAC
+
?A??ABBB=DD@D9?BCFFFFFCHFIA8FEIIDGGD=D@DHHGHHHIHIFEEIG+CE@EHFAHHHIHHAIIIFEGIIFHHH--HH.IICEGHF,=IIHH?HG(:HG2HHHFHHFFEFECGGGC6GE3G@GGHCG*3E0GBG?HGFE8<GDGE/6EGEFEFEEEFAEGFFEGEGGCECEE;GEF(EAG6-CGEGC;9/*GGEGECGG';CECA9;BGE;,FEG?EAEGCEEA?E(GCGGGAC?GGE;E?EG
@antibody_2_multiplicity_1_copy_1-1
GACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCAGAAACCCGATGCAAGTAATAGCCACTACTATCATAGTAATATGATCAGAATTGCACACTAATACACAGCCGTGTCCTCGGCTCGCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGAAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCAGCGCTATAAATAACTGAGACCC
+
?<A??B<5DD-DD@@BGFFGGGFC/IFF>FGHGFEIIFIH9IDHBF-AHH@GFGHGF,IHFFAHHFHHHHCHGFHHHHHH>I=HFI5IIIFBEHI+IGHH)HFGDI=,GHHHHHCDFD6EDFFF,FFHHBFH,,ED*FDEE(@DGEECGFG)<CE?G??GEGGEG?GGG;EC<GF#?AA((.*:CEC;GF*AEGGE/FE'#1A:G0::CE<CE@E.*8?(GA?E;;0A*EA*GG;G(C0C/A*GGF((*<
@antibody_3_multiplicity_1_copy_1-1
GAGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACACTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGGAGATACAGCGTGTTCTTTGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCTTTATAACT
+
?????/BBDDA<D-DDF-FGCG@FCHFHIH9=EIIHIHHHHIHFIEDEEHDGFFIHIEEHIFIAFHIEEGIHDGA5HFF?+HHFIHIIIEHHHHI)FHEHDBFGHHGF)HG+FDFFHEFGGDEEHEED<GHEGEGE*E*+DF2GGEEFGGCE:GG18CEA*DFGGEEGGEGA6*;(EEFEE-/EG.G(C:?EE(CCE#AECAGEC0E(FCC:CEGAFEC:GGGEG<.A;C)GG'C?.8?GE'08E0E?#4
@antibody_4_multiplicity_1_copy_1-1
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTACTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGCAATTGTCTCTGAAGATGGTGAATCTGACTTTCATGGAGTCAGCGTAGTATGTGCTACCACCGCCATAAATAACTGAGAAACAC
+
??=5?B?B@@D?DDBBFCGCG/IFHCHHBF.H7DHHIIHACGEI7HEFI-HH5GIHHFDHIEGIGCHFBBHFHHFHGH+FHHIH@IHHFHHDI-AFDHHFIFHGC6>HH@IFHH=HHGHBEDEDEFGFEF)D)GG@GGGE2GHGG4GFFEG*GBC?G:G@GGEGEC(EAG*CG*AE8:=GF/GECAG?EEE?E9/8E4EG*FAGGEC#GEGEHG><77EEG:)CC1E*??(A.?<G0G#*CGFCE/G#:C
@antibody_5_multiplicity_2_copy_1-1
CTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGATCTGGGTCCGCCACGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGTCAGATCCACCAACTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACAC
+
?,???B?BBB<DDD-DG@GFFCF8.EIHIIFEIIIHHIHIEHHHHHHFHFHEHAFHFC9FAFH=FFHIFFIH=HFHD+--FIFI+HHGIHH+IF?FHIE9EDHFH..+585FHFEH7HEHEB'EF;GE++EEC9G+=G1AG=FGE.GFGBFCEFF4GEEGEG?G((G;GGEG-:FE?EC:G+EDF<EEE*C:GEG(FG:EEECGG;C6GH?GHGBE7(?G.G/-C./<G?(E*CA(FG1EGCEGC/CE0(
@antibody_5_multiplicity_2_copy_2-1
CTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTACTATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGTTGGTGGATCTGACCTTCACGGAGACTGCGTAGTATGTGCTACCACCGCTATTAATAACTGAGACCCACACCAGCCCC
+
??,??BBB@DDDDDDD-E.CE+HHCIHHHAFHHGGHAIGFG?IAHFHHHHHIHFFIC5HICIFIFIFHHHICIHFGB+5HHIHFD@EGCIFFIHEDHHHFGHHFFHHGHIFHH:-1CEFFDHH>F6EBG?FDG9G=(FGGF3EE?EEEG,GAGFEEGGGE(CGGEEGE?FCGGGC(EGDE(AGG(;EG.?C/EAG6(GE?E.;A*EAEEH:E8*E:?./ABEC.(C:*?(?G*E>1>EG(E.DG16/C;:
@antibody_6_multiplicity_4_copy_1-1
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGTCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCCCGGATCCTGGATAGTATGTGTCACCAGCAGTACGAATAGCTGAGAGCCACTCCAG
+
?=<A?BB<DBD7DBDDCGFCC@HEFHCHHHIEI,DGHIHHC9HIFAHH=.HEAFHFIHCFF8HD=IHHH?CICHIHIHD*H5EHGIDFHFHIHGBHFHE8IG*=DHH?FH?++FHFD+HHFGGHAHFFGGFFDFGEEEFHEG*EBG'EGGECF;@G0GDGE*EGF?E>F;=:*?FA0FG(EAA?EE6ECEC(EG#?8CEGEG1F.G/:E*:8AECG8EEE<(EG(E;64G/GE:EG1G.E'?(?)C;::'
@antibody_6_multiplicity_4_copy_2-1
AGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGTCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGATCCTGGATAGTAAGTGTCACCAGCAGTACCAATAGCTGAGACCCACTCCAGACC
+
<?A=?BBBDDD9?@DBGGFFFFFIHBE>FFHHFHHIGGHIE/IFCHHIGBH=HI-G-EHFHDI-HHIAIG-CHIHHHEHAGADD-EH/HFFFHDFEHEGHHGHEFG+=HHDEHFFHHDHEGDGBF7FBEHHAEGEICE.2?DE)GGGFAG+G*G2EGEGBEFE*E.(GE0GGD?GA<G#EE+CEGE6F1G/FEEG1FGGCGG?C-:F?(FGEH:8EFACG?EE(;C6*?/C?'GG*0E?6?:G:C*(?AC
@antibody_6_multiplicity_4_copy_3-1
GGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCTGTAGCTACGATATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATACTATCCAGGATCCGTAAAGGGCCGATTCACCATCTCCATAGAAAATGCCAAGAACTCATTGTATCTTCAAATGAACAGCCTGAGAGTCGGGGACACGGCTGTGTATTACTGTGCGAGAACGC
+
?AAA?=?BDDDDDBDBFCFCCFF4FBFIHHIAHH@IIFHG.>IHGHIIIF9>IFAEHGD@55EHHFFHHIAH-IFGHDFHHFHHIIHHG3HH@I.IDGHIFHHFH?HFFD3IHHFGHD=?EHGFGGEHA6HFGF2FG*3?C=?*HFFF'GGCEEG??C:EE/1BG;#E=0GE?(E?F?'F/G0EC(GE?.0G8;/GC/EE:C;ECGH:6H(;E/#/0GFC(G:86A8ECG?F:E?FC6*E***F8*'?(E
@antibody_6_multiplicity_4_copy_4-1
AGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCTGTAGCTACGCTATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAACTATTGGTACTGCTGGTGACACATACTATCCAGGATCCGTGAAGGGCCGATTCACCATCTGCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAG
+
A?????>BBDDBDDDB?;CCFFIEHHCCHIHHFE5HHDGI9I/HH+?H9FIFIIHGHIHFHF)?H.H2EDIF@I7HICF#HDFG<;'HIH#H8)IH3HHFIHH,GHHFI?FGFH*FH*?HG?GH?FFB@AF4GC;C*GF**3EEGEGGE/GC@D:EGEF3G?<EECGE?EE@F6FFFEEAFAEGFGCED*GA?((GAGCEE(GA6E-G?E:*(G*FFCC<E;EG<EFEE:??:?EA*G??CECECEA?1(
@antibody_7_multiplicity_1_copy_1-1
GTAATTCTTCCATGGGTAGTCACCGTAGTCAGCGCGCGATATCTGGCACAGTAATACACGGCCGTGTCTGCTGCAGTCACAGAGTTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATAGGGTAACTCGACTCTTGGGGGACGGGTTGGAGTAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGGGGCTGGCGGATCCAACTCCAGCAGTAATCACCACAGC
+
?<?5ABBBDDDD-DE-FGF-?GHI>HIFF.HIC'I@GIHIHFFIHFIFCDFE>IACGIHIIFHAFHDHFIHAEII(FHFH-HIAHIFCIIAIEI3HFEFHEIIHHIHDHHHHHGHEGEFFDGFFFF@#GFG=EGGDGDFECDDGHCCEFG;GEEE*;F**?G<FFG/EAF*E*CE*GGECFGA;EG?EEAFG?GE(GEE:AEGC(CDGA9:3*EBECE<,0,GA(AC'.(:CE/#EECC*EF:G?EA(AE
@antibody_8_multiplicity_1_copy_1-1
GAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAAAAACTCCCCGAACCATAGTAATATCGAATGCATGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCACCCCTTAACGGAGCCTCGATAGTATGTGTCACCAGCAGGACATTGGCTGA
+
?????BBBDDDB9DDDFFFFFFFFHHIHHHIIIFFF=DHIIFC.FHHH>BBHHFIAIHHFFHDFIHHIHFIHH*H-HFHIHIF@EFEDI5HFHIHFFEF?HCHFCGFIH:HFHDGDGHFFH;HF*GHEHDFFEE*GGEFGEEBEGGGCFAGFDG;EE;GEEE8*G:GGEEE?GGGGFE3CG+.;G?EDCE(((6*GAGE(?;??5/*GE:?E<CG:FDE:/F;/G?(>8E?CGEG.G(*C6?6CG*GEEC
@antibody_9_multiplicity_1_copy_1-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGCCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCGGGAGTGGATTCGGAGTATCTATTATACTGGGAGCACCTACTACAACCCGTCCCTCAAAAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAATCTGAGC
+
????,?BB<DBBAADDAFFDCFCHEHHFFHDED0@EFH@G+GHDHHHHI.-@GCHHHFBAAFFFFHHH-HC/?IEHGIHFIHGGHDEHHGHHH=BDHHIHF@HH,*EGIHHHFFFDGGHD=F4HFC@BH=HEDF'DFDGF@GEF?HGGFG8G@?GGEG0E6'GDEGG??EGEDC;EC8E0GEG6GF)AF6GG6F>GE**GEGC6CEHGG?(F(GGGE(?C77=?'E6EE;EA:/EEGCEEGEC'ECG?C:
@antibody_10_multiplicity_8_copy_1-1
ACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCCTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCACTGAAGAGCAGGCTCACCATCACGAAGGACACCACCAAAAACCAGGTGGTCCTTACAATGACGAACCTGAACCCTGTGGACACAGGCACATATTACTGTTAA
+
???<?BBBD5DBAD@@FGFGCFHHHFFF>H/GIFHHCIHI.FAEAFFH@/HEFFIIHDEHIFCHHHHIH-HHFI#HCFEFG5HIGHHAI=IHGAH9H+IH/HEFGEIHHD+DEH<HDHH@+HHF3EFHEEFE6GHF@GBH@C@E(CECAEEBCEGEGCCCGGGGGGE*GG(#8?E:E(EGC(8FDG:A?EE8EE0ACEC8EC8EEFH?GA8:CA)G?:?EG,GAE*G-E:;:EC(C:GG0<*AGACGGF6
@antibody_10_multiplicity_8_copy_2-1
CTGGTGAAACCCACACAGACCCTCGCGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATACGCGCTACAGCCCATCACTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGAACCCTGTGTATACAGGCA
+
?A?AAB>-DBDD<DDDBF-FGGHH-CEHHHHEHIDGIGGIHFHHIHHIDHH7EDHFFI5+FHDIHGEFIHEH5-EIHIIIFFIHHH<8GB=IHFHFH.HHH4CH9GHHEHHH3HFHDGHHHHGFDEH,EGGBGG8GEGFGEDEF,*DDF<8E2GGC8GEEE:GC,G?EGG<CAF'CGCFCEGGEEG)GFEACE6GF-*:G(C??:?E(ECC:A@G*:(G(C:A6A8'C:8C=EFE(.A(G'C.?G*A0-;
@antibody_10_multiplicity_8_copy_3-1
CAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTAATGTAGTCGTACACGCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTTCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTGCAGTGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCGGGGCCTTTCCTGGGGGCTGACGCATCC
+
,5??ABBBDDDDDDDDF?GA5FFFIHHIHAAHDI>DHHIGHH9GIHDGHIHHFI=CFHAIHEFIAGBHC??HHC=HIF-HDHFHHHIIAIHID8IFH-4HBCFHFGEDHEH8IDHFHFEHF:HGAG.GG;EHDGGGE*GBDGDD*,GGEAG,DEGECGC2GG*AFG(0GGC:FFEGGCECFAD*G;E?-(C*GDAE;AE*?):.GGHE:C(GHC*GFF7GGE#E/?:AEGC/(E:GC0AGECGC*#AGEE
@antibody_10_multiplicity_8_copy_4-1
AGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACTTGCACCTTCTCTGGGTTCTCTCTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCACTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTAATATGACTAACATGAACCC
+
,,A??BB7DDDDD9BDFGFGGCIHIHHHHCHHCG8HIHHHEFF0GH-HHHHFHHIHDGEHHHEIAFH*.DHEHIF-HFIEIGHH-HHF<H8HHFHHHDHHGD=8AF@HHI3HFHGFD@HEHHCFEHD2B'GGC#GEEH@DGC@E*G'C*GG)GGE:GG?:G6G86FEEFG#E6<2:.6E6(?8G>F(:E<CEC?EE(?6F26A?AEDCE*EEAGEEEEG:G?G:ECGEG(C(2G<EAG/0(GG?EA/<**
@antibody_10_multiplicity_8_copy_5-1
GTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCACTGAAGAGCAGGCTCACCATCACCAAGGAGACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGAACCCTGTGGACGCAGGCACAT
+
AA???BBBD@BDD<B<6FFFGFH/FIFIHIAHIHIF,HIIIDEHFHHFECHIHD+CIF:HFC-EHIHHHGHHHI5-GHFHICHHFHIFB(IHDIHIHFHFHEHG@HHHHIFG@@DGHAH0AHFEHEEGG+(FDG4EGF;EFE*GGCEFEEGFBC/;FEGEEG'GG0CEGE*C6.?GCEEG-BECFEEC*CGE?GC.(GEGAF:EGDC::-/?CEE8??EAGE*1CC:C?(?EEE=E0GG?'*EAEAE/G?
@antibody_10_multiplicity_8_copy_6-1
TGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGGCCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGATTAGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACATCCCATCACTGAAGAGCAGGCTCACCATCACCAAGCACACCCCCAAAAACCAGGTGGTCCTTACAATGACCAACAT
+
?=?5?=BBDDDDDDBDCFFGCFFH>IEHHAH+FC>AFH+EHGHHFIDHHIEHCHHEHHIDIFDDHFFI8F?IHIFCIHHGG=EHII)FHIHHFIHIDCHEHH@FHHHHDE4HFEFEBFHHEEEGD?FFEEGHB(D#FGFG@FEF*((@EG,G8EEEE,GGDGGEG:EE*?@?GG#GG(<AG?6GFEAAF?A60;GGCDCDFFGFEGECG#GE<)C*EGCC8GE?*C?C(F*GCGD4E>EC=E2EEEE?E:
@antibody_10_multiplicity_8_copy_7-1
CGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTAATGTAGTCGTACACGCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTTCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTCCTCTTCAGTGATGGGCTGTAGCGTTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGCCCTTTCCTGGGGGCTAT
+
A???=BBBDDDD5BD?F.CAFFEHHCHEFIHFHGHHIC0H5HC=IHDEHGFDHHIHHGHAGHFIIAHIFHFFDHGAFHF7CHE+GEHEHFFDIIAI+HHFECHHHCH?H=D=HG>EHHGG=6H:H+,HGGD2*+FGBDH=E?CEGEGE=EACE;EE?EEHCG.CGF<:0;CECF*:8GGAC/E(?6EEE6E((ECGAE0CGE/=:6CA*?FCCCDEE0<@=G??CG<GCC??(CE:E6EECA:*(GFE*/
@antibody_10_multiplicity_8_copy_8-1
GAGGAGACGATGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTAATGTAGTCGTACACGCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTTCATGTTGGTCATTGTAAGGACCACCTGGTTTTCGGAGGTGTCCTTGGTGATGATGAGCCTGCTCTTCAGTCATGGGCTGTAGCGCTTATCATCATTCCAATAAAGGAGTGCAAGCCACTCCAGGGCCTTTCCTGG
+
?,???BBB@-DBBADDCFCFCGIHIIIIIIICIIHFHCDICHCHI9H=HHHIFFEFE<FA5FE/?IFH8HHEEHIBIFEH-IFGGHIHIFIIHCIH?FHD'@GEHEFHHHEHHHB=F<HEFHD<HCH9FEDFFGGE;DDG3FEGEGG#GGCCEEEEGEFEG*/EG(2*CEGE:EAE>?E60(EFE(AEC*#A6-G*.*2CE*(FE?CGE/'E7CCGCG?(G??.C?8EA?/(A0E*C6G.<GGC???(:G
@antibody_11_multiplicity_1_copy_1-1
AGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGGGGAGTGGGTATGGGCTGGATCCGTCAGCCCCAAGGAAAGGCCCTAGAGTGGCTTGCACGCATTTATTGGAATGATGATAAGCGCGACAGGCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCC
+
???=ABBBBDDB@@BDGA?CC6/ICAHIIHIFHHHGHEG99FFDGHHEHHH-IHI7HHIHEH+HFHAAHHCIIH?FCIH*HC,HH+HHHHAIEBHHHHHHE.FCHGGHECH(FHFBH=GFGHEH),FGGEC;FFD=@G(E5GEEG6GFAE>GAEGBFE*EGBFE((F=GFG(ECEAE?'GF:E(GEAE)C/(FGEGG:(EGGFE:?HFEHDA.:C(GGEG:EG(CCF;EG)EEF:'/0EE*:16CE8?AG
@antibody_12_multiplicity_2_copy_1-1
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGAGTAGTTTTCATACATTAGTAGTAGTAGTATACCATATACTACGCAGACTCTATGAAGGTCCGATTCACCATCTCCCGAGACAATGCCAAGAAGTCACTGTATCTGCAAATGAACATCCTGAGAGACGAG
+
?????<BB@BDD-DBDFFGFGFFAHI,IHIFGEC9/EHIGAFAB.FIGHHIHDFHHFHHIHIFIAF*FCIIECIGCFFH>CHHG-HCFHHFDHHCI@CFE+CHCB9FGG?HHHFBH@EDGAFH#D6HEDDGDEEEFEG?*1GGGEGGEC*BEF>EGBECEG8G=EEG)C/*E(GCDG<*0?CEGE6GGE?ECCEE(#E)CE/GEGA.FE8GGEDG8EG/@/EFE8AE8(EEEFE:F(?CEEAE:*CAF?E
@antibody_12_multiplicity_2_copy_2-1
GAGGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTATTAGTACATGACGCATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGACCCCCAGCCGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTAATTTGCAAATACAGTGACTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACATAGTCTGCGTAGTA
+
??A??BB?D@DBDD@BCFGGGEHHH8A-IHGHFF/IEH.DIHHH@HHEBH=+IHHEHIFGFHIH2'FFHGHHI=C=I+F(HH+GAHHHH=EIHEHIEID,FHHFHHGHHHHGFH#GFHF2HG'G*FFDFGDHF,EEHG;GGGECEEG*@D6686G:FEE;AG8GGECGCEG>C?E(FE*GG8-(?G8GBE9EEAEAG(=<E-E(A.*.E/*C@7EE/EECBG:G6G?*GE?CEGE0*E:EG?86DFGECC
@antibody_13_multiplicity_1_copy_1-1
GGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATATCTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCTCATAATACACAGCCGTGTCCTCGTCTCTCAGACTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGTCCTACACAGAGTCTGCGTAGTATAAGGTACTATTACTACTACTAATGT
+
??????BBDDBBDDDBGGFGFFAIHIHIHI9AHHHIIHGHGI.EGIGFH+=CGD-/AHIHH#IDHFBFIH-FF5HII@DH@EIHH+HHHHGGHFHCHIGHGH8IHHHHH.F#FEHHEFG@08GGEEH@DEHGHHGFGF?EFEE*GBHCFFEGG=E;EECGGAFG?EE(/FEG?:G>EGE8C6G:ACCGGGGE*EEA.(A:E''(8G;EEHG-(G@A:E?-C:GEG?((A?91?:6E*C;E?6GA*2G:(:
@antibody_14_multiplicity_3_copy_1-1
CGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTGCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCCTGTCCTCGTCTCTCAGGCGGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTACCAATGATGTATGAAACC
+
?A??=B@BB@DDD-==CF+FFCIIHIH+HIFFIII7IEIAGGIIG+.HF0C8EII+IF+FFFHECHF.HECBH55A5@IHC-HG-HHI#HEFHIH+F<6BFDE-FFCFG+HH6GD=8H+8CDF.@D4FE?GGE:GGE#A5*?G8G3AGGC#.EE8GG?E;D?GGCFFGFG)G6GGG(:GGEGG/A.G8@BAFE?E(*?GG;#EAGC?GE8G8)F@AG:E8E((=?E?A(::::GE6?*0*:(:?EEGE(C
@antibody_14_multiplicity_3_copy_2-1
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACATTCGGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTGGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTATATCTGCAAATGAACAGCCTGAGAGACGT
+
?55??BB3DDD5<D<DFGFGFG8+HCCIHFFDHHIEGHFCGCDHIF-@EHIHFIHI5IIHEDIHHI-5HFD-GGHEHHF5CEHHDFHECF1GH+EEIEFHHHHB*BFHHHH(DGGFH@H>FHG?HHEGCGCHEG4E+F=GE/GGFE?EFGG@GDEEBGAEFEE*EEDE;ECFF=ECFF'CFGFC82(E(A/FGEFC::GCG?8EEEH?CHF6ECEGEECE*EC(8:ACC?G?E0G:GGE?GADE(:CE)*
@antibody_14_multiplicity_3_copy_3-1
GGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATGCATTATTGGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCAGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGCACACGG
+
?9???BB-DDADD@DAE>FFGFHH;FI;CFI8HHHDFEDIHGHHHDHIEEH?H;HHGGHHIHHFFFHHHHHFCDIIGHHH-EIHFHGI-EHIIFDDHHHEHFHHHHH;EEHFHH92EF(EHGDG#F*GDH*GDFFGB;*FEG'<G6A2FAEEGGBGCBEF>EEEA4EEAE:GD:':?>?#EGECEG?G6GEAE2GG<ACEGEA?GCE6EH68EEE>CG:EGG*A*(<?AFG<C?E?F:CC4EEGC?:*:C
@antibody_15_multiplicity_1_copy_1-1
CCTCTGGATTCACCCTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGATAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAGCTCAGTGTATCTGGAAATGAACAGTCTGAGAGACGAGGACATGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTTT
+
?????BBBD?DDD?-DGGFGFGHAF;HHIIIICGHGF.IACH.IH7HFHE-=DHDHHH@HH9FHHHCII.I-H+IC5HHIIHIA=DHH*IFHIHFGGHFFHEFCFDFFHHEHFEHGFHDFGG=FDF4G1E?GGFG:GBEF?GEF@DBG0ECF=EAEGCC*GEGE2EFGGAE8>(GEC2=EFE:G(DC(GG/EAG?EE*CEC(EE*E6CEA'A(8@*EG.EE:<*/EEEE*:4-'G6C*E:CEEC#*EE'E
@antibody_16_multiplicity_15_copy_1-1
CTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGAGAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTCCGAGAGGATCAC
+
?<,??BB?BBDBBD@BFFFGFFBICICI5HAGIDIH7FIGHHH,GIF.CHIH6>HD'HD.HFGFHF+HHH-FFHFIHHIHFIHGIDHI-I-HFHIII)GHHHICDE6H+#GFH@HHEHHFGH#*E#HE(E,GH**AE6+E9FG)GGG=EGE@FEA:E;EEEEEEFEG*EGEGECGB<FEGE:*:GACCE#06EEF?1ECGCGE*?CCE:(?E8C'(FAC@?EC*:<AAGG:AEGC*A(EE(*A6CA:<GG
@antibody_16_multiplicity_15_copy_2-1
CGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAACCGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCTTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTCAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCGTTCACAGAGTCTGCGAAGTATCTCGTACTACTAC
+
?5?<?=BB?<DDDBD9FEGGGGHIIFIHH+GE?HGIIIF9I.HGEFHIHGIGDHE5I>HF@CHDI-BIIGIHHHDIIHHGEH#HEEHCFFHHHDHHDIF;FDHHH,HHHGC?BCHFFEGHGBFEEBHG;@GFEFECF?)EG@FGEDDGF'GE?CGFEECFG;?AGFEEGE*EGFE?/'=G(0?:C.G'F?EEEGGAECGE*G;GEG:GGCEGEG7***,GBFAGE>:?G6(G0:GG0-E*E?*:?8?A>A
@antibody_16_multiplicity_15_copy_3-1
GAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGACTCTGTGAAGGGCCGGTTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACATGGCTGTGTATTATTGTGCGAGAGGATCACAGCTGGGGATCTGTTTTATGATTG
+
,,==<BBBD-?DB<DDFFGFGCFFIBEH-IC/IFEI7IHHIIHCIBIGHHAHIGIIHAFHIHHIIIH+HGHHEFHCHHHFFIIEFID+-HH-EFIDFHD<AIHFFFHHHEDD@BGF4HF<FC?GG+H*G=:G5GDE8HD.CFDEGG(GFE*:G>GE@GE(GEG*C?EE<GEEEG(AG(?EE@FAEEGGB?GAGFC;'GF:G?F?;FE/G#EA>AGG(EEAGCFG:6.:/GC#8::C.(E')??=G88GG(
@antibody_16_multiplicity_15_copy_4-1
GAGGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAAGACACAGCCGTGTCCTCGTCTCTAAGGCTGTTCATTTGCAGATATAGTGAGTTCTTAGCATTGTCTCTGGAGCTGGTGAATCGGCCCTTCACAGAGTCTGCGATGTA
+
A,??=B>B<EDDBBB@GFCAFGFIEAHIHHIHHEIHIAH@A+IGFEHDHIFAHH-IHHIG-H8HI+FIAI-EIIHEDFH)DIAIHCIFHHIHFIFFIHE<HEFGE7HGFEGHDHGHHFCG?4EF+GH(E@8*EEEGEDD*GGG#FEGEG/?*;FE=EE?GGCG@GE0CGEDEC:E.ECEEEGEEE:G#F2GEDGG?;GE.C6EGA:H(EEC8D-G*=G,,('ECFAG*?C1FEGE//E/G:E*GF((/G/
@antibody_16_multiplicity_15_copy_5-1
TCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTGCAGGGAAGGGGCTGGAGTGGGTTTCTTACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGACTCGGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACAGTATCTGCAAATGAATAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGAT
+
??A?=?BBDD5?DDD@FFGFCGHHFHHII/HHHHGIIFHIEHIH9HHH>HIFHF/55HI-HHHEFA-FHH8H5+FAHDHI+HDH?FHCIHDHFIIH7I*HF<FG=HHH2FH5@;HDFFFECG*FGHDGGDDDEGGEEEEF'CF<EEEGHG@?FAGB;0**CDCG6:AEFG?F.GGECCCCAEE(GCA.EC6GGDFGE.ECGG6#G/C?CHFGDCGCG:ECEECC:;CGA6?;/D;*EGA:E:/;E*GE>?
@antibody_16_multiplicity_15_copy_6-1
ATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCAATGTATCTGCAAATGATCAGCCTGAGATACGAGGAAACGGCTGTGTATTACTATGCGAGAGGATCACAGCTGGGGATCCGTATTATGTTTACGTTTGGGGGAGTTATCGT
+
?????B??D5D@DDDDF-GFEFFF-H;HF-HDFIIIHDDGEIHIHGH8GFHHII@,GCHIDE=HD8HHEHCHHIFFE-GHF-HFIHFGIBFAFGHHHEFH+HFHFH.HHGGEG3HFH:HGDEHGHFEEGGAGEFEGEEFD.;FF@E:#E8FGEEEA#GFGFGE0E6##FECGG*C(DE(GFFF86<D626GG*EGEFGECEG:A*ECC:CCG8:/ADEEEGDCG6CC'A*A**EA0=GECA6CECE**<E
@antibody_16_multiplicity_15_copy_7-1
GGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTTGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCACATGAACAGCCTGAGAGACGAGGACAGGGCTGTCTATTACTGTGCGAGAG
+
??A?AB@B?DDDE55<G-GFEGHHF8CI.EDFCDIC=FHD/G-.G;AF=I.FIH9DHD5HHECHG@IHFGHGIHGFIHHIHIFGHGHFHH?E5E+HFH4HFHEDHHHFFFF+EHFHEDA6.DE;FEG+DGHFF?H=HFFE26EEG)BBBEECGGED?8EEGC:DE0EEF?#GCE?AEEEG(+8GGE;.GFEE*G0EGE:E#:C?EFE:??*?A:8<GCBE7,A;GE#G?4C=?(E/FA?.GAC:EECE6*
@antibody_16_multiplicity_15_copy_8-1
GAGGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATAAAGTGAGTTCCTGACATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTA
+
??9A,-B?6=D@BDDAFC+F>AHFBIHIHIFCIG7IHHAHIIHBGHFHHFCIGHDHHHHGHIHHFHFHFHFCH-FIHHHF@IEHHHFHFII=HHHCE=#HHEHAFD=IIHF=HHHFD=HG-HGHFE5HF4F?EEDGGEGGB@G)GFE@GEGGEEGG*GGEGEGCG6>FE*EG?CG?(CEGGCF?(E?*A8EAECFEE(A9*G.A;(E?C16?EGEEBGEF0?0GFGC?#GE*GEA.F*A::EEGC:A(:0
@antibody_16_multiplicity_15_copy_9-1
CGATAGCTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATATAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCATCACAGAGTCTGCGAAGTATATGGTACTACTACTACTACTAATGTATGAAACCCACTCCAGCCACTACCCTGGTGCCTGGCGGACCCAGTTCATGTTATA
+
<????-BBD5D-9D<DGGFG8GI/HEHIA?GFIE-BFIHCI9CIHEHF=IEAH9CFFHFGHHHH1HHFHEHGFHFI*IF=IHDHHGD=AHHIFFHGCFHHHEE3+H,+HF?G7FEHHFH+=FHFHFH=HGHF5BF9GF;E8C:@GE1E*+F;EEFE;FG/EFFEGCFG*GE::ECG1EE8E:A:G*G(FE0:?GG<6E8:CECE?GECC.E(@(;8*.:GE?*(9G:AACEG10CC**(C6ECCEGFE**
@antibody_16_multiplicity_15_copy_10-1
TAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTACCCCGAGTCTACGAAGTATATTGTAGTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTTCCTGG
+
??9,?B>BDD5BD=DD.EGG;FCHIFFFEH8/HC5?HEIFHIHH-D0/GI-HECECGHHHFHHIIIIH8HIIHFGHHHHAFHHH+*IHHHE,E=IAIHH/HGHFHE7GHHHEHF,HFID5FF;HG(*FGGGE@FG7HGFGGD9EG=?=;EBG*EEFEFC@C2GEFEFFECEBFEGEG-F(E'GECCAG0F/EGG1ECG?(;GA(D;CA?:AG::EEEGCGEEACCC0*AC.E>CEGF::1CE/E(EAEE(
@antibody_16_multiplicity_15_copy_11-1
CAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTTCGCAGGCTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAATTGAACAGCC
+
?,A=?B/BDBBD5DDBCGC.GF.AFIHIIFHHGHI-HIHADIHEFHHHEIHDGHFHHIHFEF.H-IHHICH-+EEFIIIAHHFEAH8HHH?I=CHB8FHIGFIGHDHGCHHIE,DFHEDE5EDBFHEFC4FGEED@G@GG,EGEE?GAE<FFEGG0G@F6C@GGG?.EEGDE?CGFEG(:/EGEEGFE)EECGE?EGA*?:DGDGG<CF?EG(EEE??3AGGGEA68:E:CGGA?E:E:*(((*ECE*(G
@antibody_16_multiplicity_15_copy_12-1
CATGACACACTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGCCTCTGGAGATGGTGAATAGGCCCTTCACAGAGTCTGCGAAGTATATGGTACTACTACTACTACTAATGTATGAGACCCACTCCAGCCCCTTCCCTGGAGCCT
+
A?==ABB?<-BDD?D@FGAGGFIHFCICIHIIHC9HIHI-H.IGAHHHFHHFEGHHHHHHGIH+IHHICFIIFIEHHIEIHIEIFBH+IGHFECFDHIAID5HHH-CFIFFHEHGGHDGHGE?HFFBDEECGE+ED4EG.(BGC*EG#FFGDHGCEEEGGG-FD6(G>EEAEG*GGCGG/EFEEFG.;CG:C'GG0GEAC:E/0F**:((?EFG7CE;F78(E:GC?G0F??CCC:CECCEG1AE?*AEG
@antibody_16_multiplicity_15_copy_13-1
TTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGATACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTACTCGTCTCTCAGGCGGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTATATGGTACTACTACTACTACTAA
+
???A?BBBDDDDDDDEF>FG8/H6ICCIFHHHAFHHI;EH)#EIIIIF7EF@F9CDDF8H@HCEIH#HHEFHEHHDHHHHI,ID?-GFFHIHCBH8IHHH:CGFHCHGHDDHD4HF<EHFHH5:HHAGGHEG?(@*@GE).GFDGFGH)EEGCE/@EA/@AE/EEAEG0.G:GEEF;AF>G?;:G?ECEEFG:GCG1GE;(ECG9(EC?AE:EGCE<(0GEGGGE;EG:A6:*E8:EGE*<A:*AGEFG(
@antibody_16_multiplicity_15_copy_14-1
GCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCTTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAATAGTAGTAGTAGTACCATATACTTCGCAGACTCTGTGAAGGGCCGATTCATCATCTCCAGAGACAATGACAAGAACTCACTGTATCTGCAAAAGAACAGC
+
,?A?A?>BBBBBD@DDGCG>DFIIFHEIHHHHFHIDI.H/FIGF;F+HHIIHFHHHEHHIGFHHIF(HFHHHHD@HHAF=5EIH+GFEE>DHHHHG?HDHD+FHDGFHHHHHCHDDEGFGGGECF*GFFH?GHEFB*40F(*EAGFE@B(G'GC?@CGGGG*GGEE6EE<AE?FG:CCCECAE8EGC(GAGGCGE(AGE(*GEAEEE-((FA@CE(B*(@B(2GGGG:EC:GC'98CG?CG0*6EE8/F:
@antibody_16_multiplicity_15_copy_15-1
GCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATCGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACACCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGCCGGCGAAGTATAGGGTACTACTACTACTACGAATGT
+
?<5?,BBBDBD<DDDDGFGG./HHHHHEEECHHEHHC7CIF95,IGHH/HH8H8HFHDHIHHH(ICGAEH5HHAHHHFFH)IHH-H'HHHHFFEFFGHGHFHF<H+HFF;4F3H8<E9H@GFF+GHEAFGH.ED?=DGEG(FB2ED?GE**;EE>?DEE*ED6GFA0/<EG>?:AGEEE(EF:/?CAE(GFE<GC(:E/C:(EC:*>FEHG:E(B(BFECEC(GAA#E(*/:/GE?G*0C*(GG*:GA*E
@antibody_17_multiplicity_1_copy_1-1
CTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTAGCTATAGCATGAATTGGGTCCGCCAAGCTCCAGGGAAGGCGCTGGAGTGGGTTTCATACATTACTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTTCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGA
+
<?=??BBAED?@95DDGFGGCGHIHHIIHHIIDDHHHD9HIEHIEHHADG>FCIDHH5HFHHCIHHHFIHIHIHHAFGEHIF3CEFIIFGC.-FIH5FAI63HIHH8C+FH#HH@4D3HGF?GFFFEF.FF;FE3EG=EGEEGED:EF?ECGE*C:FGGFCCG#GGCF:GEGCE:GGED'1GGFG6GEGF<?.6?G6FE?E:/6G?(E(CE/:CG.EGEEDGGE*;C:*/EF?E(:.)G.CC:F*4(E*D
@antibody_18_multiplicity_2_copy_1-1
GGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTACTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACGCCCCCAAACGTAACCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCCTGTTCATTTGCAGATACAGTGACTCCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGAGTA
+
A?<??BBBDDBDE@DDFF>FGFBIHHHFIF9IICHEHH=GEFCDHICIGEECHFIFIHHI=HHIIFAHIDABHFF>EHIHIDIHHI-HHHHHHDHGHHCG)FHHH.HIHHHGHHBGGCDDHH,F#G(FEA0EFG4CGGAEEH(EF>8AEEEE?EG?BGGG;GBGED*D=AGF?G;G/A;EGGG(AG;FG*E/GGGE?G(E:G?EGECGGECECCEGC(E@*8C**AEA?E(EE=6CGECFC*C*C:(*:E
@antibody_18_multiplicity_2_copy_2-1
CTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATCCCAAGGAGCCACTGTATCTGCAAATGAACAGGCTGAGAGACGAGGTCACGGCTGTGTATTTCTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATG
+
??5??>?B@BDD<DBDFF/G/GICCAHCHAHFHI/7IFICHE5H@FAH+CG2BFEFFIHD+EGG=HH8IFDFHE@HHEFHGIHHD.5HIHIIIFF5IIAHFFD.HFHFHD?A=HHEHH,HFHHFEDFECG?F@EGGGEDEGEFGEECEECC*C:EGE?6F'AC;F06EEE.E(GCDAFGG/:GCAC:GEAEEEGGA((GEE*:EGE*6AH'C/G(C;:>'EGE:GEEGEEE8EGGCCGFGGFA(EAC(EG
@antibody_19_multiplicity_2_copy_1-1
GAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTAAATGGCACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCGCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCCTACTTTAT
+
<<,?ABBADDED5BDDFGGFAGFHI+CIHHHHHIGHHEIC?IHAFD:ICIHEIIIHI>HFHFIFCFIHHIIHIFIBHI;HIH>IH-HFAEHHHH?H?/GHIEGHHFIEE4@DHD?EDHHF0FDGBEFEE#6EDF@*H=DCBEE(GGC2E.EEEGCG<G8EG?*;G?<GDE0F0FFGE+((6EEFC(EEGE<GG?(FE:E(GEFGCCHGEHGECECGE(CEEGCE/C?EE(EEECC/)C*CA*<(EG#AGC
@antibody_19_multiplicity_2_copy_2-1
AGCATGAACTGGGTCCGCCAGGATCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTGAAGGGCCGATTCACCATATCCAGAGACAATGACAAGAACTCACTGTATCTGCAAATGAACAGCCTGATAGACGAGTACACGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGCAGTTATCGTTA
+
??9?=B?BDD-@<DDBGGGGF?I+IFHIIIEEFFHHHI.FE7HFIBHHAHHGHFGGH8EHIHIEIFHHAHIFIHHHHHFI5IEHFHE8IHHH?H7+HHH+HHFFBC@HHGHHF#FHHHHGEGFF=FF(EA**GEE,FFGD?F=GFGEEEE3G?EEC<GCE;DF,G:6EG*G(F0G@GCFCGG@9CFEEFG?GAG(<16G':F(GGG;E:(0:HCB?:((((?'?<(EC6CCC:CA1?E#EE.GEE;)G?*
@antibody_20_multiplicity_8_copy_1-1
CGTAGTAGTGGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGAGCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCGGGCGGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTAGTACTACTACGAATGTATGAAACACACTCCAGC
+
5????BBBD-BDDEDDGFEAFFHH8EHFIIH>DIIHGHGEHH79HGIHI@HFHFAHHHAHHHHIHHF-AHDHGEHCHHHHHHCG(FEH:GFH37HHH;HHHIHFDEG*IEHHHHCHDFGEHH@)*HGG(DFGB9BEEGEE;B;5@D*EGFGGE2GE(EC(GGG0*:EEG0G6C4?EEA8C'.>E81<:EE<EE8EEA:0?A.CF:FAF*E6*ECEGE(/;EAG8ECG(E(?.*GG?E;/E#=GEGECAEE
@antibody_20_multiplicity_8_copy_2-1
GACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCCGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTACTACTAATGTATGAAA
+
???=?BBBBDD<@BDBFGAFFG/HC6I?/IIHGFI+EIHHEFHGH>HAHHHFGHIHHHHIHHH<+H=EFHHH@FIHGHIEGHH+FHHDFG=4DHBDEDGH3DACH@H>HHFEE=EHH,H3F-=GGDH,FEFFGGGEHGEGEH;G6EEGEEG5E*GCCGCGC*E/GCEG5*EE(GC6AG#GCG*GGG<AGE?0FG:E?FCCG/(GGC(??(;FH@EG;(<,EE:ACC)G9C:*E;GEEG(/(:GGEEG(E6
@antibody_20_multiplicity_8_copy_3-1
ATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTATATGGTACTACTAATACTACTAATGTATGAAACCCACTCCAGACCCTTCCCTGGCGCCTGGCGGACCCAGTACATGC
+
?=??AAB-D?DE5BDDC>GFFFFFFCFFCHFHII>IF+IEAIDCCH9FIHIFDFHHGAIHIEFIEGIHGHIHH5HIIICHH?-IGHHIIGHIH-H+GHHIFGG+HEHFC-.HA;HGHDGHGDHFEFFGB=GFFDF@FEEGEFFGGEEFG,EEDCGGGEE<ECGAFEEC(/<EFGCECG:4GGE=1E(0*EAF(8(FEE0EEA?A?FHEE/GCHCF**G80CEGCEG:ACA6/FCC/;CGGEE?C86E:*G
@antibody_20_multiplicity_8_copy_4-1
CCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTGATCATAATACGGATCCCCAGCTGTGATCATCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTACTACTAATGTATG
+
??,A,=><6@DDDD9DFCGFFGEIHHHE.CAHICHIFH-GIHIEHIIA?HHHGHHCHEGHGH=FHHD=CDG#IFDFE5HFHC)C,HFHIICFHEHEHIF3BH33DEFGF3H4DHDDFHHEG3G=EEECDGDEGEEIF*E22E=DCEFG=E;GEGG(@E@EAE))GE(EEEGFGG*>CF*E?;DG/C'CG?G:G(;GE?D:G<GF:()EF/?*@G*C<*G:?GC:GE*C)EEGGEE0EEGCG6E:*EF?GE
@antibody_20_multiplicity_8_copy_5-1
GAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGGTGTGCATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTGTGGGGGAGTTATCGTTATATTAACCAATGTGTCATGTACTACTCCTACTACGGTAT
+
?????BBBDBDEBDDDGFF>GCI8EIHHHHFIDHHHHHHAI7@CGHIEDEF7HE@HDHGHBIHFHD=CHHFHHGHCDHGG.IHHCHGGFICHHHIE)+HHHHFFECHGH@/',GGCE,GHHHDGGB*GBFEHEGEG+*C#>D(A(FECF;1F*DCFEDCGGGGCF;6G>EGDGGEGC8;/A?FCF0/AEE:DA(G*:(GCCEG?CE8GFA(0EFDCGEGC4,#C*GE<GCF?0EEE?'C0?C;0?GE:CC
@antibody_20_multiplicity_8_copy_6-1
GGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCGAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTTGTCTCTCAGGCTGTTCATTTGCAGGTACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGACGTATATGGTACTACTACTACTACTAATG
+
=???A??BDDBDDD-5FFF=,FHHFIFI5EHFIFIIHEF=IHIFGIFIHI-HEGCHFGHGHDHHHHFC+HEIFCCHCHHHHHFIEHHH?CDIG+FIHHCHFFHHHHGHFEHI9,HEGF=HGEG:E49@GDHCGF)EEEAGGGG'GGEEBEDGG*2B8?E'EE@?1AFEGGEGGEGG?:CEFGEEGEG#GC'CG?F(ECECA:;:E*((:AE(7:E(GE(G()?G?1(GEEA(GE:CF:E*E:-GCE(A?*
@antibody_20_multiplicity_8_copy_7-1
GAGGCTTGGTACAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGGCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGC
+
AA?=?BBB+-DDDDDECCEFFFHIHIFHCIHDIGFHIFGIFIHIH5HIE9EIHHHEH-HHIH+HIFFIHHI,HHIFHHDIHHHGEHHIHHHFBH@A?G<HD(HHGHD6EFI))HFEDDDHH*C(GE?HGCG,CFHGB<GEFGEFF*#GAAG6AG8/CB(;EG?GC<EECE:*CFF*GF#*(F:?F?C.EC?::E.EGF:8?C;E8(F(FF*FE;*<ECB;GEC0:EE*A(;EACCEE:E?.F0E-:*EEA
@antibody_20_multiplicity_8_copy_8-1
ATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGCGCCTGGAGGACCCAGTTCATGCTATATCTACTGAAGGTGAATCCAG
+
?,,5?B?5DDB-DBBD?FFFGFEHICHIAHGHHGHEIIFHHHHII.HIFBHCHIIF8HCDCHHIIC=I-FHH+FHIFCIHFGIIFIEHGHHH8FH8HHIH)HC+IHHFHHCED@DG(F@F#H65DF@HB>EBGGBGE;=EGEF=EGGEE)(EG4E?FG0GGE:FADEGEF;E,GFEGE;CE;GEACG*:G(6E:GGEAE<*GG6FEHE0**F<G@EB/FE(GGC)E?E/((:FGAC?::C?=?E:E?E'0
@antibody_21_multiplicity_16_copy_1-1
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGACTGGGGGGTACCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTGAGTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAATGAGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGCACGCAGACTCTGTGAAGGGCCGATTCACCATCTGCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAG
+
<?,??BB<DD?<AD?BG-FCGCFHFIII(I@DHCGEIIFIHHIHI..I5G?IHFH=CHICF=F+DIEDHH+DAI+@I-;-HC+EHHFIEF-HGGHHDIIIHICHHDHHDHHH;H=HGFFHHGFE1@,E4HDFHEDGG5F(*FG:EHG@EE;D4FF;GGE'GGEFCGE0.@62G'?E':GEEGGGEEGECEE:A<GF:EG?G(CG(FA(G6DE1CBG.ACCG.F=?F*E?'(6(A*(8?*0EEFF*8E6E8
@antibody_21_multiplicity_16_copy_2-1
TTCACCTTCAGTAGCTATAGCATGAACTGGGTCCACCAGGCGCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTGAAGGGCCGATTCACCATCACCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTATTGTGCGAGAGGATCACAGCTGGGGATCCGAATTATGATTACGT
+
?A?A?=BBB<BDDB5<>/CGFFEEHIEHFH/AHG/IHHHIHHHF/HFAHHIFI=HGIIDFHEGEHGCEIHEHFIIGHEHEIGHIHEFHCHIHIE-HHDIHIBFF3DHHGFHFIGEGHH..EHHDBHH);GG1(=E0EDFHGFEGAGE8EE=GD*8EG,E,GD8GEE'(GF'GCEEE<.GFEGEG(FEGG6(FE8E8GE9FA:EGE<CGA9EG8;G9)C7GE8E:A:C:'E)?GE6E'EC<G::.C:>EEC
@antibody_21_multiplicity_16_copy_3-1
AGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGGCACGGCTGTTTATTCTTG
+
??????/-D9,D@DBDFCGGFFHIHCFIIIGHHFFFHFGIGGHHHICA/9HHGFHIHIIFIEIGHDICHDBIHHHGHHHHIFEFHIFFIDIHHHDA*3FHEGHIB@FHH,EHFG?DFFGEHF1DEDEEEGHFDFFEF1@F;EDF;EGE*EGG?*8ECE#FEGCGE(@;6EG@.:G?FGGGEGEEGF?<A?GG??EGAG(EAGGC*FFFEEE.C7GCG0E;CE*F*EEACE(#CGACE8?:G(?A1:(/?E
@antibody_21_multiplicity_16_copy_4-1
CTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCGCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGACTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATATGGTACTACTACTACTACTA
+
,????B>BED+DDDD-G>F.CG0HIF-HHHHHBIFHGHFGGFFIFBI,DH.FG9AFFAIIHHFIGHFIEHEH3HHFIFF5)FHGHHIIIIIHGEFI0HHFF@+GHHHH)DH*HDFCHE@HD*DGDGGEEFGGGGDED=8DEGD63GC(AEGEE,BGG(?=EG,@FCG*EGC(GG8GEEGG'EEEFGAEGEFCEGF?;ECGCGG<E.8;E/:EHE0EEC1A2GGFFE0*6E(EAG(**8?E?E:6?AG()*
@antibody_21_multiplicity_16_copy_5-1
TCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTTTGTGAAGGGCCGATTCAACATCTCCAGAGACAATGCTAAGAACTCACTGTTTCTGTAAATGAACAGCCAGGGAGACGAGAACACGGCTGTGTATTATTGTGCGAGAGGAT
+
A5?<?B=BBBDD?DEDGCAGGFHHIIHFHFDHHIHFIHAAAIHEGH-FIBFHH0FHH+IEFBHI>FEI?F5DDHGHGH?FHG(HHF@FF8HHDGHFH-EIFFCHBHFHDFHH*HFGEGHGGGFH<EDHEFHG*5E@GGG*EGGEGE(9+GGGFEFGG(G9FFGFGEGECGEGEE;C*<E0;CGGGEEEEEG?8G(#?GEEE:E?GFFG(?(:HG0ECG?1?7CE(CE<A6*6?EC:??0?E6EC0G:EEE
@antibody_21_multiplicity_16_copy_6-1
GAGCAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAATAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCTCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTA
+
?,?,<7?=BBBDBDDDEF?GFCIIHHICFIEIIHIIH@A+HHGI+BHEGHC.H+HGFHHHHIHFGHF>HH?C4H/5HHFECHEIH@H+IAIG.HIHAEHHHH,HE:I5HEEHHHHFHEFGFD8FHH6HCGG6EG)GH#GFCAE>GEEFG+DCCEG;E*:FG'G?GG,GGGE:<.C8E(GA+?FCGEE;EG'CGGFEEGEEG*F(628E6-*:AFE7C?C1.CEG<?E(80E):?*AC:1E?:*G-E*C.C
@antibody_21_multiplicity_16_copy_7-1
CCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCTAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTAAGGCTGTTCATTTGCAGCTACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATATGGTACTAGTACTACTACTAATGTA
+
?A?=ABBBBDBDDD@DFCFFFGIHHIFABHFHHIHHFGGHFHEHHFH+HDHAIGHHF@HHH+5FIHID>FIF+CCHHIHD?=F:H@H-EFH.FHFCFFFHHEIHGBC@+HF@HHDFHHF@C:CFHGGD*BGGFGE2)FA,DF@?EEFCE4EF?G?,D(CE?=8G*EG/688EGCF<GCE?E.GFG8G<:6ECCG?CA:EEAF*:0GC)6(?E0@B(C8:F?(:FGD::FGG6E#AEEGG((8E/C.00:A
@antibody_21_multiplicity_16_copy_8-1
ATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGAAACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGAGAATCGGCCCTTCACAGAGTCTGCGTGCTATATGGTACTACTACTACTACTAATGTATGAAACCCACTC
+
?,???BB?BD@DBDDDFFFFG./ACIFFHHAGHHHDAHGG,HIFDGAHIHIHIIH.IDFFIHHHCGHEIDHIIGF-IGHIEGHBGFDFHHHHCHCF+IHIDFI,HD;HHHH5CDDGGF(E8HHDD6FE0DDDFBDEEEDC;*DDCF(G3*C?G?E5C8EDEGF6**EEE(GE.?(CG+C(/F;GGF(?GEFA?CEAE8G(:GE?/FF(G0*GH<GG*G/#CG?F?G0G*.G<'EE*AA/;C6:AC8;D0C
@antibody_21_multiplicity_16_copy_9-1
TAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTACTATATGGTACTACTACTACTACTAATGTATGGAACCCACTCCAGCCCCTTCCCTGGCGCCTGGCGGACCCTGTTCATGCTATAGCTACTGAAGGGGAATCC
+
?A???BBBBB@DDDABGF9FE8FH+FHHHEIDCFHIIHHCIHHHFHA=DDHGE=-EGFIEHIGICCH-IFCI5HHFHHGIIDFDFFHIIHBHFHHHHEHHHHFHH.@EHHBHHG+D(F?H2DFFH+;GEGE*GGGEGGFGFGEEEEGE4GE<AGF?HGGCECCC?;G:8EGGCC?GG+B.(G??F#EFGE-CGDG8EEAG*?ECFG?E(EG*C/B:/GG#C,CAD<E:G*1)?GC0EGGFCEG*':;.::
@antibody_21_multiplicity_16_copy_10-1
GACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAAAACACAGCCGTGTCCTCGTCTGTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAACCGGCCCTTCACAGAGTCTGCGCACTAGATGG
+
=????B@@BBB+DDBDCFBGGFIEIH?HIADAIIIHHEIIHAIFHAAIHEHHHFHHIICH-FIIFIG-3EIHFII*IAIHFFEDH=IH+6G-GF)HDGHEHHI=HH>H7IFGEHH>HGHHGDH@GH+HEHA2G=@E4D+>CEGF=EG(;FGGGF0FE8E#*G/G'A:0E>A'F*FGEEGF;FE8EFG2GE6GA;F?EGC:8F:GGGHCCE8FCGG(EG1C??CEE:*0:DAA?E?:E4E4#G(AF(AAGE
@antibody_21_multiplicity_16_copy_11-1
TCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACAATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTAGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATATGGTACTACTACTACTA
+
?A,?<B/<BD@D-B9@FGGGFFHEII?IFI9II9FIIF/D9EH=HHD;HII5FGEFFFEICFH'GIIEEIHFCAFHIHIHHHH9EIHHFIHHDDHHCGIGFFHHHDFFHE(G;GHEFC6H,GEDHHH,EHFGEDFIF)EEDE;E0GGE-GE8EGDEGCEAA*;FCGE(G3E6EGEEED@FCGGGF;CEEGGG(.ECG;CEA)G(GAECG(3;H(:E:E8GE/GE:A0/EEF/EE0C*G('G0:E6C>C:C
@antibody_21_multiplicity_16_copy_12-1
GTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAAGGGGCTGGAGTTGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTATTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGACT
+
?????BBBDD@D-DDDFCGC-CBHCHFHIIHHH7II-FHGIHIIFIHI-H@.HEHII+HHIFDFF.@FFHIDEH@HHIHHFHHCIF=IGHHE=HHHHHIDFHFHHHEDFHHHFH7F6BEFHHH-FEFE@FFFE5BIFEB;D?/GG<DGDFECEBD6FGEGE:EG?GGGA:8FC=E?CG<GEF6:(EAGEGF**>'?*G?C*C0CEFF1E(GAF/EGE'E:G??GE?:E:E4?.<GG*E*GE*:A1G:G#(
@antibody_21_multiplicity_16_copy_13-1
TAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAAAACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATATGGTACTACTACTACTTCTAATGTATGAAACCCACTCTAGCCCCTTCCCTGGCGCCTGGCGGACCCAGTTCATGCTATAGCTACTGAAGGTGAATCC
+
<,?=?BB?B-<@BDD->GCCFFHICFC6HFFHFIIIIDCEEEGH/CHA@IFGCIFFCHGHIHEFH=DHEFIHHF>HHHIHHDBH8HCEDHICFDHCFHHHCHBH,EHG*FCGHFEH*F/D@(FFC(GFGFAHDEGEFEGFG;BEEFCE;DGCECGECG?7CE1FGG/EC(;<:EGF60AAE:EGEEEGCG)G?6E0/EECEGEGACEEE(G69E.F:EEEEECGG(**EEC=E:9*GGDAGCE0*F(;CE
@antibody_21_multiplicity_16_copy_14-1
ATAGCATGAACTGGGTCCGCCAGGCGCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTAAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTATTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGT
+
?AA??BBBDD<@D+ADGFG?FF;IHGCIIFFFGFHHB.HIHHAFHFBFHIHEEH-I/DH-HAF?GIHH(FHH-HIH=ACH+H5EF?EFF-G6CHCHH#FHFIFFHEAHFEGF1HHFH2HA:DDD,E)GEEFGDGC#AEGFGE@G2(BG022>DCEEGE?AGG8=FD=GG(FECGEEGGD(GE<<GGFG?#/<G<CEEEEEF:::2EF-C:0AFAEE8ADDBEG:G>FE*?:GDC*E:GGF/*8'A(EE?:
@antibody_21_multiplicity_16_copy_15-1
GGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCGCCAGTGAAGGGGCTGGAGTTGGTTTCATACATTAGTAGTAGTAGTAGTACCATATAGTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCGTGAGAGACGAGGACACGGCTGTGTACTATTGTGCGAGAGG
+
?????B<BD-DDDDDDGGGGGCIIHHI8IC=HIFIE9III+IHHFGEEGA7FFIDIHA.GFA.DHIGHIGHIFDGHHH*DI5HEIIEH-FIFG-HII=HIH?HIFEH?;HF+H#EHHGDHHCDEDHED)H@F**FEEAEEGGEGGGEGEFFCGGF?G(EGGFEGG,C6AGE?G6(GGEEC:CF4ACC=CG8AEE?CFEE/E9AE?CC?G.E0CC>GGE7@E?E?**FGF?(CEA*(GC<GE.(6C<.C*:
@antibody_21_multiplicity_16_copy_16-1
GTAGTACATGATACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGGTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATATGGTACTACTACTACTACTAATGTATGAAACACACTCCAGCCCCTTCCCTG
+
????AB?BD-B+DDBDFAFF.F.IAHAEH6I/HFFHEHAIHHIHFFDIGIDGBEFEHGHGHHGEIIIAG-A?HAHIGIH'H+HIEIE+HIG=FIFEHEFEFHFHH@HD:GDHGHHHH>HDHEEEEGG@,;FEGHDE;1GAF*;@G(1E;GG;C;EFG?G'CED6EFEEGCGEE(F?(GG:GFB6GGGG8GGE>=FF(A?GG8A<:.E:GCCF7GG.GGG(EGE(.?E/E*(E:?GCCCGA(:8686;**;
@antibody_22_multiplicity_7_copy_1-1
ATGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTTGATTCACCTTCAGTAGCTATAGCATGAACTGGGACCGCGAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTCCCATATACTACGCAGACTCTGTGAAGGGCCGGTTCACCATCTCCAGAGACAATGCCAAGAAATCACTGTATCTGCAAAGGAACAGCCTGGTAGACGAAGA
+
,?5?5BB?@DDDD-BDFFCGGFIFHIICH.HHHI7HHH,IIIFIIHHF5IDHFA9I.57H>HFHHGG>IGIIFEIEIHH-HIHI8IH@IHI8HDH=HEDHH=HDFGGF=DFH@DFD=DE;,CBFF+GBEHH@2FEE6GG@=CGDEEFFF(GFA*CG1-GE*GF4E.EE)EG=GFED6<:G?(EE.G?:G?EG:A.ECF?D<8F4GAE*EHGGHACG:E78*G6::;(E*?:?C*CCA0E*(C(G(AG:8*
@antibody_22_multiplicity_7_copy_2-1
GCTATAGCATGAACTGGGACCGCGAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAAATCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACAGATGGGGATCCGTATTATGATTACGTTTGGGGGAGATAT
+
,????B5BBBDDDDBDAACFEGIICII0HHHHIGFE/FIGHHEGFHIHHBIIAIHFIHFFCB-CHEGHHE-CIFHFIHIHHIGIHEFHIH;8I?EGFH=/*AD*FHFEFFHDDEB*GFGFDGFAHHGDFGEFHFFEE0G(EFBFHEGE'E8A;FE,E;C?GGGGCECGF:G8G=GGFEDF+E(;?E?GEF:EE0EGE*GC:GE*/CHG0AE:'EC>1G:GECE.E:*?;'GCGAE(GEG-(A?)/G>:EE
@antibody_22_multiplicity_7_copy_3-1
TCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATATCTCCCCCAAACGTAATCATAATACGGATCCCCAGCTCTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGATTTCTTGGCATTGTCTCTGGAGATAGTGAATCGGCCCTTCACAGAGTCAGCGTAGTATATGGTACTACTACTACTACTAATGTATGAAACCCA
+
5???<BBBDBDDD?DDFEGGF?FE)HHEFH9GHF-HIHGH-IFHI9HGFFGIFHCFFHHHFHAI=CG+IIHIH-HH>;EGFHFIHHF#F6HHHIHI8?II3HHHHFHHGHDHHHHEDDEGE.E?H*7,=,*AFH2CDG*GFBGEGFG@G2GA;AE8AE<EE?F@:GEEEEC<G:FGGE/GE#4F<EGE6/(GAF*EEE**?C?:E(/EC:C-:EGC8F.@G24;G:GCGGC:?GC.GEE?G1C0GAE*:G
@antibody_22_multiplicity_7_copy_4-1
CCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGACCGCGAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAAATCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATC
+
???,AA>?DDDDDDB9FGFFGGF>CFBIHHFGFDGFHHH@DFH+HI=?HGFGCIHFCHFIFHFHIH?GFHHH5AHI;HIHDFEFEIHHHAGIIHHHHHD-HHHHHEG+.FHDH?HC*FHGGBFF+DDF?EGGBEE=FG>GD**B?GE?@@GGEEDEGF:G6GFC?.EGGGFAGFE(E0>FB/EGE(AAEEAGC*:E4GE0E?CA(.AE:E<EFGCA#GFE?0CE8EA?C(C/>*C?0((?E:*A8CG8?E
@antibody_22_multiplicity_7_copy_5-1
GGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAATACATGACACATTGGTTAATATAACGATATCTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGGTCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTGATTTGCAGATACAGTGATTTCTTGGCATTGGCTCTGGAGATGGTGAATCGGCCCTTTACAGAGTCTGCGTAGTATA
+
<?<???<BDDBD-DDAGCFFGGEBIIHHCFCFFFIIH@IFICIIHH@GIH/IGE.FDGIGI5ICFI=IIIDI-CHHIIAIFCHIGIFHFCCED+HHHHGHGHHHHFDHEFHHGHH.FIHH@HCE(G+HEFGHCDE@GF6*2HGFFEG;EE/EEB.E,6DEF/CGDG8:E?;E?#AGD.-GE8E1DEEEF.(C8CCE;EGGG(D0(G*CG1AE@'FGECBAECGEG;?1G8(F:C#:A)F?68*C8GAG;G
@antibody_22_multiplicity_7_copy_6-1
CTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGACCGCGAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCCGATTCTGTGAAGGGCCGATTCACCATCTCCAGACACAATGCCAAGAAATCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGA
+
=?<??BBBD5<DDB5DGAFFFC+IIHH.HHIICIHHHHHHHHICIIHH?>7HE7HEH-FFHDCHDIFIHIFCHFFHE4EFBF?GGHHCH?HEFH5HHGGCFIF+DHHGHHI)D=FHHDHFEFHGCHDHEG:GGEGIDEE:DE;FFFEEGC.CGG11GE(B?:8#F##(DE:G0ADG(GAG;C?*AC:<G;E.CF./F.08E?(GECEE?HEE@GEE?G(80E?E?AE.DG;:6<*GFED0E:E)8AEE?E
@antibody_22_multiplicity_7_copy_7-1
AGTACATGACACATTGGTTAATATAACGATATCTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCACTTAGGCTGTTCATTTGCAGATACAGTGATTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACATAGTCTACGTAGTGTATGGTACTACTACTACTACTAATGTAAGAACCCCACTCCAGCCCCTTCCCTGGT
+
?<??,?B3DEDDDD@DFGCFGFEHHIA8HH9IHIIHBHHIHHHH,ICGIFIHH?FE=HFIAGIIFHHGEEEIH5FH+HEI+AHIECCFHHDI+/HFHEHIH=HECF?C'F;*GHHH)+DHGFGGFEHBGG@BH9F9EGDE;EEGBDEBEG/*CGFG;F8GEC6CEFEGEGEEBGCEA(GGG(G<GE8'8?GEE(*6FE0:EEGGE?EG?DE;EEEA.FB<.>(F?*(.E/?;E::=EG:(?*:)EGAGE#
@antibody_23_multiplicity_1_copy_1-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGTCTGGCGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGCGCAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAAGGAAC
+
??,??BBBBDD@DD-BFFFGFGIIFFII/EHIAHHHHE9,HHDCCDHHHAGD9G@FHIFHAIHEHFIEH-EEHHGIH+HFB+HEGHHEHI7HIH=H;6HH=BHHHFHFFEHGEFHHDF5HF?HEHH++*HG;4F#G)G@E22)EEGAGCCGGEFAEFBEF?>GCGG6GECAFEA8-:CGEGGC?EEG?(?#?EGEAEG<?6E.EG;F2EFECE7G:GEEGGE8CAGG0E1CGFECEG<GE.E1EG**FEE
@antibody_24_multiplicity_1_copy_1-1
CCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGATAATATAACGATAAGTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGCCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTGCACAGAGTCTGCGTATTATATGGTACTATTACTACTACTAATGTAT
+
<???=B,>6DDDDDD@GFGGC-C8H.IHHEHI0IHDGHGHHAIB'HFHADHEDIFHIDHGGAEH5IHGGAIIEI?EGG<HHHIIHFHHHF<=HFHHDF=HH8HH*H?GDD?I*;HHFHD3;E@GGHD*BEGGEEFE;G*E*=E*BDGG3*G?E(G?G;?2EGG0CEEEBEGCGCC1G:GG=F/EF(GE::FG:EGE:E.E:*G*CA8;E*6GH<EE?D9CF'?(E;CGGEC.FA4:G?CCCF?=.)(AC6
@antibody_25_multiplicity_13_copy_1-1
ACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACAATGGTTAATATAACGATAACTCCCCCAAACGTAATCATTATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGCGAGTTCTTGGCATTGTCTCTGGAGATGGTGAAACGGCCCTTCACAGAGTCTGCGTAGTCGATGGT
+
?<A?ABB7-BDDBBBDGGCF0FI>HH+H8FIHHIGHHIHHFHFHHHFHFHIF:HGHDGGFIG'FFFH?FFIHHDFHII?DGIHHHAF6HHFHEFHHHHHE#H5HHFFHDG(HFGEEHGEFFHHGBGE.EBEEGEBGGFE<=EGFAB))HEEE?DAE:FEEGG,GAAF;G?C8GAG6EG8E?E6E(C(88EG6CG(F:FG:(AAGE:*?0:(CH7(GE(/GEG'(G(E.FE<G.EGG(G8.6:D/AE**E8
@antibody_25_multiplicity_13_copy_2-1
GCCCCAGACGTCCATACCGTAGTAGCAGTAGTACATGACACATTGGTTAATATAACGATAACGCCCCCAAAGGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTACATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAGGTGGTTCTACTACTACTATAATGTA
+
?A=??BBBBD-DB?BDGGCGGFHIF+HIHFG-FHFHEIBHHC9.EFICC@I8HG-IGHI+*E-FIFIAE-H-CH5G>-HEAHFHCFHH6HH7IHFI=E.FEHFGGF*HGHHHEEFFHDCHHHHHGDGGFG@GFFE32EFF8FBEGGHF(?EG:EGGFFFAEG;/EE;E(G=:EEEE?E??GG<(:0GGGE<?ECC**EE/EG?/CGEFEH*CF@C(CC':.:DEE(EGEC'0A::':(EG(F?E0(FEAG
@antibody_25_multiplicity_13_copy_3-1
CCTGAGACTCTCCTGTGCAGCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCGAGGGAAGGGGCTGGAGTGGGTTTCATACATTATAGTAGTACTAGTACCATCTACTACGCAGACTCTGTGAAGGGGCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACGCGCCAGTGTATTACTGTGCGAGAGGATCAGA
+
?????BBB-BD@BB5DGE8GGF/HHI;HHHHII+HEHDHHHAHHGHHF0HEHFFFICFHH7EH-E-EHDIEH-+HHHEII5DHGHIHHFDHHG-HH8HHEHH9HHHEHHDF'F@F,?HHF@E/GEFEFEHG;GHGFF@DEEGEG((';#GG;>GGEE@1G?GG*GGFE6*GEGEEGEE/ECGFEEE?/GCG*AG1:GGE(GEEG::HFGH?=F*'CE:ECEEE)DF:CE(CEE1CGA?E::*E/0EEG':
@antibody_25_multiplicity_13_copy_4-1
GAGACTCTCCTGTGCAGCTCTGGATTCACCTTCAGTAGCTATTGCATGAACTGGGTCCGCCAGGCTCGAGGGACGGGGCTGGAGTGGGTTTCATACATTATAGTAGTAGTAGTACCATCTACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGTACGCGCCTGTGTATTACTGTGCGAGAGGATCACAGCT
+
?A???/B><BD@<DD-GF;FFFEFEIFFIBIF@HHHHHIIIE(9HH=HIB.EGDHH.I=I?IFDH5IEHH-HI-IHHICH@DIHHHGHHHHHGIH+IHEHGEHFFF4+FDHGFGCH=GFGB-DGH=GHHHGEDCGFFGG38EFFHGE9E3GF;/D6?.*6*GEB*A(F:FGA6EG6AE?GE.EG6(GC,(E0G*CGADEE;CGC'GE?CH:/'GG7GGE((4/G:EEE0;:AF:GF0A2E?AF?<FC:E8
@antibody_25_multiplicity_13_copy_5-1
GGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCTTTCACAGAGTCTGCGTAGTAGATGGTACTACTACTACTATAATGTATGAAACCCACTCCAGCCCCTTCCCTCGAGCCTGGCGGACCCAGTTCATGCTATAGCGACTGAAGGTGAATCCAGAGCTGCACTGG
+
??=?,BBB?-B+D<-DGFFFEGIBIFHH-A7HHEIHHIBIIHIFHI5GCFIGAHH-AEGCFHHIHHHGFHEDC@HHIHECIDH=8E@DHHF+B@IIHGF/BHEFHH@HFF+EHHFHHG+FBFFEFFDD(GD>EFEDEF:G;=<GGFFG?GCE=GGGC./CGEEA*/EEGGAGGEGG0EEA?GFEGE?6ECECG2FG:?C(.F(*;GHAACEEAC:8(EBE((*G/GG?2:A:*C?;?:EFECC6*FA*?G
@antibody_25_multiplicity_13_copy_6-1
ACCGTGGTTCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAGACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGTCATTGCCTCTGGAGATGGTGAATCGGCTCTTCACAGAGTCTGCGTAGTAGATGGAACTACT
+
?????BBB-BD@EDBDG>FFGFIFH>IHAHAHFFIHIH+IIIBIFGHEHCHFHHHDHGIH5-EFF=IFHIEHHFH=IEFFF-H'HHDD-BI=CEGHFFI?DCHIHG0GHFHDFHD4DFDDGDEHFHE*AE=EF)E?EEFDGFFDEGEFDGG(0CGF=CFDFGG?G?EEF8GEGEG;ACGF;GF?1E)A'GGEEE#EGC/EE#8CC6EGEEEG@@:C(;G(*EEG?EA:6EGGE*;*:(GGCCG(G*CG?C
@antibody_25_multiplicity_13_copy_7-1
CCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTCGCAGATACAGTGAGTTCTTGGGATTGTCTCTGGAGATGGTGGATCGGCCCTTCACAGTGTCTGCGTAGTAGATGGTACTACTACTACTATAATGTAT
+
?<???BBBD@DDDBDD>;GFG.I6EIHHIIFF9HIHGHG*IIHFEBHFDHICHHDIHHGFHIHHGHDIAHIIHGEIH?DIH?-FIEFF5IHHHGHD)H@BF6A+GFH@G?+ED6H9E3FFHDCGGGHGF*H*8;.FFHG=5GEEGBECC(GAC(G8GGGDGGEG0EEFEEGE@D'=FEE*EAAGA?(:6#E(G-(*EEF00EFC6FEG;<'GE@E*EE;GEGGE('EEECGF:D:A?(?E:?A(E4*A'?
@antibody_25_multiplicity_13_copy_8-1
GGGTTTCATACATTATAGTAGTAGTAGTACCATCTACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACGCGCCTGTGTATTACTGTGCGAGAGGATCACCGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGTTATCTTAACCAATGTGTCATGTACTACTACTACTACGGTATGGACG
+
?,??<BB@DD@DDD5DGGGGGFHAHHIF8H/HHIIHFH,9-CHH;HEIEAHEHFFDIAHIHHHCFHIH-IH55EHAII=A=IFHDHI6IH)HBHHH/HE=H8CHFHHDHHFHHHG(GG4G@5DEF6HGGBGEDH:GGHHFGEEG@:GGGGEGGGBEG??FE*8G*@EG?EE;G(G-:FGGEEGC?:(8C?GGA*EC?8?EEGGDGGE)CE(*/GCA7EEEGCE:E>E(C'E8FCEE:?EG)EG0EAE(*:
@antibody_25_multiplicity_13_copy_9-1
GGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTTCCAGATACAGTGAGTACTTGGCTTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTGGATGGTACTACTACTACTATAATGT
+
<?A??B<>?DBDD@DD.GB+EBE8HBH;IEH/HGHFIHH?GI-E.I-5HB7/EE?IFIIF?GFHI*-IHHIAFIFGIFHHHHHIIIHFHHHIDBHABH(IBI/HHF5HHHFFCCF?.CFHIDGCFAEFGEFHEFFC4F6HBFEEGGFG2?F0ECC(EGFC:?CEGGG'EG'GEECCC,AE?(EGAGGGEE?GGEAEE:E<:E8G:E:EEE*(EEG*EE(;<?0/*CGEFD(*;6GCG00CF:EA(CCC:C
@antibody_25_multiplicity_13_copy_10-1
AGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACCCAGGCGCGTCCTCGTCTCTCAGGTTGTTCATTTGCACATACAGTGAGTTATTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAGATG
+
?,???.??BBD--?-?GCGFFG-FIIICHIH*I5EH:HIFIHGIHG=FH-H4HHFHHEIABFA8GFHHIHII-FHHHI-GIIHHHIFFCEGFHHGD-=HIHHHH6HFHGFFFDH?HHFD+HGEFEHGEHFEFCCBDGFAE*F*BE=>DFEEE;G-EFGGECC?EEE#E2?18G6DEAEG*/?E?/EGGEGCG6EEG:EC?GEDEEG6*E(/F@E*CBG<GEFGGC?EEG1*EEECACEC9EE*.A.EG*(
@antibody_25_multiplicity_13_copy_11-1
GGTCCCTGAGACTCTCCTGTGAAGCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCGAGGGAAGGGGCTGGAGTGGGTTTCATACATTATAGTAGTAGTAGTACCATCTACTTCGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACACACAGTATCTGCAAATGAACAGCCTGAGAGACGAGGACGCTCCTGTGTATTGCTGTGCGAGAGGGT
+
A?A??/><@B<-DDDDFFGEF/EAEIEIF8HGHHHAHIEI9FIIAHFG@;HH@.HFHIEC5-HHHCHGIIF.DFIF?EIEFHIGHHIHHCHHDEAIFHGFHHGHDFEFHCH,HFFG4F=GGHDH9EGFBD#H>EGEG;GFDEFBG?G*E*F@GG0#CGEE>EEC*CGGEEEG*=;(D0).6FA(EC(*AEEE8:(:EG:6CG/E*?EECEEE@(E*CE0G?GCC)CFE?*GGG(A(=*CGE6C.866E(?
@antibody_25_multiplicity_13_copy_12-1
TTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTCATCCTCTCGCACAGTAATACACAGGCGCGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAGATGGTACTACTACTACTTTAGT
+
??5?ABB?DBBDDEBDGCGC+GFI.FIHHHHIHIHHGFHEH>AH8FIIHHBHHHHHIFFF?BDH+IAFAIHHIIE-CDIHI?FHHIFHFH-GIE@I=EFD?,'9HD=7F6HFCD*HBEFF.F*HH=HHEB@FC@F;EGAHG8E3EE(EGE:G1;GGCFGGG*C;?(CFGEFFF0G2EGFAAG6C*GCCE<:E?EGEE0?AF(*C2GEEE?)*:9E?7GGG:(CCE:/0AAC1CEEEC;?:EA<)E#?'#9
@antibody_25_multiplicity_13_copy_13-1
TCCCTGAGACTCTCCTGTGCAGCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCGAGGGAAGGGGCTGGAGTGGGTTTCATACATTATAGTAGTAGTAGTACCATCTACTACGCAGACTATGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACCAGGACGCCCCTGTGTATTACTGTGCGAGAGGATCA
+
?5?,?>BBDDD-AB?DCGG;BFHI0;EIFIHIII+ECHIHIFHCHH.HH-HHHEHHF5GHIIHHIHI;BIH=AFEHAEGHFEHIHFHIHIHFIE=HI<I@IHD<+GHBHEIBGG3C+FAFFHHF;(E98DC,HE=)*(>GC>/GG;;GFCDA;AGBA5EDEFEC;EE?EE8(G<GEC0E0EGCE:6GE?CGF-C4?.EEG:EG-GFFAG;CA8G(A*(#@BG/C?:GCGA;00/:0G*CG?*8C):*/<*
@antibody_26_multiplicity_1_copy_1-1
CAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGCGAAGGGCCGATTCATCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCC
+
??<??B@<<BD<DD<DGF;CGCHHIIEHIIHHHHIGHFHIHFI@H)IHGIHFCDI?-DHI5FFH5ECHHHHB-FEHFBFI?=EFFEGFHADHGHFHHHEFFHHFCHBH7GGDGHGH1*EF@F?G9F@H=EEEB+GEH,1.FFCAEG@EGE.+:?FAGG?GCFEEFC-FC:G(G-?;GEFG/GG<*EEGEGGGC?D8EEG*FE/EFCHEGEE*@C@A0G;EE/D2A*?*E:6A(<*FEGCEA1GGE6:G/C
@antibody_27_multiplicity_1_copy_1-1
CAGACGTCCATGTAGTAGTAGTAGTAGTAATGCATTTAAGTTATAATAAGTCCCCGAAGCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACCGCCGTGTCCGCGGCGGTCACAGAGCTCAGGTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGCGACGGGTTGTAGTAGTTGCTCCTAGTATAATAGTTGTACCCAATCCACTCCCGTCCCTTCCCT
+
?,??=BB?DD<D+DDDCFCFDFFHE5-IEHBIIIGIG@C0IFGIIEHCI#HAGIHH+HHEFI@AIH5DHEEHHHFHICHICF-HFHGFECHH)HHHEI5#CFHH5IE5B,IFF)4HGF+HGGGGEFFGEFGFHDE/BF:EF9G5:GGGEGG<EEGGGEFC9EG8GA>(GCEFE?GE:EEEE?G*FG)E?F(C:(E'?G(?;C(GFGC'C(E*@C0*<8FE(G*:GE:8C:CGFEEDC4D)8:-CG:E0AA
@antibody_28_multiplicity_1_copy_1-1
CCCCTTGCACCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTCAGTTATAATAACTCCCCGAAACATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCACCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACTGACATGGTCACTCGACTCTTAAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAG
+
A????BBB-DD9BDADFCGFG//AHAI-ICIII>FEHDAHHHH-HIIC.IHHIHIHIHHHIFHIFI5I@CGHI@IHIII+HHHHGHEFFICCDH+HH;HHE=HEDFHCDHD.F*HHG=D)(FBCCBHHDEGFFEGGGG,=FCA*C/G'>8(?E?EGECGGGEEE(CAG>C0GFCG(DG(EG+GE?AAFE6EEF((FA?EEEGEC8CCE;C?:E:GGE7E;?9G/:GGE8E:'AG?E:G;C?EG)GE'CGE
@antibody_29_multiplicity_1_copy_1-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGAGGGGCTGTATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGCATTGGGTTCATCTATTATAGAGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATCTGAATCGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGC
+
?????>/BDB5DDDBDEFGGFFHHFHHHH?BHH-I?DIIIFIEIHHH.CEHHIAFDIIIH85CH8AIE>H>GHFEFIIF?D@I>EFFCEFHFF(AG@#HDHHHED+HCHAECECEGFHHH*FDEFEHGEF)6FGEGG=*GDDGFEAB7G1G#F?ECEB/(G16EGECEGCC8G?GAE6EE<DEGEG??=AA<EEGA.6(GEA*?EGE:*6F?E>=?:EED(-GCEEGEGGEA:EG(EC6GE(6A;CGE0C
@antibody_30_multiplicity_1_copy_1-1
TTGTCCCTTGGCCCCAGACATAAAAAGCATCACGCGGAATTTTATAATAACTCCCCGAACCATAGTAATACATAACGCATATACATTAATACACGGCCGTGTCCTCGCTTTTCAGACTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCCGTTGTCCCACCATTAGCTTTGCTTTTAATATAGCCTACCCACTCCAGCCCCTT
+
??A?=AB?DD7B-DDDGGGFF/HHIHHHHH=E=9IFGHHIEHDE@II.HHF?HHHHEF.-?AECCCGHH7H#HHDIHCICHEEGB'-HG7HHDHHFID.HEHH7FII+BHCIDFFFFFHHFFFGBC@@ECHGGFGCFGCGGEG1*CEEGEECG(83ACBGE?EEGEFEC*E;EA?EEG8C?EG6EG?(=EGGGAAGG.C;4GCE:G?GEC=G8*.G(AG>(E8G/CE(E0;G*GE;E'6:AC8EE?EEFC
@antibody_31_multiplicity_3_copy_1-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGGTGGATCCCGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTAATTCTATTATAGTGGTAGCACCTACTACAACCCGTCCCTCAAGCGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCCGAGCTCTGCGACGG
+
=?A=??B?DB?DDDBD>CCFF=HHH.HAHFII-I/FCHH9IHHGHICH/FFGG>BI@H@H@5HAIHH-F;AFHHHGHIDHFH?IHEII*9H@BDE.IH=DHDHHIFBGFF=H+DHHGHGFHDG*F*1EG@GGEDEEFFG0')G*BGGGEEEDG<DD>EG*FEG1G:EEGCEGCEGFAEEG:(;(:ECC6?EGG<GFCC?:G'(:EGHGECFEE(FFE::GCFEA*E1C0CE(CF:/E8*8EG(<'G0E*A
@antibody_31_multiplicity_3_copy_2-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTATTACATGATCTTATAATAACGAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAAATGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTACCACTATAATAGATGTACCCA
+
A???<?+BDDD<D@DDFF6FFFCHFCHIFI-GFHIGII.FIHFHIE9DI@HFHII?CH?HHA,IH#EHIEIH)DEIHF?GGIHDIHF=FGHIHHHEH+HHEHGEHHDFCEHHDHHBEDDGG*FEGDFFEEDG:G*)FAEGECEGGE,CFC*EDEG:GEFBGG(.G*0C@E=GGFGG:G:G;<CEG:GGEE:ED:F?<GEECGC;E<.G0?GAE:(CCG?8=EGGFE/*CGE'G6:CC?CEE?*:E/F9(2
@antibody_31_multiplicity_3_copy_3-1
AGCTGCAGGAGTCGGTCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCTGCAGCAGTAGTAACTGGTGGGGCTGGATCCCGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGCGGTAGCACCTACTACAACCCGTCCCTCCAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTGCCTGAAGCTGCGCTCTGT
+
,??,A?BBD9DBDBD-CCFGFFIHHH.FHFHHIFHIHCGGEIHHFHHGHCD5GBHIHHFGBID+DIIIAEEFDICHG)-CCDEHG/HEI=H-II.DIH=8@FGFEHIHHI*HDDGHEEHCEGDEGDGG?GGD<CGEHFBFFCEGE;FGEE;GCEC1F(GGGE?GGGCGEFE@((<E:GEFEFEG8(GG(FGGA/F:*8)EGE(GE;EF00CEH1C/7C,:;G*E*GG1)(G#CGG.8AG?E?*CDCEG/F
@antibody_32_multiplicity_3_copy_1-1
GGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGAGCAGCGTCTGGAGTCACCTTCATTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGAGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAACACTATGCAGACTCCGGGAAGGACCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATTAACCGCCTGAGAGCCGTGGACACGGCTG
+
???<5@-BBD5DDDDDE8FCGFFEHHIEC>HIHIAHFA#HI9HHHEF9E5E+FHD-@BEFEIFIIGFCHFIFGH-EIGFCHHCIFFIGHEHIBCH,H@DDH?H.HHEHDHHHEHHHFG@*H(H7@F;GGE8DEGEAEGGGEFEGEBE(GG*GGG(GE8GCEGF#F*=?G*,?FE2?GEAGCBG8?G0GGG?DGGCE(EGGGG2CE<HC'0CAC:EG.FG-E-EC*.*/GG(EG44?C)#C4?'EECEG?C
@antibody_32_multiplicity_3_copy_2-1
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCATTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATCTGATGGAAGTAATAAACACTATGCAGACTCCGTGAAGGCCCGATTCACCATCTCCAGAGACAATTCCAAGAATAAGCGGTATCTGCAAATGA
+
?A?A?B<BDDDBDB-E>CGGFGIBI?HHII+IIGI9FIHIH?EFGEFHGAFI9F7IFHHGHHFG><HG#IFG;HIHIBAFEHFFIGFFDIIIHCFHEHDEHHHIDHG?HHG-CHF>EHFGHEFEFGBHGE=F2GEDE*E?F*BGHG2DEFHB*EGEB#E'EFEEE*G*1C?GCEGC?GGGEG/E<G:EGFEAC6G(:G*A:?:EG(*8GH(CE0*G(?CG.0?C<:ED0E#?(6*#8/01)1EE<FE?08
@antibody_32_multiplicity_3_copy_3-1
GTTCCCTGGCCCCAGGCGTCGAACCAGTTGTCATATGTGATCGATTAGTTACTGTAGTATGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCGGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTATGGAGATGGTGAATCGGGCTTTCACGGAGTCTGCATAGTGTTTATTGCTTCCATCATAGGATATAAGTGCCACCCACTCCAGACCCTTGCCTGGAGCCTGGCGGAC
+
?=A?,?--BBD9DDDB.FF@GGFHH-8@HFIAHIIH(-HFFAFEHIHIF9IE.DHHDHHHAHIHEIDEIHHEIIHHHCHCEHGEHEI.:HHDEHIHHAHHIFHHFFHCHDFHHHDF?DGDHFFDAEHHFGEF@EEFG+GEB?E,3GFAG@EGF(?GE.G(G?E'EGEE*C(AEECF<)(;?E:(ECG#EE(?GE?EEG*EA*((ECHGCH*G@:GGEEG:CGEACG*0G/G;8G?G:6EF*EE?*A;F8:
@antibody_33_multiplicity_1_copy_1-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCAACTTCAGTAGCTATAGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGAAGTGGGTGGCAGTTATATCATTTGAGGGAAGTAATAAATACTATTCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATCTGCAAATGAAC
+
A?A??=B>D@DDDDDDFGFGGEFCHI.IIHIIFHD+IHDHI70HHIADHH.GIFHFEHCAFIIHHAHHHIDH+EDHDF-I+5FIG<FHHHIBHHIDIHIHH?FHFHFHIFGIF*HH;DHHHG2DFHFEFEBBFFG+?AF;FC;>C/;ECGC8EEE+D(E*EGA9C8<ECGG/<G?E(E#CCAEGGG(9'E;ECEEGEGC.G9:.4DE8(EEA(.@G*A(,(:EAG?:C:EE1GG:*?(:?EGGE)9C.ED
@antibody_34_multiplicity_1_copy_1-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTCGCTATGTCATGCACTGGGTCCGCCAGGCTCCAGCCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTTATAAAAACTATGCAGAGTCCGTGTAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCC
+
=?A?ABB>/BD?BDDDEFFFFFEACBII>EIFHI/HHIHHEFIHIFIDHGHA-HEDIB-.FHFIHFHDFCIHGHAFB5HIHC-HIFIIHIIIHFIDHFG7HFH=CHGFHBDFED8EGHD:HD+FFHGEEBE0F;@GHG@GGEDCGEFDEGE?AEFGEE?GFF)CG??G#EFGG-?FEG0#GE;:5G/ECAE:*EEGGGFGACGAE6///:/*H@;*?AEGFA*G0EG.EE*)*(AE2CE:GG?E:EGE0E
@antibody_35_multiplicity_2_copy_1-1
AGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCACTTGTCATATGTGATCGATTAGTTACTGAAGTCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAGTCGGCCCTTCACGGAGTCTGCATACGATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGTCT
+
?A=??B-B--DDD5DBFGFGFGIH+IFFHIHIIIDCED9EEICCIHGHHHECHEHHDAIHIHHHGIIH-IIEIAGIIIGHHHHF:H)FHI<HHHF+HFHHEHHDHF=HEGD-EIFFFFHAEHHHFDH@FGGHEF<>)BGCG@EB@GGG@EGEEGE3*EAF>-EEFFGG(F/GGE:9?GGEEG:GEF/E?CAEDG0:EG'FE.EEEGFGGEC?EE@8CCGFG;??:CE(AEF*ECE?AC::8FEGC**(C*
@antibody_35_multiplicity_2_copy_2-1
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCACTTGTCATATGTGATCGATTAGTTACTGTAGTCTGCATTCGGATCCAGTAATACACAGCCGTGTCTTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATACGGTTTATTACTTCCTTCATATGATATAACTGCCACCCAATCCAGCCCCTTGT
+
?A9AA7-@D@DEB<DD>FGFFFAF>IIIICFHCGHCHHH0IA.BDHHF=FIGH5II+HHIIIH+F>BIHHIHH,H-HFFHHFAHF+GFH=DH:HHHIHFHFF?CFHD(DHH+HHGEH:HFC*:DHGGGECDGFE*4CC4EGGEGF?BEC*-E/<GGGFEAGG8EC:FFEG=CEGA?(EGAFGGG(FEGC?;A?C(EEEC*EEE8CGCDE:G:*F*0DF,(/?AAEA1?0ECE<)GG#??CE:EE.G(EE*
@antibody_36_multiplicity_4_copy_1-1
GTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCAGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTTTGCAGACTCCGCGAAGGCCCGATTCACCATCTCAAGAGACAATTCCAAGGACACGCTGTATCTGCAAATGAACA
+
?????BBBDDBBDDDDGGFGGDIIEI8CFCIIIHHHDGFADHHIIEFIBIH5>H/FF?HHFHHF5EIEHEFIHIIHCCHF-DFBIHHDH6)IHHEHIEIHHFFFED6GFHHFHEHHHCHFDHFHFGFE*F+FHEH@G*G=FFFEHDBGE@CG=GGGECAEGC<GG9(E;GFGCEECGG<C(EA:C/((C?EAEG6C)8*;GG6?<EF0C(ECEGE**E/C*FGFE*:E:?(:66ECG?E:?:F*6C1::;
@antibody_36_multiplicity_4_copy_2-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTTTGCAGACTCCGTGAAGGCCCGATTCACCATCTCCAGAGACAATTCCAAGAACAAGCTGTATCTGCAAATGATC
+
A=?=?B>BE<D55DEDGAG>CCCHH/HFIH/IIHCDFFBEGHFHFFG:GFCHHFD>FHGFGHFF?HHFIHHEF(HHFDIHH-GDFHFHHICIFHFG-HIHHHAIHIHHCGHHGD5+IFHFD+FGFH@FG4ECFF@BFG:GEGF65F;2<(EE*:<E(C@GEG(:E?C*:EGEDEGE>GECG?G(C2EDEG:)F=:8EE;E:0AEE8:G5HA0:@7ECG:,GC/EE?G:(*(::A'GE8GG1:(AE866/A
@antibody_36_multiplicity_4_copy_3-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATACATACTTTGCAGACTCCGTGAAGGCCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAA
+
?,???BB?D?BB@DD<CGGAFFFIEHHI>FHHFI9CHIGH8H-D.HFDF.FHHHHICAIFGHIIF-I5IFH*-HD8GHFIHHHEGFEHHD(+HII<#HCIDIIEHCFDHHBEFHHHEHFHBFHHFG2FFCEGAE@#FFADCEGGDEEFD<EEGEEBBEGGGCG6G-6CECG#GEF:GAGAEEG?*EEC6CA-G;:E?A((FG(EAFH?/FEE@E(A0EG@.7AGCEDG*EGGCGCGE<:G/(CAECGG1E
@antibody_36_multiplicity_4_copy_4-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTCTGCAGACTCCGTGAAGGCCCGATTCACCATCTCCAGAGACAATTCCATCAACACGCTGTATCTGCAAATGAACAGTC
+
?A???B>BBBBDDD-DFCG?FFF?/IEHHIHAIHIAE@9HFF.B=9HHDFIHHDII=7GHIEIHHHI(IIHEEHGFH7AIG(HEDHBFHH=HIIDHH;HH)CIEHFHFGHEIHHD3FFF4=FF0FHGCHEHHFGCECHGGG;GF88FEE9FFFBG;;EE9GC6E=C*ECGC8(;G8AEGGEEE?GDE((G6(??EEEE-.EC<EE*H*EE(6-ECG8(G:(.;<A'G1E':;AE(6EF::?>AC*)A;*A
@antibody_37_multiplicity_3_copy_1-1
GGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTAAGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGACAGTTATATCATATTATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCCATTCACCATCTCCAGAGACAATTCTAAGAACACGCTGTATCTGGAAATGAACAGCCTGAGAGCCGAGGGCAC
+
=??=??B795<BDDDDG.GGFFHDHHFHHFHHBGIHHHHIIICHEHH?HGH.AFDHIHCG-HDBDAHIIGHHDIFGG5H5HF?HIFFI5HF8EHDHH+GHGCEH5HDGHHHEDH+A@E.DHEE=*FGGF=E7DFGED,H3GFE?EEEEGEGEG<GGGEFDE/EGGCC4EC<C(EEE/G*GCGE?0?;GGGAC(GAG:GGE98*:GEEGEHG.EACGFEGEE0(E*?C;8C)AE/EDGACC:AE*G/'EGE
@antibody_37_multiplicity_3_copy_2-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTAAGGCATGCACTGGGTCCGCCAGGCTCCAGTCAAGGGGCTGGAGTGGGTGACAGTTATATCATATGATAGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCCATCCACTATCTCCAGAGACACTTCCAAGAACACGCTGTTTCTGCAAATGAAC
+
<??AAB=BDDDDBDDB;GFFFFCHHFCFIHG>FD,EICDII>HEI.G9IIHFGHIIB7E9HHCAICFHFHHEHAHHC<H;9FHHCGHFHIGEHHGFHHCCGHGDI8H?BHDD?HHECFGHD@.HHFAGEEGH?E<:E0BFGEGHCGCEB*BE?CD*GEFA#E=:GCAEEE6A4.ACGEG;F?GGE:GEGEGG?)(?CAFG#G;/(EEG:E8GH(GC:G(-EGGGG(9??(:?GCC'0*GAE0AC6?*A:*
@antibody_37_multiplicity_3_copy_3-1
GTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCGTCAGTAGCTAAGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGACAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCCATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGT
+
???A?,+BDADD?BDDG;GEF8IBIIHFFIHEIFEGFEIIHHHHIFFIG7?IAI*IHHE0HIEHEHIHHHHDFFIFHCCDDE>FD@FIIHIHHE<IH,HHHBHDHHGEHHG=,HFDHHBGFBD9FE#EEFHBGGECE*FDG@EGG'2GGCEDEGE(:ECE*BGG6A0EAF(/GEGGE(GCA?GG/?G?G?GGEEEF(GC?ECCEGACCA<GFEEEE(E(GGGECEA:E:E(G6A?2GGE:9E.G>FE??E
@antibody_38_multiplicity_1_copy_1-1
CCCCAGGGGTCGAACCAGTTGTCATAAGTGATCGATTAGTTACTGTAGTCTGCATTCGGATCCACTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCGCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATAAGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGTCAGGCGGACACAGTGCAA
+
A????BBB/DDDEDDDGGCGEFHIFCIHH/IHFHI77HH@E+HDHFAGFFAHIHFFHD,GEH5HFIHGHEHIED5IHDGIHHHHE+I8EIHHHHD?HIH@DCIHF3G;E'8HGHFHHDHHCFFH=G,GGFG*GGFDG8E?:E-G@EFGGFG(;EGCB(*.FG3EFFGEGAG(GGG/CE(:0G:?C8EG:EGGE(C?FAGEEGEEFCE9GFA(EE@:G(,,EG(:(CEEGE?EA)::A(A?F#ACEGGCG#
@antibody_39_multiplicity_5_copy_1-1
AGACTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCAGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTAAGAGCCGAGGACACGGCTGTGTATTACTG
+
???A??9BDDED@DDDGGCGGGHHIFHHH8IIGFIIHIGHHGIHIIFHHHGHF9FBFIH:IH5FIICFIHIH5HD-HHHFDC5HEHHHFHHF-IHIHIDHH:FHHHHGBFHFHIH#FGGH@FECE9;A7E*GEEEDH@G:FGEEGEEB?6?EEEEGFG;G:?EEE((E?GFGF?CEGGG(G(CEE*E?GF.(GEEEEE:GEGG?;?H*6E/0EEE?E:EC(FE(C:E2(G0EG/).CG8EE?G?(CEEGA
@antibody_39_multiplicity_5_copy_2-1
TCTGGGGGAGGCGTGGTCCAGACTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCAGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAATCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGG
+
?????B+7BBDDD-D5GGGFGFHIFCCHFIHDEIHHHHHI+9HH=EH79HH7@CIGF7>H-IIEIHIFEHCEHIIHBHHDEFFFHDIIE+HFIHHH?G.F2DHH>HFEDDGGGHH7;HHEHFGG9EFCGFGHGEFI0*BDBGGGGGGGFGBEE(DFCGG?EE8A(G?0GEE1CC#6=G(GG?ECA(1FG*GCE/GEG*GEE?G(EG6GG:GFDE:GEAEECE*0EGGE(E?E*:EE/GE(/EEE:*E#?:
@antibody_39_multiplicity_5_copy_3-1
TTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGAGTAATTACTGTAGTCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGGGTCTGCATAGTATTTATTACTTCCATCATATGATATATCTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCTGACC
+
=????BBBBDDDDDD-FGGFFFBHIHHEHIIIGGHDICHFHHHGECGHIEFEHGIG,GHHGHHIIG/IHHBFFIIHAEG=HHFCEEHFHF7EIH=IEBHIIIEFI<68FGCIEG?GHHHGC+HBH.>=BH,?HDFGEFHG?=GEGH?FG;C*?B@0CE?ECBGCEC?4*=#?CGG:G(GE:<ECEGEGCGEG/C6GGCGGEG0*FG=E(6::C#E(G7(@(E4.(?GGEGEAFGCCGG6G*C/CCFCA*C
@antibody_39_multiplicity_5_copy_4-1
CCAGACTGTGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCAGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCACACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGCACACGCTGTCTCTGCAAATGGACAGCCTGAGAGCCGAGGACACGGCTGTGTATTAC
+
?<???B>B+AD<DD@DGGFFCCCFHIHHFFICHIGFCH@CIIFHFGFFCHIFI,HHIF=EH5GDIIH-GHDEHH5-IGFCBEH=FFHCHHHHIIHHHEHFIIHHFHHF@.HEEDFHG;HFHE+GEGEC:=F64BFEGCH3DEEFGGEE#B*GF.E*G0A(?G6C6GG,5G:EDE;?EEGEGGCEG*EG6(GCG(G)GE0'E?C(GE?CA1(?(A('CEGEEE0EEGEEEGE:80:6GEE:GEEG2EGEAE
@antibody_39_multiplicity_5_copy_5-1
GAGACGGTGACCAGGATTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGAGTAATTACTATAGTCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTCTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATCGTATTTATTTCTTCCATCATATGATATATCTGCCAGCCACTCCAGCCCCTTGCC
+
?A?<?BBBDD@DB@DDFFGAGGFIBIHFHHAIHH9FBIDHHF9HHIHDEHF,FHIHHF-A;B5HHA-I5DHHHHFDG-FHHHH;HHH=AHDDIFIHG+HHD@@HHG:DGG+CEHDHFIHGGCHFFHC+HGFB(G8GB?*GG0*6GCHECG?*?:EG3GG.GEAG;DEEEEACFAEEEE/(EA*FEFEEEAEAG(4(CEE/?GE(6.EGEFG6.(GEEC:@GGEE(GFCE?E(16*?;E:(A66E60:(EC
@antibody_40_multiplicity_1_copy_1-1
AGGGGTCGAACCAGTTGTCACATGTGAACGATTAGTTACTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATATTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCACCTTGCCTGGAGCCTGGCGGTCCCAGTGCATGCCA
+
?????B?BDB9DBB@DEGFG-GCHFICIH+EGFIIIICIGGIEIEGEHDHDDFFHHD-GH-H=FH,DGC>IH5AGFHHIHG@5HHIGHIIHIHHEDHHHHHHFHHI,EHH?C,CIG<FE,EH)HFDB=GHHEEE@BEAE8<FD@GCG,G?6;88;EEEGBCGGG?(4E?FGEC1FCEEC?FECGEEE8*AEC6??CAC*E0G0E#GHCAAE1(8*EGEGG(A?6FEE1/EG:C(GCGG*::FA:)C*G6(
@antibody_41_multiplicity_1_copy_1-1
ACCAGGGTTCCCTGGCCCCAGGGGTCGAAGCAGTTGTCTTATGTGATCGATTAGTTACTGTAGATTGCATTCGGAGCCAGTAATACACAGACGTGTCCTCGGCTCTCAGTCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGATTTAACTGCCACCCACTCCAGCCGCTTACCTGGAGGCTG
+
?5=?AA7B<5BBDDDBFFGFCGI@I6>HHHHGHIHHAI.EIGHFI9HFGHHHFGHBGHHCFDH-*EH@5HFI@IE+IIFGH5<IHI@8HHE9+H?,@HBDGH=HFFHFF#HH2+HGHHGFGHGGHGGHFH@6EDGIGEE7ED)EEG3BGGGEGECFB8FG1G)E;GEG:(.EC0*GG8.G'GAGDEEGG6FG(GE;E::G:?AECCCAEE:EEEC*?#G80E68CFC*(EG:*:(CEC(?*8*EGCE8CE
@antibody_42_multiplicity_1_copy_1-1
GACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATTTGTGATCGATTAGTTACTGTGGTCTGCATTCGGATCCCGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGTCCCTTCACGGAGTCTGCATAGTATTTATTATTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGG
+
5????BBB@ADDDDDDFF6FGGHIHHIFIEDIHHGHC7DFFIICHHIEA-I9HF8F.IHIA)IHHEEIFGCHEIHIHHCHH8IHG#+HIIF,HEHHH@FIHHGIHFHD?+0H=HFGHF5HEFHBHGGEH;DEGGEC@CEDCECEEG)ED6EGEC(E/GGGG<EE.GGA=CFE('(EG(6<6E(GG);#G2GFACACC<FEEC:EC:??<CEC)E:GECGCEG:*AECGG:CEEE?:)EE;86F:G*:CE:
@antibody_43_multiplicity_1_copy_1-1
TGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTGACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGTCAAGGGCTGGAGTGGGTGGCAGCTATATCATATGATGGAAGTAATAAATACTCTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGCATCTGCAAATAAAAAGC
+
????=BB7DD@DDDDDGGG+FG-;IHIIHHHIHIHII/IFI7EI+7GIHFIFDIGBHD+FIHFHHIFFICHIEIHE-EDIHCDICH-II3FIHHGBHHGH,DHECFHDHH4E,E?D+B=*DFHHCE5HCFFDGDF*G?CE*DG4FGDF4EGDGFB?2D;C(GEG;?GGE:CEE6E>*GG8EFECCGEE<GG?FE0GG(G?:?GGCC*EC*EGH<B:3/GA(EEF=GE0GEC6*;(CE*-90G6(0E:?G/
@antibody_44_multiplicity_74_copy_1-1
CAGCCGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATCATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGGCGATTCACCGTCTCCAGAGACATTTCCAAGAACACGCTGTATCTGCAAATGAACAGCC
+
?,,,,BB>+?DBDBDDGFFG.FIH>EHHAIIHI+HIH@IHEG-HHIHHDIFEFDIFGHIHFIC@IHIHIIF?EFI-DHHGH+HIEHFHCEHHDHHCGHHFGDGHHFHHIFFFFAFHHHGH);FDH9EDFDG9F>GAEG8E@E*GFEEE=;E>B#E82GEG?:GGBG*GE:CGFEEDG.G6?EAEEGFEF:C(A?GE/GEE0*CGE(?D/?EAH*(?GE'EG?F?EE*GEECEE*E?.(G:<EE6EECEAC
@antibody_44_multiplicity_74_copy_2-1
TTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGTTACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAATGCATGCCATAGCTGCTGCTGGTGAATCCAGACGCTGCAC
+
??AA?>BB<DDDDBDDGEFCFGHHHHIFIHAH7AHIFIHGI,IHFF8DHHF=FIHIHHFHFHCGHHFIHIEFIE*EH5GFHIG8IE8G=HIH(CIHIEHHDHICAIFH+ICHHHHHHHD3EDFEEF0EHFG:EGDFGGEGGFEFDEECDGEG()?EEBGEGFEDEG.AFE6E@F?F2G*EEE?EEE(0GGEGE::80?EGGEC:AEHCC(()C@E*GE8EEGC8(EA1.#**EC:)::CG:DGF(CGG8/
@antibody_44_multiplicity_74_copy_3-1
AGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATAGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCT
+
,5?A?B/B6?BBBDDBGGFFCGHICI>HIIIIIHIBII7I+GEFABHIIFD@.H-DH@IFIIFIFD*E=5E>GHGHHCGHHHHHGHI*IHGIHIHI9HCCHFEFIHIHIFDFB,7GHHGHG9G@HF5,DDC:GFEFEEDDGFG:FHGEGECEE(GEEGEG:GGGDCEGGG:GE/(=.GG(?.EG/CAE>GCCG?A<FG.EG?ECAEFCADEEE4CFEGBGGG=E6E#'E*ED?6.GFG>6?GG*.?GE::
@antibody_44_multiplicity_74_copy_4-1
GCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGACTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGGTGGAGTGGGTGGCAGTTATATCATTTGATGGAACTAATAAATACTATGCAGATTCCGTGAAGGGCCGATTCAGCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTT
+
?=?<?>BBDD?DD9DDCGFAGFCHHHFBHEG+H9A9EIHAFI:FIIH5HFCHIFFHIHHH>CHHEHHHHFHICHE7H=AFHF4GHG=HEIDF6HIFHHHDIGDADGDHHF=?HBGFGH3HGDDG=D*GHHHGE=*FFBECFEEEG2GDG'BEBE6EG9=G):EDBE*(GEBE'G0FG)0F+C:A(?GGD*EE:?GEG(EGCGECGE:EF?CGFE8G(*EC0?*?E)(E*ECCE0*AG<0EEEAC?E??G/
@antibody_44_multiplicity_74_copy_5-1
TCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATCGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGGCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATCTGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGCCGGAACC
+
??A??<BA?BDDD?5DFCFGGCHH08IIC@EHHC.CEHHG-H7IH?FAEI.A?HHAHHIIIEFFFGHHC+5CG@55DGDHFEHHIGHHDHH5I-FFGI/HI=HFDIGFFH-H+HFIDBGFHDFHEHDHGEFGEE?GEF@GEBGE*BEBE9GDEAAG=EF*G?GEF(;4FC(8FGEG/.*E<GGF.;E?G<CGE;?:=CA(GA8E:GC?GCG6@GGC0CG(E9G;C1CFEGGE>(:EGE(G:G*EG(6(A*
@antibody_44_multiplicity_74_copy_6-1
GACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAACTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATCTAGTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCT
+
??A?A?BBDD@DDDDDGFF?GFHFFDIIHIH/HHHHII=HHFHEIFHHHCHFHFHIHHICGHCC-HIIHIH?DAF=HAHDEFH)HHIF8IHHFHHGFHE8HHCH+HHGHHH1IF3HI3+3HFGEDEHG*AGF6*E;FDFDGEEG*EF*EF6EAG(E:G?;3*G=.=CFE/0EEEEF06FFGGA/EAEG>G(C#GE**(GE/G6FDECEG:AE.EGE.CEABEGAACCCC?0E:?AG)GAG1GC:E?*FGE
@antibody_44_multiplicity_74_copy_7-1
TGTGATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTAATTAGTTCCATCATATGATATAACTGCCACCCACTACAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATGACATAGCTACTGAGGGTG
+
<??,?7>BDDD@DDD@FFG>+FHIHH0HICAAHHBIHFHA/GFHIHIF?IF?GIICGIHGAIHHEHHH7EIAHDIH-IIAHFEFFCHIBEFE=I+FHHCHH=HHFHDFHDGFHHH+(FH@GDFHBFAH;EG*EFFGEGB0.GEGFEGEGFGEGAD:GE,G(GGECEEGDFGEEC?6G(GFFEAEGFGEAGECEE#)6CGE1E1E/AH(CEF680G*GEE@E?E?(EC16:G?((*/?G0GC(-E/(G*EE
@antibody_44_multiplicity_74_copy_8-1
CTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATACGATGGAACTCATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAATAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGGAT
+
AA???BB?BD<5DBDDBFFGGCHHHIIFF>CF/HIHHHIIA-IIEGHF+5DIDIGIHFF-HHFHCFCH(>HA@F+FIHHIH-IIIFIHHFHFIII=E=HEDFFFHFHH8GGHGFHFHH(GBFH=FHDG#93BEEFBGDG*GEGEGFGGEGCFEBG0;8G;?'EGE((ECGEAECGC*G:EGE?AG1C(?A;EAE?GE?A/?GCG;<:?*CGG'7:G?EGE*16CGC?EGFE8E6*(C:;EE:CEAEEGAC
@antibody_44_multiplicity_74_copy_9-1
ATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTGATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGCACAACCTGAGAGCCGAGGACACGGCTGTGTATTACTGGATCCGAATGCAGATTACAATAACTAATCGATCACATATG
+
?????BBBDDD-DD?BGFEGFGIHIFHAHFHCIFHH.GAHIHHHCI.@GFII9IHICC?HHHIFIFIII>HHIFH5CHCHI=H7IC6CFCI)HHFH7FHIGEHFHEFHIHGHH@+HE9HHDGH6E?GFFFEHG>DEEGEEDGE35EGEEFAGE,GG?GEGCGG=/1GEG8-?.EC:#:FEGGCC)C??>G*EFGGGGECGFE0G*D.*EHEEF0*GEA4G::C(/AG.*<(GG0E(EG*?EE*CG0?CCE
@antibody_44_multiplicity_74_copy_10-1
GGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAAGGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGGATCCGAAT
+
,A???BBBDDDD@BDDFG@GFFHEFHCHFCIGBHHHHHH9@HHFH./CIBIFHGHA;HHGIHI=EHHHCFIEIGHHGHHFIHHHCDHE+HHIEH9HEHEGD@H3HFH88FFH=8FDEDFEHEE@4EGED0HFAGFG;CGAGD=GEG@G*G;G<E3AGGFAGEG:BEGEGGFE?GEFEGEFEEEG:F/8EGCECAFFGF;EE(?GGGEEE2??H(7*F<:A/E(C.F<(CEE9E*1C(G8E)E/GE<(AE:
@antibody_44_multiplicity_74_copy_11-1
GTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTCATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCCGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCATGCGTGGAGCCTGGCGGACCCAGTGCATGGCATAGC
+
A????BB>DDBD?DDBEGFF?FCHHF+FI>HIGDDI9I(HEFCFCIHFIE>+HEG>HGGHH5HIEHHFHH8H5DCECIH=>H=HAHII8FHHF9HHHF*FD<CEFFHGDDHF9H?DE,=FEG=HGGFFBF#EF@GIFDEGF@AG(E'DE8GGG#FEG;;(F;EBC?A(EGG@06*4E+E(:CG(AEE8GG:E(EGC(8CE-AG:D(?*.H/?<(@EE(GAG/GGGG?G(GC/6C?EEEGEE(*()AEECE
@antibody_44_multiplicity_74_copy_12-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGTCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGATGTATCTGCAAATGAACAGCC
+
?AA???-BBDB@B<DDBGFG.GHCHIHFAH9HH.FAFFHHIIIEIFC@DH9EEHFIGIEHHFC5FHCHIHFIHA?HHFHHII:EGHEIHHH7IHBFFF?D?G?HHDFBG?IGI6HFG<F@G#DGGE59GBEHGEFDG/ED@EG@EGF?G2DE2EBG*E(GECGCGEFFE:.GE((?GFEEGG?GEEGE(GCE;8)8EFG:G((E(*HGFACE:FDGB?BA:G/C)6EE#EGGE(CE*ACGG*A0G*(:A?
@antibody_44_multiplicity_74_copy_13-1
GTCTGGGGCAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGCTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCTATTCACCATCTCCAGAGACAATTCCAGAAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAG
+
?5?<?BBB-DDADBDDFF.FGCH6EE6FE>IHDFHHIH-+FHEII>IEHIHG-FHDHHHIHHHIIDFIHFI>I>5HDI>IHIGHE-8IHHHFDED;HHIEIHFHIGHAFH@CHH+HG=HDHGG*(H;FE3GEHDDGG-*@G?EFGEEEEEGE;EE;CEGGFEAEGEEGFE(EFE@EGG9EC)*EEEGG4EGG:0C8FGGEE(8<CCHCC-*G10CEE?EG'EE8E6AC6A*EA:*GF(?:*C6:EE*?0G
@antibody_44_multiplicity_74_copy_14-1
TGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTTGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACGCCGTGAAAGGGCGATTCACCATCTCTAGAGACAATTCCAAGCACACGCTGTATCTGCAAATGGACAG
+
?A??=?BBDDDBA-ADFFGF.GFHHIIFHHEHH,EHFIH9HIFI+HHHIH-IGFFAEFHIIIGHIHEAHHCFHHEH5?FIHFIDHEF3HIIHHF=H=FHH<+#HHEHHFHG=DFE,HH;EH5HFF*BFE*DE,DDFFGB*GG<6CE;*CBE.DCEGCGEGGG@G;EEGEGGCF*E*EE0GGE(?GE;;EG(CE?CGG*FCGEGEE?F?(H;GA><=(EED?E**#C(GEFACA::1E*CE(GE?0(E0C<
@antibody_44_multiplicity_74_copy_15-1
CCCTGGCCCCAGTGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGGATTTATTAGTTCCATCATATGATATAACTGCCACCCAATCCAGCCCCTTGCCTGGAGCCTGGCGGACCCA
+
?AA<<>?BDBDD-D@DAFGFF.HCIIFCFIIIII9I/FHHHGDHIFF0HAHDB.F+IHCEH=DFIED*HIHFEIACFHE5HIEIIHIIG:AICFEAHHBEFIHHHHHDFCE;4GI(EHHHH+H>E>D8GEE8E=GD)GFEHGE+EE,GEGGDGFEDGGEECGEG6E08?FE>E8@?FC?/A/E?G(FEG<8:;G(A?0EEG6GE?8H(E01G:E:*E(EE:GGCFGG/)CEGEEC)G?*AC:?G(EGEEE
@antibody_44_multiplicity_74_copy_16-1
CGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCTGTGTCCTCGGCTCTCAGGGTGTTCATTTGCAGATACAGCGTGTTCGTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATGCCATAGCTA
+
???,?>B-D@D-DBDDG8GC8FFHIHAFIHIAEFBHHIHIBH*+HHHHIFIIHAHHIH+HDHIG-I*HIHG-*G5HDHF5<EIIGHHEDH,GEIIFHIHHHEHGHHE3GH@H(@FFH.HHFHEHGECFE:CHE2ECHGDEEE@EFGGDGFCEEGC:=EFEFGE;)(E(GGEACGG*EGDCEGG*E:<GGGCEG(GG)?GG6E:E?.EGG*ACH<EDDGBAGG(FGGF'5EG?<.'E8DE1E.EEA?8):E
@antibody_44_multiplicity_74_copy_17-1
AGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTTCAAGAACACGCTGTATCTGCAAATGAGCAGCCTGAGAGCCGAGGGCACGGCTGTGTATTACTGGATCCGAATGCAGATTACAAGAACTAATCGA
+
?=??9>B>@DBD-BDEGF/-GFCHHACIFHHIIHIIHH=I,FH0HI.GF9HFFH99IEIDIHAH?IHHFHHF/AGH-HCGHHI(GI<FE/HAHHHHHFH6@DGCFIHFF:H9HH9EHBG5DDCH(4GGFDGGFCGGAGDGGBGG6G,G:F(EGAC#C/FGCEEGFEGGA?F;EEGEE(EEFE/FGCF<EC8GGFGE=GEE-AGEGF?CGH8EE@@CG/EAEGACE?2(6GE;8A(68:E*:(EG:*:04*
@antibody_44_multiplicity_74_copy_18-1
GGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGAGCAGGGCCGATTCACCATATCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACAAGGCTGTGTATTACTGGATCCGAAT
+
???<?B?B?DDDDBBBFGEFFFFHCIHCHCDFHHGFHHHHEGHIHI??HFF+.HHCH=FFEHHIC>CHHIH-F?IIII=GFHGFFAH+D+FHH=FHDHH#H@,HDHHDH*HDGDGHEDHGDD<HEFGF@EFGFFFGFE/EEGG9*E(EFG(H?:GEFFAG9GFFEBE<GEFEEEEEGEGEEGEG/ECG:FFCEC0?FEEEA?:GFGAEC?8/;FGA:A:C8(GGC*;:FG(666*(*AEEGGE/EEC'1G
@antibody_44_multiplicity_74_copy_19-1
GAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGAACGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGAGACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTACCACCCACTCCAGCGCCTT
+
A?AA=B<BDABDDD-BFGCFFGFHFIHHIE?IH=IHHIGEAHCHFD/HID.HIFEEAH'99=IHCHFHHHIIG>HHFHGFHGIHID8,78>BC=HFHD+H,IFG,HEFFHHDDH+7H<=HBD>EEHGBAGGBG=GG.*8EGGG(EG7E(@E?EEEGEC,G:G'G(FE0GGEEEEE8CFECG#ECE??.ECGG<GF?ECCA8/GGEE(*;EE:E:E7E*:=C08E((*EAC*EE*C;EC?G1(4G:(*G*;
@antibody_44_multiplicity_74_copy_20-1
TGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTACTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATGCCATAGCTACTGAAGGTGAATCCTG
+
?=??=BB3E9?@-,@DCFGGFGIIIHICHEFHGHEHFHHFIIHIHHF.I@IHIIFIFFBIHHH+CHHHGDID+F<H5HI5HHHHH9HIGHI+EG-GDH,HHHIHE+HFGGFCD<HHBFHGBHGFDGHEE(;BG.9?2GEFDHGF6FEC:DGC;EGECGGFG*GG1*G;GEG?EFGECEGEGGG(EGCGEBECCE:EE8FEEEG:AGHG=HA6F@:?7E;G/G>ECC08EGFCEEE(AEFEA8(8E8DG('
@antibody_44_multiplicity_74_copy_21-1
CCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCGCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTACCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATG
+
5????+BB6DBDDDDDFF/BFGHH-HIHICAIHHHCH7HIIIHFH9D.HECI=HG?FFHCHI@FHHGEHA5H-H:HHFHFHIEHHHI=EHEIGGD+=HEHHFGH3HHHHEBGDFD*E7=FGFF8HG;*EEGDGE?GHGGG7GEEEGEGGECE(GEGEGGG<GA*;EG:?F6CEEG.C;G;G:FG(CFE6EEAEGCEAAGE/*(FEGH**E?GH.E(CCEE7:*E0CACG?8)A:G10E::CE0AEGC:?6
@antibody_44_multiplicity_74_copy_22-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAA
+
??A??BBBDBBDDDDDCF-FF/HFFEHIAHHIIH9HCIIIFEF9ICIAHIH-IEFEHIEHFHGFEHIGHIEHAHI=IHEHHIHHC1HHI6FEIIHCGHHIHIHHHHHFF:.IIHF@HEHGEEHDDGEGD4FG*EFF,E1EE;EEGGFEAE@FG?G?GCG<EE.E.F681<EEC(::GGG;E(GE:GG1:GAECC9E/?E:E?GG?04?*HEEHC:8<)?CGE8:1AG;ECD?GC:8ECCEA1A?EEE)E*
@antibody_44_multiplicity_74_copy_23-1
AGTTATTGTAATCTGCATTCGGAGCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACTGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGATTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTTCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATGCCATAGCTACTGAAGGTGTATCCAGACGCTGCACAG
+
?5???B>BDD-ED-@DF6EFCCFIFHFIIFDHGICAHFIE@IEH-FHFGIIH=FFFIIDIDFFHFHH=IHFIHHHH-FCHECCFHHHHH+GHGHFIFDIDIECHIHG)DHGFHHHFFG/*GFH?ED+GE(HEE;>D*FDBEGGCFFG.EG26EGAG;CEFCE6FEA)E#CGC?FFGEEGGC+(G(?E:E9G(E(F>?GG?8GFCEC?/(?(CA*@CB(E,8C.GEG6GE0:G**?ECEGE*G.C(A(?CE
@antibody_44_multiplicity_74_copy_24-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGGAGACTCCCTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAAC
+
?55??BBBDD=DDDBDGEFGFFCHAAFBBIIII5HEHAHFHH>GHFCGHHF<=HHDHIFIHFHHFEI@FHFIFHF?IHHHEIHFHFHDF*8BFHIH5IIGGFFHHH,HFHFHGA@9FHEHHE2@BH)DHHGEDADA7D*F'EEEFEF@C(::E?CE?CG0CFEFGGG);GE;E.G9EEC(EE:GGEE*GE6<;EG8EG:FGGGA(FEE<(EGEGGCCACA(EE:?ECGEEECEE'EAC?EE.E:*AECG:
@antibody_44_multiplicity_74_copy_25-1
TGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGCCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGATACAATTCCAAGAACACGCTGTATCTGCAAATGAAGAGCCTGAGAGCCGAGGACACGGCTGGGTA
+
,,,??B?BDDBDDDDDGFFGCGIFH/HFIIHIIHFF9HAIIGHH?B.IGHHHHHIAHHHGH+FHGHHHBIG>FIHG?HFHEIEIHE+AIHHHH(-6HHHHH=I<4HHCDHHGH7FFEFGDHDHFDHFHGDGEEGEEC3FE,E6(EEEGG;@GE*EFG3FECE(G:EAEEG*FE8F-E?(EC?EGA#E=.?GEFG?GCEC.ECG/EE:?G:G<EC7GCF:E*..G(AFA.8DEEAG?*.EG?E:)0A(E::
@antibody_44_multiplicity_74_copy_26-1
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATCTGATCGATTAGTTATTGTAATCTGCATTCGGATCCATTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTGATTAGTTCCTTCATCTGATATAATTGCCACCCACTCCAGCTCCTTG
+
,?????B?DDDD@DDDGGFGGGHIHFE?IIHIHIHHCG9=IIH9IEGH-7GHI/HFFIGFHIEEII5IFA/DAHEIIHHIIEHHFDAH=H+IHEDFDEFHFFHHI=GHHEHHGEGHFHGGEGFHHGD@3GGF9F85FFGFHFEEG(EEG=;3GG*GEC*E.G:;C?A*G?EGG.EG0.AG?EG6;((GC*CEGEF<G)?G?'G9*?):CA*EH*G7/G(D(C*G*G:(GDG6DEAE*CGCG*:G/8*:6*
@antibody_44_multiplicity_74_copy_27-1
GACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGAAGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCGT
+
???5=<BB-@BDD=DDGCFGFFIIHHHCG+HIIHI.IH+IIFGHFFECGIIIGHI@EFEHFHHDHFEF=EEIHHH#-ICGIBFFIFHEHI*AHHF=IHH4IH+GHHGHHH=FHGHHHF=GD=HHGCHGHFGGDGEGEGE*FFEE?EE:GEG8FF'CG#*GEGGGE8G#,@(FGE?4(E?G:8(GG(=G(AGE4ECEE:EGDFEC?GEACH:E*<E(?GG@8EG?;?.*EGG.EAC(:1?E*EA6(*8?(0
@antibody_44_multiplicity_74_copy_28-1
GTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCAGGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATCAATACTATGCAGACTCCGTGAAGGGTCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAG
+
??A??B?B-BDDEDDDFGGFF>IIHF66HFD=HEI+HAIHFIAFHHEAHCH?EG>HIAIHG>H=FF>+H5HIIIEHHHIDHHF.5GIIHHHAI@DCHFD?FI5FHF+FHHHHFIHFFGF;EHDD9FFGGGGCFGFEBFG?EEGGEFEGCG,FGC*GGEEFAEGGCEEE?AGGGGF?E6;G(?EGEEGC0C6CG2CAFG(*6GG'EE<8FC(GHCEC-CG:G/EG:*:*'?/1:(4)EA:A)::GG(?(A;
@antibody_44_multiplicity_74_copy_29-1
CTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGCCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCTTCATATGCTATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGT
+
?5???BB>DDDE@DDDFCG-FAHHIF>EEHHDHH9F9HH+FGIH=HFFHEFDF+HFEHHHGCHCHIGHHIHIFHFFDHI,8EEHEIIHHGDDH*FEII#FHHDAFHHHFFHGH#9*HHGHFHH<HEEGDE:9;ECF4GBFC(?,(C0HBFGGEFGC8C4EG?EGEGEGGGC/GE8GG?G:GEGE?GGC:(G#?EGGACE2:.;*ECHEEEFE@E9EE00G8,GCEEC(686A?AC*GAEE4A=C6C8GE?
@antibody_44_multiplicity_74_copy_30-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAATGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGGACTAATAAATACTATGCAGACGCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAA
+
?<?A?BABDDDDD?DDEFGGFGHHHIFICHIHHDGEII+FHHDFIHEAADIH-FDGDHFG-FIHGFIFBIHHHICGHGHHHGFHIHE=EHHF)HIHIHHAHHIFF>H(HFHEH@5HHEH>2FF4*EF)DE?**:EEB?EGF@?EECCAF;EGEGGFCEFEGGF##,E??G6G:CEEEGGB(?4E8(?EC(:CGGCG#G6<G?:0EFFAEEEEHG@/GEEAFGGEG>EG:E.8-??G0/6GE(CEG(GGEC
@antibody_44_multiplicity_74_copy_31-1
CTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATGTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGCTGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATAGGATATAACTGCCACTCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCGGT
+
5????@?BD<DBBDDDF6;CGFIECIIFEHFFFI9IBFEHHHIHHGF@GGEF>=HD9HHFFIHHHHFH@HFHFFFIIH?FAFHEHGHH@@IGIH5HFGFH<HAFCFF+BGFE(?GFG?BHD@ADHDHDGEHG@.CEEGEGBG/C#FGEG*C7?ED6GAEEECCGDFAHCGFFEGHEEG=AGEE14G?G8FEG/GFEE(E(G>EC/E.EE?'C'CE0?G0EEEAGE6?::'?*:*C?GE*A**(-CE:(EA
@antibody_44_multiplicity_74_copy_32-1
AGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGCACACGCTGTATCTGCAAATGAACAGTCT
+
?????BBBDBD-EBDDFCFGGFEFEFIIHHGH/IIGHHII>H)8IIHF9@EHGHDHI'GHGIEHIAIFIIFIGF-FCHHEH27DHFIHFGEHFHFCHEHHCHHHDH3FDHH*HHDF=@>FGFDH*G=GHGE9FHGGFG@GFGGEG=3GC@DGFFGFC4E@GGCCG;<E.EEGCCC;EE6GFEGC;G8E(EGGE<<CCCGEGAAAGFEA:H?'@@CE:E::?//GAA<GG:CGEG<CE((GG?G8E=G()1
@antibody_44_multiplicity_74_copy_33-1
GAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAGTCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTTTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCC
+
<A??AB>BD@@DDBD<?GFCGCIHFHEE?HHFGH9FFFHIGIHFCDFE9IFI@FHGHIHIEGCHIE-EHH:#HIFI-HE?HH=I.HFIHBHIHIHHDHHHFIHDHABHHFIH@7FCHH3E9HBGHGE8ECHGBG5*GBGGFGEGG33G*;2:*BGG1A(EEGDGEEGEGFCEEGCE-E?4FB?FE:EGEEA*EFG??EG/A?EG?.CAEEEA.G0F*GEECGE1ECC*8?6EEGC*((AEE**GG:E)/<
@antibody_44_multiplicity_74_copy_34-1
TGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGTGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGAATCTGCAAATGAATAGCCTGAGAGCCGAGGACGCGGCTGAGTATTACTGGATCCGAATGCAGAT
+
??AA?5B<DBB-DBD@CFGFF;EHHHFF.HFHIEHHFAHHGIHIAFBFHII/-DHHI;8IHFHHH4=ICHHHHFHHHH+FHIGHCDG=EH-IIHHHHHFHF;FHG.HDHHHGG@EHEHHGEHGDFCG@HC(CEE?GEG9DEGG#'AGD*F2DFGF;(ECGFC;0GCGC:6FEGFE#GCCG.EAF=(G?E?;;FCAEGA#(DFECC:CAEHAFAFCEGC(@G:EEE(4E?2EGG:??CGG:G8*:*C)G/*
@antibody_44_multiplicity_74_copy_35-1
GATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCAATTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTTTTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGTGGACCCAGTGCATGCCATAGCTACTGAAGGAGAATCGAGACGCTGC
+
????AB?ABDDD+<DDGF-FFF7IFHHHFCIIHFCHIGIDFHHFHCIHII7DG@DHHIFC=F@HHECGH-H-HFFFHEIGCIHH<IGIII=ICDHIHHFEH8FGGHH=)HGCHDHHDEH?CH;E7GDGFGHFGD0C+GE-F#CDC?=EEGGGGGAGFEEC@EG*GGCGGGGEG?G-E6E0.CGG?;GGGA?.G:6F8EE*?EE*'E6CFHEG<EFEGEEE(GGG0(E?CACG/0(0F0EC*;C?(:(G(E
@antibody_44_multiplicity_74_copy_36-1
TTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGATTTGTCTCAGGAGATGCTGAATCGGCCCTTCACGGAGACTGCATAGTATTTATTATTTCCATCATATGATATAACTGCCACCCACTCCAGCCCGTTGCCTGGAGCCTGGCGGACC
+
?????BB<-DB@DDDBFFFGGFHEICHIHFII+EHIHFIHIFIECHHHFDGEHCHFFDEIHCIHGHH=IGHHHH+IFHHHI>5GEHIHIDHHFHEH4HIIEHH;EH4HEHGBHGH?DGH?HFG@H3*+HH*CFGE*EEGG;CG#GF:=?GC(E8=E>?E9;EDG>GGF<FEC(CCG*E6?EE?'EECGFG(GCCGE;FACCGGC<>C?GEEA0'BGCGE<FF;::0GC#<)A0G'A:AG.*CC9C(**GG
@antibody_44_multiplicity_74_copy_37-1
TGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGCAACTAATAAATACTATGCAGACTCCGTAAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGCATTACTGGATCCGAATGCAGAC
+
??????>BDDDDDDD?FF+8FGIIHIFHIH/EAFHGHHIIHIHHHFH>HHBIG@H.IDHIIHA>IHHGGGGBE5HHFGI-C5-HCIHABF-AICDHIHEFDHHHHEEDHDD+EEHFCFGEHGFGHGFHFHCGFGEE>GF(*H,ECGGECEG;CEGBBE;GEEG:A?EE*BE/AEEECC:F+8GCEGF(EGG(CF:E(G:*:F:E?E:F6CC:ECE>?C?GB:GG*/D.(G8:EAG(2.E?C:E8E?C/G#
@antibody_44_multiplicity_74_copy_38-1
ATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCAACATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATGCCATAGCTACTGATGGTGAATC
+
A=????BB<DDDDD@DAFG+GGCII.IHFFHGHFI.HEIHIIHHFHHGDHGDFHIEHHICCHHIIGIGHICHHHE-FIHHG5IIHIDHH>HHHEHGHHIFFAI-HD6EBHHHHHGFHH+DHG:F,G.GD*BG@@G1EGEFEDC@@GGGFG@EEC9E8>DE?E=EG#EBGG(CAAEE<AEG/FEE/E<=GEF6?#E:'8EG0E:CGG(66C.?:E'A?:E:#CA<C*CC:.?AEEGEA(GEC((EE(6):G
@antibody_44_multiplicity_74_copy_39-1
TCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCTTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATACACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGCCACGGCTGTGTATTA
+
??A,5@BBDB9D?DDDC.CFFFHHHHIIFIIBHHCH/+FHFFFHIFGAFHHHACFHHBGA.FEH,GE5GHHIIAFIHH5IHHHHI<FHEIHFC<IDHDE.H+HHBDHH.HGGFEDFFG.GFH*GHHHFBBF,CEGEGF8GEGD*-FEECE=GC>EC;EGDGEE*GCEE(ECECGEECGGFE8EGA::EG*(EEEECG:/GGEC<?GFGGEECH8@?CEG:EGG:CDE?FG:E?E(EEECEC11A?CGG1F
@antibody_44_multiplicity_74_copy_40-1
GTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATTCAGCGTGGTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCCGGAGC
+
??<??/B<DD@ADDE<GFFFFFHIHHIFICFIIGHHGEHFHIHGFHHAIIHFH@DEHCHHFIFCF+HHDF5+EHGH='H+IFFHHHIDIHIFHEHHEEHHHHH)E(HF)FFIHHGEGFGF+EHFGEEHF+EEG+E*+*E,EG*CGFFC3AG9FFFC,6CF:G/GGEGGED*GA0?0FGEG:A'G*E?2GEG(EGGCCGCG?DGEE:HA6?:AE:=F#EGG:GGGFF=:EF:*<:F(CE?E(E/E#AA'.A
@antibody_44_multiplicity_74_copy_41-1
GCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGTGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATACATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACCGG
+
?????5B<DDA-DDBDFFG/FGHI6A>HHHGF-IHEIFFHAHH5B5HHFHHIGFHHHIC5HHFHF-HFFAIGHHHIHFH:IE5FHIIEI;FFHHI5HHF<HFHHI?GHF?HEFHH@HGFGGHHEFHEBFGDE=G+<+FGEGFG?EEDC9GGGEG;*GEAEDEGEEGFEEE0A?GEGEG8EF6E?0EA(?EDE;A?F?)AGEC:GCFF(EHEA/9E:G*;8EFG'2:EC;0C(EE(0CE6:EGEG0A0.CA
@antibody_44_multiplicity_74_copy_42-1
AGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCACCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAGGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACCCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGGGGCGAGGACACGGCT
+
?????+BB@DDDDDDDFGFGGFIFAFHFI6-GHHIFHIIHHHH)FHHHE@HDHEHHHCCFEDIIHHEEH;I=HH>=<IIF-FHHHDHFGHHHIHHHFI*I-#7HHCHH=H+@?HHHHFDE?+?=GHH1GH,GG<FEDF3ED:FEGEEGGE:0FB?C;6E'(EGGEEC(;EEEE00CEE:E6AEGEG9G(EG*1F#G?AGEG?0CC;H*F.EGC@G0:((>EGAGE?E(EADEEE*8((:G/(FE=EFEEG
@antibody_44_multiplicity_74_copy_43-1
ATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGACTGGAGCCTGGCGGACCCAGTGCATGCCACAGCTACTGAAGGTGAATCCAGACGCTGCACAGGAGA
+
?????B?BDD@D9D<ACGF.GFIIIHAFHIHIFFF0@HIIHDIHHIHIHCIFHHFFFGHIEHIHIEHIIHIEIIIHIHHHIGIGCFIHHHH:DHH8IF6H7--IHHGHG9EFGDHHFHEEF'FGF@GEFG@GGBFG=?FFCG0G9GFFG//=/EGFGE9CEC*CEF;GGGE<FE2GEGE?GEE#9CEG(G?E:AGG.6E(G1;EFAD?:*E/E0/GDGGEE:1GE/EF:?G:C.(:CCEEE:G?A*?*#:
@antibody_44_multiplicity_74_copy_44-1
GTGGAGTCTGGGGGAGGCGTGGTCTAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCCTGAAGGGCCGATTCACCATCTGCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGTGAT
+
???A????D@DDDBEECG8FGEGG0HHH;IIIIHIFIDHIFCHCGHCHHDCFGHIHCHCEHBDGHAHHFEHHGEII5=HHFIDIGAGHHH+EHDHHFGEHHHFD=EDCFHIHHDHDE<H6GHEFB;:FFEEEAGGD:HEEGEEFG0G<?GBGGFE*GEFE))G?GEEGE:EEFG0E*#F?G(;EEFEEAAGCCGE<C?;*CGE:GEFGEC8ECC8::GEE=E*ECF**.<0E1EG*CE(664EEE))'(E
@antibody_44_multiplicity_74_copy_45-1
AGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTTCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGTTACAGCGTGTTCTTGGAATTGTCGCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCTTTGCCTGGAGCCTGGCGCCCCCAGTGCATGCCC
+
??<??>B?D?DDD@<-FGCGFFICIHFEHIH>GHIHIHIIHHFHHGH+CIHHFHHDFCG@=IDHH5AFH-ACGHH?-F@DCIIHHHI8IFD+FFHIHHD6HFDCI*E+FFDGF?D6H@@HFEHHHDGEH2EFEGGEG?E3FGF0GG=G:CEGGDFEFEGFECC*.?EGE/G:GE?GEDEFG=EEE68AE4*:EC?EEGC:G?CGGEEE6A?(EGE?*GEE'FGC::0(/E:/'E(#?ECE1GEGG:8G/(
@antibody_44_multiplicity_74_copy_46-1
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCACATGAGATAACTGCCACCCACTCCAGCCCCTCGC
+
????ABBBBDDDDADECFFGFF6CF>9>FHFCFHIDHGC+E(IIDHIF*GFFIGHEHHFIBHAGG=H=HI?HI-H-HHGHDII@FHFIFHIGH=IIDH:HFDHDDEEH8HFEHFF?,H=EG9HBBGAEED?GEG:G-EF;B*E*E(=EGCGEEGGFE*.GC@GG(GE.E??F?GGGGG?F?:?FG6CE:EEEGACGA*GG?6EEGAAF?ECEHGCG'GC7?(E6A1(G:GEC-:6*EEG*??F:2:920E
@antibody_44_multiplicity_74_copy_47-1
AGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTAAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGTATAGTATTTATTACTTCCATCATGTGATATAACTGCCACTCACTCCAGCCCCTTGCCT
+
???A?9BB<DDBBDDD@FFFFG/I@EFE.AIIHHHFIHIIHEEHHIFIHIH=HHIIHDAIFAHIIGDH+5HGFIC6IHIFGHHE=HBIHEHCGG7EIE,IFHFHHHHGDHIHDG)F.@EHF:*HF6BFECFGHHEFFC;G3<EEFEGGG8EA@F;GGEE:FGGFGEAEGECGE'BCE8:C?GEECGC:?GC(GCEGG(?GDFF6F/EA<FGEEC8*BE?ECFEA6A80CC'(;E6*GFC0C:F6G*:9EE
@antibody_44_multiplicity_74_copy_48-1
TCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATGTGCAGACACAGCGTGTTCTTGGAATTGTCTCAGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATGGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCGAGCCCCTTGCCTGGAGCCTGGCGGACCC
+
??=?=?-BADED@DE-G>CGFFHFIIFHFIIHH0/IF7HHIHE@HEBFFFAHHHAHFHEHGBF>CFIGFHIFGEH@HHGI)HHHEIDHFHGIHH)HAIFHHEI;HFD<?H'?FHHGF+EHFHHAFH.GGEEEGDFDGGEGEE1G:GEFGHFEGEFEEG?C:EGGGD?F?FEG6FG?EC#ECE.<=GFFEG/FEGEEAG:EEGEFEA*;G*G:F(E*F<G@;#.GGFA>EE(?CC06':CF??*0?E:8(0
@antibody_44_multiplicity_74_copy_49-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGATCTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAA
+
???,5B?BDDDDDB?D+G6GFFIHIIHHH>HFHCFHHHCHEID>CF/CC=IHHHCFHH5FIHHGH-=HHE8IDE5FH?HIDGHHDID*HEFHI.IH<8EHFFHHHH,EIH@C;H*EGDECFGGFGGBHGEGAGEGEDGGDE*EFGE(DGDEE8DGG8:GGEE;E***CGGGEGA6GG98FEG6F8/E?<C?G(EC*EECCC;(CE2:C?A:G8AEAC<EGF,EFD:G0F?E:EEE:G(E6?(0EAG*(0G
@antibody_44_multiplicity_74_copy_50-1
GTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGGGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAACTAATAAATACTATGCCGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACA
+
???????9?@@DBDEDFFFGCFEIF-IHH.D0FHHIIH0=IEHFHGA7.HIED==H>ICHIFHE>BD-IE@IHHDB>FDA@=FFCHIFHBIGHHHHH+HHEHHHGH+HEDHFFCHGHHHDHHGFFFAEFH4GGGGCFGGH.FEEGA,F*#GGGFEE=FGGEGEEECGA:F@?CFF?GGG(GG(EEE/G;GEGF:ACE/EGG(*8FGCFECGAAG/(?:GE0CCGEG?<)-/G/8*G*CEE*C/C?:CECA
@antibody_44_multiplicity_74_copy_51-1
GGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCAATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGACCACGCTGTATCTGCAAATGAACAGCTTGAGAGCCGAGGACA
+
<?????BBDDBDBBDBFCCGFGICHIICHFIHIFGGHFIDECIHGF+IHCHCIHFHGDHIHHHHI5IGFIHH-GEGIEFFHDHGH-6EEIEIHIGG.FIFEH<E2FHHHBEDF)HC+HFEGHDAGGGG9FDE;EG@GE6EFEG0EEBECGG*E:?EGGAGEECEG5GGEGCAC;CGGFE3EC86ECEC?GAGCGACG:<E6EGEG?DE*(GEA(FGBA?E<ECFCG:C2C*?8((/?CGACE*(EGG.;:
@antibody_44_multiplicity_74_copy_52-1
GAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCCTCATATGATATAACTGCCACCCACGCCAGCCCCTTGGCTGGAGCCTGGCGTACCCAGTGCATGCCATAGCTAC
+
<??A??BBDDDB5BDBFGFFGFIIE-+IHEHHIDHAH@HDIHHI.FBFCHHC-H5DH85FFH-DIHFGI5HHHDHHHH@HFI*FH8HHCHIHHIHGH;IFCH2HHHHFDHDGHDIFEGIFEH*HGGDDGAG+GGHFEF+FECCCECGGGGEAFE0C=DF.EE6DA0*FG/CACFEG(EGG??:GF??'F**AE:GG?GE0G(CAF0?GE:FGE(G??7?-:CCGE:E*0<6.?EC/GG'C0E?EE:00AC
@antibody_44_multiplicity_74_copy_53-1
GGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGATGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGCCTCTGGAGATGCTGAATCGGCCCTTCACGGAGTCTGCATAGTCTTTATTAGTTCCATCATATGATATTCCTGCCACCCACTCCAGCTCCTTGCCTGGAG
+
?5?A?BABD<D55@DBGFGFGGIHIF/.IIHHIEHHI#CH=HIAHHFH=FFHBAF>FGAEFHIE-HIIH7HHHHIFDD=FHGBHHHI8?=FGIFHIIHIGHHBFCIHFDHHHEIH(GG7HHFBGHHFGFFBC@EFEEEGFEFEGFBGBGG*GD@E=:2GFF:#GEE?G66EEG:CEE8GD-G;D*EE<GE#DG#ACEECGF)AE:F*EGH8(ECCF3:,(G,CE*G6ECEC;E'GGE(EEGGEE?:ACCC
@antibody_44_multiplicity_74_copy_54-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTCGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAAGGACC
+
???,AB=B@BDDD9D5F>CFAGCBHI-IIF=HIIHHHIGIDIH.I/=GAEIEC,FHIFHHHHHHGEFCBH>FHHFHHG7HHI>-IHHI+FHH=EFHHHHHGI9@GGHCIH+HH?HHHFHHHFF0GHGEGE4@E@EIF/:FG>EFCCE*G=GGFCGEBEG(1G>E9EEGFEEEG)A8CG;?G(6EA-8EE*EG(GA8EG*:CEG<E6C)#E?GECE/EGG>GC0GCC0*?:;GG2/C?DE?:(?*C*8/#*
@antibody_44_multiplicity_74_copy_55-1
GAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGTGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCCCTCCAGCCCCTTGCC
+
<?????=ABDD@D@D@CGGGGFEIIEIEHHEIGI/I;DAFIIHHIDHBAH7I1EHIGGAC8F-HD5EFEFH?DDHCGHFHEFGFHDEDHFGHHGF8HHFH97IEEHGHEHFGDHH)=DDHGGGFB4FGG*FG9F?ECF?EEF?GE=GFE:E7GBF0DAG:BE(E/;GCG/GEF:A?C<GGCEG<GEA?G?C;GEEGEE?EE?*ACCEGEEE*:E@/?EC<)GDGA:F1G*FC?G#G?EG*<E1D?CEE;:
@antibody_44_multiplicity_74_copy_56-1
TGAGGAGACGGTGACGAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGTTGTTCATTTGCAGATACAGCGTGTTCTTGGAAATGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTCGTTCCATCATATGATATAACAGCCACCCACTCGAGCCCCT
+
A?=?ABBBD@,9DDD+FFCFG>HI>AIHHHIHHIFHHHFFIFFE8CEHHH@GHHFHHCFDIDHHC-+HHF-HHFIHHDFEHHHF>D?HFH-FHHIIHIHHDHDICBHHF=>@HHFH<GGFDGH+EG*DGGGHE:GFCFEFGFGEEE?F4GACE<DG#E=F;0FF>ECE:G?GE6C;EEGEC:*GCCGCG(000GGAA;GE:8EG?G*GC(EG:EGE0E,,E:8G**8A?0*C?EAECCE*C:*G'GC.CE
@antibody_44_multiplicity_74_copy_57-1
CAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTGCATCATATGATACTACTGACACCCACTCCAGCCCCTTGCCTGGAGCCTGGC
+
???5?B?BAD--?BDDGGG>GGCHC@/.ICHH9@HHIIIDHIDHA-EIHD,H-CEDEEEEHIIH-H5IHIC@HFHIF-IDEI+E=FHFHHHCHHHHEHHIHI8HEHHHHFIAE*FFE*HHHG@FDHDFG*FFHFBCEG+EC*EF./:E2*EGFEEGEGECG:'GG?/C.8GC:C*?E<FE?/EGE(G:GEEEFECEGE#GEGAG8C8EEH=((G(EG##ECE?<6FG*?G**EA('G8EE0(E6GE(EE(
@antibody_44_multiplicity_74_copy_58-1
TAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATAATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCGTGCCATAGCTACTGATGGTGAATCCAGACGCTGCACA
+
??<?<B?BBDBBDD5BGCGFFFIHIHH.EEHIHHHHEIEHHHI;I/FHDEFHIEEHIHHD@E5HIHGCHHHDDHFCIHI5+FHIHIHHHFIIHIHHH?HFHHH;FHEDHDEHG)GDICHHGHGEGE*EFGGEEEEGDG4#0EFFEA)EEG@8G#EEEE*GDGCGAGGEFGEGABEFEE:/EC<?CGGGAGGFG<E86CGG?EEEG<CCGEEA*GEDEEB,E=GCECEF(EE?4A)-EAEE/:*:6GG#C:
@antibody_44_multiplicity_74_copy_59-1
TAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGGCCCAGTGCATGCCATAGCTACTGAAGGTGAATCCAGACGCTGCACAGGAGAGTGTCAGGGACCTCCCAGGCTGGA
+
,??=?BBB?DD9D<@D.FGEFFFE.HHIIHIIIHIHFHHHIEHIFHHF@EHHI*HIHHIGCIFAFEHHIECHHHHIHDDHHICGI.FHHF=HDFIHHHDHIFFGD8FHEGFHFGEEGHHD7++DFHHBF8GFF?:GCEEF1GEEEGG;FGEGGE*CEGE6(CGEEGCGCGEEGG(CGGEEFG:EC<GG9C*:GGGCE::/6EE(EEACEH'=H:GACG?E;AG0:FC(*G08CF:9AEE*EE?D):*C/?
@antibody_44_multiplicity_74_copy_60-1
AGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTAGTACCATCATATGATATATTTGCCACCCACTCCACCCCATTGCGTGGAGCCCGGCG
+
?,A?<B?BDBBBB<D<FFFGCCAHHHBEHI/B+IHAHH,@-FGFFIFHG-HHDHAIDEAIEC5EBHFHEFIEHDH:>-IH5HEEEGCHHFG+HHEH-HFE<DHHGCHHDHCEDFGGHH=G@FGG:*E?GGEG80FFCEAECEGFGE?GCCEEGC?-DE?8EFGEGE?.:EEEGE8G'CGAFEGEG*F?F(C;FCGE-0E?E?GEG(EGAC00#(GG.E8GEE.C/(*:0ECG*ACGA-EGCG*CG#A*CE
@antibody_44_multiplicity_74_copy_61-1
TGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATCTCATATGATGGAACTAATAAATAGTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTAGCTGCAAAGGAACAGCCTGAGAGCCGAGGAC
+
???=?BBA6DDBEDADCFGCG,FBH6IFHCCIHIAIIICIGIDFHFAIH9-H9FHHFH=IIEIGCIE-IGIFFAH+HIIFII+-EIHHHIHFAFIFF@FDHFHIGEI4@HF9HF=+DHHHHDCHG8D+CGDG*GGE;GFCF+EEEEEGE;F@EG:<(E?@8E6:DGFEFAGBCAFGG:FBACEGAG(A;?ECGGE?E>GCEGG'6EH*FEC..*GCG(G0?CC9<0C*ACC*;<*CG(EEE*FG6F:.G1
@antibody_44_multiplicity_74_copy_62-1
TCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCGCCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGGGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTCGATCCGAATCC
+
?A??ABB?DD@DDD<DCEFFFGICH>HIHHH/H.GHH@HEHIICII=0BHFHGDIAFH?ICH-HHGEFH-HAIFEIFFIHIDEGHDHIHHH(GHHDE;HH@D)8HEHIHHFH+HCFIHEHFBH..FDEGGCG2CHGFGGDFA-F*B?*9EGGGEGG?0?GGEG*GFGCEEF=GGGG*2G:FFGEAFAEGEEG/AGG/E:E:GG(EGHG(F(EC#:GEECE;-CAC??E*E?;C;?;6:/9*0)C0:A(((
@antibody_44_multiplicity_74_copy_63-1
CTATGGCATGCACTGGGTCCGCCGGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGGATCCGAATGCAGATTACAATAACTAATCGATCACATATGACAACTGGCTTGACC
+
?=9??BBBDBDDDDDDGGGFGFF/IHHIIHHHHIFICCIHHGF=IEIH.HAHFGHD=E=IHHHFHIFH5CFHHHHGIH=,GDHIHHBIIDHH,F7HEGFFHHIDFHHFEHFH3DHHHHHH8FE<HFGCH/FFGFGB<EFEE;@EEGCAG0*GFE*FGGGGGEEE,DG?(EFCGGG:G;DEAEE(GEEGCEG=2CG:GGCGC8?:29C)CHEFA@F?'C<A-7E:EECCC(A(6E:?(EAAE6:-C*CCCG
@antibody_44_multiplicity_74_copy_64-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGTACTGGGTTCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACTCGCTATATCTGCAAATGAACAGCC
+
??=?<B>BDDD<<=<DF?FEEEF;HC;IFHIIFIAHGF=CIIE5?F+HGHIHHEHFFIFHHCHICHFHIHHIG5IHGIEIHEHFHHH-FAH+FFIH#FCIHIHF.HIGHEFEG>HBGFC2G*5HE,FEEGDDF@GG+F@G(FBFGGGEE*E**F(EFEG:;0EGA:ECGG?GEEEAEAGGCC(C.*GGEE'GGCE.E:CE)FCE?(HGAFGG:G;?G77CG8<EE'F?8:(:*CG?CF:'E-EG(*:G:A
@antibody_44_multiplicity_74_copy_65-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGAATCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGCGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAAC
+
?????BB@DBDBDD-AGFFGFGHH>AIHI?IHIHHH9EIHHH9EH=GFH=-DIFH*HHHHHHEHDHCE-5+HH=IECFHHGH-F>IFHFIE8GHHHFIIFI#7H9**EFH:HD?EFIH:EGEF@HBHD8GG5GGGIGGBAED=GEE;EABGGFE:EE*GFGFGGEFGCE(E'CGGGAGEE;CEGGGECGE:F:)EFF?/;AF;FE(EG(8E:E74AGEGG:.EC11:GC?6G0AEECAECE:F:A(EAEE
@antibody_44_multiplicity_74_copy_66-1
CTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTTATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGGATTACTGGAT
+
5<A?ABBBD<DD5D@?GFFF;GHEII@EHHHHHHAHIIBH7(I@H@EHHHIHGF>FECHIHFHGII>IHDGIDFIIHDHEIF=FIDHBGG?DHHHHHHHF<@CFH@F;FHFDEFH@HFEBHFFGD@EH*7D;CEEGFGG,GDD3G(BEEEGC.A*CEEAEEEEG88EG(EGGG?GG?:CGG:6GD:<GEEC:80*??F8??/6>A*.E<CC.EE(:G;8CGEF*GG?0EEC(EE:1E?G*'?6E.9(*C6
@antibody_44_multiplicity_74_copy_67-1
CGCTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTTTGCATAGTATGTATTAGTTCCATCACATGATATAACTGCCACCCACTCGAGCCCCTTGCCTCGA
+
??,?=5B+DDBBD@BDFGFFGF8IH.IE8FGHFHBHHAHEIHHHIIGGHIIFFIDIIC@5HHHIIHFHIIHHHFFFDIIIHHEAHH-HHBHFHFDH/HDHFIHIE3FGHDFH*HHHDHF+HDEGGFEG?FFFECEGDGDA:GG;EFGGEEGEFA6CGE*--EEEG:E?/GE>EEC:6A*EFG.C;:G6FG:GEGCC.GF8E?CAFGEG:EE'EECGG;)E4;CE6G6<G'CC:(#*GC)/6E/G:EE9(G
@antibody_44_multiplicity_74_copy_68-1
ACGGTGACCAGGTTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGGGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCCTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCGTGG
+
9??,?B>3DBD@-DD-FGGGCAIH@/IFFHHHI>HFHHGG0+H=HF>>D+IFAHIDHIHCFFHDFCHCIIHIIC-HHBHHBHEEFCHD5DGGH=H)EECDDHBCIDHGFGEGCGHGHFHHGDEDE3DGEEHFC9GADFGG?:CEG=*EFGEC@GEFGGDCCCGEEFGGCEEEGG'E/);GGF1:EFGEE?G*EGF6EE((?EE0EEFEE'CEEEG??G(,0G0GGG*CC*CGE0):EF(AFA/C**(?G(
@antibody_44_multiplicity_74_copy_69-1
GAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCACGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCCGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGGATCCGA
+
5,?9?-B3DDDBB@DDGGFGGFFFBII/CIIFIHGGHGHEDAHHE@8AIH=HIF>9F0@HI8IHHFAAHHFIH#G)@HA5-DH#HI<7IDHHEHHIIH5HEFH+F?+HHCHHFFH=EHCD+H=EFGDFEECGGHGC0GGG(EEEH?EC*GF.GGEAEFGG./EG)D:6=)G?ECFEEAGE:EEGC1;GG-GG8EG:G*A8/;CEE8>:E:GFHEE:E(7E*)E:DCCCCGEE66?G?E*(((EGCC.:C;
@antibody_44_multiplicity_74_copy_70-1
GTCCAGCTTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGCAGTGGGTGCCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGACCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATT
+
<?A5??>.6EDDDDDDGFF?EFICHIFFIHI,II=HBFIDFHHIEEF9IICDFIFIHIEHGEHFCH=F-IHEFD?HHGHGFIHHHCHH7IDH?IIEH(HHH@#DF=HHHGF#F=HAEEHEB(HEHHFFGCDGECHGEGF*C0*F?GGE6FGCFGFEFB=EEE?#G>G;*E>CE?/G*(?:E;EB.8(GE:?*FE-EGGFGA'=G<AE?A)E/<-CA<E8GGCGC0(.(GGG;G8:0E*C*./8?:FGC?*
@antibody_44_multiplicity_74_copy_71-1
GAGACGGTGACCAGGGTTCTCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCCAAGTATTTATTAGTTCCATCAAATGATATAACTGCCACCCACTCCTGCCCCTTGCC
+
,?=??>B<BD-B+DDD/CG-FFCEHHHHHHHHIIHHIHHDHHHGFIIF=HFH8HIH5FFHBI5AHHHHGFII+FGFFFHG5A=BHIIIGDFHDGHIDGHHHHHH7=CFGHHG:+HH+GHFH===FH=HEGF?EC(FE>*G:GEA#B:)GGEG(F(EE:EG(/8EC86FC:EE68G6DG:CGF?GA?DGC'GE-*(C;68E?G4D(GECGHGEE7E#C*G(*GC6(CE:EGG.E*EE*;:(60EF?:FG?E
@antibody_44_multiplicity_74_copy_72-1
AGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTGCATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCACTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGACCTTCACGGAGTCTGCATAGTATTTATTAGTTCCATCATATGATATAACTGCCACCCACTCCGGTCCCTTGCCTGGAGCCTGGCG
+
??A?,@-BDD@DDBD@FFC8FFFHIFIHHEI8IIHIEHGDEHH0IDDEIGFFIHHH0HAHI@II-FHE-AGEHEFHHHIF-FHI-HH<EHIDHH=H?H?B#HFHHHFFFFHFHGEH=HHEFGGEEGCFFEGF'?EGHGDD;?GGG:EG*ECE;G(EGA:CEG(E*CE*8GCA4;:GCGGC?9*C6-*GA;A(1AE:F<<G:E:?GC<<:0EC@F(CG*C:?G<C8(E(:(GCE6GEE6'G?EAECA:?CE
@antibody_44_multiplicity_74_copy_73-1
GAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGTCATATGTGATCGATTAGTTATTGTAATCTACATTCGGATCCAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTACTTGGAACTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATCTATTAGTTCCATCATATGATATAACTGGCACCCACTCCAGCCACTTGCC
+
??=??B?B-5DDDDBDC+EGGGFE,FFHCHIH.BCHHHGHHDHAIHH=HIIFHEHIH@GHIGEIHGHCIIHGBEH5-CCH57DIFIHI7EHIH8IFHFHGFEIHHHHHHHFHHGHEGFDGH3GF?FHGHE@DG>GDGEGEDDEC';EEFGAE#G(:EGGD@/GG?E@(<<EEEGGE0E:GCE?CA?EG:E=CE(CGEFGG'CEECC8E(AACHEG;(C0:(AEEC6C8(?6(GEE?:GG::<E0*EC.1E
@antibody_44_multiplicity_74_copy_74-1
GTGGAGTCTGGGGGAGGCGTGTTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATTGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCAGCATCTCCAGAGACAATTCCAAGAACACGCTGTATCAGCAAATGAACAGCCTGAGAG
+
?????<BB<AD+D?DDGCFAF>FCCFBHIEHHID9HFHAGHIGH0EFHGII:IDD@HFHHHGEHHFIII=FH-H=:5GIHFHHF-IHHFED-HGHFHHFHHHDHHFHHHHCCFHGFH,;=EE@.HGEGCGDGFFF=HCGGG**EGEGFFGGGC(*:FEG#C;GGGD5FFGEFGE0G:GEGGCG?CGC6A?6FD)E?CG):GEGF:*EA*::(E-@*#G:@/A/ECGG(E(:CE:;G?(:A8CCGEG(EE:
@antibody_45_multiplicity_1_copy_1-1
TGAGGAGACAGTGACCAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCGCTGTAGATCAGTCACCGTAGTCCCGGCTACAATATTTCTCTCGCACAGTAATACACAGCCGTGACCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCATGGAATTGTCCCTGGAGATGGTGAATCGGCCCTTCTCGGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACT
+
??A,?B5?DDDDBD@BGFCGFGIHI./FEHFCIEDHCEIIIFICI9GIGHH,FHGDHGHI.I7ICEHFHHFF*EHIF.IHHHIAEFFII+IIIII@CHGHDH4D<HDFH@DFH9F,FHIDHHAHG2.HGFGHEG?EEEH.EAEDD*EGGE,G@AG*CG)(EGGGE6EGEE(6FEE,EGGEAGCE:?EE=EEGCEF(E9G<E(CAEGC*G?E8@*GDBC/E7ECE<:E)AE</EEC:E*?C?(GE-E<C4C
@antibody_46_multiplicity_22_copy_1-1
CTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACTCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAAAGAACAGCCTGAGAGCCGAGGACACGGCCGTG
+
?=<??</BDDDBDB?DG6FGGFFEIH;I>FFIHHHIHHGEDIHHEHA-HHHH@@-IH=HHG=HIH+IAHDFH@,FFHHFHDDFFFFEIG.HIAEIHEHHHIDG6DHG,FHHHAH/FEEFHEDGFFFDGE7FDD=EF1GFEGCB'ACEEF6E0D9EGGGG6(CDCEGGEFE<EGEE:G-GE:;EEA?E6:??:FFE?EEG::8F6E;AE?80ECG7G.E(@*?EG*40EF/G)?E8*GEE:GGG:E.1GG8
@antibody_46_multiplicity_22_copy_2-1
AGGTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCACACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCAACTCCAGAGACAACCCCACGAACTCACTGTATCTGCAAATGAACAGCCT
+
?A=??BB5DD@DDB@?FFFFF>IIFIHH/F9IFFDHIIIFH+IBEBEIHIFA-@,F+HI.+I*EDC-1BIFHIFH=G?-D-FF8HFGH@FHAEHFHHGHIEIH@EFDHGD*GHFG?H5GHEC8GGFDF(HFDG:E>EGG,)HFFECG?DE;GFAEEGG3GGE:EGEGACGCCG**:BGCFCEE0G4EE(GEGCEC:??EE/#0G(:.A0C6E.FE#GAE#78FEG:G:CC(EC0EC?E(C:1/A(GA(:0
@antibody_46_multiplicity_22_copy_3-1
CCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGATACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGGCCGTCTCCTCGGCTCTCAGGCTGTTCATTTGCACATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTGC
+
<5?==@BBDD@@B@?DFFF8AEAHI8IF.-FDAHGF+ICHHGI9H:HIHAIHF9EFACHCD5FFHIHHHIGEEFFIHCHCFHIHID@IGICHIH,HFHG.HIFHFHHHHF=DB6+*E@*H1BF+GFGBBBDG?FFFEDEDGFF#GF)/G*GG@C(*GGA0(EG;?EGEGA*FGFFFCGGAGE?*(?0G.C(/(G?<E.GCC(:AF(-8GHDEEGEE0GC:>E??CEE.GEE:EGE?GFEEE1?:*0(6*C
@antibody_46_multiplicity_22_copy_4-1
GGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGACCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGATTCTGTGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGTCCCTTACCT
+
???=?/BBDD<DBB?DFGFAF/CHFHFHIH5IGF9IGIG7HHHIIIIFHGH@GHIIFCHFHHECIF-FCFFHIAHHIGCHIHIGGHFIIIEHHHIHI+H=GEHFFGCF)FBH@0FGHHFHGHFBEFGDFFE*GDEDGFGG*HG?*@GGGEFFB=GGFE/A<EA2GFEFC?EC?CE?EE8EGG?:(8'FG*)(EA0C/E:CGGG6:ECG(ECGCG8C(8;G;?GGE(AGEE?CC;EEG:DGG/G?(-(*::
@antibody_46_multiplicity_22_copy_5-1
TTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGT
+
?<???BB<DDDDEBBDF.GG-FHHIHHFFFEFH-HHI.HGICEHHHFIHAHHHFBG?IIHF=II>FF=FIHCBIIHFEHIFDG-HHHHHFEIGBHHHDHIDDCF2A;FFHEHHHHFFFE2HGHDGHHE2FEDGFGGFGD;EF,EE#GGEA,AG*EFGE-G0EAGG(GFG;GAGGFBGEACGCEGD?ECGECG/EG-FEGEGEGGEE6EAEG?'E:CGGGFC;EE(CEE;D?::?*G*:AAG?GG./?-*:
@antibody_46_multiplicity_22_copy_6-1
TGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCCGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTTTCTGCAAAAGAACAGCGTGCG
+
95???B=B@DBDDDBDFAGGGGIHFC>HHHIIHHFGCGIFGFCH8HGHHEHHIFAFHDIEIICHHG;HI4AEFF=GIHCHIHDIBFEHHD-H.DDHHFFHFGHHH+DHHFEFCGFE(H8GH=D(EFF1H*GCFF.EFC=AGEGH6?D6GEGGE/GGEE*EEGG8CGEG8G?G?(GC<?E8GA*ACGA)ECE-:?;E0GE?EG:GG6?-CH;::@EE?(EGC:GEE6:E*G*EE<ECC'E(G':.:(GE*C
@antibody_46_multiplicity_22_copy_7-1
TCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCTAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCATGTACTCACTGTATCTGCAAATGAACAGCCTGAGCGCCGAGGACACGGCCGTGTATTA
+
????ABBBB@D-<DD@F8FGGF>FHHHIF/IHHIFHFIHH.FHAIHEGHHFHEFIIAHHHHHDFHHIIFFHFHDHHHI;FHG4II5H5HHHGDIHHFHHH8=CHEHF?HFGCHH4HHHHFDFHFEGDGFGFFHGEDFGE?A*E=FE*ECGGEEG;GFEG;ACG?:;EGG(G;*CCGGC;:C0GG'(GECEGG'E*6GEGGEG-F?CE9GFCAH<@G?8EGGCEG4E**?((*G*G:EAAC:G(68;0CCG
@antibody_46_multiplicity_22_copy_8-1
CCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCGCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTAGAGATGATGAATCGGCCCTTCACAGAGTCCGCGTAGTTTGAGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGTCCCTTCCCTGGAGCTTGGCGGATCCAGCCCATGTAG
+
??????-BB<DBED<@FGGG>GHHIHHHFI+IFGHHHHHIH/EHIFIG>IFCH*IHGHCIGCHIHFGE=5DI>HH-IHHIFICCI8HGHIFA=C,HHHIHHDHHHCHHHEH?DHECH4GF(+G:BGHGCGFG2:EGDCE*F8>GGE/GEGEEG9G(GEG8ED#EEECGGGGDG/AGECG?8>GGCEG?<GCE<C:G(EEGCE?CEEA?*:E:CC8G77:C*E2?6A08*G*CA?(0*AC/E/?6EE0GG?
@antibody_46_multiplicity_22_copy_9-1
AGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGAATCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTAAGAGCCGA
+
?????BBBDDDDDDD<CFG>>GIIHFHIH;DCHHHI-CGH?FCIB99FFHFGHDFCHH57IEDGIIEI+HH>IH;@ICGEIIHHCAIHIIHIC5F-IHIIEH+DE=FCEHFDHDH#FHHEGFDHFFHFCGEFEEGGE@GG7E:GF*G9GFEE?G?GE6CFGGAB?4,GC(EEEGC:GCAE+G*?F?6:CEGCA:FEAGCEG.:AGEEG*HC/HECEGEG@8FFD(C6?AE/;E?EE*:C.:*:/CEEC?E
@antibody_46_multiplicity_22_copy_10-1
CTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCACCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTAAGAGCCCAGGACACGGCCGTGTATTACTGTGCGAGAATTGAACATCCAA
+
5??,<B?BDDBDBDEDG-FGCCIHIH.AHFEHHHHIHIFFHHII.IIIIEI?GIHEFHFIIHGHC8GHIHIHFIHFHGFHHFHEEEHHI-HIHAGIDIHAHHH3FEF7HHHGCEHFGFDFFHED2HCDGGEEEAEGEHGDGEG2GGEEEG.(GECGAE>)EFEGGGGEGFGGAGG<FEG6EG8??E:E0CEE20E*/<E*'CG?:GE#C?0G:@:EGC7(GGE*(06/AF:A86EC.?CEEEC(*GC'?F
@antibody_46_multiplicity_22_copy_11-1
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAATAAGACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTGTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACAATTGT
+
????A@/BDDBDDA?B>GFFFFFIHICIICIHGECGHDIGIDAHFE9G>FHF?>FHIGHHHGDAHFHDHFHHHHE-5FHCIFHIHIHGHECDHFFFHIHFEEHI?CICHGFFH#EFH+HFE2G3F2FDH?GDEFCFGBGEGBGGB@>AA/GE:EFEE>GECEGG?2E*CEE;GBG*E8AG>-ECE9**C(EGECFGEA(#GE8EG6FC?-?E8G*E*4GC8C?GG/GCCGC??E*;GGG:(6(6**(1:G
@antibody_46_multiplicity_22_copy_12-1
AGGAGACGGTGATCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGGTTGTGTAACTACTACTACTACTAATGTAA
+
5????>B7DD+D-BDBEGFGGGCAHFHIHEHHIII?9ICIFCHFHFHIACGH/HIH5HGHI>EHI>I5I5IDEHHIICH5FCIGII=IHHHGHIEHICHIDH@GEHEDH(EEBCH60H1FFG.CFEHFFGEGEFDGCF'AFCEGEEGEC*?GFA8?E/F9G6G?F?(#G(?ECGEG?DEEEGE8*ECFF6GE?GG#/G'*G:E?/8;AEH*0EE@E?FC.#?E::E:?C:ACC0GE?0.)(86EGCA8?(
@antibody_46_multiplicity_22_copy_13-1
CTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATTTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAATTGAACACCTAACGTATTACTATGTTCGGGGAGTTATTATAAGGCCAGGG
+
?????9><BB@9DB<DBG6GCGFB;HFFIIFHHIAHIFHCHIEE@FHEFHIHHFHHI5AHIGFHDGD=HIEGHHHHIH5FE-IIFHHEHH7HEGFHIHHHGHBBFHIFF,HH6HHFEEH=BHHFDC'BGFHEE4EI*EEEE>BFG'9BEGEEGA0*E2@CF;F?A??AFEG@G0GG0.*E'E4FF;G<A.E.?AAEEEGA?GE8GEH(E)EEDEC=(?E@C:CFEG?:C?EG0<(-((0E*ECEC*(C?C
@antibody_46_multiplicity_22_copy_14-1
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACGGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTATTACTAATGT
+
<????BB3DDDD@DD@GCGG;G?EC-F;CIEFHIIAHFCEEIIGHHHHIGG,CHEFHHGHHH=EH-FFFHHHFH5BFHIECFEFIHIHEFFIAGCHGHCHBHFHFGHHDH+F#EHHHHFB@H7EED<GHDG,;;FFFECH*DE*FE(E<EGCEGFG:GE*;A4BEGG::;8=EE?;(AG:GEE?C?1E6GEA.GEEEEFFGG(AE?EEECFC(@GCE(,GGE:GC(C.E:GA8GGF:C?G(6A*C;C:?E
@antibody_46_multiplicity_22_copy_15-1
CGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCGTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTCTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTTTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACT
+
????AA>?BDDDBDDD-GAFGGIHEFH>HIHIICHHHI,IHIIIHEHH.HEIH-HIFF5IEHH@HFIDBI@HHIHEDCIEIDCHEIHHDHHHEFHIHHCHFEH9D6FGDFHDG*HHHGF3F<FGFCGAGH4@AFDEGF#(2GBFGAFFG>GCCC/GEG(EF3EGGGCEECEG:GE()0FGAEAEGCCD:EGGEEGCE6G8ECGF:CF>EC<GHEEG**?>E:8:G(E?6EDE*CC;*:EEF'CEE6DE:(
@antibody_46_multiplicity_22_copy_16-1
GGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATACACCGTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACA
+
?A=?A<9BD@BEDDDDG.FGFGIHI8IHHEIEE9HCDHIIIEIHHH9HHHEIFAGFCF.HHII)IHCCEAACF=HCHIHCH==IEHEH7FDHDCHDH+F<BHEHH4HEHGFFHGEHDGFEHG=BHHEG#GG=E6G+>ED2(GEFEGFFE0*EG;GF:;C:(8CC?*EDEGEEE.<6(GGEGG4F*GC<-FC/GGE4G(EAG1GE:6E;*EG(C(FDG3G)G:2G*E(GEE?EF;0*CG?CA:EG:?A:D;
@antibody_46_multiplicity_22_copy_17-1
CCCAGGGGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTGATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGCGATGTTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCTAATCCCTTCCCTGGA
+
??=??B+-9DDDBDDBG@GGCGIHCHHHII-FHEICIICIHIHIGHEDHIIIHHHIDEGCDGGIHG-GGDFAC-AHHFIFFIE?HI-ICH=FIHEH;FAHHGHHGHGCDFGHEHHHHHH(EHEDFGHG7<CGFHE@G*E8EGGGGFGFEFFGF1<AG;#GC?F#?:;/;E>FE-ECFB*?+F6FGA(EE(EG?AGEE.EFEGC<(*EFAF(CD8:AE;//?G(E0G8E)GCEG(*G*EECCE*/G:CCDE
@antibody_46_multiplicity_22_copy_18-1
TCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCACAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGTCCCTTCCCTGGAGCCTGGCG
+
??5??B9BE@DDDBBDFF?GFFFHH8DHI/IFHI>7GCHGFAIDGF=IHCHCHIHE5IHI-HBHHEH-FFFHGFIIH5IGEGH/GGFHG6FGHHAFHHFEDH-HE+H,=FGFHDFFHHH=HEFFHGHGFE,GC8EE;<FBF;FFE:14G,@GEGECEE;=G?*/CEEEG?GECE2GE;GE?:CF*G1E;?G*EG8GEGC?/;GEFGA?6AGCE@:E8A?CE:D?6E;EEF/E*';GGE8/06EFCGCF;G
@antibody_46_multiplicity_22_copy_19-1
TGGGGGAAGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATGCACCATCTCCAGAGACAACGGCAAGAACTCACTGTATCTGCAAATGAACAGCCAGAGAGACGAGGAC
+
??5A,<B3DDB@-BDDFGFGGGIHIHIHHIHHFHHGIHGEDHGD,FHHEEF+EAHCHHHEGFIIIFDHIHI5FFFFH@5+FG+HHHIE@HHH-FF*HHHHFHHH@5CHCDHHHHEEFDGGHBC*FG*EEG8GEGEFGGE;*EGGE::GEGED(GEFEE0G?=EG.:E(G(;GE(FG8GGEEC'E=CAGGDE8E?GGECGCC*C(*6H:*HGE@GCE>GB:?.A*A?G(GEA?GG?G*?10:*#C(?8::E
@antibody_46_multiplicity_22_copy_20-1
CTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAATTGAACATCCAACGTAT
+
<A???5>B<D@D@D?BGGDFDFHH>H;IHHBIHHHFHIIIH@DHHFIGDD-GHHIIG.HCHH5FFHH?HHICHAIFGIHH=IEIHEH.EFD,AEFH=IHHFH(.HHFDHD+H4EHGGFGHHHHHDDFEAA@FG@GF46GGDGGE?E5GGGFGGEG*G@E5EEGAGEGGEFGGEECG6EE6CAG4GE:GGE(C?GF/<E*GAGG'D?HEGCG;FGCFCEEC?EGECEEE?GEEECE:GD(G*G.GECE4:=
@antibody_46_multiplicity_22_copy_21-1
GAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGGTACCCTGGCCTTATAATAACTCCCCGAACATAGTAATACGTTGGATGTTCAATTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTAGTGCTACTAATGTA
+
???=?5B<BBBBDADDFFFCEGIFH;ICHIHAF7FIA9IGGFHDHEHIIACD@5HH@G-HFHIHHBHIDHFHI-IFFHFEIHHIH=HHHIH5HFHFHFDH3HFIHFFI+HDHEHH+HGHFFEG+GEEDHF2HCEHGGDGG6=GEHFEGBCEGF9GEE=GEGGE8CE*AGG?G6*C6FG*(?EG(FEEAGAGE:CGEGG#GG;F(?86*4:*CHGDEC-G:CGGE<F?:E?*DEGE(*G*8*0E'*:CCAC
@antibody_46_multiplicity_22_copy_22-1
TGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGGGCTGGATCCGCCAGGCTCCTGGGAAGGGACTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACAACGCAGACTCTGTGAAGGTCCGATTCACCATCTACAGAGACCACGCCAAGAACTCACTGTATCTACAAATGAACAGACTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCG
+
???9?B<BDDD?@<?D/FF8GG>HHFHHIIDGFHHCHHI=BGEFGF/HHFHHEHAI.HHIHIEIFH5IF+-HFEIIHIGFE-IHH8GHH=HEIICFHDE4EFHHHFHEF1HH=GDHGHGEHDGGBH;H=EHEGF:E.GGEGE?G4EGG?E?-GGG'GGGGEGC?EEGE?E**1?(<FG(G?=()6G*GGGG?G>EAGAG((#/2:0A'GCG:E(=GG?GF?F/:*EEG1CG6C*?F8FF6:EA(FF#E4G
@antibody_47_multiplicity_2_copy_1-1
CTGAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGTCCGGTTGGTTCGAGGCATAGCAGCTGGTACTACTACAATATCCCATGGATTTGCCATGCAGAGTAATACATGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGATCTGGTTCTTGGACGTGTCTATTGATAGGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCACACTGTAATAGATATACCGAA
+
,?A?5<BBBDDDBDDDFFFG6FIEHIIIIFHIIHFIHIHIHFHH/>HHHIFHFF.-E-IBFF>EIGEFDHDH<IFA--HHIAHFHHFIHE+=HAFHHHIHGBHH<IH@#FHHGGEBCG,HH3'GBE=G/1FFB@:E=GE<CE:G*E:A:?;8B;GEEGCF((?A<CEC<:EEEFEF:E(AG:E9C?F(<-E?.GE?>;FEC?.2*EH<?HE:07CEC7EF::*A8EEC(C*AG2E(GC:0C(?E1G:E*G
@antibody_47_multiplicity_2_copy_2-1
CCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGAACCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTCGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAATAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGAGTATTACTGTGCATGGCAAATCCATGGGATA
+
<???5BB@DBDD-@@DBGGGCFEIIFFHBEIFHHHHFHIIIHHIHIFIHDHIHIHGE@DGFDHIIHFF:EBIIHHHH=HFFFB.EIHH-I5F/HE+FHFGIGFHE9HICEEGHFGHE@FF(GH.F;4GGEDGHGFDGCBHFEEC-6BEBGGBEGCGGEGFG0EGG<;EEEE:*4E6=GEEEEG*<:G6EFGEGCEEEF<8:GA>(GC;E*G<EE@GG?(E.G;'?GE(DG6GGD/GCC01E*C:EG0E:6
@antibody_48_multiplicity_1_copy_1-1
CTACTACAATATCCCATGGATTTGCCATGGCACAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGACTCGACTCTTGAGGGAGGGATTGTAGTTGGTGCTCCCACTGTAATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGACCCAGCTCCAGTAGTAACTATTGATGGAGCAACCAGACACAGT
+
???AAAB-DBE@DDB5GGGGGGACH8HIHCF9HIIHFGHBHHFH.HHIEFHADHFIH6HGE@HI7HHFIEHHIIEIFIIHFFIH.DHHEEDHFHHHEAIDFGHFFCFHBDFFGE7GFGFHHGEEEHHG2GHFCGGF,CEAEGG:;GGFE@EDGGGCGE/GC)EFGCAGFF<>E(CFG:CCCGGAGEFE6GEEG*;FCEF6<GCG'GEG((:CH*GFEECFB,?:2E*E8GGCG:?G*(E/()E(-CFE.:
@antibody_49_multiplicity_1_copy_1-1
AACCACTACTATCATATTAATATTAAACTGACTATACCGCACAGTAATACACGACAGTGTCCTCAGCCTTTAGGCTGCAGATCTGCAGATATGACGTGCTGACAGAGGTGTCAAATGAGAGGACAAACCGTCCTGTGAAGCCCTGGGCATACGTTCGGTCCCCCGTGTTGGTGTTGATCCATCCCATCCACTCAAGCCCTTGTCCAGGGGCCTGTCGCACCCAATCCATAGCATAGCTAGTGAAGTTGTA
+
???=?BBBBDD-DB+DGGAGGFHHICCI/IAHHHHHHAIH>FHHHHDFHF-GIH9HIEHIDHGIFCFIFFHFHFIFADHHHHEHFFECHI8IHHI@HE+5HHGE+FHCHEID#DHEG6FE*GDG>@HHEHH6FEEFH*GFDGGD*GFFG@,GGCE(EEG*EG8*CEECEE''=GC?F-(EA+E8C6:'E6(:*:;CFGGCAGCEGGHDGH0:*ECCGECCGEEGF(AE#:(?0A((:(C6(EA*?'C8E/
@antibody_50_multiplicity_2_copy_1-1
CCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCACAGTTATTTATAGCTGTGGTAGCACATACTACCCAGACTCCGTGAAGGGCCGATTCACCATGTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTGCTGTGCGA
+
5???,>B<DBDDBDD=FGF/CFEHIHHBEHIFIHCIHIIHAHDG,@HFIIFBHHHFEGHH,FIHI5HHIHD-CGHCH?HH<-HHHH5I-HH/IGIHHHGF@HGEB#GH=@EDC+HHFHHGFFGFHFDF,GH@EEFFE1EEBGGEGFDDFAGAFFGF;4;?G:EDE(2.6EECCEG9:?EGEE8<:GGC-6E(?6CG8E*?6FFE:EECG;?CHEE*DECEG7E2?/0DE8GG'EA8<1E:C*E?EAA:/(
@antibody_50_multiplicity_2_copy_2-1
GTGCAGCTGGTGGACTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCTGTGGTAGCACATACTACCCAGACTCCGTGAAAGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCC
+
?????BB=DDDDDE-DCBG6CEHH-FHAHIIHHCIAHHFHDHIIHIHI=F-FHHHH,FIHFHC-I-BFHFIICHIIHGIHII>HHIFHFDFHIHHHHI9FEIFGHEGEHF?HFDE+@GGFH4AHGHFEGFG=F8GAE?E?FGG*'?,;GGFGGGEEG:GEGEGCGEE;F;CCGACGEE6C;G:*FGEE#E:G9':GCG8:)EE(G(HCC/GE#.FEGA:G'CE6C(1(G?:G(GG(GGA?*?-*C#FA?-
@antibody_51_multiplicity_1_copy_1-1
GGGACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTATTCAGCGGATCCCCGATCGATCGTATAATAACCACTCCAAAAATCGTAATGACGTCCCCGGGTCGCACAGTAATACACAGCCGTGTCCTCAGCCCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTGTGGAGAAGGTGAATCTGGCCTTCACTGAGTCTGAGTAGTATGTGCTACCACAGCTATAAATAACTGAGACCCACT
+
?,?A<>BBD?DD@D9DGFGFEFHHHIHEHHGIHDIHGHFEH/.II>HHFH*H=HDHHHH5FDIIGHHIE+=I.AH-DGHH4HFBFHHIGHIHHIHDHG;IGCHHEHHH<EEA4HEFF0EHFDGEBFFH#GGEHF4CCGGE.;E;GGEC'G=E@G#ECECCC;G?G(E:FCEGE:#E0EG0E(FFGF;?AEFFGE(EEEGC(C<EE;.FGHGAHE7GBC7G*GCGEDE:0CE1()FE:GC4GAEG/GEC:(
@antibody_52_multiplicity_1_copy_1-1
CAGTGATTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTAGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAAAGTCGAATCACCATCTCAGAAGACACGTCCAAGAACCAGTTCTACCTGAACCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGCATTACTGTGCGAGATTACGCGCATTACGATTTTTGGAGTCGTTATTATTCCGATCAAGC
+
???9,+?B?DDDDDBDFF@GFGH>8HH;HFGFIHG+HHIIHHFCEHHH@IGHH>HHHEHFHAHHI@HHIHFGEHHHEFEFEI5IIHHH?DIIFHHDHEHHI@=DHHH=A;GFHGDHFHFF#FEE=(FHDEFCEGEDEBEFD(5CFE@2;GF;?4EC6:CEEGF(F;C:EGGGGG:ECCEE:?FCC?GEC6'(0E(GGC(A:G;-GCE<G:G/CEEGGACAECAE:CE4GEE4CG:A?GE:0EAE:*E:A9
@antibody_53_multiplicity_24_copy_1-1
TGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATAATACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAATACGCTGTATCTGCAAATGAACAGCCTGAG
+
??A??BBBBBDDDDBDD9GF.FIHIHIIFBI?HIHFEF@HHI@HIFFCFFIFIH9HC+HHBGHHECIHH=-D=AH-G@DIH;FFHGCIGHHHEDEHFE2HF9=GDHHHIHHFH*HGF+FHH,F5DHFFBGFFGF?*EGGEEEHEEG2GGEGFFEGGEEEF:8CGGE(AAGGG?GCFEEEE1E?G/0FEEA;FEEFA6GECEDAG?FE(<?EAHG:(((EEBGA'C6?E(*/ECCCG=1'ECC*AA?CC?/
@antibody_53_multiplicity_24_copy_2-1
TCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGATAGTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTACAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGCTAGCCT
+
??5??BBBDDDDED@BFGGGGGH/IICH,ICIFEFHID9HIIFIFGEHFIGFH.FGIH.IGCIIGCGDFHIEFBCHHFF-FIF<IHHIFHIHIHHFI?HEHFH8HHHDDBEH*HHHFEHH7GGHEDEDEHF0EB>#*#BB<EG?BG6F:GE@E:?GEEAGEGGG9.G<.:E?GEE);EGCEAE*EG*GCAF(?EGCFGEG(:1GEEHG:E?E((GCGGCA?:AEG?/E8GE:*F/GA(FEE0AE1::.:F
@antibody_53_multiplicity_24_copy_3-1
GGAGACGGTGACCGTGGTCCCTTGCCCCCAAACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGGCGTGACCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGCACCGGCCCTTTACGGAGTCTCCGTAGTATGTGCTACCA
+
??<?A@BB@DD-D-DDGFG6FEICIEFFHFIHEAHEHA=H=IHHIGEH?BHHGFIFHEHEHIHIIGAFHD5HAHF<CHHFHG5EIIHHEHIIFHIF=-HHEHFFHHGHFE=DHCFGBDDFH@FCHEFHEDFG?,=GGFEA'FEGG(E6BFE6G2CFEGFGACEEDG??EGEEE(AE(FEAE>CAAG/GFGG):CEE?GGGECC;CEFCCAG#E@@*0CGG?F(C:C8E?/A)EG;*E.E0CA0:GC?(*?
@antibody_53_multiplicity_24_copy_4-1
GGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCCGGCTCCTGAGAACGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGCGACTCCGTGAAGGGCCGGTTCACCATCTCATGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAAC
+
?????B<?DBDBBDDDGGFGGFEFACFH?EIHHHHGEIHHEEIH@GC9EHIEADHEFIIHEH.ICHFFHIAIC;HEHHFIHF?HHH(.HIHIHHIHGDD@BF;FFHH,F.HIF+H-HG:EFGEBEC)GECHFF3H6GF:<F,;;3G?GEC@;*ECDGD?CE?GABGC/EE?CECEF?FEG,G(/CCE?GGEE*EGAE:D>GFEC:88EGFA)EC7*GEBFE,?EE0*AADE8??EEEG6CEEE?0GA.EG
@antibody_53_multiplicity_24_copy_5-1
TCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATTCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAATGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGGATCTGCAAATGAACAGCCTGAGAGCCGTGAACACGGCCGTATATTGCTGTGCGCTAGCCT
+
??A??<B=<BBDDDBBEGDF0EFI>HIHEHIHGIGAI=E;GH-FGEHH#IF.BHHDCHHGDH,HHFHHH-HIHHE>IIIIIC+*IIEBH+HHHHGE7DHHEFGH=H+7HH.G83G+HHBFHHDFFGHFHG=B;F=CE?D>4EG?ECAE>EG/A<FGGECG;E8B;AEFEGGECEGG'/A:E??GCGECD#?EEC(EGEA?E?'*GG(#G?8EECB-C*C(*GEE<E</AEC-*C6*?6*>C:G8G??;AG
@antibody_53_multiplicity_24_copy_6-1
TGGGGGAGGCTTGGTACAGCCTGGTGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTGGCACATACTACGGAGACTCCGTGAAGGGTCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCATATGAACAGCCTGAGATCCGAGGAC
+
???5A@?B+@5B-BD-EG,*-GIF>/+IHF?IHIIHCCFCFGHFHAF-IF-IEIAFIAEGGFECCCIFFCHHH5+FCFF5HFI/E=GBEHHH5IID6HHFIB4HD6HFFDGCHFDIGH?HFHFFGFGGCE?@FBGGDFCGGG(FCCFG*GGEECGAGG*6:?CGE0EGGGEFGEC4G+*GGGCE6CG(9G6A/E6EEFCAE(1DEEEEEEEEE(.ECGFEG(*GC8C/((CE)E:E:'<(E#C:(E*AEG
@antibody_53_multiplicity_24_copy_7-1
GCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCGGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGGACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCAACTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTG
+
???A?B7BDDDDDEDDFAAFGAFECAHFHHIFIIEHCFFIHIICIHHFHIHHI=ICCGHI=GDIEGHGHIGHIEHIIFDHE-FEADHFH8FHHHHH5FEHEHFC4=+#GDHHE+@FDGHHHAHEGFBG(FGDD9EEBEEGG4F88GEDEECBF;EEGGAGC(5F6E8C6E<GEG.GGF:A8EEGF?=E6EAEEE?F/C0<*A:F??E/*FC:@0*.C?EEG,9CEC;E*A)/G:G1EC;E;G(E(.GACC
@antibody_53_multiplicity_24_copy_8-1
GGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGATCTGGGTCCGCCACGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGATACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACATGCTGTATCTGCAAATGAACAGCCTGAGAGCC
+
???,5BBBDD@EBDBDFGGCFCHFE.HIFBIFHHFIGIF7HH7IIFEHE5HIDEEGE'FHADIIHEH?C*CHGDHFHIIIIHICIDHCD#IFDHEI=I3EID'FGGHBFH@EE8FBE@EF@DHE6BEA?EF=FEF<0EDE9EGEECFGE*EFCE.EEEEGG9'EFEEG*'?;E/E/CA(GCEEFGF1E6GC'GCEE/6C86ECEG-H;CH:GAGE?EE(GCCGC(?0/CE?E;FA0G8A=.E6CEF#:C(
@antibody_53_multiplicity_24_copy_9-1
AGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTTGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAATGGGTCTCAACTATTAGTGGTAGTGGTGGTAGCACATACTACGGCGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGGATCTGCAAATGAACAGCCTGAGAGCCGTCGACACGGCCGTATATTACTG
+
5??=?@>9@9DBDDBDFGE;>FHEFEHHFICHHHHI9I)EIIHHEIHHIIIICHCGHH5DHCHFIFD+EDED-I-EHH?HG+HHHHDGHEHCHGHFIHFC)HF,HGEE?F#HFGE<EGFHHD5EGFGGECGEHDEEGGGHAGFGE#GGEEGEGGGEEF?GG2=GEEDADA?F:GEEGAEEG?'E/G1EEACCDEAG?F;F.EC?CG(C<C#/H(EGGGC@:GGFE6EG((E.C0A*.AC?(CCGC;G?8?
@antibody_53_multiplicity_24_copy_10-1
TACAGCCTGGGGGGTCCCTGAGGCTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCTGGTTCACCATCTCAAGAGACAATTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTA
+
?<A??BBB@B-D-D@DFF>FGG-I6HF.AHHHIH.F8IIFDIIDI@9CHBHH0HH>DIAFHIAGGCIH-HHDHHGHIHHHHHCHFHIHH7/DIDHFFHHFFHH@FBHEHGHF@>DFHCCFDDHBFFFH@EDF>HGF=EGG6GEB#GGGG,EACBEGG-F/E(FF(EB;H?601EC1??(?AEEEG(EE0<GE?EC?#FE#(E.6:D?EF?G/HAGEC?CEE:;GGE:GCGGCCGEEA*;:A4??E:0-EE
@antibody_53_multiplicity_24_copy_11-1
GGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCTGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGCTAGCTTCGCTCTCGATGGATATTGTAGTAGTAG
+
?A??A/9BBDDDBDDBFFFGGFF.FIF-BEH.CAF0CGIHGH/H5H-HFFFBHHC>HGAIHHIIHDIIHIH-GHHHFH=H-HIHE=I(H-IFHHEGIDFHBIHHGEBH)DH0HFH=GH=DH(GEGHHG=EDDDHHGB9GBEEDBG<EFGEGFEE0BE(*ECCGFAGEE*CGEG;GGC:E?FAG?G*E?*EGC*G:CFG(G:G?.-.HC<CG*HFBEG*)GF#AGGE:EC:AE4EG:GGG1:E:0?EG:E(
@antibody_53_multiplicity_24_copy_12-1
GTGACCGTGGTCCCTTGCCCCCAAACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTGTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGCCCTTCACGGAGTCTCCGTAGTATGTGCTACGACCACTAC
+
<???ABB?BBDDD@DBFGCFGFHHEFEFIAIIIHFHEH.HIIFG#IHFHIHFFEHHH-+GCHGIFHHHFHBFHHHHFHIIFHEHI8FH?G6EDHDHEI@HHE+DHHHDEHBHDFGDF+HGFHHGFCBG?EEGGE,EDGGFEHEGE.2)5GFEGFACGE93GEGE6(6EGG6CGE?CECCGA3C;GEEG9GG.CGEEGG*GF::EGC.CGC=:EECC?1?E':EA/?(*:.G*<-E0EGECA(F/E:E/C*
@antibody_53_multiplicity_24_copy_13-1
AAACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGGCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAACGCACAGTAATGTACGGCCGTGTCCTCGGATCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGCCCTTCACGGACTCTCCGTAGAATGTGCTACCACCAGTACCACTAATAGCTGAGACTCACTC
+
???=?<BBD9BBD@BDGFFGFFIIIFCIHHHHI9HHCH9IHFC#HHHEIF.FHIAHCFHIICFHDAEFHFFDHGDE-IHIDHE-GGHHHEHHH-GHCHCH6G2H#E3+DHIFBEFGHCEGFHD+HGG=FHHFE+EEDEEE0E*BGEGEGA>C>EC;A;CG8BDECG2F@EAC6CEGGEEFGG//?E?EEECG(GCAEE2#:CAAG*AGE'EEFEE.:*EGE7FE*;1EG?E6G/EE6*CG*8CG(:(9?E
@antibody_53_multiplicity_24_copy_14-1
CGGTGACCGTGGTCCCTTGCCCCCAAACGTCCATACCGTAGTAGTAGTAGTACTGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGTGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGGCTCTTGAGATGGTGAACCGGCCCTTCACGGAGTCTCCGTAGTATGCACTACCACCATT
+
??,A?BB-B9BDDDDBCCDGF-HFIHIEEHEIIFIDDHDHIHHGFCHHF+EI-HDIF-BHHFHFHFHIBIGIF-FHDCEHCHGDFH=HHEFFHIHEFGCHEHHHH(GICHGFF3GHHHGGIH(GHHHED>HFGEDFEGEGF79:=GG)EEFEEF8EE6GGAGC8CFFGE?E?CGCEECE(G?EEGE(CGG</GE<4A(*(?E?ECF?(2(*/;EE:<EE/E(:AECE*CE.G?AEG6('?**C<E6D*'?
@antibody_53_multiplicity_24_copy_15-1
AGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGGGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGGCTCCGTGATGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTCAATCTGCAAATGAA
+
55?A5BB<DD<DBDD?G-FGFCI;IC/IEHHFHIFHGIIIFIHHGIHFIBFEFDFDFFDHIHIHHEFI5BIF=G-HFHIFIEHEH+HIFHHFHHI7HE5HG(DHFEBH=>D=FHFHH*HEHFGE'GEG*FGFFH9'BCGEE:EG.GG(GGDG?3;?GE*G:FCFFEFGGEA@FG:GG(GGG;E'@G:8C?*E(CAE(.EGEG8CGA?EA6C8A/:F#C#CE)/FCCCDE.C?.EG'*1EC?0EG:)E:CE
@antibody_53_multiplicity_24_copy_16-1
GGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGCCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCC
+
??A??97BDD@EADDE?GFF-FHI-II>HI=DE9I.BI-HIDH,IF+-@HHAIFI+EI?.ICD?E=AF-B>IFHIE?IFDF-FFGFFHFHHDH-E(AGFCHG++EHEFHHH@H5G@FIHHFG*DGEDHGG:EA=EE*GHGEFGBGEE@ED**1.CGEEG?BGFE1>08//GEGGGECCGGFGGGG?FAGEE?EAGEEGGE*FAGE?C*E:(C0(@.?0C;E0E:CAG0AEGCC:A6EG:?0:G<;:AEA)
@antibody_53_multiplicity_24_copy_17-1
TGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGTGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGGGC
+
?5,?<BB?DD@DBBBDGEGFF?CFHFII9IEHIFH9DDFHHHA+HHHHHG9FHEHBHHIHGBFFFIHH@HDIDFI-IHHH4H-HIHIHFHGHIIDFHH+IHDHHHHHFDFAE>C*7HHHDGB5G4E,H30GFDFEGDDEFGEGGGG*GGG*E*:=6E@(ECG?EDFEG*(CGEAGC?G:6F=EFCGGG8GEEFF:6CGGEG?CCE<HG6*-G@FEFEEEGC8A:(EACC?)>ECF?FE?(FAG1:E(*8E
@antibody_53_multiplicity_24_copy_18-1
AGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACCGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGCTGGTGAACCGGCCCTTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCACTCGAGCCCCTTCTCAGG
+
???=ABBBDD-DDDDDFFG>GGHFHIFHIBDHIHHIEGHBIHHGFFFHH7IGHFHFDCI-FAHFIED?HHEHDH=HAGGIHFEFH@HIFH,HIH#HIDHHI=CAHEH6HDHDGDGEEFEG;EEH*EGHFFEFFFGF#EFGGF*EGFG@5=G?EC>FFGEBE*G5GEFG0CEG#EAG?20CA+EGCGE6F:D:>AA(G-G*C?GCG>A6CCEFE:E(*?7GEE/G*CG)EE/.*.E(A(8GCGE/*A16G?
@antibody_53_multiplicity_24_copy_19-1
ATACGGTGACCGTGGTCCCTTGCCCCCAAACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGCCCTTCACGGAGTCTCCGAAGTATGGGCTATCACC
+
?,?A?B>B@DDDDD@D@F>G>GICIHIFBIIHIEHHBIDFHHHGHI7HEBHF.GH,@FFEEFICHGIHE--IHHEEHFI=HHGH=8HDGIHHFGIIIHHDHH0HGFHDHHFEFHHFHFHFFECHH@GGHE.G*:DEE;GA)?EE3E*0GGEE?GB/G*GGD#FE6*GE<GG?(EF0GG;GEGCGEF'EFGE9G:E*<EEDCEFC/DE*?H('ECG98GF(G<8FCGGGCD?(80C?E/A*(C*E)(G:GE
@antibody_53_multiplicity_24_copy_20-1
TGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTGCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCATGAACACGCTGTATGTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTATATTACTGTGCG
+
A????BBBDDB-<DDD8FFFGAEFFHFFI.HIHIHBH+HHIIH8HCIHHE0FFEHI.IEI'HHHHCHDCFHCFDD5F>I-FIFIC=HD6(?6HHHH+HHDIGFFHHFBHEDCCH5FHHGHHHHGFF@F@HG?EBF@G,EFEFGECH(*GFGFEGB)EEEEEEGGFC9EEEAG:<EE;EE):CFE:(EEE??GG0GEE.8(EEGGFAA(GH*/AFFEGC?@FE?EG:0????*G;'EE?EE=GGFEEAC.G
@antibody_53_multiplicity_24_copy_21-1
CCCAAACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGCCCCTTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCA
+
,????BB=ADDBBDB@FE+CFFH.HHH>HHHHGII=IDE7CIFHIHHEIHGH@-HHHFHEIFIFFHFDIHE;HHHHDEHD-EICFHH5IHFHID=FIHHHBHIHFHEHH<HHFH9HEHHBFAHEE8GEFECGABFFGGDFHBFE/F;EFGE2;EEEFB(CFA:GEFEBEG(E;E(?C:F(8A2AGEGE(((E?:EGG6:E/;:?G:E?CA?EEC'E8'?:(AG?EC8EEA6GE?:EEG(/:?F*'FE1G0
@antibody_53_multiplicity_24_copy_22-1
TGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGAGAAGGGGCTGGAGTGGGTCTCAGCTATTTGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCTAGAACGGGCTGTATCTGCAACTGAACAGCCTGAGAGCCGAGGAC
+
??A?AB?BDDD<DDD5FGE*+FHHIHFC>CHHHHHHDIIHGIIEHEFCAHCABHH+F?DHFHEIDHEGHBC0I,FHEHHGEIHGHGHCHHHIH(HHH/BFDFGDFHHHGGBHFHEDDHFHF@G3@FG(FHEGD#*GGGEEEFBGEF@FEFE.GB:/GG0DGE?AE?*E/EGE08EEGF;?CGC?*EAGEEAE*EGEGG0GA(CD8#*(E<?.*EB2:G.G<C?A*8*G/:GC:A*CA0C/AG:CCEEGCG
@antibody_53_multiplicity_24_copy_23-1
TCCCTTGCCCCCAAACGTCCATACCGTAGTAGTAGTAGTATTGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGTGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGACTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGGCCTTCACGGAGTCTCCATAGTATGTGCTAGCACCACTACCACTAATAGC
+
?<=?A?BBDDDDDD5BCFCFGGEIIIFHHIH;9IG-=AG-0EHGHHH5A,HAHHIHHFE-EI>FHGFHHHHH2FAIIIIAIGEHEEFIHHIIH+FDHH+?HHHHCIGBHFEHHGHDHA=GH,FF3HGFGGGDFF#GEEHEHCEGG;=GCCE@C,FE*E,G?G:GC:EGFEAFGFEGGGE?66EE:;'=E*-GG<F;CA00'CGG:CE/<AACEG'G7(,G*7G(CE:G*?**GG(/?E:E0E6EE6CG8E
@antibody_53_multiplicity_24_copy_24-1
AACGTCCATACCGTGGTAGTAGTTGTAATGATCGTCGTTCCGCCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTCCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGCCCTTGACGGAGTCTCCGTAGTATGTGCTACCTCCACCACCACTAATAGGTGAGACCCACTCC
+
????A/BBBDBDBD-DCFGFGGI#FHFEAHHHE-AC4IHGFIEHHEHIHFDHBDHGH9HIHFHIFHAGHHIIH=HFFBE=GHHHHGCHHIHEFDEH*FDHB7GHC:AGDFHH*FFHHGFEFHGHB*FBEGGFHEE:EFFG1DE5GGGFED86CG(EGEGCEF(E*EEE0@?:EGAEF?:AEAC#:CE.0CCE*C./GEE*'G=EFE6CGAGCE@CGG.,#CCEE)EE(A?-A??/0*:EGECAC()AF/C
@antibody_54_multiplicity_2_copy_1-1
CGTTCCGCCGGCGCATAGCAGCTGATGCTACTACAATATCCATCGAGAGCGAGGCTAGCGCACATAATATACGGCCGTGTCCTCGCCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACCGGCCCTTCACGGAGTCTCCGTAGTACGTGCTACCACCACTATCAGTTCTAGCTGAGACCTAGTCCAGCCCCGTTCCTGGAGCCCGGCGGACCCAGCTCATG
+
,??A,BB,D@DDDD<D@DGFGGHH8F//FFIFICFI/CIHFIFAHFHHHF9FBHID*IEFF@HFEIFF9EIFACHHHCGEHHHHCH-CHFHIGDFHAH<DI)H<DDHHFE?+HHH+FHD,AH+GIEE=+EE'E,8GCHFFBGF7EE;*EE/E=7@<EFCE:GEFGFE/E)GGGE*C-<CEEE0GEC*6*CF<6?G'(C.ECGE;CFEE(**EE8C8EE?E)/#8CG:C??:G:G/EEF:EG??AE(E:C/
@antibody_54_multiplicity_2_copy_2-1
TGCAGCCTCTGGATTCACCATTAGCAGCTATGCCATGAGCTGGGTCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTACTGATTGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACATCCTGAGAGGCGAGTACACGGCCGTATATTATGTGCGCTAGCCTCGCTCTCGAAGGATATTG
+
?????5??DD@<B<DDGFF+F-HFCE8HFH@9EHHIII9GGFHHFFFAI.AH5HIDI5HEHIF-H=IF:IHGDDDHHHHHHI=HH=+HCHIIHD+=FIGFHCI=FBH)HFGFFHD,HDGH+FHFHHG@H=FGEFGGGFGF4D8E(EEGG@FGGFCFE.GE?E@E49CGG;EGEECE*GAG;.E*FGFC*EG?::G?A?:6EF*-ACECC);E1GGGGE?G:;:CC6GGC***G218EGE2#('.GE*F?A
@antibody_55_multiplicity_2_copy_1-1
TAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGTACTACTACAATATCCATCGAGAGCGAGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAACGGGCCCTTCACAGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCACTCCAGCCCCTTCCCTGGAGC
+
???,?BB>ADDB5A<@CGC/F8FIFEHFHHHIAGIFIIHBHIGHCHHFFIGH+HHE-FHHIEGIHFFHFIHIICF:H<HA-II/HHFH>IFIEHIIDFHHDDG@FHDCIHE+HE6F3FEBFG@GF?FGF?EGEHGGG;1GGEGFGGAGEE0GBAEGE@EGE0FG,FGGGGGGAFE2EG(/C/'FCEEGG;G?AE8C;GA/G8G2GC=E<?EECECG?*E8<CCE/E/AECCCECEE(*9:?'*GECE*EA
@antibody_55_multiplicity_2_copy_2-1
ACGACCATATCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGCGAGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCGCTTGAGATGGTGAACGGGCCCTTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACAACTAGTAGCTGAGACCCACTCCAG
+
<????BB>DDDDADBBGFFGFFEI>IEEE.FGHI..GID0HIIHHF@H.HHG5IEAHHF#HHFEGGFIGGI(EIH5EIHFGEIHCCHIH5IGHFHCH-5EH(EHH5HDIHGFHFH@GG;FG.HFEGFDGGFDGH;F'-GHGEEFHEGF0G:G*3AEGGGEEDGCCG)C*GBGEGED;A0AA?6ACCG:AEF(1ECCECGEC:CG(G?:;CEEFE(47G?EE0EGE)?<C6'GA?GC>6EEE?:A/>E?:.
@antibody_56_multiplicity_2_copy_1-1
GCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTTCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTGCGTGAAGGGCCGGTTCACCATCTCAAGAGACAAGTCCAAGAACACGCTGTATCTGCAAATTAACAGCCTGAGAGCCGAGGACACGGCCATATATTACTGTGGGCTAGCCTCGCTCTCGATGGATATTG
+
?<A??B?BDDDDDEDD?FFAFGHIFIIIHF-IHIIIH=HDHEIHDHFFBIGHHIHDIG>FIAFF8=FHCIII5HHFHIHHHBGHA5I6HIGH>HICHDI08IIBHGGCFCHCEEHFFHG.G+FHHE*GGHGGHGHF@EGFFGG.8FEED>F/@>G,FGGCGE>G><EEFA*C*GE:E0GGAC(EEGE?GCFGGGE89:EGEEAEEGH0(E*?**GE(E,G*GF)FC:(EG(:E?G::E?<?CEADE8E?:
@antibody_56_multiplicity_2_copy_2-1
GCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTTCAGGGAAGGGGCTGGAGTTGGTCTCAGCAATTAGTGGAAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAAAGACAATTCCAGGAACACGCTGTATCTCCAGATGAACAGC
+
==???-BB@DD<DDDDCGEF-FFHCFHEFIIH.CFGCIIGIHHHHI?HIFFIIHF@DIFHHF.HGFDHFA->HHHFHIEFFHFEHHGHHIEGCFDHHGE;HFDFH+HFH@HEHDGE,4>HHFB;GEGFH9FFEG#EGGGG*G=G#GB*GEGGG(GFEG?DGGGCGGGFGEEGCGGCE/CEE<?C<<0F(A6G?0?///GGFCG6:EEGG(?A:EGDG'=G?CGEE:GE?EE12E?A?':6(EE::CG8C6
@antibody_57_multiplicity_7_copy_1-1
CTGAGAGTCTCCTGTGCAGCCTCTGGATTCACCTTTATCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGGGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATAGTACGGAGACTCCGTGAAGGCCCGGTTCACCATCTCAAGAGACAATTCCAAGAACATGCCGTATCTGCAAATCAACAGACTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGCTAGCTCGCT
+
??5<?9B?BD-D<<BDFFFG.CCIBFHIIH-GI>HGC>HHHHIIHDFEHHAHIFH0H5IHHIIHIGIAHHHEFH?=IGFGAH>/IH?HHIEFIDIHHI#FGHHHEHHDDEHFHHFHGFFEFHHE7GDHGDA?HG*CFHEGCBDB8G;FDG8GEGDFFFECGGEGFE=CEG@G(E:9CBGG/(GE#:CFG#/GFEGC?*GGG/GGF(*:AH*C(G:(.EE(EGGCEEG#GFGEGECEFE(8D*FE(*E/EC
@antibody_57_multiplicity_7_copy_2-1
GCCTGGGGGGTCCCTGAGAGTCTCCTGTGCAGCCTCTGGATTCACCTTTATCAGCTATGCCATGAGCTGGGTCCGCCACGCTCCAGGGAAGGGGCTGGGGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATAGTACGGAGACTCCGTGAAGGCCCGGTTCACCATCTCAAGCGACAATTCCAAGAACACGCTGTATCTGCAAATGATCAGACTGAGAGCCGAGGACACGGCCGTATATTACTGT
+
,????BBBDBD5-DDDFF.GCCIHHICHFAIHHGDFEIFIFIIFEEIHHIGI:EHH:HGHIG*HICI?BEIGBHHF5H+HHGHHHFGI?IF.FFHDHHFHHED285G@HGHF*H=H'FG<F5@HFH,=EEHDG@EGCGH-EGEEEEAE;GFF*GEEFEF:GEEFGGE6GE;?CFFGA(EEG?6(8EEG8?/6GEGGE?GAG8E8GA6:AEFA(GB9E(1F;:G:GF*C0*G(:C66'?A?/8F018?F:D
@antibody_57_multiplicity_7_copy_3-1
TTGGTACAGCCTGGGGGGTCCCTGAGAGTCTCCTGTGCAGCCTCTGGATTCACCTTTATCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGGGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATAGTACGGAGACTCCGTGAAGGCCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAACGAACAGACTGAGAGCCGAGGAAACGGCCGTAG
+
A?<??>BBDD9<BDD5GGFEF/HHHHIFHI>HDEGHGFAIID.CIHEHGI9;IHHHFHIBHIIICDGHHHHFIHHHDIHHIHHHFHFIGEICDH@F9H-HDH@1CHHFHECFH)EDGG:=H9E@HFF+7FGDCGEEF=GEE;GE;AFGGGGGGC0GGFGGCF@EEF8BG1FC?EGDGE?GC?G?EG;CE:A(GEEE?GG:#EE;ACE?((:A>)EGG(?E9EE6??FE9E(8CECG*:8.:ACEC:CC;(
@antibody_57_multiplicity_7_copy_4-1
GAGTCTCCTGTGCAGCCTCTGGATTCACCTTTATCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGGGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATAGTACCGAGACTCCGTGACGGCCCGGTTCACCATCTCAAGAGCCAATTCCAAGAACACGCTGTGCGTGCAAATGAACAGACTGAGAGGCGCGGACACGGCCGTATATTACTGTGCGCTAGCTCGGTCTCG
+
??<?AB,BDD-D@-ADGFF/FCFF/HIAHFI@H9HHHHHHDH@FHF@FIGFFHHHHFHII@HIIIHHHFA=HHDIFH=HFHCHEIHIEEICFHBEGHHIDI6HHEHCHH(DGC4H=GHFHGGEDHGGGFGHEGGB:FE#EEB.FDGG(FBGDGCFGGEEE<B#)/?:FF:<;E@GG:FGG)GA#/(F/D8EEEEFEGG?E/EGEGFC*C:(E*@E8B??GCGE*E?EC?)-CEG.CECE8GEG'*?0CEC
@antibody_57_multiplicity_7_copy_5-1
CGGTGACCGTGGTCCCTTGCCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGTACTACTACAATATCCACCGAGAGCGAGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGACATGGTGAACCGGGCCTTCACGGAGTCTCCGTACTATGTGGTACCACCACCA
+
?????@?><ADDDDBDGGFCGGIIIII+HHHHDHIIIE8IHIIEHEDH=HHIGHIFFHF>DAHFHHEHIFHEDGHIHIHIHFH-5HGHGIHH.E<HIFEHHH)+EH*3FGH#HH,(EFFHEBFFFFBE(F;GE;GGGGG;EF;EE?EGGGF:::EFGG.GC=EGCCE0?C?F.D/EEEBCD(EE9:?G.CGEEA?(GG/*:CG?GGHEC:GG;EDCFGCG::AGEEGCE*CGC?8?:.'E?'EEC86;/E
@antibody_57_multiplicity_7_copy_6-1
GAGGAGACGGTGACCGTGGTCCCTTGCCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATGATCTTCGTTCCGCCGGCGCATAGCAGCTGGTGCTACTACAATATCCATCGAGAGCGAGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGTTCTCAGTCTGTTCATTTGCAGATACAGCGTGTTCTTGGAAGTGTCTCTTGAGATGGTGAACCGGGCCTTTACGGAGTCTCCGTACTATGTGCTAGC
+
?=,?,BBBBBDBDBDDBEFGFG.FFEFB+HHIHHHIHCFIH=FDF@0GFHDIGDDHGGIH>HGIE*HIC-IHA>IGDIIHHBHBGHIIEIHFH'EI*IHC'HH?HHHIHGHFH@H@HG?CGGGDGHBGG*HGFG(EFFEE;+(G@F*9C>C(G#AEGECGE@E>0EEG?*@E6AAB'CEAEGAEGE0G9CEFF;'GGEE:FGEG<(:<CFE(E(EDEE?G7GE#8EG0?C?.C*(F/:.C*FEEG8:C(E
@antibody_57_multiplicity_7_copy_7-1
CCCTTGCCCCCAGACGGCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGTACTACTACAATATCCATCGAGAGCGAGCTAGCGCACAGTAATATACGGCCGAGTCCTCGGCTCTCAGTCTGTTCATTTGCAAATACAGCGTGTTCGTGGAATTGTCTCTTGAGATGGTGAACCGGGCCTTCACGGAGTGTCCGTACTATGTGCTACCACCACTACCAATAATAGCTG
+
5<<A?AB>B@DD-+A?8+FGFFHHFH,HFFIHGIHHFIIH@H@AHFEHFIHHFDFHIFEFH@I55FIFEH5FFCHIHHHIHFHAHIIHEBIIEH*FBHHFHHHI,EIH=HFHI+)GHHBD+@BD)BG@+EFFDEFDGFGGAEG@EGGEF*FF?G(?2FE:;*GEEEG?*G8A<GEEFC.CDG*EE.GGGCG(CGEG;C:?<AED?88*E?C*.CFFEEEC2ECE?*EECG(G;E?EGEEA'6C*E?G?0C
@antibody_58_multiplicity_1_copy_1-1
GGGGTCCCTGAGTCTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCATGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTTCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAAAGCCGAGGACACGGCCGTATATAACTGTGCGCTA
+
?5??,BBBBDD5DDD?FFFCFGIH6ACIHFIEGHHHAH/G:IG+EIAIEH5HHI@HIFGHHFI.AFHEIHH+F?-H-CHFIH,HGCEGHH=BD)DFFHHFEEFHFFFFHHHFFH:H)EEFAFGEFHGHFEDHGFFA5HFFGE@DDCCDGFGG;ECFE:E4EG(CEEEFECCEGEG?#6EFGEE(8*EE:?GG8G?FCGC.?GE:ECDEE8=AH(B(*/E@BC8EACAGCG)GGE*?*E#EG:.E:CE?EA
@antibody_59_multiplicity_1_copy_1-1
TTCCACCGGCGCATAGCAGGTGGTACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTATTGGAATTGTCTGTTGAGATGGTGAACCGGCCCTTCACTGAGTCTCCGTTGTATGTGCTACCACCACTACCACTAATAGCTGTGACCCACTCCAGCCCCTTCCCTGGAGCCTTGGGGACCCACCTCGTGC
+
?,?,=BB=DDDB<-@DGFFFGFIH.FFHI>IH?HHFD=GIIEE9EFH=HFGHHCAHGHEFHDIHHF-IGGIFH@H+HD>FHH.DHDIFHCHGFHD=ID3FHIHG-FGHHHHCCIF*CEE(F+FHFG*FH2HF(G;,<FFGBEHEEEEGGGG@GA:EG;,G?(E@GEB(A(GEEG*::E#GCG;?*CG(EGGGGC0G*CGCCE(.A.?EE>E//GC8:<:G:/E6CG(E?G*GA/(G:;C(E..F(C*:':
@antibody_60_multiplicity_1_copy_1-1
TAGTAGTAGTAATGATCGTCGTTCCGCCGGCACATAGCAGCTGGTACTGCTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGGTCTTGGAATTGTCTCTTGAGATGGTGAACTGGCCCTTCATGGAGTCTCCGTAGTATGTGCTACCACTACTACCACTAATAGCTGTGACCCACTGCAGCCCCTTCCCTGGAG
+
?????79?+DBDDEDDGFGGFFIHEIHHHHFH9IHF9HH9HI+.IFFH/DGGHE.-DHHHC-GD,5H8HCBD5BEIHHHHI-5HFAHHHHEIHH@HHHHHIHHII=HGHFCHFDFHFDE=HG*EF?HEHFHGEGGEGF#G:>EFE6EGEG*?E*E*?EE6:CGE<F(9E(GE;E;FEEE.EEA*FG0GEE.EG(>:F?A:??GEG*?EEHE:E)@?(C<C*A:)CC::GEC8(?GGA0C6-:AE;G*?:?
@antibody_61_multiplicity_22_copy_1-1
TAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGCGAGGCTAGCGCGCAGTAATATACGTCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATAAAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAAACGGCCCTTCACGGAGTCTCCGTAGTATGCGCTACCACCACAACCACTAATAGCTGAGACCCACGCCAGCCCCTTCCCAGGAGCCTGTC
+
=5<??>BB+DDBDDDD8GFFG>?CIHHHCFIGHIIHAIGBHEGFHI.HHG>FHCHFHD5IHIFAIDI*IFAHHH#DG-I-G5G0ECG-FHI5FEDEH?EHGFC+.CDGDDGHD:HGDCGGGGG=H#EE;GHF@>FBDGGF6EDEE:(GDFE3BB@?AFFEEE*EGFG;EFGF280E?6DEGGG/?*AEF():E.GEGGFADE*EE8?(?FE6FD@*EEE@EEEAGC(E<E*G>0C*?G0EEG(?A:C.*8
@antibody_61_multiplicity_22_copy_2-1
GAGGAGACGGTGACCGTGGTCCCTTGCCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGGGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTTCTCGGCTCTTAGGCTGTTCATTTGCAGATACATCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAATCGGCCCTTCACGGAGTCTCCGTAGTATGTGCTAC
+
<A???BBB6<<5BDDDCC;GFCI8EIFFIIFIIHDG@AICEIDHIHF@5G8GH0HIIIEHHHHHEIIF-IHEHHHHHCIHHIBEIHDIHHHGCGIGFIIFHFHHDGDHH=GE-HH+FH*=FHFFCF6FFH2CEGGGD1F*@<ECG6CD*CEE861CF<*?;6EEGCC?E(AF:F'/GAEGF(CG2E<GE?4GCEEA('EE((::F:?EEHE?HG8)CCG2G-*:FEEGE??E?E(6G?GC8?G0?.8GE5
@antibody_61_multiplicity_22_copy_3-1
TTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTTGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATATCAAGAGACAATTCCAAGAACACGCTGTATCTGCGGATGAACAGCCTGAGAGCCGAAGTCACGGCCGTAT
+
??A???B@DED5-D@D?AGGGFHHHHHH>FHGIHFFIIHDIDEI+GH?HH:HIHDHFH9GBHIBEDG5C8EAEH@F,IFHGH@GEF+HC=DFHBH>FICH3GHF7HH=H?HDHHHICHHEHHGG;DGFC*4DFGGFFEGEEEG@CE?E?GG.GGG**EEBEEF;ECG5GEEA,AECGGG'FG,EEGEFE?*6GFAC1:EGG0?GCG?:E?;C:@/#:GEF0GG-E?CEE.EA:*?E'E*E.;/?E:?)10
@antibody_61_multiplicity_22_copy_4-1
AGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTTGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCCCCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCCCTAGCCTCGCTCTGGATGGATATTGTA
+
?A????B-DDDBDBEDFGCFCGHHIH,/IFHHFI5HDHHIG>AIF?H-IIH*H.HHGHHF?D-GD5?GHHD-IFIDGHEEHIEAI#HGHEHHHHEHIFDHCFH+HHDDDGGHFHIFHGHGHGFFEGDDAEGEHEEG*F+BBF:GE8<EG*4GFEA8CEEE*CG(GCGG0G6CE?8*CAE;CE(*;?:EGF6G-0GGEEFEEG(*8:4EEEGGAG*E8><,*C(0EG*/EGF9FG<(*CEE:CEEAE?E*E
@antibody_61_multiplicity_22_copy_5-1
CAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGGAGCACATACTACGGAGTCTCCGTGCAGGGCCGTTTCACCATCTCAAGGGACAATTCCAAGAACACGCTGTATCTGCAAAGGAACAGCCTGAGAGCGTGGGACACGGCCGTATATTACT
+
,?A,??BBDD+BDDDDFGFFFCACAHIIIIFIFDIHHIBGHCHIHEHFC8IHE5IFHHFFGHBHI-EEIGHEHGEFHIHIIHHEHHHEB6HHHHFHHHHHBHIH.EAHCHHCGFFDHBG7DDGH4=FHGEF)*FG3GHG3GFCE6GG*#C;AEG@F*GEG?@G@GFCGF@GEG:#/GF8#/A=F:EC?A0:EC0G<G;(EEG/E./E*GH*#7@ECG7E:?GGE*E)'(*CE(E1/FG:EE?E'EA?EE1
@antibody_61_multiplicity_22_copy_6-1
GTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAAACGGCCCTTCACGGAGCCTCCGAGGTATGTGCCACCACCACTACCACTAATAGCCGAGACCCACGCCGGCCCCGTCCCAGGAGACTGGCGG
+
??????BBDDDDBDDBGFCGFFHEEFHHIIEHHHDHIIHFHH@,@HEIDGIIIG?=HHHHHIFEFHI?FFGBIHCIFGIHIIHHFHIDEHIHFE;HHIHEEEFCIHBE<?*+.GHFCHHFDGEFHEEGE?*GEEHE96G@BGBDE3GFGE<.=EF1(*GE=G:FC4;E?(FEG(G?0FGG?0(EEFEEGC1(A?FECG:E(G;GG66-G/*9:.EGG?EEGGE:0C#EC4?C/E?/GC:EE;(*AE)?/E
@antibody_61_multiplicity_22_copy_7-1
TGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGTGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCGGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCAGTTTCACCATCTCAACAGACAATTCCAAGAACACGCTGTATCTGCAACTGAACAGCCTGAG
+
???<</BBDB@DDDBDGG.->F?>@IHI+HDGIIHAIGIIHAHH-;-HI.H9HIBHHIHHHI-HHHHH)HHHIFFIGFHFFFHADHIIHHGEGHIC<HI<FGHDHD3EHHH8)EDC+C2GHFHC+HE=FDCHG:;FE?)*GG8G7D8:E=GDGGEGE/G:E<0?B?GFEGFBGG>G=C*GEG;?EG1>#.CC?EEEGEA=E0EA(G?;=?/G:@:G:A7:CEEG:AC**G?E*(0.#A?:GC10'A*9G:
@antibody_61_multiplicity_22_copy_8-1
CCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACACACTACAGAGAAACCGTGAAGGGCCGTTTCACCATCTCAAAAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACCCGGCCGTATATTACTGTGCGCTAGCCTCG
+
??A??>BBDBDDDED@GFF.8FAHIHH-IHIH@IIHIFFHHCFHCHHIF9IGH,IHHGHHDGDFECIEHC+EFFIHCHFHHE=FF866HHHICICGC*HHCH.HCH=FGG+DH>HCCHDHF+GG+HBBH##8G,F##GEEDEG@EEEGCGFGGCEGAG,=G-BE6(E6G(F;EED*5GGEEECCGG?;GACECG;EGGFEGCGC(?C6;AEG'-BG*E8G*ECDCG4?EG*EA(/C?EEE*?D*C**EE:
@antibody_61_multiplicity_22_copy_9-1
AGGAGACAGTGACCGTGGTCCCTTGCCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGAGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAACTGTCTCTTGACATGGTGAAACGGCCCTTCACGGAGTCTCCGTAGTATGTTCTACC
+
??,??BB-DDD@DDDDEFGFGFI6IIIHI(HHIHCHCHH9CFEI-IHEFGIF=HFIHEHGFDACIFH--5?CGF5GFHHHEH5FGHD6IHHB,HFI-II7-8EGFF(H@HFFGGH#:,2HHG:HEEGEEGEEGGHD>H:DGFGDBEDDFECE0EEEG?GC*DGG=GACGEGE6E(C6CGGG8?GEFCEG?G(FG'(E?CCF8*GF.AGC8E?A(;*FEEE*EGGAGG*0:C#CEG:E:1:CGE#'()EEE
@antibody_61_multiplicity_22_copy_10-1
CCCCAGACGTCCATACCGTAGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGCGAGGCTAGCACACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAAACGGCCCTTCACAGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCC
+
?????>B7DDDDDA?DGFGF.GIEHH>H6FHIHAFFF=GDHAHHFID-FDGGIFHGII8ICHIII?FDCHFII=GDIHEFIHIIAHF*GGIHDHH@IIF6HHIHHFHH=-C.H,HHGEH=HHH+GE@FDFFHDFE@HB*5CA=9C72GE.2@GGBEAE<E(GECCGEC?EEEGFF8GG4?G;EG0GECAFGBECF(C?CE#(?GE)(EG6GGACEE?:(E('*ECGEG86E86(-'*0C(<AFF'C?:G?
@antibody_61_multiplicity_22_copy_11-1
GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGAAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGA
+
?????BBB@DDDDDBDFGEFGBFHHICHH8HCF3IIHIHHGIE@HGH?FIHD,8HHIIBF,IGFIGDFFHAHHFIFIGGEEDGFFEIDD=HD(*HIGHFHHHHDIFHHH:7CEGGHHFH;FFEFFHFHGHGEECFEGCBFEDGGGEEGGEGEGC*CBEA8E(E,@?E'EGEG8DF2G<GFEG8E?:GEG:GC:AEDE(E6G05(EG0C601G.@BAE?,CCGGE:?:GAG*;(:>C2C*?E88FCE:6*?
@antibody_61_multiplicity_22_copy_12-1
TGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCTGTGAAGGGCCGTTTCACCATCTCAAGAGACTATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGGGCCGAGGACACGGCCGTATATTACTGTGCGCTAGCCTCGCTCTCGATGGATATTGTAGTAGTC
+
??=A=BBBD@DBDDDDECEFGFHHIF+IHIHAHI9IIIFF-CHIHFGIHHEFFIAFDAFI-8+H-5FIIH@IIHIH-FHHDH-HHC+IFFHFGH,GIFEHAFH.>HHA??HEHH+GH,FEEEGHBGE:AGHE;GECE*EF?>G:G#GG*CBEF*CGGF**C(DEGGG<G?G0EG?CG(CGCE?*EE(EA*EF-(?GG0*FAGGGE6?C9E?E@EE*?EEEG:CG:GF1(G'?FG:C*E*:>AGE0EGC?C
@antibody_61_multiplicity_22_copy_13-1
GAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCATCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCTTGAGAGCCGAGGACCCGGC
+
?????=BBDDDDD<DDFFFGFGHHIEHBHHID0HHHIHBHEHFCHE+CIHIGHHCGIHHHCHHDEEIAH3HIHIADCAG-HFGF+HIIFHHHBDHGHHHDHDDF?FHEG@FDFHGFGFFH+#FACEGGBD+/ECEFF?H;DDEG@*EGEGGEGDG?GE(0F*:<CFG'GG:A:E;CEF>6E+FECCG?GGCEGEG??E?:EEEF0G8GCCG6CEG(1E?,EFEEAC'E8<(FGCC(?FGG:G.GC(GEE8
@antibody_61_multiplicity_22_copy_14-1
ATCGTCGTTCCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATGGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAAACGGCCCTTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCACGCCAGCCCCTTCCCAGGAGCCTGTCAGACCCAG
+
AA???+BBB-D-D<BDGFFC/FH<IEC;>HD9HHFGHIIAIFCHFHFA.HF9FIA=BFCE'FFHAHIIGI-DCCHHHCHH-?IF/.HDFHHF6I*DHI?#HBD<F,H?DFHEGHHHH@HDHFGHDG>HGDGFE4GG:E#EHGFFGECFE@GEFFC(DEG8GFGAGE:GG:CG6.EGEGE*2EEG6GGECFF?CEE?(G<((EG6FE*:CE?E7GB?F;':(EEC:8F?**?*E?:CG?G>*8':/?E(EE
@antibody_61_multiplicity_22_copy_15-1
GTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGTTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGTCCGTTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAG
+
?????BBB?DDDDBDDFFFFCFIIIHFHHB@FHFHDIEIIIHHFIIIHHFDH5CHII-GFCHHIIE5IHIHFHEHGEH5I=FHBHD=FEHHGDFEDHF+DDHHH@FCF7DEBGHE>;FFE4DHEG=FEFFFGECEFFF(GGCGE=CFBGAFGEE??FGE<CAGGECA?0B',EGEG?C6*EGG:C8D.G6??C;-(EC?GF?GC;E=EGCEE@EGEG?GFC0.(A8*.E?GAEGG(?8C?E6**GGFE:E
@antibody_61_multiplicity_22_copy_16-1
GGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCAACTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAAG
+
??<9?B?BDD5DDDDDGGFEG.HHIHHHIHHC-HFIGHII,IGGFFFCBHF-I+HHH;DHHIHIHIH+GGIGEFIHHFIICEI.FHH.HIHFHEEFDIFHFDDHHCFDGD=HG*HHFFH>EFF=HHF:GHG?=8GGDB(GE:F;;E4FG2GAFEEEBGF3GEA(E;GGEGG*GE;2GAGGCF*.2DECC?E?GG?E.0DEGAEGGG(F:HEEEEGF/C:EGGGEE:9G?EC?.0:(*>E::<)G(GE0;(
@antibody_61_multiplicity_22_copy_17-1
GTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTGTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAATGGTAGTGGTGGTAGCACATACTACGGAGACTGCGTGTAGGGCCGTTTCACCATCTCATGGGACAATTCCAAGAACACGCTGTATCTGCGAATGAACA
+
?<<?A>BABDDDDBDBFFFFGGFIIHFHII/H+CIIFGFH.FGHH.H=HEHDAID@FHHEGHIGIHFEIH(#5GHHGEH5HFFHDHIHCHIHFH=FEHHEEHEF=H7H;HHHC4FFHE.HHHFEGGG*AEDF;FHCE*GEGFA9FFEE*FC*EGECEACGFFAGA?8FA*?<FECC:GG?E0@?'GEE**?GFEF.GGG8G/CEEG*GFH0A(CE(;AE@CG::C(??G9EG?)C(GEGEC**CCGCG:4
@antibody_61_multiplicity_22_copy_18-1
GAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGACCGCCAGGCCCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGCGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATCTCAAGAGACATTTCCAAGAACACGCTATATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGC
+
,9???BB?DDD<DDD+CFFFGFIHFAHIHHHHH=HIIICHIHHHDIHFHEIGIHCDHH?FFH/IHHIHH?+FIH--HHGAIFHI-IAIHEE.IF+HIIDF7DHIHHIFHFGGHDFH@GHHH*HHEHFCHGG),EHGEGD*EGFBB9=EGGCFGAEC@9E;GA=(G:G?0A?E?GGE)('GGAEGE1?G?G/>9??(D;;EEE8GC(CC*C?*HG(C.??A:CEAG)C?<E(G:6GF::;<EE?CEA*GFA
@antibody_61_multiplicity_22_copy_19-1
CCGCCGGCGCATAGCAGCTGGGACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGAAACGGCCCTTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCACGCCAGCCCCTTCCCAGGAGCCTGGCGGACCCAGCTCATGGCA
+
=????BB+DDDDD-DDFFAEFG?IICIIC;IHHHIEHFEF/IIHHHFFDGHHFHHDIFA8G@H+HGDEHGHIEHF5FHFHD#FHHIIHF,HIACHIH<AFHHEHFHHHFEGGEHD+H8G@<D*DFH?=HDFF9GEEEDDGFGE*GG0EGFG'GGAEFEEFG??G:EEF(GEFG;FE#G2GEGGEE6(AEE*CG?A-GGGGEEECFC(F=6EG*CBFEA8@.:G(E8/C.(CGC:?;E?**EE#E:?C)GF
@antibody_61_multiplicity_22_copy_20-1
AGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGCAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTATTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATCTCAATAGACAATTCCAAGAACACGCTGTATCTGCAAATGAA
+
A??<?BB>DD<B9@-ACGG/FGACIHHEFIGFFDHIIFIF/?H@EHFHHAHCIHFHEH/HHG,IHHHHIHIIIH-AFFHIGD=FIHDDFEI4HI-FFH,EHICFHDHIHDH<F+FFFHGH+FHGF#BHGCCEBEGGFEGCFGEAGGFCFE@G(>EE>GE()GDA??:GF*?CGEFEEC'CG=6GCFAEEGFEE6GGC)G1//EGG>ECEEGEH*BAFF,@EGG?(E;AG4E';8'0CEE::CG6E:EA.E
@antibody_61_multiplicity_22_copy_21-1
CAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCAGTGAAGGGCCGTTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATATGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACT
+
=??,?BBBDDDE?<D@?G8FGEI/ICIEBHIFC=GHHIIEHGDIH=8HI@DHF9HFDHHFEFHFGAICIIFHFHHIHHHHHHFCIBH?H=H/HEGIFGCFFH5HDHH+DEH)6#BH?H6HHGIEHFEEHFGE:G@EEHEFA1GD1GC@FE=E*<GGF=AEF**GG??C=F.EGGGGF:8CEAGEEGE;(GGFGGEG:G;CE?'C6GAG)E?EH@@C/GE4GEGGEEEGC(?6??EC:-C?EG*E8?0?;(
@antibody_61_multiplicity_22_copy_22-1
GTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCACCTATGCCATGAGCTGGGTGCGCCAGGCTCCTGGGAAGGGGCTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGTTTCACCATCTCAAGAGACAATTCCAAGAGCACCCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATT
+
9????BBB?DDBDBD-FGFGGFCHFH>H8IIDIHHFAFIFIGHIHDIDIFCI7FGF@H-CH-FFH?HHGHIF-HAIH#5HFEHHHEIHII(FIFHGHF=II-EIHFHFFHCH?HFHDEG:DFFD*CGFFHFFHGEEDCGG=;GD:=:DEGEGC(8CAGGGGEDFBG@E??EEC;GECGGGFDG*EGCGGCEEG*C<(FG>'CFAEE#*CH(:AG@GGGEE:AC6CGCCEAGEGE/D1.EE*E(CE:CC0:
@antibody_62_multiplicity_1_copy_1-1
GGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCTCCAGGCTCCAGGGAAGGGACTGGCGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCCGGTTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGCTACG
+
??,?A@B?DDD<DDDDFBAFFGCFCHFFI>HHFHFFIIHHHFH>IGIFH*H?IIG>GHGFI-IEHCHHI=AHFIHDFHH-HEAHCHHHHC,GCIHH7EE6FGHHFG+H=GHHH#D3GHH@8HGDGE9GGEG;HFHD6H6@EGGEGAEF=CGB8EEGGFFE:EF/:FCAFEE?EEFEG>0GEG?FCGE?E?GGGEG(A??(GG?AC(H:?(8G'CEAB:E,CEGA;GAE6GE.E*C0/A?ACE?C0*'C:E
@antibody_63_multiplicity_3_copy_1-1
AGTAGTAGTAGTAATGATCGTCGTTCCGCCGGCGCATAACAGCTGATACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTTGAGATGGTGATCCGGCCCTTCACGGAGCCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGAGACCCACTCCAGCCCCTTCCCGGG
+
?A?A<5BBDB?DDBDDFFCFCCC+FHHFH,I9IG9?HHH.IIHGD9CHHFFHHHHICFEIFBIFH-G=HDAHAHIFHCBFHH=D6IDEEHCHH@>EBHFHHHF*CFFHHGDC3FF?DHFFCFEHGEBH,FGH=>HEFCC=GFEG'G2BEEGG8?GGFGGFEEFGFE6AGEEG,GF.GGCCC?;EE#C:G:GEFE?E:CG6GA()?F0/EEE)HGE?F(EF:C?(1ECA8?E6FE:.??:*(G0GEE8AFG
@antibody_63_multiplicity_3_copy_2-1
CTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCCGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGGAGACTCCGTGAAGTGCCTGATCACCATCTCAAGAGACAATTCAAAGAACACGCTGTATCTGAAAATCAACAGCCTGA
+
,<,??BBBDBDDDE@DC8GFFGHIFFIEHFGHGHEAI.HIF9FI5HHEHHHIHEHIHHCF-HBG?FH=G>IHCDHDHDHFIFFHHBGFIHHIEIFFFIHH3FHDHAGFF,HEF;H0DDF?HC.D@EGFEBEEF*GB??FFAEGFEGFG2:G,C*CEE(8G?EAGE(8G<GCE?C6G6GE>(E?CEE#6E2(GF?G??(4EGE*0G:H..EA0;EE#BE0.E7*CCGGG((CGCE(CG(E(E*/(GE(8:/
@antibody_63_multiplicity_3_copy_3-1
GCATAACAGCTGATACTACTACAATATCCATCGAGAGCGAGGCTAGCGCACAGTAATATACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGAGTGTTCTTGGAATTGTCTCTTGAGATGGTGATCCGGCCCCTCACGGAGTCTCCGTAGTATGTGCTACCACCACTACCACTAATAGCTGATACCCACTCCAGCCCCTTCCCGTGAGCCTGGCGGACCCAGCTCAGGGCATAGGTGCT
+
?9????BBBBBBD9DDFFFF>FIIIFFIFHHHHDE@HIHHD?I-CIIHEH8F@+A?FH=H5HFHHHHDGHIHHIHHIHFCDFHFFHHHEHGFCH-IFHBHFAH#>DH+H?DAGHFHG.HHGBDH*DGE?HDF5GFA;DB1EEB,DG*GGGGE':C(E8EE/G;;EFDG0FGE>8FEGFEGEECEEGE/G*G(G#;DFE?GC:CEA8?AGH;CAE*)CE7CE'CE'F/ECAEGE/E.<#C:GFG:C(?*EC
@antibody_64_multiplicity_3_copy_1-1
TGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCATGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGTGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGCAGTTATATCATATGATGGAAGGAATAAATAATACGCAGACTCCGTGAAGGGCCGATTCACCATCTACAGAGACAATGCTAAGAACACGCTGTATTTTCAGATGAACAGCCTGAGAGCTGAGGACA
+
?<A5=BBBDDDBDB-=CEEGFGHE9HHHHIGC@FEFHIIHHI.HE/HGF+CIHH=HDHEIIH=IIFCHCBFI5GHFGDHID+HIIHH?H45GHCFHHHFHHHHHECBHFIHH'EHH9FHGF+@DBF(G=EEHD;GFDGEGG*EGD?GEFG?AGDE*GEG5)A*CDGGGFCEEC,EG?C?(:E?(GG*GCG#E8(GEGGCE:#=E*GC??FAC;ED7EE,(C,CE.??(:EEAEG/GGE:0?EEE?:G(')
@antibody_64_multiplicity_3_copy_2-1
GAGGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGCTCGAACCTGCAGTATAATAACCACTCCAAAAATCGTAATACCATGGCCGGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATATGAAGATACAGCGTGTCCTTAGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATTTATTCCTTCCATCATATGATATAAC
+
<?=??@@7DDDDD-DDGCFGGGH8HF;=HFHH0IHHFIHAHH=CHIIHCGFIDIIHC7HHFHFGGI+HHHIFAIHHIFDBIH5BH9IHCHHHEI-HH2HGHGHHFFGFHHHHFHIHHHGHGBFH8FGHFDEEGDBCGGFFECEG*EGGEEG*GC(GGGGE0?GGE<:C'G*E=EE?/C/E(GEG;EG:AEGEGGCC(EG(EGEFC.*ED61E*FC?B:EFG?<G6E<8?0:G*GEC(E8C(?/*2DADG*
@antibody_64_multiplicity_3_copy_3-1
CCTTCAGTACCTATGCTATGCACTGTGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGCAGTTATATCATATGATGGAAGGAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCTAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCCGGCCATGGTATTACGATTTTTGGAGTGGTTATTATACTGCAG
+
,?A??+?BDBDB?,DDGGG@E;HFBIEIEIFFGFIEF9IIGHAHGHGFHFGIG5CH/FHFFIHICF5GGIFIFGGIEIEIEHHHHIFIGICIIHH-CHGHHHH=E),HHEFD,D,HCFGGEHFDGBEGHGEGG*G+*GFH=>A@EC.FGGC=FGEB6G:4FEGDFEEFE8FFB'GGA'E-GG?CGGFGEG(AEGG?C?)(CGEGGEE0E6:A*CGG?EG(DG?0E6C:CC:(?(G6EC=:ECEF0EEC:C
@antibody_65_multiplicity_1_copy_1-1
TTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCTCCAAATTCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGGGCTCTGTGACCGCCGCAGACACGGCTGTGTATAACTGTGCGAGA
+
?????BB=9BDADDB@G?CG?FIIEIHFI6IIIHGGFAHFHHHF>IG,IHH8AHIFHHHHHHEGEHIHIGIEIHH-F55FHHGIFFF-IAHHIH?DH,HFGHHFDDFHEG2=EF,HHEHHFEFEBGFGGE>B?GFE8=:EG@E,GFGF*EFEG@(<GFGF18GA#FG0GGEE7:EGGEEG2?E/EE?E8?<?C;ECGAEG?6CCA.A:E(6F@EGG8:CACEE('?CGE*E*:1DE:((G*0EAGE?/GG
@antibody_66_multiplicity_1_copy_1-1
CTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGTTCCAGGGAAGGGGCTGAAGTGGGTTTCATACATTAATCGTAGTACCAGTACATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGACAAGCACTCACTGTATTTGCAAATGAACCGCCTGAGAGCCGAGCACACGGCTGTGTATTACTGTTCATGAGAAGCTCATATATG
+
??A?ABBBBDBDBDDBG.GFFFIAF/AFHICIHAHFIHFC+HHFFIH@+FHHHGHBGHG=HH5DHHHHEIIEGGHIFC#GHH-EDHGHHIIFHIHGHDD)98EGGHF#5FFH=FHEDE;HEHD+HHFF=GFBGHGEG>EGFGEGEE6FG@E=>G?2GGFGEC=C@(G1<=(G0EEE(F:GGG(6E??D-(CECE*EEGGG0GG;AAFC0(;/F@@CEE(EECA*1CFG?EGCAEGG*E?:EE?A(E(E?)
@antibody_67_multiplicity_2_copy_1-1
TCCCTTGCCCCCAGACGTCCATAACGTAGTAGTAGTAGTAAAGGATCCACCATGGAATAGCAGTCACCACCAGAATATGCATATATGAGCTTCTCATGAACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACCGAGTCTGCGTAGTATATGGTGCTAATACTACTACTAATGTATGAAACCCAC
+
=?A,?-BBDDDDD@?D-GGFBCCHHEHIFHAHH5HI7AGI=IFHCHCCDIHF/HIH.GHFCHIHIGHIH(HH#CGCHHFIH*FHHEEIHICIH6HHHDF?DDHDFEF@HH=FHF4GHEFFDGFHG@FCEHEF?@GFECGE5GGGE(E=D(GEFBECE0EG*(E=?CGFFE:GE6GG8A8EAG8':FAEG(EG)04?E(*;E;.:CG8E:?0E=@EC*#:'(GG*(*?D-AGEE((0G8E.E'E'::C?:F
@antibody_67_multiplicity_2_copy_2-1
CTTGCCCCCAGACGTCCATAACGTAGTAGTAGTAGTAAAGGATCCACCATGGAATAGCAGTCACCACCACAATATGCAGATATGAGCTTCTCATGAACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTGATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCATAGTATATGGTACTACTACTACTACTAATGTATGAAACCCACTCC
+
??<A?BBBDDDBD<DDFACCFFIIHIHEAFGGCHGHFEFICI9HIIHH9IIHFHGAHIFIEIFGFHCHIHHAFHHFHF'HDIEHHHIGHEF6@HHHFHDFDHGHFE.(H1HIHHHGHF2FHFGH=@EFHGH@FEG(GG)E(FEGF:EEFE'E*EE=GGGGFFG?8G?GG@CGGGFE(?.FG/:GFE8EEGA?E?EG2GGG88F6*CH.FHGE**EGEGB@GEEE*?C:::8AC(ECCCE:AC)CEE>?EF
@antibody_68_multiplicity_3_copy_1-1
TGAGGGGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATACCGTAGTAGTAGTAGTGCGCGCGCCGCGCGTCGTTCCAGTTATACCGCGCGACGCGAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCCCCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGCGACTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAACGAGTGCAAGCCACTCCAGGGC
+
<,=?<=B-6D@BDDDDAGF/FGIHFHHIHCIHDCIFFIFFHHHHEHAFHHF,HFH8IEIFGI7H+I,FHFHGIF<C?DHHI-HHFEHFHHH=GIHGIHHHCGB=HDE,GHHFHF;EHHHEFFFHFDEE6@6DGCEFEGF+FEEFGF*EEGGGECGGE?CFDE(4FEF??CBGGGEEEF;(E/GGCGG*)=GCFGEC?AFEG/EE(:?EGEECEEC0B?:CE,#AGEG:'EGFGCAGEFAE?*:*EE:./C
@antibody_68_multiplicity_3_copy_2-1
CGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATACCGTAGTAGTAGTAGTGCGCGCGCCGCGTGTCGTTCCAGTTATACCGCGGGACGCGAATATGTGCCTGTGTCCCCAGGGTCCATGTTGGTCATTGTAAGGACAACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGACTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCGACTACAGGGCCTTTCCTG
+
?,??5BB>-D@D-<?BFGEFE/FEIFIGBCIHEIHFHAHHIHA'HEF>DHHGH8HHFH5HHIF-HHFGIHAIFEICHCEHI+EH;7AHHDAGCGHIDHF=HHI-HHDF+GDHGFFGGFBDGEGHGCH*2D;GG6GGG#7GEDG1G?GEGGGEAEE*GC/GE?EECB=?AC;GF)GE?F.(EGEGA#G8A*)(?EEEGFG?068G:6CCGEECC.CG.A(CC,CGE(CEFC)#E:G(?:C:G*G=6;6;F:
@antibody_68_multiplicity_3_copy_3-1
TTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACATGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTTAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGAACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGTCCCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACA
+
==A??B<=BD5DDDDDGFFFFGCH.AHIIHF@HEIGHIH9HHHHEHHE-5IFH.IHAHH5=ICICIDIIHIHFHCHFH+FIIIHIHH9EDBFDFDFEGF=EFHH.HFFHFHFEHCDFHEHHF=@HEF?GHD<DHGEGDGEGF#;E?EGGGEGCG*@:FE(EF:GE*BEC:G:GGC?3G:*EGG*E(?FEGG?EG?6(EECGEEEC((EG:EE*EEEE#CAE:E::*C<E.ECE?:8A;G:CEGE:C?*CG
@antibody_69_multiplicity_1_copy_1-1
CCTTGAAGGAGTCTAGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTCGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAACGGCCCTGGCGTGTCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGTCCATCTTTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTAGATTGACCAA
+
?=??<BB@EDDBDD5BG/FFGGHFI8CHIIIF>GIDCHHACDFHIG+HGF@GDHI/H-HHIF7-HIDIGH-HIFFIIFHFHHI-FH=3HHHH-IHHHIHDHHHH@DH.GBFEHEFA5FDH@*FBHD'FBGHHEGGE)DFEE0GEEDEEGGD,GGAF<ACEGAEC/:G1EEF0EEE*)0EGGG(GG?E0EGEE;('?:GCFC8G.GC6GEFGCFG@E8GGGGAC.CCCE?#CG0?(*G6*?)##GG:C.1A
@antibody_70_multiplicity_1_copy_1-1
GAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCGCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCGGTCTCTGAAGAGCAGCTCACCATCACCAAGGACACCTCCAAAGACCATGTGGTCCTTACAATGACCAACATGG
+
???=?B>>DDDD@DBDFEF7CFFHEHHFFIDIDH/HFDIE9HHEI-DFFHGHAI?FEHHHHIHHHHF-HBEIH-AH5F>FIHIAG5HHHEGDE+IIHE(FFED=EFHFHHHHFHHHHFHFHCG+CG#GH(BEDEEFGC*F?GEFEEFDGEGEFEFGBFG?F,E'E7EEDF:EEEC0*.EGECE=)<;AG*EE6=EFC?:G(AEE*GE6(:/EEEGE(0,#:EEA(>0AE?<EGG;GG).G::AG)?E*CE
@antibody_71_multiplicity_1_copy_1-1
TGCCCCAGACGTCCATACCGTAGTAGTATAGTAATCTCGAGGGGGGATCCACGTGGGAATAGCAGTCACCACCACAATATGGGCGCCTTAAACAGAAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCACTGGAGATGTTGAATTGGCCCTTCACGGAGCCTGGATAGTATGTGTCACAAGCAGTACCGATAGCTGAAACCCACTCCAGAGCTTT
+
?=?5?@-BB5DDDDDEGEGCGFII+H8HHHHHIHHFIHIEHHHHFGG?HEEFH/FHHFDG?II+GHFE=DHH+ADFHHGE,HHHI5EHGH*HHIH#GIEHDHEDIHHGE=HEHG*HGEE=HEGEDEEGDGEFEGGECDHFEGHEE#@2CE@;GGEACG1FEE>/:#EECE0GA/AG.EGC86E011CE.E:F)CG;CAFGGGE:G*(*EHCG**'::CF@('.*AG?G?.E8(?C(CC*/AC(CE(G(AE
@antibody_72_multiplicity_1_copy_1-1
GTGCAGCTGGTGGAGTCTGGGGGAGACTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTGTGGATTCACCTTCAGTAGCTACGACATTCACGGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTAGTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCAATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGAC
+
?????BBBBDDDD<DDFF8GGFF6IIFECEI@HHGFFIHHGDHIFHIHIIHHGIIEICH8GGCI-HDFHI=,@H+FEI=DHH4FHIHHCBHHHHHHFH6IHC(HH+ECHFFH@F1HFGEGH(DFHH;CGABEEBEDBGE<@HGEEH?GFEEEEG(EG9FECG,G9E/D?EEEEEG3E1.:FFG?EGFCGCG?C).EE:(GGE?C6:EEAFG/CEC*C:CCECG/EGE01E(*??CCE8:*(:1C(EEC'1
@antibody_73_multiplicity_1_copy_1-1
CAGACGTCCATACCGTAGTATTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGCGAGAACTGATTCTTGGATGTGTCTGGGTTAATGGTTATTCGCCTTTTCACAGATACTGCATAATCATTATACCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGG
+
5A???BBBD@DDDD5DFFFF,GAIH8HHIHHIH,HIHHF>IEHHHIHIG.HGIHGHHI>HHHHEHEDAIHEHI-FHIIGFI=IIIFHHEHFIDIDHCG(.4DHHE6FB+HG(+FHHHFF+BHHEGBDHGD*GFGFGG4*G,EG6#G(GCEGEEG(?GB<FE?D:#0*G=/F@FECFCCDG#=?C(@E(EGE?0/C/:EGCEEF?<9*EEDCEFG*G7FGGEE/GEEGG1GAGE:6GA:E.G0FE)GC6E?
@antibody_74_multiplicity_13_copy_1-1
GCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATTAACCCAGCCACATCCAAGAACCAGTTCTCCCTGCAGCTGAATTCTGTGACTCCCGAGGACAGGCTGTGTATTACTG
+
,?9??BBBD@DBDBBDGEFFFFFHHH>+FFHGHHHE/HI+HFFFHH7HIHIGIDIFI.GEFIH.HFFHIAHHGIICHIHHGH=GI/II=FCGFIHIFHHD#DHFDHHHHFF@>GG:GFHHH=DE,HDEGHFG=E>E3GCGBGGEEEE:;EG8F?EF+G8GFGEG:EA@EE*GC#:GEF)F?(GG:BE?:G*GEEGG68.EG6C:6E2FA9CE:AECG?G)7G(GCGEE.E<GGF6/A?GGEACGG:?EE8
@antibody_74_multiplicity_13_copy_2-1
CCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCATAGTAATACACAGCGTGTCCTCGGGAGTCACAGAATTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTCCACAGATACTGCATAATCATTACACCACTTGGACCTGTAGTATGTCCTTCCCAGC
+
??=A<BBB-DBDDBDBGFGFGFIHHFHAEHHIFHIHHIGHHHCH+II+GIGFCE/IHHIIEHIHDH5IHGHD@HIAHHAAHHGIIHHHEHHHDHBGFDFIH#DHH7IFH=HFH<FHG<FHH8F3GGF6HH5FHDEGEE@CEGGCG@.FCEE<E8ACGGEFGEBGGGEA6GEEEDGEE)A(EG::.EEGA#E:EG(CFEFGCAE/GEHCE/E6-FB8<#0E#GGCFGGCCEC(**0#E(A:/*A:GGA0GE
@antibody_74_multiplicity_13_copy_3-1
GACGTCCATACCGTAGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCACAGTAATACACAGCGTGTCCTCGGGAGTCGCGGAATTCAGCTGCAGGGAGAACTGGATCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATACCACTTCGACCTGTAGTATGTCCTTCCCAGCCTCTCAAGGCCT
+
<????BBB<DD@+?DDGAGG/GHICHIHHIDIHI>FF-HGHGHHHHHFHH+HHHHHCFGHFHH+HHFIH5EFGI5+GHF@EFII6FHEH?-8HH=FDFDHGHDIGE#H3E6FHHDHEH*6,-@HGDCHGEGA,H@ED?EEEEG?E/GG(GG-*:GFE;E8FACFAE?EGG*ACGEGGEGGEG(EGG>A6GEG6GECDG/?E8E(*:H(FFG>E(GC(7G4*C(9?EEGCG:/*G1/0/0(G/:C06*6?(
@antibody_74_multiplicity_13_copy_4-1
TGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCACAGTAATACACAGCGTGTCCTCGGGAGTCATAGAATTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTAT
+
,?,??B?BDAD@DDDDG6FFFFFIFEHAIEH7HIIGHBFHFDH./FHHFAE.HH-5HHCI-IIHHH-FIFIEHGFHI?FEEHFIEFIAACIC?IHHHHAHCIHHFDFEFHHHFHGHEFHFHHGHHEGFDG;EG+CDCFFFEBD+AGGEEG2@GG8F?G?EGC*EDCGF*EDEGGE.FEF:CGD<EEGGE:C<ECG(GGGGA:E:(:?FG(':HCCC.C<EEEG?6F?)E6'(AC:CEE:CE:GCG?*('>
@antibody_74_multiplicity_13_copy_5-1
CTGCAGCAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTGACCTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAACCAGGTCTCCCTGCTGCTGAA
+
<?A?<BB3DDB<DDB@>CCFF/CICAFA;IGE;FIDIHEHHHHAGIFH?G.FHDFHFHIGHFHHHHIGF:<IHH5CHFHIIHEG.HDFHAI8GHHCDHHHHHGFHHHEIE@H@FECBGGGHFHD4FED;;GGHDBEGGGG=GGDE9EEG@BEG0GGE@:GC(EBBGG=FE.GEG=(GGEF+G?G(/FEAGCGG(1=G'EEEEC:CE:CEH:EHDCGE:C,7GG/((AG(#CED*'*F8C?/F*(?EG*#?
@antibody_74_multiplicity_13_copy_6-1
CCAGACGTCCATACCGTAGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCACAGTAATACACAGCGTGTCCTCGGGAGTCACAGAATTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATACGACTTGGACCTGTAGTATGTCCTGCCCAGCCACTGAAGG
+
A????BBBDDDB?DDDG>FCFGEHHHCH-AEIHIHIHGHG@CHEADIIEC9HIEFH*HA-HFIFDGFII5E+D-EFE>DHEEEEHHIHF)H0FHFH=HH)HH*8HEF?FHHH,+,HHHE1HH<DGFHGDEG9DGA=,FCEE*?E.A=G;EG4E(E8ECGGGEG6D;AEGEGCE:GFC+EEEDF*E6:*E0GAGGE:0GF*CEC1G?H?AC('HF*CG?DCCCG:AACE::EF*/'(AG?G??G?1(G0:A
@antibody_74_multiplicity_13_copy_7-1
CTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAACCAGTCCTCCCTGCAGCTGAATTCTGTGACTCCCGAGTACACGCTGTGTATTACTGTGCATATCCGGAGGATAT
+
<?9??<?BDDDDB@D5GFGFG0I89IIFFEHHHI-EIFIHIGGAH+CFH*IG.HH?FGGHHCFF'FHIHHFH5IHHII7GIIIIHH<,8HIIHDEHHIHFH=IH#HFHHFFFFEF+HG.*@HHH@@GH=ECGFBEFGGEEDG/GCEG?;G@CG8CGC6GEE1@?BGG?ECG(?GGEEEGEE,(A:BAEE:*6?ACE0<GGEGGGEEE:AAGGC#@E?E?GGA*:FC#GFGEAEEAC?*FEAEE*E*G/F0
@antibody_74_multiplicity_13_copy_8-1
CACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAAAGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAACCAGTTCTCCCTGCAGCTGAATTCTGTGACTCCCGAGGACACGCTGTGGATTACTGTGCATATCCGG
+
?A,<<>BABDBDDDDDFGFFG-F@IBIBHFE8FFDGHIIIIAHFHDB@IHFIHH.HIHHFCIGGEHIHHHHFIAHHFIHEHADEIEII@HFFHIHHHHH?GDHEFEHHCH4HHE5HGHHHF:3=(H#FGFG<GCEBED*GH4EGEFE*EAG:CGBCGBGEGFEGG0)EE*AE9G>EEGE6(E?CAEG9GGEGE?ECCE(GG@CG:EEFC:GCE:G/GF?GE)E.?AEG0EG'*:#:'C.AG*(D<(E:F/
@antibody_74_multiplicity_13_copy_9-1
GGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTTTCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAAACCCAGTTCTCCCTGCAGCTGAATTCTGTGACTCCCGAGG
+
?,??,BBBDDDDDB@DA;CG>EFIHI@FCIGHI+IIHHH7FGHDHHIII8HIFIHHIIC.HHHHHHHCDFEHHIHGHHEHHIG=IEIHA=IIHHHDECGHGH;EHHHDG2HE+EFHGEHGFGG<DAEFEG=HFCA?;HEF*@*2EE/5GGGCEEEGFGE/FE(AG?E(=GG?8GCFAEG9AEEG2GGGG;GEGGGF:AGC?EFCA68EE(G(ECGGBFE:(EFGEEEG)CA?/:GCA*:.*:0GE0E0(A
@antibody_74_multiplicity_13_copy_10-1
AGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGGATATGCACAGTAATACACAGCGTGTCCTCGGGAGTCACAGAATTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCTTTATACCACTTGGACCTGTAGTATGTCCTTCCCAGCCACGCAAGGCCTCTCGATGGGGACTG
+
?AAA9BBBDB<B?DBD@FFEFFI,HCH/IHFDGFAHDIE9CFGEIH=-FHEIECIIFFIEIDHEHHHHG5HHFEIF+,FFHHFIIFIDHHHH--IHHHE@H5HDEHGFHHHFF9EEFDG@+=H4@GFHEH#B(GEDE(G?GEFEE(G'@E;BEGCGF*E:GEEGCGBGG*2GEG?6G06(EA@1?FG(FE:F:EFEE*EC6E?ECEH:F(;?@ECE?AE.(GG:EEG/EAEG0(EEECG?C0E(F:E0E?
@antibody_74_multiplicity_13_copy_11-1
TTGGCCCCAGACCTCCATACCGTAGTAGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAGCTGGTACTACTACAATATCCTCCGCATATGCACAGGAATGCACAGCGTGCCCTCGGGAGTCACAGAATTCAGCTGCAGGGAGAACTGGGGCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTCCACAGATACTGCATAATCATTATACCACTTGGACCTGTAGTATGTCCTTCCCAGCTAC
+
??=?AB+BDDBDD@DDCCF>CG8>FCBCFH6H=EC+ACH9HIIE8H.DIFE>EFCHHFIIIIHICIIE-HFHGCIHIIHIE5IHGBF5HD#FAHEFHCHHH+DCDCH@@F(FFH=#=F0GG/HHGC=DEGG@G:E.D1@EE@G3?03CE;G<?G##<8AFG:GGA?GEC//GA**E68GEAGGEGGE((GE#*EGAGE(:F06/8:E?AE)FCG@:GG<GG(GGEE?A??E/CG:E0'/CC6?(0E:)EE
@antibody_74_multiplicity_13_copy_12-1
AGTAGTAGTAATTCATGATCGATTCAGTCGACCATAGCAACTGGTACTACTACAATATCCTCCGGATATGCACAGAAATACACAGCGTGTCCTCGGGAGTCACAGAATTCAGCTGCAGGGAGACCTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAACACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGGCCTCTCGATGGGGACTGCCT
+
,=???BB99E@DDDDD0GFCFGI>HHIIHFIIHEHIIAI+@AHHHEHHD9HH.HHGFHEC-AIHFHGFHFFIGIH#E?HHCFCDAIHHH+HHBHEHFHI=:DIHDGHGH?0HFD2GCHDHH3F#HGFDFEEFGE@IGGEEGECEGE3,?DG*EE*C?EEG1*CGCEG@CAG@G/FFEGGF;FFE8G(CCE6EFEC6/:CCE;GCAE:GA*EEHA@(:ACE/E<G2E*;(CGEGE-66?.EAE::0E;?0F
@antibody_74_multiplicity_13_copy_13-1
TACAACTGCAGCAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTACAACAGTGCTGCTTGGGACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGAATAATGATTATGCAGTATCTGTGCAAAGTCGAATAACCATCAACCCAGACACAACCAAGAACCAGTTCTCCCTGCAC
+
???A?BBBDDDDDDDDFFFG?CHHHHII98GIIEIH/FGHIIHHGIA*GHIH+H8HEIGF-IEIA5GCFIICIFHEFIEIHDGHHHF8HIGHHHFIHH5CHIFHF?IH.DGHF+FEGHF:HHGFF3EEHFFGEHEG3DE;F;G=>EEGEGG@GEGDFAGEGCCCCG?E;GEG#E(:.EGEEGG?CEE1GEGFG81<(AF::A.:#1C*ECE9@CCG*:'(EFFE'G((?E:E/?G/C:8:EGC/=*(A:(
@antibody_75_multiplicity_1_copy_1-1
GGTGCATCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGCTTCTGGATACAGCTTTACCAGCTACTGGACCGGCTGGGTGCGCCAGATGCTCGGGAAAGGCTTGGAGTGGATGGGGATCATCTATCCGGGTGGCTCTGATACCAGATTCAGACCGTCCTTCCAAGGTCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGAAGTGGAGC
+
??=??BB<ADD5DDD@AFAFECEIEIFHHE?=HFFBIDE;+HAHD9IFG-IHDBHG.I=HDCHIGI.F?EF?2HIEHHH?HHI-HHHHGHFHHIHEHHHII+7+HIECHIEFGDFEH*?BGFHEEFGD=EB8ED;ICE9HEEE*FGDEGEEE*E*E(GG::(AEBDEEGFEC7*CG'G?GAGECCEGCCEEEEG:(?FE:C<EE?)C?GE?:EGE.DCD(85EG*GGAEEE*G?E:A/E:G(CC#8ECF:
@antibody_76_multiplicity_2_copy_1-1
TCCAGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCGCTAGCAACAGTGCTGCTTGGAACCGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGTTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTAGAATAACCATCAACCCAGACACATCCAAGAACCAGTTCTCGCTGCAGCTGAACTCTATGACTCCC
+
???A??<BBDBBDBDDFGGGGGHHHHIHHHHFHHEFHGIIFEEAH7HEHG7HFHFAD<IHIH-G-EHHHHHII+>H5HIIDIHHHIIH+HHIFHEFH.AHHHGHHHD*E<HG,FDGF?EFHHECEFFDGGGEFD4FHDFCEEGE*?0EDEGAC?EGG66EGG'EB0:AEGEGAECAGEG6GFC?#G.G*:CG:CEEEEG(CEGG.A6GG(*GEC8EC?ECD.CFE(?6E:::G8.'E:GC;'C.AEG'-C
@antibody_76_multiplicity_2_copy_2-1
ACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACATTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATAGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAACCAGTTCTCCCTGCCGCTGAACTCTGTTACTCCCGAGGAA
+
????AB?A-BDDD5DDFEFCG+HBII+HHIHIGGHFIHH+IHHIH8H9FCDAC+E-IEGHCAHHH5IHIHHIECH-DE>HGFHHF+HFFDIHFH7IHIGFH)DHCIHFE-*HFHFHH@>5E0FGFGG<G;FC;G?DG6G,=GGFECEBEEDGF'E?FBCCEGEEFGGEGFE8ECG(F<A:GF*EFFFC(6GC.C*G?(>?EGC::<=GEE0AA:G7GEE(GCC#'EF<E*E?G0E4A#/)E:?*C?:C*'
@antibody_77_multiplicity_1_copy_1-1
CTGGCCCCAGTAGTCAAAATAGCGCGTTTAATGTCGTTCCAGTTGTAAGCGCTCGGAGTGCACTCGCACAGTAATACACGACCGTGTCGTCAGATCTCAGCCTGGTCAGCTCCATGTAGTCTGTGCTGATGGACGTGTCCCTGTACTGGTGACCCTGCCCTGAAACCTCTGTGCATAGTTTGTTCCACGACCGTTGGGGTCGATCCGTCCCATCCACTCAAGCCCTTGTCCAGGGGCCTGTCGCTCCGAG
+
?,?A,A5<DD@DDDBDEFGFGGH>IHHHFIAEIHCIID/HBDHHHIFIHFFF==GIHCF-@HE-,FIIH*HHDEFICHHH5C@CFH3IIG+I-E+3HIIFIGBCHH8IDHHE=HFFFGFE5FD;GE@FD8HDF7EDFFCGE*CFGG8DEEFE*(FGCGCF(AGECE#/1A*ECCA>?EEG(AA*A*GE#?A(EAE*GE6'':EAE'EGC:ECE*EG1EE1G,6CAGE<CF=C*(GE(CECG?*ACEAE:0
@antibody_78_multiplicity_2_copy_1-1
AGTAGTCAAAGTAGACATGTTAGCCATATAGTTCCAGTTATAAGCGCTCGCTAGGCTCGACACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTCTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCCCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACCACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGATCCAGCTCAT
+
A5A??B??DD<D9DDDFFFAGG>>FFIB/HI+HIHFIIHHFHCFFHCHIHIIDI,HFIHGHHGEF-HEIC+DICHDHI+HFIHHIHEEH)HAHDF-E*ECDEF@G=FEIF+FEH?DEFFHFE-+FF7HFE,GGEGBFCEFGF+.C?CFFGE/?E8G4?FEEFCC?=EGE=E?GEA8GEGCECEG(EE4G>GE(0G;AE4GGE6F:EH*8FCF1(E7E1?EB09C:8EEGGEEEFCG<A'C8A<?C#E:.*
@antibody_78_multiplicity_2_copy_2-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGACATGTTAGCCATATAGTTCCAGTTATAAGCGCTCGCTAGGCTCGACACAGTAATACACGGCCGTGTCCTCGACTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCCCGGGAGATGGTGAATCGGCCTTTCACAGAGTCTGCGTAGTATATGGTACTACCACTACTAATAATGTATGAAATCCAATTCAGCC
+
????<?B>DBDBDBDDFGGCBG0+HIIHHHH=IGGIHIBCF.GIFIHHHF*HF.HI-HFGEAH?HI?EIEFDEICHHHFFCFCHG*HHHI).5HCHHEIGHEHHCHFHHHEHEFFHF+DDHDE*HFGEGFHEGFB4FG*DFDBGGGGEG*GGC6GAFEFE.FGGB:,GG2?EEEECC?G?AE6FF((CEFGECGEG(EFGG(E?E*F)AE?F8DCGEC?1;<GE6CC:6;8*?E?(G4*:GA***C)E/?
@antibody_79_multiplicity_7_copy_1-1
TCCCTTGGCCCCAGACGTCCATAGCGTAGTAGTAATAGTAATGCATACGCTGAAATTTTATAATAACTCCCCGAACCATAGTAATCATGCGATCGTCTCTCGCACAGTAATACACGGCCGTGTCGTCAGATATCAGCCTGCTCAGCTCCATGTAGGCTGTGCTGATGGACGTGTCCCTGGTCATGGTGACCCTGCCCTGAAACTGCTGTGCATCGTTTGTGCCACCAATGTTAGGGTTGATCCATCCCAT
+
???=,-B?BD@DDD-DGGF-AGIIIIH>IBIGHHHHHCH.IIIIIIGIHHIHHIHHIBHHFHCHEHEII++IIIHIICHH(HFHGAFFE->HHEFI8HI+HIHHIHGHHDGHH(FE>HGFHH7F2FF?CF@#E0GEF@DEEGCCGGF*GBEF,EA8:GBECEDGE4A@CEGGE.8EGGEE0+A8EEAGEE?G:FGGG0.:GG*A';HG*CE:E(B:EF0:CC1E6(C*/E;(C??CE<AFG0*?6AE':G
@antibody_79_multiplicity_7_copy_2-1
CATAGCGTAGTAGTAATAGTAATGCATACGCTGAAATTTGATAATAACTCCCCGAACCATAGTAATCATGCGATCGTCTCTCGCACAGTAATACACGGCCGTGTCGTCAGATCTCAGCCTGCTCAGCTCCATGTAGGCTGTGCTGATGGACGTGTCCCTGGTCATGGTGACCCTGCCCTGAAACTTCTGTGCATCGTTTGTGCCACCACTGTTATGGTTGATCCATCCCATCCACTCAAGCCCTTGTCCA
+
,A?<?BBBBDD@DDDECGGCGEFCI.IHHIEIIIIHHIG-HACC,HBDHIFFCIH7IFHHF5FF+EHH7DHHFIIFH-HFI3HBIFDHH5FD@HH@-FH>HHHIHHFEHIHH+GHHH6HH??HDHFEHGD4EHGEFEGGBFFGG?GF:GEG-EGCECGE;6EE2EGF*FEBC?A8E4GE)?E0GCECG?G(CEEE(E>/?GCF:GGEGGA(0(0*CEC?'C?A)((-E?:(:EECCE:CCECEEEG:>?E
@antibody_79_multiplicity_7_copy_3-1
GAGGAGACGGCGACCGTGCTCCGTTGGCCCCAGACGTCCATAGCGTAGTAGTAATAGTAATGCATACGCTGAAATTTTATAATAACTCCCCGAACCATAGTAATCATGCGATCGTCTATCGCACAGTAATACACGGCCGTGTCGTCAGATCTCAACCTGCTCAGCTCCATGTAGGCTGTGCTGATGGACGTGTCCCTGGTCATGGTGACCCTGCCCTGAAACTTCTGTGCATCGTTTGTGCCACCACTGT
+
5??<,BBBBDB-DDD9FG?CGF-HHHFHIIHIH9@HIIH@HIBIH.9CHCFHHFBCIHHHHFHCGIIEHGFDFHDIHF5FHGIDICGHHEHFHEH=AGFIIHCEFFC(HDFEHFGHF*FED.GHED3FGFEGDF*G2?GGE;?AEGG8GEE4E@/GE:CCFG0)E6GECEEGFF.?E(C?CGCG9EGGE:6A*>CEC:6FGEEEAEHGF?88:E/C0G;G/C98EEF6G((EEE;*?6(/C6>GGC=*AE
@antibody_79_multiplicity_7_copy_4-1
CCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGCCTACTAGATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACGGTGGTGGCACAAACGATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATCACTGTG
+
A?=A<B<BBBDBADBDG8FG.FHHICHHFIHFHIEIFFHHHFIIDBF.D8HDFFIDHHHIGHDAFG)HIHFHIDGCFIDHI)IFFHHIFGIHIAIFHI8HHF=HHHH:GIHFIHHEFGEH+CF)EFE+EEF/GGFFCDFGDEDD9BGEG/CGCGGFEAGGGC(F,EAC(';CEEFEGE:EEEEGEEEGGCGEGG?GEE<EEC(**FEG:HEGC8EGEAGCGG0EGCCA-G*E?.GAGC?1A(*#8GG(9G
@antibody_79_multiplicity_7_copy_5-1
GGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTCCTGGATACACCTTCACCGCTTACTAGATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAATGGTGGCACAAACGAGGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGACCTGAGCAGACTGAGATCTGACGACA
+
=??=,BBB@?D@DDD?GFFCGGFII>HH+HFEHBHHHIFIADIIHH-H9FH5B=I-BFHCCIGHIIDHIHG,HGIH-IC=EIBG:-HEG8GHIIFIHHHHCIH)FHHFGHGHHHEHHH@DHGHHFDGEHD98DG:GEG?4EG#DED@DAEF?*E6EGG(G?8GE(*?EGEEC?EFG*G?ACGECEE*CE/>G<:A??EG/0EDC::?<:EEEC7**G7CC<FAE(GG?CECE:(.C:AGC*C4CE:EEC6
@antibody_79_multiplicity_7_copy_6-1
TCTGGGGCTGAGGTGAAGAGGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGCCTACTAGATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACGATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGGCACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCAGACG
+
?A???BBBDD5BD,BDC>C+GFIHIEHEIE->CIIHIHGFAHH+GIIHI@HHHHCHIHHHIIICHHHGFDHHHFHDCHIAHHIGE.+CHHIHHHIEGHHI*HGHH7I=HHDEG=HH@H=HG1GDHGFDEEAEHGBGG@*E=CGGEEGEEGE*GCCG*G/ECA(B(??GE?@FE.E*F?E02>8*EEGECG9G?:6?EC4)ECF?E?A:E*AE@EGG/EEEEGC#*E:E*AEGGA6CEEE?E2.-F(*(EE
@antibody_79_multiplicity_7_copy_7-1
CTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGCCTACTAGATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGCTGGATCAACCCTAACAGTGGTGGCACAAACGATGCACAGAAGTTTCAGGGCAGGGTCGCGATGACCAGGGGCACGTCCATCAGCACAGCCTACATGGAGCTGTGCAGGCTGA
+
??,A?BBBBDDDDDDEFAGFCFHII+AHII@IFCHHHHHIG@FAH9>@DIHFFCDCCFI>EIIHAHFHFIHH5AIHD+IFIGIEH=HIGFIHFIFGHHEIH+HHBHFFHEHFHHHFHDEDGE.HDEEG?GGGGEFG*(CFC<43GGEF4GHFA*FEE8CFG6EEE6EE6G?E(CEG;6EA+E*AEFG:G<GGCDC#E#EGGG;G:GHC(CG*0GCGE?,EE,A(CG(6GE(EC:EE/C90**:8(E.E-8
@antibody_80_multiplicity_1_copy_1-1
TGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTCACCGGGAATATCGCTAGCGGTATAGCATACACCATTAGTACAATATCCGATCCCGAGAGCTCCTCGCACAGTAATACACAGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGCTTCTTGGACGTGTCTACAGATATGATGACTCGACTCTTGAGGGACGGGTTGTAGTTGGGGCTTCCACTATGATTGATTTCCC
+
???<?>BBDD@BBBDD0>EFAF?ICI>IHIHFHAGIFIHIHI9I=HHAHIHHGHHHGHHBGDGCFI=HIHGFHHCH>HIHHHH;E<HIHGIDHGF,FGHCDCHHHHHHGFH@'BDDD,=*F<CAFFCH8H?E;GBGFGG8CECCEEFGEGG8G6CEGEEGEE?EDEE(CA8FFE(A(E:EC-GA:0GGEAG:(-GCECCGFEEC/EH0?(GG/E8?E.?CC7EC:E(G*CGG6C?<:6CE:<C?(EEEG0
@antibody_81_multiplicity_3_copy_1-1
CCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAATACTGGTGCTGGATCCGCCAGCCCCTAGGGAAAGGGCTGGAGTGGATTCGGGAAATCAATCATAGTGGAAGCACCAACAACAACCCGTCCCTCATGAGTCGAGCCACCATATCATTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACC
+
???A?BBBDD<D@DBAGGGCG+/IHIBIIIGGHEFIH9HHHH?HDFII?IAIIBHHAIFAHIHE5I@HIHEHFFEHHEHICHHAIHH+FCCC#HG5HHHHE@;HHFDEHHCHFI+DFHDHHF8H@F.G>HEE*E0FGCGE*9EE8EFF@(E?EF?F?AED;GG?@GG6?GE?G,F)EEFGE?(#G;E:E6EFGE'<CGCFE-(E6GEE<?CGECGEFCG@EC*E(*GC#?:EA;0E/E?A.G:EA-;:C0
@antibody_81_multiplicity_3_copy_2-1
ACGGTGACCATTGTGCCTTGGCCCCAGACATCAAAAGCATCACGCGGATCTATAGCATACACCACCAGTACAATATCCGCGATAGGTAGCTACGCACGGTAATACACAGGCGTGTCCGCGGCGGTGACAGAGCTCAGGTTCAGGGAGAACTGGTTCTTGGACGTGTCTAATGATATGGTGGCTCGACTCTAGAGGGACGGGTTGTTGTTGGTGCTTCCACTATGATTGATTTCCCGAATCCACTCCAGCC
+
?<?<?BBBADDDBDAD@FCG;GFI6HHBHCHEFIFHHCHICFIFHAFIGHHHF)FFHIHEA5HHIICH5HHDIHHHHIHCGCHICDEICIDFIHHHH+HHHAIHHHFFG8H5DFHFGDEH8F?*E*HH+EGGFFECA*FG8DGEGGGD6C>?GC?BC8BEE(?6EGCGG6FGEEC<EAEEEGGE:/GE;?*G??GG/AGGEEG(;A:FEHCCE=.GB*DE?ECEGCE*GE*?8*ACAE<6EFE?/F;CG#
@antibody_81_multiplicity_3_copy_3-1
GACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGTGCTGGATCCGCCAGCCCCTAGGGAAAGGGCTGGAGTGGATTCGGGAAATCAATCATAATGGAAGCACCAACAACAACCCGTCCCTCAAGAGTCGAGCCACCATATCATTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGCCTGTGTA
+
?A=?A>BB?+A--DDDFGFFFFIFIHFHIEHHEIGDIG-AGEBG@I)HHFE=IDFIHHFHI.FCIHFIAFIHH?IHIIHHFIIFAEDIIHHIHI>HHHFHIFFHFFFFE2DHH8/5ED.EHGDGGECEHF@G)FFEG*HA5@G*C*:FC?*BGB#EF?GEG2EGF.EE4CG=EG?GGDE;EFEE(E1EG*?F8GEGG/D*EA?9;E82.HAFEG@ECC?@EE*FCEECG8EAE#EGEG*EECC?AG)*A?
@antibody_82_multiplicity_5_copy_1-1
GGGGGTCCCTGAGCCTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCCTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATACGGTATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGCCCGATTCACCATCTCAAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGGTACAG
+
????<B?=@DDDD-@B+AFGCCHIECIHHIIFHFCHIGI=FG.IFCEFFIAG>HFF+F+HEIIIE8HCGHEHIFHFH-HIIIF-HHFHCGEGFDFHFIHHGBHFGFH+FGHEFDE=+HHCC@GGE+DG*?FFDBHGFGG(AGDF*GG/EFBGG#EC*F6.GGE?(E6EC(EEGGAGF6G?G?-F=E*?<:C:G*C#EEE*E:EC:(A'8?<)EAGGGG;8/EA.FG.CCEE6(<E:?/:CCCE6)A1(?C
@antibody_82_multiplicity_5_copy_2-1
CCCAGACGTCCATACCGTAGTAGTAGTAGTCGCGCGACAGACGTTAACCATAGCTGTATCCACAGCTGGTAACTGTACCAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGTTGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCAGCATACCGTATAAATGCCACCCACTCCAGCCCCATGCCTGGAGCCT
+
<?<?=?>@-D-D5?DBFGCFGGIH>EHIAFHF@HIFI@HI+HH9H?E8IGHIFFFFH,FHF#8HH+IH?FH?5ACIDGIB(H-F+GIHGEHIEHF(HDHHHDHHF+HHGFHG3HH6EHHH3DGEH;EEE*@/D*GF0EDFG?=H.60EGG=H;GC*(GEDGFE0GAGGF:EECEEEGFGFE+FGG.G(GCCE4GGG:EG(F?E6(?EG.CEEE:EE?CE:G,G((E':?F:0.'?/;((ACC66GFG8:C
@antibody_82_multiplicity_5_copy_3-1
CCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATACGGTATGATGGAAGTAATCAATACTATGCAGACTCCGTCAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTCAGGACACGGCTGTGTATTACTGGTACAGTTACCAG
+
=A=?A?-BBDDDDB@<FGFF>FIEH-FHFHBHHFHHHHIIEGH9HHCEHHHH5EIHFEFHIHFHIH>GD:FHHIHEHHHCFAHGGHAH,HHI,HHIHHFHHHFDHIGFH=G=DEGH;HF>D29DHFAFBFEHEG?2FGEDG(E:E8GEGEF9EGEEDEGE?CEE-FFFE96C:EEEGC/EGGGCE?GGGGE8>6GAGE/AE;FGG?CEEECEA;*GE(GCGDE:ECEE*E*F)GE(66E(G6E9CE8-F6
@antibody_82_multiplicity_5_copy_4-1
AGGCGTGGTCCAGCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATACGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTGCAAATGAAAAGCCTGAGAGCTGAGGACACGGCTG
+
?9?A?/B?DDDDB<BDDFGF>FHIIFII+AAHEHFHHIIEFH;HHF>II.F.H=HHGHHGHHI.CFHHDH,HC=EIFFHFFBF7EDHHIEEHIDHCHFIH-IFD.H8G,HHF+EFDFD3EFE3FFGG<BFHCFDEFHF:(E+EEE*GGCGCGAEDG?1#EFGGB??G<G8=B;FGEGFE.EGGGAAFECF/:EGEG0E8(ECAG6:EGG.*E)(CAB:,G'70E*EE8<G:*:E)AGEAGECAGC(:*6?
@antibody_82_multiplicity_5_copy_5-1
CCGTAGTAGTAGTAGTCGCGCGACAGACGTTAACCATAGCTGTATCCACAGCTGGTAACTGTACCAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATACCGTATAAATGCCACCCGCTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGC
+
?<??A<?B+DD@-@B9GCFE-F@IIHHHIBHFF=HFDHHEHHFHIHIIIF9IICIHHGHHHEI-FHFHE-I,HDHHIHGIIHIIHIHHFDE.HD7IHFH.FF6CHHHGGEGFHFEHE*DGDFGHGHGFBDFFFGG@FFG6'CFGGGE6#GGAEE.=CGGE1C@F26GFGFGG*EFGEAGE:GFEAGGFEECF(EE0GCGE:EC?886EC10E#G@?E0/AEC4E8EG*8FECC0FE?(?G0CE0A(C8/E
@antibody_83_multiplicity_1_copy_1-1
ACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTTCCGGGATTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATGCAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACATAGTCTGCGTAATTTGTGTAACTGCTACTACTACTAATGTATTAAACCCACTCCAGCCCCTTCC
+
???<AB/>BB@D@DD<CGFFG>EFEHFHHEHD?IF.HGDHHGDII@ICIFHHFI9HFFFIH0?HIGHGIICHFFFFHFHFHCAC6DIHHDFEEH(E+HHIHIG7EHFHEIB:@EDDF?HBE@FGGFHGCGFHF;0I,EGEEGEFCGGGGF/CGE*E,*ABGGBE1CC:G<EC:/.EG'CGED<C(?(/A?C8?FEC8*E/?:EC?E(:EA.?H@GGEG,,8C;C;G'C(EE?G6G0GG?C:CG8'E1EE:
@antibody_84_multiplicity_1_copy_1-1
GGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGCGCTGAATCTCCCGGGACTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAGTCGGCCCTTCTCAGAGTCTGCGTAGTTTGTGAAACTACTACTACTACTAATGTATGAAACCCACTCTAGCCCC
+
=????BBBBDDBAADBGFBGFGHEFIHIHIEIDHHI-HHG.FIEHHGGFHEHFHIHHHHDFI=HFHGGCIIDFHGIFIFHHHGIHHH@5FFGDG5HCH=FGIHHH3H8.CHHHEHFHEGHGHEHEFFF'GHEGFDEF3EFCCD@F*FEECE6AG*FCF@CC>G*G;ECAG.E<EGGEECGGG*6F1G*G0C8A?;4DEEGEECG/AFE'6EG)E*FGGGE-<GCE.E/G8(AGC?*G.EG:>G?*(6''.
@antibody_85_multiplicity_1_copy_1-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCAGTAGTTACTATAGTCTAATTATTCTGTTCCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTATCTGGAGATGGTGAATCGGACCTTCACAGAGTCTGCGTACTTTGTGTAACGACTACTAGTACTAATGTATGAAACCCACTCCAGCCCCTTA
+
???=?BB?EBD<BDDDBFF@FBFI>HIIHE+HHHHIGHDGIIHEEGCF>HHHHHHHFGH-HHHFDEEHIH+IFHDHIF*5IHIHFGHHICHHIF5=HFHHHHGDDHHD@HD=E=HHGEFFFBDEFEFBGBGFHEGB4FEBEGEGG?EEEG(*=AEGEG(B:GG8;FCAAGEGEGEE:/'F.(G??:*G6.=?G8D6GGC:G*(C)EH:E#(G(G/?*8;:=EE:E*AE(G#G((:*E:?<:?0:8:E:C(
@antibody_86_multiplicity_1_copy_1-1
CCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATTGTTAATCGGCCCTTCCCAGAGTCTGCGTAGTTTGTGTAACTACTATTACTAATAATGTATGTAACCCACTCCAGCCCCTTCCCTGGAGCCGGGCGGA
+
??A???BBDDDBDD@<CFF8FGIHBFHHIFGHIF@EHH>FHIHFHHHI>IIHIH=55HHI5-GIFH5IFCDIIIEHHHGHHFFHCGHDBEADFH5HDAHHEIFEHHHFGF=CHFHHHFC>HEEA*EHDFFGHEDBB0;FFEGGEBFDA?EE0'GA*?;BGG<G?E)EE<6?GG/;:GED(<G/;EC?GEEGAGEECE/*G;?E8CGA:EH;GEA*AG??A(8FGGA:CC??GE/*6*AAE;FC*6CC*((
@antibody_87_multiplicity_1_copy_1-1
CTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGACTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGAATCCAGCTCAAGTAGTAGTCACTGAAGGTGAATCCAGAGTCTGCGCAGGAGAGTCTCAGGGACCCGC
+
??A??BB>DDBBBDD5FFGFGC8HFFIC6EEIHDC9>HEHBHIHGHH9FGGEHHH-+HD5.GIHH:HHHIFIGEFI4I-FFHHAAHCBFFDGIA;HDHFIHHHD+DC9@DGGHDHHHH9CEEGCFGHGFCGD(FF*GG9G(FEGGAGG;G'E?FGFEEE(G;CGGGGEF*EFF*EFAAEE:E(C6G1EAEE:G(*EG(6E*ECGF'E/?(ECCEGEC*?GE(-C(6/(8:E:(//G/E(AEE(:?(*G*?
@antibody_88_multiplicity_1_copy_1-1
TCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGTGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAAATACGCAGACTCTGTCAAGGGCCGAGTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGGACAGCCTGAGAGCCGTGGACACGGCCGTGGATTACTGTGCGGGAGGTA
+
?A??A@BBDDBD<BDBCCF8ECIIIHIHHHHFHI?HFIC;IHHIIAB-FH=HHIHHHHFCDIGIIHF@GHCD5IBI'FIFI-+HIHFGCHHFH@EHHHH@BHFDHHAHH;7H?9G+HHFHH@EFDF**CG?EFFFC;G*,G8G6@E;GEFGAG=G;GG>.ECE0G;C6*E;(E46GE?G*GEAGG1)EG?FEE?EEC(GEC(E*6FHF*EG)@:G7B#G@:EGGGCEADA)*CE0E?*AAE?C*EA:*A0
@antibody_89_multiplicity_2_copy_1-1
GGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACAACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAATAGTAGTAGTAACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGTACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACG
+
A????B?BBDDDDDDDECF,FGCCIFHFFIHFC9IH-FFFI-IIHHFHIIHHHIHGFFIHAH5FH5IHFDIFEICHHHHHFFDIFIGHFFFHIHHHHHDIICEC>GIH.FGFHHE?HHHB?DG1GFFE@GD9*FD==B*@GFFEE,GCGEE,GA8EGGG(E@8EGEG.FGAEE(0(*GCGEG(@;8G*GG.E;:<6E/;C(EGEE*EEGHECHEG8GG;GF?C)EF8?GCG'*FCEG.?G**?*G6:F*C
@antibody_89_multiplicity_2_copy_2-1
GCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGTTTCACCTTCAGTGACTACAACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAATAGTAGTAGTAACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCGAATGAACAGCCTG
+
=,???9@+BDDDD@BDGEFCFFFFF/8HHHIHHHHGIIG=GBH;FIHE?AHHHIIIIIHFHF>D5HHIH#IIAGIGEHHFHE+CAI7+IHFG)HH7CEIHEHHFFHHH7H@HH@H;4+=HGFEG5;GDEGHGFF@I92F@GGHG)GG3G(/EEEBFF,G0GGGCE*CE:*GGGGFGGE*FE6C8EEG?GGCEF?G;A?GEAED?E::?G>.CCCE/:EC(BGE8:DCEG?6:*EEE(G*G40?EE*G'E<
@antibody_90_multiplicity_10_copy_1-1
ATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGCATGGGCCCTTCACCGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGGCCCTTCCCTGCAGCCTGGCGGATCCAGCTC
+
?,?A?BB<DD?BB-BDFGFFFGFIHIII;I5HIIHBF0EIHGEIFHG7F,GHHHHFHGBHFDGF+5GF@HFH@HHHA5HH:=EIIIDHGFGIHIDHIH+=GFHHIGA6GHHHHHGHHHFECHDHHFFGCFHGGGDGDEGGBEE?E=*E#EG?E,/AEE6G8/E*GGG?CG;FCGGG(G?(E+;G1?:FGAE-C:0C0(EEGG>:F:*F6AGEC)EEBGB@9(AE:E.AEG(CE;ECCG<E80AE8*?E(F
@antibody_90_multiplicity_10_copy_2-1
TGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCCATTCACCATCTCCAGAGACAACGCCAAGTACTCCCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGGC
+
??=A?5BBDD@BDDEDFCFCCFFFCIFHIHCHFFGHGC9EIEHF9HDHHIH/CAFF-HIIF?FHFHDIIE<IHHEHFGCAFICH<HI@FI3H8GEHEHFEHFCFCF-GIDHEAHHDFHEHHFFHHHEDEGFCCGGE?G';HFE<FEE8BGG8CE-BCEEGC6*EGG2.E4?EGFFE66EC(EEA/EEC:<;EC?:?*AAECE0?AGHE(C((*EB4:.EC?G)F9:.<ECG00*CD#?0(G6*GFA.*CF
@antibody_90_multiplicity_10_copy_3-1
GTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTATCAGGCTGTTCATTTGCAGAAACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATGGGCCCTTCACCGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTCATGTATGAAACCCACTCCAGGCCCTTCCCTGGAA
+
??=??B<?DBDD?DBD>8FFGE+FH>IH;IAIGFHIHIDFACHEI0HI>>FIFFFHGDGH?HHHIFGHCHIFIHHHHEHIF>IIHCH-FCHHHC3HHHFHDE1=-HHH#GHFHFDCHHD<;HGH0GGFC*DEEEFE/EA0,GEGEGG?G?CG/(G:FEGGE0EGE7@EEEEFE:E(GC?FEEEFEAGAGEA>GG0?(CGE'EACFGEF?HC(C*F*CEC:CGC:EEEE/CA/.GEGF8E0*16C:*EEF0
@antibody_90_multiplicity_10_copy_4-1
AGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCACGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAAGTACGCAGATTCGGTGAAGGGCCCATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGA
+
?,??,BB><-D-DDBBC;>F;F;FHH+HHAHED?HE+HGAHFCI9GFDHFHHHHIFBIIH.HIDHHGH?IIHD#HFGIH#FCHAIHH7GHHH?HHHDDHECFIFFHHHGEHHGF9FHGFF=DHDHG58HFE=#EFE*D?FF+EBEFGEBAGEEGFEEGEEE(GEECGEF*2E1FFECE6EF/0?(GGEEA:6AGEG?C?*ECEE6=?EFC:EE@GE:E;G)C/ACF:G:E(G*CC:G#GEA*6-A/EEG*
@antibody_90_multiplicity_10_copy_5-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAATGGCCTGGAGTGGGTTTCATACATTTGTAGTACTAGTAGTTACACAAACTACGCAGACTCGGTGAAGTGCCCATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAA
+
?????BBBDBDBDE+BBFFFFGHIFH>HF?GCHIHIHHI@IFGHEGIFHCIA,G=FICIFFFHHD>HIHFIHHFAII+FHCEIDHIHHBGCGHHD+HHHGDH5ICDI6DFHFHGGFFDEGGF@F@EF#DEEF?FEEGEE)G@EFG8<DDE0.#AE;F7;(EFEF>0/(EE)EGE:EEC((G/.GAE*/G?0AGE*:G8:CF<'EG86CE6CC<E@E;CG0EGCEEEGCG2'DC'0:0<EEC::GGEC6/A
@antibody_90_multiplicity_10_copy_6-1
TGGTCAAGCCTGGAGGGTCCCTGAGACTCCCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCCATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTA
+
?A???+B>DDDD@DD@F.FFGGIHHIIIH+IIIHHIHAIGIII0FGEIGIECI>IH7HFHHCHHHDGEFGHDEHEH=HHHGIHFIHI-HFHDHAIEFFHHIE+DIEI1HGHFFFHECHEG8(HG?HHFEFDDHEFGFEGE/FGE0FGCE?*E?(@DG?GBGAEGF<ECGEGG;GA?E6E/CEEEEG(E:(G*?EG(GCAE*?C?;FEGG:(<HEGEEG8GG7(;FG>E?E8A-EF?A?:?E?EC/E6GCA
@antibody_90_multiplicity_10_copy_7-1
CCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATGGGCCCTTCACCGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGGCCCTTCCCTGGAGCCTGCCGCATCCAGCTCATGGAGTAGTCAGTGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCAGGGACC
+
?9A?=B<BDDDDBBD@FFFFGGHFIAHFI-IHAICFHFEGBIIFDHHH@D-IDHECIHHHHFGIDHDHIHC5F*GHH5EIEFIH=CHIIFHHHCHIHHHHFIHHHEGHFHHHAFDDH+DGE+E9CH-1GGG@GG*F.EEED,AEEEGBE2GG8?0C<:E)GB?F*?B1GFE6GGECCEE(EE(FG/0(?E*;G?GGE?.C(EEGE;:)FH*AC/1?:<BCGCFGGEGA*GG/EA(;E:?C6C(EE0/'AC
@antibody_90_multiplicity_10_copy_8-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTCATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATGGGCCCTCCACCGAGTCTGCGTAGTTTGTGTAACTACTACTACTACTATTGTTTGAAACCCAC
+
??,??BB@DDDDDB9<GFGGF88HII>IF.?IF@HHHG+E@H@/HCBHIIHC-HHIGHIIHIH5-DHHHHIHDIIIA#H*IECIIIIHHHFFH<GHFCF(ICH@AH=EHHEG3GG1FFF+CHEH+HGE++EHB=:EGAGE*/G8FE>*(G0AFE>GCG8EGEC<FEEEGCGGDGG,C96CG<EEFGC0GEEG6G(GDEA?(?6C62EE?E(?(E(EECGC*C?:AA0'*C:0GCE*E:E))E>*C?G8GE
@antibody_90_multiplicity_10_copy_9-1
GGAGTCTGGGGGAGGCTTGCTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGGAGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCCATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCATATGAACAGCCTGAGGGCC
+
5??5=?BADB5@-BBBEGC/0GIHIIHHHFIHIHI7IHGHIHIIIAD@IFBIF@GD5+HHFHFEE?FAHHIHDHH-IICIEFIHHFIHFHDHFH=HHFHGCHAFFHFEHHCH*5GFFF5H?DGFHG:FCH0EEBGG+D?G(EG*ECE#GFG(GEEGDEEFEE6*G(GGC8ECEAC/EG/EE'EEE*C(FGE>EG??G<6:CFE(/*4G(;?E;G:G(EGFEE*0C?CAEEE0A;8E??AAEG.(E?#G.G
@antibody_90_multiplicity_10_copy_10-1
CCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCCATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGTACAGAATAATTAGACTACAGTAACTCCCGGGAGAT
+
?=,?,@B?@B@DDDEDGFGFFCF-FFIC+HIHIICID>EGFGIIIHHHFHAHIGHDIHGIGEHFAHFFHHHB5HAIFHHHFHFEEBH@I-*EFHHGD=H,HHCHCEHH>EFG:HHEHFFHFF?H/HDDH;EGGFEIGCE*FGFGGE8GGEEE9GA?EEEEFGCEEGCC:GCGG(EEEFCEC(GEG:GCG?.E;C(EAC.EAEC?E*#-GAE:AEF:GEEEGF86:9GEE*:*DE?0E?:EGGG:CEC?::
@antibody_91_multiplicity_22_copy_1-1
ATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGGATAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTGCCCTGGAGCCTGCCGGATCCAGCTCATGTACTACTCACTGAACG
+
?????BBBD@D<9DDB9EFGFGCFHHCHFHDIEIHHCHEHHAHHIFIIHHHEFIH(HHGIFHIHGHFH5HDHHIHHEHHI@BCH-IHHH.H@HHHC@=HDH4IF*GHE*FD@GFHGEED2EHB;F(DF9<GGAG=BD0EDEGE<BBGFE9F**G:EGE<*E*GGG(0?1EEEE:GGEEC/G66G*?C(GE*CFG?EGCG*/EFEFEA:?H?6(C*-GE/E:90(2CE0GE:*:*E*E/?)(E8*:<01':
@antibody_91_multiplicity_22_copy_2-1
CGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGCGCCTGCCCTGGAGCCTGGCGGATCCAGCACATGTACTCGTC
+
=????BBBDBDBAD@BGGGFGCBIFIIHBHHFFGI79I-IDHDGCFHI@HE=HF87FIHHHEIIHIIHIIH=HIHHEEHFI+HHGHHIHEH*HHHDFHIEHHFBGIHHDHD8GHH9FE+HGFH@/GEFEEG:HBDE??DEGFEEE@EGEEG?:FE?EGFG:E/8GCE(E(EDE(G*<DGG)E-:AECG?:GDFGEE??EG?*C(.?*?F'9GE@*(GCG1EEECE?.(EE'*G?*(E0<C0C?GGC#E*G
@antibody_91_multiplicity_22_copy_3-1
GACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCGCAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCCTAGTTTGTGCAACTGCTACTACTACTAATGTATGAAACCCACTCCAGCCCCTGCCCTGGAGCCTGGCGGATCCAG
+
AAA??B=>@DDD-DDDF?FF+FBFHCBH6IG.IFHCIIFCFIIFFF=IHHFH.GIHH@?H-HHIIF-IBFIGFIHHFIHIHIGHFGC=HEIHHHGH(HGCIGHDFFHHEFHHFEFHHGHEHH+GEFEE1HF(EBBGF:GHFFG/GCGG(G:GF=G*G?EG;*GE@/EG?CGGGG#G8GE:GG8C(GEF8#EC)C*?EE?G'<EG.EH;EECCAEGAEC8GBG8C<:GGG6EGCAGE6GGG???G*::EEC
@antibody_91_multiplicity_22_copy_4-1
ACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCAGAGAGTCTGCTTAGTTTGTGTAACTACTACTTCTACTAATGTATGAATCCCACTCCAGCCCCTGCC
+
?<???B??DBD<D5DDEGCFFG/HCIHC/IIHIHIHIFHHHHHDHHIIF?CIIDH>=EEABEI@IIHHAFFHIIIGHIFI-HHIHF8IHF.HHIIGHHEIIHHHHHE=HH*HCHG*>HHH7HGGHGCGCFFA:C0FGEGE0G@CFGCGEAEF?AE8GFG;<CCBEE(EGG8GFC?A<E/GGFE0'G>GE./GDE96(:FG.GGG?:0EG:AFHGG#G8GC=)?GEE(EGFC(ECF*E'EE6*?6)?6'C0
@antibody_91_multiplicity_22_copy_5-1
GTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGCGGCTGGAGTGGGTTTCATACATTAGTAGTTGTAGTAGTTACACAAACTCAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAG
+
??<<?B/BDDBDDDBBCFCFFFCECIBI5>+HHAHIHHFEFHIIHFDHIGAE-EHC8HAAHAHEEFE*@HEFFDEIHHHG(IH+EFDF-FHIHD?HHFHH+.@FEFFHI@EI;@*EFDHFGDE=FFH3HGGHGHE3EGHEGCE*EEE'F=ECEGEGEE(E:GEGGG*?E(EEA-EGEGG:4CEEC)EGCECECGE=EEE:E:E(?:HG6E*?3EGEECC7*GGCFAGC/?EGEAG'EFGGCG6EC0<:EG
@antibody_91_multiplicity_22_copy_6-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGAGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCAGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGAAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAAC
+
??5??BB>DDDDDDADGG=GFCHEHIAHIIHFFHIHHCHFHH@5AF+I/9HGEFHIFIHAHCH#IFHHGDI=I5B-FBIGDHIH@HHHH9HFECFCGIHIAH<.HD9DF#HHHHDHFHE;H(F?@HEGG9GHGG*F/4GE8F@GBEFFB*G;*CC@?FG*GF'FE(CE8?/?GA1:GGG1GG?G/E:A?8C6GCG?C9GEC(GAA(E9GD?F@EEC?GGE/:G(EE?0G:FA=EGEEA'E*:??)0G?.E
@antibody_91_multiplicity_22_copy_7-1
GGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGGATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTGCCCTGGAGCCTGGCT
+
?5?<AB5=<DDD5DDDGFG-6FHIIHFFIIHIIFIIFI.GHIIHFIEF@?FCHH5FGFHFDGC?I?+A>-HH-GGGFHHGI@HGIHIG?HHFD,G1AGDDHH+HEG.HDH;@IHGHFFEGDAHFBEFEHGFEFF*G=/EEGFEGE@GGG?E,EEEEG8)GGFCECCCEEGGDEECGG=GEECEGG;EGCEGA?8GEE>8*86EEFGEE6C8EHGEG00FEEEG)FGE?/GC?**-G(EA8:EG9CC.EE#
@antibody_91_multiplicity_22_copy_8-1
ACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGACTTCGTGGCGTTGTCTATGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTACTACTAATGTATGAATCCCAGTCCATCCCCAGCCCTGGAGCCTGGCGGATCCAGC
+
??=??>?B/D@BDDDEG.GFGGEEF0FHHHHCBIGI9HHACHFHHDHGDFIID>BGAGCHIIIAIFII=G1EEFIIHHFI=EIFF3IHH8FH+EHIHHHHCH-FE,EIHHHHHHBEH3HF?C+@FG0@EHHFG'00+E,G0HF*GGEEGC.1E5A/GCAC??G(>*0@D:.E8FEGE'EEAEEGFG#E?=(EEGEF(E)CG1()GE'CEE(G:EG(EGEG0ECEE*AEFC8EE:ECGE-C?0CCGAEC<;
@antibody_91_multiplicity_22_copy_9-1
TGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGTTGGAGTGGATTTCATACATTAGTAGTAGTAGTAGTTACGCAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAG
+
?5<??BBBBDB@BB@DFFGGC@FE8HHCFHFHHGIDEFIHIEI-H5H=FFIHGFHG-EHG''@HF*IHFIF==C@HDHHH-HCH-I68EHHEHH3CH*H'HC<IFDHHHEDIIFF+FF;HEG,=D:EH;AH#E5HGDEEAGFAG:GGEC*CFFDG(E<(FD'FG0EEE:*F,FGGGFGE*GGGE;EEGGEC<E0-FFE:GFG*EG(CEGHEGFCC*7/G(F<;CA?::0C8GC:CA>'.:GG0EAEGEGE
@antibody_91_multiplicity_22_copy_10-1
ACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTCCTACTACTACTAATGTATGAAACCCACTCCGGGCCCTGCCCTGGAGCCTGGCTGATCCGGCTCATGTACTAGTCACTGAAGGTGAATACAGAGGCT
+
???=?BB3BDDDDB@DFFFFGGEHEIEIHE?IAGDIDI-HHIF->HHHCFIIECHHAHFH5GHCIHC5HCHA-(BAHIHHFHHHIEC;=HHBIEFH=HIHHHHHH*H=IHHEFGHEH?FHGA7GFEFFHEDG)=EF=EG;4EEE:EGGFEGCF((:EEGEG,;G=FEC,AE:G/G*EF*<:GEG#E(C0GG.G2*/GEEG(0.G:G(GE*.G*EE*=FECECECEEEC?/A?:C?CA??.CC(E:EECC;
@antibody_91_multiplicity_22_copy_11-1
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCCCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCACTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTACTACTAATCTATGAAACCCACT
+
?,???BBBB-D?D@DDGF>GCFHBHHHIIFICGHHHGDFHEFI+GGIB+/IDGFFA?,I-FICIFIHHAIGFDDFHHFIHFH+IDF3FGIFIIHHEGD.H@G,FHF6GHIDCHD;*H@E@@G*2DGEGHEE3HEEFHE=GEEGCG1CEAFFEEFEGCGECA6E>EGGED/CGEC?AEEGFAD:G1FEEE?GGC?8/:/FE:6EGEG/(EHFGA(GEFC0AF)?:?E?EE/<G;(EG(G#CGEC:F?'CG.
@antibody_91_multiplicity_22_copy_12-1
CCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTAGTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCCCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTATCTACTACTACTACTAATGTATGAAACTCACTCCAGCCCCTGCCCTGGAGCGT
+
?A??=B@BBAEDDDADGGFCFFIFHHIIFAGH=IEFIHC=ICIHH,FFIHHHAFHHIHHFID-I@ECIIF4HHIFBIHGIG-FHFDGFIEHHGHHHIIHHEHHHGI-FHGDBGGH+HDEHF*F*GDFGCBFFGAEE?EGG.(0FFGFE?/BG3GGG=EEEF6*ECEGE(FE/FEGCEEGFE:EE.?E?G*GE:G*EA(6CFEEC6?HEGFAC'G1*:EB,G:E**EECEGGCAC(EGG?EEE0EE;G(*:
@antibody_91_multiplicity_22_copy_13-1
GCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTACTACTAATGTATGAACCCCACTTCAGCCCCTGCCCTGGAGCCTGGCGG
+
???=<B=BD@5DD<<DGFFGFGHH>IIIIIDHHHIHC7FHEFHIGHHFFFAICHFEGFBFFF?II,H55IHFFFDIB#EHFFFH-IIHD+IHF=HE?DFCD@GHHHFHHHE>@HHBGFHHFGFHH0AHDF@FGG@CEF.ADEEE;6GGFEF??;:0?C.EG@:E(CGE((GCC:GE?FCG:+:C:AEDFE,EG=AGE?CE?:/FC*?EFFE(HGC*?(E-EEGE#4EEC*?G:CEEC(C?F8?E2GEC'<
@antibody_91_multiplicity_22_copy_14-1
CTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTG
+
?????BBB-DDD?DDDGFBFGGF/;IEICEHHIIIFHHIHGGHHEIFAGHHFF,FFHHFII>HI5HCHC5CHHHCHHHI5CHGHHI8GHHGHH:HHHHEHHGGEBH/HFIHGHEBDDDHHHCGED:1*GEHFGEG+;GGEGF2EHBGAEF?CGGF?GG?G:9C*EA0F?G?;EBGEEFG:C,E?G;EG*GF;G1?ECC=E?EGGGEEECAFGC<0CEE?EC/GA:6(EE:C(G?(E0C<E(/ACAE)*??
@antibody_91_multiplicity_22_copy_15-1
TGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTTGCGTTGTCTCTGGAGATGGTGAATCGGGCCTTCACAGAGTCTGCTTAGTTTGTGTAGCTACTACTACTACTAATGTATGAAACCCACTCCAGCCGCTGCCCTGGA
+
???5A@BB6BB@EDDDGGGFF8HI/F//IHIGFHHEIFBIHH-HIIFHI>.FAH@C?BE/HDGIHIAGEEFIHFGHEIEAIEGA+HFAHHDFIHEHHG.IHFHHHDD7=FD:HHDHEG*=DCF;HHGFEGE;=DGIEG*FECGB(*:CF;EGD*,BGGGAECEFF6E=*FGE(EG(FGCC6GAEGCGG8F6F6ECGE.*GG(?GE4HA0:G<07G*EEGGC.CEE(CA.E:GEEF<FEE#(E:/G/8AG8
@antibody_91_multiplicity_22_copy_16-1
TGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCGAGAACTCACTGTATCTGCCAATGAACAGCCTGAGAGC
+
9A<??BBB@5DB@DB?G0EGFGCFHHCHFEGHDH>I-HFCHFGI9H.HHFHFEIH-F-HHD-DGHFFH*HHHIDH-+HII-HDFH-FI5-HE;IHHE?EEH=-HFHHFFHCFDFHHFBGFDEHEEF*GGE(FE-EGGB>;GEE?GEGCEFGG0F<EC?>8E?G*A9G,C/?CEGEA>EEG:EF?<GGE6*GF?EGEFFE6GGE?G6E*EAGG#E;:E/GF7EDC:A.*0G9(FG?E(/EECEEC>*G(5F
@antibody_91_multiplicity_22_copy_17-1
CTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTTGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACGACGCCAAGAACCCACTGTATCTGCAAGTGTACAGCCTGAGAGCCGAGGA
+
5??=??>BDBDDB?DDFFBF/CIHHICIIHF=FHEHIG;IHHF@I/.GHC>HF9F.IHIIEDIHHDEHHFHF5HHIIHGGHHBCHHDHCCHGFH3CHEIFHFHHDFH:.CGHHH,FED,FFF*H040GE#B3E6GFEFGFGEEE<E(EG.6AF89F??EE>GGFGECD:8*HEEEF.E?GEC:?EA)GEECGA:E<GGE((F(E?E?C9E?G)E:EG;BDGG?:/GC(F:*G-.AAEGG(A:GCG/2G?E
@antibody_91_multiplicity_22_copy_18-1
GCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTAACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAGCAGCGTGAGAGCGGCGGACACGGCCGTGTATTACTGT
+
??????A>BDBB?@DDFFFGCGHHFHIIF..@GGHHHIIIHCDHF9FHHIHIHDHIIGIDH)FIFIH=HG5GHEDIFHH4GG+@HH>HC8IH;CHG1DHHHHEEHGEDA0EHGEHD5HHDHGH0HFF'G?GFG<GGG;.G@EEGGC+G?G<<F;@FGGFE(E:GF(EC:FAC8G;G8?GC<+EG;GE*EAEEGGEEG:(1G?E/6G.?-#E?*>@>0(?G?.C:(.G'?G/;:EAACCGECC*EG?(*A?
@antibody_91_multiplicity_22_copy_19-1
ACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTCTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTTATTTGCAGATACAGTGAGTTCTTAGCGTTGTCTCTGGAGATGGTGAATCGCACCTTCACAGAGCCTGCTTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTGCCCTGGAGCCTGGCGGATCCAGG
+
???A?BB-DDDD<DDDFGEGF+CHH?6IICDHIHHIFAIIHHHHECFHIHGGHH#?H.IHEAGDH=.ADI=IGHHHIIFHGHE=HEDEFC5HEHH=HIDHHFHD+C+H2FHGCIHHDH(G42CEF3FA#G+G;G1>G32HEGEFG?E.6EF?EGE6'9C(GCG-2G?)(C(E:E=GGF*G6F6EEFGEG6EGEEGEC:FCEFGGA:F6GH/*E:F<*E((FEG?:G*E/G.EE*C*;?8:8??GE06EG8
@antibody_91_multiplicity_22_copy_20-1
TGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCGCCGTATCTGCAAATGAACAGCCTGAGGGCCGAGGACACGGTCGCGTATTACTGTGCGAGAAGTACAGG
+
??<???BBDBDDDABDGCFFFGFFIFIIIH9HHDGIH@HFHHDEHFHGHAII>CF=GD*GI5;HEGFHHI@5HFFEH5HFDHEFIHGFIGIIH,FHHHH=HHCE*HHHHF?H5FCH@GE9=E(GEEEHB*H#G?CGGGEDBFBD9ECB;FEB*EGEGEA2EA2;ECG<?EEE6GG?C=EEG'G(CGC??FCG*E'EGGF:CAGE<EHE'C:GC*(GGC8::E*<6*G1(EAA*:)?(G*(?:(G?*E?C(
@antibody_91_multiplicity_22_copy_21-1
GCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGATTCCTTGGCGTTGTCTCTGGAAATGGTGAATCGGCCCTTCACAGAGTCTGCTTAGTTTGTGTAACTACTACTTCTACTAATGTATGAAACCCACTCCAGCCCCTGCCCTGGAGCCTGGCGGATCCAGCCCATGTACT
+
,?A??,-B6DB9DDADGFFG+FIBHH/I+.H9HHIDHIHHHIHII+GHFHFFDFGHIHHIHFI?IIFHH5FE5?CI?HHGGIIHFFHEIADHGDHF7,4H=FACGF4H+H@GG+D(FHEFHF)EGGHHGHGGDG,GB8EBGFGDF7D8GFEG@E@(A6G**EGCE'=G6F*GCG?.(E<GAGGEA*EE:EF<1FEEFGCGEDG(C*0CEAA*8:EE><?CG.F'GAEE?.C(E:**?6C.E(6G:GAC6G
@antibody_91_multiplicity_22_copy_22-1
AGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCAGGCTCCAGGGCAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTAAGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTCTCTGCAAATGAACAGCCTGAGAGCCGG
+
??,??<?BDD@DDDDBFGFCEGHEFFHCH>FFIFIHGCFIHHFE@IHHH8I-IGEFIIHHIIIIAHHHIIHHFIIGHGDHHCHGHIHHHF8HC'HFHDIH8FFFDEH6HCHEECH,5GFHHGF>GCFEEEBFGF'?HGBG:G*E8GE?E:,CGFEEG)GCE>GCGGEGGGE(GEEGC66G?;:0GFEGFE8<G.EF(>EG86G(GEH:E.*(@;4:(G,FC:*??E.A*E?:G=:EG8(C?*EE?G*AE/
@antibody_92_multiplicity_1_copy_1-1
CTGGTGGAGTCTGGGGGAGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTATGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGAGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAATAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCGAGAAACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTTGAG
+
????=@B3D@EDDE9DGF/FFFHHFEI;CFHHCEHFHEGFGGEIFFHAIIHAFFHHHHIHIGE5H#FEDIHHDIHHCFH-CHCHIIFHGEFFHHGFHIHIHFHIDDGFHEFHHHFHFHF#5HEHFHDCGH@EDGEF/G)FAEE8?GGGFDGG>8EGGG(FG=:?.EG8EGGGBAGE:G?G>+EC8?:7:;G0C*AEE8F8)E#AGG#/F<)*@EDE*FE@*ECCEG.A*GE.AEC?CCC?GEA:?)GCGE
@antibody_93_multiplicity_2_copy_1-1
GAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATTAGCTGGACCCGCGAGGCTCCAGCGAAGTGGCTGGAGTGGGTTTTATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACACCGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCG
+
?????B>?DDD+DBDD?FFGGGFIFICFHIICHHH+EHFHFDH.HHHHIIFIHHH,HIFAIFFGIIG;HHIIIH#HCHD=GH#>FH@IHH?HHG(HEGHIDHHCDHHFF*GHHG,0EA+.G?FFFFCH2+GDGGEIEAE(BGGGE(*G>/GG@EEG8FG?FEEEC)CGAGGEFGE>GE.1E'(GEEGE:EGG?CAEDGEGEEC?C#E?EEC;EE::**G:EG:(?EEGA:E*E/A8/*EEE/*CE:FG?F
@antibody_93_multiplicity_2_copy_2-1
TGTCCCTTGGCCCCAGACATCAAAAGCAACGTGGTGAATCTCCCGGGAGTTACTATAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTTTGTGTAACTACTACTACTACGAATGTATAATACCCACTGCAGCACCTTCCCTGGA
+
9????<+B6A?-DBB+GFGG8GHCIHI+>HBE.H-IH-FHEHH+H(+GGHFHH*HGHHGHEHIE:I@HIHFC--DI-DFHIHAHHI?FHH1HDI@FID+HHF=HFEHFG+HGH:BF3EHGHHF?HFFGGFGFGGEB?6FG;FCGFEEGGCEG@GG:EE(CGGGGEE/GEFEFAGE*E/GAC?/E6*GEEG(EE'?<CC.(8EFEECE.ECC(FEE'EEE0BEE-E(?0CC8E8(:GCG(*?A-8)G8E?'
@antibody_94_multiplicity_5_copy_1-1
GTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCCGGCTCCAGGGAAGGGGCTGGAGTCGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAACGCCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAACGAACAGCCTGAGAGCCGAG
+
=5???BB-E<BBDBE<FFFGGFIF+FBHH-+H?I>HFIHFIIHH?HIH9HH/IHGIIHHFHH=HGCFIIICIHIHIHHHH?AI,HFIHIH:HDCFHFHHFHHDFHHDFFHDGH5GHFFEE=F#EGE+*+FEFDF*,EBE)4GF/G@G@G6EGEEA=GC?*GFF@BFBG(GG6EE;CG#EE/?EEGGGG86G/GEC9CF.CE(E8EGEAG;'GECEC?EBCE?EE**GCG#(C(EEEA<):E*:8C(E(C6
@antibody_94_multiplicity_5_copy_2-1
TGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACATTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCCGGCGATGGTGAATCGGGCCTTCACAGAGTCTGGGTAGTTTGTGGAACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCGGGC
+
??,??B??D-5-DBB@G.GGGFII>HIE8>4IH6GHHHIFH/FFFHG>HF.FI+C.HAFHEFHHF,FIHFCGGHHIDDIIH+FH+HHHHIF-F5HH8CHHHHD5F+HHDHGHHHFHG+GEH5ED>@3CEG0HFD/+E)FFGAEG?(GG*E;)EECGGE*8<27GE<GG>EE:G/.*/GG8E(:.EEGCGGE8*E)EGGA6EGAA(CC0C??GAC*(*GC,G(:(E?CE<GGGG8<GEG*01?/C(6E*2/
@antibody_94_multiplicity_5_copy_3-1
TGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCAAATTATTCTGTACCTCTCGCACATTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGGTGGTGAATCGGGCCTTCACAGAGTCTGCGTAGGTTGTGTAACTACTACTACTGCTAATGTATGAAACCCACTCCAGCCCCTT
+
???,?B?BDBBBDDB-FGFFFFFHFFAHF6EIIH/HIEFHHHIGD?GH.HDHFH9H-CFGEHGA?GH+HIHFHFIHGFHHAIAHHDGHGH4HFHHH+HHHG-C8F3HHFGFGFGAIHGFEEG+H?HE@EHHHH@)EBGCFEGAGEEGA*EEE8EBBEFE#EEGEFGG#G:EBGG?AA8ECE:GGG:0CGECC6AGG?GG8#EEGCG>G(H:E07C(BEC<;GEC:E?DC:FCG?C?6F:8EC'GEA(1.A
@antibody_94_multiplicity_5_copy_4-1
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACATTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGGCCTTCACAGAGTCTGCGTAGTTCGTGTAACTACTACTACTACTAATGTATGAAACCCACTC
+
???=A?BBBBDDDDDD;FE/GFIIH?HF8HHGI/HIFGFHHEIE>H.CIFDIHCHFEFHFIGHIHFHIIIFH@FHDIIFIBHIIIHFC<CH/HFICHG+HFF8GHHHHHCHHHGHHD>HEEFE*HDCFGC>?FCGE;E5GFGGEDECEGAG/GC4EFC?EEDE@FCFGGGFEEE8G0EEGGEGEG*:ECC.*GFAE.(CGG4ECEECG:)E(EEEEEF:7:?:/*EE8E/6C:E*(CCGECCE8:;G*//
@antibody_94_multiplicity_5_copy_5-1
AAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCCGGCCCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGCCCGATTCACCAACTCCAGAGACAACGCCAATAACTCACTGTATCTGCAAATGA
+
,,???/+BD@BDBDDBFFEGGFHHIII@H/EH7HIHHICF5GCF.7HHHIDFFIIFHIGDIHHIFHH5GIFHEHIEHHIBF=HHIHDHFHIEHHEIFIIHHEF8HDFFHDGBE@IEGC1+H+EEGGD>GC(EFEFEF'GEBEEFEEGAG*CG1F;GCE**G*EBE:F.:EEE(./EE.GE6;;;GC6?G:CE?G(F4FG???GACG(0(HE80GC*?EB:GGG1F(G#EF</00CE-CF0AA?E?GEEC2
@antibody_95_multiplicity_3_copy_1-1
CCCTTGGCCCCAGACATCAAAAGCAACGTGGTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGCCTCTCAGGCTGTTCATTTGCAGATACAGTGATTCTTGGCGTTGTCTCTGGAGACGGTGAATTGGCCCTTCACAGAGTCTGCGTAGTTTTTGTAACTAATACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCT
+
??????BBDDB@<DD@GFFGDCHFHIHIHHI@9GHFHHIGEEHFHFHFI7E>DIFIHIHFFHGHAAIIHHEI-IEHDI@:IFCCEH5:HIGIHIGH.EHH7HH=HHH+HI=HFEHHHHHFHBFF:HC@CGHDGFEEECFBCGGF,GD*G:EEC(/EGCF=;EEG8(EEA/GEGGAGFFGEGE:;E?FEECFG*?F:?;GEAG?8EE.CA**;E<D0E?E:FA*GEG.*/(FCG.EEEG.1#6ACC*E0??
@antibody_95_multiplicity_3_copy_2-1
CAGACATCAAAAGCAACGTGGTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGCCTCTCAGGCTGTTCATTTGCAGATACAGTGATTCTTGGCGTTTTCTCTGGAGACGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTAATACTACTACTAATGTATGAAACCCACTCCAGCCCCATCCCTGTAGCCTGGCGTATCCA
+
???A?BB?DDDBDDDDFF;FFGEF;HIHHHHFGDD-CHFICIFIH>I.FIF.HHFICFHH>D'HFCHHIIH@HI>G+IGGIIGHHIHIFDHGGH,IHHGHG0HCIIHIHBFH=HGHHCGDF@GHGGGFEBBGD10C*GB#GFG,FEGEFEG7EE(CEGGG'/FA:GE=EG=EE0E<ECG?GFCCACGG:EE:FCEG:/8GGC?EEGH0?EC1@GEE?AEC*:FGE?G#C)FAC/)**G8?CECGC6E'E:
@antibody_95_multiplicity_3_copy_3-1
CCTTGGCCCCAGACATCAAAAGCAACGTGGTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGTACAGTAATACACGGCCGTGTCCTCGCCTCTCATGCTGTTCATTTGCAGATACAGTGATTCTTGGCGTTGTCTCTGGAGAGGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTAATACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGACCCTG
+
????AB>>A-<DBDDDGGFFCFHIFFEECI@HIHIID7IG9.EFHIFGHH?IFHHHC/+F-?IIHHHIHHFIHHDFHHIDE)CHI+F56GG=HFIF8HFHAHHHF+@*H+DH+FGHFHHFEFGHGFDHBFGEEF;GFCG=C?2DFFB;F@G.FE*E*CCA*6FEFGC?1BEEEEG=;2CGC9G*E(EECGGC(EGFCA(EFC(?)GE<((6A70CG7*CE'A*(**ECCF/::6E?.1E06GD?*/:86E
@antibody_96_multiplicity_1_copy_1-1
CCCATGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTTGAGATGGTGAATCGGCCCTTCACACAGTCTGCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCGCTCCAGCCCCTTCCCTGGAGCC
+
??5???<BDBDD<BDBGFFGFFHIEEHIEFH/IHHHIIHHAGFDHAHHH8GIHAHIFFHHHFHH?FD=DHHFDIH->CIHDFHIGEHIHGHFIF-IHE6,:HFEH+EHCBEFFHEHB;HHFFBFHCEFFFFF</HG3CECEGGHG8GG@GGGC'C<?GGGAECEEC:EEEG6EF6;G6:2(#'A'?E;-C(AGCGCG(*CE)E2GFAEGEGGEG@E3GG:?GE:?CE0CEE8G:?E.F?*?6***?E:?C
@antibody_97_multiplicity_93_copy_1-1
CTGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGCACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGAGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACTGAGTCTGCGTAATTTGTGTAACTACGACTACTAATAATGTATGAAAGCCA
+
<,???BBABDBDD@DD@FGGCGHIEIHHAA.FCGHHI>-FIGCDHH.HIIHCIA5CIHH8HIFID5HCCHGIIHDHDEDDDIFCIHFI@D,I3FHEGEGHHIHHHHFH?H@FFGGF=HFD@F=CHHFEB**:(F(FEEEF6F3FCF:EFEGG/G*GGEC*EC:E.;AEEGCGEECG6ECG6:E;0E:G?E(G':E*AGF*G.GCE:CEGHE#07:;GC:8*:6*CG6GFG(E*G0E/EA(C((E68*/E:
@antibody_97_multiplicity_93_copy_2-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGGCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTACTAGTAGTCGTAGTTACACAAACTACGCAGACCCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAA
+
9?5?=BB@DD<@DDDDFFGGG>HIBIFIBAHFIHI-GHFEHGGI@IFFF5CEAICEHHCIHHAGGIGIHI>AEH-FGFIIF-CHIFIHI>HHIH<FHHDEFEFHHG@FH'DE-FH(HHGHH>EHGFCE;EGFGBDGGE2FEDGEGGEGG=EGC(E:EGEFCC@8EEGC*G'EBG*;GEGEGEC8E(A/GGG?A-CGE??F???E?AH8(HGGC:((=A3:?(EE**EFA-CFAGCG:A*:?G1G19(CE0
@antibody_97_multiplicity_93_copy_3-1
GAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGCTTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCG
+
??,???,BB<D@<5DDAAGGFCIF.IH>II.HI7GFFG=HHIHHICD7E-HHDH5DGHFFHF+FGFHHHHEEH5IHDAHHBGDF7EHHI6IHGIIIFHHBF)G?7FHEGFHHH?>HFHFEHFHEFHEHF+*(+E<;GGEECE??EC=(<GE0ACEG?GEGGFGG<G.6GEE:(GCE8EEAA)CECGCEF.EEG?E(?E69>FA?EGHFAE/FEEB*CGF@(:(FEEGG<(0EGC(A?G8GC?E1(*:C(*
@antibody_97_multiplicity_93_copy_4-1
GTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGATTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGGGAAGGGCCGATTCACCATCTCCAGAGACTACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAG
+
?????BB-DDDDD<D,GAFGGGHFIEH-HIGEHHHEHHEGFIEHIIHH,EHHI.=HEHHIHB?GIHHFEIHHI5FHI5HIFCHEEH5HHHGEIHHHFGCHGIDE,G?IHHHHIGDDFEHH@DC@H#HBE=GH;8C?FE<C?6B?GEE:GB34ECAECAEGEEGEE/GAEGEF/GGGEC'CF/E?CGFG/AEEGD8EE#G0GEG*CGH#?HA)*G@CG.?GC,CAEE(6EG>EC:F(/E(AEACE?G;:*E
@antibody_97_multiplicity_93_copy_5-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCATTCACAGCGTCTGCGTAGTATGTGTAACTACGACTACTAATAATGTATGAAACCCGC
+
<A=?,BB?<@D5DDBDAFF6F5FEHHHH/?+E-EI=HHFIIIIGH;IIHHICHFF=IIH-+HE-I=?HHFFHFC?CE=AIH@5FHHGHG=HGHHHHIHDH-HFFHGH>HH,EH=HFG8H=BFGHC;G=GHGGFCCEGGEEFEGFFE*DEGEGE;FFBDG.BFGGG:?G,G:GBGC*CCEGC(EG8CDEG?E0(E(GE>FF*GECGGC;A'8G(GE::0E,C?:CG:CCC8?E0G/*GE?:EC/EAF(E(E
@antibody_97_multiplicity_93_copy_6-1
ACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAAGTGGCCCTTCACAGCGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCAGTTCCCTGGAGCCCGGCGGATCCAGCTCATGTGGTAGT
+
??,?AB5BDDDEBDDD+FGFFGHHIFH08HGHDHFDIF=FIHFC/CI0HHH?HCHHHDHHI=CCHGFHHGIH-EH5FHADHHFEI>IHFHCFHFHDHIHHFHDFH,FEHHGEEHGC+FHE(HGGDDH@=FGEA7G8;DEG'(BCGGEGCAEC<:#EDGFEEE.FEGGGC?GC?*F<G?;=EEEFGE;:CGGGEGE6GC(:EFE'G?:FEC(/.EGG://E.GEEG:GEEGGAECACGE:A6;C<(A::E?
@antibody_97_multiplicity_93_copy_7-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCTTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGGCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCAAC
+
=5,<ABAB-B<DDDDAGEFGFFHHFFH5/FHFHHGFGHIG/9IHIHHH9@HHHDF+HI5HCHIHFEII-ID7+DHI-EH?FDH2HC5;-@HDHHIDIH6IHE-HHHHHHFHFHGFAHFDHGH*FFHGFGGEE=ECG;*D3E4E8FGCEEE?,E@E=8BFG8<CAFE*GEC(6EE?:CEEG:GGG0E(=GF0GGC<E-?EFFEG;0:CEG/A((@G0GGBEEEEE*G;1:G'*EG=E/G<((F((1G0*EE
@antibody_97_multiplicity_93_copy_8-1
GCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCAGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACGGTATCTGCAGATGAACAGC
+
,<???=B.D<BDBBDD?FG9GFHEIHIIHFHIHAICEHDEHHA8IHH#IE7HHH+HAIHIBEHHFHHHDIIIH(IGHHGGIHDHEEAG@HFEI(IFHH(IHHHDHHHFF?HDHBHHFHEFGGHFGGHEEHD=G6EGG08CA,EGACGFA@CGG=EF(E*ECBF=D.GC:.FD6?CCE>0GECFCE;/EE88*EG?GG:?0?(EC='HG:(GFCE:/G?GCC(E*GG(G0?(C?E(EEGEG(AEA*GEG:C
@antibody_97_multiplicity_93_copy_9-1
CAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTACAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGCCGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCAAAGAACTCACGGTATCTGCAAATGAACAGCC
+
??59?<BB<D@9D@D<CGFFEGAHFFIIIH9HFCHHEGAFDFG5G9AH7HAFFDIHHHHFFHIHIHHA5HHEIIFG-GC=-FGGHGECEIHHHHGHD+HEHDHHBICDFFEFHH#DDDFF@8DHGGEHG2BEDG;EGCFBF*GEGGF:*=F@BG0#FEGEE:GG((CGC*0*1GEGF76GAG(EG0EEEEG8FG*GGCE<EF?EEGEA'H4?E8(C?E(G?(0.G:GFEC-:;AG(:C?:?CE-GEE0AE
@antibody_97_multiplicity_93_copy_10-1
CTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAAGGCCGATTCACCATCTCCAGAGACAACGCCAAGAGCACACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACAGCCGTGTATTACTGTGC
+
A<?=??B<BDDD5@DDCFGCCFH6H>HHIIHI-@AHG7HHIHHIHFHIHG=IIH.FHH4HFHHFHHI>IHHH5FHHH-HHHHHFGHIECI+HHH-DGIFEH@IHHFFEG7H0HFFE1EGDCGHGEHHGHD;EE81*FED9EB?EGFGG*E.A6G*EG(AFCE:GE?G:F?AAEEGA<E6?+;E:6EE(E'F(CGG(6G:G*E:E.*(?E0EFA:(EGEECE?E1:C8A:A??)E*0E*C?:61EA6:?GG
@antibody_97_multiplicity_93_copy_11-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTCCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCAC
+
<?<5ABBBDDB@A<<DG@FGGFFAIEHIHI+IHAIFIHEHGHHHHHAHIHFHDHHCIC=HI=FFDDHCH-H?HEHDIIHHHBFHI=-HEAEEDHHGHGHHGEH8GFEGF?EHEHH@HHH=HBE@H=FGFDD;F*B8EEFGGGG*FE?ED8FCC2E;@:GGE?**?@:GGGEEGDED(GGC(EFAF?E(CCGGEG'G;6F0#AFFGC:G?8??H*EE?:EGEEGCEGAG(6((DFEA9(;C8EG/EEE0'A
@antibody_97_multiplicity_93_copy_12-1
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGAGTAACTACGACTACTAATAATGTATGGAACCCACTC
+
A????>?BDDD<ABDDGFF/GGFIFHHFIHIICIHHIIIHIGI>HDHHIGHHFIGIGABFH5DIIIGHIFGHIFIHHH=G?HCHHHFCIHHHHHHGH=DHHHEF6=HHHI>HHEFF+HGHFBF4*@FGDGDGFF=FG*CE(EDGGG;GFGG8GB?(EGGGE2E8FGGEG1GGEAEC8F:GEGGE>:EG(?EEC8G8GEEGEEE?(;E5(H(EH(.7:E':(EGCFEEE??D**:?*C.8C*:0(;:0D(0
@antibody_97_multiplicity_93_copy_13-1
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTCTTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCGCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCTTTCACAGAGTCTGCGGAGTTTTTGTAACTACGACTACTAATAATGTCTGAAACCCACTC
+
?A?,?BB>@BBDDDDDGFFFFGEIICFFHIH>I@AGH+HHGIGIFIHCFFHHDIHAC?GH'CHIEIDHIHFFHID3HIE@F-IH-HHDHDIHFHHHHHGHHH'EHDFHDHHGHGBHDHH#AHGFGEDE?G*GF*>ECE+EAG2GEBFF@FFEFE*CGBFG-GGFGG</E?EG*FGE(E8>;GEG?F:**G(6FGGEG0EAC<8C(''(C6<E)(E?EGCGGC(E?G68*GEC0G(1G(8?6C/:CFE;E0
@antibody_97_multiplicity_93_copy_14-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTTAAATTCTTCTGTACCTCTCGCACAGTAATGCACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTGTCTGGAGCTGGTGGATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCAC
+
????9BBBD<DDD@BDGFFFFGCH6CAFHIDIDHFFH9IICHG,HHHHF+@IIFF*GHF+GHIHCDIHEHHGFIG:H-HB-H-#BH(H7FHHIHD>HDH=*DHFD1F):?B?HC?=H?HHFFEF?FF'GE9GFG@GGFGGG**GB=G'CGGGC;CEGGEECEEGBEG1AF#4G(G(;G*EEGCG*GCGGGC6EG1GE#(GE()C*GD<GEGAC@>C4EB(EG1:G=0A<6?)8?C;?*E6ECE0G(E*E/
@antibody_97_multiplicity_93_copy_15-1
CCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTCACACAAACTACGCAGACTCTGTGAGGGGCCGATTCACCATCTCCAGAGACAACGGCAAGAACTCACTGTATCCGCAAATGAACAGCTTGAGAGCCGAGGACACGGCCGTGTTTTACTGTGCGAGAGGTACAGAATAATTTGA
+
?=?A?B?BBDD5DDBBAFGFFFICI;CIEHFIIHIFI@IFIHFHEH-F9IHHFHHEH+D/HH+H@II>IHFIGIHHHH@HGIFIHBCFCFGHIGF<FDDEIHDFFH@4GDH*C8HHD+DFFGDEAFFFGGGGE5BGHEGEFFEGGDG0E)EGGGCGDGE?EC*(EAGEFGGCEC?CG+E;.+0GGCG??AEGEE#9GGEEGE(A(?HGA?*CC:B?E:E(E8(<G(CGG6CEFC/GG(E;?GGG*:6FCG
@antibody_97_multiplicity_93_copy_16-1
AGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCATAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGCTACAGAATAATTTGACTACGGTTACTCCCGGGAGATTCAGC
+
AA???ABB6DDD@DD-CG-GGF+HHCFBCEICDCIHHHCHC=EFIIFBHFIHIIFF-HGCIFF5HDH5IHH,IIFIIH5H>IFIHHFHFI#DCFEHHIHFHFGHFHGCHHHHFBHDH+3CH3E/EGG*FFED3HHEGEFE8E;FFGGEG)GG3?GEGEEE?/GC,GGGCECE(E;FC8A?:6(?AGG?ECGFEG0EEGE/CGECCG:G*E0<E7E0)CCEG??C6C0GCE*(EEC1EE*E?6*0?E:A8G
@antibody_97_multiplicity_93_copy_17-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGGGAACGCCAAGAACTCACTGTATCTGCAAATGAA
+
???=9.BBB@7DBDDDGGFGFFCCFHIICC7I/HIBHGIBH9IIIEHH>?HHHII@GI5H>@FAIFEHHEHEFHCBIII-IHHHHHICHIIH=EIIHEHFHFHI+H;IH8+HHHFFGEGEEFCFGBEEF.G/EE'E@3EG?EF*D1E*EAEGGFBEGG*EGGEA<EGEE?CGG(G6/E:EFECECF6AE:GA(?E:GEECG-?E.;E:EHGCE:(*(8BCB8GCCEE?1AG(C:CEC:G::EG((G*).A
@antibody_97_multiplicity_93_copy_18-1
GTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTGTCTGCAAATGAAGAGCCGGAGAGCCGAGGACACGGCCGTGTATTATTGAGCGAGAGGT
+
<?????BBDD@B?DDD>FFCGFEHF>>HHIHIHFFEH;9-IEFI;>GBHIFHFH?HHCFEB--HFFIIGIIDDFCEFHG?HIHIGIH@6IFDIFIEHHEEHDGIHHD.FHBHGHH3HFCHEG6E,HGHGH<EBFEGEFGGE3G3(F=G8EFE(GG.FEGEE1GGGCE8-EGEEEEF?GEC?:G?GGAECA:(C6G;ECCE*A8F(GC?E(F(8F>4EEG1*.8C:*FGC:CEEEAEC#);(G?1EE?>?:
@antibody_97_multiplicity_93_copy_19-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGGAACTACGACTACTAATAATGTATGAAACCTAC
+
?5????BBD5DDDDDDF?GFFAEIAHEECBFIE9IIFGHDHHIBFHIIHHG@HHIICCDFFHFHHDGIHEAAH=EBHBAFIHGHGFHHHI<IGHH7H,*FE@H6DHDH-FDH3HGF5C@G4DFFG9FF=FHEGFE*EGGE??EBG)G(AGFC?@G)CEEE2EGG8EGEAG6E.EG(EE*GEF:G'.GAECGE(GE9CEGFAG<DE-E5EE(<@:/A?(FGBEECE:E(GCE:C*F.1?:G(?6?E?G*?E
@antibody_97_multiplicity_93_copy_20-1
CGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTGACTACGACTACTAATAATGTATGAGACCCACTCCAGCCC
+
=???=BB<D-DDDDD=GFFFFFHIFFIFIFH/=HHEH?FHAIGIEIICEGHH+FGEHFHHHDHIIFAHFG-HEGFHGFHHIFHII*BHGIAD>H?-<DHHHH8*8FGHHDFHHHFFHG9EFDFG*GG;(DFGGGG(BCF2EGGBGCGGGG;E;G@<E(CEB(A>G/?(CG4#GG?F:+E:GEF0C(A')EEAEGECGGEAEEAEEE;GFF(ECFGGG:GG#C;E?G6?GEFC?80(GAGE:GAEE?ECEE
@antibody_97_multiplicity_93_copy_21-1
CCCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGCTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTAGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAATCCAGAGGCTACACAGGAGAGTCTCAGGGACCCTCCA
+
?,???BB=DD@BBBDBGG??FGFF@FIF>HFHHI=DFHFFEHHHIEII=IIHHE,HHHCIEHHHGH#HCF?GIH-HIIH;IHHGIHDHHFHII.HFHHDH.EEI3FH/DF@:,HG#HHGED@CCCHFHFGGF@=FCEEDGGEGGEEG<CEEEGGGGFEGBCFGEGEGC(8;GE/F/EE?G:GEGEAG?GGE9EEFC:EG:E/.A:GCGCFFEE@E:EEECC:E*GCC-*C?GEC:G>EEGCCC8G8CEG/
@antibody_97_multiplicity_93_copy_22-1
AGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCTTTTGCACATACAGTGAGTTCTTGGCGTTGTGTCAGGAGATGGTTAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTGCGACTACTAATAATGTATGCAACCAACTCCAG
+
=??=?B>BBD-DBDBDFGFFFGIFHFFHFFEHCIIHGIIIHIDHHGHIDCEH=A?HGFFIHHHIFFGIFFHIFIH*FDIHFEFHFHDIIHIHCHHHI=GFG@DH,HHF@H=G@G@G<FF;HFH?+FG)FBE<EF,EEHGFG'C*EEFFG?GGFF*G<GGG*;HEG*GC(F*GGCGAGE(FGGEEEEAFE:EECE(:EGEEEEEC*EFG:FE*E@E1(*GD;C/E*0GE*D?E:)0?E#?GE*(?AECCGC
@antibody_97_multiplicity_93_copy_23-1
AGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACGCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGAAAATGAATAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTG
+
?<???BBBBBDBD@DDEFFGGFFIHIFHIEHHGIG-IFIFHHH@HFH8H?+FHFFDDHI.>HHHGIHFFGHI5D>IHHIDHIHGF=HHIHH.CDHHC?IHHHGHHHGEDFG0FDFHEDEDH3E<DHGF.G*FBFE*=GEEEHEG@0FED*GC8@EE<@G@G(G<EB?G?E<FEGEGG<E>?CECE0GGCG0AG.EECG?FCEC1?)(6<CCEH**E:'BEGE(GEE?0CEG(8?4CA8EEE6?E:A:CAE
@antibody_97_multiplicity_93_copy_24-1
GGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTTATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTTGAGAGCCGAGGACACGGCCGAGTATTACAGTGCGAGACGTACAGAAGTATTTGACTACGGTAACCCCC
+
???<?5BBDBDDDD-ACFGGGGHAH/IECH-IFH=9IH.EIG7H-9IDFH+FGFGIGFDHADHGIHHHCH,I*5H-BHEHBEIHHHHDIII+=HG9DIHFHHFHI5H@HHHHBHFHC9@:H1<1FF?GF*C=HGGGGC-E?G@EEFDGGEGGE*G=F(*@*CE'(:GGE#<FGE4C6E:G(0FE7EGGEG0E?EE?FE4;EA'CG0H(E*(E:E@A?:;(:AEC(AGF***EA*8;:.?G8?EA/)#C:8
@antibody_97_multiplicity_93_copy_25-1
AGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACGCACTGTATCTGCAAATGCACAGCCT
+
???<AB<?<BDD<+-DGFGFGGCICHIHIIHHHDHG(IHACHHEGHIFCHIIGAHHIHEHGIEI-IF-HICIFIDIH<EIIEHFGH=FBF,HCEHDDHE,HGIDFDB@EF5CHHGDFHGF5G@DHGFBFGCEDCFGEGGGCH*6GFEBE*GEF*GFGCGA=;FEE@AG.<GC;GE/EGCGG?CE?;A.E?CGE.CGAEGCGEG6DC>(?EG?(A(?EAC>EG6:(E:A?6G:GGCA:FCECA(CG*(EAA
@antibody_97_multiplicity_93_copy_26-1
GACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGCCCTCGCCTCTCAGTCTGTTCATTTGCAGATAAAGTGAGTTCTTGGCGTTGTTTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCAGCGTAGTTTGTGTAACTACGATTACTAATATTGTATGAAACCCACTCCAGC
+
??A?=<BBDDD5DBDBFFCFFGCHC6HHIAHIIHE+H+H+I-9HFHHHII0FHDIIEHHBH+IGGCG-C-555AHFHF5HF@@=F=IHHHHFHHH,IE8CEAEFEHHIFHHH(HHEHH+FEHHHGG*GH8GDC<GF0EEED?@E#4GGGGEDFCDC*E((EGCG**C6EGEG4GA5G/(GGE?EGE#G0(GEG?CGAG/GGEGGE:*C?/A?EEGCCGCE'C:GGEG9E(6AE/?:?CFFE6.:(*G?*?
@antibody_97_multiplicity_93_copy_27-1
CCAGTGCAGCCTCTGGATTCACCTTCAGTGACGACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAATTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGTACAGAATAATTTGA
+
??,?,BBB-D-DBBD?CF?GEE-FHEE/IHHH+HI+GHIHI-IEFHGH>HEFHEHFGIGFHIIHHHHIEHFDHEH,IIH:HIGFCCHHBE6HE-FHH-H=H;EDFHEEHHFEHHHI;FGDHH03GFHFFFG?G7E,HGEGFG<EGGEGE;<?G@CGG=DAG:EE@GE?F#*CG>GE6AEEEGGC(6:GAE-8GEE-E<A:<CE6ECHGFAC:8;E:CG,GC0)?EEC:)GC<;.C*C?G?F?E*E?:1<?
@antibody_97_multiplicity_93_copy_28-1
ACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGCTGAATCGGCCCTTCACAGAGTCTGCATAGATTGTGTAACTACGTCTACAAATAATGTATGAAACCCACTCCAACCCCTTCA
+
?=A==BB-A5DDDDD-GGGFGF>HHIIIHEIIHI-HFGHHHCHAH/AHIIFHHGDIE8IIFIHIHHH?CDHHFDHDEI-CIGIH*DHEFFCHEIH*H??HFHGH;E.FE8GDGGHGHDH=G5HH(EHGF:FHH.G3EGEGG2)EFG/E8GFG-EG/GGGEGBEGC;*G(EEGEEDACEGEEECE(:EG*CC(GG'9.)(0EE/;0EEE/C.E(C:(F#GGCAG:;GCA'CCE*EG::CG?)'-*A?*:?*
@antibody_97_multiplicity_93_copy_29-1
GCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTTTCCTCGGCTCTCAGGCTGTTCATTTGTAGGTACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCCGGCGG
+
????AB?.DDD@DDDEFFGCCAIIIHBHFCHFHIIHHCHFI8GIHIHFFHGGIFGH8HDGIHHFGHI-IGFHHHHDHFH*A7G-G*HHHI#GHHIBGHCFEG=HDH=H3HHCHFDDF*H?(HGGFFH'E.EFFEEG;FG@DGE;AFEGG=GGGEEE0BEECG6GCFGEBFGFE;GFG?EEECCCGG'):EEECEEG?C?E6.CE??A;EHG*:AD:>E<C.G6ECG?G<EECG*08?CC(AC*E'E):6<
@antibody_97_multiplicity_93_copy_30-1
AGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTTTAACTACGACTACTAATAATGTATGAAACCAACTCCAGCCCCTTCCCTGGAGCCCGGCGGATCCA
+
?????BB?D5@<DDBD+GCFFGH/FEFECHFHFI>HIHIGHAH@IHH+HIF@HIB.DGEFAHIGF.?DH-H@BCDBIIBGIHHHHHHIE,EGHDI.E-EH9IID=DF5DHGBCCHH*FGEFHGC=GDEGFDGEC8FEEGG;CGDEG>EDGGGGF=GCEC4.EGEG.?CE(6GA*:GGCC<>A:(#CGAG?D(GCEGEG::G?(?C::?EEEG(G#(:GB8:G:0?G(GG81GD86*CA?00(.6G/:-*E
@antibody_97_multiplicity_93_copy_31-1
TGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCGGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAAGGAACATCCTGAGCGACGAGGAC
+
???A,B95@D5<D@DDG6FGFCH7HHCICEAIBHICF.DHHEHFFDHFECDIFII,H=IHFIHGHHH;HIHH>EIHHHIIHBHB@HCHH-H+,FHH4@HHIGF9HCHEHGCGHHHHFHG?)@@+FGGFGFEG;GGIHECG9EEGD?GG;D(;E=?,G)EFF*EGGEGG*.E:E(,G<GGC:GEG(GGGGEEEE;CCF9<G>G(GG*H6GEE4C8GE*GCG?7C'AGA60E(AE*?C08E.#?:AE:*E/C
@antibody_97_multiplicity_93_copy_32-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCATGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTATTTTGTGTAACTACTACTACTAATAATGTATGAAACCCACTCCAGCCCCTTC
+
,?=,<BABD5DDDD<BFF-FGF.HFFIHCCIEI8FIHHIDHI9@IBFFHFHHHIF?CCHFFHHEHIEFHCHE=HFIHHEHA=FIIH5B#IHFGDHCB+HHD@+EHFDHBGDEHGDGEEHE@EHGFFHGFEFGFF;EHE#;G@EFGGB@02FAEEG2*GGE@EEG(E?(G?:GEEEACGEE(<GEFFEFEECGGGF(C((C>:AGG(4?GFGG(EBEC*C,EGGEGEE:EEE(G*GG.(6*E/(FGAC<C0
@antibody_97_multiplicity_93_copy_33-1
CCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCCGGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAAT
+
<<??ABB>DDDBD-DBFFFFFFIFCEIHHB8HFIHFFDHE7IHIIHAGCHCH@=IFFHIIIIHEH5H=E>FF-+D-HFHH-HFCIFHCDG-CFHGCH5EICHEDHGDDHHI)GFCEHHFH@F@F@FGHG+GGG:9DFEEF>EFGGG8FEFFGAGCEE8C?;:8GA??#EGEGC?EC6F0GCGEFFG:?/EE?FE:*(C*E?EEF(666G<G?0D.GC?8EGF(EC9ECEG6*CEGE(*FG?E:C;ACGGE
@antibody_97_multiplicity_93_copy_34-1
GGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCAACTCCAGCCCCTTCCCTCGAGCCCGGCGGATCCAGCTCATATAGTAGTCACTGAAGGTGAATCCA
+
?????BB<DDEBBD<?FGFFF8IH=IHIHIFIFHIDGHFFFFHHIIHGHE/?FHHFHGEFGHDIF,-HHF=-HIHHHFCGHDH<7FHHIH?FGFCHFDH8HH?EFHI@C?HHFD+FGGDFEEHHG*G<C@BGGE<D=3EEB6CFDD8GGEEDGB?ECGFE2GEGAEAEGGG(G;F?EG;E<EG((:EA0?';:E:E4E(G?G#:4ECFDE?FA>GACAGEEGGG?0CCECA(AA:E0EAEAFCG/??EG8
@antibody_97_multiplicity_93_copy_35-1
CAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTCGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGCAACCCACTCCAGCCGCTTCCCTGGAGCCCGGCGGATCG
+
???A?BBB@DDDBDDDFGFFFFI.'HEIFHCID+HHHF.IBHGGGHEIHIF?FDAFHFEAIGICGHIB-I+CFFHIDII-IEACHEHEHHGHEFHH=HIAHIFIFIHHHHHH(HHF9FHHEDFFGDEGHD'EBDEFDDBC2G13G,FGEEFGG4EEEGDC;DGEGC/4FCCG?EG(EEG8/E*GEEE*CGDEAC0/G:;EEEAG:?HGGH(*@*((EC.0CEGG((#G8:?GGFE40E*.C*8G0:'GG*
@antibody_97_multiplicity_93_copy_36-1
GCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAGCTACGCAGACTCTGTGAAGGGCCGATTCAGCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAGTGAACAGCCTGAGAGCCGAGGACACGCCCGTGCATTACTGT
+
??A?<BBBD<BDD5DBGFFFFFE?IIIIHFIGIIH@IHIHHFF@FAFFHHHEFIFFIEEHHDIH=HHICHHIIIIF3FHHDF.HGGIFHDIFFI-HHHFHF(HFHHHI3GHEIHHFDHH**GEEFFH?CEHGEF?CA(BCE*FEGEG5CG8CEEG**G?A::(EG;G(<6BG8GA(E?4G(?8EGGEGFG9GG:EFCAGEE6CE0GEE.HC10EE(E:GA).?(?GGF:EAFGGC(E:EG0**<EE??*:
@antibody_97_multiplicity_93_copy_37-1
TCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTTAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCATCACAGAGTCTGCGTAGTTTGTGTAACTACGACTATTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCA
+
<9???>BBDDDDDDDDFE;GGFHIEC-F5HGEI7HHEHEHHHH;BDHGGHFF.=FEDFHFB5H-@EHFI(-FHHGII+FFHHHHICIAHHGHH+HHEHC?HDGEHIAH#GDHD+E?CEDHHGGGGEF.*G@FHGGGF*GFEGDG#F*?*C.(3FFG:@G;(:GGGFGEFE?AEE<EA?GBEGCFE/EGAE(CGGAED?<<GEEC8G.E2HGGH@ECB8:GG::E.E?E#EGG6C??AC(EAGA;8*GE:/
@antibody_97_multiplicity_93_copy_38-1
GAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCATCATCGCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCCGTGTATTACTGTGCGAG
+
???,ABB5B@9DDDDBAFCCGFEFIIIICIGICDI;IIADIDCF5=HCHIFGGHIFHHFHHHHHIFIHBIIAB?HDDDFI;IFHHDI:IEIG+FDIH-HIIH@AHHF)IHH3HCHBFGDEH>HHF+HE4FE2CFB/BF1AEGC8;'CEFEGEGGECGEGG,:'CF?E#GE?CEEEEEG=;E:G>GAEFGCEGEE;AGEAG:E;E8FAFEE(0HGCG8.E(E>G9)1E(G(G/E8GG):EE(EGGC:EEA<
@antibody_97_multiplicity_93_copy_39-1
TGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGTCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCATATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCGGGAGCCCGGC
+
A??,?BBBBD-DDDD+AFG0C>FIHFIIHH-HIHHGIAEDHEHFHEFIIDIAEE+HH+HCHHHG'AIIE55IEHF=IH-II--EF/8)5HDHCI5C,I2EI=EEHHFHFFHFFHHHHHHHE,FFHFGHEHDE(FGGC2EGEA;.GGGFFGE8G'GGEEFGE(CEE/AG;GFG6GG/GGGDECEAAA/GGGGCG?GEA:CE18A?*:CG(:?EEGG*>*(;GGEF8E=EGG8.(EA-GG'#0:CG:C(CC(
@antibody_97_multiplicity_93_copy_40-1
CCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACTTGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCATAGACAACGTCAAGAACTCACTGTATCGGCAAATGAACAGTCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGTAC
+
????A?B-BA@BDD@BFGEFGFBHIHFFHIHIHIBHEHHHIHIHA@=H>F8IHCFHHHIFHHDCHFHI-AGIHFHIHIGHDHHIH/HHIHIHC<HHGGHGHCGFHDF=3HHEEED=FHGEDFHFFGE3B7FGD0CGCF*DEGFG?GHFFFG*;GEGEGGG)EFCE'?GEA?86G(CG((EE'EGG:EE6EC:./EE/GEG1GG?G(EE*E?EE*EE;?3CGEE*E8EG*?E88EC*E8GE(8CE:0?ECC
@antibody_97_multiplicity_93_copy_41-1
TCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCCCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGCATCCGCCGGGCTCTAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGG
+
?A???BB?D5D5DEDD>FFFFCHIFIHEHHIFHGHDFHHIHE+EEHIFEEIHGGHHFF5II)FGF-HHHBHCFHFHFF-HHIFDGI-IE=ID=DHHEFEHH.+#HFHCHHHGHDH@DH3FHHH+BFFFHHEEHEEGG:HGGGCF;8GEGGGGGGG2@EE8EGEEC*<<<:G6.AG?CEECEE?CC<EEG0G<.CECEGEF0EG:(ECC?6GGH8::CFG:GGC(::CG88D?GCEG60?C?:?6CEC)CA
@antibody_97_multiplicity_93_copy_42-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAATGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAA
+
?,?A=BB?D=5D5D<DGGFFG-F;H+I/IHIHHGHIIHCHHEFHIFFHAHIIHDICDID-HAHFHEEFIF,HHEDHHHCIFAH7FHEHHHH=HGFDHHHH@H=HIFFH*HGEHDFDHHHFDGFH=)9HGGFGEFGE);+*GEEFGGGGEGBGEGGFGGEEE2E*G;DGCEG:.?GG6EGFC,EGGAEG>:CGAGG/0CGEGFE((C#64FGEHEEGG:E:C16G.4(:EGGCECCE*CG8?GG:AC/AFG
@antibody_97_multiplicity_93_copy_43-1
AAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGACACCCACTCCAGCCCCTTCCCTGGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAAACCAAGGGCTGCAAAGGAG
+
=,9A?B<BBD<DDDDBFFFGAGHHIIIFCE@GFDF9+HIF?9DHI>IBGHIHGFDFFAHHFIIH-FH4HHFIIHHHHHI?5HHHCIIH=H7HH+EHF;H@HI.HHHFD<DEC05HD+HH=FHG+HHFD,DEHCEFG-,1=DEEEE>FEGEFEECECC:ECE(BFE#EE,FGC66GFAE?A+GGCAAGEEC0#CCFGC?EE(?'6CGHGA06C0(GCBF:G7?GEGEE?)4G*CG:(E0G4;)EC*E*A?;
@antibody_97_multiplicity_93_copy_44-1
CCATTGTCCCTTGGCGCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCCGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTATCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTAATTTGTGTAACTAGGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCC
+
??,5?BB5DBB-DBD,GG>CCGHFHFIFIIDFHDGFIIGGBIGI77IIII9/HHGEDFH8FHFIIHCIHHFHFHHGIHFHHGHDEEHHH?H.IIIIH;HFHB@@IHHHE#GHFE7HGGDEHHEGHDFFEEH8F;BFGGEAGH6DD?1GGCCE;FA('GECAEEGFGEFEGGEG*G??'?2AEFE?(E?G8E;G:6E#E:EE88E<.HE.*ECEC((CE?CE,EC;G.;D?'6C1EG:CA?E1G?E'?8CF
@antibody_97_multiplicity_93_copy_45-1
TTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAAGCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTCACTACGACTAATAATAATGTATGAAACCCACTCCAGCCCCTTCCGTGGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAATTCAGAGG
+
AA????BBDD9D-+DDFFFFFGHHCHFIHHHHHI.HCHHIHHHHH@DIHHHEFCHHIAGHH+F@IFI=5F5HIHFFIHFHDIIH6HC(HHHFH/GHGEHHHHCGGGHF;DHE=HHCE=B+HHEFHH?E@HHGG:EAFBFGEE9FC4GF@0F.G.EGGGC9F@(CCCE,E<G:G#G*/FFAGCCGC*FCG*EEAEGF'EGEGEGEEEEGC?8:FE*:EGEEG</:G**GEGECEA-?0E8E/AG#/(6GG'
@antibody_97_multiplicity_93_copy_46-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTGTTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCATTCACAGAGTCTGCGTAGTTTGTGTAACTTCGACTACTAATAATGTATGAAACCCACTCCAGCCACTTC
+
?55?,BBBBDBDBDBDFFFFCFFBIHCIHIC0.EF>@I,HIFG@@HHHACIEHFFEIHAHHFHHHIHHIH>H5HICEFIGHIH@CDG7IHHGIE=GDHA<HDHHHHH;5HGHGEHHGDHFHFHHH3D3HE@EG*5EGGFGF@EAEA*?EGFEEF?BGEDF*E:GE?BC<#8G<E8GG:)C3GGEC/G=E?GFG4EECGGEG*E1EE'EG)**HGE?*EEFGECGE.C6)?G'CA/:0/G/6*9*)(?.D*
@antibody_97_multiplicity_93_copy_47-1
CCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCATTCCAGCCCCTTCCCTGGACCCCGGCGGAT
+
A?=??B+?B@DD@BD@FGGGFGFFIH+,/CE.HGFIIFFDH@HHFHIHHHH9FIFDHFEHHHH@II?IEF=HHIGIGEH=IDCF?HHH6IEHGIHFIIECFFIHCFHHHFHHH##HGGFGFHE,GDEFAGGF;GEDA@,GFGEDGE=E?F?GEEG?GCG61FF?E:EGCFF0E?EDGEG*C:GGGF0F/(G:FEC?F//:GG?A0GH'CH*G*GGGEGEG(E*F6E/(E:8C/C(:?G:'E?GF?EE/EA
@antibody_97_multiplicity_93_copy_48-1
CCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAATCTGCGTAGTTTTTGTAACTACGCCTACTAATAATGTATGGAACCCACTCCAGCCCCTACCCTGGAGCCCAGCGGATCCGGCTCATGTAGTAGTCACTGAAGGTGAATCCAGAGGCTGCACAGTAGAGTCTCAGGGACC
+
<????BB<DDDBDDDBGGGCCGHIIIICHFIHHFCIIH5FIIHFI8HHIGIBFGIDFIF*DDHIHIIFGIHGIEIHFHFF=CHGHHHCFACHFIGIHEEDC#H,EHHHC1+EDGHI1F@FGE,*DFH0G@D*@+0EFG<GG?6;GG:GDCA(FC*GGG(F8CGCCGG(E(GE=GE(GGG<60<GC?FA<G*C6GGEEEE?ECGGCEH<?HDCHG@A./F@GGG*EEEA::E(EE'60GCCE**EGA0*E(
@antibody_97_multiplicity_93_copy_49-1
CCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGCGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTCGAGATGGTGAATCCGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTGCTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCCGGCGGATC
+
5??AAB<BDDBDD-@DFCFGFFBHIIFAHI@HAFH-@HHHF+FI.HHHHDGEHHIGGCH5IHH==D@CIIIEIE@IHIGGBIHIHHFBI+DIHIIIB=;5I(EHEFH9FDHGDFFH<H3)HDHFBHEEHFEHFGGGBFGFGEA8#F*6E88=E(GFG?,GGEGCCE<E;:?-FE;F:?GEC(GG(EEGGEGE6E'E::0CACE4GFH4*HFCHE@G7GG(CEEE:E6CG>):EEAE??'C6E(*>?(C:G
@antibody_97_multiplicity_93_copy_50-1
GAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTTGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCTCTACACAGAGTCTGCGAAGTTTGTGTAACTACGGCTACTAATAATGTATGAAACCCACTCCA
+
?<????BB@DD-DDDDFFFGGG8HIHCHEHFII9FFFIIHHHHHG55IFGHBFHI@F.IHHAFHCHHHHHA>FHHIHHICCHFHFDHHEHF*HHHIGFG5(HCFEHE=FAEHHHCCHH#DFED=?G+G;FG;:GFEGGE=*GGGE-*EG*GEE*EEGE@G8(7?GFFEEAGE=FDGGECFE:8#:FE*AG*EG:GGGECEG?60*E(G0AEEEFEGD?GG8)A/::(9GCEEG'GGEGFE:?A'86GGCF
@antibody_97_multiplicity_93_copy_51-1
GACTCTCCTGTACAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAATAGCCTGATAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGTACAGAATA
+
,?A??B>BDBD-DDADCCFFG-E6HIEIFHFFGFIHI,BGEHG.DHHFIDIIDCIHIAHFH8H=FGHFGIIHGEHHIF>IH-HIDHHDHFHHGDHIHFECDBIHFHFF9FEHG9FHHB*FFF1,GGHE*DFDEF*GCEEEGG5EGFCFGC?EGAEFGE9(GGB<CC8FGE6FA>;;GEGFG-:GAFCA:EAGCE8G*?EGGFE:(GCGA?E:CG*GEC8G2EFE>(CA?/;:GGCGF*G6?CCG?CE*/*
@antibody_97_multiplicity_93_copy_52-1
CTGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGGCTCTGGAGATGGTGAAGCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACCACTAATAATGTATGAATCCCA
+
9??55BBBD-DDD@DBGCGEFGHHACHIIEI0?CADII-H)G=HHHIFHIHAHDHHFGHFHFFIHH-FH5IHG6-5HIGFHCHFGF:IHHDH'HFHCGHHHHD,IE=HDH#,HGFDHF?G?ED?,GGC@FHGEAGEEGHGEHGDEAFEGG;G;E1?8GECCE.GFG;>G;'B:GFG*A?G6CG@GGE)E/C*EDG?A/E6?EEEA:?CEE?F*40#*E)GGCGCGGG?#?C:(*G?>8G(G:F(A((CE*
@antibody_97_multiplicity_93_copy_53-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGGCTGCGTAGTTTATGTAACTACGACTACTAATAATGTATGGAAACCACTCCAGCCCCTTC
+
???A5??BDDDDDE@BG/FCFAICF>FC6HEIEIHFAIIHIICHIF@HFHIIIH>CIHFIDHHGHFHHFHFDHHIHI?DEI5DHIFIHIEHAIFHGHF?C3GFH.FDIGFDFFF4FHH=HDHHB@FG*HGBHDFFE:GDFDF6G8>B(;EGE?GEEBBE=6F;ECGGEF8<.GAGGE?GFFF6GEGAG4G*?E>FG0ECGFE'E(GCE:A;G1CGE;;EC.EEE#CC.*'(GE(?E(G8::C:A(84:CF
@antibody_97_multiplicity_93_copy_54-1
AGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTAACTGTACCTGCAAATGAAAAGCCTGAGAGCCGAAGACACGGCC
+
<?<=?@??DD?DDEDDFAGFF-EFIHHHIIGIFHC9IGFI@GHHF=HHDH@IHFDH.H@IHHII5*+IGEHHHGFAH-IHH<HEGIIHH=FEHCDHCDHHGFDDHHFFHEDDFHGHHFFFGHHDH(#?BFGG6,H)FDE@GGE=F73EFE6DBGF@GFE:CAGECGEGA#<(GF<EGA.EG:G61EC-AG=F:::E/EECEFCCEE(C*.(G@(.CEDE,CGGE**:9FFECE1*0G.E(9E'DE*/?EE
@antibody_97_multiplicity_93_copy_55-1
ACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTGCACAGAGTCTGCGTAGTTTGTGTAACTACGAATACTAATAATGTACAAATCCCACTCCAGCCCCTTCCCTGGAGCCCGGCGGATCCAGCTCATGTAGTAGT
+
<??A?<@BDD-D5?BDGF>CFFAIIHHHHH/HHIHFII+HI-9IAFI8HID=FF=C>GIHCICHHH,HH-CH-EHCHFEFFHFHIHI+7IHEHHIGHICD+FH3HFDDHGG<,(HHFHHGGFHFEHHHG@;GFHHAD?E2G*?G+6GE#G?FC6?FH=EGCFFGFF;(GF0FFAEGC?CC(E8AFC(FEEE(?A(#*:((G/EEC:CGCH?EEEG?''0EEFEG1EG:GG:G*(CC:.AF*G?E?;*?;8
@antibody_97_multiplicity_93_copy_56-1
ATTGTCCCTTGGCCCCAGACATCAGAAGCAACGTGCTGAATCTCCCGGGACTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTG
+
,<???9?>DDDD@DBDCFFC?GHH.EHHIIIICHEIHHAFF@/HHFFIII.IHHGH+8EH88HEHICAFFHHFHE:IHIHH(HFHDDHFHHFH<HAIHEEBH+HFEHEIH;GHHHE4@=EGGHCGFEGEGHEF*:IDGBBEDG;@GEC'FFFCEG.*CGC*GGEG)E0GGCC:?EC/+F0FEG*(F8**GC/FAEEC;E?**E??:EC?CE*(A7*/A07?E>.**EC<;GA?CEEFC6.*F8*6?/?G:
@antibody_97_multiplicity_93_copy_57-1
TGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGATTCTGTGAAGGGCCGATTGACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGC
+
??=A?BBBB@DDDBDB/FGGGGAHE6CEEHII79IHHIFIICHHHCIHHHEFHFIIGAAHH-HH8HEHFHHFHCIEFIIIHAFCHE57GDI?DHHEB@<HHHIF+IHFHGFFHHGD7GEFHCG;HFEHGFFEEEGEEFGD:CGG1E9=.EGGFE0EGEEE10)EEGG6EFEE(?E6EEAG6+FGEGCCC(.E/0(F(GGEEC:EEEHA?88D;GCFFG:8G?E*CEGCEE/<6?*'*G?A/E*ACC:??C
@antibody_97_multiplicity_93_copy_58-1
TGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCAGAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGGGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTGGTGTAACTCCGCCCACTAATAATGTATGAAACCCACTCCAGCCCCTTACCTGGAGCCAGTCGGATCCAGCTCTTGTATTAGTGACTGA
+
??A?ABBBDBBBADBBGECFFF8AHIIEIHFFIEHIHHIFICH/+HFH.HBHEDHH@G-ICFEAH+-DHIHF-5F4IIIIG+GHEDHFHHFIIH?GHBHC.DG<EHB?H++D+F+DHFGF?3F,GFFEGAFGE9HG*8GG;G*?E,E?F?GGBBG*GCEGE*E*:EG=FE(GE*0*0E?GG-E0AC8?GE.CEFEG??1*(6GE:*E?E(0E-EEC8GG,E#C<E*:)??.AD**G6E8#F?CG/:A>8;
@antibody_97_multiplicity_93_copy_59-1
GAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTGGCAGATACAGTGATTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTGGTTTGTGTAAGTACTACTACTAATAATGTATGAAACCCACTCCA
+
?????BBB@D-D-BDDFE/GGG9HIFFIFII9HFHE9H5E>=HAFFHHHHHHHHEF9HFHFFHIHCDHHEIIFHIH5HHHEEEI-HFADHHHADHHFHFBBF#H4IE?GHHHCCHDHCE*+2G@DDHG=EHDGHGGG?'E:GED6@EGE*GE3EFEGE=.(9DG0AE(EFEEEG(F8EEEEE6G:G:6EC;EEEAFG)FCF?1?:6)AGE*C>:<D.DEE((6EED?EE00?C;EECF0=C:GGC6?EE2
@antibody_97_multiplicity_93_copy_60-1
CTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTCCGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGAAACGGCCGTG
+
?<???BBBDD+DDDDDGEGGFFHEHIFIIIHG/HHHIHDFCD-IAHEHICHEGDH/9II5HHGIC5FAHHHHIHHIDIHC?FHHH=HHIHHHFDHHEIHIHCHFHEFHEA@FFH+=HGHHEFFGH,B:*H*F7G,G2EGDFGG8FGAEE0=GFFEEGGEGFFEGCEEEGEGECFF*EGE/+FGFCE<8?G'(ECG(GDEGGCCA86CF1HG:EG'/B:?F4?GFFEFE6?E1G0C*?*GC*EEEEEG-*:
@antibody_97_multiplicity_93_copy_61-1
AGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTTGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTACTAATGTATGAAACCCAGTCCAGATCCTTCCCTGGAGCCCGCCTGATCCAGTTCATGTAG
+
?5?=?B7??DD@BDDDFFFEGEHFIIHFHHIFHGHI@HFFFIGHIEEGHIHG@EI-CGFHCF5IHHII=@@F>H-IIFGHCE-EHIFHGHHH7HHH>FHDGHHHFHHD,=HDFHFHHHGEGBHGGFFHHA=E(G/EEFFEGEG@ED;DAGGG0FEG@:G;CGECGFGCCEG=0GEE6E(CEGAEEGEG6?#E?EG/?GCF?C(C:C.?/0FEH0;C/G:<0:GCGGE:E**(C*AECC/EE(?E/E8:CC
@antibody_97_multiplicity_93_copy_62-1
TCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTCCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCCCTCCAGCCCCTTCCCTGGAGCCCGGCGGATCCAGCTCA
+
5A???>BA6?9BDDDDFGGEFFHHEIIE6FHBF9HIE+CFBEHIH>GDIFGHIA@?--F=FIDHIHHCHHGII5HHCDICHGHHHIHHI+HFI)@HHHIGFFFFG66HE,HHFHF=G:HF=FH'F2GDGGG@A<FGAFEEGEEA0GDF/=@?G=?CA(F,GE@(EGGGE?DAEGEFGGC(6F:GGC?9C#=<CE>/C*((?C?(CGF?G:?(HEGG*:,D:?GEG/G?6GAC?EDGE?8CEECC8CA:GC
@antibody_97_multiplicity_93_copy_63-1
TGACCATTGTCCCTTGGCCCCACACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTATCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGCGAATCGGCCCTTCACAGAGTCCGCGTAGTTTGTGTAACTACGACTACTAAAAATGTATGAAACCCACTCAAGCCCATT
+
9?<??BB5DA@D5EDDGCFBGG+CHFHHH>DIIFFHIIIHAIHCIHIIHG/GF/HIFFH+HHHGAAC,-IHCIFFI5FHIHIFDI>CEHHEAH/HHCHHDHHFHIHH,=FHHDEA?FEEI@G=GGGFHFE@EHFBGEGGECGEE;FFE,9E?GF*EEEE:GGEGCGGGGGC*EGEGECCEEGGAEGG:EECE?(CEG?DE*GFEGACAFH*?H(ECGEFC77.C:E61GEG(EEEA*0GG*(8G((?(E8
@antibody_97_multiplicity_93_copy_64-1
CTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTCGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACGCACTGTATCTGCAAATGAACAGCCTGAAAGCCGAGGACACGGCCGAGTAGTACTGTGCGAGAGGTTCAGAATAAT
+
=?5A?BBBD@D+DDDBGCCGAGHHHIEIHHHIHHIICHHHIGHHIAIHE(FFH+7DHECF-HEHE7HFID=HHHEHI>?D=GHHHH8E;EH>I,HD=DHIFHH8G+HF?HHDCF.H@=)DEGEEG3FHDDGG+FGFFE*G=G*E866BA8EFGG.F*FEC(E4*.GEFDFEECE(EF6GG?CE6CFGCCCGDGGE'G:FAG?(?G)HE9HEC:@EE*D1E((*G#EGGGE;F(<1G?.DE#:08DG'EA/
@antibody_97_multiplicity_93_copy_65-1
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTACGTACGACTACTAATAATGTATGACACCCACT
+
=????B5?DDDDDEDAFF;GF8IFCHIFIIF9GIGCEHGDIFIHEDIHH+H.7FFDHEHHFIHHHBIIHECHH+EIDCHICAIEHEHFHA-I5HHHIGHHHICE'FCDHH:HH)BFDHHHHHHHGFGGHFDGFE1FGCGF2GE*GFE?EE8CCGA/E,GEE*;;E?GEEE/EEEFCA?EGFG0-FC8;EGE6(GAE60*FE6C:G4E0C<G6**<GCC/)CG8CED-GE1EA?/E2:<=EE:(E?:E(GG
@antibody_97_multiplicity_93_copy_66-1
GTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTAATAATAAGGTATGAAGCCCACTCCAGCCCTT
+
?5???B?BD+BDDDDB?FFFCFHHFECHFFDIGHHIDIGIIHFHDIIFCEIFHG-.HDH0HIIIHFHHBDHIIIGCIFH5HFGFIHFHH?HF.HEHI/F=EI/DIGFHHIHFEFHDHBHHDF9E=EH3ED@GCCHAGE*FDG7GDG*C7G.EE<GFEGG*,GGC>GE(:EEEEGAGFC=G?A?GE0E/G?8G<G?DFGEGE:D0(G*E:?EEEGB8*G?#:C#CC<(::D:GFF(GE*CGA6C00(?8(E
@antibody_97_multiplicity_93_copy_67-1
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTAACTGCAAATGAACAG
+
?A<?A?B>B9?+D9DDGGGFGFHHIHHIIIHHHHGHIII8-I9GIICHICCIGHHFBEE8-HHHE@F-5A?54CH1?HI,I+IGHFIIHAIHIHG@HHCHIEI+GG7HDHHBHFGGHFFGGFEF=HFHGGGG:GGFDGAFGGGFEECDGG*EBE5ECGD8EAGF6EBEEE6;EGGGC??C1A(CG6G:G?CEE<:FGE:?8AEE?CEGFH:G@=@7C:BAEGG6-8G(G1?*CGE#A?E8?*1E?C(GG?
@antibody_97_multiplicity_93_copy_68-1
ACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTTTGCGTAGTTTGTGTTACTACGACTACTGATAATGTATGAAACCCACTCCAGGG
+
55???BBBDD@DB<DDGFCGGFHIFIEEFFEHGHDIGBGGIH>CHI?HFEFDH5A?IFFDHHHAFIIH-FBIIEAHCECHHHHFHIHHFIH@GGEHFDHFHHFH-HBDHFHFHHHGGE@4BHBGEFFGG@CDHFG*B*C8E;EEGE*EG?FG:GFEC?D.EFCDC?EEAGGGGB:GG<CEC(CEG1:;AE?G?F;E(F??E./CC??:EEF(E:EE?GGFC9EE'GA(EE?0GCE?G(E?E?ACE.0*(*
@antibody_97_multiplicity_93_copy_69-1
GGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCGGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTCTCTGCAAATGAACAGCCTAAGAGCCGAGGACACGGCCGTGTATTACTGTGGGCGAGGTACAGAATAATTTGACTACTGTAACTCCC
+
?=A??BBBDDD@5BBDFCFGGF6HI>EHE+H/EHHHH?CFHIHHBHHHI.HIFHGDHHI-HH8+EIGIIHCHHHFHH=FGA-FHHIIHHHHHFHHHG)HFHH.DGGH3HEGHE#E=HBGGHD@EHG;EGGGEEGF*EE3HGFF@F+DE@*B?BEF?:GEGEE?#CG(GC6F<GEEEEG1GGC(6GEC*E)G(E:(G*(EC6CE(G6CC(E?G*@*(*C,EC,E*:E(?EEGG8CG6E?EF**E0AF1C::
@antibody_97_multiplicity_93_copy_70-1
GCTGGTGGAGTCTGGTGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCAGCAAATGAACAGCCTG
+
??A?A>=BDDD@D<D+GGFFFFEIHFHHHFCGI7.IECFIHD7FEHEAFIH?H8IDFFH>IIHHIHHAH--ED<HHHIHBIGEFHCH-HFAGEHDCDIFIIFDDFHHBHFEHHH=FHHGFBGHFEBGF?HF=EGEGG;(FFDCF*E<GAGDEECGGEEEGE:GG*CGGEGE::GG;:G0EGEG>GG:EDF?*G?((EGG9E?AG.8*?8:GGEF:EEC81:C::G=:C2/EGC0EE?G'C*ECGCGC:?E
@antibody_97_multiplicity_93_copy_71-1
GAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTACGAAACCCACTCCAGCCCCTGCCCTGCAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAATCCAG
+
,A???BB7DDBDD@DDCGDFCCH-H@IEBHHCHFHHDEHC/IHH9?CFIGI8HE=CF/GHH8HFFCIHFFHGEFBFHFHGIHHGIHHEHCIFDHHHHHBC,HHEEHHHCFE+IHFHF@ABE4GFGEBF+EG3CEEF@9EEEGEEFGE?8EEEF*1DECGEFEEH)*E?;,EGG0AE*FG:C<E*?GEG0C?G-GG0(CA:E*(C8?*:.HCC07EC'*:/CE(ECGFC?6FG:F?C0?E:;:FCA?(AC:
@antibody_97_multiplicity_93_copy_72-1
CCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTATCTGGAGATGGTGAATCGGCCCTTCACAGAGCCTGCGTAGTTTGTGTAACTACGACTACTAATCATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCG
+
???5?B?7B?-DD5D?FFGFGFHIEHHIIHHHIIHHHIHI5HHHHFHFIGHIHFH9I/IIHHFFHAI--HI=FFH=HDFHHDGHH;HHAHGH>I-H-)H7HGCIIH<H.GEHHHFFH:?+GGGHFGEFG4FEFGEFFEBF2EEGEGEA/ECG?*EGG)CE6)(GGEAEGE?.:G'EGDGG+:E?:</*?DECEE:C/E'/0<:?/:HGEFGF'C.:F:<,EGC:EEEF;EGA(0F/?E*.CGGCA*F8:/
@antibody_97_multiplicity_93_copy_73-1
AGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTTACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATAAATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGCTTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCT
+
???A?BB7BDDDD<DDFGECGEHHHHAEHEIFHDFIIHIFEHH?HFIBCAFIFIFIHHCAHIFF@HC-F/FHH+HCFHFHHHGCHI=EHEFEDHHFHHFIIHHGHEH?H;HHHDHFB(HGD@(F)GHFFBEEH*'FDGGCGE*FGG=(GGF@8FG9DEFGG:EG=EDE<?G*GGGEGGEGGA/(.G:ECGE?.#*?CEGEGGFEGE;ECHEC=FCAEEG/ECAEAC-G**EGGACE*GCCE1**(CCE:C
@antibody_97_multiplicity_93_copy_74-1
TGTCCCTTGGCCCCAGACATCAAAACCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCGGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCGTGAGATGGTGAATCCGCCCTTCACAGAGTCTGCGTAGGTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCCTGGA
+
????,ABBD-AD<5BDGFGFGCHCI+IFIF.H?FIAHIIFIDIIEDH.HFFEHIGHIF.II5HIFH.=F-FBDE=GGIH5DIFIIIGIFHHDHF@)IC=EDGFFHHIDFFEHFHFEGH@*FHC2EE4EF@FGG;BEG?G8F7G;GBEE@FEFEFG(0GCE3*EG;ECGG6*E?GG00?ECG2/EGGEGGGEG(*G:F81E?::E*(E6=?E:CEFAE??C?(C?.?EGCECG(FC*G::0EG?6C6E8C*
@antibody_97_multiplicity_93_copy_75-1
TCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCTGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAGCCCACTCCAGCCCCTTCCCTGGAGCCCGGCGGACCCAGCACATGTAGTAGTCACTGAAGGTGA
+
?A???BB?BDD5DDDDFGGGFFHFB8HCHFHHFIFHIIIDFHEIHIH0HGICAHHEHDGFHBII?AGIIFCE?GCHFIIIGHCHFHI#)FFHHCHHF5HEFHHHEHFHHCH@HHHDGHDG>GDGHGEAH:EDH/GBGBGEEEFEEEG(?*ECFG4EFEGEFAGFCGG;6GGECE.GGGG9GCEE?E:(;(EG?EEECEGECE:G0?E/6C>*HGE:DG;G#GF:CA(()GECCG?E6(G?A6C?.:EE8(
@antibody_97_multiplicity_93_copy_76-1
GTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGCGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTAACTCAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACA
+
=????<BB@DB<B?@<F6GGGGHFI/;H.IHEIFICHHIHHBHIEIIIIIIIHFDHFEGGECH;HHE+@=HHDFGHFFGFDFD8HHICHFH<HFCAIGB,HHHHD?FHGHHHC@HHGH=FBHFH=GH-B;5GHGF@GHGEGFC*G>HEH8*=GE(,CG8E5?C/((AG(3CGGFGFGG?G(A/GG0(A/6G;CAACAEACGG=EE8AC.EA0*C-*E/BF=A*EFA68*EEGA'E(1*C:FGAGAC)/EA
@antibody_97_multiplicity_93_copy_77-1
TAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTTCGTAGTTTGTGTAACTACGACTACTAATAATGTATAAAACCCACTCAAGCCCCTTCCCTGGAGCCCGGCGGATCCAGCTCATGTAGCAGTCAATGAAGTTGAATCCAGAGGCTGCAC
+
A<,??BB>BBDDDDDBG.GFFFIIIH6HHHFHIGF@F@FHGIGEHIHGIFIEHIAHHCF=IHHH5IIF-C5F5HHHFFCEH?HFIH8H(GHI@DHCBHHCHHHHCFHHHHHF(GH#EHFEEBDFE*GFGDGE#EE@G-GEGGGGCGGFFE(1FBE;BBGHEEEE0GGG(FEGEDGG?GE#CE.6GEA2(84EGE?GE2GEGAE?GE4/CE/G8:0(GC7'E?ED(#CE/A:(GG<EACG(4)'?:.A8EE
@antibody_97_multiplicity_93_copy_78-1
CCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGATGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTATGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAATTGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTG
+
?A?,?BBBD-5@EED<FFFFG-AHIIEHIF@EFHEH>DFHEGIDFHFHIH0HHB@FIF.IHAA>HFHHH?FHHE+IHFHHIHFHIG=IIAIHE(HIFHHIH9HDFHB@<HH9GAHFGHFF#DCDD+CGFHFD*EEE=FEBEEE;E:F?(8G(E)BF.ECFE(GECEGE;EGGG?GCCEEDGCE:DGGEA?=G?<AFF?A'G;FEEF/(AFC8:'BEF??4EE*(GAGEF6EECA;*8A.E:EGCE<:AEE
@antibody_97_multiplicity_93_copy_79-1
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAATTACACAAACTACGCAGAATCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAGTGTACAG
+
,????5BBDD+D<D9EFFGCFGEIFGFHE-HFHHI7HHIGHI=HFBH.HHDDFF>HIGFAHIGEFFFI5DFHCFHHHFHD5IGHEHFBAHFHHHI*=EICHDIHHGEDHHFIHIF0GHCHFFEBEEBEG?FDEF+5?DD4CG46GF=EEE;9GECB(EGFGE(=-/A?EFCGEEGC60GFE#GEE:GEGEAE*AG6C8CGGGGC?EHCGE:AE*G:?FG4B:GCEEE/G4.F*G:AE*(CE6(?:'EEEC
@antibody_97_multiplicity_93_copy_80-1
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTAATACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTCTTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACCGCCTGAGAGCCGATGGCACGGTCGTGTATTACTGTGCGAGAGGTACAG
+
?????BBBBDDBDBBDACGEG?HHHFFFIHEHIIIFGF+ICI@@/FHCHHGHHBAFGGHE-IIIIIEFAEEE=FFAH5FGHHAFIFHHHHHHHHHGH=IHFC,GHFHFG+HDH,GHEEE@H=HEHGHFHGBE+CGFGFHCFGEEG:BBEEEEGEGFAG:=ECEFEEAC.AFF:?:1CECG/GAG?:EE(FGE6CCGGF;(*#F;:GAECHEEE(C*:(E<FC('(AGG2*(:*EC?E'*0FEECE6E(:?
@antibody_97_multiplicity_93_copy_81-1
GTCCCTTGGCCGCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTATCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCGAGCCACTTCCCTGGAG
+
?<?5,BBBDBD?BD@DGF6/'B/F/FHFFHIHICHI@HHHIFI.A+IIHIIH8+I?FGFHBEFIG?HHHFEGH;HI=FHHFHDFH@HAHIIHEEHHFHF8IHHHH5GHFEFH-HCHHHHFGHE+?>GFG=GGGBEEDGBG@GFCEG6EE0GDGCE8E?F@CEG8FCE(AGGEFEG?AGFG+EA(*G8E(GGCAGE*;9-E0G6GC(0F(HF*E00EG?:G:/?E(GE:0GG:F*6:.?*/8G:G*?C(FF
@antibody_97_multiplicity_93_copy_82-1
GCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTCAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTAGTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAATAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGC
+
=??,<9B?D@ADB@-DCFFFG@I=C8CIFHHHIIH,I=FHEHHHHHFI--GH@EIEF7EHHHFGH+GH=HBFFHIACE?DFH,GIIHEI=#HIFIHFF<GDDHHIHH@3HFFFFHFEGGDHGHG+GAECDHEFG;EEGFEG0(CEGGGEE9C/G*8G@E*EEE7?FEGECCECCGG?EGGGG?(G?8FEFG6?A?E.#AF?F:G6(FCEEADCEEC(F7EE'FG?.AC.G:CEC:FC*:.EEE0A:EC.G
@antibody_97_multiplicity_93_copy_83-1
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGGAGTTTGTGTAACTACGACTACCAATAATGTATGAAACCCACT
+
=???A?BB6DBEDDDDGE;FFFHHEHHIFEIHIGIIHHHI0IHHFFDFHFH=HGHI8EHHHHCF>CAIHHHIFFHHHHAG@IHHGCHHHH8-EEFFGHDEAH@HCHFIGGFHG(F*BDFGHGG4H;EEGGGGEGEGFGG8E=GG=CGDEE0E?GE;GGEEECE:=GGGFEG6GG.(/+CFEE0G?E(=EEG?(AC;=A-((*6GG;H#?:E'FGG*CG?/E;AEEGG(;((<*84'C*'G;EG.CE8*EE
@antibody_97_multiplicity_93_copy_84-1
GGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACGGCCGGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGG
+
A5,,?BBBB@@DDDDBFGBFCAII-FFIIHHIIHIHFGBHHFEGHHH=HIGH-GH.HI-HHHFFADIHH4@CFFHA-FDHEHEFEIF=HFHFIAH?FHH,HHD=?HDBEGHHE6HGHEGHHE;GFHHHFE(ABCDE=FEE:D:EE6*EEG<?<CGG;GGFAGGE(?G:GEF*GGEAGEGCAGEE?E?DC*9EG0<GC:*?FFAEEG(ECH*GFEB*?EEFGFCEGFC?*EEG?*C*(CEC?E?4CE:GC'
@antibody_97_multiplicity_93_copy_85-1
TGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACACTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCGGAGTGGTTTGTTTAACTACGAATACTAATAATGTATGAAACCCACTCCAGGCCCTTCCCTGGA
+
????ABB>BDDDDD@D-GGFC;8H>IHHICIDHHHHF)HHHCHDIIHIHGGHHHEHGHFE+DGHHII=IHIHHHHHFGHI+DHHH8FEIHHII;GH,FHI/HGHCDHGHEFHGDFEEHGDFDBFEG?E2HE;FG'G<FDGGGGE;;GEGEGDF(G.F(EG(GGFGGEGEGGDGEGGGFDF:?.G=G(G#EE(AEE0E:*(.GCGEAH?2>*AE7@G0?G0GC4;1GAE-CE8C:/*E(AG:C:GEEG#*E
@antibody_97_multiplicity_93_copy_86-1
TTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTGTCTAACTACGACTACTAATAATGTATGAAACCCACTCCAGCCCCTTCCTTGGAGCCCGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAATCCAGAGG
+
5????BBBDDBDB<<DECGGGGICH5IBHFIH@HDHFIBIHGFHGFHHHFGGAEHIFG3IIIH5GHIHHIH5F-HIGEH5H@HIGFHHIIHHHEID5H+HHHH<HHIDHHEHHHGBDEH>DGH*#HC0FDGE(FEG8E*(,DFGC@(EE(GGFGGFF<GAEEFE6:@?EA?FFGE(:EEGECF<9E'GGG9AAGGE*8GEE*A:(G?:C#**AG@EC?CA1EGCEE*E'G?C(GF*E.;:.A?C:E8G/E
@antibody_97_multiplicity_93_copy_87-1
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCGGATAAAGTGAGTTCTTGGCGTTGTCTGAGGAGATGGTGAATCGGCCCTTTACAGCGTATTCGTAGTTTGTGTAACGACGACTACTAATAATGTATTAAACCGACT
+
<??9=BB=BDDBDDD@FAFEFGHHIICBICEIIH/+DIBHEHIIDDAHFHIHHGAGFFHAHI=FHAFIIGFC@C@FFE-H-IGHGHDIIIIHH;HFDCDCHHFHHGCCHDHHCFFH,HF*GFFEFEGHF*.DFE;EHDFGEEEG(8E,G*2EEEG?*F0EF:GBE-GECCC##GG(*?.GA:CGG?8GG?EECC#.EFE#6*#6(F8..=*CCCC?FE:E#GAA<ACG6:G??GC?EECG*E:E/F*(A<
@antibody_97_multiplicity_93_copy_88-1
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGCATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAAATACACAGACTCTGTGAAGGCCCGATTCACCATCTCCAGAGACAACGCCTAGAACTCACTGTATCTGCAAATGAAC
+
???A?B7=DDDDBD-DGCFFFGIHEI/8HHIAF99EIBFHHIF9HFHHHF98E0HGIHHFEFHHGHIGHEIHCEHIHFFDHHEIH*HGHAI-HGH5=HHHHHF-H)HGEEH.H3-F5GHHGHHDDFEE?HD*EG2DF'G*DF7?F<FGGEFECEGE89*B/BCE(EGFEGGGEG(;.F*G?FAE<1?C?AFCE0#FEGC*G<G?9GE?EE6G@DEEE',(?GA*'AGD?=E6ECCGC*06E?1*'GEEGG
@antibody_97_multiplicity_93_copy_89-1
CGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCACTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGACTGGGTAGTTTGTGTAACTACGACTACTATTAATGTATGAAACGCACTCCAGCCC
+
???A?BBBBDDBDD?DFGF8GCIH/H>HICGFHIFIHHHHFAIHH>EE+HFHI=CIHEGHHIICHE>DIH#EHI5G7FH<+>IID5HIFEHICH7IHCDHHD.GD=IEFHFFHDE,E=#GEFFF=GFHHGGF4G=DG3FEG1GFDBGFEGEGC*EEF(EEG;AG(EAGEGCC*?.CEG6GEEFGE8AA:G(*)?)*FA(??AFAEGH8E#4?EG::0EE@CECC(CEFGE0:*GEEGA(CA0G*/0::G(
@antibody_97_multiplicity_93_copy_90-1
GGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGTAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACGACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGG
+
???5?BBBBDBDDBD<///GG8FHI8HHIEEHHHIF9HHFDIIHFHHFHHFFIHIHHFGHHHGFFDHFIFH@FHIHCH@HFGCECB?IHHHEF>HHFF3DHHFDFDIHH=FCGGFHHGGECEGFFDDHGE:F:EGEGG8EGEGE8BBGGG?8CGGG:*GGDGEEC=.8'=FGGECGGEGEE'G(GEG(EEG*EAE'EE6EGGCFCGE:ECG:CF;<?:?(G:/CEEC6CEFCE;:*8G:F?8*G*?0?CC
@antibody_97_multiplicity_93_copy_91-1
TGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACCGTAGTCAAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATGTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGCCCCTTCACAGAGTCTGCGTAGTTTGTGTAACTACGACTACTAATAATGTATGAAACCCACTCCACCCGATT
+
????9BBBD@DB@DDDGGGFF.IIF8HFF+IHIFAICIH+?FFEIDIHIHFFHDBCEIGHIEFHHGHHFEIGH@HGFHCEFHHEHHG7HIHHE-EIHHHI;GFHHBCIHFDCHHFHHHHEHF*@FD20=G#BCEHGF:GEE9FE)6@F-*:(E;=*EA8F*8GBEG?8(4EE?:0?AB(CC:CGAE(GG6EG?C?GAE(CEE(GG2:0C;DGCGGGEGFC*?C?GF:8?:E)GE(EG:G?CA?*A:(*6E
@antibody_97_multiplicity_93_copy_92-1
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGAATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCAAACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACTACGCCAAGAACTCACTGTATCTGCAAATGAACAG
+
<??A?BBBDD<<DBBD;G+E.>8HIH.FHAHIHCHFIHIH.IIGDDIE@IHAIHHIEHCIHIHF-FHIIGHIFGGHHFIHEGIE@HAFDFF-D8GEHAAGHHF1DHHHDHHG5HHCDIGFE'FF4)HF?*2GGEG(EEGF=FCBC9EE868E7F/?FGGGGGFGEEGG;FECCGEF*6A:?EFC8GEGFDGFCEEG8?GC*CGCCC8CEEEG*C@::(8,C)GGE?GGEE:G6*:EDC0:-G60?CAECE
@antibody_97_multiplicity_93_copy_93-1
TGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTATTAGTAGTCGTAGTTACACAAACTACGCTGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGC
+
=9?=?BB=?D-DDDDDFGFGAGFBFIEI+HIEHHHFHGHH0H9I,IHFIE5#>FAGFFFFIDHHH5ICGFIHIIFIH=DHFEHHHH-7DHGAH5HF?HHHIF=HEGH=H+H5EFG3CG?F>FFHGDDGGGEGDFFF4EGGEEGGHEG?9*FBEB:BEE6EAE<E/G?;=*GEEGEEAAGECEG(GG?CACGE(*>0GEA6E?G::?HEEE**8G.(GCC7G?G(A20?ECC?GAD/EAEA/FC?EEAC0(
@antibody_98_multiplicity_1_copy_1-1
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACTCTCGCACAGTAATACACGGCCGTGTCCTCGGTTCTCAGGCTGTTCATTTGCACATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTAACAGAGTCTTCGTAGTTTGTGTAACTACTACTACTACTAATGTATGAAACCCCCTCC
+
??5??B/?<BD5DBDD8FFGFGCHCIHEIFEGDFEGCEHFHAFGF@FFHHEAHGHIFF=DHFHIHIFH;?5HDF>HHH-EEFG)IEIEHIHHE>HIIIH--HHECHHHEH4HEGG@HFFFFH+G.FG*EE.F?GGEEG:GG@E,G<@EFF6=E:GFFFF=0GG@EEF0CG#2-E:GFCEC1EEFFECD?:FC#CEE.AEC:EE?8G:G;E?A<G7*DEEGG<:GF(AG?*AEE*((G8G8'8E:1G>EC(
@antibody_99_multiplicity_2_copy_1-1
GAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTACACAGAGTCAGCGTAGTTTGTGTAAATACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGTCTGGCGCATCCAGCTCATGTAGTAGTCACTGAA
+
=??A?@>?DBDB@DDDFGFFGFIHC/HFBIHGCCFHHHI9IHGAFIIHIFDHH'EI.HDCGHHHIIFGHFHH;IHGIHAHIFHHFIHGHHHBHDHHCE:HHHDHHHDFFFDFHH;BHGGFFDG@FFGGGHEEEFB9FEF-GGEFGEGECE.GGF*A<GGGFCC?.ECE5#F(G=FEGE?::A)'-.??G?;EEEGG=?CC?:C:C:H?G6C.EE/EEA#EE:;AG::6CEEGG//??*E:::?GGCCE*C
@antibody_99_multiplicity_2_copy_2-1
CTACTACATGAGCTGGATGCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTATTTACACAAACTACGCTGACTCTGTGTAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGTACCGAATGATTAGACTACAGTAACTCCCGGGAGATTCAGCACGTT
+
<?<??B+BDDD<DD@5FCFFGG-IEIFIICAD/FIHEIFCG;EI+GIFHH=HE>FG+HE*IFCIH5GIIH@FIFCII3EHHFBIHHFHEHHE?HEHHHHHGI:EED@CEFHHHHHEFCHHHE0,2EHH0GFFFGGI')=DEGBBG6ECCE5AG;CGE?GEGC:E2(E4*FEEEGGEGCG<GGEE0GEE0??*ECEGC:GEGC-E8G6*?(?8#GG/FAGGE.(AEE9*G6EGEFCGEE'*E::E81G*DE
@antibody_100_multiplicity_1_copy_1-1
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTGCTGAATCTCCCGGTAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGGGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGCCTGCGTAGTTTGTGTAACTACTACTGCTACTAATGTATGAAAACCACTC
+
?=?A?@>BDDBB?9@EFGGFACEHIHIIFII.C-I/FAIFI9H/AH/HHHIHIC@IH-HA+HBCH?DIE,EC:IDDHEHC+HIII+IH2HI7D+EHAHHFHIHHHHHF;HH=FG;EG+3GGHGHH*G9FEF3E8G?GFF*BE;FHB-EC:B,0,(*2F;F6FGEGEEG.CGCFG*F?6CE?EECFECGCEEEA?(8GEGG*F;GF?E(C'EGE@:C(E?A?G(F6(((EGGGE6ECC;C*;6G*C4CC(G
@antibody_101_multiplicity_1_copy_1-1
GACGGTGACCATTGTCCCTTGGCCTCAGACATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTCTAATTATTCTGTACCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACATAGTCTGCGTAGTTTGTGTAACTTCTACTACTACTACTGTATGAAACCCACTCCAGC
+
??5??BBBDDDD@<DDG+FFGFH-'C.EIHHCIHHHCCHIBIGF0EIIEGGCI+CHCD?IHHAHEI5F5HDDHHHHIGHDI5GH8HHEIHEHFFEHEF?FIFHFI=*HGGCGHHEHE*+DHDHBGDH+F*EFE*HE;#CGEEBA;FHEF*GECGF/)E6EEE<(E:CF:FEG;F(CC(G*+EECC8ECFE0C:ACGEGEFE)EFGE09E(;EEF7/(EEFBE4E.ECEA*A'/(E(DG6:GC)E:8G;(A
@antibody_102_multiplicity_1_copy_1-1
CTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTATACATGAGCTGGATCCGTTAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAATTGTAGTATTACACATACTACGCACACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGA
+
???A?9BB<B-+@-DDFFFACEHIFIAIA6EHHHHFHHEIIEIIEHHI5I-DDH?HHDHHEHFIFI=+FFHDHHCIAIHDHHG-GHHAIDI@(EIFD4FHFCH*H9HHHHBHFGH+CF@.G6AGE>,GBEDFFAFEDEDABEGG?FGE;*EG7FEEGF?0/EFFGC60GEC?*A.?)GF;G;//GFEGAGGDCE:<*?A)GF?G.A91?HA?3CC.:7GE.G0EC?GEE;EE*(C6AF?GEF8#<E*E(*
@antibody_103_multiplicity_3_copy_1-1
TCCCGGGAGTTACTGTAGTGTAATTATTCTGTACCTCTCGCACAGTAAGACACGGCCGTGGCCTCGGCACTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGAGTTGTCTCTGGAGATGGTGCATCGGCCCATCACAGAGTCTGCGTAGTTTGTGTTACTAGTACTACTACTAATGTATGAAACCCACTCCAGCCCTTCCCTGGAGCCTGGCGGATCCAGCTCATGTAGTAGTCACTGAAGGTGAA
+
???5=BBBD?DD-DDB8FFG8GIHIIFIEEIHIEHI9EFHF@7FHHHHDDGE7F.IDFIHHH>GIHF-#HHFIHHGFGCHHHIH6IHFFHI,FIGFHIFHHH?GGH)HFCF6HFHHFGEHDAHG@D*HAEGGDGEGGEF6F=?EE2E(FGGG(EE<GE76*G(CEC;CGGEC.GGFGDFE?EE?56E*GE:GD;?6EEECC/GEGG:F?'?ECGGE*CFG/)GE;0F'E?A/C?EA:#8E'C;CC:8DG*
@antibody_103_multiplicity_3_copy_2-1
ATCAAAAGCAACGTGCTGAATCTCCCGGGAGTTACTGTAGTGTAATTATTCTGTACCTCTCGCACAGTAAGACACGGCCGTGGCCTCGGCTCTCAGGCTGTTCACTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCATCACAGAGTCTGCGTAGTTTGTGTAACTAGTACTACTACTAATGTATGAAACCCACTCCAGCCCTTCCCTGGAGCCTGGCGGATCCAGCTCA
+
5?5?=B<-B<DDEDDD/EGGF8IAHE(H8HIC.-HEIIEFIIHIHDIHHHFIHFIEHIHHHHIHHHIHF5IEIHDHI-FFHIEECEHHEFGI8EGHHEFDFFHE#H(HHFEFDGHFHEDBHH,H3FGHG8@;EGEEEEDDGFG?CFF?*HEGGEFGGCGGE(GGGCEBGGFGEE(G?F(AFD7DGG?G?6EG6EGG*:?G*(FEEGCGEC:;HAFG>/GE;EAC88A;CE:CF*6AGE?C0EF/*D*?E'
@antibody_103_multiplicity_3_copy_3-1
GTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTACTAGTTACACAAACTACGCAGACTCTGTGATGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATGTGCAAATGAACAGCCTGAGAGCCGAGGCCACGGCCGTGTCTTACTGTGCGAGAGGTACAGAATAATTACACTAC
+
?????B<B/DDDDDDDGFFFFFEHAIEE/FGFIDAGDEIEAHHHEGG9-@HFGIIHIAIIHEDFHFHHHHIHEHEH5HH=IEHFEF;AH)87EFGHHEHF3G9E=FHCBGE;HHF>CGDHGEHHGEGEFDGGGG*GCG6EEEEDA9EEGGAE=:DGE;C8E:GB*G?BGCGAGCF*E;E?)GF<(6:EAEEGFE:GCC6:G'EEA<HGC?:E8(G87*EEEACC'E;?6CE-C:GGCEG*)/E:1CA?E:
@antibody_104_multiplicity_1_copy_1-1
TGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTATATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAAGTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGA
+
?5<=<-BBDB5DD-ED/CGFGGEHFBH.>FHHGIHHI9GHFHF7HFHHGG.CFEIHFGHHHH*DGHHFHCI.HE?DHIH=FIEHABHHHG>G+?HGHFHGHHHE=HGHGEHHC@HEEDHHG3EGB4BHF.E6G+E'GGGBBE=EGGG.:G*GGEE8EG8,GE:GFEGCEEFG8GAGG:(G++G(EC6.??8:GA(EGG*CCG?EEEDCGDCGE;G0E*:,BC:?G?(G6-;EGE:E:F1.=E*(((0E*?
@antibody_105_multiplicity_39_copy_1-1
TGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACCGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGATCGATTCATCA
+
?????+B>DDDDDBDDGEFFGEHHHIIHHHHGFFICFGF9IIIH;HF*IIFICIFHHEGHIDIDHHFI>H,IHIGHHIHGI5F2)HII8FFIHECA+H=?E=3H;HHHFDBDEGEEEBAFFFE6HFCH@E(FE1EFF)B2BEEF*GGDG:GEF;EEGGEG;EEFEG@;GEA?*FG.DGEC(?GFCC?;?G:E=F8GEC*E*AG0*G:EEEGE'GBC>EEECG/GE?E?GE*G/(*8F<FA*E0*ECC(>:
@antibody_105_multiplicity_39_copy_2-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTGCCCCCTGAAGCTGAGCTCTGTGCCC
+
?,???BBBDDDD@BD@GG@GGGH/FFI8>IIHIH-HCHIHHHHHHGIHC/G?HAACH@EH?DD?HEHIIHHG-@CIH?HHB5IIE6DHDHGFHHGHI-GHH+EH@GFHH1GH?FHFF(CGFG.DEFGDFC@=CEGE)B;FDFEE:@GF@8DGGE*<GGEE1FFC?EG?GHG/FBEGEEEGEGEDAEE?E:GEGE*8(GCGGAGEFEC?*H8EHG:8DGD.0AF/(G?*EGGE6G:(?E>AEC8CAAF*??
@antibody_105_multiplicity_39_copy_3-1
GCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTAACCATATCCGTAGACACGTCCAAGAACCAGTTCCACCTGAAGCTGAGCTCTGTGACCGCC
+
???=5B5BD+DB@BDDG8ACGGHICFHFIIIHEEHFHHIHHHIIIHEIHF+HEHFGI+HIHHF-I+FHHFFFIEFI#HHH5HFFEHIDHHBGGHHGHICDEHHDH,5HHHHHFI=HG+*EH@HCGEGCDHFFEBGDCG;GFGF3GGGEGGGF.FGG0E*CEEGGGF?/ED*:?G?*E:EE.C666*G=E(E6EE/A?ACGGE**?A6'EFCE9EGAEGEAG?EC#EG:/?6'':*>E:?;*G*:C(E>G?
@antibody_105_multiplicity_39_copy_4-1
CGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGTGAACTGGTTCTTGGACGTGACTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTCGTATAGATACACCCAATCC
+
,?<???BBDDDDBDD5CGGCGFFC>=EHIFHIDIF/>IHHIHFA@IDFHAHHHIHI.IFIF,HHH+HIIDGHHHIIH-DGCH5IHHIHHDHAEEH4EEIDGFHDDH='HEFI=GIHEHGA9EEEG+EHDEAGG:92GA2FEEFG:FFEECFEF,'C3ECEGEBFFEGEFG<@EG(EEE:*(GEE(E(06AE(GGFEAE8-CCA(?CEG/HG0HEGGBG(E:EE8C?GG'**CCACGG1F**E:GA/FG*F
@antibody_105_multiplicity_39_copy_5-1
AGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGATCTGGTCATTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTGGTAGTTGGTGCTCCCACTGGTATAGATATACC
+
?????B<B9DBDD-<<GF>AF-IIIF0HIHHEIGIDC9?EIGCIGEIDI.FH0EF-HFGHICIIHI-HIA-HHDH+HHEGHH(HIGHHICEHFCH(,HHIHHHF.FFHHH,GF,DEFHHE=DCFFHFFFDEE=?HAEEGEAG+FGC)DA(GEB'GGGEAEGG,#G*=EE(#GG*EGAE:EEG(GGGEGCGC?FE?EEE86E8'C:C?E(C:EC;CC:/BE.G*G?AC((E4EG6/6EAGE(.?C?G*E*C
@antibody_105_multiplicity_39_copy_6-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATTCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGAGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGACGCTGAGTTC
+
=????BB<DEDDDDBEFCFF.GHIIH-IF+HHHCDHHIHHIHFGIHFHHIBIHHHFDHEHHIBF>FIHFGFFIHHIFDGB?H-HFHCHFGC6GFFHHEF7HHFHFDGHF(HHHHEHGFF*(G7E4F*GGEHF*DAEFG9.G,FE#*EFEGFEFG*GA*E2EEEEGGGCE)EC/:G0<?FG:CCG:CEEE?EGG?CE8?(GAE?CE6EGCAFEH8E*E>E7E:6AEE*F(.E?E(G?6C?E)0?G?*(*=E
@antibody_105_multiplicity_39_copy_7-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCACCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTAAATCCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCAGAAGCTGAGCTCTGTGACCGCCGCA
+
???5?B>BD@DDD@ADFFFGGFHCIBCEIIHHEGI9IIII@HHHIHHBF5ICFGFDHHGGF8CHGIHFIHF+DII5HFDAGDFIHHCFFHHHH+FDIBHHH-HIIH/H@EHHGCGDHHGEFE3DEFFEGCDEDAECGEG1GGGC*CE(7=CEEEG/GEEEFG)(*E?'G?/F*G*.:E/AGCGEGGEG?0C(GC()G?*GE6EE(EE:AHE:@EF8BA(ECCEC'FEG/EGEGC?G6.4E(GG:?ECG/E
@antibody_105_multiplicity_39_copy_8-1
AGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGCTCCAATAG
+
??9,=B=BD@D@DDDDGCGEGGH-HICHHEB7HE9I@DHHFGIIIHHHIHIHHFH)BIHHAHHIIHH8IFHFIHDHFIFEHFIAHHAIHHHHGFHF=EH=HDGHHHECHHFD?FFH?FHHDFFGH7BHEG,4(EFGB)*GGE=GHEG8;GGEAE@1EE*G?4'?EF0GF8GEE(EEEAGG/F?A0EDE(EE<EEE?:E<GF/CC0G0F?HEAEGGGC?CCG,FEE;GGG:GE??:C??:E?G/-G((::A
@antibody_105_multiplicity_39_copy_9-1
GGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTAGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGACCTCTGTGACCGCCGCAGACACGGCCGTGTATTAA
+
?????BBB-DDDD@DB+GGFGGCBIEIHHHHI@IHIH-HHHCFGF?HFIHIHH/IFEHAIFIIHIGFFGI-D>FHFHFHF;HCHHAAIIEIFCHI+DFFHEG*FHHHF@GHDD;HHD7HCEHGFFFFHH+FCEFFEEEGE4GGCGGA;G=E@**GFFEEEE<G'GEE?.CG:8EE-AG?:(EC*F?FCE?*:E#:CEEEE(DG60C;C:EE<:7@#C/B8CCA(CEA*:0E<EECG/G???.EE:.EG:*
@antibody_105_multiplicity_39_copy_10-1
CGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCGGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGA
+
???A?/B9BD-D7DBDAGGFC>@FCIIICFIHIGFHGHHIFIDFHHDHG0FHAG>EFIAGDIICFEIH-HHFFHH,FIHH+AGBHHHIHHGHHFI*HHHHFF.HBHHGHHEHHHHFFFEH3HGGDGGHFFG#HGG:EGFBDG,<G'E?EH=EGG?8FG1=EG=EE*E.G@C:?CA*CG?GGECGCEG.E*?:GEECE?DCEGEG?G'GG;EGF/E8GE?CEEEE8?*GEE;?CG?GG?EGE?FACCE?:*
@antibody_105_multiplicity_39_copy_11-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTTTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGATCTCT
+
A??<,BB3DD-DDBDDGDFGGCF+HIFH8.H.FIAFIHFH.G9GHHFGI+DHCHHIH@HHBAHG@HH+FAHFHHIEFEHDE-IHHHGDH7IIDHFFEDFHFI@HH0DHF+BH4=CHHG+GGHFHE+DGCFEFFFF?GG60GCGGEGFAEFGCEEB.EEGG?CEG(((FG8GEEEEGE<7;G+EEEGE0EEGGGCEGCEE?GEG?6E:FFA'ECE@(C(7,E7GCECC1:8C.FCA(*EEG.EEC?(EG*G
@antibody_105_multiplicity_39_copy_12-1
CCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCGGCGACGTTCACAGAGCTCAGCTTCAGGGGGAAGTGGTTCTTGGACGTGTCTACGGATATGGAGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGCGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
,,A??@<<D?D<DDDBFFGFFFHCH?8-0I/9I.IHFIHA9FEICHDID-FHHIIC-ID=IEBHEIFHI+H#F-IHH=FI>HHHHHIHHDIHG,EH,HFIHDI)DHH(HI#,HHHFEHD'H?FFAGCBEG@(H=)>#F=GE>HEGGGCE?CEDG(EE@GGG(GG;(*;E?6<D1ECGEEEF((0G*FC?EC?EC6GC:(*C8?G?G?:C(E:*FBGG1?8EFC?6E8EG:EAC*AG(F*CGGEGE5GC?8
@antibody_105_multiplicity_39_copy_13-1
ACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGGTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTTACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATAAACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGCTCCAGTAGTAATTACTGATGGAGCCACCAGAGAC
+
?5??<BB@@@DDE-@DGGFFGFIH>HHCHHIHHF+IFIAH9HF/HHHHFICECCIEHGGG=E=HH=HIIHF-FH=CDHHHGIIHCIIIFGGHHHEEHHCHGHHHDH=FFH@HH>G4+F+F+FHG)D8G8DDFGHE4GFF?EG6EGFEGBEEC*D3.F>FGE)CC(GEGE-(0G6EFG/E2E.CFDEG6GEG?EAEE<:CG?CG0EEHCEEE?E/*7EG?CC?G.EEF(G:G0EG;A?8'*GE?CEAEC?0
@antibody_105_multiplicity_39_copy_14-1
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTAACAGAGCTCAGCTTCAGGGGAAACTGGTTCTGGGACGTATCTACGGATATGGTGATTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATA
+
???<??BBDDDDBDDDFGF8G.IFFHIHF-@>HIEHC=FHHCH=HHIBDFDIFCEHHBG0CHAIHFGHGIFC-=EHHEHIH-H=DAIIFFIH-AGHHIDIHHCHHFFFHDDFE-FFBFFFHF2HFFE<EF:DDD?*GFEEGF#BFEGGGAEGGEFC,.EEFEG(G.,FGEAF6A#GGGGG+;EGF?8GBEC0??6?A:*6FAGGEGFEEEAGH*EEBGCFCGGG8/6E?:G0EE*?EG#?A?8:AGGGE?
@antibody_105_multiplicity_39_copy_15-1
GGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAAGCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGATTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGAGATACCCAATCCACTCCAGTC
+
?A5?=BBBDDB-DEBDFGCGFGECIHIAHCDACFHFIHFHBHHIHIGCIH:FGFHFIFGHHHHHIF5IIFG-I<+H5HH,CIFHC*6/FHHIEFHDHH6H<HH7HHHHDFHFDA<FABFFH>F)F9BCGDHHGF)EDF?E0GHD84GCBCG*EC.'EB?BE9?EG?G/G:E(6EC?F:E*EE/*G:*AE?E4EGE<9EA1G(8'EE<CGHC?AEC:GCE@G?CA:6ECG*EE/GEGA(::GGE;C0E?E:
@antibody_105_multiplicity_39_copy_16-1
GAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGCCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTATTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGCAGGGGTTGTGGTTGGTGCTCCCACTGGTATAGATATAC
+
??,,,>BBADD@@@ADFEFFFACE>ABECC>>H@@HFIDHHIHH-IGHDICH7FHAGIFHCHHIHIGIHHGBHDHHCE?FDF-EHIHDIII.GHI@HF<E.HGHHE>+HDFHGF@EEGFCFFD2C?BHFD@FHG=G)CGFEBE;GFE:C*EGEFGGG<FCEGGEE8?EE*?(AF:0CE?FFEE?AE*<GFEAEEG:G*G?0/?CGEE<:H('EE;(:?;./#CFE;)C?GGC*0)GEE:(C:(6(:8:EC
@antibody_105_multiplicity_39_copy_17-1
GAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCCACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGCTCCAGTACTAACTACTGATG
+
?=???>-BD9ADDDD@FGFFCCECHHHFCCIIFEAHGCCEEGIH@HIHHHCHHFICIHHCIHICH>ICE5FGGFEHIEEHIGEHIEHIIG7HI.,HBIIFIEIFHD6HGF>EHFHHHHGGBGF?HFHHEGEE9DHGE*E0EEEBHE*F;GEDEGEBEEBG?FEC,C:ECEFG7:.6E6GGG?:C;FFF:(FDG:GGE*E(E;GGCG(./HG(8/BCG7:0:(E(:CGGEAG:EF06F0:#*:(:?AF:E*
@antibody_105_multiplicity_39_copy_18-1
CTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATACGTAGACACGTCCAAGAACCAGTTCCCCCTGAATCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGATCTATTCATC
+
??,??BBBDD5BD95DCFGG6F-EFIHHH-H=HHHC?HII-IDI+EGDIF9II=DD5IIHIHHGBGHE*HA-GFIGHFHHIHHHIHIIHIHHFHCH#HH)FI,HFIE+EIH@H@HGHHGGHDEBGFGGEFGGFGFIGG*9GFCEGAAG;GEG:G=GE'GGEEE?E8??'?CGGFCFGFE6E(0FG?EAAE:#-G;EGEGGG:GEG;CGG(*D*:;(E(?GCEGEA61AE(?C8::6CG0CG:*(C?(/??
@antibody_105_multiplicity_39_copy_19-1
CGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGTATCCAGCTCTAGTAGTAACTAC
+
?,?,?B?B<ADBDDAD@GFFFGCFCHHHFECFFHFIFHFGIIHEI+CIIIEFHGHIDFFHHHII-EIFIEIHEHIAH?AHIGIHIHHEAAIIHIHHDHC63.HEHHFEHHHH6HF4G?EHDDF,@EHE@,EC9@FGG/<EF:BG*FGFG?E;E*?FE/6F8EG?GE/EE?<CCE:E;/6/AE?GEEE0EEGF?G(6A0G*C*CGEE?GFCG0/9(FEEG@<F.EE0G(<E*EECE?:)6*C08E?:C0GA
@antibody_105_multiplicity_39_copy_20-1
AGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGCGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTCGACGTGTCTACGGATATGGGGACTCGATTCTTGAGGGAGGGGTTGTAGCTGGTGCTCCCACTGGTATAGATATACC
+
?????BBBD<+BDBDDFEFGFFCHIHICECIIIFFGCDEHFECHHHA?5HIGBA/IHI?7=-5IFFEHHHEIIGHFDHHEGGHHHIHHHHHIHHH=7)HHHIHFFDHH,EHFHHAFFHHDFF=C?HECH)HEHFGDGFGGGGEGEF?8E;EGFE;GEE7BE0GEFEGE:GE6F#G?E6C*AG#(C6GGF):?6#GGEECFE(G;(GEE((F?HF@AG;>E?C(CCGA/DGG/(GA*E(EE*C/(:C?:GE
@antibody_105_multiplicity_39_copy_21-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCGTCCTTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGGAGCTGAGCTCTGTGACCGCCGCA
+
??,A?BBBDDDDBBDDFGGGGF=IIHFHCHII9IIHHI>FG+=HDGGHFDH=HHIHBDFFIBFI(FHGCHHHHID-FHHHIFIH-HFD.HHIIIIIDHFFG@+D*DEFI5>HFIHFH=GHHDHGBGGEE)HH=H@??EE=FF;,FGEE*@AGE-FGGB?AC:?E6EFB#?EE(FEFE;:EEEE(E;GCE)FG:GCAC4ECC;)CGE8E#A:CHGCC*=GE?EEEE*(*:ECE(C6(:?C:GGFEE::FE2
@antibody_105_multiplicity_39_copy_22-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGCTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTTGTTTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGATTCACTATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGATCTCG
+
????AB-B@+5BDBDBGFFGF;HFIHAFHHH*C/H=HH5HH@.HFHIDDD@IEIE5FFGIIII8+HBHFDECFFHH,HIDI?BCIGEGIHFHHEIHI;EFEHHHHFFH,FBHFE=FHFHG@DFHFFFFFHHHEFFEH#C*EEGGG3EFEEEFFGECE?G*<GGFEE8DEEEG'CGGECE*GGFEGAGCEGEGEDE6*FEE:*E:EE.*GE0EEG<E;7,G(EFE/?G6/CG?EAE0(E9(A?E0<*GE:'
@antibody_105_multiplicity_39_copy_23-1
GGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCCCAGAGCTCAGCTTTAGGGGGAACTGGTTCCTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTCTAGTTGGTGGTCCCACTGGTCTGGATATACCCAATCCACTCCAGTCCCTTCCCTG
+
A??5?BB?DDBDDDDDGFGCCGIHHAHCHHHGCIHGE?HHH+GGFEBFIAH;IFHGG>HIHFFHCHCFIIBHIH>FIEHHFFIFHFIEHHDAIHI@F?HE;HI6E,F@EEHHHH=F@)HGG9HFGGG8HDE#HD1CEEEFGDEE8E:CE((@6GGGEEGEGCEGFE9-:EG*G?E.GGCEGCFG?EGG:FC./'#GE6GGFEGF#EHGA:?:E-:(E*GGGA*GA*F*9EG(?FF??E:E#E*EE:EC?E
@antibody_105_multiplicity_39_copy_24-1
AATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGCGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGCTCCAGTCGTGACTACTGATGGACCCACCAGAGACAGTGCAAG
+
?=???-BB6ADDBD+DEGGFEGH;IHCECCEIG.D+.IH>9GIFDIHGHH@5GH@FBFHFHIDIIFIIEH+FIIHCIHHHEIHHGIAHFH.IHEIGHHFIFFEFF/HEHF:HDHHHHHEBFE8>GHFEG#EDEGGGGD6EG@CH;(F*G0AEECE?C=F<<,EEG=CEEE(AFAAGA)G:6;EEE:GGCE6EEE;DGE/D61GGC8HG:H*A*E-EG)E@EG(?C:GAG('.1G*E*(C;GEE'<GE:(;
@antibody_105_multiplicity_39_copy_25-1
GAGACCCTGTCCCTCACCTGCACTGTCTCTCGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCTTGAAGCTGAGCTCTGTGTCCGCCGCAGACACGGCCGTGTATTACTGTGCGAGATCGA
+
AA??=BBBB@DBDDE?GGFGG.IFHHH0>FH0FEGHHFIIHHEFHDGD9AAHC/AHHIHHDFIHHD-CHI@?HFGEHIHH@HHFHHIFHHDI4-FHEFHIFI+=FGF+FHHGHEHE(HHGF+FG2HDED@DG?DGFGBFC@DGGFGAFG/BD6G*=ECEGEGFG;EA(GGA*??GG2:EG?G?CFAEAF:??,G.?EC??AECEG?E.D?(G>@9(EGBC*EG0EGC:?GEEC*AC?/E'CEEG**GEG:
@antibody_105_multiplicity_39_copy_26-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATCGCTGT
+
?<???>BB?DDBD?DBGCGFFAHHHIIHHHHIH@HFFHIGGHIFHHHFIFHFGF@ADIHHFFH-HAFIHDE5H-FGH-IHFH=HIDICDHIH:HHHH+FFDHG+HHFGHECDHE7HF2*HGHFHF>EB@HFEF;EE*GGGB6@=EC)GE*G9(?GEDEGECD*GEEBEE?EGCGGG0GGE(EE)GEE:/AGCGGCAAG#G*EEC?E:CE*(EEEECB;ECEE(CCCGG:GE?A?GF)*:E1;9G*(?C:/
@antibody_105_multiplicity_39_copy_27-1
ACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGTCCCCAGGGAAGGGACTGGAGTGGAATGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAACAGTCGAGTCACCATAACCGTAGACACGTCCAAGAACCAGTTCCCCGTGAAGCGGAGCTCTGTGACCGCCGCAGACACGGCCGTGTAT
+
?=???BBBD+D@D@DDGFFCEE-HIHHICIFICHIH@HCIHHAFIHDH5HIF+I8HFHHHH,GIHDHIHHHCGIHFHH5HGI=HICFD#5HH8DHHGCHDIGFFFIH=HHHDH#HHB3HB=GHCHF,EGGGGA?:F;HGGGF8GFGEGGE/4?(C>EDFC8E*CE:(G9GE-EGG8EC*EG6G860CFE0/EE8)8A*GEGEEACEE/#EFGHE0'EEE:EGG<*(CA.C()/EAD8*E6EC1C0?CG(?
@antibody_105_multiplicity_39_copy_28-1
TGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGATCGATTCATCATGAGATATTCTAGTGGTGGTATCTGGTACTCCCGCGCGGCTCTATAG
+
????ABB?BDBDDDDDCFCF.FIIBBCHFFI)HDHHHDII@FFIHEHIHHFHEFHFHHAIA>IHEHFIIFHIH?HFFFF?DHIHCH(HFAHHDHEHEHF@*A6HDH#HDEHF9H*DD*0G@H=EFEHG9EH;F+GGGGE;6EF?1FECFEGGD/AGEAFEFFG=GE*FAEGE(EE0::DGGCG8E*.(AGE(EC;?(?(AGGG'CC/EEEEC(@ECBGCFE:F:E*EEAE/?C'?(CCE6/6E0CAE(::
@antibody_105_multiplicity_39_copy_29-1
CTGGTGAAGCCTTCGGAGACCCTGTCCCTCATCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCCAGAACCAGTTCCCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATT
+
?????B@BD@DDD@D@CGGGGGI8E=FIHHH-CBHHHIEG/H9III/.HI+HHHH.IAIGIHH-H-HFIIHIHIIGHIGHIGEHFAHDEHHADDCIEHDBHI=FHIHGHF4HHEFCF=FHHAH*E=HG*<HG:)DIH>EGEEEEGGFE6;AGC@GGDGEE*EA:EE5EGE?C:GG6GEEGGGG61G(EFE'G(?GEG.GEE;1G.**GEEGCEFEFEE?A<?8?E6GD<G<*/C(:C.6:G/FA(C:E:D
@antibody_105_multiplicity_39_copy_30-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTATTGGAGCTGGATCCGGCAGCCCCCAGGGATGGGACTGTAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTCCAACCCCTCCCTCAAGAGTCAAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCTGAAGCTGACCTCTGTGA
+
?,?A?BBBDDDDDDDD.+GFG;HIIFIHF.IH.FHHHHHFIGHFFFEFFIIF/FC+H/HC8HI?IHIH?HI-,HFF-HHFHHHHCIHIIFD5(ACIH.HIHHIHDE1DIHHHHFEHE+HEF*EE@FEHF#HCFGHG?(2=GGGE>;DE?=GF?A2DGECEEAG,9FGCG#EEGC:GEEEGGCC#EECE*G(E,GE;EEE?E:(?E:?8GH(E:CEG((C-FCEG>?1GGG:C*:GEC8G<*#'??C:ACE
@antibody_105_multiplicity_39_copy_31-1
TCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTGCCACTGGTATAGATATACCCAATCCACTCCAATCCCTTCCCTGGGGGGTGCCGGATCCAGCTCA
+
?<???BBB<-BDDDDD08CGCFHHIHF>IH/HHHFIEIFFIHEIHIHH.HEEFHHEE.FEHFIB=EAF?GH+CIIHIFF+@HEGF+HH5C,HH+HHEI5FFHFHHDEHHHHHF2EH6=F?DFGHFFGHEGDGEGECHG*FEGEGGGGGGC8BGG?EEGEGEFG:E?EE/E6E@EE:EA8EE?GE:*6EGEEEACGGF<=GFCC*..<ECC06FGG(((E(E?E(FCGCF0ACE#EE*(?CACE9CC:CD(
@antibody_105_multiplicity_39_copy_32-1
ACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATACCAGTGGGAGCACCAACTACAACCCCTCACTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGATCCCCCTGAAGCTAAGCTCTGTAACCGCCGCAGTCACGGCCGTGTATTACTGTGCGAGATCGATTC
+
??=?=?BBD-DB?+D@FGFEFAHFEHIHEIIIHCGIGIFIICE,CHCHGH=HIH?CH9IHIIHH'AFF+HFIIHI4F?IIIIHIHH=FI(BHIIFH.HE5GHIFFHFH+EGIEAH<H'FH(GFHFHGFGHG@FFF*F#GFCDEFEEGEE@=EGGCEF0/C/GEGE8G*8EFEG?0EGGG?00G(G8EE?EGAAE6GE#GGEE?DGC'E?H)C)GCG*(C@EAF(G#GE'GCCCG-A>.8E*:6.2E*:FC
@antibody_105_multiplicity_39_copy_33-1
GTGACCAGGGTTCCTTGGCCCCAGGAGTTGAACCAGATCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCGCTGGTATAGATATACCCAATCCAC
+
??,,???BDBBDD?DBFBCGAF8IHFHF,CIHIIHE#IEHDHGHH9.EDECFHEEDHHHH-FDIBIDBHGHI?:HIBHCFIFHHH<IEIHIII@I2ICDHHHGH'?HBHHGHDEDHF?DEG@EFDDFDEGH;GEHGFFGDEE*GGCGDE.G:A6FEDBGG8G(G>GEGEE:58?G-EGE/G<>/AGEG?EECAEAEE(C<EECGGAHD6AE(EG1(GGG8CCEG9(CG*G6EEEEC*C*8(E:EEAEE?E
@antibody_105_multiplicity_39_copy_34-1
ACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATACACCCAATCCACTCCAGTCCCTTCCCTGGGGGGTGCCGGATCC
+
?,?A?BBBADD<DD@@>GFBEGIACHHHHHIEHGC-FHHH@+HHHIIHHGIIFH>GFH>IE,AIFEIHIGF'H+HCIHIHEIHHHHC@FE.HECHHHHHF7HFHHCHH(HFDHHHFG3G,EGGGHDEEHHGHG?FFEDEE=GFGGEDEFGE*E@FEE1GE(EEGG*E:EGEEF?EEGG(EGEEDG?GACGGCAA;6CF?GEGEA8*H*(HEGC8B>C?EG/E?CGEE??*:*(GA6G?:'?GGG0::EE(
@antibody_105_multiplicity_39_copy_35-1
CGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGGCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGAACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTTGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGA
+
?,?AABBB,DDDBDDB;FFCFGHFEIH/HIHIIGIHIH@IHHHHIAC9HHEDFIHHH-HFHFFHIBFIHFHE+H5+HD9C-FFGEID-+IGHFHGDIH1HDHIDF.D+EEDEHHH.G2:G.FFFEHGDGG#HFHB**E/DGCFFGEFEEGBFDG:FGG(EF(EB(GC*?EC8G1GFEEC?AE'FC6E;*EGFE?.E*CE?G*DF:?CGGH8:E:'*BC?C(/:EA?8CGGGG(AE6E1.E*>GECGF*?0
@antibody_105_multiplicity_39_copy_36-1
AGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTCTATAGAGCCGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACTCGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGTTTCTTGGACGTTTCTACGGATATGGTGACTCGACTCTTGAGGGAGGGGTTGTCCTTGGTGCTCCCACTGGTATAGATATACC
+
????9BB.D<BBDD@E;GG/C>AIIFBHHHIGFC6GI+HHAIIIG7IHIIH.+HHH3IFHFFAHHCCFCHIFFHEIHEGHC6HCHH+IGGHIHHHF(HHDGHHIDHH)=EHEFEFDHF@E#HDHFHAFGHGDEEBFA4FDEDFGG??EGDGG??EG8GEGFC>:GEG'EEC.G*(F??B(EAGGECFF:<EGEG.AAGA#EF*EG/>*AE/*(GGE?E?C((CEGE(?D??01AE(C*/(E:*F8*?CEG
@antibody_105_multiplicity_39_copy_37-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGTGAAGGGACTGGAGTGGATTGGGTATATCTATCCCAGTCGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGCCCACGAACCAGTTCGCCCTGAAGCTGAGCTCTGTGATCGC
+
5A=?AAB5DDDDDDB-GFGAGDCHHHCHHEFHDH+CIIDHHAHEHHFGDEH9GHH;EHHHIIFCGFFFCH5HHHIGFEIHHHH5FEBH-HH-HID>FHHHDHCID@FHFFEI+5+FECCFHHFFGGG7ECFFGGF<*.GEE>EEBE#FF?3E#E>GCGGF:EC*C'=C/.GE?A8EG8<ECA6CGA2??((CECEGCF?EG:14E?E?C#GG@*>;BCEECE8)*F(CC?)AE6E0C?C*?A(EC:*)GE
@antibody_105_multiplicity_39_copy_38-1
CGCGCGGGAGTACCAGATACCACCACTACAATATCTCATGATGAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGTGAACTGGTTCTTGGACGTGTCTACGTATATGGTGACTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGTGCTGCCGGATCCAGCTCCAGAAGTAACC
+
????A?BBDD<DDDDAGFCEG;CHIICCHIIEEHICHHHE9IIHFDHDHIGE7HIIF@;C-IFEFCG>HDFH8AEFF4HI-CE@IE+FF=HF+IHFCCHIFHHG+#HF.GE<HGDHHD+DEFGEFEGGFDG'@EEAEEFE(HEGFGEE,EGE7EGFGEEEG;E:E(CGE*CE(G?EFG:G?G>CC/6AFEGFGCGCC?AGAGACFE-CC<?F:E9EEA/C*(:'A0AGCGGGE6:?G?#:E:*((;EEE'
@antibody_105_multiplicity_39_copy_39-1
AGTACCAGATACCACCACTACAATATCTCATGATTAATCGATCTCGCACAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGGGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTGGAGGGAGGGGTTGTAGTTGGTGCTCCCACTGGTATAGATATACCCAATCCACTCCAGTCCCTTCCCTTGGGGCTGCCGGATCCAGCTCCAGTAGTAACTACTGATGG
+
???9??B<DDBDDD?DFGGGFGHE,HEHHIHIHF+FHIG9HHH9HH.IGHIIGH@GFFA-FHII?IDHIHIGFFHI=HHHFHGIFHHH,HHFFHFGHHDGD5IHFGFG@D@GHGFED*3DGHG*F*FAFGGGGGEDBGGE3-(,FEEGEEB>CG?G(G0EEGEDEGGGGF<GG<(EGCEAGFE;FG1FE;C6*GEEGACE*EEGGE?E0H(*EE@?CC.,EC:GCGA?:G/<CG6ACC0E?6F(G/:;EA
@antibody_106_multiplicity_1_copy_1-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCAGGTAGTAGTAGTAGTATACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTATCAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTACTTTGAATCATCTCTGGAGATGGTGAACCTGCCTTTCACCGACGCAGCATATGCTGTCGCGTAATTGTTAGCTTTGCTTC
+
??AA??B@BB?B@E<DEFFFFFHH8FHFHIGHHGHEHFH,HHFIHFGII.FFFIIFDGHIFCFIHI?DEHD(FHI>IF>IGHEIGEEHH6H=E-IHI<-CHECDH;EHGFGIIHHF=6@H?H)EHICG6DHGF:8EAE;GGGGGEECGFEFGAF@2FEGGGGFDGGG8?(G8FE)B<C/GGFF2C'</E0GAGEFGAE(EEGGCEGFG:HF/ED;/DE:,E0AEE:C/GEFCCE(8CF/EE'GAC6C*FG
@antibody_107_multiplicity_6_copy_1-1
GGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGATTCCGGGAAAGGGCTGGAGTGGGGTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGGGAAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACGCGGCGTATCTGCAAAGGAACAGCCTG
+
??,??<>BDDDDDDDDEGG6/CEHHF,HHI>-GAI;EII+HHHIG@HH.HH7I8HGFH+IH=IIDH5GHIGBHI=:9II@HHCGHHICGI=*85IEH3HH+DHHDHHEHGFEDHHHFH?HGDHHEH==*HG+AEGE?EGG+BACG*BEGEEEFEC*CE<EEGEF?;:EEGCF?E(<F?FEF:(CECE(GFCCEG6G1?AG?GEECEH8GEEEFE.A7EC1?GE(GFG)0;GC/A*E)'G#CCC??EGC?:
@antibody_107_multiplicity_6_copy_2-1
CAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGATTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGTCGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACGGCCGTGCATTACTGTAGATCTAACTGTTAGTACGTATA
+
?<???BB56DDDDD?BGDF@FEEHIIFH-HHGIIHEF9FGIHFHGGIDHGFFHH+HFFFGAII-HHE-HHGFFIIHFI*@FFHAIHHFI=I?IHAHEFHI,?EF'DBF=CFFG6GFGEHGFGGEEH*GEGFEGHGG@H?D=GGGGE?EG/9EGGG?GGG=EEEDED?GCE8E;(A(EEECEEGCEFECEEE<??EGFGE8CGGEG6EAE:GAHFGECE)8:ECE*2CG/8*D.G:(*(AG8?84/.EEEG
@antibody_107_multiplicity_6_copy_3-1
TGGTGGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGATTCCGGGAAAGGGCTCGAGTGGGTTGGCCGTATTGGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAG
+
?A?AAB@B?DB5DD5DGGFCGG8H.HFAECIHCHH9DIHFGIGCHGHHCEIID-FEHHFHIFG5I-@@IHGFFIHAFDIHHIGHII<GHHEHIHHHHHIHFF5HEHHHHHFFHHCFHE(FHD*G*GEGEEFGGFF8AEG4DBE*;GEG0EEGGEEG81FEE@C@G(C6E??GEG(FEEFE;6E/E8(F?GAG*F*GGC0AFAA?6C*E*FA<HGBE0C?C:E:?C??:GCEEG.**C0GE(:'G8?C?GG
@antibody_107_multiplicity_6_copy_4-1
TTTTCAGGCTGTTCATTTGCAGATACGTCGTGTTCTTTGAATCATCTCTGGAGATGGTGAACCTGCCTTTCACCGACGCAGCATACGCTGTCGCGTAACTGTTAGCTTTGCTTCTAATACGGCCAACCCACTCCAGCCCTTTCCCGGAATCCTGGCGGACCCAGTGCATAGCAGAGCCACTGAAGGTGAAACCAGAGGCTGCACAGGAGAGTTTCAGGGACCCCCCAGGCTGGACCAAGACTCCCCCGGA
+
?<???BB?@<BDDDBDGCFGGGEI+HC.HIHI7=GIHFCIGHGC9HIIIFHI=+H=GHA@HI?HIHHHIHGFEIHFHFCHHIFII#-HHCHH,HDIDHHAH(GHH'DFFF#CFE?FEBH@EFGEDHEFGHGEH@DG@ECF(CGEFHG*<G?ECGGEGC?E@G,;8C(CGA#GEGC?G?A(.EECDE/?GA#8?*ACCCGCFGCAEGEE0)E:E2E/EGCE8CGCC:()EGCAEGGCEC*#DE6:G(?CG(
@antibody_107_multiplicity_6_copy_5-1
TGCAGCTGGTGGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCGAGGATTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAACGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATTTGCCAAA
+
??5A?B.BDD@DDE@@F8+>GFIFHIIHIIHEHHCH=DCHCFHHFHIHHIIHCHIHHHFHHIHCHIHHBIFFDI-HHIFGHC-++IIHHCEBB=FH77HDIHHDHHHGGA#EF+EFHB:FEEGFF6EF?HG=GEEF+=>ED?GG@B;;EAGGFEE=EGGGFFGE3A;:ECGGEFEG'G(E.GCG?G'GEGEAEEGEG.GCDE?0?((?G*GGH:E2*E,ECE**?(E?.DGE66FC8GG*GE(F(E(.A*
@antibody_107_multiplicity_6_copy_6-1
TCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAATAGTACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTAACAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGGTGAACCTGCCTTTCACCGACGCAGCATATGCTGTCGCGTAACTGTTAGCTTTGCTTCTAATACGGCCAACCCAC
+
??=?=+@BBDDBDDB@CF?;FGH/>HH+IHHGIIH,I7ICHFGDHHF+EG9IAHIDDHEA@IHIHEIHFHHI5BCIIHIE-ICDHBGHHHIHHHHEHHH6HH3HHDGHHFIHFB=+EGH,EHHHDGD.E9<+FAGEEB6DG6B?CEAF(6FDGEC?AEAGGEGEFEG:GGEE.GGC:)*:8FE*AG?EEECA/;GGFEGEEC6F>G6C(:E6(@<A<E,G=C:AE.:CF:0AE>:*:AC<E;CEEG0)C:
@antibody_108_multiplicity_1_copy_1-1
CCCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACGGGGTCCGCCAGGCTTCCGGGAAAGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCAGCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACGGCTGTGTATTACTGTAGATCTAACTGTTTGT
+
9,=??B<BDBBB95BDFG-GAFHHH-IIHEHIEHHI7HFHIHIIHCHD.HDBGHHCHG5FHHDIDHIEDCI2HIIG=HHAHIE6HIEGGFICIACAH.F8DF@+E:FFHCGF=HFHHHDE?CF-EGBBGFD#,E*DFEGEGDGG@EF2A'EE?GEEFFGEC;EDEEG?(EFGGEE6(A??AFFEE::AG-G???FGGE:G.GE(D?6EECG(1EEGGG:FG.*6CG2<??9C<GCG:EAG6?G?*C:#>C
@antibody_109_multiplicity_3_copy_1-1
GCAGCTGGTGGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAAGTCTCCTGTGCAGCCTCTGGGTCCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGACTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAATCAAAACTAACAGTTACGCGACAGCATATGCTGCGTAGGTGCAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGGAAATG
+
=,A?A>B<DDDB-BBDGGFFGFH0HFIHIHHCHHIHIHHDFHHFIIIHHF9GIHHG-FIIIHCH?I5IHH>IBHFIHCHDHHHGHEIHHIHHGHDHHEGFIHF@DH?HHH+FHHHA(HHGHDED+FHGHE=GHE*@@;*:**FFGEGGEEECGGEGEEGEGGCGDC/EE6GE:C?#(9GEGAGF?CFG#E?GCEGG*GEE(?::FE:GE(?DA1;EE(EECGC(E?GE:A?:FDCD/E?GGE?8'E'CGC
@antibody_109_multiplicity_3_copy_2-1
CCTGAAAGTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGACTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAATCAAAACTAACAGTTACGCGACAGCATATGCTGCGTCGGTGCTAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACGGCCGCGTATTAATGTAGATCT
+
?,?<=B/<BDDDDDDDC>GGEFFHCEHA.IFFIHHCEHFHFB*@IFHCGF,HIFF:HIDHIH=I8H5FAFIGHIHHECHIHHHHC8HIIIHIFHHGEHHFDHHHHGEHH+HEHFHHFFHFEFEH?@DE,?HDGG2EDEE'EAC=F?;=G'F<E1(EAC0CE(FEGGG88E:EFEGCFGEEG?ECCF(E*6*E8F((E(8ECA?:G*EE(:0(CGBGECEEEE:GC<G*?*EGA**?6E*:(6:C*ECE82
@antibody_109_multiplicity_3_copy_3-1
ACTAACAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGGTGAACCTGCCTTGCACCGACGCAGCATATGCTGTCGCGTAACTGTTAGTTTTGATGCTAATACGGCCAACCCACTCCAGCCCTTTCCCGGAAGTCTGGCGGACCCAGTGCATAGCAGAGCCACTGAAGGTGAACCCAGAGGCTGCACGGGA
+
?????BB>BDDBDD<DGFGFAFAHEIIFHEFHI0CIGI+IIH>HFCABH@HHHHEIH5FDFHHEHI55I5IHH*F=CGEHHIFFHHFFHHH=FFFIDG5-HIHEI;FCHHHCGFGE=IGHGD++GE+HH9HE6GG4G8CEGAFEF@GG?EFGGG#E;*C.:AE@(?CGCF?=GGEE0DAAG+?FG?:(AE/EGEGGG:G?G)EGG;C*EHAEHECE)EFA<G':EG8C*(G(*AG*E?.C8C60:E(??F
@antibody_110_multiplicity_4_copy_1-1
GGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCTCTGGGTTCATCTTCAGTGGCTCTGCTATGCAGTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATTCACAGAACACGGCGTTTCTGCAAATGAACAGCCTGA
+
????<BBB9DDDDDDDFDGFGGIHHIHHEFEHEHAGFHIG.GFH@I5G9I,,HIHFHA+5GEHHHI=5G*GHFHAHHDIHA*HIIEEHGEHIHHHFHHFIHHGCHHHEHH,+HHHG6CEFF=F6G@EBHGBGGGHEEFGBEGC?EAGFE>@(CG4*GEAGDEF:?EEECCGG:;(GEGEG-F#CE/ECEGC.A*<EFG<.;:GCCG:GGEGGCGB((GCEEGG*'.EE((G:8FEEF*EEFCE:C*;C(G
@antibody_110_multiplicity_4_copy_2-1
GAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAACTCTGGGTTCATCTTCAGTGGCTCTGCTATGCATTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAACGAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAAATGATTCAAGGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCGAGGAC
+
?????B/BDDDEDDDDFFGCGFCHBI;IIHIHDFCGIDGGH/GE+F7H.IIIF>HHIHFIEFGGHHIHIEIGFFHFHI+IHIH=-FHIA-HFFEI3IHHH+HEFI,HHHHHGGFHGHEGHEEEHGCHFHEE)*GE'G.GFGE?EGG3EAFEF6GEG:CE:GG:GEEGCEE(E)=GG6(CCF(*GGEE1G:?F/EEF*C0E.684C.(E/C(GC*ECEAECEG:EAGCC?E:CGCE;DEGE0(DE*>/EGE
@antibody_110_multiplicity_4_copy_3-1
ACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTAACAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGGTGAACCTGCCTGTCACCGACGCAGCATATGCTGTCGCCTAACTGTTAGCTTTGCTTCTAATTCGGCC
+
???A?BBBDDDDDBD-F.FGEFIHCBFAHHHIFCHAIF.HHHHFICFFDHCGDI-F>FHHI-FEC=F+FFHB5CH-FIFHHH5IH>FHGIDFIHH5H88BGHEHIHHEH)HFGIE:9GHFF)#EGGFEGFFDDHGCGEFFEE5:EEAF:(>F*=7FGE6F?F(EEGGEEE/((;:EFC:GECEEEE:E?A;E*;6E6*8EE?EEEG8:?A*GHE@C?E(E#:<*CCFED(A1<0GG**/AA8:>#EG:<G
@antibody_110_multiplicity_4_copy_4-1
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTAACAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATGATCTCTGGAGATGGTGAACCTGCCTTTCACCGACGCAGCATATGCTGTCGCGTAACTGTTAGCTTTGCTTCTAAT
+
?<???>@B-BD@BDDDGFFFGGIIFFBIEHFIHEHIGIHHCHHGFF.EIHIHHHHIIHICEDIIGGIIDHFFA5IHGIIFHH7CFHCFF/HHEHHHIGHD;AHDDGHHFH8IFBBHHE=DEGHGBFF@HDE2E*DFE;EGGEGBF30EE?GGGFE8?;B?EFBGGFEAG*?FE8(>?/GFAEE<A?CECFGGD:G=GEEFEGC6(DC<E:(#HE:<(EGCCGCG*?:(GGGCE>EFG6*CA0C?GGEGCE
@antibody_111_multiplicity_1_copy_1-1
CAGCTGGTGGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCGGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTACTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGAAGGTTCACCATCTCCAGAGATAAATCAAAGAACACGGCGTATCTGCAAATTA
+
?,,<?ABB@D?@DD@B;GCGFGEFHHIIHFHIFH.CAHHFHIH>FHFGFGDHFG?.A.HHFHHHEHIFFGHIDDIHIFADIFIDI>E6B>IHHHCIF(FHG=HHFGFDHGFHHFHHGBHHEHDHEFHGFEEHE(GGE42DFF-F6#EG>EEEBGEFCEEGG#GA(E8EE?GBGG'GGEF:(<F?-;)CFE=EE-GEE(2?>*E6*E1*8H::0(D::EE(8#EG*CAECE)GEE*E?6GE./G:1?CA*:
@antibody_112_multiplicity_4_copy_1-1
GTCCGCCCGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGAAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATACAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACGGCCGTTTATTACTGTAGATGAAAATGTTAGTACGTATAGCTGGAACTACGTGCACCACGTGTTCCCGGTACTACTACTA
+
?5???BBBBDE5DDA-F8BCGFIECFHHHFHFHIIIIGIC9IEHHGH8HHEFDBHFH?5EHHH-HF+FIIHIHIGEE5FIHHD8IIHFIHHHEEHHHHDGFHFDHHGHHHHHG)HFHEHH#FEDHH8FED6H9E?GEFFCFE/@EGFCCE<C=EE/EFF#*GG:A6GFGE(E'.FC(CGA(GE;E?@('(()G':006G(FGCFG:8'E'?EH)(C??C@?EA8EE?EG8EE*:?*CC*:C?(CC**G?E
@antibody_112_multiplicity_4_copy_2-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTACCGGGAACACGTGGTGCACGTAGTTCCAGTTATACGTACTAACATTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGGTACGCCGTGTTCTTTGAATCATCTCTGGAGATGGTGATCCTGCCTTTCACCGACGCAGCATATGCTGTCGCGTAACTGTTAGCTTTTCTT
+
??=??BBBDDDDDDDDGCFGF8+I-HHEHIEEHGIEIH>FHHFFDCI.FFIHGIHGHDH95,FHFEHEIIHHGIIHBHHGBHEHG5A.EIAFIGIFHHHHHFD8E@HFHF'43EHFEHGGHG+GBH2HGGGE8HEE7@G*FG4GAGDFFGBEFC:GB?G*(EE5EGEF6EGGEGEFF(CC(EGF((FA=EC??GCGF(EGEDF(ACF/C/DCHA:GB#7EEE((CA(8CE/(:G*E?FGG#??EGEE:EG
@antibody_112_multiplicity_4_copy_3-1
TGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGGTATGCACTGGGTCCGCCCGGCTCCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGAAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGATGAAAGGCAGGTTCACCATCTCCAGAGACGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCTAGGACACGGCCGTGTATTACTGTAGATCTAA
+
??A?<BBBDDDB??DD,G;F/G8B;C8EHIHIHHHHEFFI@IEDI/HIIHFIGF=HHAI9IFIGIH;=-GIAEDFDE5DBHH>F+DIHFHHFCHH,FH@GE=HHE+HH63HHHHDH<@EFH3H;GF?CEDGGEEEGEADEC9E#*FF;G*FG5EGG:,;ECGEGAGEF8G;E*EE.>:?*:GG?DF<EGC?:AG(EEEAGCE?E:GEC(HE:HAE?7G((??:E0:AGGGE<A*GE#C8(AG:?:GEAEF
@antibody_112_multiplicity_4_copy_4-1
CTGGGTCCGCCCGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGAAAAGCTAACAGTTACGCGACAGCATGTGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACGGTCGTGTATTACTGTAGATCTAAATGTTAGTACGTATAACTGGAACTACGTGCACCACGTGTTCCCGGTACTACT
+
????59@BD9D5DDBDGC>GGFHH*;(HHHDIG-FHAHIHHHHHD.D?CFI8IGGIHGHACIIHIF-#IIHHGEFHEHIH#HHICAHHHGIHEIFCDFCDFHIH3FHF,FH+?FHEGH7E@'?FHFG=*GEEFEEGGH3GE*GFEGG?E*EF*F;GAG6BFEGAG6(E36CE8?:F*8GE;E=?;C?E?CGGGE?GG?CGCGEE6FA:G?G6H*C7CFEG8EG0?.(0AC/G?EECA(F??ED<E.C:#<
@antibody_113_multiplicity_1_copy_1-1
TGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACCGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACCATCTCAAGAGATGATTCAAAGAACCCGGCGTATCTGCAAATGAAAAGCCTGAAAACCGAGGACACGGCCGTGTATTACTGTAGATCTTACTGTTAGTACGTATAACTGGAACTACGTGCACCACGTATTCCC
+
A<?,?BBBDDDEDBDDFGGCFG/HHIIAEFHEHIE.HHI@FH>EHIHDIGFFFFIIFH-H@GIHFAHIIH8D-CHIBF5-IGFCIE=FIA+=HIHI=HI)=,DADH*F:;FHGH?F=DH=EHD+H2)HFHHG(?HAGHF*,3#FG;;6E(@GGEGFEGE?GE(GGG6FGGGGGGEGGGGAG<:FF/C?(/EGEEGCEG4CFGCEE/CEGC(GE:EC?*G@1A>G*0>E/C/GAEC/E*EECFC:*4G?:E
@antibody_114_multiplicity_4_copy_1-1
GCTGGTGGAGTCCGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAATCTTACAGTTACGCGACACATATGCTGCGTCGGTGAAAGGCAGGTTCATCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACG
+
<???,BBBBDDADD9DGFFG/CC.IEIHHC=H+FG/IDHD/FGHHGFHHIFICGI.HHHDIHII+EIIHH>HIHCH,HFIGHHHEHH5CFE+*BH+GHIIF-GEHH9HDFFHD8FGGAGHFHHF:GFFEFFGF/=:GBG(G<G,B?FGECFGBEEE?)(FEEE0EF?CGHCF8:GCCEAGG+F0E:EG<EEG66GGG8:G6EE?GAH;G1.E:GGG.CG@*C8:E0*C?:>C'GGG<E/:G:(00#.:?(
@antibody_114_multiplicity_4_copy_2-1
GACGTCCATGTAGTAGTAGTAGTAGTACCGGGAATACGTGGTGCACGTAGCTCCAGTTATACCTACTAACAATTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGATGAACCTGCCTTTCACCGACGCAGCATATGTGTCGCGTAACTGTAAGATTTGGGTCTAATACGGCCACCCCACTCCAGCCCTTTCCC
+
???<5BB3DDEDDB-AFFGFGGHFHIIEH6HIIIAII+IGIIIHAIIHFH(CHGHFFFH+FE#CDA;AA+H#IFH9CHHGHHHECEHHHEH#HHDHHEIHEFHDHHFIF6FHHBB)FHF2;:2GGDEEFEAHG+?FFEF*F<GED:EGH)G69GGGA@<GFDGEE#<6EG::*6EC?1??6:C?6:1CDAA6F6E;6GCEGEGGFE?*EE?GHG8((?CCEGEC)AE8?6#8GG0ECCE80*/*G?*(EE
@antibody_114_multiplicity_4_copy_3-1
GTAGTAGTAGTACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTAACAGTTAGATCTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGATAAACCTGCCTTTCACCGACGCAGCATATGTGTCGCGTAACTGTTAGATTCGCTTCTAATAGGGCCAACGCACTCCAGCCCTTTCCCGGAAGCCTGGCGGAT
+
5?,=?<BBBDBDDDDDGGGGCEFHIIEH,HD?IEFDFCHHB.8-IHIIFHHHH.DH)GE,CG?@HFF-HIHH-HHIEHIH@GFIHHHHAIHFEHG)<H.HHHFHGAHHHGHH.(HGGF?HDG:FEFFFDF@4EFGGGFGE=EEAEBG*F(GGGGE9E9FGGGG;EG6?EGGFA;GFEGG<GE:EEGF:GC.F<-GFG/(C*G6A(/1EG#GEE)@=G*CGCEEEEDCEEC8F<?6?C?(A?F8*GC?EE'
@antibody_114_multiplicity_4_copy_4-1
ATGTAGTAGTAGTAGTAGTACCGGGAATACGTGGTGCACGTAGTTCCAGTTATACGTACTAACAGTTAGATCTACAGTAATACACCGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGTCGTGTTCTTTGAATCATCTCTGGAGATGATGAACCTGCCTTTCACCGACGCAGCATATGTGTCGCGTAACTGTTAGATTTGCTTTTGATACGGCCAACCCACTCCAGCCCTTTCCCGGAAGCC
+
???<ABB>DDDE@DBDCEGGG>IIHEH>AEGH=HHIHHCHAHHFHIAIA9I?BH-I.HICIFHI-HIH8AEDIIHHHHHIHFIIC+IDHHGH=DHAHHHHH?9HIHDHFHG@@F>EFHGBH-GHDD*0GHHF**;IFDF,8@@CGDFCCBE8CB'EE)FEGF(GF:GCEEEFGFGE0EGEGCE?FEGCEEGEAGE//CEE.(?GF?EG(CA'H*@EE</@(((A'CC***F000.'CEGC0;C.?GG/8)
@antibody_115_multiplicity_1_copy_1-1
GAGTCCGGGGGAGACTTGGTCCAGCCTGGGGGGTCCCTGAAATTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAACTACCAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCACGTTCACGATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACGGCCTGA
+
9=???+BBDDDBDDBDF8FF,FIEHFFCFHIHI?IF?H@-EIEHFHHIHCGHHEHFHDH-IFHHHG-HIAHD5IIFFGE+HHHG<GIHHGHHIFEFHF+HGH#HHH#)FE+.4GG@7FHHHGEH1FDHHDGEHF,EF+E(DE.E@FEC1E7*CEGD6:A1EGEDEEG?FE?.6CEC(8F/FG6*?)CC:FEEF6/CG-EEE(EFA86A?HC.EE7*EEEGB0E6=FE1G?EC??=EEC/(?E/6?<:/*G
@antibody_116_multiplicity_3_copy_1-1
TCCAGCCTGGGGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAACTAACACTTACGCGAAATCATATGCTGCGTCGGTGAAAGGCAGCTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGCAAACCGAGGACACGGCCGT
+
??=??B5<DBDDD@BDG>FCGGCIHFIHHHHF+IBHHDI@HGHIHIIFIEHIDHHHCHFHF=?FIE-HGIH-DDIIAIE@AI+FHIDIGHHHHI?HAAFHI6HDEH4FGEHHDG:+FE)H(HGGGHFG+GE*H2BCGDGAFDGG#,#ED(EEG?;E2FB9EG;EGEGEGEGEGGEGGED=EGE?0GF;E.C6GEEE*E?G00A.GG*F?E*GCE.EEGG7(??G'*E*EG#E*?G(6(FCCG?*ECE:?E
@antibody_116_multiplicity_3_copy_2-1
CTGGGGGGTCCCTGAAACTCGCCTGTGCAGCCTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAAGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAACTAACACTTACGCGACAGCCTATGCTGCGTCGGTGAAAGGCAGCTTCACCATCTACAGAGAGGATTCAAAGAACACGGCGTATCTGCAAGTGAACAGCCTGAAAACCGAGGACACGGCCGTGTATTA
+
?5???B??B<DBB@DBGFFC+FIIIHFHFCHHEHCIIGCFHHHIIIAHFHIF+HCIAHFGH-.-HD+GHCIAIF+HFAFHHDBHIFH5I#HH,HHHHH4FIHHHDHHHH@FFFGCEHHEHHHGHFEED@FG@ED9FGGDF*G9EDDGC?<A.4GGECEGEGFGC(G1GFEEG?F;E.(G?:<C?6AGEGG*GEG:EE?ECG0:.GCF'CE>E(E(4*'EGGFECE(/??EG8G*=EC*E*G*EGGF*'FF
@antibody_116_multiplicity_3_copy_3-1
CTCTGGGTTCACCTTCAGTGGCTCTGCTATGCACTGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGCCGTATTAGAAGCAAAACTAACACTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGCTTCACCATCTCCAGAGATGATTCAAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAAACCCAGGACACGGCCGTGTATTACTGTAGATCTAACTGTTAGTACGTATAACTG
+
?????BBBB-DDDD?DFCFCGEC/5HHFFHHIFIFHIIFAII.HDAFHFII=C@@DHHHIFAIH.DEI@H7-F?HHEIFHIEH=GIF8H--ICIHDDHCFFDFHF,FH+HEH;<-G+FGGFGFGG>HHH,BEDFAGFFEGEGFEGG6G;GEEE<@;C80C<CGEGG?FEFC*C0E@GF;(EGE('G:A*?E>ECGEC.A.GG6:GGEFDFG*EC*EB?'CEEF?6E(EE?GC1(G.G?G?4EAG9C?EGA
@antibody_117_multiplicity_8_copy_1-1
GGCAGCAGCGCTCTCAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGAAGATACAGAGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCATTCACGGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCTTTGCCTGGAGCCTGGCGGTCCCAGTGCGTAACATAGATACTGAAAGTGAATCCAGAGGCTGCCCAGGAGAGTCTCAG
+
?5?A5BBB-DBB++@DCFFGA+HFHAHIH+HE@HDCF.HGHIIHIIFCHH@HHH=EHHEFI-HIHH=#IHFHHCDHAHIHF#FDHHHHFIIBIG9HECH?HIHHBHDEG=+I=FDHHHEDGAEFGF;HGF5FFGAGFE8<F=;GFEEE?GGG/AEGGEFEAG:GECF>GGCE(E?E#G;:F+.GAEE98?FC0GAF?/#:#AF(((E(GH:E(@BAG(E.;?EA;(6E/6G/EE1EEGEEGG:G:E:1EG
@antibody_117_multiplicity_8_copy_2-1
GGAGTCTGGGGGAGGCGTGGTCCAGCTGGGAGGTCCCTGAGACTCTCCTGGGCAGCCTCTGGAGTCACCTTCAGTATCTATGCTATGCACTGGGACCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAATGGCCGATTTACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATCAACACCCTGAGAGCTG
+
??????BBDDBDDDDDGFFGF?HCHIFIFEIDHFHHH9F9HHH5FFHB-B/HEHHHH5HIFHA*IHGGHHHFG*FIFI-F@5IFIHCGHIF/FH4DDHH)ECFHCHHHHH)HHHDGGF+EDFEG*FHD(FDDGF+*EFF5CFG*E@E?FFE'3(F8EEEE@FG/CG2GEFGGCGGG*E:F8GF>GDC?6GGCEEEGEEE*CEGGCGFE?(?CH*FEE:'E.G8ECEE(A?-G()ECGA*6C?E;CC(/G)
@antibody_117_multiplicity_8_copy_3-1
GTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCTGGGAGGTCCCTGAGACTCTCCTGGGCAGCCTCTGGATTCACCTGCAGTATCTATGCTATGCACTGGGACCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAATGGCCGATTCACTATCTCCAGAGACAATTCCAAGAACACGCTCTATCTTCAAATGAACAG
+
??=A?BB>-A<DADEDG>6FGFF6IHIFIIHHHIHEICGIGHHHEH8AH@GHHIHHFHIDFHIIHECHGHHIAFGF,HHHH-HGIFAEI?HFIFFHHHD=BH(EDGHD3E4HFGDE'EGHF?EEFGH?DBDE;DGEGEFGGGFCEGFDCCDGEG@#E?:GEE?EG((EEFEEE6GG*E?CGE>=CE>GGCE<GGGEGG?EEG(/GG'(?:C0HEB?:E:,7G?/G:GG66?G(A((:((E:AG66:CC)G
@antibody_117_multiplicity_8_copy_4-1
TGCACTGGGACCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGTCTCCGTGAATGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGAGCGCTGCTGCCGACATTACTATGGTTCGGGGACTTATTATGTCCGTAGACCACATATTGC
+
?????BBBD?DDDDDBCGGFFAHEEIHIFHHFEFH+CFIHGHHFHHHHFHDHHHIIHHII=HEFIIF5DEIHIG*F5H=GCECI*CIHIHHIFHDEHHFIHCHHHHBHDDCFGFEGGC@FIGEEFFF@B):2@GGGC(FEBG,GAEEGFFCFCF(GCF*EF:FGGEG:ECGG:GFC?<AGGEE?AE1F?:A(A*G;EEC6*:(;*FE?(*=GEG:.EAGGE:G'?G:GCE/E#0G)GE?(EEGAE1C:CC
@antibody_117_multiplicity_8_copy_5-1
CTGGGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATGCACTGGGACCGCCAGGCTCCAGGCTAGGGGCTGGAGTGGGTGGCAGTTATCCCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAATGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAAGGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGAGCGCTGCTGCCGGCATTACTAT
+
=????>>@D?DDDDBB/FF/FGHIIIHFB?/GIFIHH>I9EFIIIAEIHH-DFH?CGHHHHH-H#I>H,IHEEHDDHHDEDEHHIHIFEF+.-2H-IHH(HCD)HGDF3FHEHDHGHH)C@+DB5HD2GG2E,EEGGF?G>GBG=>E1GEC8FECGEEG?EGFE@6C:GE6*EC(EEEGE=.EGE*E:EEE8C9FF?/G9E*;8C>H/GEE8FA/CCGE7?8?FA0CF:C((C:6*C*6CE#EC?G*GEE
@antibody_117_multiplicity_8_copy_6-1
GCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCTGGGAGGTCCCTGAGACTCTCCTGGGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATGCACTGGGACCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAATGGCCGATTCACCATCTCCAGAGACAATTACAAGAAAACGCTGTATCTTCAAATGGACAGCC
+
??,??BBBDDA@DDBDGFFEFEHCH)H>CHDB?EHIH9IGH/HCHI@HFH.HIHIHHHH(AIADCH5IHIFFIIHHHHG?FHIEFII?HH?HHEIHIIHHH+IHIFGH=,HFGHHHHG.CDAHHFGFEGDHFDGDBDGHEGGGEFFEDCEEEFEE;?.EGCEEFCGGGEG?EG?.CGEG@+CGFGCG:EE6G(EECCC;/CEE:GFEG?C/A'*7GC07(E?GE(C2A(AEA(:EG.?EAGGG#(*GA:/
@antibody_117_multiplicity_8_copy_7-1
TGGCCCCCGATATCAAAAGCAATATGTGGTCTACGTATATAATAAGTCCCCGAACCATAGTAATGCCGGCAGCAGCGCTCACAGTAATACACAGCCGTGTCCTCAGCTCTGAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGCGATGGTGAATCGGCCATTCACGGAGTCTGCGTAGTATTTATTACTTCAATCATATGATATAACTGCCACCCACTTCAGCCCCTTGCCTGGAG
+
?<?A=BBBDD@D@+<D8CGGG?FHH-HHHFGGHHGHCCHIHIEIIFHIHFIFHC/-CHGHCICHHHGHHCHH=HG-?B+HHI=A>CCFIH9BHEIAIFIHHFCHCHHEHH#FH<GHDH:DFBE(FE>EG,,DEB)FGG*FE*6:;FGEE*FG@:GGE.8?8;EEEEACBC*GC9#EGG(?GF::G0GC:0EA??'GG?6;E://A.E:)EE(CG:AG:G7BECEGCEFGE*E(6E?<AE?6:AE/E0/**
@antibody_117_multiplicity_8_copy_8-1
CTATGCACTGGGACCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGAGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAATGGCCCATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGAGCGGTGCTGCCGGCATTACTATGGTTCGGGGACTTATTATATACGTAGACCACATAT
+
=A<???BB<D5D@DBDFFG+CFBHEFHHHHEIHFEHHHIHGIHHF#=HGIHHFI=HDHE+GHICICHHIHFFGIIHI-HFIF-FEBIHIDHFHHHHHDCHHG#DFH+FIHHHHHED+DHHFEEBHHGGB*EHFE@#D@ECG@CG1E06GG/CCEECEC/FCEEGGGG?3CEGEGGEEGGCGGF6A<EGEEE*16(**G?8?G6GGGECGCGE@EGEGADC*,E6:E:<EEC#EEGCEC(C)G:??0/:CE
@antibody_118_multiplicity_1_copy_1-1
GGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACAGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGCCAGTTATATCATATGATGGAATTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATTCCAAGAACATGCTGTATCTTCAAATGAACAGCCTGACAGCTTAGGACA
+
?,??,<BBDDB5DB@DFF>CGGHCAEHHFIIHIGGIHII-HC9HFEFIHG2GGHHHHDFCBAH=HD5/AI5H5ADGFHFCCFHHIFFHHHIHHHIF(IF@HGHIH@F3HHD+D'HDF4+.H*HFHGHGGEHGHGFF*9FGHGG@GFECFEEEEB7C16<GE;EE*A(.EEGCEGEEE8G:EAF;EGEF#GEE(?'.E(:(E6C?(6HC?HE(0C=F?GC@G8GGCG(.G80E?E(AGG(1EE:#8CECC:
@antibody_119_multiplicity_1_copy_1-1
TAGTAATGCCGGCAGCAGCGCTCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGCGAATCGGCCCTTCACCGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCGTGCCTGGAGCCTGGCGGGCCCAGTGCATAGCATAGCTATGAAGGTGAATCCAGAGGCTGCACAGGA
+
??<??/>BDDBDBB5BGGGGGGEHHHCHHIIIH+H.7HIHHEHIHHADH5/H-E9HIDFF5ECHEHHFGH55HHIEE@HICHGDIHIHHF8IHEGI-3EGHFHE0HHFHCDHHH;GE+F?EF+0GF+HFEE=GHEGE;??DE6;B@GEB@GFGGGECGDG;G.GFEG?F(E0EE?GG.C0A:G*(EEAC*?EGCEE(CGFCAG('6HG:>GECGEEB?(GC?C?E*#ECGCG:A(:EG.G0.CE':;?E?
@antibody_120_multiplicity_2_copy_1-1
CATCAAAAGCAAGTCCACAATTGGTAGTAGCTCCCACTATAGCCGGCGACGTCTCTAGTACAGTAATACACGGCTGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGGTTTTGGAACCATCTCTTGAGATGGTGAATCTGCCTTTCACAGACGCGGTGTATTCGGTTGTCCCACTATAAGCTTTGCTTCTAATGAAACCTACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGAACCGGC
+
?<???BBBD@DBD@BB8FGCFFICHCCHIIHHAFIH?HGHI-IGCDHEHHGCIEFFGHIGHHAHI.GIHIHHIG#=HHFFFIHFCIHHHHACDEI=FF64EHHC5HEHFH?HGHDHH-EDGFFHHE5@G?C8GGDGEFFHAGGGE;E@?GEGE*GCE*EB>GE(FFG?AE>EC1CG?G:EGFCAGCE?C;EE**FGGE*0;?EEC0EE*H:GEE<A/(EE:?<??*08E:?(C/E):?E>8*:GEE:'E(
@antibody_120_multiplicity_2_copy_2-1
CAGACATCAAAAGCAAGTCCACAATTGGTAGTAGCTCCCACTATAGCCGGCGACGTCTCTAGTACAGTAATACACGGCTGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGCTTTTGGAACCATCTCTTGAGATGGTGAATCTGCCTTTCACACACGCGGTGTATTCTGTTGTCCCACTATAAGCTTTGCTTCTAATGAAACCTACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGAAC
+
??9?<B@BDDD-DBADF.FFGAH/>FIHEIIIHIGHIHHGHAGFFHAHHGDGHHHHAEFFC>FIIHHIGEDIFHEHFFH-IHHHH?EHGH@HHGGHD*HHDHHHFIFHF)HEHEHEF6:HGCFEG21H3FFEED)GCEFFEEHCGGFCGGBE*G#GG.F,FBE*EEGGGEECGEFGCD6A?CG??G/?*GCF0GGG?EF::AE8(C(CG0G:EGEGFE:GCEEECAAG06.?EGEE:E*:FGC?E*?CFE
@antibody_121_multiplicity_2_copy_1-1
GTACAGCTTCTGGATTCACCTTTGGTGATTATGCTAGGAGCTGGTTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTAGTTTTCATTAGAAGCAAAGCTTATGGTGGGAGAACAGAATACACAGCGTCTGTGAAAGGCAGATTCACCATCTCAAGAGATGGTTCCAAAAGCATCGCCTATCTGCAAATGAACAGTCTGAAAACCGAGGACACAGCCGTGTATTACTGTACTAGAGACGTGGCCGGCTA
+
<??,?9BBBBBDBD99CGG>FC.HHHFBHIFIHAIGEH/HIF9CIAE=?=CHECFIHH5FHFDEG-HHHHDF-EHIGH+HICECFH?DGCHAHIF-I.HFHIHHEEHH;HE#HGCEEEFHFBH3,E;HEHE;G?G>EFGFCBEAGGEA::*FCGGEBGCFGGGFGGGECG.F/FG(EE?EFAA/?/EE(GAGF:DF'A:A8?0?(0?CEE8C#EE<E7GE/?CGC*ECAG'E2.'6::E(((C(C0:9<:
@antibody_121_multiplicity_2_copy_2-1
AGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAAGCTCGACAATAGGTAGTAGCTCCCACTATAGCCGGCGACGTCTCTAGTACAGTAATACACGGCTGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGCTTTTGGAACCATCTCTTGAGATGGTGAATCTGCCTTTCACAGACGCTGTGTAGTCTTTTGTCCCACCATAAGCTTTGCTTCTAATGAAAACTACCCCCTTC
+
?=?A?<BBD?DDDD@DGGGFFGHF-;HH+9IHFIGIIIHH?EHHIIGHHFDE<HH>I-HI=HFFHHEHHIFI?IFIIIHHAHIDHFFHGAFHIHIHHD@F<GDDFHCEFHHGGHHC@CHGE>@DH:GFDHGEE3FGFG?5F7F@GEE*G>F9CGEBG@GA?FFFGCEE?GEGGA0GGEGEGEG2A;C?E?EF)ACGF(A(G(GFA(E:EAGAHFE;(*EEB:?CEF??GEAEF>C6?*A)CAAA8*E:0?
@antibody_122_multiplicity_3_copy_1-1
TGTCCCTTGGCCCCAGATATCAAAAGCATCAAGCTGACCCTAAACATGGGAATAGCAGTCACCACCACAATATGCTGCGCGCAGCATTTAATCAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCCACTGACATGGTTACGCGACTCTTGAGGGACGGGTTGTTGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGGCCCTT
+
??<??BBBDD-DDBDB>AFGAGHCHIHAIHHCFHIIGHHIAHIIIFDIHIHHHFIFEFHD>?FGHBECHHCIE-HAF+AIIIHHFH@HIHI*HFGHHHHEHIAHIHIFH<FH,*GFFG@FE:FBFHGHGFCDEE6ED,GC=C?ACGFGEGCGGG6EGGEEEFG(6GEEGEG6G*C2G+(AGA=G2CAG?GBGE6GE(C6(G(4E*EHGEH>E:ECA'G?@EE48G*G'C*(A*086E.0?*A(:*CE*?/
@antibody_122_multiplicity_3_copy_2-1
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCCCCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGTCTGGATCCGGGAGCCCCCAGAGAAGGGACTGGAGTGGATTGGGTACATCAATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTAACCATGTCAATATACACGTCCAAGAACCAGATCTCCCTGCAGGTGAGCTCTGTGACCGCCGC
+
,??<<BBBDDDDBDDBCCBGFGCIH>IEHIGHEIHGHDGCIAH7-FFDHHAIFFHAFHFIHHHIHDE-GHCEHHFICH-HFCHHHHI-DF+HCHHHHIHDH#HFHHB+HDH(FGH(?H,E;/?DFG,EGGGDGAFF9GFG+EGE-EE?DEEEEGG?EGFCFCEEEA>F6GE:CAEEG:FAFAGA1EEFE?.:EFG:*(G9#CACG.HF?E/**#B:E)(/?/?'G48':069EEECEE:*?A/C?CF*EG
@antibody_122_multiplicity_3_copy_3-1
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGCCCCGAGGGAAGGGACTGGAGTGTATTGGGTACATCGATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTAACCTTGTAAGTAGATACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGC
+
?5???BBBDBDD@DD@8AEGGGHIFFHBHEHGFHEHHDHFHHIH7HI@I@IHIHHDIEFHHI5IHFHFHAHIHHHHFHIDHH)HEHIEIEIGC+FHFIDH+IHHGGFH,F=H=>DFH3GGEG@FGFE#EFGEFG=0BFGC*2H;@@E#CBFFGG;EEEEG;EAF;EGE0GG6GG@0(G1B:G(6F:G6GC('G?F.FEEGAA(<8?A::DECAEE/GC<EG=EFECG?*C:AG?E/E1?(E*C0E6:EEE
@antibody_123_multiplicity_1_copy_1-1
AGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAGATCAAAATTAATATAATAACCACTCCAAAAATCGTAATGCATGCCGCGCACGGCACGTGGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGTCTGTGCTCGTGGATTCGTCCGTGGTAATCGTGACTCTGTCCTGGAACTCCTGTGCGTAGTTTGCTGTACCAAAAATAGGGATGAGCCCTCCCATCCA
+
????5??BBDDDDBDDGFGGFFICHFIIECIIHGEHHHFIGIF-@IHIHFH/IHDH89GFEFFHIHFG?HFHHHHHHDHDHFEH6HCBHHHI8IHIG<FHHH?EHH+EHHGG3H/?EDDHHHHHGGH?GDGF=GGGFG2EFF3FE;GGE;GB#GAFD<G;EEGFEEE6EEF<<GGEGGECG?EG)'EC:EEF:CCF*GGEEEGGCGCAE(GE@DEAD?GFGCC6'('*(GFECEA(E(?;(:*?GEF?.E
@antibody_124_multiplicity_1_copy_1-1
CTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGAAGGCACCTTCAACAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTCGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAGCTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCACGGACGAATCCACGAGCAGAGCCTACATGGAGCTCAGCAGCCTGA
+
A??5?BBBD<BD<BDBGFGE@FHH;FHIIIIIHD69DIHCIH@9*5FHGD,HHGBIHHHHHHHEIIF-HIDHHFHHF>EIFEHCHH7HFIFIGCDE#HFHFHEIH(GE=HDF=HGHFHFHFHG,0(E1FGG0D,/A-FE=EGFEECE1-'GFGFFGF/*CGGE/GEAG6G6EFG:A8FC<FAGE.EEGEE:EDEEA8G??GCGE?6HCG?EEEE8G;GE(CGC(D6?F4E/*:.EE:D.1'GFEC*CGG8
@antibody_125_multiplicity_1_copy_1-1
TCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTTGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACCATTACCACGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGTACACGGCCGTGTATAACCACGCGGCGT
+
???A?B><DD<D@DBDFAFFFFIIHICHC8@HHHFE@HFICHHFDIIH=G@G-IGHHH;+HCGGHIHIF8HGHFIHFHFGCFIDFHHDCIDI=HFHH=HHDFFHHDGBHHH?EHFH=BHE7?DBHG+EGGC+=FGIGE9GBGGFECDEEBGEE?GCGGGGF(GGEFGE.GACF?(:ECG6EFG6GEEGE<F:?E*G?GCCGGGE-GFE:EGG<E/;<E:GG(*8E16G)E?GC6AE*4?:E::*#??:*E
@antibody_126_multiplicity_3_copy_1-1
TGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTGTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCAATTCAACATCTCCAGAGAAAATGCTAAGAACTCCTTGCATCTTCAAAAGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTA
+
?5A??BBBD<BBDDDBFGFFFFIHHBFHHH=IH9CEIAIIECEIIHEHGI.IEIHI.'FHHGHDHHGHIEH7GI*FHEI4AIIFIHFIHHH6E?EHHHFH-IHGHHHF;HFDHEHGH4FEH;F@CG*9FEGFEF3BEHFEG,GEEE@CFGGEGAF<*GBE>:8FG?GA<EG(EGE*AGC'E:EEC;GE(/.;?;G/DGCFAAF(2A.C8DCGE*C8?:E@?GEE.CGEA:?GE0GGC(?ECGE:(/C>?:
@antibody_126_multiplicity_3_copy_2-1
TGACCAGGGTGTCCGGGCCCCAGTGCTGGAAGTATTGAGCGCGCTCTCGCGATTCGAATATAACCATTACTCCCCCAAACGTAATCATAATAGTACTTGTGTACGCGACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGAGACAAGGAGTTCTTGGCATTTTCCCTTGAGATGGTGAATTGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTACCAATAGCTGAGA
+
??A?,BBBBDBD-?BDFG/E>F+H>FFHHEHFIHH/#FIFH=HHD?HIIHBIEBHFHII'CGEC.HD.=5FIB5HFCEE5+G-EHHHDHHDH5HI=EBCFDGDFHHHH2>H6GHFDF;F7GGHGBGHFH+H?F?F?HEH*EG:?GEECFGECFA3G*GE#*D;EEGGE?GEGEG*CAEG(E:C;EE8EEEEE.F8EE(?GGGECFGH0?E6GHE8C.A)E*E66A?G(?:G88EE)AE1G??F?()G/?#
@antibody_126_multiplicity_3_copy_3-1
GTATTCAGCGCGCTCTCGCGATTCGAATATCACCATAACTCCCCCAAACGTAATCATAATAGTACTTGTGTACGCGACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTGGGCATTTTCTCTAGAGATGGTGAATTGGCCCTTCACGGAGCCTGGATAGTATTTGTCACCAGCAGTACCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCG
+
,?55?=B3@?5BDDD-FFAGGFFII@FHF.-GH;H9E7?GCCHHIFHGIIEIFHHDH8H5?HHHI-I=8IHE@EI<HHHHHIFIGC@AEIDFHHCHH-HH*C=@G;D=HHHEH4D?DEDFDFHHB;FH?@G?EHDG.E*GEF?8GEB+GEE-*E)AFEAGG6*:0C.:G6*CG?EEFGFECAECGEFE:(C#8E6?G;CGAE?:GGHEEE0-HFEGB?BE?GEDAGG?/?<C'EFGDE?;<CA:?*1G?E
@antibody_127_multiplicity_1_copy_1-1
CCAGTTGTCGATAGTATCAATTGAACCATAGCTGTATCCCTGCAGATCTAGACACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCGCAGATCTTGCATAATCATTATACCACTTGCATCTGTAGTATGTCCTTCCCAGCCACTCAAGGCCTCTCGATGGGGACTGGCTGATCCACTTCCAAGCAT
+
????ABBB-D?D5DD->FGAGC?H?CIH/8FGGIBFIHIIHIFHHCHHHHHDHIII=HFAHHHCHHHHFFG-FHHIIFHGIFHHFHHGE?H-IBDHHHCECHEHF+FEF=HFGFCH:HEE3HEH=GFHEGDFEF=GFF:.GHECEF@FFE)GEEFG0BFE/(:EEBA@'ECGEG0(EBE?#E(E1FA;-.G80GEF?(*?EC.(?:(GEE6EA:8C(EF.EE<GE(EG*E:E0?ECEEA:?EGEG.;'E0
@antibody_128_multiplicity_1_copy_1-1
TCCCTGAAACTCTCCTGTGCAGCCTCGGGGTTCACCTTCAGTGGCTCTGCTATGCCCTGGGTCCGCCAGGCTTCCGGGAAAGGTCTGGAGTGGGTTGGCCGTATTAGAAGCAAAGCTAACAGTTACGCGACAGCATATGCTGCGTCGGTGAAAGGCAGGTTCACTATCTCCAGAGATGATTCAAAGAACACGGCGTATTTGCAAATGAACAGGCTGAAAACCGAGGACACGGCCGTGTATTACTGTACTA
+
?????B><D?DDDDD+CGCFGFEFAI-FHCHIHFF@IHDGHIFFF?FHIGIIACDE?EHHGFH@HIDHFG-IEFFHGHDGABGFFHHH-F?HHHHFGHIHEIHHFBEHHGF)HHE3GHFGDG=HEGEHFDGHCFFFGGEEEGE9GG?CGGG>E4;GGEFEGEE/#:FF.?AE:GEGGG?GE;'8A8*<EGGE:AE:EA#EE?8G:GH/F*GC@GEE/E#GDG?G6**FA*A0?E*ECGE<(EG:EC*F:*
@antibody_129_multiplicity_1_copy_1-1
ATCGTAGTAATAACCACTACTATCATAGTAATGCGTACGAACACATGTTGGCCATAGTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAGATGGTGAACCTGCCTTTCACCGACGCAGCATATGCTGTCGCGTAACTGTTAGCTTTGCTTCTAATACGGCCAACCCACTCCAGACCTTTCCCCGAAGCCTGGCGGACCCAGTG
+
??<=,BB?DDDDB<BDGGGFFFHH6HIFHHIA-@F9I+FGHH@IIFGHFFDHIHD-FCF:IFCIFG-DGFH4-H'ICGHHIIFIHHI-IEAHHFH,HHEE=IFCHF5HHHFHHHHDFGEEHF@FHHFGGG*GGE-EG9EGGGEEGCGCG>FGFGEEG*?EG@EFFE;EFE?EEG6>6(E6:?*G8EC)EFEE'6;EEC;C)E*EA:HE:AECEFBG?GG(EECEFG>C:E(?0*GC:E/C/G*GEAE*?E
@antibody_130_multiplicity_1_copy_1-1
CTTGGCCCCAGACATCAAAAGCATCACGTACGAGGATCGTAGTAATAACGACTACTATCATAGTAATACGTACGAGCACATCTTGGCCATAGTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATACGCCGTGTTCTTTGAATCATCTCTGGAAATGGTGAAACTGCCTTTCACCCACGCAGCATATGCTGTCGCGTAACTGTTAGCTTTGCTTCTAATACGGCCAACCCGC
+
???<,BBBD9DDDDED;FGFGGHHHFHFA.HHIFHIIHDHHHHFHGIHII@IIHGF4;ICAFHIHFHHHIGFHIHDFHIFH'EGHIIHIHI6BHIIIHHHH.:F(HHFFFH;F=G=HFHHEHHFEHEEFH8D+@F,*CEEGCFBEAEEG@C<(BFDA2GG0G?8/G<2?FE((A?EEFGCG?E#E?CGC9GE**E8(G?>EG?E>E8G?/<?AG@(:FGE#E8*GG:GGD1CCC6G1?ECC*G)):*:*(
@antibody_131_multiplicity_1_copy_1-1
TTTGCCCCAGACGTCCATAGCGTAGTAGTAGTAGTACATGCACTTTAAGTTATAATAACTCCCCGAACCATAGTAATATCCGGATAGGATATGCACAGTAATACACAGCCGTGTCCTCGTCTCGCAGGCTGTTCATTTGCAGATTCAGTGAGTTCTTGCATTGTCTCTGGAGATGGTGAATCGGCCCGTCACAGAGTCCGCGTAGTATATGGTACTACTAATACTACTAATGTATGGAACCCACTCCAGC
+
A??5<=BADDBD?D<BG?G-FFFHH,HAFHIFEHGFHIHFH9EIIF@HG8HHH7DD8IFFHFHIHBDFIIHH-IGIFHHIHEHDFIHGIIIHDHFIHHFHH4FH,HGFF;D@FHEHHHDHHBE*HG*GEEF4E(GEGBGEE;EG.GFGGGGF:8F*GGGE6CEEC@.?E#FG6@G;?C88CGGE*EE(?CCCF#(.=0AG0/G>CEEE.EGCEF(E?EFE*:0G:8GC?=ACA:GG(?E*.CDF>ECE<?
@antibody_132_multiplicity_2_copy_1-1
ACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTCGGTGTGGCCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGGATGATGATAAGCGCTACGGCCCATCTCTGAAGATCAGGCTCACCATCACCAAGCACACGTCCAAAAACCAGGTGGTCCTTACAATGACCAAAATGGACCCTGTGGACACAGCCACATATTAG
+
?????<?BDDDDDDBDGFEFG>GHHHHHIFAH*HHHHID>IBHFHIHGC-HI@DFHIIFIFHFFI?IH=@HIEED-CIHF,FDAHHIHHEGIHHFHIDF2F9IHFCHHCDHDGCE=HDGFG9EFHGDH*GHEGH*@;GGDGGEEGGFGBCCGEGCCEF@EC?G;:(CAG;FFG??G?GGE>6DEGG*EEA.GE.6F/E/GGGEG.GFAGEG3EAGE<G8G<<GGA(ECEGCAE0:F/(6*C08<E.*(*:
@antibody_132_multiplicity_2_copy_2-1
TCTCTGGGTTCTCACTCAGCACTAGTGGAGTCGGTGTGGCCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGGATGATGATCAGCGCTACGGCCCATCTCTGAAGATCAGGATCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACGATGACCAAAATGGACCCTGTGGACACAGCCACATATTAGTGTGGACAACGTTTTACGCGAGGTATATTGGG
+
??=,?B?BDDDDDD9DFGGF@FHICH*IFHI.HC9FIFIHDHE@FFHI9HDCCHCFFCEIHEIFFIHDDHIFDCHHHFHH-HIEH-H-D*IIEHEHH+IIHHFH-IFHF,DFH.HF7EFEEEDG:FEGFCG@8@*=?EGEEHHE*FG9/BEEEF:GBEEGGE6GE:.GFGC?GCFG.E(8GEEE<G>EAGE6?E*GG6GE(:GGEEFE.HGG@ECEBF:FEE#)A*(:8GG:.E0E:#C?EA?0*GGCE*
@antibody_133_multiplicity_1_copy_1-1
CCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTACTGGGATGATGATAAGCGCTACCGCCCATCTCTGAAGACCAGTCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGCCACATATTACTG
+
???<?B?BD@@DDBD@CGGGG;CHIIECHHHG.IHHHIAE+FIHHFHIEHIEH-IHICIHHF-HFHG-FHEFIDIHHHHICFCHF;GFEEIIH(H6HC=IHFFHHFEBIH0@DDIHEF)GHHFFHEFFFGFD0H*FDDGC@GEE;E=EG=8F;G<80GFEE?GE=#?EB0GE(C*:G?FGDGDEEEGECEAGF?E'?GEEGC:GG?6EEHC*EGE?EC,/)A.GFEG.C?FAG*AE?E?*CG/:GGEC?G
@antibody_134_multiplicity_1_copy_1-1
TGGGCCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGCTTGAGTGGATGGGAGGGATCATCCCTATATTTGGCACAGCAAACTACGCACAGAATTCCAGGGGAGAGTCACGAGTACCGCGGACGAATCCACGAGCACAGCCTACATAGAGCTGAGCAGCCCGAGATCTGAGGACAC
+
???=AA9BBBDBBDD@FGGCGGCCIFHC-AIHGHIFII=EEIHHGFHIDH>*FEBEHIGHIFEFI5HIIIBDHHHD=FAF+DFGHHHAFDHFH*HH:HF7FHECE5FFFGHFH?IEGHF,HDEFD@,EGEE=*GEEGGGDEFGAGGFEF=EEEG:G8?:GFE*FDE4A?GFFEEGCEEG6GDG?CG*E8:DGGEE?(FE<F?GAGGHCEFE?:CEEBE:E'FCG?/4?GGEE4E*0DGE0E<C(F:E8)(
@antibody_135_multiplicity_1_copy_1-1
CCAGTAGTCAAAGTAGCTAGCCTGGTCGACGAGCTCCTATACTCAGCGCTTGGTGATCATGAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGCCAGTGTCTGTAGACGTGTCCGCGCTTATGGTGACTCTGCCCTGGAGCTTCTCTGCGTGTATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGTCCTTTTCCAGGGGCCTGTTGCACCCAGTGCATGT
+
?A???B-BD@DBD<EDFFFGCCI6F.CHHHH9GGI'IIHH-HIGHHI@DF?FHIG+IHHGAEHHHFHHCC@CHIHEHHFIIHFGGIGFHBIHGFDAHHHH#I8HHH(HDFH>I*GFH7HFDGBG*EHGCFFCFGHEEH6FEGGEGEGFEF;GDCEEGC:2)GCEEC8GB?EG(E;GG/EEGEA:(GEG<G(?EAG*F/(/AEGC60:2:EE*A*<A(G?:F?EAECCCECE/8CCAEGE(C<*(A??A?F
@antibody_136_multiplicity_3_copy_1-1
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGCTAGCCTGGCCGACGAGCTGCTATACTCAGCGCTTGGTGATCATGAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGATCAGCTCCATGTTGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACGAGTCCCATCCACTCAAGCCCTTTTC
+
=????B=BD?DDDD@-FCGC88HHF..EBFIFIGHCAHCAIHHFFHFI/?A>CIHHIHI0>HFI?-9EHDFHI+-FIFFIGG(HFHEEHCFHIHH*HHEHIHFHHFDGHGFD-FIFADGHF+EEH(EFGFCFDFE'#GEGDG.ED,GECECGEF?EFE*E@B*EGEEGC6FF.G9EG((<EA.:*?EGGF=:*?G(GCG<EE(EE:4C:8EGEG*E/EC,CF<E*0E(EE;6<?GGC*<G:*EGGGC*E*
@antibody_136_multiplicity_3_copy_2-1
TACAGTGTGGGGCTGAGGTGAAGAAGCCTGGGACTACAGTGAAAATCTCCTGCAAGATTTCTGGATACACCTTCACCGACTTCTACATGCACTCGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCCAGTACACGTCTACAGACACAGCCTACATGGAGCTGATCAGCCTGAGATC
+
????9=-3D-DAD@DD;FGECEIIHI?AEHB=CHGEIGFHHDHIFHHG>FHEHHAFGEGHIHI5EEE=HHHCHF5C5HHC=FGHIHCGIHCHF-IHECH(HFCHHDHHHF:*HGHHB*?:GEH-EHGG*EGGGGEG<?F0FG5ECG8EGBEFFEG*DEGEGE@GCFEEG:EEGGG;F-FECCB(G1/AEGGEA/AGGGAE*(;(F::C?(8EAEF?EGF@FEG6E;(E8??:?E<8GCE6D(#*CE?;E8
@antibody_136_multiplicity_3_copy_3-1
CTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGACTACAGTGAAAATCTCCTGCAAGATTTCTGGATACACCTTCACCGACTTCTACATGCACTCGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATTCGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCTGACACGTCTACAGACACAGCCTACATCGAGCTGATCAGCCTGT
+
,????BB5BDD@@@DDGCGGFGI8A48IFEDGHHIHHHHIHHAHHHHGHGACC-EF5FDFHGHF>HIHGGH5+HIHEFC=IFE>FHGGIHIHAHHDFHHIBF#C=HHFD;G>FHDHFHDEE=HFHGGCEG=F<=GC#FF@GADB4F1ECDGGEGCCE<E-GGF*GEBG:*8(?E?C9CGEFGA<GEEEG;EG(?GGG<G#?((EE<(FE(?A(EEG??B<E,1E?-D2?A1EC6?*CAG0C4CCG;A:E'
@antibody_137_multiplicity_3_copy_1-1
GGTTCCCTGGCCCCAGTAGTCAAAGTAGCTAGCCTGGCCGACGAGCTGCTATATTCATCGCTTGGTGATCATGAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGCTTATGGTGACTCTGCCCTGGAAGTTCTCTGCGTGTATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCCAGGGGCGTGTTGCA
+
?A?A<B5>DD+DDBDDFGGG.FE6F88ICI+9IH+,E8CHHCCHGAHHIFHIHHI-I#I-II<IG=IHB-GICHHHHBFHHIHDHGEHGDHFCHDHH8G)=IIEHGIFHF3CEGF:+GHFHEH99;GHBCHDBGFGEFB6)DCDGGE#E?EDEDEFEBFGEE/GEFFGCG/CACG?;??EEG*.8EGFGEDC6E?E?'EEGG0?:GEC:H4FE:GGGEEE:19AEC/.CGGCE(GG(C?8AC(6GG0EEG
@antibody_137_multiplicity_3_copy_2-1
TGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGCTAGCCTGGCCGACGAGCTGCTATATTCAGCGCTTGGTGATCATGAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGATGTGTCTGTAGACGTGTCCGCGCTTATGGTGACTCTGCCCTGGAAGTTCTCTGCGTGTATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCAGTCAAGCCCTTTTCCAGGGGCC
+
A???5BB3-BD-B+DDFECFGFHCCFIHAHH?IHI-II9+/H0FHII@=AHIGG@HHICIHH+GEIHDHHEHEF#IAI=D=ICHFFF@DH-HF/EHIHIGFCBHGBHH=HHDH;H)FD>GHAFDCGH=FHF*6GGF(EB9;?EGCBGGEGEE;(FEGFEEE?EF/;B2EE?GGEE6GCGECCGECE(>?EFGG:E(C(/(EAGC*AE(GEC:*AGC)GG@CD?AF(A8(E:E(-8.CG/?CEEE*C10?*
@antibody_137_multiplicity_3_copy_3-1
TCCCTGGCCCCAGTAGTGAAAGTAGCTAGCCTGGCCGACGAGCTGCTATATTCAGCGCTTGGTGATCATGAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGCTTATGGTGACTCTGCCCTGGAAGTTCTCTGCGTGTATTGTTTCACCATCTTCAGGATCTACAAGTCCCATCCACTCAAGCCCTTTTCCAGGGGCCTGTTGCACCC
+
?A,??BBBBABDB<-?F9G>FG@HFHC8HIHFIHIH.HIGHDI>EIDH-=HF5H0FFDGIC>F.HEHHHGDHHBHI>IHAIDH--HGGHIG++H5H3HHH3HFHH)H-HCCHFHHFEDH?CE@C@C*CGF8HDEFCECDEEE@HB2EEEEGEGGG.<GB*EEGGGE6EGEGE(0E?:GGECF=AE6CG*GGE:GC8EEEC)EG*EAAGA?DG(G8E'EE,CCEEA.G'EEAE1?GGG:F8D<*E0;?1*(
@antibody_138_multiplicity_1_copy_1-1
CAGCTGTTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGAACCTGAAGATGGTGAAACACTATACGCAGAGAACTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACATACACAGCCTACATGGAGCTGAGCAGCC
+
??,?,BBBDDDDDDDDFGDFGGEFHE+HHFHDHHHHFCHBH-HFHHICFDH9CIFHCFFHH>IFIHIAHHEFH5IDHIFI45-EIG3CIGIHHHIFEIHIGHF/IDEG3HG=HGFH2FHHHHGEFFHHFEG+CC8AEEGE8CFGG6GGEFGEEEG:>G*G<GGE:GFFBE?EGGCF/6FEGE9C?0EEGE?5E6EF/ACCGFGEEACGE8ECHEG:GCFG8-(G:EE?(.GGGGEE:/CG?*::G6CEE?
@antibody_139_multiplicity_1_copy_1-1
GCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGATTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAACCCGTTCTCCCTGCAGCTGAACTCTGAGACTCCCGAGGACACGGCTGTG
+
5=A?AB-@BA<B<+9DGGFCEFHA/I-FHH7HIIDIHDDIGFFHFFI5FGDH-HH7HHFEGFIFF=D,EGIHHEE5HC?=HFHHCHHIECDHHBA,DF/HH+EHEGH-HH@F@HAEFIDGAFFHGGHH,HFHHGECD<D6HEE;EGEGGGEGC-G0FE-GEEFEE<GGC4GCEEE(?+G(GCG;EFA;AC)G*FCE#:?AA>F(G?)-AH0<@/EGGG/:?78CGE(#G??;E0?CC?EG>E8EGGEGFE
@antibody_140_multiplicity_23_copy_1-1
GCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCAAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATCACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGAACTCTGTGACTCCCGAGGACACGGCTGTGTATTAC
+
??A?<>BBB@=@DBBDFFFCFCCI>H6IIIHHDH7FIIIEI-GGEHDICH)IIAHIHHHHHG5HB?5.IIEIIHFDHH=HF=HCED@*IIHHFHEHHFHHEHHEH1HAHHH+HFC.GE3GBG@FEE,>GFH9EFE;F*CCF>DEFEECGFG8C:FFEGGDCGEGBG(G(AAFEE<8?GE:DEAGE(E;GCE66:(D8*C:AFGGC8.E(EGC.@>F?G(7:E?AGAG/CA?G8<GEC(ACEA*EG?C6:E
@antibody_140_multiplicity_23_copy_2-1
TGTCACGGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCTTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTAGACTTTTCACAGACACTGCATAATCATTATAGCACTTAGACCTGAAGTATCTCCATCCCAGCCACTC
+
,?A?=><=BDD-D@@B-CGGGCIFHHCCFI7HH-IID9IG.IGHIHIIIHIHIH.GFDHHBHCHHAHICGFDDIICGHBFF55CH@H@FFIHA.EICHIFEEHHBFHH@H#F)4HHCEHGHH@HHFH+DGEF57@CFHGGGGAG*GFADFG;E*9AE*CGGGEGGF=EF:?E6EE:E<DGGA(?A6EG:'F*G=(E#;:ECC<E(GHC*<?GE@>(CGGF'EGF(GC(6EEE:(;:G0EGA*G/A62*60
@antibody_140_multiplicity_23_copy_3-1
CGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAGCTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGGCCTCTCGATGGGGA
+
??9??BBBD<@DDBDBGGAFFFCH.FHHEIHHDI0HGHE0HGH-H9EHIFFEIGIIHGH=FEHH/HAGEFHII=IHCCE>HHFH>FHII.+DEHHFHIHHFFHDFHHHH=HFHAHHGFHFFHGGFF>=F#(GDG8GDGE;.=EGDEFGGEEEA<=GGC)AC*;FGAE8?GAA6G8ECGEA@GFE/GDGAE8FEACAEGEGGG?*FCE8?*EE(@</?G)E?:AGEG??GG?GFEGE6CGCE?:EEDG.?G
@antibody_140_multiplicity_23_copy_4-1
CAGCTGCAGCAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGTATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTATAGGTCCAAGTTCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTATCCCTGCAGC
+
?A<??B?BDDDDBEB<FEF/GGAFIIFFFEIFD,HIIIEHIIF?HHCDIGEGGFIDCDHHHHIHHHHHGHDEHHFF5HHI>IFHEEIHHH?-=.HHHED@8FFHIH5+FHHFGE=HG*EBFFCGF*EADFEE.G7*F=/(G*EEEFD*FFAA?EGGEC(GGCA(6C*FE6GE:@GE#AEF+GG?CG.G</G:D/;ED?A.C2EECE;CGH6GH0::*A:@C,E(6GEE8*GE:AAE*E6(E?(CC:GEE-
@antibody_140_multiplicity_23_copy_5-1
TGAGGAGACAGTGACCAGGGTGTCACGGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCTTACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAG
+
?????ABBD@DEDADDFFCGCFHICCFH8>FIFHCCIH9IH+IGDH.HECFFHIE)-HH=HIIBH-FHHFFFFDIH-IEE5HHIH=IHHGHHGHH,H3HDF(HHDFFEEHHFFFE*FBGDGEH<HF?FGGG;GE(*GED>AGFFDGGG8D=GF,GFF6@CG0EFEEFC**EA(<(C8G??6E/GE*E=:GE/G:GCFDGGED/EF6(GG?:.H@(ACEEEC?FAEEG?.G4E?<;0C>*AE<CCEE(28E
@antibody_140_multiplicity_23_copy_6-1
ACAGTGACCAGGGTGTCACGGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAGCTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGAATAATCATTTTAGCACTTGAACCTGTAGTATGTCC
+
A??<?@BBD@@D@DB-FFGGGGIIEHFHHHIHD+HHFHGCHHIIHDIDHH=HF9FHGHF0GBHHB@BGHHHECH@HH+IHH5BCCHIHFDHHFEGHFH4+DHEFDFC+FCHCDHEFEC?HFHFHB7EFGFG*BHEEEFEGG?2;(EEEFG;<FG,GGEEE(AF@@:GFGBEGEFGE:EGGA6/*G8(GEEEFG:(:AGG;6E)E?(=CE;CGCE(?E*:CEE8E#:G?*GE:AE(EE;::EE:*?;A/?E
@antibody_140_multiplicity_23_copy_7-1
TCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCTGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTCCTTGCATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGGCCTCTCCATGGGG
+
??A,??BB?D@DDBDD>EGGEFFHF+HIHHEHFDH+H0HHHHEAIIH7DFIG.CIFCGEI.HGFH-FD5IIHG>IG-GHDIFHIHHEIDHHE@DHID8=EI#7F=)H@FFFEHBDFHFE<=<EDE7?F@DH;DHFE'EEEG#GG=9C,FF=GGE8;FBGGEF*GFEBF6G:.G)G0:;:GGCFF(GGF:FEGCFF.A/GE('EG(E-:F<0EEGCEGCC,:7GEGEF?FEGGEEGE0(G(:.E)*:EGF:
@antibody_140_multiplicity_23_copy_8-1
GGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAATAATACACAGTCGTGTCCTCGGGAGTCACCGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCGCAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGGCC
+
???=,BBBBDBDDBDDEFDEFGCIBEF8ICFIH.+HIIHBIIHEDG.GIEHD@I-DCFFBHHIFH#@HIHHHFFIHI-CHEIIGIIHDF6F3HFGGFH*E@H*H)(DH+FGEFFHFFFGHG#HEEEHGHH*2F,FF,GE4CGEGEB:GGGGEGFG8(FGGEG*<#FG*E=:G:EFEGGEGE?;AG.EGGCGCA(EAFCCAFE?G;*E:G0(CA;G??C?9G;E:<?E*G*AEEGE(G:9G?:?GC::(FE
@antibody_140_multiplicity_23_copy_9-1
CATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGCTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATGCAATAAACCGTTCTCCCTGCAGCTGAACTCTGTGACTCGCGAGGACACGACTGTGTATTACTGTGCAAGAGGCCGGCCTGTAGGG
+
,????BBB-DDBBDD@CFCDE8HI?IHIFFGGIFIHIH,IEHAHIHHAAIFFI-E9IH:FDGHBHHHHFHFHFGCFAIGEIIHHI-III)E6H(DDH-H)H?HDHHHHH66GIHFHHEHHE=HH=/;G8HGH1E?FCGE*GEFGE5GCEF*GGGFHGGG*GE(G*<EB#)CGE*F(:EAE:CE*<:*:.G?GC?GEEAGEC=C(A1*EEA:GFF'*(*;/GE*?GGGC:G*E.CECEG*?:<:*.:00?A
@antibody_140_multiplicity_23_copy_10-1
AGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGAATTCTGTGACTCCCGATGACACGGCTGTGTATTACTG
+
??A=,>BBBDBD-D@D>GGAGCFHHFFCCHHHHHHHHHGICIIDH@IHHIIH9CCHHGIHDHFIC5FIHIIIHI?E-4-IIIH/?HIHEHGHFHFHHHHHHFGEFHHFHHDHGHHHGFEHDHEGFGDEFG,?DFEG;13GGDED;:0GFEEGC(F#G*EAGEE?.GG?,**GCE;EEAAAGGA6G*8F/E((:E??D;EE?ECF6EAG(E:GEE(EE:BEGCF0).CC?*2EEECG?GF?E*:?D;-:CC
@antibody_140_multiplicity_23_copy_11-1
GCTGCAGCAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACAATCAACCCAGACACATCCAAGAAAGCGCCCTCCCTGCAGCTG
+
?,???5?=DDB<DD<DGGC@GG@EHFECHHIEHHI-H9CIIH3IGAHF9IHIHHCFIFHFIFHHIGHFHHEHDFGHGCCH=HHHFHCF?HH.BHHI+<FHHH=-IHHFHI1HHGH>DHFEGEFGH+GH;9EHGFHG=G>GGBGEGEF:D;E(E*GE0EC?FG:EC:;EGCEFEC:EGGEAG?CE?:GCG?EE.G(E):0(EEE?/GH*FECFHG;8*:EGC?AE:C1:E<=?)*E1)E:G8EC/EG?E0*
@antibody_140_multiplicity_23_copy_12-1
CATAAACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGTGTCTGGGGTGATGGTTATTCGTCTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAAGGCCTCTCGATGGGGACTGCCTGATCCAGTTCCAAGCAGCACTGTTGCTA
+
,???,B?BBBBB5BBBFFFG+CCIEIHHIFIIIAH,HHII9EB@HGG.IIII9/HFICIHHHHGI-HGHFFIHGICIFDIE<HFAGH+HHHCFEHEFCH=H:IEHHGGFHFHHB0#GH*DEGFH+@;EEHE('EDFEG9GEEEEGEEECEFG;?E?DFEGE1GEE6;GGBGEG<GFGA1.GGGG*C:E.G?EG0?E<ED:G<FGDEE<*EAGC:GEE.0EGCCGEGCG?(0::'.GEE/G?CEGFECAFE
@antibody_140_multiplicity_23_copy_13-1
GTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTCCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGGCACATCCAAGAAACAGTTCTCCCTGCAGCTGAACTCTGTG
+
??A???B3B9@DDDD-FGFCGGEFHHHCGHHIGGHAH=C8CFI5HH=FFHH?GHH?F=FIHHIBCGEIHGIHIIHHFIIIHHI/EHCHHHHFEFHHHHFFEF?BDHHHHHGEEFEG*FEG+HHEDFH?EDFFGGGIFFFEEAGGG5DGFFEFED.GGG0AAFG(DG'.EFEGG?EFC+E(FGFA?G?;GAE0*E6E?6EFG1EGCAEGC(G:HEE;CGD>;,C?EEGGGCEEEAC1G.)<0GC0C6A-/*
@antibody_140_multiplicity_23_copy_14-1
TCACGGCCCCAGAGATCGAAGTACCAGTTTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTAACAGAGTTCAGCTGCAGGGAGGACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCGTAATCATCATAGCACTTGGACCTGTAGTATGTCCTTCCCAGCCACTCAA
+
??,?<?BBBDDDD@DBGBFFBFACFICE0HDHFEIHHIIIHFHFHHHHHI9HHC.->CEBIHHCHHHDGH)IIHEGAIIII5HHEHHFIIHHFFIB8HFHDFH@)HH@HGIHHHEHEHEDHH,CD)EEFGHG@E*@DFD;@DGG*?GE8>FG7G<DGEGEDGCE?CGE(;G?EF7EG((.;F*AE<G?GEG??/GEDF=E'/GEGG:G#:G9((EC:?G0GEC;F?G;49G4?EF9E(*E:*G:*AG;GE
@antibody_140_multiplicity_23_copy_15-1
ACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTTTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTAGATGTGTCTGGGTTGATGGTTATTCGACTCTTCACAGATACTGCATAATCATTATTGCACTTGGACCTGTAGTATGTGCTTCCCAGCCACTCAAGGCCTCTCGGTGGGGACTGCCT
+
?,??9?BBDEEDDD-DFGF>FGEIIHI.CEGHF/9GEH/IH.HHGHF=GHC7HFIH9IHECIIG+#IEHI5DIIHGHCH?IHCHD=;E#HHCHHHHHHI@H+FGH?IFEGHDEHHFHHHHFF8CHGHEEGFGG(EG;D@EGGGBFEGEEFE28EC0C?EF2<E'<(GCCGGBGEEE=E*G:EG?6:CEC(?E:GECGAGAAEF:AAEEGFA*@@BEDG/)GCE1A:EAECG*8D:E((:GFE*4*AEE?'
@antibody_140_multiplicity_23_copy_16-1
CAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTGTAATGATTATGCAGTATCTTTGGAAAGGCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGAACTCGG
+
?????=@BD@DDDDDDFFFFFAAHHHIIHHIFIHCHHHHFHGCHDHGHIHFFIFIF?HEHED?EHEIFHFHFHI*)HGHGE<IDHHHHGIGH@H*HHICHFH+?H,?EGHHH)H1GFGDHFGGGDGF;FGGHFG8EGAGD;E?=CBGGG)GEGE8(8F:GCGG(FGEE4:GAG.E,C?G??EG(0G*?E:*(4G(GEC?GE:6C?EEEGC(:1G;=F?EAEEAECCE:((0E8?0C*E:(6?:?6CE*'?
@antibody_140_multiplicity_23_copy_17-1
CTGCAGGAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCAACAGTGCTGCTTGGAAGTGGATCAGGCAGTCCCCATGGAGAGGCCTTGAGTGCCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGA
+
????AB/B9BDDDDBDGGFFFFHH+->>HFIC7HHIFHHGIGIHACFI9HDGAH9AHBDDHCFHIIHEHDHGHHCHIHHIFIGHHHHEHIGEAII:HGFEH.HEHI>HHHGIHIFEFDGDB8FEHFEGHG7FGGHFG/;EGFEFF**?AFEEG3GGE@EE-E8GE0EE;FG6CCG*DG?FEG:AG*/E?E*C?:AGAGAEE?EGFE):C?G*88B7:CEE:G(E*?CA;G*G6FG(?(6G>6(C??FE(C
@antibody_140_multiplicity_23_copy_18-1
TGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGCCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATAGCACTTGGACCTGTAGTATCTCCTTCCCAGCCACGCAAGGCCTCTCGATGGGGCCTGCCTGAACC
+
?5?A?BB=DD+D-@?BF>?FGFIIB6IFAE=HFIHIFGIEFIDFDFHGFHAFBICE*?H@FHHHHEHIHHB-HFGIH:FAIGH+GHFGIIHEHF-EHHDEEFFHHHHFH7HHGAH+H;FH84(HE,;2GEE*GGHEFF*EGFBEG*EG;GEA*E/EE>EBEGCCGBGC*GGGE8?E;FACEGEFCF:(#GAEGFGE*GG0GG(C(?*:)AEE;>CE*EE,C,E?FEGGCG*>E*GE?##A?C8EGE?*A/
@antibody_140_multiplicity_23_copy_19-1
GGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGAACTCTGTGACTCCCGAGGACACGGCTGTGTATTACTGTGCAAGAGGCCGGCCTATAGGGATATTGTGCTGGTGGTGTATGCTATAAGCGTTACCCTGAATACACTGGTA
+
A????B/BD<DDD@DBFFFGGGIIHIFIIIGIDDHIHHHHH@FHEIHIFDHFIFCFDGECFH>HIHFHE-CIAHHFGEFIHIEHEHIH-DHF(HIIHFHHFHHHFE+HHFHAD'HGFG;FHHHHGHHAEE*GDGEF;EEGG@G8@FFFBGA;F?*C;GEECECFEGBE?GC/)C<?(G'AG?EDEEGEDC<G-EEECG6EEEGF#**((*AG@G@GC8E(EGGFCC?(?CE.0CG0E(6E*ECAC'?*0)
@antibody_140_multiplicity_23_copy_20-1
AGGAGACAGTGGCCAGGGTGTCACGGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACACTATCCCTATAGGCCGGCCTCTTGCACAGTAATACACAGCCGTGACCTCGGGAGTCACAGAGTTCAGCCGCAGGGAGAATTGTTTCTTGGATGTTTCTGGGTTGAAGGTTATTCGACTTTTCACAGATACTGCATAATCATTATTGCACTTGCACCTGTAGTA
+
?,,,,BB@<DB-B<DDG8FGFCIIEF8HHHDCHECHIHI+FF-HFGH=GEIIHHHH=IEHFGHIHIHHHGHIHHH@5FDHH?HCIFI#DDHHHDHF@AIHHHHFBFGDHHHEHEGHHFHHHEFFFBHGEHE'E=EFEGG@FFEE*=EGG<FEEA,2EGGGGBGCEA'(?G?GEGEE*GCG8+AEACGGCEF?#EECGED:EF86EFHEF8CG<GEE<CEE/?*/(EE(A08)G?8C6*:(:F'EEE:*.(
@antibody_140_multiplicity_23_copy_21-1
GGACAGTGTCTCTAGCAACAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGCTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATCCAAGAAACAGTTCTCCCTGCAGCTGAACTCTGTGACTCCCCAGGACACGGCTGTGTATTACTGTGCAAGAGGCCGGCCTATAGGGATATTGTAC
+
?????B?>?DD<D<DDGGEFFFHEAAF?E+H0H/FCHHFH>IHI=FG0CHHHFEHGFBHHCFHHF<HIHBGIACHDHEEH-IFFDCIHFGEHH-CA?)IHBFHEHGH@HHHHHDD*F9GHFHEEHFF;FE)GHG*ECFF0EEGCG;C@BG(GGC=GGF,D=/48G:F6GC<?#8EGAG*EG.DGCEG?CGFEGGGG(CGGG8/G?EEEEH?EHGC?C:EG0AE/:?G>GG1E/;EC*?8E8C?0?GC'/:
@antibody_140_multiplicity_23_copy_22-1
ACAGTGACCAGGGTGTCACGGCCCCAGAGATCGAAGTACCAGTGTATTCAGGGTAACGCTTATAGCATACACCACCAGTACAATATCCCTATAGGCCGGTCTCTTGCACAGTAATACACAGCCGTGTCCGCGGGAGTCACAGAGTTCAGCTGCACGGAGAACTGTTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTGTAGCACTTGGACCTGTAGTATGTCC
+
?<?,?BBBD@@@BDDDGFFC8G/HHAEHAHEHH@HIHBHFFIHHGFHEI-F.+GGFHHCHFGF5HI.>=HGFH--IFHEFHHFHDI9IHEH/HI?EICF#HHFFHFFE*HHGFBDH@EFHFAHD;5F*D#*?GEFGG,;GGGEC6G*B.E=FG:'G@EGEE#FEDCAAEE:?CFEEDEGE<(:)8:'CGG(CGFGC0?FEFGG8ECE./EEAEGCG*C;GB=AA*?G:EEGCCFE8:A>A*)GEG:C)FG
@antibody_140_multiplicity_23_copy_23-1
CCGGCCTCTTGCACAGTAATACACAGCCGTGTCCTCGGGAGTCACAGAGTTCAGCTGCAGGGAGAACTGTTTCTTGGATGAGTCTGGGTTGATGGTTATTCGACTTTCCACAGATACTGCATAATCATTATAGCACTTGGACCTGTGGTATGTCCTTCCCAGCCACTCAAGGCCTCTCGATGGGGACTGCCTGATCCAGTTCCAAGCAGCTGTGTTGCTAGAGACACTGTCCCCGGAGATGGCACAGGTG
+
5?A??BB>DDDDBD@DG@GGGFAEIHFF8IHCFHHC.DFHIIFBFH9AHI=HGDIFIBHIIF@E.HG6IIIHHCIIH+5F#C*GFIIE7HE-5FF=:HCIH.HCDH?#HDFHFFBHD5@EGFEGHGHHF9H<?GEEEEE8GGG;A*(E8=GGECEE8EEFFCGG2;AEFFEEEEEGEECFGCEEF:(GGCECGC?'EEEAA:G(FCH?6?*(EECCGDBE()0GCCG60CECECEC)CG6GG:CCG*A?C
@antibody_141_multiplicity_1_copy_1-1
ATAACGATAACTCCCCCAAACGTAATCATAATATCATGATTAGCCTCGAGTGCACAGTAATATGTGGCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGCCCACCTGGTTTTTGGAGGTGTCCTTGGTCATGGTGAGCCTGCTCTTCAGACATGCGCTGTAGCGCTTATCATCATCCCAATAAATGAGTGCAAGCGACTCCAGGGCCTTTCCTGGGGTCTGACGGATCCAGCCCACACCGACTCCAC
+
=??,?BBB?@DD-BBDGCGG;CCHIEHBH;HIFH+ACGHFHHIHIDFIFEHFFI@DCHFIH=IAHIEHE-AIH+GHDIFHAA-H8CIEIECHF+H(I5H@=I)HIGECFHHGHHBH.-CHEEFGEEGDEFEFEEEE#FFEDEHAE=?E@EEEG(ABD(EGE6E*EGEEE?(GG(8;:CFCG0(E1?(EAECGGGGCGE*?G/:E4AHAFEGEEG@G:?CE*GCGGC?E*C*GE:CFEA2C.*0G(CE6':
@antibody_142_multiplicity_3_copy_1-1
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGCTGCTACTACTACAATATCGTGCACTTTATGCAGCTTGGCACAGTAATACACGGCCGTGCCCTCAGCACTCAGGTTGTTCATTAGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGGGATAGTGACTCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTAATGGATGAGACCCACTCCAGA
+
???A=BB-+BBDBDDDFGFCFFH;HHHHHF+9IH9CHIDH@HEGEC.I+GAFHHFH=5FHGFHFIIHGHH-HFEDHGEHHHHIHFFCGFHDIH+EHIHEHHFFIHHHAHBHHHGDDHFHEHHBHHFFHEHE,CG,IEF5CGG#GDB*BGGFFGGEFC;EG1.GCGGBCEEFC?F:E'<GF(EEFC)EG:/EA:CF/A*DGE:AGGECGGCEG(:EC:3?C:(GCCEEGE0F<?60?GE<E.*C1::EEA/
@antibody_142_multiplicity_3_copy_2-1
TGCTACTACTACAATATCGTGCACTTTATGCAGCTTGGCACAGTAATACACGGCCGTGCCCTCAGCACTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGCAGATGGTGAATCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTAATGGATGAGGCCCACTCCAGACCCTTCCCTGGAGCTGGCGGATCCAGTTCATTTCATTGCTATGACGGTGAATCCAGAGGC
+
?????B?BDDDDDBDEFCGFGFHIHHEFICHFIHIFI9EHHCHHFAGIFFFEIIDGEGIAHGFGIDHHE4HID5GHDIHHF+IEIAHCHHFE@HH7#HHEHFDHFHGHH@E@ADF.FAD.HFEHE;*EGHFDDH?GFFEEGGE*6)4E?CE(GGGB0(FGGC6=AA('(EDGB(GE*((?CE?AE?EE?AC:FEC*GC*G(DGAEFHEGHG:C:E*C?EGE9-CGECE*EE-0CCE???68;AEC.G/AC
@antibody_142_multiplicity_3_copy_3-1
TGGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGCTGCTACTACTACAATATCGTGCACTTTATGCAGCTTGGCACAGTAATACACGGCCGTGCCCTCAGCACTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGAAGATGGTGAATCTGCCCTTCCTGGCGTCTGCGTAGTATGTGCTACCACCACTAATGGATGAGACCCACTCTAGACCCTTCCCTGGAGCTGGC
+
??<?=BBBBA?DDDBBFFGFF;HHHH8CEIHIIIFIFHHHIH7HDEIHHIA@-HHHCHIFHHFFGHFHFIFEGGIHHHFGHHHHEDHGIGIH=DIHIEEDCHGHCFFI@HFHE,HGDC,BGHGH@GE1*GD@EGGF<AFC*+AD4GGD:HEGGCF8**?*FE@:B6GECCGCE/GE(FG:FE)EGFGGF)(EE?EGCDCGG?<AC*(CF'ECEE7CC(B:*CFEECE8(**'A??GA??:?*F(G)A:*(
@antibody_143_multiplicity_1_copy_1-1
GAGACGGTGACCAGGGTTCCCTGGCTCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGTAGCTGGTACTAATACAATATCGTGCACTTTATGCAGCTTGGCACAGTAATACACGGCCGTGCCCTCACCTCTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGACATGGTGGGTCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCCCTAATGGATGAGACCCACTCC
+
?9?=AB?BDBD5BDDDF.GF/.HHI-8CFCH-FCCEHGCGHHG9HII,,HF4HIHHIHIF+HFEHHHFIHHHFDH?DHADHGEFF84FIIHIH=DEHHHHGFFIHC.HIC@GHFH>FHFFHDEFEGG,EEGHH8GFDGEC:FGG;G(FGE=FGE;<@(@FEGEE0E*CEEFE@EEEAE:.+CGG(G*?#A(DAEGC:(GEEE?G:GAEAEEC)C@*CA?CFA#0*GE;GC)C0?C?:G(ECE0E0CEE(0
@antibody_144_multiplicity_1_copy_1-1
GAGTCTGGGGGAGGCTTGGTACAGCCTAGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAATGAGATGAGGTGGATCAGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTCTCATCCATTAGTGGTGGTAGCACATACTACGCAGACTCCAGGTAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAACCTGAGAGCTGAGGGCA
+
A????B?BDDBD=DBDCGE>E8HEIHIEIFAHIF+FIEFG8HFCHHIHGDIHEG+D-HHH@HH./HFIHHFIFH-ID+HHDHGH=GIAEFIF=GGB*H8HHFHI7HHEHH+HAFFDIEFDHEGHH62HH?GFFDEGHE*FH+F=E9EEEGGCBE?=EB2EEG006EG6'GG'GC:EEE(.EGCG?E/GG:CC(EE86A?8:086EAE0*E:EEEDG?EG>G;FGG?0*FC:*EA::GG?'EEE8?21EG*
@antibody_145_multiplicity_2_copy_1-1
GGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGCTGGTACTACTACAATATCGTGCACTTTATGCAGCTTGGCACAGTAATACACGGCCGTGCCCTCAGCTCTCCGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAAATGTCTCTGGAGATGGTGAATCTGCCCTTCCTGGAGACAGCGTAGTATGTGCTACCACCACTAATGGATGAGACCCACTCCAGACCCTTCCCTGGAGACCGGC
+
?5<??B??6D5DDBDBC-6CCGC/A>0HHH?FHEH/IIFIHGHGH@HIAHAFGFFHFFE=?FFIHIIFIDEFHIHF4FFCCGHHIIEEGHFHIHFHHE(HHDHCCHHD1HFDF3HD1BFFHH8GGFDEGDHEFGFGE=2E6EFEFFGGGCAE=CCGGF=G)6;EGGEA(EG68EEG2EEGGGE(:(G0E.GF:/C/GGCGC:/EEGCG?*G0HC4/C*:807'?;?C:;':F4?AG6#EC)EE(.G.D(?
@antibody_145_multiplicity_2_copy_2-1
CAGCTTGGCACAGCAATACACGGCCGTGCCCTCAGCTCTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAAATGTCTCTGGAGACGGTGAATCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTAATGGATGAGACCCACTCCAGACCCTTCCCTGGAGACTGGCGGATCCAGCACATCTCATTGCTACTGACGGTGAATCCCGAGGCTGCACAGGAGCGTTTCAGGGACCCCTTA
+
?????BBBBDDD<B-DFAFEGFI/FCEHHHEGFHH@H/IIHHHHIHDHIHHHAHHHIIAHHFIIIH-FH-@FHICGHFIHAHCFGIIEI-IGGIFFHGHDGHH3HHGFDFHFD@HH/G+HGHE3GGEDD;FGH@GF*E*AGHF;;DG?GG:EGEFEC6GF@EE?GCGGGG*EGFG6*FC(EEEC/?/EC-:FEEGA,G8GG:EGGA((/A*F'E:.*AECCG:/D:CE6EC.(/((C*)EC/ACGEE(2:
@antibody_146_multiplicity_9_copy_1-1
GCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTAGGGGGTTCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACGAGATGAGCTGGATCCGCCAGGCTCCATGGAAGGGTCTGGAGTGGGTCTCATCCATTAGTGGTGGTAGCACATACTACGCAGACTCCAGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTCTCTTCAAATGAACAACCTGAGA
+
???=?B/@BBD?@BDBGBGEG9EIFHHIICIGIHHHEH-HIHHB+FGIGDDFEGDH@HF-IEFI--HEHHIHDHHDIEDGGGIHIAF>IIAHBHHCH@GEHEIIHHCH3FEGHDEHEH#DG=+HGG)EGEGEGFEGEFFE*(5GAEGEBGGGGGGFEG*CAFG4CAGGGECGEEGG(GD?EA<E<(?GGA;.00:EC0CAEGA???6?/EEF(GB:GE/F/?G:C/G(::?(-F?A0CG:8C.8CCCA:E
@antibody_146_multiplicity_9_copy_2-1
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGATGGTACTACTACAATATCGTGCACTTTATGCAGCTTGTCACATTAATACACGGCCGTGCCCTCAGCTCTCAGGTTGTTCATTTGAAGATACATGGTGTTCTTGGAATAGTCTCTGGAGATGGTGAGTCTGCCCTTCCTGGAGTCTGCGTAGTAGATGCTACCACCACTAATGGATGAGACCCGCT
+
?A??A<B=B?DBBDB@GFGGF;5F.HICIHHHH;@HDHHGIHHDB-FIHFHDFHHFDGH-A=HHCHCFGIHFGHHHHIHCEBGHI;=@HHCHHHGIHHF7GAFIHIHEH<FCD#H>6HDGGFFFDHEHFGH.HE*FEF#CGEE)EE;EDEC*GGE;F#*?G(AGDCEGGE6F#EFE-G6ECDE=:*CG*E6GECE(G4GGE'EEE?2F:>:EFGG(GA#'G0GCEDDAEA:?AG*/06G?C6*<*)?(??
@antibody_146_multiplicity_9_copy_3-1
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGATGGTACTACTACAATATCGTGCACTTTATGCAGCTTGTCACATTAATACACGGCCGTGCCCTCAGCTCTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTAATGGATGATACCCGCTT
+
?????B?BD-BDDDDDFC+FCGHIHFHF6HHHFIFHIHHHHIECHHHI.HHDF@45GHFHAICFIH>IAHFHGHI5GHIHFHHHHIIBGDHHCI-7GAIHHFFE,EFGIE.EHH=FGHG;CFGEEGFGHEEGGG+G8EE3GEEFBE?GEG*GDG<GEFEE6(?GGAGGF<*EEE8G/CGE?GCEFEC?A)GE**CGA?G0EGE:CG6E8*;C(F:ECE,GEG?G'GF?/ECEE4G0(*E82*E8G*(;E.
@antibody_146_multiplicity_9_copy_4-1
GTAGCAACGAGATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTCTCATCCATTAGTGGTGGTTGCACATACTACGCAGACTCCAGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTCCAAATGAACAACCTGAGAACAGAGGGCACGGCCGTGTATTAATGTGACAAGCTGCATAAAGTGCACGATATTGTAGTATTCCCATCTGCTATGCGGATCCC
+
,9?A,BB<BDDBBD<DCGAGFGHF.IEHICBIFIIFHHGIBIFGIG?IFDI-8GF=EHI>III@IHGHGIHHHI-HFBHIFFIGIEHDIGFHGEIE-FHGDF:*E?HHE@HHGFCFHHHHD9FGEFHEHGH:@0<E@GAEGGAEEEGAAF-EGF?A:?G**F:?GBG(.(E#GGEB?DEE:F0(AA?EE*EEGGGE0FE:F<:E/E-C6E(?C7BGEFB8G(GEGG?'E*8A?A2C6:'?*(FC68?F*G
@antibody_146_multiplicity_9_copy_5-1
ACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACGAGATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTCTCATCCATTAGTGGTGGTAGCACATACTACGCAGACTCCAGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAACCTGAGAGCTGAGGGCACGGCCGTGTATTAATGTGACAAGCTGCATAAAGTGCACGAT
+
???A?BBBDDDDDBB@GFGFFFICIHHHIFIHBHGIH9IE5HHHIIHIHGF5HFDHIIFHEDEGHHFFHFHIIEFIEDHHH=IHG@DF>HDFIHHHDDI)HHHGHDF=F=HCDHHHHH2,GDFFGE6*F.+>FGFE;*EF=EGECF5@E<B>EGFA6GBFGCGE?EGCEE/GGG=?EAE:EGC(E.?FGECF(A8?G.EEEGCEGEHA)?EE8*EG1GE)E,FEC(GC-E*ECC:?:/F:CA'ECDEEC9
@antibody_146_multiplicity_9_copy_6-1
CTGAGGAGACGGTGACCAGTGTTCCCTGGCCCCAGTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGATGGTACTACTACAATATCGTGCACTTTATGCAGCTTGTCACATTAATACACGGCCGTGCCCTCAGCTCTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTTATGGATGAGACCC
+
AA5??BB9DDDDDEDD.FF8?CCIHIFFFCHF=HIICFI8EHHHH/HHGIHHAIGHHH=B+HG9GFIHHIHIHCH=DEHHDFFFFIA?HDEHIHHG=H6HHHHDIEFCH7IHFFCHDEH-GDHG*G4=E?HAHFEGGG7EG8BEEEBGG@GEEF;EC@FGEE0C8EA(CCEAEGF*?(G:?GFGEGAG:)GEEG(GC?GGF?:?0'CC(?E?7A4E?CEEEC::A:*GE#GA;*GA*:G/EECG*ECA::
@antibody_146_multiplicity_9_copy_7-1
AGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACGAGATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTCTCATCCATTAGTGGTGGTAGCACATACTACGCAGACTCCAGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTAAAATGAACAACCTGAGAGCTGAGGGCACGGCCGTGTATTAATGTGACAAGCTGC
+
???5?<B@--<@DB?DCFGAG8HFGIHHHIHEHIFF?EH@FHF-/FGDIDFHEIIHIGEHEIIHIC/-FHBHFGHGIDHIG>HH=HH7IHHEHH,HH8H?HIHCFHHEHF@EFH8GBGGBEEFBHFHFFGGEGFF6?BE,FEE?BEGE4EFEG:GGFFE@E:E2G?=GEE(;=CCEG?((GEEGG?EE(.GC<DE(FG(>C(EECG;A;;C0(*GGBEBAE:G(EC*C;*GF/?CE?G*E/CG0EG**AC
@antibody_146_multiplicity_9_copy_8-1
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTAGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACGAGATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGTCTTATCCATTAGTGGTGGTAGCACATACTACGCAGACTCCAGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAACCT
+
A???5BB?EEDDDDBDFGFGGCHH;CHIH>HHH>FHH=IH9FGHCHHHG-HFD-HFCGFHHIDBIHHHHHCHIHGBF-II5FCFG-HHH.FCIHFHA@FHHHFHDHHHHHF+@HFGH9DE?GF.EHHE*DBGGFE:EEGE=BED(GGG*A8?GFABE;GEE*DCFGE?CAGEEAGE?GCA:EE6:GEG(?CEAGG/GEC:G:GCEF.GED:G.G*?EE7EGE;?C:C?FGEE/A/E6:EGFGF'EG:?CC
@antibody_146_multiplicity_9_copy_9-1
AGACGGTGACCAGGGTTCCCTGGCCCCACTAGTCAAAGTAGTCGCGGGATCCGCATAGCAGATGGTACTACTACAATATCGTGCACTTTATGCAGCTTGTCACATTAATACACGCCCGTGCCCTCAGCTCTCAGGTTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCGGGAGATGGTGAATCTGCCCTTCCTGGAGTCTGCGTAGTATGTGCTACCACCACTAATGGATGAGACCCACTCCA
+
=????BBBDBB@DDBDE>8FFFFFHIHC-IHEHII-HHHC-IFIIHH9IHHHCIIHIFHIFHDIHCI>IHEIGHHFGGFFEIIGIH?I<IIGG@FIEF;@IFIG<HHHDDHFCH#AF<8G.H5F;FFEHFFG*FD;D;GEEF,FE,GG=GEAGFG*<CE-G1G(F@9(EGEGEEE'E?GG:E6.?G6E?EE?GE?CGCC>A*2GEEHAGH;1EC;GBC?E0'*GC?A?G'E<*G:EC:0A:AEGG'E??0
@antibody_147_multiplicity_1_copy_1-1
TAGGGGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGATTCACCGTCAGTATCAATGAGACGAGCTGGATCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGTGTCTCATCCATTAGTGGTGGTAGCACATACTACGCAGAATCCAGGAAGGGCAGATACACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAACCTGAGAGCTGAGGGCACGGCCGTGTATTACTGTGCCAAGCTG
+
?,???>BBD?DDDDDDFAFGFFEF-EHIF-FI-C?FFHICHFHA+GHHHDHIIHFI==HG?:FADFFHIFHHHGIHIHEGIIGHHIHHIFE=HHDH*HF)IBHHHHEGDH3AGGHDFG4F*EFFHGDHEG#EGG;EDE,F::GFFGG;C*EDE;GDH?CEGCGG61?EEB6FEGE:FCC.EGDG5C?6EFEE0EA<FEG?(G/CGEEE(*FC*:B:EFB<C,GEE:GAGEGGE'AEC0<C:/.??CE*<*
@antibody_148_multiplicity_2_copy_1-1
GACCAGGGTGCCACGGCCCCAGAGATCGAAGTAACAGTAGCATGAAATATATATAGTCGTTCCAGTTATACCCAATTGAGGCCTTGCACAGTAATACAAGGCGGTGTCCTCAGTTCTCAGACTGTTCATTTGCAGAGACAGGGAGTTTTTGCTGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAAAGTCTGCATAGTATGTGATACCACCATCCCAACTTATAAGAGAGACCCACACCAGACCCTTC
+
??,=AABBDD-@@BBDCCFFFFIIHHIFIFIH9.I8GHHCGHFH.HGDI*HCFFIIIIEHDFEFF=FHH-IAHEHHID+HDH+HI'HIIIH?DHGHIHEHHDHHGGFFHFD((DHHDDH=BEDE?G':FDGEFE**.EEGGFGGGEG>GFC*HEE:BEAGG*@CEACEGGEFECEEGEFG9)G6E?A#GEGEE2(?CC(<<E'GGE?G0(E?-CCFFGFEDE;:G>E:EEE*6EG/::(?:EEA/;:(8*
@antibody_148_multiplicity_2_copy_2-1
GGTCCCAGAGATCGAAGTACCAGTAGCATGCAATACATATAGTCGTTCCAGTTATACCCAATTGAGGCCTTGCACAGTAATACAAGGCGGTGTCCTCAGTTCTCAGACTGTTCATTTGCAGATACAGGGAGTTGTTGCTGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCATAGTATGTGATTCCACCATCCCAACTTATAAGAGAGACCCACTCCAAACCCTTCCCCGGAGCTTGACG
+
??A??BB>DD9DD--DGAGGFC;HHHCHBEHHHHFEFHFIGHF/GGHEHF5IH@HDIIH-8HHH@IIGHDE@HHCBAHGHAHHHHFIHDHHFEDIFBHIH+CIHHBH5IEH>HFHGHH>@GGFHHFE=DD(DE#(E=GE:ADC;G;GGGGGEFEEEGGG@=GEFGE7GEE3F#CGGEEEEEE8;8FG8EECGE(E?EF?.CCGCGF?CC((*E:@G#:,E(CCCE4G8'0??D8GA(6GC8(E'8)G8:(
@antibody_149_multiplicity_4_copy_1-1
CCCGGGGCCTCGGTGAAGGTTTCCTGCAAGGCTTCTGGATACACCTTCACTAGCTATGCTATGAATTGGGTGCGACAGGCCCCTGGTCAAGGTCTTGAGTGGATGGGATGGATCAACACCAACACTAGGAACCCAACGTTTAACCAGGGCTTCACAGGACGCTTTGTCTTCTCCTTGGACACCTCTGTCAGCACGTCATATCTGCAGATCTGCAACCTAAAGGCTGAGGACACTGCCGTGTATAACTGTG
+
??,??B+BBBD-DDDD7GGGFFCHAH>FEFIIEI>AG?IIGHI=DHIEHH?FIEI:H8F.GDIH5IIH-HEG??HFIFHH)H+I8*1I;HIHHHEHH=EHHHDHHHDHDHEDHECHEDGFHF*FEDD;EFH?C@.*+CFC?(EGDGFF1B;GG<CAEFEGCC6EE;EEECGFCEEFA?CCEE?EGFG?C;>GECC8E0G6CFGG?EEEG*0CEC(C9GGE.0CED'G8.E?EC<CGG/EG8F<':?AC:?
@antibody_149_multiplicity_4_copy_2-1
GCTGGTGCAATCTGGGTCTGAGTTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCTTCTGGATACACCTTCACTAGCTATGCTATGAATTGGGTGCGATAGGCCCCTGGGCAAGGTCTTGAGTGGATGGGATGGATCAACACCAACACTAGGAACCCAACGTTTGACCAGGGCTTCACAGGACGCTTTGTCTTCTCCTTGGACACCTCTGTCAGCACGTCATATCTGCAGATCTGCAGCCTA
+
<<,?,-B?DDDDDDDBFEFGFFHCIHFHEBHGFHHFH=HHIHFHFI9IDGHHIDHHICFCF8HHHCIHEG>?IGIEGIBHFHFFIDCIFH;HHHFGHE,AH@DHH<*7+BHFHCHHF*HHGHFDFHGEDGF2HGGFGGFG)EEGFBG6BEGGEE=GEGCGGGGGFFCEE)EEE)E?AACEGAEAGF?CFE:EE2??GEGCFE)?EEEGG(EG@48:GDEE:G:G*E6(>1A*EC?A.)?***GA80E2EA
@antibody_149_multiplicity_4_copy_3-1
GACGGTGACCATTGTCCCTTGGCCCCAGATATCAAAAGCATCCCGGGGATCGTATAGCATACACCATTAGTACAATAACCTGTACACGTCAGAACTCGAGTCTCGCACAGTAATACACGGCAGTGTCCTCAGCCTTTAGGCTGCAGATCTGCAGATATGACGTGCTGACAGAGGCGTCCAAGGAGAAGACAAAGCGTCCTGTGAAGCCCTGGTCAAACGTTGGGTTCCTAGTGTTGGTGTTGATCCATCC
+
???=??BADDD<BDDDGFGGGFAIHFEHIIHHHIIHBHIIHH-IHGHHIHFH9GHHIIFHHIFHIC/(IIIFHICFFI*FGFBHIHEHHHHHHI+F=8FI+EDHDFCHFCIHG@FFHHCGEG;HF=DGBGFCHG)AE?GGEGF'):EGGFE@EF9,GEG16EC6CCCGE>E(/;*4CE/?;FEECEF?6EC?(GCC:G:G)GG6(G?ACAEE0:BE'/G0E>CE/G6?EA8F:/(:*:ECEA:GEECEG?
@antibody_149_multiplicity_4_copy_4-1
CCCTTGGCCCCAGATATCAAAAGCATCCCGGGGATCGTATAGCATACACCATTAGTACAATAACCTGTACCCGTCAGAACTCGAGTCTCGCACAGTAATACACGGCTGAGTCCTCAGCCTTTAGGCTGCAGATCTGCAGATATGACGTCCTGACAGAGGTGTCCAAGGAGAAGACAAAGCGTCCTGTGAAGCCCTGGTCCAACGTTGGGTTCCTAGTGTTGGTGTTGATCCATCCCATCCACTCAAGACC
+
?5???B?BBDDB-BBB6FFEGGIFHH6HFH@HIHFEGHHHEH+EIFHIIAAH+A/GH>C?IFIHICIDHH(+;+EIFIIE-+I-C)HI?H6I8IHI<F@HI@H.A@#G-HH7HH=+HHIHF0HF#EF7GFHGGGGI(GE,FD;E:CEG(EGEFG1F>EG*?GG(EFGEEEF<GGGG8CG:(GFEEGAGC8GEGFEECE:#0G:GF(HGCH3CFG8AEE;0F8GE(C?A6CA?CE?:E;:6:AE*<(C.CG
@antibody_150_multiplicity_1_copy_1-1
CGGTGACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTCTTCCTAGGTGCGACAGTACTGTCGTTCCAGTTATACGAGCTCATCGATCAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGGGACTCGACTCTTGATGGAGGGGTTGTAGTTGGTGCTCCCACTGTCATAGATATACCCAATCCACTTCAGTCCCTCCCCGGGG
+
5,5??BBB+DDDDDBDG;CF,GHHF;BHIHD7HFH-+GI,IFHHIIEH#H=+FHFHHHEHEHHIHH*HIIIHDFH>FIHFFIFIHIHFGIAHGIHEGH;FHIDHFHHHHH,3FFH=DGFGFGE+F9E.GEEEEG?GE/E;GEACG=E6GGGCE=C?BFB::GEEEG?'GE:E6CG(EC6CCGF(6/>EGEE(C<EG(GGGC.EEEEE0GFE?F;BGBEC:;0;EAGECECA0E(E9CA?C:(#*:<)E*C
@antibody_151_multiplicity_1_copy_1-1
AGGCGTATTGCAATCGTCACCGTAGTACATGTCGTCACGTCGCACAGTGATACAAGGCCGTGTCCTCGGCTCTCAGACTGTTCATTTGCAGATACAGGGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCATAACCTGTGCTACCAGCATTCCAATTAATACCAGAGACCCACTCCAGCCCCTTCCCTGGAGCTTGGCGGACCCAGCTCATGCATAATCATCAAAGGTG
+
AA?AA??BDD-D<DDDFCGFFGHFH8HHEIHEIECIHGHG-H.>DI,H5IIHIFIHFH@HHHIGIAFFHIHHGHHHHHEHHDFHHEA?IEIHIHIHIF+HEH=HGHGBGHHB+DHHFHHF=GH'FHGFDG*FE=DIHG;EF,FFCEEGB?CEGAED?6GEGG2B0EA-AEE#E=FGE.FG?-A:AGEEGE2GC<1EFCE*#:*ECFC0G9.6>CBE?(<:DC.)E:ECE;CECE;*AF8=)?C>G(*8*?
@antibody_152_multiplicity_1_copy_1-1
TCGAACCAGTTGTGATCAGAGGGCAAGTCTAGATAGTCACCGTAGTCGATCGTTCTTGAATTCGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGATCCATGTAGGCTGTGCTTATGGAGGTGTTCCTGGTCATGGTGACTCTGCCCTGGAACTTCTGTGCATAGCCTGTGTTACCACTGTTAGGGTTCATCCATCCAATCCACTCAAGCCCTTGTCCGGTGGCCTGTCGCAACCAGT
+
????,BBBEBB-DDD?GF6GGEIEHEGAI+9HIHCIHHFHIHHHFIHEFHBB++FHDII@IIHHHIHIHHFHFI-HIH-BFDFGDHBGH*HHIFDGFHFIHHFIHGHHDHHHH?=CHDGGDDCCGFG*B9HGHEGGGEE<?>G=CHEBA1GED:G,EE/GE*EEECCCGGE.GC?ACEEFGE?6F/:CE??<AGGGA?:<*GA*:ECE?*A.EE;AGCGCG0E:/E/C'?G*661CGE26EE;?;EG16E
@antibody_153_multiplicity_1_copy_1-1
TCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTGACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGACTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCTCCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACC
+
<AA??59@D@DDBDBDECGBCGHFIHHFE,FGIFIHFIIF=HAF@FAFH5HH.=@IHHDIHHEHI=EE+CH=IHGIAHFHHIGH-HHHFIGBGHIFHCHHFDID+FDB?HHHGFGG4DDFCGGGFF6EGG@5*?D+FE@G?;FGECEFEF;GEGEGCE?1CE=DEEEA6F.CGF6E*E8E;AEE6*EEFGE0?GEGC*:EG?#E.066E?GGEAEGC4C7(0?<*G:C(C1GG1C(;E6*.*(GAEE(G8
@antibody_154_multiplicity_3_copy_1-1
GCGCTCCCCAGTTCACGTGCTAGACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCATCACGGAGTCTGGGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACACCAGCCCCTTCCCTGGAGGCTGGCGGACCCAGCTCATATAGTTGCTACTGACGCTGAACCCAGAGGCTGCACAGGAGA
+
?<???>7BD-DB-@DBCFFFFGHIHEFH;/IIDHHIHHIFHHHHIDIAHDH5@FIIHEHHFGHHIAGHHEIE5HI-IHCF+IGAEG(IHHH7IFHIG7FBFFFFIEFH6HD:GHDH@DHHHF#GHFGDG8E3EHEEA(BCFEEB@F;EG(CGECECG?FFC;GG6A?CAEF(*6??GEEGE(E(A6C?C/(F?GEC4GGCCEECEGFE?C?GC'GG0::EB:?E.#4:G(F;C?G:6EGC.8?E8:C?CF
@antibody_154_multiplicity_3_copy_2-1
ACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAATTGGATCTCGCGCTCCCCAGTTCACGTGCTAGACAGTAATACACGGCCGTGTCCTCGGCTCTGAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCATCACAGAGTCTGGGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCTACACCAGCCCCTTCACTGGAGGCTGGCGGACCC
+
?????B=?DDABBEEDFGGCCG+FICICHE;GIHIDFIG-FHFHHFFI@FCFACH8FHE9HFGH=DHGBBGHHIEFDHFF:HHDHGFDIHFHIHF=.:HDD/H5I+GCHHGHGE.EHEGH+HF+GH=GHG'AGGDGGGGEGECBGDFEGACG<GGGF(FEFFGEE:>?G8GFE.(EEF/=GC*6=G.GGGEEEE:(EC?EE/C?:CHE6HG0A*@E(AE#:>EGGGGC?::(?E:E00<?/:CC?G8?;'
@antibody_154_multiplicity_3_copy_3-1
GAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGGATCCCGCGCTCCCCAGTTCACGTGCTAGACAGTAATACACGGCCGTGTCCTCGACTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCATCACAGAGTCTGGGTAGTATGTGCTACCACAGCTATAAATAACTCAGTCCCACTCCAGCCCCTTCCCTGGAGGCTGGC
+
?,??,?A5-D@DDDDDEAFGGCIHFH/>+EIHF@IFFFGFIH+G.IDF+HDI+8GFHHGHHF??F-GHFI=CF>HFIIHIH)IH8F5HIHFHIGHEHE*H@=-GDHICHHCDH1HHF,FEFH;EEHGHDGGEGGH2EGC3FEEEEE@)EGE*FEE(E?GGGE?GC;GG8<GGFC<AFEA:<F;G=FGGGGEGCGFG*EE:GE*E(?(FF?'(0:GA(G:(EGG8EE*ECE(AA*/A?0:6C::EC91C0A
@antibody_155_multiplicity_1_copy_1-1
GGGGTCGAACCAGTTGGATCACGCGCTGCCCAGTTCACGTGCTAGACAGTAATACACGGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGATGAATCGGCACTTCACAGAGTCTGCGTAGTATGTGCTACCAACGCTATAAATAACTGAGACCCACTCCACCCCCTTCCCTGGAGGCTGGCGGACCCAGCTCATGTACTTACTACTGACGGTG
+
5????B?BDD<DBBE+FFGFFGFH8.I-HF/HIHFIHHHHHICIBCIHHHEFFHHFHHFD?G'I>FIH*HAHGFFHHBFDHHHAEFHI5IBCGC5HHIDHHF,5HFHDGBFEH*FCE3=F1DGFFG6#FDFCGFDEH,FEA2G;6EDEEEGEGE0B@<CGEG;=EEECE?GGCG(E<C#FGG?GEB0GECF0?GAGC(:.?6GE((8;C6(A0@8EE?C@G7C0/G'EG6E1?EGAE*E8:EEA/G0G8E
@antibody_156_multiplicity_4_copy_1-1
GGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCCGGGTCCGCCAGCCTCCAGGGAAGGGGCTGGAGTGGGGCTCATTATTTATAGCGGTGGTACCACATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGAAAATACCGAGAACACGCTGTATCTTCAAATTAACAGCC
+
??A<?BB?DDDBDDDB@GFGGG5HCFHI+IGHIFIEHFHAIFGGHIHIIFHICHFF?8F@1HHI-H>HIHIIIFFHFAHEHFCH?HADHGFHCCHDHHIHFHHDD+IGBGHHH4F,HGDF;GDDHHFFGFE.EHDF(B;?G*GG8EGG;9CBGEEFE:C<FFA*FEFFGGGGGGE)CCGEE;GAGC.?ECE?0GCGC*E?GC/G?EHE*H;E*/*GE0::EFEEE(D*-.A*CD'G:GE?EG*G*0GE:/
@antibody_156_multiplicity_4_copy_2-1
GTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCCGGGTCCGCCAGCCTCCAGGGAAGGGGCTGGAGTGGGGCTCATTATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCACAGACAATACCAAAAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACGCGGCCGTTTATTACTGTCAAGCACGGGAAC
+
A?A??BB?D5@-DBDDGGFFC>E6C>FIHHHHIHFFH7HEAIE.AIH>HEHIFHIHIEFFI.IIHBEBDIFFHHFIHCIEGGCIFCHEHIHH,HFHHHHIHDEDHH4FH*HFFHEH=H9GHH=HEFF;CE8GFE+E;5(,:GEFFGEGFEEEEEEG>GGEC(@#EAEEEEFEA:?'(GGFCA?GGFE:EEE.EG.*?EEF:CAEEEEECAAGEEEEB>G/GE:AE?C'(:E:E0G:G?(;F?8C*'<C:;
@antibody_156_multiplicity_4_copy_3-1
TTCCCTGGCCCCAGGGGTCGAACCAGTTGGATCTCGCGCTCCCCAGTTCACGTGCTAGACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGTATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATGTGCTACCACCGATATAAATAATGAGCCCCACTCCAGCCCCCTCCCTGGAGGCTGGCGGACCCGGCTCATGTAGTTG
+
?????BB=?B?DE5DDF>FE8FHCIIHHAIFG@HIIHH@HAEFAF@HHDCIEHHFHFAFHIHI>EH5IHCHHFIHH-FFDHEHFIIIDAEHAIHEDGF=IGHHIHFHHH,HEEFH@FGEFH?GHH(CDEEDG*HGFDEA;E;EGE@*(GEEGECGEC3GFE(EEGC2AGCECE*?2??6:FF/?.#FC/E6EEF*E-:GGEA?0CE<EGCGE8*(<*FF7>GFGEGAE*;EEE.G0E0GEEG?G(?0*1(
@antibody_156_multiplicity_4_copy_4-1
GAGACGGTGACCAGGGTTCCCTGGCCCCAGGGGTCGAACCAGTTGGATCTCGCGCTCCCCAGTTCACGTGCTCGACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGTATTGTCTCTGGAGATGGTGAAGCGGCCCTTCACAGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAATGAGCCCCACTCCAGCCCCTACCCTGGAGGCTGGCGGAC
+
???<ABBB?-D5BBD@GG+FGFHBIH.CH>CEIHGID9FF=IGGCIH@HHHH.GI+IIDH,FHIICHCE=HF-IICIHFHB<EDHDDH@G-AII=H3I.F+HH.HGDF.H*DHEFDFGHG?HH*GHHGHH4GFGH?D@FEGFFEG8GEGF=#E():GGGGG(GDGFE:G?EGG?CGC;C<GE;AE>EE:CC*D:E?G0EGA4E?C*:G?E.8:@EGE.CGE(G*:CA6E(.*0GAEGEC:=ECE**CE60
@antibody_157_multiplicity_1_copy_1-1
GCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAACCTCTGGGTTCACCGTCAGTAACAACTACATTAGCTGGGTCCGCCAGCCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGAAGGGCCGATTCACGATCTCCAGAGATAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGA
+
?<?A?BBBDEDBDDDDGDFGGEDCI>FCFIHHAHHI@AG7ADGHHFHHH-FHEHHCHDFAC/IFHFEHHHHHIDFHHIDF(HIEEHH-.ICEI#HHFHDIG-HFD:IH4BD5HDF=,H@8HEEGEHCGGFGEFEGGEFGFG*FGC8GC(,EGEGEGGGEEAB(GGGFCEE'CEF6GG(:G/EEEC:?<GGG<:G/(EGA8?AEG/FE#FHGGEEC*FF?FE:)G61GG(:/>EE8FC'F:GE8A:EC*C'
@antibody_158_multiplicity_2_copy_1-1
TGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGGTTTACCAGCTACTGGATTGGCTGGGTGCGCCAGATGCCCGGGTAAGGCCTGGAGTGGATGGGGATCATCAATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAACACCGCCTACCTGCAGTGGAGCAG
+
?A?AAB>BDD@DDD?BGG+FFFHHFCC'AFHIFIIFHIHHHIFBIFFHFFEHIHEDIFE8HHIAHHFFHAID-DFIHIH#EIHCH?GHHHHFGHH@HIHD=GG?HH(FHHF+HCCFEG=HEHEHGHH@GFEH+H8GG6=FGEFEGGG:E*/GGEFEBFG;?@:A=@/-C?F>GAFE6EGEFGEEA<AEG:G:C(EE?EGFGC(GGFCGC?E6:7GEC:?AC8E(:8EEGC?F*?EG4/GECCGFEFA0*G
@antibody_158_multiplicity_2_copy_2-1
AGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATTGGCTGGGTGCGCCAGATGCCCGGGTAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCTAGGTCACCATCTCAGCCGTCAAGTCCATCAACACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCCGACACCGCCAT
+
??<?,B=-DDDDBBADFFGFGCC+HHFI>HHH+IB7HF9;CHHFIHIEFHHDHHDFHHCH5ID5IF@FHCHIH>DHI;IFHHHFFIHIH(HHIHHHCHDHIHHHHHEH+D@HHH7=HH-BHGGHEEGF@HE?F=GE3@B8EEG@@GDGGE9F*GEEC@2E8EFGGE@GGE#A(GE?FG;EAA?A?GGE6#8?EG/?EC:A(:E((;?F6E?CHEG:CFGEF,(?'0ECD(GE6EE:#(*/C?EC*EFC?E
@antibody_159_multiplicity_2_copy_1-1
GATCGAAGTACCAGTAGAAGCTTGAGACTAGTTATAATAACCAGTCAAAATATCGTAGTAAGCGCTAAGCTTTATCTTTTGCACAGTAATACAAGGCGGTGTCCTCAGATCTCAGACTGTTCATTTGCAGATACAGGGAGTTTTTTCTGTTGTCTCTGGAGATGGTGAATCAGCCCTTCACAGAGTCTGCCTAGTATGTGCTACCACCATCCCAGCTAATAAGAGAGACCCACTCCAGACCCTGCCCCGG
+
?A???<BBDBDDD@DD8GEGFGIICHHHH@F.=IHHI>IHFIFHI/E-+HIEGHDHF)EI?H+CGHHFHHI5GEIFF@FFHFHCCIIHI@H/HHEDEIH.HG?=HIG?6IFHF@+G9HD+(H8HFE-HDFHH;43I*F28FEG)G#FGGGGGG*FDDGAGC?FECGECEEE*:E/GEFGCEG?CG'G:F4#6CFEGE::(GF*(?8(GGH:EEE(CEGE@(ECAC::(CA*?:0?C???;:EG(:(AGG6
@antibody_159_multiplicity_2_copy_2-1
GACCAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGAAGCTTGAGACTAGTTATAATAACCAGTCAAAATATCGTAATAAGCGCTAAGCTTTATCTTTTGCACAGTAATACAAGGCGGTGTCCTCAGTTCTCAGACTGTTCATTTGCAGATACAGGGAGTTTTTGCTGTTGTCTCTGGAGATGGTGAATCGGCTCTTCACAGAGTCTGCATAGTATGTGCTACCACCATCCCAACGAATACGAGAG
+
?<,,??BBDDDDDD+BCF?-GFI@FB+IEI/II9-DFHHABEHHAH>F-DFHICIEFI?HHAHHDHIHDGHFHEBIHEDIGHHFIGHDEHIIIGH=.GHEIFHHHHHF=HEGFHHEEGFGEEFDHCEHG3?GEGE:GHFGGGEBGEE?.:GEEEFCF6@E=E:FAEG*EEGCCCE?G?EGCAC'G/AE;E(C.86CF(CACCFGGC8EFEE:*(:G0ECA;CGAE*GC*?GEFECE0E<#A(6C*AC6/*
@antibody_160_multiplicity_1_copy_1-1
CAGATCTTTTCAAGCTTTTTGCACAGTAATACAAGGCCATGTCCTCAGCTCTCAGACTGTTCATTTGCAGATACAGGGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCCGCATAGCCTATGCTACCACTATTCCGACTAATACCTGAGACCCACTCCAGGCCCTTCCCTGGAGCTTGCCGTACCCAGTGCATGGCATAATCATCAAAGGTGTATCCAGAGGCTGCACAGGA
+
??A??BB3BD-D-BD-CFF@G.IHHI.>IIDHCAIH/HHGGH=G.HGC-IEII5HHIHHHFIFH-FA<5HHGFHIGDFHEEIAD-HIIFHHHH=EHGFHHCB,HHI1.FHEHHFHHCHGFEEDHFFE'+(FB?FGIFG*HFEFDGE06CGFF:'EFEGFFG?G-GG*EF/CCE/FCFGE*E:FF:=CG6.E*?C6:::EG?*?G6.8GGEGCHE;0(E'7GC:2GA?6E*1(0CG?E*:CE80E(AG)6G
@antibody_161_multiplicity_2_copy_1-1
CGGAGTCACGTGTGATATGCATCATTAATACACGGCTGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGTTTTTGGAAACATCTCTTGAGATGGTGAATCTGCCTTTCACAGACGCGGCGTATTCTGTTGTCCCACCATAAGATTTGATTCTAATGAAACCTACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCCCAAAGGATAATCACCAAAGGTGAATCCAGAAGCTGTA
+
<????B?BD<D@DD@DFGGAG>EI;FF6CIIFHHHI9IHHI;IGH?DAIDEHEGHFI+F>IEFFHIDIHIHHIGAHHFHGH-EIHIEG(HHI+(DHIGHHFEGEHHHF+HHHH@GD?HG?GD*GDDECG?+;EFEB=EF?,EGGFE'GBFHGG(E?B(E/<E?F0FG@/EE83CGGGGE*EEGEEEGGEC*FG?C*(CA0(G?6:;#(9E/G<-C#EA#7F,GE?AGAG8EG.G*?6*AAEC;*EG*>:*
@antibody_161_multiplicity_2_copy_2-1
AGTGACCAGGGTGCCACGGCCCCAGAGATCGAATTACCAGAATTGACCGCGCTAGTGACCGGAGTCACGTGTGATATGCATCATTAATACACGGCAGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGTTTTTGGAATCATCTCTTGAGATGGTGAATATGCCTTTCACAGACGCGGCGTATACTGTTGTCCCACCATAAGATTTGCTTCTAATGAAACCTACCCACTCCACCCCCTTCC
+
?5??5?BB@9DDBD<BGFFGC8FHIIFHIHHIIFEIHIEHIAFA0GGII7H?@9HI-=HIHEHHH-G@IHIHIDIIHFIHFHHHHGGHHCHFGHI-HGCFC,23DHIIDHHGFF@@HGHFHGHD?HDGDE<EF@FG4EGCEEGGG6*GGGAEE6GGG9EAEFG;GC((#GCCAA?:CCG:A;FGAEFAF?EC(CEGGE(GCA?GEE(.(H>?8*@EE/GACEGC*CC(/CGEG:AEGAE#A*:E0E:GG:
@antibody_162_multiplicity_2_copy_1-1
ATATCAGACGCAGCTCGAGGGTATAAGCATAACTCCCCCAAACGTAATCATAATACAGCTGTCGGCTTAATCGCACAGTAATACACGCCGGTGTCCACTGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTTGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTGCCTGGGTCCTGCCGGA
+
??5??@/B<<DDB,+DFFFCCF>IBB>IH>HIHIEFCFIEFHHHHHEDCHFF?GDEHEDBFII.HDFIHFDI=IHIHI5IHGFH-H.HIEIFEIF-=H'H@DGDC,6HH@HGHAEHHEEGGDHH@EHD=HHD@EEEEFCDG:GEC@:-EEFBGF?*1=C?<?ECE.G.F2CE?AGEE.E:ECEE0FE;GGE66*EG4AGGE?AGE?A:C*C.CGEEE:GE0AG?C?0EF*C>A#0/:C?EEGG2GCGCFF
@antibody_162_multiplicity_2_copy_2-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGACCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTACTATAGTGGGAGCACCTTCAACAACCCGTCCATCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAGCTCTGTGACCG
+
,9???BB>BBBDDD@DFFGG6GHHIHIHCACEEHHIF=IHFDGDIH2H,IG7HAHHHHEIHGAI-HHFHHI>IFFI5FF5DIA67IHHHIHCGH?GHHHEHHFHCHFDBHFFHFFHFBFH@D@F5D7F@HHGGDDG8G?CEEGA6A+EEFEEGG@'.CE@AE*'GCG(66BFF.GGA(CGE(CEGFEG*:8AG:AEE?FGC/D9:C*ECCA6EGFAE?<EEC*AEC/?GG9;)EC::EGF/:(E0G0E6A
@antibody_163_multiplicity_1_copy_1-1
CCCAGTAGTCAAAGTATATTCTTAACTGCATAACCATAGCTGTATCCATATCAGGATATCCAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAAATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACCGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGTCATGTAGAT
+
=?????BB?DDDDDDD.CGCG8IEIAIIHIEIGIH.EGHGEHIHHHEHH@HHCHI.HH-HHEHIDDIHHHIIFHHIFIFA5CHEIHFHGFC(HHIIIIFHHEG+7=HF.DG=FFFD1HHF69FGGFFGE(D6DG:EG#GHBE4GGE*G@GEC,G,GEFEGFGG*F2EE2CECGE6F:9EC60G:/G.EEFC>EC??EGGE:E/*:;HCCCGEEEGEEG?0EGA?:FEGEEEG6EGA*EGC:G0GC)E/(*
@antibody_164_multiplicity_1_copy_1-1
TGCAGCTGGTGGAGACTGGAGGAGCCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGGAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTAGAGCGGTGGTATCACATACTACGCAGACTCCGTTAAGGGCAGACTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAACGAACAGCCT
+
?=5A?B?BADDDDBDDFGBFFFCHIFHHHIHH@HHHGHGHHDAFG.IH-/AHFECAHHIFHFHH-DHFII-HBCIHDIGDIHHFI#HHHFIGHHDH+HEIHEGHGGGHF*IEHHGGH?DFFDHE+A@-HE*FGFED***E.*GGGEDEEE:0G8EGCE'A6(GGEE?EEA*EAGA69FFFAGG:)=6CG8E(:E'G/;CEEC:G>E*C=H:EF*GG?*:::G?CE?:EEEA4:E/C:8*E*::G?1EE:(
@antibody_165_multiplicity_4_copy_1-1
TAGTGAAAGTATATTCTTAACTGCATAACCATAGCTGTATCCATATCAGGATATCCAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCAGGGCGTCTGCGTAGTATGTGCGACCACCGCTATAAACAAGTGAGACCCACTCCAGCCCCTTCCCTGGAGTCTGGCGGACCCTGCTCATGTAGTTGCTA
+
?<????B=DD--B@DD-FFFGFFIEHHIBHGHHEIIHH9E.@EFE9IEFEHEICDCHIAIFHF-HFIEI-H)AHFFIEHEHHHGHIHHHHHCFID?FCFEDHEFHHHG+GHG;F1HEHE;FHEHGF1:GEE*EGE.EAFEGE6GG=GBG;EE*GEGBEG.(C1C8EEEG2:EEAEEECGCEAGE*CCC(CE(GEC(1GEG*GEE::?EE98:E7GEE?,EGEEE60E?.C<4?#GE26?GAE.*G*ECAF
@antibody_165_multiplicity_4_copy_2-1
GATCCAGCCTGGGGGGTCCCTGAGACTCTCCAGTGCAGCCTCTGGGTTCACCGTCAGTAGCGACTACATGAGCCGGTTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCCCAGTTATTTATAGCGGTGGTCGCACATACTACGCAGACGCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAACGAACAGCCTGAGAGCCGAGGAGACGGCCGGGTATTAC
+
=?A,?BBBBDD<DDDD@FEFFCEH-IHHIIH-GH9HFH@HFIHEGHIH+D?HFFDFAHIIHGI.I+HDHIHAHGGE+FI-H+HAFIHHHHHE9GF*G=DD),FHGH9GE#GI*C>F?HHHEF1FHEEEFGFFG)DBGEG<ED=EECGG0GEEBEG;(DEE6:/G:E8*GG?BACGGFFEGE:?GG<*GEECGGEEGGG(GG?:6F**CGF??#E:G'<EEG,CEE8EE*FCG*E/GG8?E(F)(C:GCDC
@antibody_165_multiplicity_4_copy_3-1
GAGGAGGCTTGATCCAACCTGGGGGGTCCCTGAGACTGTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCGACTACATGAGCCGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTAATAGCGGTGGTCGCACATACTACGCAGACGCCGCGAAGGGCCGATTCTCCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACATCCTGAGAGCCCAGGACACGGC
+
??A?9BB9B9DDBD<D+CGGC/CFCHFFEEH7HHHIH-II@GHGFH>F-I.DIDH.H+F+D85IHHHDHH)HIHCEGEHG?HH)IF/HFGHHHHHDEDGIHGHHCH8H6HBCFHCEEDHGGFEDDHFFB(F+E;GFGGD*FEA.EEEGGCEEGGG@GAG:AD=GE*EE(GEFDGGG?8G(EAEC??F;EECG(EEEE:/F.ECEC:EFA?FGE@@(E/<8EE.F?GA.*CG09;EEC:C#E:G?E:A:?F
@antibody_165_multiplicity_4_copy_4-1
AGCCTCTGGGTTCACCGTCAGTAGCGACTACATGAGCCGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTCGCTCATACTACGCAGACGCCGTGAAGGGACGATTCACCATCTCCAGAGCCAATTCCAAGAACACGCTGAATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGGATATCCTGAGGTGGATACAGCTATGGTTAAGCA
+
??5??BBB@DDDDBDBFEAF-GHHIHIIHFCA?EIHCHFFFICEEIHH>HF@HIHGFHFCIHE8H8IIH@F.5HFFF)-GHFHFFFIIID+IHF,HFHH?(HC3FGFHGFCEHHHC=F.5G2+FE1-GHFHHE;*GFEE@GGEGFB#GG,GE8G,EG6CGFBG9EG#8CEC?CG*'<+F*0EE<EEGCG:CEE>E'8E6E?EGEEGEGGCG.*CBE79,(BCEGE<#'*/C?E?*:=F/;:*A?CG)E..
@antibody_166_multiplicity_1_copy_1-1
GCCCCAGATATCAAAACCATTCGATTGCGCTGGCGCTATAGTAACTCCCCGAACCATAGTAATTTTAAAAACGTTTGTGCTACAGTAATACACGGCTGTGTCCTCGGTTTTCAGAATGTTCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGACATGGAGAATCTGCCTTTCACGGGTGCAGCGTAGTCTGTTGTCCCACCATCAGTTTTGCTTTTAATCCGGCCAACCCACTCCAGGCCCTTC
+
?9???BBBBD@DDD-DFFDCGCIIHFHIHIIF+>AGIHFFHHHFIHIF7CHIFFI?HHIDGHHHIHIHED8HHIAHH5IHEHHH*GHH5H-HGH5EEI9HDCEH+FGHGGEH9HF;EEHF/H*FF4HG2HED<GA=BGGGB4FE*@EEEEGECG;G'*G/(?C:(EC@C86F?G.?*EFE(E?CECAEE6EEC(FCE/E*?GFEEGHFCEAC:EGG1??EC(;G**?E60GC)E.EC)C(E(C(ECGG'6
@antibody_167_multiplicity_1_copy_1-1
CTGGTGCAATCTGGGTCTGAGTTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCTTCTGGATACACCTTCACTAGCTATGCTATGAATTGGGTGTGACAGGCGCCTGGACAAGGCCTCGAGTCGTTGGGATGGATCAACACCAACACTGGGAGCCCAACGTATGCCCAGCGCTTCACAGGACGGTTTGTCTTCTCCTTGGACACCTCTGTCAGCATGACATATATGCAGATCAGTAGCATAA
+
?????BBBDD<DBDDBGFFGEC-FIIH88HHHF+FHHIAGHE=/8+FIHHIH)IDIIII-HHHIHIHFHHHHIIH-II+FHIDHIHHIFHII@HIHFG=ABHH?HDBH<C#H@DF8HH(;FH7FF#EHEE+FEGG3GGF*:FGCG@EF=EGFCGAGGFFC:G(EEGEEGAEG(A;GEEEF+ECCAF=?A(EEGE.?EFF<*<8/EC.6*FG/:@EE*GGCGE*E?6)GGG8*.?6EG:GG.G*?:E*?C*
@antibody_168_multiplicity_1_copy_1-1
TGGATACACCTTCACTAGCTATGCTAAGAATTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACACCAACACTGGGAAACGAACGTATGCCCAGGACTTCACAGGACGGTTTGTCTTCTCCTTGGAAACCTCTGTCAGCATGGCATATCTGCAGATCAGCAGCCTAAAGACTGAGGACACTGCCGTGTATTACTGTGCGGGTATGTAAAACGATCGCTATAGCAGCAGTTGG
+
<<A,?B?BDD5ADDD9,FC?GCFHIBHFFAEHFEHIIIHHHHHHHHHH-IHIA8GIDEFHFHCHIHHHHFEFII6HHICHHIHII?IDFFIHI-HHHEHGHHIHH*CFHF2HDHGDHGF@HEIHEFGBGCGE6F+IF@EEFE?G7G?GEF.E/.BEEGFE?EGC6GAG<FCG8EG?EG:GF?CGAE?#E(CGEC?EAECE?GCCC:FG:HGG:@FE(*EE/,EEC(?GEGCGE*A8;66C10C?A?*CCE
@antibody_169_multiplicity_1_copy_1-1
TGGTGCAATCTCGGTCTGAGTTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCTTCTGGATACACCTTCACTAGCTATGCTAGGAATTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAAAACCAACACTGGGAACCCAACGAATGCCCAGGGCTTCACAGGACGGTTTGTCTTCTCCTTGGACACCTCTGTCAGTATGGCATATCTGCAGATCAGCAGCCTAAA
+
?=?=?-BBDDDDDDDDFFFGCG@HHIHHHEEHHIHCIHIFEH.DFIA)FHHHEI,HHHEFIHIFGGHF*FHE5HGGHHG0DCHH-HFHFH<DCIHHFCIFHHHHGCACHHD<HHHHF+GHGG=HGGF/HEEFB>DGDEH@6ADG;*GF0EEG?GEGE8GEEE6GEEE#GE<*GE((EGFF?AEE00CE?A9GG?GCGCCF*EGG:GHGEEEG*-C8:GGC:,C.A<D8F)(GEFE(EEG:?C:CEFEGEE
@antibody_170_multiplicity_1_copy_1-1
ACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTGCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCCTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATGGATGTACCCAATCCACTCCAGGCCCTTACCTGGTGGCTGACGGATCCAGCTCCAGGAGTAACCACCACTGCTGATTGAGACACCAGAGACAGCACAGGTGAGGGA
+
???<?B?BD@DEBDDDCGFFFFEIHIIIIFEFIIHHIHIHIGHEIEH?EDHHIIGFIFFHIHAHGHFFFFIDHHHHHDI-GHHEH@HFH<DGHFDCIHHEIGGH*-FHEEHHHF4FGHHCH,GFEHGEEEFEG@?GBFFEHECG/EBF@8G;<EGEEEGGGFEGGEG2?EE?*'46CCGEEGGFCEAG;AG:*?*GGG*:?FCAFEE2*AGE:EBE>GEE:CF;GG:GF;*/*CCG8/(:CG(GCACG:.
@antibody_171_multiplicity_2_copy_1-1
ACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGCTAGATGTTCCCAATCCACTCCAGGCCCTTCCCTGGTGTCTGCCGGATCGAGCTCCAGGA
+
?5???>-BDDDDDB-?FGGFFDIFHHFIIHADIHHHIHFH@IHIFH7IF-E-ECFIIHHHGIIFHG-G-FDAFI5HGAHIBIIG?EG**CHH:HHHCH@DEFFHDGGHH@HH6GDCHHCHHIE'G@GH,G>E@F8E,F:FGGEGCG4=EC*ECDE*E8GEG8(;F6EGGGEEE*EGGE0CG8G=E??6C?GCDGE:#?(G.EAEEGECCFGCHFEC*-EEBC(G?E1?(86/EEG?CCG*:EC:C:GE?C
@antibody_171_multiplicity_2_copy_2-1
GCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGAACTGACTACTGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGCTAGATGTACCCAATCCACTCCAGGCCCTTCCTTGGTGGCTGCCGGCTCCAGCTCCAGGAGTAACCACCACTGCT
+
A?A??B>BDDBDD-5DGGGFGFHIEIFIHHFHFF9B9E=IDFH/FHFEGEHGIFF7CHIHEFEHHFHHHHGI?AIGIFHFHFIGHCH-IHHAI?HGGF@=DHIEHHHH@GIH#HDH*HHHEG*DHGGD?HEEEEGCAEGE8G>9GEGGCGFGEF*CDGFEF9G?EFEG?E:CCCE6GEG:AEGG:(?EG(;E6;GFGAE;GEE:/;A(G?:6H8-/:AF,B,EE<A?;GGEEE;(FD?G?E*EE:EGC0E
@antibody_172_multiplicity_5_copy_1-1
GGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTGCTCCTGGAGCTGGATCCGGCAGGCACCAGGGAAGGGCTTGGAGTGGATTGGGGACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCACTTCTCCCTGAAGATGAGCTCTGTGACCGCTGCGGACACGGCCCTG
+
?<??9@=BDBDBDD<DFGFFFGIHI8I-IIHH=CGCHHHDIEHGBH@HFHEHH?EHBAH?5?HBEAFHHIIHDH-FDBCHIGFHHHAHIHIIIH5=HFHGFH8HF>#HECEDHHHDE#5CG#=FGBGEFFH*E,FG?FEEGGGEEEGGEG;CGCGEEE-;?*=F1GEAE.GCGEGC:GCGFE6EG.;CFAE(CGFEE?G:CEE?<EHC?6=*FCEEE(,@?E?EE0:?C0EGG::0G.E0:(:*A)E**G
@antibody_172_multiplicity_5_copy_2-1
ACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCTTGGGAGATCGGACGAGCTTCTGTACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAAGCCACTCCAGGCCCTTCCCTGGTGC
+
?AA??B?BB+@<DDDD?FFEFCEFFIHIAHG,HGEGAH9FHEG@'E0=IHFFIHHDFFCH-HHHIH+=E7GHFIIFCIF?HHGHF?HHHIFHHIAHHBHID@HH:HHEGEFB?HHG+FEFFG6,FCFDED@GEGCFE=G+ECAFAGABEFGGDGG(;EAEGEACCEGGGGGA::(C6?FEGEE@EDAE.E?(6ECE8CCG<C>CE?HGEEAD:GGEB:CCGEE.?)EEA0CEEG::66*FGA?0?:(GC?
@antibody_172_multiplicity_5_copy_3-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCTTGGGAGATCGGACGAGCTTCTGTACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTCAGGGACGGGTTGTCGTGGGTGCTCCCAGTACGATAGATGTACCCAATCCACTCCAGGCCATTCCCTGGTG
+
=????BB<<D@D?DDBFAGG'CHEICGHHIIHFGHHCDHF?ICDIHHDIGCIHH>GIHDFG>CHGHFHIAI5=BEIIIDHEFHICIG8FHHIHHHEG7IGDIHE=HE.HGHIHGH=FECH6GGHFDBHE@EF>H'DGCDEGAEGGEHAG?,GGFGE**EE@G6EG6GFE4=BCF:<9:E'CEGC?FGAGAG/;#E00?GEC/GGG6-(AE*G7(:CF0GECEEEE=GGEFC/GC(FE.G.E'(((8CE??
@antibody_172_multiplicity_5_copy_4-1
CGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTGCTCCTGGAGCTGGATCCGGCAGGCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGCGGGAGCACCTACTTCAACCCGTCCCTCAAAAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTTAAGCTGAGCTCGGTGACCGCTGCG
+
?A?,??=B<DD-BDBBGFGAGFHEFIFEHIH0IH?EHE9IIHIDHDHFHFGHH-I@IEFF>)GIGH@DIC@HH-IFEHHIIAHHCHHCICH5C=IHH5IHD4E5=EFFH4FHD,FFGDGGFCGGDGE*GDF(EG2E=EG*ECGGCC@(EGF/-CGD*:EGE'GGGGC)CA*GEGGG;(#GGEGG(EA*GGGAGE;EEEFG(GGEEEEGEEGE<EE?CGC@E?EE(':EE*CEGC?E2(EGEAC(4.>E*G
@antibody_172_multiplicity_5_copy_5-1
AGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTGCTCCTGGAGCTGGATTCGGCAGGCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTC
+
???,5BBBDD-DDDDDFGGFGF/EFCIFIIHFEGGFI.HIHHF@HIHDHHHFIHHDIHHHHE-HHF@HGIHIHI-CIHFHC@5;IHFHH+G-FHH-IIHFHFEFFFGE+#HC=)E'HGHEGDE+GB3G@G>H@EEFGGGGGG;,GE.F;GGG7CGGE'FGGGG*C4E?*E;GCC*;G6G((GG0:G*GGFEEEAFGCC:EGCE?GEEEECFF@EGED(CAE,.?AG:G;CC:((EGE:D?E?20./GE/:
@antibody_173_multiplicity_3_copy_1-1
AAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTACTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGCTGACGGATCCAGCTCCAGGAGTCAC
+
?55A?BBBBDBD=-DBGGGG8GFEIFEFHHFHHGFIIEHEIHIIHFEHDAFEIHHHAHAHEGEIIHHIIA@HI#HHFIDH+HIIFGHHFIFHFHHEEDA>FDHDDEHHC4CCH>@@GHHHHAFBH8F@DFDGH2H@EGGFG*GE=HGGGEGGGCGEEEGG28E)>E?E?*?01/FA/E5(+GGG?FCG:?EAC1AEEE?GEE(GEE6G:?G?:E0EBE?EG((?0A)E*?EG*EEFAGEE8C*C:8*EGA
@antibody_173_multiplicity_3_copy_2-1
AGCTGCAGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTGACTCCTGGAGCGGGATCCGTCAGCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATAGCAGTAGACAGGTCCAAGAACCATTTCTCCCTGAAGCT
+
???,ABB<DDBDDBBBGFF.-G.HIIFFGIHIHDIHIHIH@9DIFH9EDHEDFEI@CDGHB'HICGHC.FHBFI+HG=0HHFIBHHEI.HHDH>=IHHCH+HHFHHDEHD#HHHHEH@BHHG)GH;GEGH9GGHCFGEHFGGEEGBGEEGEEFE;EEG/DG<?F7EBG(AEG?#?:?(GFG<8EEA???CE2EGGGC6EEC?AF?EHEEF?E*CBFGE,80F?FE8E:?<GGE8E(GECCC#:CCE???A
@antibody_173_multiplicity_3_copy_3-1
AGACAGCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCAAAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTGAGGGACGGGTTGTTGTAGGTGCTCCCACTATGATAAATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGCTGACGGATCCATCTCCAG
+
?????+B??<DD9DB-CGGFCGFHIFEICHGHIH9HHIHIICHIHI-.HIFIHHGF8HFEEH)CF5HAIF,HHHHFGHFCHH@BHHHHFIIHHII-5HCIIDHHHGIEEFFHCH=HDGFGFFE@FECFHEFHFDEEGEG;GC88GAG@GEGEGDFEGG)FCEF*G;EFF@GEE'FE?EG:6FF.6CEGCEEG:AG*EAG?EEG=EEHG?E6CAGEEB8EGG:E*EC0:G(EEEC'?0G?CAC(#CEC(G0
@antibody_174_multiplicity_1_copy_1-1
CAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGAACCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCAGCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTTCCTCAAGAGTCGAGTCACCATAGCAGTAGACAGGTCGAAGAACCAGTTCTCCCAGAAGCTGAGCTCTGTGA
+
?????BB-D<<DB@<DGFF>FGHIHIHHCIHHHGIE+FEGGFFHHFDEIIFHHIGCHAH'AFHHIHIII5EFFH=I*FDICHHHH.+FDIFFE-I8HHIHHC3EHBEHFGHHBEFHEF+GEEHGEHG3GFGFGG'FHCEEG;?/EFGGAGEE;EAEE(F?EEGE?G0??EF6EG;9E'*GGEE(*GEEG?GEFF(GE2:GE#.?G?EE?EE68/7<(GGG*EAGCAG4E*0:*:E)E8E(G81*????6:
@antibody_175_multiplicity_4_copy_1-1
TCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGACTCCATCAGCAGTGGTGGTTCTTCCTGGAGCTGGATCCGACAGCCACCAGGGAAGGGCATGGAGTGGATTGGGTACATCTATCATAGTGGGTGCACCTACTACAATCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTC
+
????97?BDDDDDEABAEEFFAH+FFIHFIHID:HFCI+IFHFIGHDHHGIAHGA-H=HC-F>DGIHHHHHAII@GFF5CI+FHHHHFHEHHHHHAFFHDHEFH?GFGHFHHF,DHFHD@;HHHEGHH+G6H+EG?H<FGFEE/EG*(FC=G8(EEFEEFCEFC(EE(FAGAFEC6AC:*GCGGCED.9GGEEEGE(EEEGC(EGCF:GH?E@:EEG-G,*EED:E/;8E*//-E*CC;ACE0G(FEGGC
@antibody_175_multiplicity_4_copy_2-1
AAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTGAGGGATGGATTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGTGTCTGTCGGATCCCGCTCCAGGAAGAAC
+
??5?ABB3DBD-@DDDFGGCFC.EHFIIAH5HCAI=HGA=HHAIFIHHHGICHIGFEDEFIFI5GIB8FECIIEIECG+HII,HHH8=HFHHHHHDFIFHCGH7HHF+5FH3EHH=EHC@DGH*DFDGFFEG==G'G@*GFGGGGF,;EBCG*?GCG0*CGE6GEGGC;G<GG6GEGGGA680:CGE;(EEG.GEFFE6#EAGCEE1?C#EE1GGEFAGG)CE0:?G**.*ECG:*C?A)?6EC*C2G(*
@antibody_175_multiplicity_4_copy_3-1
AGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACTCTTGAGGGACGAATTGTAGTAGGTGCTCCCACTAGGATAGATGTACCCAATCCACTCCAGGCCCG
+
?<=9?BB-BDDBADDDG/GF+FIIEFIHIHIFHDHI.IIFIHH@GFHDFFHFHGC7I8HHHH5FIHEIGCFFHIHEFAHHHDAFHFFHFCF7IGFHIHHFI=HH:FIFGFC,HEEFHHB;HFBH(FGHDFEBFCHGFG=?EDA:GFFEEGEEEGBED(EFEGG:8GGGG0(;E@C;G(ECG:GAG1GA6>/E1.G?(G0GG6*CCCECC?GCEEGCGEG(G,E.1EA6CC*CE4G:EEE6(EEC=C.88*
@antibody_175_multiplicity_4_copy_4-1
CCCTCACCTGCGCTGTCTCTGGTGACTCCATCAGCAGTGGTGGTTCTTCCTGGAGCTGGATCCGACAGCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGAGGGAGCACCTACTACAATCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGCAAGGTCCAAGAACCAGTTCTCCCTGAATCTGAGCTCTGTGACCGCTGCGGACACGGGCGTGTATTACTCATGTGCAATATAGTA
+
<??A<?BBBDDD?B<DECGGCEIIIIH6>IGE0HECIH>CD+IFEIHHDHGG+EFICHIEHFHH5HHIGIAHI-5C+HHDHEHHH6GHIG.GIH@IFIIHH7HH=HI=FHF)*:GF@+D1FEFEHGEEFDBEEGBEE=FHG(HG8EEBEGD2=GE:EGEA8GGEE#(6:E06F//GEE1>EEAECGG.FCAG94CG1CG?0*CG8EEG:F/E>CBF?;G.E;(GAAEEGE(*GCG*.CG??*/ECCC(GA
@antibody_176_multiplicity_2_copy_1-1
AGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTTGTTACTCCTGGAGCCGGATCCGGCAGCTACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGCGAGCACCTAGTACAACCCGTCCCTCAAGAGTCGAGTCACCATATGAGTAGACAGGTCCAAGAACCATTTCTCCCCAAAGCTGAGCTCTGTGAC
+
???,9BBBDDDBDDBDCGGCA0HHE;>FHHIE9CECH9HFHEH9HIIIHH8HHHEIHFEH-BH?EIEI-ICH@IHHHHHEDH-IHFHEH*IICHIGHDFH=HEDF;17HHF(GFH2HGEGFCFGHECEGF,G;E3EE:FBG*BEE:EDGG*C=E6)'CEFGEE6GEECG@EFAG=G/G<GG?:GG?(GECEE'/GGFC?EG(?0GE(*C:G:C09?C:87EEGEGEEE:(:*(E6(:6.EA*(*:6?EAE
@antibody_176_multiplicity_2_copy_2-1
CCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGTTTCCGCAGCGGTCACAGAGCTTAGCTTCAGGGAGAAATGGTTCTTGGACCTGTCTACTGATATGGTTAATCGACTCTTGAGGAACGGGTTGTACTAGCTGCTCCCACTATGATAGATGTACCCCATCCACTCCAGGCCCTTCCCTGGAGGC
+
??=<?BBBD-DDBDDDGFFGGGFIF/HHHF+G9DHHCF=IFHHHAIG.GIIFHECDEHHH+HD5IHH@-IIFFGIHFGHIFHECIHGCDC*DIDFII;3+I-FFGEHIHFH@+BEHHH4H*5BHDFHDFHDF*FHF)GEGCEHCED?C=BC?DE=F.8(F6CB:(@G*4AGCFGFA>GFC?(EEEGAE(CA6FE?G(.G0CFE4E?CG?9AE:*;GGEC(.G0GCCEDEEE*?;9*EE()(?E:C(*AEC
@antibody_177_multiplicity_1_copy_1-1
AAGAGACGATGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGCTGCTATACTATATTGCACATGAGTAATACACGGCCGGGTCCGCAGCGGTCACAGTGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTATTGATATGGTGACTCGACTCTTGAGGGACGGGTTGTCGTAGGTGCGCCCACTATGATAGATGTACCCAATCCATTCCAGGCCC
+
??,??BABDBD=D-DDCGFFFF>CFHHH6IIHHIECHH?GIHHEHGHHDE=HHBH,HEGH@FGHCHIIE-E@HIF>FCIHGIA>=IAHDHHFI3ABH:+,@EBHAHHFHH,DGCEH?FFE>4G==HDH#DH<F8GGFGCEEDFHE*FFE=6FAGGEG8CGEAG6CGG.E>EGE;G8?EGGG(E/GAEEEGE(8C6E?.EG?:GGCG/EC(E?)/CGC(E,G7..E:E(?AGEEFE/EGG/#AA(E((0)E
@antibody_178_multiplicity_29_copy_1-1
ATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGTGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATCATAGATGTACCCAATCCACTCCCGGCCCTTCCCTGGTGGATGC
+
<<??<BBBDDDDD?DDFGFFG>H-@IEBHIHIIFFA@AHIIEFHFIDIHHDHIIHIH=?FIHBIIG--HHIGHD?ADF-5=EIIAHIIH-EHHFHHIHHGBHIIH9;4F@?GF(FGGFFFFH@@@GG3EEFF.FFGFFH3G8FB8?GGFEB;;ECC@;EFF(@GEGE<EEA@G(EG<EFGG(.)ECCFEGCAGF.EEFF*A*A6-G*?CH:?H@B?GG/CEEGE?(8GE(*1*A?1?ACG:G6.8EC.AE
@antibody_178_multiplicity_29_copy_2-1
GCTGCAGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGACATCCACCAGGGAGGGGCCTGGAGTGGATTGGGTACATCTATCCTAGTGGGAGCACCTACTACAACCCGTGCCCGAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCACCCTGAAGCTT
+
?5A??9BBDDBDD@DDGF>GGFIHIFHHIHGIIFFHGEFIHHHDHDHGIIEHE@E.GIHGHIFGEHIHIEHHI?IHFHBEHF/HHFI=FFH+FIGHHFEHHHCHI=EEHFHEHH=F+#GEEBEG?HEGDFD(EEFEFGGEEEGD4GG:GEEBFG*GGEF6/#8EEG*:FGE6ACEC?CE:G3EE*ECG#/**/:EE'FGEECG'GAC:F(AE7G7:CE8CE:EGC;CC*A:E'/EGC8.::C(AC0E*G(
@antibody_178_multiplicity_29_copy_3-1
AGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGTCGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACGCCAGGCCCTT
+
9???<B>BDBBDBDDDGGFGGCHHIAIIEH@GHHIHH@FFFHHHFC@F+HEH+HGIIEHC5IHHGGC-HGFI>AHGFIIFH?AHIHHI)E98CHHHBHHHE.HFCFHGEHHHH9GHH6GHEHHFEFBFDHEFH;*<FGGGFFGEGEBEEGCGF?E:FFG,E:FEAFFGEDG?6FGG6+EF(GEF./GGGFGCGEG:?E6(*(>:E*6G0EE8E:#E?GC7EAEE*CGA6*C;.ECGGEF*A?:*E:E*6:
@antibody_178_multiplicity_29_copy_4-1
CTTGGCCCCAGACAGCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTCGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGATCC
+
???=ABBB@<D=DD5BFFG?CFAHHIHF?IGIHIIGEI9GIHHHIHIHIHHCCHHHHF-I@FHHEHIHG5IFHH;G@I-@HHEHH+GDFG=HIH<CD8HHAH@HCDCEDDFHHHGFH.GAFHGEFGFGHEE++FGBGGE8=,G6GEEFFAG;-EEECAC?EGAFE*GC(EE;EEAE,G4F9'G;EEGGG:8D*C8EE4'EEEG?)0H0)HG:HFCC??C8EEEE/G:E*::FG./G:'*:G(CGF.A0C'
@antibody_178_multiplicity_29_copy_5-1
TCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTCTCATAGTGCGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCACCATATCAGTAGGCATGTCCAAGAACCAGTTCTCCCTAAAGCTGAGCTCTGTGAACGCTGCGGACCCGGCCGGGTATTACTCAT
+
????=BB?DBEDBDB-;/FGFGH>F/CIIE/HCIFFHDHGHHDI.HI@HFIIFF-IFDHCHIIHHD)DGHH5CI-DF-FIGEIIHIH>CHFHFDF5GFEI-IIDH+GC4HAGB5FH+D(CHEHAFED'GFHGFG:DGFE)EFEGG1FGCF/<G*DEEFEA?E:GCA6AGFBECG?;(G*CE6EE:'*EEEGG.1FCCGGCE6G(/::60?EEC8:E9?BG(AG*CEE(CAA.E?0EE?#FECC:FF**0A
@antibody_178_multiplicity_29_copy_6-1
CCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGCTACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCAAAGTGGGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCACCATATCAGTAGACAGGTCCAGGAACCACTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTCTTGTGCAATATAGTAT
+
?????BBBBDBDB@B?GFFFCGFH+IEHHIHBHDH-IEIFIE=CFFF?+HHDHIIHHBFEIIFHABH5FGFDHGFCHHEIGI-DH(*FCFHCF>HGEDHHHIHGFEHD+(.FH;HF;HHDAGFFG@+*EFG;FFFIHD?'DBE?ECGE6FGCCBG/EG6GEG*0EF/E*AECE(E(CCEE0AGCEEE8EE*5E2<-GAEGE.??2#?DAH(C:G(GEE07::?GAE':(D8EEC*GCA?(<ACE?CE(0F
@antibody_178_multiplicity_29_copy_7-1
CATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAAGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGTTAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGCGGATGTCGGATCCAGCTCCAGGAGT
+
?????B?=DD?DDAEDFFAGDGHEHHEIFHIIFHE,HHCFDF/HH.HIFIHHHBIFI>EFHCFIIHIG=AIEFI5IIHIEHHIGIHIHIC8HFFHDIGH9HHF5GG+FEIH#HHFFFEDEFEHHGF6GHGGFEBFIGGE*F@*DGEGEG6GCEG;<AAG?6GGE(EEFAGG(;GC6C?E:CCEG;F*E((G6GEFG<?EE?AEC:*EE?;GFE@E(/EE0E??C*.??AG(E;E:CE'6*:*G)AC*C8E
@antibody_178_multiplicity_29_copy_8-1
TTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCGGTGTCCGCAGCGGTCACAGAGCTCAGCTTCGGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACCGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTGCAGGCCCTTCCCTGGTGGATGCCGGATCCA
+
?????BBBDD<DDDDDFFCGFGIHHFFHEFE,IIHFHGIGIIFHI5HFHIA>H+IFFDIHHCHH-EIHHH,HHFFGGII5I*CH+-(FEI)IBHHDIGHHDHDHDHEHGDHFDH*D#*GDHGD=DHEBE=GFH:E@FGGB*FFAFFEFF;GFG@G46;CEC?2BCEE*CEAC:'EGE:ECAE-6GG?G/ECCGEG;6A?EGEG*EE#AGEG6/G@GGEG#?AC:(:C6EGECCEE:?EE86C???G<:C:
@antibody_178_multiplicity_29_copy_9-1
AGTAATACACGGCAGTGTCCGCAGCGGTCACAGAGCTCAGCATCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGATCCAGCTCCAGGAGTAACCACCACTGCTGATGGAGCCACCAGAGACAGCGCATGTGAGGGACAGGGTCTATGAAGC
+
<????B?BBDD9A-BDABFFFCIHFH.-FFIHIHFHFHGHH/IH79GCDHHH5HFFDGFHIEAHIGDECH,HHIGHIIIAHHII>FEFIHIHI<HIHHDHFDGA.IHIHH=HF,FGFHHEFH9F*GEFEFEGGG+GGHGGGHEE*GGEGGG?GGFGE0E(FGGEGGCEG@CG?G?AG?GE;EG-EE(8EE:AC0G:.?G*E?GG8;:)E*EFFCG?*GEEBF*GG(1*?*1(A0GEA1E(:?F*#EA)E.
@antibody_178_multiplicity_29_copy_10-1
CCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGGATTACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAAATGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGGCTCTTCGGGGACCGGTTGTAGTAGGTGCTCCCACGATGATAGATGTACCCAATCCACTACAGGCCCTTCCCTGGTGGATGCCGTAT
+
??,??BBBDDDDBDDDFGDGGF/EHB->IHGH7GFG+HIIHIIIDHHHHHFDGFG>HGCFIH*-+EG+*FIH>HGFG-I#IEDFHHGEFHHEEHFEIHEI@DGD*IHF+GFHHHDFFHHHEFBG8FH*EBHFEEGEEEHEGEDG@FBGC6FFEGCFEBFGEEC(19EEEE(EGC?:*EGCFE6>EEGGGEFCA0CC?((GE*CDDEEE<E((@7;GE:GE(E)?ECG*CG(.(AEC/?0A/4AC?E?/*:
@antibody_178_multiplicity_29_copy_11-1
AAGAGACGGTGACGATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCGCCCACTATGATAGATGTACCCAATCCACTCCAGGACCT
+
??????BBDBB@B5DBGFFF8G;HHHHCHHH;IFHFHGFFHHHIHHDF0H/?F@HIH-CFGHHF-5HHGI.AGH==CFHDIHFDHIDHIGIHBGHCHGH+FICHHE(HHG#G>EHHE+EDFEHGHFGE/GEEFFE@GEHEGG11CGGFGCGEFG*ECGGEE@G=GADFFC?ECBFF>FC:+AEF.E?CE8G8CGC?6G)G:?EEE?@G(F0..FG:C8E,BE:GCE6EC:EGD0C:CG:CEAEE9C*EGE
@antibody_178_multiplicity_29_copy_12-1
CTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGACCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGAGCC
+
?????BB=DBBDDDDDGG6F/GH6IFH6HE+IHHFDHEF5HHH=9EHIDIHEHCFGG.H,FHIIAF5HHFHC=EECH=BHIH5H#GAHGHHHEHHGHH?F@HHD9HFH'GFIFFGFHHHEFFBHHHDGFE@GBGHDFEHF(DFEGCGG-G=E=EC:AEGG*8EAGEEE)EC*(*EGCAED+G(>?CCE*CD0E0CEF.:GEEGFE?E*E?EF9E*C(C/,GE:CFE*CF:?CG:;DE(E;::/CG8.#E:
@antibody_178_multiplicity_29_copy_13-1
TGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCTGTCCCTGAAGAGTCGAGCCACCTTATCAGTAGACAGGTCCAAGAACCAGTTATCCCTGTAGCTGAGCTCTGT
+
???<=BB<D<DBBD?DFFCFGGCFEBH?HIIHEFHG=HHHHC+IIAHFGI.GGDIHFHI5GIHHCF3EIH'HH+HHBEIH;*>HDIFHHEHI@FHFHHHHDHFIH,GHEFFFFG*HGEE<G+:HEG=2FGGGE;G3>BGEGEGB*G*ECEG(EGGGFGG:GFG;GFA'G=EFEC(FA+AEE/FG'EFEEEG<AGC6EF6D(E;E/?ACAF6GHGGGCEEG;A9E:EGGC(?CEE6G'E???C:<C0:(FG
@antibody_178_multiplicity_29_copy_14-1
ACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAGCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGAACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCCCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCGCT
+
??AA?B/BDDDBDD@@GCFFFCIHI86IHIHFIHFH=G.,IHFF8HG0HIHE>HH5HHIEHHHHDI5FF>FCHHHHD-IIIHD(D#8+HIEHHIDHIE8EFFH<=3HE9HEIDG#FF4FE)HHFG@DGEE4GGF(IGGCGFFGG>GDGGG8GG1EEAGBG:EF(*FGGE?E;GC,0?EG7C(*//EEC?(:ECGEEED?:GGCEAEHE(EGAFGDGC:>G:C?ECG<*AE?:EF(*?GE?DEF?C?:/EE
@antibody_178_multiplicity_29_copy_15-1
TGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCCGAAGAGTCGAGCCACCATATCATTAGGCAGGTCCAAGAACCGGTTCTCCCTGAAGCTGAGCTCTGT
+
???5??BB9DD?BDDBFFFFFGIHEFHEIIGGHIHBEEAFIHGDH+HIH>G-IEH@HAFGIHIHHFHIHIEGHHHAHD>FFHFDIIFH=HI.HHHEBFEHEHDHEH47<CFFHHHGH.?HH=HEHFF;HHHCE8@G(BG6EDEA;AGGC0G7?FE<A6C?*?EECGCC(?EEE*GGAFEEGEF(6;:CBEFCG<(6(AE*E(E</A*C/F*G:GGC/8GCFE(EG)G'A?*.AE?C*C*8:01C*1*6?(
@antibody_178_multiplicity_29_copy_16-1
GCTCAGGACTGGTGAAGCCTTCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGA
+
???A?BBB-@BD<DD@?GCGGFCHHFHHHHFC>HAGIHFIIHHIAD5DADD?HFHDHEIEIEGIIHFICHHIEHIFHIHIAI-HFH'CIIHHDIH6HAIHHHH@DHH+GEHHDIFGGFHGFEEGEAGHEFG@EEEF+HFFBFCEEG8ABGGFABDEE6EGG?.4FEFGCCCF(F;EEAGG?GEE*G:E*FCG(EGF(EEC0G66EAH*FEG*CCEEBG4CEE>E:;C:*)E6GG?C?2E/GC8?*'(AG1
@antibody_178_multiplicity_29_copy_17-1
GACAATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGGTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGAACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAGTCCTCTCCCGGCCCTTCCCTGGTGG
+
??5,?@B>D<BDDB<?GAFFGCHF+HHHHH-GG?H?GIFGIHDIIEIIFGEFHIHHGFEC-FHGF-HIIIDIFGHEHHACEFH+EDHIH5-HFH7HHHHHFHHHFEC;;EEFHHF5;@HGCHEFFEED05HF(EEDGFEGGGDGFGGGGGE:FGGBA?ECBEGB*BFGG:GGG:EEGECG?G((FG?(*GCCEAFEECCEE?EEE::CFEA*CC*:;A;@?EFG*CCF(GAE:*=G:C<*8E1E6:*CE;
@antibody_178_multiplicity_29_copy_18-1
GAATAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACCATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCCCAGAGCTCAGCTTCAGGGAGAACTGGTACTTGGACCGGTCTACTGATATGGTGGCTCGACTCTGCAGGGACGGGCTGTAGTAGGTGCACCCACTATGATAGATGTACCCAATCCACACCAGGCCC
+
???5??+<@=DDBDB@FGGFEEIHHFIHFIHCHAECGEFHFEEH3HIHHH=IIIFFDEIHDHHHHII5DCHHGIFHHD?AID(H5F8EHIIIHHHBHHDHHIFDHHHF4HHH=GGB+HFHGEG=#EDF*FEGEH5EGGGGGEGG6E8:8FGG(EG(*AE.G/GC((GGGFEF:CE?GGEGCCFC(FC.#/:G:/:;0(**EEFG.C:G:EGE*E1/BE:@FC:(EC:EC?G8*E06*?/?***6E:?0(E
@antibody_178_multiplicity_29_copy_19-1
TTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCTCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCC
+
<?A??B>BDDDDD9<DGCGAGGEHFCIH-IICGHHHFIHIG/II?IH7CHCAFFHHHHFHHBIIIHHEFDEHEAHFAHGFEHGH9EGHIIFG*EFIH.BCEFIHHHHHEF4G+GE=HHHHGDDGFGFEGGF+;FFGCEEFGE?G8E2#BGGGA/EGG3?EGGEGC?FEG:?FFEFGGGG?GE9)FFGEG66EGGE?*C#GE:E?E=:E*.GGF1GEGG1G(?C(0:?:E?.:EEE?*G*/***G8)A1GE
@antibody_178_multiplicity_29_copy_20-1
GACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCGTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGCTGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGATCCAGCTCCGGGA
+
???=?/B<DBDB5B9DFFFFGGHHIH.F+IIHHHIHHHHDIFHIHHG>C5H.I=HIHHEHHCFEHCHFHFHGHAEEHHFIH-IHAHHIEIHI7IBH=IDHFHD.IGEHEHH;HHHHEFHGEDFEBGDDFF;HEE*DGD0@1GDGE>GGFEDGGGC(EEC:9E9EG;GGEG.EFDE:E?G?GA>E;EEG?(#CE6#CAG?GGAEEG6HCCFF>0*GAEE:(E8C:?CEE?(E:A?G:CEF*AD?EE?*A*:
@antibody_178_multiplicity_29_copy_21-1
CCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCAACCACCAGGGAAGGGCCTGGACTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCACCAGATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCTGTGTATTACTCATTTGCAAT
+
,????B<BD5DBEDDDGF/FFC+IIHFIHFHHHI@FIDEIEI@EF.HCFHH.IHIH=FHHHAGG@HH=H/I5I#FD-IFFH-GHHGDHIHHHI-+9HHCFH6GH6H*=HFGFF*-BFDHD7FH/FH?@GEFFE<DEHDFGG?CD?DEFEEHF,GGEFGGECE#GEBAEFGDE:FGC.E.F(.C,G=FE;E0E.0AFCEA:EGFGEE<E6AA:CG@C7*0AE;)GAAEG0(1GG'EAE)/GAC/'CC?ECC
@antibody_178_multiplicity_29_copy_22-1
ACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCCCCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACAGGGCCGTGTATTACTCATGTGCAATATAGTATAGCACTCGTCCGATCTCCCAGGACGCGCGCTGATGCTTTTGATG
+
A??<ABB5+D-DD5DDGG/>GFFCFC=I?CH?H8EGHDHH:HGHHIHGHHHF=IHF?HDDHIFE+HHHHAFIHHHCHDHEICH-=CGDHHGHHHIHFHF=HHIEFHG-H?EHEHHF=DGHH=FGHEDDHGEFEEHGHEGGF@EG=CECE/AE?G8;AEE@:HGECGCCEA:/EF*F'E*EEA*G8:'CEEFGEECGEG?.:E:F:<C:FEG?HG1/*7EFE?E:.-:E(EG8/.(??CE6/AC*?E8A(G
@antibody_178_multiplicity_29_copy_23-1
AGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGATCCAGCTCCAGGAGTAACCACCACTGCT
+
?<?,??BB@DDBDDABFGE;G/IHHIH?HHHEHAF+GEIH>HIHG@IHHEIHEHFHHII@FGFIHH#,IHHIHHHIHHHGIHADFH3-FIBHGHH7CH<6HH24EH,IFHFEEGGH=GHFGHD:F*AGGDGD+GEDFECHAGDFEGEEE?*A;CDFCEC9G9EG'GAECEEEDG?GGECEGDG*G8F6G6AE?GE?F'G6EDG.C.H?F?GEHEFEGEGEE7?***AG*?(EGGG?(GEE8EC*=:E:GE
@antibody_178_multiplicity_29_copy_24-1
TGAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGCAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTGCAGGCC
+
?????BB>9D5?EDBDGF??FFIIIHCICHIIHCFHHIIHHIIHH@GGHHHIIGHH-IGDHFI8HEIC5HIHHI>DIHHH@EF+H-HHIC-HH+H8EGEFCDII::C2HHGHAHHHIFHHGHFDH9E=FFFGGEG#FG-CGF8#EGGEEFE=EGEC1GEFE.ECE:C?/DEG/EGFEG?2EGA2GGEGE*E-6*CG;G(A>E?A?:/G.C*E:CG.:A,GCE'EFAC*;CAE2E*C(1A.ECG'*F*::0
@antibody_178_multiplicity_29_copy_25-1
GCTGCAGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCATAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTGACTCCTGGAGCTGGATCCGGCATCCACCAGGGAAGGGCCTGGAGTGGATTTGGTACATCTAGCATAGTGGCAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCAACATATCAGTAGACAGGCCCAAGAACCTGTTCTCCCTGAAGCTG
+
??A??BBBDDDB?DDB8AFFFE;/IIFFCFHI+HHHF.+7HIGHFIIF,G5GHAHH=I7FDH=DAHHFHHGCHIIIHIEIFFF>HIHHIII.H,EHH(@DHHGDHF=FEFDHHGHDFGHEFHE,HGGEGHGEFAG9FGEGAGF)CEBG*;?EHEEGCCB*A.EGA;GG(EG?<EAEGEC(GEEG?:EEEGFG*:FACE?C::FCF*(FECFC7@@CEG98G#.(8GAEDE0F(#:F*;CFG?:*EEC?EG
@antibody_178_multiplicity_29_copy_26-1
TGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCATACACCAGGGAAGGGCCTGGAGTGGATTGGGAACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTGAAGAGTCGAGCCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGAATTACTCATGTGCAATATA
+
?=???BBBD-DDDDDDFFFGGCHHICCFHHIEIEHH>G=HHHHAGIHIGDIFFF7FGDHDIGGIH8EHHFF*-IAHIIHFCFHHHHIE7HH,AIIH7CHHH-HHIHBHHHDH7(FHHF=H@GHDGG?G'GEFGH@GGEFE4GD?GG,GE>FEGFGEE2AEGE,GE@ECFAGG?<(?6+*E?G:2C2EG<GC8EEG:GEECGC?6E?CGACCE@EGFGEE/C2>1E;ACG*(FC<(:EA1*)EF??E1::(
@antibody_178_multiplicity_29_copy_27-1
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCTGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCC
+
???A?BABDD-DDDD@7GCCFFHBHHIIFFHIIII>FCIFHIICHHFHEHHHIFHFIHDFAHDIH--IDIFIHEADIHIA5HHIIHFIEHEGFHFIHFIHDDHHHH;FFIGFGEFGHHFCFHGGD.GHEFFGHEFECFGFFE:CGEGGDEGGBFEEFBE<G;GGEECG=AEGGF;E?6CEECEG(.EFC.#C?G?GCFFE*?EG*GE?(H(E@CEAE77,:7CE.GCEE:;EEGEEG6*G2.CCE0(:>6
@antibody_178_multiplicity_29_copy_28-1
ACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCAGCGCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTATTGGACCTGTCTACTGAAATGGTGGCTCGAGTCTTCAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTTCCT
+
,5A?ABBB6-DD?5D-CGFC+FIIHE6IIHIIIIFIHHHHHGFIG8IHHGIHIIHHBHH7GFIECE=HIHEHBHHHHFFGIEDHEIGGH,HBFHGHHHEHEHFFCH;HDFE?HGH-GFFDF(FHFHEDEGHGDD=E=BEEGGEEEEE(G5CE6GAEFFG1EGGG;'BC?GG(ECEGG;#GA?AC*E/FA(GGGEE.E(C'G?(?EE?EG?E:EGEEEGCGG?GG-CGGCAG?EGECC*6AAGE/FC#??A
@antibody_178_multiplicity_29_copy_29-1
GCGCGTCCTGGGAGATCGGACGAGTGCTATACTATATTGCACATGAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGGCTCGACTCTTCAGGGACGGGTTGTAGGAGGTGCTCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGGATGCCGGATCCAGCACCAGGAGTAACCACCACTGCTGAT
+
=?????BBDDBD<ADD/8FCGAHHHIIHHIHHGF6+HHIFICA0FHHFHEHGF=5.I*HFIF7EHAEDHCHHFHHHFFDCHIH6IH?IHHDHCEIHFB=,FHHHD?GHGHHAHFDHDEF'@HGE4FBFGDF+H:G@CEGG?FHG?@EEE:EGG18(ECEAF6CE?:GEEFCGCAEEE?0:CEGAE/C?C'E80'GC8EGFC?EGE;E;EEC(;CB(EG?,G':((*A6FA(9EC/CGEE??:AEEGE:E*
@antibody_179_multiplicity_1_copy_1-1
GTACCGACGTGCATAGCAGCTGGTACTACTACAATATCCGGCCAGTCATTTAAACGCACAGTAATACACGGCCGTGTCCGCGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGAGGGGTTGTAGTAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGGTGCTGGCGGATCCAGCTCCAGTAGCAAC
+
A??<??B?B@DDDD<BCFGFFEFFF8H>IIIHHHI-HHFIIBHH.HID?HHH>I>H/HHIHFHCIGDHDHHAHEHH-H+BHHIHH+CHHHHFE@HCHHHHFG*@HHHHGH+,GHHCHHHHGFBHFG?@G*,3F1BDG:?E1AEF=;G:*GGG?9FGGG(EG,FE8GG*5(E<?GGD1GE8EEGGFEEEEE?CF*GG(FG8GCC*C?EE/0EEEECC?40GGC?CD;CE*AGGG:(>ECGEEEA??*GE8*
@antibody_180_multiplicity_1_copy_1-1
CCAGTAGTCAAAGTAGGTACCGACGTGCATAGCAGCTGGTACTACTACAATATACGGCCATTCATTTAAACGCACAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACAGGTTCTTGGACGTGTCTACTGATATGGTAACTCGACTCTTTAGGGACAGGTTGTAGTAGGTGCTCCCACTGTAATAGATGTATCCAATCCACTCCAGGCCCGTCACTGGGTGCTGGCGGAT
+
?????A+BBDDDDBBDDFGG/BIFCHIIA>HIHCHIHHFIGIIID?DGHIBH@--FHIEH-IHHADFHHHH5HFIHH@E==FHDGHH?HIIHIHE(HHHHDEHHHGHDHHEHE+*HHGHFFH@EEEED*.GCDE4*#FBFEEEGFEGE*FGEE*GGEB?EC1GGEGGEE*?=EE8A0GF8EEF*EE':'<FCAE6GEGE8(GCECE)EDHG.CD70:7?:C/EGEGG;F?CG8'EECE?/A8:'FA.*EC
@antibody_181_multiplicity_1_copy_1-1
GGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGGTCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCTTGGAGTGGATGGGGAGGATTGATCCTAGGGACTCTTATACCAAGTACAGCCCGTCCTTCCAAGGCCACGTCACCATCTCCGCTGACAAGTCCATGACACTGCCTACCTGCTGTGGAGCAGCATGAAGGCGCGGACACCGCCATGTA
+
??<???BBDDDDDBBBFG?CEFIHBF>/FHCEGFHHHHGGII@FEGHHEHIHFHCG>EHG.HHG-F;HHG+HFAAHHIFIHDF+IHH6I8H+HEGHHHGF.G=FHD=C:F4HHFHG?DG9ED;BFF,;=FFA(FFFGGG'AGGGEEEEGCF?EGE8DEAE(GG)EEFC?ECEC2EGE-CEC6F#G81AECGF;FFE:C*E'C*CEE?:EFF*HC*GE:;CE:6G*(E<CEGC1#GEC:)6*F:)??'/E:
@antibody_182_multiplicity_4_copy_1-1
CAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGACCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATGCAGCTTTACCAGCTACTGCATCAGCTGGGTGTGCCAGATGCCCGGGAAAGGCTTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATACCAACTACAGCCCGTCCCTCCAAGGCCACGTCAACATCTCAGCTGATAAGTCCATCACCACTGCCTACCTGCAGTGGAGGAGCC
+
????A5>BBD<DDDBDGGGFGFIFFII+HICCH.HH=HGGFHI.DCII?HFI@FFGFFG=EHEHHHDHFHCHD(IGCIFEHICHEHEHIHHCG5ICHDIDHC+=CHHFH+HEHH3CFEHE=GFGGFGFGGGF'GG?FEEEE@FC8GEE8EGB8EGG*GEGEAEE9AGGFB?0EGDFG'?GC<:EF0EGG(EC?1)ECGA08E;FEECCEHA8*EGGF?EE?<0EC8:G*E*:??**.CCG?(*CC#??:.
@antibody_182_multiplicity_4_copy_2-1
GTGCAGTCTGGAGCAGAGGTGAAAAAGACCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGCATCAGCTGGGTGTGCCAGATGCCCGGGAAAGGCTTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATACCAACTACAGCCCGTCCCTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCACCACTGCCTACATGCAGTGGAGCAGCCTGAAGG
+
??,?=BBBBB@DBD?DG/EFGF8CCH.HII+HI/C-IHICI-9DHDIDDCHIHHAHFBECCEH-FI-DHIFHIGIGHHHIIGIGE-DHDHIFHHF@HGFEFHHDDHHHFFHFHHHCH=H+GGFEEHF.EHEGGCHIHFGE,GGGEG=CG.EEGGG?FEB0EFG?GF:GC*CEG<CAGEFGF0AEGAGFG/GCGEEFAGEFG*:F?E0??H6((EE(G?EGCE?>:**E#FAGGEE:?GCEFEFG;?G:FC
@antibody_182_multiplicity_4_copy_3-1
TGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTAATATTGACTCTGTACAGTTCCAGTTATACCCCTAGGCTCTATTACCGCGTCTCGCACAGTAATACATGGCGGTGTCCGAGCCTACAGCCTGCTCCACTGCAGGTAGGCAGCGGTGATCGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAGGGACGGGCTGTAGTTGGTATAAGAGTAACTAGGATCAATACTCCCCACCCACTCCAAGCC
+
?????+B9@DBDDDDBGFE8CDHIHHHHIHHFGI-HIHICFDBIIH.HCFHFHGB-IHHHGEAIECHDHGF5HHIHFIEHE=IIH?IHIHFFIHEDHIFFFHG0FFHHFHFHHEFFFE;E+FGH#*@GHF:DEFEI,HGEG@0GEEC*'EE*G:)G;?E6GGECCGCEG;GEC(C(EF*E:EE0EE,GGFGGEC:G:EC*GAE:A0;(G?E/H@;C(?<'/:FEE(E'E**AAEEGG(GG?C(6':E(E*
@antibody_182_multiplicity_4_copy_4-1
ACAGTTCCAGTTATACCCCTAGGCTCTATTACCGCATCTCGCACAGTAATACATGGCGGTGTCCGAGCCTTCAGGCTGCTCCACTGCAGGAAGGCAGTGGTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAGGGACGGGCTGTAGTTGGTATAAGAGTCACTAGAATCAATCCTCCCCATCCACTCCAAGCCTTTCCCGGGCATCTGGCACACCCAGCTGATGCAGTAGCTGGTAAAGCTGT
+
??<5??BB?@DD@DBDGFCG;FEBIFFHHCIGHIH0EF.FHHEHGH?EIE-IIE=HHF9EHIHCICE>GEGI0HHHEHIB5I?IADHHHH(EHHHFHHHF5+E?H#H4HFDHEEHFGEDDHDFFH8HGHE?HEE5CEGDBBF;F(G<ECEGAFEGFEFEE>FEG;E*FAD'E*9?-6DFDGEFE/E?E=G:EEE<F:?CEFC8GECHGGE;G;(CAEG/GE???(E.:(EGE.*EFCDEC:#?C((*CG1
@antibody_183_multiplicity_1_copy_1-1
CCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTAATATTGACTCTGTACCGTTCCAGTTATACCCCTAGGCTCTATTACCGCGTCTCGCACAGTAATACATGGCGGTGTCCGAGCCTTCAGGCTGCTCCACTGCAGGTAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGTAGGACGGGCTGTAGTTGGTATCAGAGTCACTAAGATCAATCCTCCCCATCCACTCCAAGCCTTT
+
<????<BBBDDDBBBBG-CFFGHIAHHHIHFIFII+IEHCIFICH?HG@HIHGHHHDFF5<H.FGIFF55HIFEA*FHGHFGEI4-HEFIFHHFI6DDFEFIDHDFHH;DCGHFFHF39I*FFGHEG?F=E)0GGC?EGCG:GEFCC@EE@EGG/G8G*GGEG*AECE6AGGEEE2GGCC?EG;AG/EF6AFE:G(G6EGCAGG(A*(:CAE.:GC7G(G/AEGECGAEA?6G=0GE:G(E<CGE??G?A
@antibody_184_multiplicity_1_copy_1-1
TAATAACCATAGCTGTATCCAATATAACCGAGCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCAGGAGATGGTGAATCTGCCCTTAACAGAGTTTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCCGTCCCTTCCCTGGAGCCTGGCGGACCCAGTGCATACCATAGCTACTGAAGTTGAATC
+
<AA,?BB5<@DDBDDDFGFG>GIHI;IF>FGFDFF:IHA9I9ICHHHIEFIF=IHIIHE59HFEIHFIFHICHIFCFABHH=5H+IHIHH5HGF=F0GFFIFHHBIHG9IDG4ED8DH7(F?H*FHEFEG*E;F(DFGGFG9CGEEGGC,GG?EGGECEG8ECA6CEF<EC(EFG0<GGEGEC4?@#GECGG#:40EFGG;;GGGF(:EHFEE:EGEEF:8E08G;?C*:??C<:C/?EF;C?(G0'?'E
@antibody_185_multiplicity_10_copy_1-1
GTGCAGCCTCTGGATTCACCTTCACTAGCTATGCTATGCACTGGGTCCGGCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAAACTCTGTCAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGGGGAGCCTGAGAGCTCAGGTCATGGCTGTGAATTACTGTGCGAAGCTCGGTTATATTGGATACAG
+
?????<?BDDDBDBBDCFGFCA/IHHIHCHFHEIIHIAIHHH+H)FIBIIHC=H,HCIFFFH8HHI=G=I5HH5EHFDHFCFHEIH>BHHHICHHHHHCHHDGDEHHH(H@CIHFHEG8H=GHEEF,#CBGHEA>GH*EHFF?FEGFGEFGEEGGGAGGE;EEFFEEFF.FCGG*?EF6*CGEGFEE(CCEE(*AFEGCA':GG/G.FE:G*:CG((E,C.E2/ECGACAGCEE:EC?C1EA:((8*(G.
@antibody_185_multiplicity_10_copy_2-1
AGGGTCCCTTGGCCCCAGTAGTCAAAGTAGGCGCCATTTAATACCCATAGCTGTATCCAATATAACCGAGCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGGAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACAGAGTTTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCAGTCCCTTACCAGGAGCCTG
+
5A=??7>?BDD@DD-AA>C>FGHFFHHAHH-HHE=IFFCHEIH#FHDGIFHFACIGIFHHCHFIIFHCHIHIHGI-DBG=H-HHDFEBHIHIH=HFHHHDHECEH@E.EHAHHHH==HDHH,HE>GGGEEH#F<DECFEFEGEDE?EE;GE#GEC(B8FGEFG;G*F6F?G:(?EEE+.EGEEF8(FE:E=E8(G(*E8FGGGG:EAFECCC80:A8(GAC8/E:*E>E#/EG/C6E((:CAGEE*0G*/
@antibody_185_multiplicity_10_copy_3-1
GAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTAGCTATGCTATGCACTGGGTCCGGCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAAACTCTGTGAAGGGCAGATTCAACATCTCCAGAGACAACTCCAAGAACACGCTGTAACCTCAAATGGGCAGCCTGAGAGCTGAGGAGATGGC
+
<????,@BDBD@BDDDGCFFCGEF-IBCHHHHFHEIHHFIIIA9HHIEHDH+IIFIHGCA)IHFE-CHHGHFEIGIFF>CHHDHHHHD@HF@HDGIDHHHCFDGCHEH=FHH@9EHHH(HGEHEFEDH=HGDCHGEF;;GF*EG:GEGGEFEGFGE6=EA6;ED8EGGE/F?6?*?:E6*6GE/EEFEG:GGCECE*?CEC2'EC*HEE*EGHA'A(E,GG,G?E:(EECC*EAE-CEE8EC-E'.*(G6
@antibody_185_multiplicity_10_copy_4-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGGCGCCATTTAATAACCATAGCAGTATCCAATATAACCGAGCCTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATTGTGAATCTGCCCCTCACAGAGTTTGCATAATATGTGCTACCCCCATTACTAATAAGAGTTGAAACATATTCGCGTCCCTTC
+
5A=??B7BD<BDDD?BFEF>FG6CCIHH;GHDFIHIGHHEIIAEEEHHHIH=IHE.HHHHDF,HDHHHF=I@I5FCFIIIIH'HGFHD@H-FI3ICHHH-HHCHHHHCGH9FF9AHFH:FF>HEBHFHFEHCB<H6GGCCEEG(EGGGG(EE;EGDCEBGGA?8E:?:(EEE(?EE;EE4E#EFCA4GGDGFG(G;:6C:FGGF:C?C(HEEH7@:EC/A(G0G(**::CC*C?GFG4:G)'CG0G0E?:
@antibody_185_multiplicity_10_copy_5-1
CTAGCTATGCTATGCACTGGGTCCGGCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAAACTCTGTGAAGGGCAGATTCACCATCTCCAGAGACAATACCGAGAACACGCTGTATCTTCAAATGGGCAGCCTGGGAGCTGAGGACATGGCTGTGTATTACTGTGCGAAGCTCGGTTATATTGGATACAGCTATGGTTATTAAATGGCGGCTTC
+
<<???=/B@DD<DDDDF8CFCGIHAIFIEIDH//IHDIFGFIHIH.HB=HHEHFIHADHF@HIBHHHIH)FIIIHHIDH-IEFHHDDHGHDHH8HEHFDEFH=FGHIF+HG**HFG3HFFFG;)GHDFDFGG@H0GG*AGGGGGFDEF6GAEECFA@GGEEE@FECE?CF*6EGG8:BGA;6GFEE)GEGA.CEGG(?:C.>EE1DH?GEE0HEGA<':GGE(:;G:?9CF?G?((GG?GC*(AE(G.(0
@antibody_185_multiplicity_10_copy_6-1
CCCTTGGCCCCAGTAGTCAAAGTAGGCGCCATTTAATAACCATAGCTGTATCCAATATAACCGAGCTTCGCACAGTAAGACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACAGAGTTTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCAGTCCCTTCCCTGGAGCCTGCCGGT
+
AA,,?>B>DBB<D@BDGFEGGFFIHFHHH0HH-HHGH@HFGIG-IHHHDHH9FIIIFFHIH?FHHIIF5HHGFEHEI=#DIHEEHEDIHHHEIDHHCH-DEHHH=EH<FHEEFHGIHHHGGGHFHG?5FBEG09E@EDCGAF;FCGFAFEGCAGG;E*A8AEGCGCE:FG(GE:EGGC8E'.G=GGCEGFF:CEE6*2AF)AEEEADEFE:FH7*F)EB'?86EGFG(G:F(ECE:G6GEG.CE:EC?8*
@antibody_185_multiplicity_10_copy_7-1
CATTTAATAACCATAGCTGTATCCAATATAACCGAGCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTAAATCTGCCCTTCACAGAGTTTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCAGTCCTTTCCCTGGAGCCTGCCGGACCCAGTGCATAGCATAGCTAGTGAAGGAG
+
<???AB?BDB?DDDDD>;GFFGICIFII;IIEIH+I-EHIHIHFGEHHFGBID-@0FIIHIHHHCHGD-C=H5H-HII5FEDDHEFHHFHEDC5IFHFHIHHHHFHCFFEHHGHEHEHGGFHHGHH*GDFGHDDFGHG6E3G=FGEE;E2GGHGEGGEG/;E(EGEAGDC=E?C:*GF=CG6?G(GFGAEGE*G4GECF(G'E6CF:?CCF<E*.EGGC;CAGC?*CGC:GA:CEE:G*EAG-/(8GG0?
@antibody_185_multiplicity_10_copy_8-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGGCGCCATTTAATAACCATAGCTGTATCCAATATAACCGAGCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGTCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACAGAGTGTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCAGTCCCTA
+
,????B57D@DDADDDAFAFFF8FHC>HIHHIIIFHHFIIHHGHF>EHHFBCIDHFFHICEH+CGEI'HHI5FFHIH5FEGHGFH-ICHHF+FFDHHCHDIHEFE>CHCG=H;G5HGH1EGEE5HFHEGGGGG06#@CGEGG.#E;G=/GEGDGG?EGF?FEGCE/CFC>8?:=?GC:GE8E?EC8GG*E:F#:2E?E<EGC((E?F.DFEE@G=F./E7EGGE0-8CEC8C':CED:F/.?GA=69A?)
@antibody_185_multiplicity_10_copy_9-1
AGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACATTCACTAGCTATGCTATGCACTGGGTCCGGCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAAACTCTGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGGGCAGACTGAGAGCTGA
+
?????B?BDD-DD<D@FFFGFGHFHHHEH8HFICHCI-HFHHH=IEEDHHIEGHH=9FFHF+IFCHH+HDE-IIAHEGIIDICHHIHHCACHB-IFHGFDHHDHHFFHHFH=E2HHHGF6HGGHGGDD?FFGDGEG@GG5BFAFG/EFGGGEEEEA=GECE7?FGGF:FE?G>EE(E/FA+EGE(CG::EEEFGAEE*GAE1?GEGH?*EE10EG4(GB8B,G4G:GE?E*(G?GE?F'AAEEE:CG:?:
@antibody_185_multiplicity_10_copy_10-1
CAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGGCGCCATTTAATAACCATATCTGTATCCAATATAACCGAGCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGTTGAATCTGCCCTTCACAGAGTTTGCATAATATGTGCTACCCCCATTACTACTAATAGCTGAAACATATTCCAGTCCCTTCCCTGGAGCCT
+
<A<???BBDDBBDD<-BGCGGG0A+IAIFHIHH5IFFGFBIHHFAHFEFH.CF;EF5FDF>AIHCI5HEFHC-CHCHIGCHHFIHHDH@G8DHIIHH-E?FIEG@HHIH?@FHGDDDFHEH.GF+FEHFG+4FEFGCBG:EGE1EGDGEC8DEGGECCC(,E2GGFE2GC?CAGEGFGE1=FEEEE6GGEGG((EGF?'EE<2(0EHGEC(G8CCE*EEG:CG<CE5;(6*EA8EEGECC*C<:*G*0EE
@antibody_186_multiplicity_1_copy_1-1
ATAACCATAGTTGTATCCAATATAACCGATCTTCGCACAGTAATACACAGCCATGTCCTCAGCTCTCAGGCTGCCCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACAGAGTTTGCATAATATGTGCTATCCCCATTACTACTAATAGCTGAAACATATTCCAGTTCCTTCCCAGGAGCCTGGCGGACCCAGTGCATAGCATAGCTACTGAAGGTGAATCTA
+
=???=A?BDD@D@DDB)>GC-GHCIIE-B+HGFE,HHFFHHHFII5BIA?DCIHFIHHIHHG@IHAHFGIIBGE-GEDGGFHHEF+CIH=HEHHDEIHHFHGHCHHH9H<GDHDFBDH@HHH@EGEGGCE=#GG@FEGGCHDEGE1GGG:GF*G+GEGEF:FF*EGFGFE<FGGEEGECFE:AE6CCE:'?AE#C0G9(EE;AE*G/G?DE(E(EGC8DE8G*GGC*EE-?C?F/AE:?*G-*C/GCE*/
@antibody_187_multiplicity_1_copy_1-1
GACAGTGACCAGGGTGCCACGGCCCCAGAGATCGAAGTAGCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGTCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGGTACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGATATAACTGCCA
+
??5?=><B?DDDBDD@FG;FFFFIIFHHHFF-IGI@HIIHIFHDDHFHFGF-IHHI9FHHHIHHEHIIHHHG(CHDHBI@HFBHAIHDFB-D5HIFGHD=HHHH-FHHGHHCC9HE5FGFGGGGFG,HFD88?GFA6E(FBGGE*GG8<EFG*DEE8EEFGFG(CE?EG?:>=*F?GECGG.F(E;EEG6AEG:E:EGFE;GGD(EHG::G:@E:GGGEE(G?G1).G(GE;GEGG:EEC(CF?6.:*(G
@antibody_188_multiplicity_27_copy_1-1
GCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGTAATGAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCCAGACCACGCTGTATCTGCAAATGTACAGC
+
<A?A?B@BAD5B55BBDGF+ACHIIHHHHEHICFIHIAA=ICFIDHCGHHGIHIHGFEICHH=H7IFI-H,IHFHIA)GIHIHEIHHFIHHGHHCHHHHHBHFHIDH<DE#HDH=?EHFDH+GDGHHAFEGG#@FIEE0GG0E-GF?=FFEEG:FE,EEE(CA(EG(,C/G::C?(*E<F;E6'GGCGC.EEEGE/FE:6E(AGAEHC80:CHACE:GEE(8:C*GEGAG**GA(?0GG?*.GGC:EG8;
@antibody_188_multiplicity_27_copy_2-1
GTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTTGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTGATGAATCCTATGCAGACTCCATGAAGGGCCGATCCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTGTGAGCCGAG
+
5=???BBBADD<@BDDFFGCFGCIAIEICIHFIIIHHIHHH9IHFCH+HGDCGFBHFFFHD=HC-HIHHFCBG#IICHII+?<GHE8IHHFIHD?HI,AHFFHHFHHGCHFCHGHEHHBFDGFHHGFGGGE:*B#EGGG1EEC;H)EGGFE4CG#;FE(C;EE?FEEE?EFE#)GG*@GG'?(?<(EGEE?F(G(F?EAE:0?:80:;C*8C@:GE:?EGGGEGEEE/:.FC:-FC:)EE.(8C8*0C?E
@antibody_188_multiplicity_27_copy_3-1
GTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATATTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATTGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGATATAACTGCCACCCGATCCAGCCC
+
????A<-B?D-DB?BDFGC.BGIIHHHHIHGBCHI9HIHIHHIIH/H=II@@I-@HHH8HDGHF?HGIG-H#HHHFHHGHHHHFHIIFH.IHHH?HEHGHHEHDHHHF@<;HHH>EH:GD?GHGE9DGGGEE3AFIGBEHEEF4EGE;G:E8GDG=E5G>GCE(E<GCEDCG#,(CGEEGE((CCGEGGE6GGFGEGGGCA?AAAAH?GA:CA<GG4EF18G*0E*EE(E1AGCG?(EEG*(?C:??A*8
@antibody_188_multiplicity_27_copy_4-1
GAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGAAGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAAGCTGTATCGGCAAATGTACAGCATGAGAGCCGAGGACACGGC
+
<<?<???B@DDDDA@AFB6GFGHIFCH>+HHCHBFHFHGHHF=FHEH0FHIHFFGHHDHHHHHHH5-=HGHCHHHF+DFFIECEHHIEIIIHFHDAHEDFHHHHHCIHFF9EHDGEHGGHEFGH;H'GBCB#<GFG(EEEHEGFGD)GGFFC8D?@B?1EECEE:6E:FGEFCCB<FC)E(G*66?CDEE()GEE-E6?C)G/C?CE*GFFGEG/E1E:E4:F.GC8EEC)EA2:GE(GDEEC?CE0E<?
@antibody_188_multiplicity_27_copy_5-1
TGCCTCGGACCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCAGCCCTTCACGGAGTCTGCATAGTATTCATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCC
+
5??,,B5?-BDD<BDDGGFGFACF8I;HIHII0HI>IIGIF9GGFDIF-GEHHGIHF-CDH?BHH;HH5:HFBIIHCH+DEEIIHHHDHIGF+HIHHHCHHHDHH=FIHFCDH+DGHHHGHDHHHHFGFGEAEG6AGF?G0E1GECEAACG3FGGEGECA;GEFEEGE;6A@EC:GFF=#-4.G'-CFEG*GEEC;:AFCE)E*CG*8E?8EC>CCB':(F?FAG:E0EAE:C??(:A6(G?E<E:G1:0
@antibody_188_multiplicity_27_copy_6-1
TGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGGACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGTAGTAATAAATACAATGCAGACTCCGTGAAGGGCCGATTCCCCATCTCCAGAGACAATTCCAAGAACACGCTGGATCTGCAAATGTACAGCCTGAGAGA
+
?????BB?9DDDD@DBFFCGEGH>I>FHHHIIGHGICF/ECHI.HHE-DGHGFFHDFIIIHHHIDCHFGIHHEHHIEI(HGH5ICHBHH(HCHFCIHIE,H,H<HF5HF6FHHFH3CHGHHD-FFCE;BG?*GG;EB?EFCGE?E?BF3HE'?EEGGGG*G8/E(>)?EDGG@CGFE?BF?GFEC>A?=AA(ECEEEEG4/FGC0G0F:CCCA:*GCA7FFCG<(CGE1EG:AGEDFG?)AGCG.EEE.(
@antibody_188_multiplicity_27_copy_7-1
GTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGACCGATTCACCATCTCCAGAGACGATTCCAAGAAGACGCTGTATCTGCAAAGGTACAGCCGGATAGCCGGGGACACGGCTGTGTATTACTGTGCGAGTCGA
+
A?<??BB??DBDDDDDC8FFGGIF(IFHIIFHGGEIFICHHHIEIG.CHFHF8FH8E,H=IAIEH5DIIFFFIFHIIH5F5HHBAFDGF7HEDFHHGHHFD5HBFF4E@@HDHFF)HGFDG*FHE>GHHECBE)EGEE>FFGGEC@E8G(DE*GEE5?C4EEC.EGG0@:FG.EECG(EE)G?*GGE(*G6EEEG;?FAE#.E*E.CC0)68(C<G?G#AG0.CEGE)E/EE:;FGA:AC?EF?0/;C*;
@antibody_188_multiplicity_27_copy_8-1
CCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTAAGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGTCGACAGGCATTAAGTATTAGCATTTTTGGAGTGGTTAT
+
???5A?B--DD9D<DDFFGG?FEIFFHH.FHICAICFHCF0IGHIIFFG@9HHFF4HIHHDEHFFGHH.H==HHHFGCHIFIH*EI7IHHH++EFFH'?HHDIDHHHDHFCDFHDGGEGF=EF?GHFEHGDFHDHG*FHH9=BEGE@EGG*2AEAGDGEBEGGE0G<6E:0FCC?AGEGGCG(EC?EG60:FG8:)/C8EE?A*EEAE6?EE;E:E(GE7*GG()6*6E:G?E;A<(G*46EFC>*:?('
@antibody_188_multiplicity_27_copy_9-1
CCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCTTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGA
+
?<?=??B@D<DDB-DDFCFFFFIHEFFHCFHHHGI/HFFHGEGHDEFHFHC-@.HFF*IHFGDII-#HFF5HHHHIHIGCHHDHHIC@I5HEHIDF,DIFH-?DHH6EGGGC@H(HG@HFCGGGGHAGB>;GAC,GH84EFFGGEGF*GFE;ECG:B:GEC,CECDBAEEG?/E1EAGE<E6CGCA1GE*AG6FCE6GGF<E(A<6HE(CGEE;C7EE(:F?0G*EC:A?*E*/0?:*(<EGG>0ACG0C
@antibody_188_multiplicity_27_copy_10-1
TGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGAAGATTTACAGCCTGAGAGCCGAGGACACGCCTGCGTC
+
??A<<BA@@D5B<DDDGFG?68H+HIHIIAHFHHHHFI8HFAIGIEFIHA5HCHHIHFHFHFHAIEIF@IIG5HI--E*HG5FHH-HFGFI.HHDHI8?-+)G:HF@HH@FCDHH+HFFEHDEGHFFHGFHGFEGEGH?F8FGDEFEC@GF::,G0FCGC(G-F@G06GAF((ECE?GGEEEEFEEG>GGEGEFE'EF0C*GD.CGEFEC?<((*EE#GCGECC<0C#GEC*E(0*GFGE:8'?:**G*)
@antibody_188_multiplicity_27_copy_11-1
GCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTCATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGACTTTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCAATCATATGATATGACTGCCACCCACTCCAACCCCTTGCCTG
+
<?=??-BBDE-5?D@DGCGGAFIHEIHEAIHFEIH-IFIHFIHGHHFHIDE=HDH+BGEEG,HHIFHIHHF+GIGEHIIH?AHIFHIH-DIHDHDCHI8HHGH-F1EAIBH6EGIH;HD?:>GEGHFFGF5E9FEFGGGFHEGC9G*AFCEGE0;6#FEGCG@EEF-;EGGECFGEEGG?;?/EA?GA(D:A;EGE;GGGGGA:E:H04ECAHE.?GGEGB';EC0?F.;EG0(8E:*#AF?GF((0G(G
@antibody_188_multiplicity_27_copy_12-1
GGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACATCGTGTTCTTGGAATTGGCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGATATAACTGCCACCCTCTCCAGC
+
?,???>B?DB5DD<BBFGDBF-IHH>CBEHHIH@A>FHFIAGIIGD59+EDFF7IIB55FHHEDIFFAAH>E3I=HDBHDGIHHIHH@HHHEHHHFDHHFHHHHHH?HHH@FHHBGEHH(GDDB<GFEG?G@GDGE1GEHGEDEDE(GEGG;.*D>G(EE;AF(EEEFEGF:E0EGFEE:AABCAGE:G;F'EC(6'EGCCEEGF:HCGAE6F*E0G<BEE4E.EE;E:8/EGEEE(C/G(G)EGE'E)?
@antibody_188_multiplicity_27_copy_13-1
GGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTGCGCCAGTCTCCAGGCAAGGGGCTGGCGTGGGTGGCAGTTATATCATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCACCAGAGACAATTCCAAGAACACGGTGTATCCGCAAATGTACAGCCTGAGAGCC
+
,9?5=7?B6B<DDB<BGGEGFGIHGIFGFIGG/HHDHHIH@IFHDG-IFEHH9HDGFHIHHFCH+HHHFHGHHIAHFBHHGFGHIH=FF6DIGFHG-ECFIHIGG8DHDIGHE-EEHEHBFH=HEGEE#FGHBGEGGGF;G@G4B?E1E>C3;E*E6EG6*G.AEE/E?FF(GE6=GEACGEEG0EE<*EC1?CCG(EC??6A>FDEE/H(GEEGE8C(;(AA?GG;#CF:F(E/F8E??EA;8*:(:E*
@antibody_188_multiplicity_27_copy_14-1
CCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGTTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAAACAATTCCAAGAACACGCTGTATCTGCTAAGGTACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTG
+
?????=A3DDBDDDD-F/AFGBHHH>CIIHEHCH9IHGICFEIC.GDHHFIEGHIDHBEHIHF?@FIIII-A@IFBFHHIIHCHFDH.F-HFH(GHFFHDEHFFGHHHEEHE-HHEAGFFG;HB;EHFGEG8:;FFG;E?E@EE>CGDGEGEEGGFAF?.>#;C6GG(GE=EEF)G-(?(D>E(6AFC/GE?GFE.DE0C0AGG0#E:((:C;GCC::G@8CE6:A;E/A8:G0/(0G:4GCE6?8EECE
@antibody_188_multiplicity_27_copy_15-1
TGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGCATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGAGGGAAGTAATAAATACTATGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTAGCTGCAAATGTACAGCCTGAG
+
??9???B?DBADDDDDFAECFFC>AHFI6HHIEIHHCCIAH=I7HHHDIIFAHHDHCHHDBF@FCH'FIIHGIGHHC>I-IFCHIGDC-HGCCHHFFHHDGEHFHDCIEB*EGCHGG:HGHBH9GFF:@DEGF6?DDECFED,;EGG@,EG#GG3EEEFFG*CE8EGEG6;EE?F(<E??'??F6C?E(G?G(FC6?:E?AGGG9EHC*8F*C*GEC/?E*EC/?G<E6(*E#GA1C?ECE?E/CCG*E1
@antibody_188_multiplicity_27_copy_16-1
AGGAGACAGTGACCAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATGCAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCTTCATAAGATATAACT
+
<?AA??B>DAD@D<D@G>8GGFFHIEIIIHDAFD3HHIHF*HHHHIIH.IEHFHFF+DDIIG=DHAHBIHHIC=H+-FH=FIIHHFBHHFHHIHHHIHHH5DHEEFEFHHF?HFHGH;DEFHHEGGHFBFEDG@F=FGEDG+EGEEEBEFF6FEECBE#E(EGGEE*=CEE?E6*8EED:86AGGG:.?:E?EE:?(;EAG6EE?FEG:66C@C</BC:EEG(AA:EAC?GACC(G?EGE'*/:CAA)*E
@antibody_188_multiplicity_27_copy_17-1
GAGGAGACAGTGACCAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGTCGTGTCCTCGGCTCTGAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACGTCCATCATAGGATATAAC
+
=?==?B>7DBDDD-DDFG;GGGFI0II>IH=>IEFGIHHHI-HF.ACHIEGH9IH@IHDH8FI7H8GGHIDFIHHIIIHID@HF5DGIHHHI+HIHHF8AFEGE6DD*DHHF+FH9HD,FHGE'CEFGGG#9(EE4GF6(EHEFEBF?EGFEE6EGE:E?GECG1GGGE0G*.CFEECG<:EGFE@E0E0CAFG;GE:F*AE1C*G(F;H(C@G:(4F3EGE*E??D'E?*(*8A0*CG??(GEG4G))*
@antibody_188_multiplicity_27_copy_18-1
CAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATAAACAGCCGTCTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAAGTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATATGACATAACTGACACCCACTCCA
+
?5??,BBBDD@--DDDGF8FGGHIFFFIEID@IHIIDFEIBHICEFIDHIHHHBF.HHIIH=IFHHEI?HHE-HFEIEHHBAFIFHIIGHHIIHFHHHHHDFID(FHIH;HHD+HGHGF@ED?D/FHFCFCEG?GGEDG=EE(GEFCCBGEF=FH@?GGEE6(BAG>G9/*EE-C?GFE.E+GGFG/GFGC8/DEC?F?CGA/ECDH;;AAGC7E:(G:EGEG(8AAC:F(.10EEEC((G?#ACEECD(
@antibody_188_multiplicity_27_copy_19-1
CCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGAATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTT
+
?<??A9BB@DEBDD=D?CGFF0HC>IH>HIDI0HFIHIIHGI=BFDIGFGI(HHCHGHH5HI+HFFH(DHHHFIIH5HDFCCFHHHFDGCED@EIHHHHHFFHHCFGD-HHD(@#HHF'DFDFGFFDDCH@FBGEE:GG>FEEFEEEEGEGEG@=EGEF)DGFEF*3GGG(FAECGGGAGC.?:AEE0(A6C?G/(G:GG/GEC?(A>GE/?HAE8G:?GECA#?C(;GG6GEF?.GF?FCC2?(FE(**
@antibody_188_multiplicity_27_copy_20-1
GGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATAATATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTGAGAGCC
+
,5=??>B7D-<BDD-BFFC@GFHF;AIH/HH?IHHEIDFHEGI.HIF@HHDHIHIIIHHIHI-FHHHHIICAEAC?AHDH5GFIDFI@AH3HH87?HHHHHHHHII-?FEHGHDG+GG@H8CFFDFG3BEGG@EG@EGD*9CFGE?G=G:GGDDEFG@G:EE(G/G*EECEGF?F?EEE?GC:;GFGG(GGEA'ECGE*CGE:E(G#CECGCH*EGGEEGDECGE(AAECGD:/::*:GEEE:EE*CCG8
@antibody_188_multiplicity_27_copy_21-1
CCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGGATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAGTACTATGCAGACTCCGTGAAGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTCAGAGCCGAGGACACGGCTGTGTATTACTGTG
+
,????BBBDDBBDD<BAGECGFHHFHI+FI?GHHCHHI-+IGEHEF5F?FHII@HEHGE'FFFB-HHHHHHF5H>FABHEGGBFHHHED+EHFHHGDFIH=G@CEDHFFFHHHHEFG3GH5HFFFCHGGHFGEG#GHE;EHGDGGFCDG(>GGFCEGCEE@(CFGCDG#E:#EEG>?8E*8GG4EAFCE:(G:CE(G0FGFGG:EECGG0G*(G:C8(#G:(GCCEC?E::C:0EGG:EGAC'AA8*E:*
@antibody_188_multiplicity_27_copy_22-1
GGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGAATCACCATCTACAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTGAGAGCCGAGGACACGGCTGTGTAT
+
??,<?>BBDBDADBDDCFBG+FH-FHHECICIHCIHFH,III9HB.GFFHDF@HFFEIHHIIFH-EDFIEEH5FADFHHHEI5FHGIIGHHFHH3HAEIIHCHHGHHHFGHHEH3+@H*GFF)4E2FFEFEHG.FCGE?=.GGEEGEFGECE*CEDE;GGGDGEEDG@G)E*GAED?(:6EEEEG8GAAG:6?(EGCE0CEEDCG(H:*0AEE(7E84(E*:FA:C:E(A8E*E/*G*:G:EC(EEE(GE
@antibody_188_multiplicity_27_copy_23-1
AGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTATCTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGACTG
+
A????BB5@<DD<EDAACGCGF@HCIFEHH/HFHCHFIIHIFG(EIDF-IHIHHHHHI-DG5IHH)HAIEHHH@HIIIFII)IHHFEFEEHHFGHAG,EEE++H@HH;H@8H@H@HEFEGHHE=EHDHHF@DFA@GH*GF?GCDGEC?GFGFE@G*:3G6F8DACE.AFGHGG??GFE*E?GAG68#A?GE(.G?CECG:AG1?.C6G):E?7G=?/<EA::C?6GGE:E(EC4*EE9CEC**E*?.4EG
@antibody_188_multiplicity_27_copy_24-1
AGACTCTCTTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGTGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGTACAGCCTGAGAGCCGAGGACAACGCTGTGTATTACTGTGCGAGTCGACTGGCAT
+
?<,??=BB/DB@DD<<GEFGGEHFFCHIIEFHGF5/GHHHHIHIHH0H.HDIHHD=IH8IIFFFHGF535HHIDHH+HF0?H#IFE.FIAEIHHD@CHDDHHHH-FF4IH?6E=+HE4+ECDCG*FHB41EGGDEIFG)FF;G*CGGFGG*4/BG6GFCGGGFE98EG*EEFGAG.0EG(?G0B6GEGEGGCFE/GEEFF??C4E?:FG*G0HGD.G*,E'G*EA6E*GAG;E?CAEE:CG-EG*:(*?*
@antibody_188_multiplicity_27_copy_25-1
GAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGCTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCGGTGTCCTCGGCTCTCAGGCTGTACATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCATAGTCTTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTCGCCTGGAGACTGGCGCA
+
??<??<B9BDDDDBD-GG>FCG8IIEFCIHGGIHEHH-HIHHIGIHGHFHCHFEHDGIFGHIIHF.?55HIHEIDAGHHIEIGHD6-H+HDHF4CH=EHC3HIEHCFBHD-DCFIFG*CGFFDHFEFFGEGGDG=)HF?GGA86G8ED:G*F?AEGG;CEF<CHGE(G:<G.EG:?/GE?EFGG(DEFEG>A6E?61A0?E(C*'EA.C*A(F@GGGAECBGGEC8FEEG(8#C<'/E*CGCEEGCAE(*
@antibody_188_multiplicity_27_copy_26-1
ACCAGGGTGCCACGGCCCCAGAGATCGAAGTACCAGTAGCTATAGTTAATATAATAACCACTCCAAAAATGGTAATACTTAATGCCAGTCGACTCGCACAGTAATACACAGCCGTGTGCTCGGCTCTCAGGCTGTACATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTCCATAGTATTGATTACTTCCATCATATGATATAAATGCCACCCACTC
+
????A>>B@DBBDDDDGAD8@FFIFHHAF8.@HIHH=HHFAHHHH.HEBHFEDH.HFHHHHIHFHD,IIG?-CHHIHAAIIGDCDEIHIHDHH+BEEC=CHDDHIHHH)HHHFH=GC*BBGEHDE3FGCFHHG@GG0FF2EC*GB=EE?FFG7E=EFGCGDAGAEG;ECGFG6FFCG;G6GE*)<?EG*(GD?GGGE(C/G0'(GECGGAGG)*#??E=AE:G#6EFGF:*E?*E:G0/FC.EE6E(C?;
@antibody_188_multiplicity_27_copy_27-1
CCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGAGTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTACAAATGTACAGCCTGAGGGCCGAGGACACGGCTCCGTATTACTGTG
+
?A?5<?BB6AD?DDDBEF>FFFF>H>HFIFHHFGHHHEGHHFIF9FHF.HHHF.HI@ED5HHH+DAHIFIHIDHCFIIH-HFHCFHBHHFHGDDGFFIFHH+H@HHFHHAHFGFHHHHFGC@=EEFHGFBEEC*FGG8EEC?GGEEGEEE=FEC8GG(GE@?/E?GE.G#E;;E.G8GAEAE?GGCGGCECFGE?:?F?:FGC#CEHEC1:GEEGE(ECCC#:?CEEG?G*0GC0:-(#E06AGE:CG**
@antibody_189_multiplicity_1_copy_1-1
CCCAGATATCAAAAGCATCAAATTGGGTTATAGAGTAGCAGCTACCACCACTACAATATCCTGATCAAAGCTAGTTCTCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTCCTTGGAGTTGTCTCTGGTGATGGTGTATCGGCCTCTCACGGAGTCTGCATAGTATTTATTACTTCCATCATACCATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGC
+
A???=BBBD@DE<5DD?G8;FFIH8F/BICCIIIH?HAHAFH?FHI.HI=IBHHHH-HIII.HIIAIHEHHHEI+II-HHAGIHAHHBEF+CGHIFHII8HHHHGHHFHF4HHHH5FBDHFDH*HHEGGEGE8ECF@*+HE8GE/EEEGGCC)ADG?GF0=EEB(G(>G*;@:.F?E:GCG:GGE8GF'EG:6CE8:EC*EEAGF*6A<(G::E:GG7EGGC*(GE8.:E6G<CG*E(C(*?:?(C6GEF
@antibody_190_multiplicity_3_copy_1-1
ACCATTGTCCCTTGGCCCCAGATATCAAAAGCATCAACTTGGCTTATAGAGTAGCAGCGACCACCACTACAATATCCTGATCAAAGCTAGTTCGAACAGTAATACACAGCCGTGTCCTCGGCTCTCAGCTGTTCATTTGCACATACAGCGTGTTCTTGGAGTTGCCTCTGGATCTGGTGAATCGGCCTTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATACCATATAACTGCCACCCACTCCAG
+
?,???BBBDD@DDB5BFF;GF/FEFIF+CF.IHHHEFGHIFIHCCHHHDHHHHIH'IC*8H-I>HHF5-=IF-HHCG5IHHHDFH/FGEFHIFH#BBFDDFCHGH3HE>H*HED@HEFEFHHFCEFEFGFGDGEGGEE/F>3EEDEEF2GBGGG<>AEG5?FE1->GEFG6G)EEC8G6?FC:E:CFE(EE??*CA?>G*:*(=ECEGCH.6@@EEFC.G*F0?GDF8GE</G?ACG0?<*CC?G:*EF0
@antibody_190_multiplicity_3_copy_2-1
GTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAGTACTATGCAGACTCCGTGGAAGGCCGATTCACCAGCTCCCGGGACAACTCCAAGAACACGCTGCATGTGCAAATGAACAACTGAGAGC
+
=???<BB3DDDBDB@DFGG8C?FBIIHCHF=IIHHIHFI?IGHFHHD.GD=HFFIADFFIHFIH)HGHIGHHIBAHIFHFHH<IB'<FGFFCHEHHICFHH=HHDH@>:HFHFGGGGH3+?FC(GHHG=DEGE*EFGEGGCCEGG?EEGEE6*G8GG'EGA#GF*8CGF?E*E?GEEC*C#EE(CEG:EC0(CGFC)6?FC#G(:FEE8E66:E:EC0G8E(:)G(C(2GFEGEE/A8GEG*G.G0G<;E
@antibody_190_multiplicity_3_copy_3-1
TATAGAGTAGCAGCTACCACCACTACAATATCCTGATCAAAGCTAGTTCGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGCTGTTCTTTTGCACATACAGCGTGTTCTTGGAGTTGTCTCTGGGGCTGGTGAATCGGCCTTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATACCATATAACTGCCACCCACTCCAGTCCCTTGCCTGGAGCCTGGCGGACCCTGTGCATGCCATAGCTAC
+
?????-BBD<?DD5<DFFCB/FI>FIFIIF=GDHIIHFFDHHBFHEDIHG.H-HIFHDEHHFII;IHIE5-HHC@-GFIBIIIIHHEF-H)HIIH.IEI@FIHH=(IHFHHDHHBHFF;F3;C+9G5#;H<FH*E+*EFECEF@2GGED*8E:CEA;EABEEGEEAEEF=G*EE?FE:AG;DCAGGE(EGA:A:FGCA?:E<<:GE#CF?A(FGBEG*EA()EA:A:EFE(?#:EGGE?E(GEGE/AC86
@antibody_191_multiplicity_1_copy_1-1
TGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTGGGCCCCGCGGGAATAGCAGTCACCACCACAATATGCTAGCTCAAGCCGGTCTCTGGCAAAATAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGACCCTTGAGGGACGAGTTGTAGTAGGTTCTCCCACTATGATAGATGTACCCAAGCCACTCCAGGCCCTT
+
A????BBBDDDD5B?DGGFFFGAFFEIHIHHI9CFII>EH,IF9?GI.FGGIEHEHIDFIH+HIA-HIAIGAHIDHF5HHHEHIIIHHC-HI/FHDFFAHEHHIGIHH/GHHHDFHC>GEADECGAE8FFGHCEHGEFFEBB:=EF(GGF<*GEAEGGFDCDCEGAD?(.F?CGEGEEEC6GE*CGE;ECEGG(EE?*GA6EEEE0C8E0EF(0GCGEFC(ACGC/CG8C:?:G'G*A*EEECEGA6G*)
@antibody_192_multiplicity_1_copy_1-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAATCAAAGTGGGCCCCGCGGGAATAGCAGTCACCACCACAATATGTAGCTCAAGCCGGTCTCTGGCACATTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGAATTTTGAGGGACGGGTTGTACTAGGTGCACCCACCATGATAAATGTACGCAATCCACTCCA
+
??A,?>5BBD,?DBDDGFFF.GHI+HHICF@H.;HHEIHHHHHEIH,HCFCDEI.EEHCH5ED=FIHHHFEG+-HIHHHI@HCFHDHIIIG-CHAHHIBFEFIEFHDCFHBHGE.AGH=FGFGHDGEHGFEHHDDE*EFECG;G@@,G'=EFG*E/GG*EEEEEFGGGAEAEEEEFFEEFGGCE(GEGGFAA8GGGEFE*A(EGC<E:G/GE.@@0<)(2FAC(??G*2E0EEGC:2*C*9AG?G2C1:E
@antibody_193_multiplicity_5_copy_1-1
AGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGCTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCTGGCAGTCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGATCACCTACTACAACCCGTCCCTCAAGAGACGAGTCACCATATCAGTAGAAAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTA
+
????ABB?DBDD+D@DGCGGGFHIHH.IHI+BGHHGHGH#H-HHHIEH8CFHHHHCFHI-FICIHHECAICIIIHHHI?H-GHHEDHHIHHEHI@FHFHHDHHBHCHF.HC8EHHG*FEHC@=H;DEGGHFHGC9DEGFEGGF<GCGGG@E+EG*E*ECFCGF/<GDFF8?E-GEG<EE*F;06(8F*E*G((E/;?EG(E:EG0:EAE:CCCEECGAEACCCC(EF>1E?G(GE14?C'E*A6E1ECE?
@antibody_193_multiplicity_5_copy_2-1
CACCACAATATGCTAGCTCAAGCCGGTCTCTGGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCAACTGATATGGTGACTCGTCTCTTGAGGGACGGGTTGTAGTAGGTGATCCCACTATGATAGATGTACCCAATCCTCTCGAGGCCCTTCCCTGGTGACTGCCGGATCCAGCTCCAACAGTAACCACCACTGCTGATGGAGCCACC
+
A??<?BBBBD+@@<D<EGFFFCHHFIHI+HHIFC7HHHFIGFAHG9HHHEDFGIIIIHIIFGIHHIFCHHCI5FGHFBDBGGHIGHHFDHDH?/DHIHIFF@FFFH#H*D4FHGFC;DFEHHH*H?GGGGBBGFGEEFCEGDGFGEG1EEEEACE6ECGC6:E)G@D?#FFG/FE..E:F(E??'GCE:AGAECC?FGEFE?EE(?F/G'GGE18E(E7:(,ECE*G?GC0CGG:G:*)0*G*E.;?0(E
@antibody_193_multiplicity_5_copy_3-1
CAGTAGTCAAAGTGGGCCCCGCGGGAATAACAGTCACCACCACAATATGCTAGCTCAAGCCGGTCTCTGGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCCGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTGATATGGTGACTCGTCTCTTGAGGGACGGGTTGTGGTAGGTGATCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCTCTGGTGTCTGCCGGATCC
+
,???A9BBDDDDDDDB@?GFGGICH*BF.;I9IGIIHFEI.IHGHAHHDHF-FFC5FFGFGFGFHEEEHHEHFI555IIEHEFIHH-9IHHFI*HHE4IIHCHI<H,BFHF*CHIHE+*EFFGEFF/HFHG==D;CH=EE3GECGEA=EBE1G@ECGE@CE*EGCF*CGEGGECA>GEDCG#EE;(.(EAC<CG(GE*:CE/C*CF?AAFF:F<G)?*,(BC:GA=E*A'C(*).EGA(88GC*/C.CC8
@antibody_193_multiplicity_5_copy_4-1
TGGCCCCAGTAGTCAAAGTGGGCCCCGCGGGAATAACAGTCACCACCACAATATGCTAGCTCAAGCCGGTCTCTGGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGAGCTGTCTCCTGGTATGGTGACTCGTCTCTTGAGGGACGGTTTGTAGTAGGTGATCCCACTATGATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGGTGACTGCC
+
???<5B5BD@DDBDDDBCGGECI>FIFHHIH:HFEHIFHIH8EHH/GIDFIHGIHHH.GFIIFHDHFBI-IF<CDIDHHG5H-HHHFBHIHHHIE7HHDGHCHHF=HHHF@H?BFHHHHFHEBGDFGG?HDG>AGFDDA@GE;#EFFEEE'CG>#=FF*GFCGGEEEGGF;F0CFF*C9E(:(GC(10F:(CEG?:AF:<CC(EGF?G:CD:EE8*E?:<E;E60*ACGEG:*GGGE6G#E?8?(ACCGG
@antibody_193_multiplicity_5_copy_5-1
CTCCATCAGCAGTGGTGGCTACTCCTGGAGCTGGATCCGGCAGTCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGATCACCTACTAAAACCCGTCCCTCAAGAGACGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGTCCGTGTATTACTGTGCTAGAGACCGGCTTGAGCTAGCATATTGTGGTGGTGAC
+
?A???BB?B<DDDDDDGF/GCFFIBHHFE6ABIIHGIFHAGHHFDFH5HHHIC9IFHFHIGH,GHHIH-HHG?EHFHGFHECGGEFHIHGHEDHHIGHHHDE#FHHHED@HGEE*GHHFFDDHF3FFFC-8EE9GIGEB;F8G0EGG=EAGGEECF:G?EGCG@EG?CBEE*E?81(GAE:+CFEGCGEE>E*:GE'.G?EEC?GECGCFCEH'CCGG?CEE*EGG?G*<9EGE(E:AEF:0C/0)E((*
@antibody_194_multiplicity_1_copy_1-1
AGCTGCAGGAGTCCGCCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCAGTCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACTACCCGTCCCTCAAGAGTAGAGTCACCATAACAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTC
+
??A??BBBDD-BBDDBFGGGGGI6C8IIFHIIHIFFH.IHIIICHHGDFFA@>;CEA=DHI:EFIHHHHFCHE5HIHED-HFBHGF@HGFCEGGHF<EIHH?FIDAIHFCH?G+H8E6HHFH@HEGCF4>CGDFGEGGD@(@EFADFFEEEGDFGGE)CE<ECE?<**(CA(EFEG*CEEG(C<F:.:<CGC*;#AC(CCCFD-C6'EED*AECE?EGE(:AC?ECE4C6E((8/A?/*(E/?:E/E?(:
@antibody_195_multiplicity_1_copy_1-1
TCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGTTCCGGCAGTCACCAGGGAAGGGCCTGGAGTGGGTTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACTAGTCCAAGACCCAGTTCTCCCTGAAGCTGAACTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGC
+
???,??7BBDDBDBDDGGGF/FHIEHI>HHHF=HGIIGHEEDHIHEFEDCIEHH?IC>IHIHAIEHH@IDFCFI-IDFDGH?HDHI@I-=HIHIH2FHCFHHHCGH=H*EDGF,HDHHC(.HHHHGHDD9G.GDCBGD(GFBE>CEEBCFBEE=AEG=G?CEA)GE?GG@FFEAGGFA:*'EDEFF8EG(G?E:ACGE:FG'CE??C(EE*E8E@G?CE@ECE6F(EEEG?EGG888E:'??EE(*C:D:
@antibody_196_multiplicity_1_copy_1-1
AGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTGGGCCCCGCGGGAATAGCAGTCACCACCACAATATGCTAGCTCAAGCCGGTCTCTGGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACCTGTCTACTTATATGGTGACTCGACCCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATGTACTCAATCCGCTC
+
?=???BBBD@DD@DD<F+FFGFFHHHBH;EHHGI@9IIHH-CHDHHE-HHHFAIIHG>DHFI5HHCIH+FF-HIDAGHB+FHFGHFBDHFIHEIH6=FH=H4BF+FGGIHGEFHH=EHEHEBGG<DGCGEEFEFHEHE-H<FCFE8GG64GECE<EGGFEC/;GE8EEEEEG8GDF(:F6@EEE-G/GGGE:GG6EGE9E8GCAEG0E/HGCAE.CB:C:*,C(GEEG?GCCE('?G-**((C?CE'*GA
@antibody_197_multiplicity_1_copy_1-1
AGACGTCCATACCGTAGTAGTAGTAGTATGCAGATAATTTTATAATAACCAGTCAAAATATCGTAATAGGCCGTTCGGCGCGCAATAATACACGGCCGTGTCGTCAGATCTCAGCCTGCTCACCTCCATGTAGCCTGTGCTGATGGACGTGTCCCTGGTCATGGTGACCCACCCCTGAAACTTCTGTGCATCGTTAGTGCCACCACTGTTAGGGTTGATCCATCCCATCCACTCAAGCCCTTGTCCAGCG
+
A?A??B<BDBEDDDDD-CGFFGAHFH,IFCHGHH9IFDHIHHFIHDHHFH*HF@GHHGH5HGGEBHEGHIDCHH=CIIIEFH5HIHHH=FHHHC@(HFFFEHHHDH6=GHFHHFHH0EE@G.#FC;FHFHEGF#GGGG*BGE;EGG?G?E:GE:CGAGGGG<FE;DDG?E;(GCEG?FGE?GAG/FGCEE;EGG**AC(E#:EGE:EG(CA?CF:EC.,8F<EE:GEE?F>?**:E;(C<C(E*E(E;/F
@antibody_198_multiplicity_1_copy_1-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTGGTTACTACTGGGGCTGGATCCGGCAGCCCCCAGGGAAGGGGCTGGAGTGGATTAGGAGTATCTATCATAGTGGGAGCACCTAGTACAACCAGTCCCTCGAGAGTCGTGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCTCTGAAGCTGAGCTCTGTCACCG
+
?9A?<?BBDDDBDDDDGGCGGGHEFIHIF0G,CFGFH9@0HHFDE/CIIFIIDH7HFHGHHIHIDDCIFEIHIE-DEDCBH5+IH<G2HIIHHHF7IHIDHH+H+6:EEEFHFFH(GC0E@HH*FD8FH)GGGGFGGG=?-F8EAGEG6EBBE=C.EEEDEC;?;G1/EAAF(C6?AE:C8EFEE.F:EAE(FG?GEC*?FA(FG8-4G<E(HAECC?E,EA*C:?C(GC<D#??FCC(?GE?E**2CA(
@antibody_199_multiplicity_1_copy_1-1
GAGGAGACGGTGCCCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAATAGTAGTAAGTACCGTTAACGTCGTTCCAGTTGTAGCGCGCTTCCGCGTCTCGAAGTAATACACGGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGACTCGACTTTTGGGGGACGCGTTGTAGTAGGTGTCCCACTATGATAGATACTCCCAATCCAC
+
A???<BBBBDDD-DBDCGCFFGIH>FEF>IH/@CHE/HHFFH9FCFDFFF.HBIFDDHHFHCFHF>IFHHHICHDFAFHGHHEIHHEIGIF2CHHHHHIGEHFGFHHG+H/HFEH<>77G/EGC@EG,3GFEEGGGEGDEEECGG;GGA*ECEBEFGCFG8??E8:CEGG0A;D6(E.(G4E;EGG?E:(EA?GGC'?*G.8<?ECA<EA8E(C@(=EEDE:G(.GA.:C*?E?EAG.E?C(/CAAEF/?
@antibody_200_multiplicity_2_copy_1-1
GTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTAAGTACCGTTAACGTCGTTCCAGTTGTAGCGCGCTTCCGCGTCTCGAAGGAATACACGGGCGTGTCTGCGGCGGTCACAGAGCTCTGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGAGATGGTGACTCGATTCCTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGG
+
?,AA?BB7EBDBDDD5GFGFF6FHHCCCHCI+EIIHHHHHHAIHHIHFDHHIH=GFDHHHIHHCGHH5CFHIHHF5FIHHGEG=FIGHH)FHH@HIHH3+IHHGEEGHD5FHEHHHHEEFEGBHH*HGFHGFFF,#HFGAF8*,#GGGB;EFGFEGFEEACAG.GG/GEG:>G?@G:/GE??89GF(E:EGEGFEGEGF:EGCE:GECGCG:E0BEGC?.(:EG*AEF:A)GACCE?/.:D*C?8(.0AC
@antibody_200_multiplicity_2_copy_2-1
GGTGAAGCCTTCGGAGACCATGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTGGTTACTACTGGGGCTGGATCCGTCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATCATAGGGGGAGCACCTACTACAACCCGTCCCTCTGGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTAG
+
A<?A,??BD@DBDDD<>GFGGEC>FHH>FHIEIGDIHGFGH-HIHF=HDGFCHHEAC'EHHAHGHIECFHHIHFICH7IIHDBEIGG8GHHBIFHFFIHHHDHDHHFEHDEFFFHFHAFFH7FGFC?GAGFG#E*F=EG*G@EBF;FFC;3AAF*GG?E:#?G'E(EGEEG?GAEEE<8GC?.E'3CGA.6AA0A(2(GEEEGA(CHDE*?3@CG?E??(CCAGEGGFGECAAAGCGE*EF?G0GECC0#
@antibody_201_multiplicity_2_copy_1-1
TGCAGCTGGTGGAGTCTGAAGGAGGCTTGATCCAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGACAAGCTCCAGGGAAGGGCCCGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGTTTCACCATCTCCAGAGACAATTACAAGAACACGCTGTATCTTCAAATGAAGAGCCT
+
,=???BBBDD<DDDDDGGGFG.F@FFFHHE/HHHI9GFHFIIIHHH.HF#/F-FGFHHCF?DIHIHHFIFHIBHGIDGHHGH5H@HIIF@DHF?CEHHHHDFHFHAE<H)H@HHHHFGHHH+E:?FE(E+GGEE?CFEEDE>EB*=8EGGDEGGF:C4:G:GEEEGG:C@EGE(:E:A((>CE::?CECEEEE0:*G.<?AG:GGCC*FC.(HE;0*EFC;<6GAA(AC:E'-(G(A>*6G4:G(C(*:G
@antibody_201_multiplicity_2_copy_2-1
CGGTGACCGTGGTCTCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAATAGATCTGCGCATTATAAGCAAAACTCCCCCAAACGTAATCATAATATAGCTATCTCGACTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAGACGGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATA
+
??A?ABBB9DD-9D+-FGFEFFH@FHHICIIHDICAHIIHIHHIFHI0GEE.IHACEI'GHIAIHF-DEII@GH5IA-IHFEHD=IGFHGIGF)F+EFDHC;HHHHHHHGFBH9FHHHEGE?@G?FGFHH86,GGFFEEEGGFGG:FG*(ED;G-CCGG?FGCGG8EEEG#EGF?FGGEGG??4*AEC6AEGA(E866EE,E:GACE:C:1CCCEEG/,(CEGGEE*GGEEGAGFG??/GE;;8F(GE/(
@antibody_202_multiplicity_9_copy_1-1
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAGATCTGCGCATTATCAGCATAACTCCCCCAAACGTAATCATAATATAGCTATTTCGACTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGGCTCAGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATGTGCTACCACCGCTATAA
+
A???A?BBDDD@D-BDFFFFFGHC7H/EECIDI;IIFII0HHDHHHCC/HHFFFHGIHHAIHFHHFH-CF=IIFHHIHHIHGE+IIHIHF)FIF<HHHHH+HHI?FG)DDHHHDHHBEFHGF>FHCCFHHFHGDGGGEGHFGGE6E;BGG,EC?;BEEGCCEC6G@(EFGECG?GGG(;FG??/EEC#GCC?GFCE*E:GCF9<**8G*AEGE*(:EA:CGEGEA?ACGE:?ACECDGCE=:C-?C?(*E
@antibody_202_multiplicity_9_copy_2-1
AGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACGTGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGTAGACTCTGTGAAGGGCCGATTCACCATCTCCTGAGACAATTCCAAGAACACGATGTATCTTCAAATGAACAGCCTGAGAGCGGAGGACACGGCC
+
,??A?B9?D=5-DDDDGFFDGFFHHHF;.EH9@DIIC=EIDFIIIHHHFFI8IDGHHIHHD>IFFIEGIHFAIE?I(HHF@HFIHIHHIDE8F>FHIHAHDG+AH?.HHH=9BF8HFGFEHHECHHHGF-GGFGHEG*;GFCGGG.GCGCFF36G'GGGEGECECCG?C*5/B/G::GEG::E?AE??A8G;F<F/EEA(EE0(E/:G#FF6(AC?GGE;(ECFG;GCG?CEGEECG#?GE6*EEC1C?(
@antibody_202_multiplicity_9_copy_3-1
GTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCTGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTCCTGTGCGAGTCGAGATGGCTATATTATGATTACGTTTGGGGCAGTTATGCTGA
+
<????B?B<DBDDDDBCFGGFGHF6HIHHIHIFCH0IIH/H/HHH.IHHHH8HCFHHFEGFIFH?-H/IF=HFHDIHAHFHHFFHH-GAEIHEF>FFHFEBHHH@@HHEF>:HGFGEF8FH.*8E=FHHH@7E8FFBBEEFFFE;;:EFA,EC/EG?:E:3GAEGGA??GGGCECEEE0CG:G8=EGEFEEGE'DC#GE;EE6'*EEE:E..H(>7E;E@GA:AAEGACEE1:G4;CE*EC6G?:8EGC?
@antibody_202_multiplicity_9_copy_4-1
AGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGGGGGTCTCAGTTATTTATAGCGGTGGTAGCCCATACTACGCAGACTCTGTGAAGCGCCGATTCACCATCTCCTGAGACAACTCCCAGAACACGCTGTATCTTCAAATGAACACCCTGAGATCCGAGGA
+
<???9B-BD=BDDDB9BFAFGGIIIIHHFHIHEHIFHI7F?G-IIFI@H=HFIHDHFIEHHCFHHEBFEDHFHHEH5DHHFGDD8HIGFCEIFHHBIIHC=DHH)HF7==HFH?HHGGB4HF*>4GD*FGBG;GE<FGAG*;BFCHEGEE,D/0E;GG<EGEAG?G.GFAGGE*EG(GGEEG)EGEGGE(A?CE:FC?E8EC'1DC#EAF:GE<EEG?CABGEGCGE':?6GG6*?E*'-G6*CCE8A*E
@antibody_202_multiplicity_9_copy_5-1
GGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGAGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCTGTGAAGGGCCGATTCACCCTCTCCTGAGACAGTTCCACGAACAAGCTGTATCTTCAAATGAACAGC
+
?????B>BBBBDDDDDGFGGF?IHH/ICH@EHHICDEFHHH>FHIH@ICIIHIH@GHIHH5I-HHCI+HHHDH+HHHIGIHFHH=HEIHIGHIGGHHFHDIFFHFDDACH=*5HHBF=9C=F*5+FGGGFHGGEECFGEGEEGECGGGGG3*E88EEG<EE:BBEGE?E*8(E*E'GBGF<GFE/G6FGA<?EEE0A<CG?E#(EE(CGH:8H(G(G*GFB,*(EE0-*E*?6*AGEC?E?EG?EF?EG:
@antibody_202_multiplicity_9_copy_6-1
TCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGAAGGGCCGATTCAGCATCTCCTGAGACAATTCCAAGAACACGCTGTTTCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGGCTGTGTATTGGTGTGCGAGTCGGGATAGCTATATTATGATTACGTTTGGGG
+
?????BB?BD<BD+DDGFGFFF6CEHFIH.IIHHHIFE9HHDIHCIF.GAF-HFCH/GHHHHH?G5IHF-F-DFHFDIFH=IHHE)HFHF*.8HBHH=E.@H7F<HHFHDAH-IFEIHGFCGFDDGH*G=0#G=EIG8DEDEBEEFGEEE(G0E7DAGE:8E:#EEGEEA*(GAEA(;GEEGCFCE1FEEGE**EFEE?<(A?GEF6E((?EHFB>?E,G0#E:*?(E*?#*E:GA-/6/0CG*;:?EGC
@antibody_202_multiplicity_9_copy_7-1
GGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAGATCTGCGCATTATCAGCATAACTCCCCCAAACGTAATCATAATATAGCTATCTCGACTCGCACAGTAATACACGGCCGTGTCATCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGACTTGTCTCAGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATGTGCGACCACCGCTAT
+
??=55<B?EEB-BDDDCFFFGG->HHEEHHHGAHHEIEGIEHIH7HDE7HHIFHI=DCFHHI@HHH,FIGB?@+HCHIGHH5H-HHAIHHHFFHAIFCEEHFFHF@I8?FHHFEHCH(?FFHHHG*G1A9EGFGF,GF;**GGEBFG2FGE?GE8EEGEF.GEFE;FEGGEGGDD68?>G;G0(A<EG:*E?G:(ECF8:EG/E:EECGH?*HC/:EE0(EF?E(??A.CEF?G?EA**:*??GGC0E:;
@antibody_202_multiplicity_9_copy_8-1
AGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGCAGGGCCGATTCACCATCTCCTGAGACAATTCAAAGAACACGCTGTATCTTCAAATGAACAGCGTGAGAGCCGAGGACACGGCC
+
=???<5BBDB-BDBD<FFGGCFHCFBEIHHHI.EFCFII+EIFHE@IHHHHIEC0HFEHIIDHIFI5HI+HAI6IECHIIHHHIHIH9A/I+EHIHHIFHIBHIDHDFFCF,HBHF,FFBFFBHC;FH9HE8990EGCG>EAABE?GEFCF?GG(:*E(:EEAEEC'AFGE;0GEEG?*EEFGEEGFFCFGG8:EFEE*<CECEA(/?<6(GHGCEG:?=';:1CGG-?(?GEG?(GC?:EA6E?E?:(G
@antibody_202_multiplicity_9_copy_9-1
GGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCTGAGAAAAGTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAG
+
=???ABB?DBDB<DDBFGFGGFI-FHHIFH>HIFFIIFCFH7HHHGI-GFHFIHGFDCAHHDCHHHHFIHHFHEIEHIEEE@HEIDHBFIHB<IHHHF)F:HHHIH?HHF+HGHCFIHGEGEFHEEFHGEDG<HG6FGG?DG8GFCEF?*,GEEGG*BGGG-FG*E/FCGGGG(FEC.:E2?EEGCCGF;GE?EEA(E*CE#:C(G*A(<(6EEFC(:CFC<?GGG8GE;?::EF?DGEE1FGFAE;AGG
@antibody_203_multiplicity_1_copy_1-1
GTGAAGCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTCCCGGAGCTGGATCCGCCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAGCACGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCACTTCTACCTGTAGCTGAGCTCTGTCACCGCCGCGGACACGGCAGTGTATTACTG
+
??A?<BBB?BDBDBDBFGCGGF8FIIHICHHIHHHIDEHFHCHFF@HI9HIIF-EFIIC=GI+CHH5IHHCFIIHEIFE,CDIHEEICDBEH=EHHHIHHHHIHHHHG+BGCFFHHHHH*HCG4FFGEEE(==HGGFFBFGGGADG#;EG>E;GFFEE8GG8/.6GGGE6E?GCEB;EEGEFCEE/C/EE)EE4EG#CECE8EEE<'GGEE?=0(#:A,G#0CE</C;E9F:ACG.G'(ECE*GG*G1A(
@antibody_204_multiplicity_3_copy_1-1
GTGCAGCTGCAGGAGTCGGGCCCAGGCCTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGTGAAATCAATCATAGGGGAAGCACCAATTACAACCCGTCCCTCAATAGTCGAATCACCATGTCATAGACACGTCCAAGAACCAATTCTACCTGAAGCTGAGCTCTGT
+
?????B7BDBDBDDDBFGGEFC-IHH,HFEFE@IAHHDCIHIFGHDHACHFIHFHG?H8GIFHIFIHI=IHHH==GFIHHF+FCG+HHHH8HAHHGHCEHI=GHDHDGFH7HHF*DFGH?EHGFGB2FEEEEFG;GEDCG=EG)GGCEE;EG4AEGEEEGHG?EFCA;GE6G*G#GF?C:EG2E:EEE:GE:FGFC?*E*EG*GF*FC?0EG.GC?CG,FGE(ECF8GGG'EE*AC.8.C?G?CEGG<G(
@antibody_204_multiplicity_3_copy_2-1
AGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCGCAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAATTGGTTCTTGGACGTGTCTATGACATGGTGATTCGACTATTGAGGGACGGGTTGTAATTGGTGCTTCCCCTATGATTGGTTACCCCAATCCACTCCAGTC
+
?<?A?BBB6@5<DDDD8CG/F@CEHHIHH-IICBIHIIHIIHIH0IF@5BAHEFIIHHHEIFE+HBHFIBDIHCHI-II>-?HFGHFEHIHGFHGI+1EIDHI*HFHHEHHFHHHFF-H>*EFEA+EB8GADD=E1F?G#+GE(F8E?=?D?EGFG(*G6G;E2CG;(*6(3(C6EEEGFG?GA;E1?E0CE?GEEFGEG(FG(80EFFECEHC':30CG:#AEG-?E(*C(GC**EFGAA?*AG*E*8:
@antibody_204_multiplicity_3_copy_3-1
CAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAATTGGTTCTTGGACGTGTCTATGACATGGTGATTCGACTATTGAGGGACGGGTTGTAATTGGTGCTTCCCCTATGATTGAATTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCTGCTCCAGTAGCAACCACTAAAGGACCCACCATAGACAGCGCAG
+
<??5?<7=DADDDDDDFAFF@GFH-E>CHFDIHII?-IEHCADH=IFG>HHDH?IHFII,F-I5IHCIHFHIHIHHII?,HIDF,?.G7IGFIEGHIHHH9GFHF#EEIFEHEG;EH@HH.DC#FGHFEF@E;F;FFEGFGBD@GEEFFEEFFFF@DEGG?'ACEDGAGGGG6A((GEED+6:FGG(<EG*FGA0EG*GEGGC//D6G4HA:(E(GD*0,G:GFE'?A*62*(E408?.?:CE:6E6EG?
@antibody_205_multiplicity_3_copy_1-1
AGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTTGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTATTTGATGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTC
+
???,5B<BDBBBDBDBAGAGFGIIHE8FHICEHHEIEFHIH=F.FDEHIFFFF@C>FDGICH5IFFHHHFHFHIFICHFA?IGHIHHFI?CAHE-BHHHE?FHHE*GFHIHHH=EHHI=H:EHHFH.BGGEG?;EE;*HG)FFGG,FE+GE;7C.GC8G-GEG:ECEGDEEE?CA)CGEEF+EGCGEGGEGG-G.E:FEEC80EECF(CAE8C:*G*EF(?EGCC*6FGEA:GE(C.FCC80EE?GECEC
@antibody_205_multiplicity_3_copy_2-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTTGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTCATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGACTACTGACATGGTGATTCGACTTTTGAGCGACGGGTTGTATTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCA
+
5????BB<?BDBDD-BGFCFCFI;HHFCIIHIGFHAICD@GHGIAGC.AFHEHHFFAHHIHFI=HHDHHFH=ACIEHAFIHIBFHHHHFFH>HHDE?FIHHHI*HHEF)HEGGFH:;GHF#EGG(HH<DGH?EH@BGEGG=3DGFBGGGFBG2GE4GE@:D?CG:E3G0GG@G8.EEGCCEECFE*GEE6E*C(GEE*EFGA*GE2E(0HCGEGE:GCFEECE*CEE6E:#EE)E860:?.E6EEG*E?G
@antibody_205_multiplicity_3_copy_3-1
GACGGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGCTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGACGGGACCGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCAACAAATACAACCCGTCCCACAAGAGTCGAATCAACATGTCAGTAGACACGTGCAAGACCCAGTTCTAACTGAAGCTGAGCTCTGTGTCCGCCGCGGACACGGCCGTGTA
+
???A?BBB@BD5DDD<GGFFFGHHIFHHHI>@FI+IFIFHDEH=HACHIH=GGHIFCG+HF>IH5IHFHIIIAH-IHDHHHH-EGIHHGHGHIFFIDIF'HEI*H'HHDF@3:BEG?>DFHGEG4GGEG6EFEDFCDEGE(*F8@*FD=GG5FCGG;E:#GEF:GCE:GCFGCC-EDG(EG(GECE?EAEE/(??GEG*E6GEE:E:EC<?:@4FFG.?:E(?E;ED(CEEEC8:EGCA?GGE8*C*(E?
@antibody_206_multiplicity_3_copy_1-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGCGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAATACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACGAGTTCTACCTGAAGCTGAGCTCT
+
<????B9=DD-DDDBBFFGFE8IFHIH8I?+4HFI+.ICHHCECIGGFICIADIGIHI-G8-HHFFHFFHIAIBFIHIEH+DHE7CEHBEDDFHHHDFAHC7H=D6IHHDFHF@CGEFDFGFG2DFGF*H=@+GDD(C@GEFG0G*F?EGFAEECG/8C22EB:CEECGFBEC:E?=?EF<;(FFAEGEGGEA<GGG?:G(ECCF*E(?:GECG@7:G(EF'A0::#6C6*EFC*DEGE(*ADC<(ECGF
@antibody_206_multiplicity_3_copy_2-1
CGCGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGCCGTGTCTGCTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTATTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCGCCAGTAGTAACCACTGAAGGATCCACC
+
??5??B?BDDDDDEDDFFEFF>HHHAAIFIDFEFIHC8GHIFHEED8HHF9IFHFIIHHFH+HHEFEGGHCFIHHEIH-G4>FHIIHIGFDIFHHHE,;HHE?H,H#IF+FG?H14HFHBH??C)HHDHH4FCBED(ECEEG,EF8FEFEEEGGGGFF6EF>BGEF?E6EGEC):*:GEGE6E?G?2E(??FEEEGCGCEEC6GCA(E;EEGE.0EC<?CEE:/?G.GGEAC*EAE(C;:*'.G*:CCD'
@antibody_206_multiplicity_3_copy_3-1
GCCCCAGTAGTCAAAGTAGCAGCTCACCGCGCGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGGACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAGCTGGTTCTTAGACGTGTCTACTGACATGGTGATTCGACTCTTGACGGACGGGTTGTATTGGTGCTGCAACTATAATTGATTTCCCCAATCCACTCCAGTCCCTTCCTTGTGGACTGGCGGATCCAG
+
5A???BBBDDDDDBDBGGFEFC.HII/HEICFIIHHHFHH7AFGFHHFGBHIFHGEHHIHF-ACIHIH5F#@HFHICFEHGIHIHADCH=I=A@E=I?HIGH8)+HHD-DHGBGFHHHHEHHF#6H;HHGHEE*EEGEFGFEDG9GFGEFAEEGEFEEFECE0GFE:E(G?FCEEEE?C0GEEEC*?0E(F(EGGAC#GCG.88EFE:*/?(FGE:)GBEG7FE*E(CEG(A(8EE)?(-C>/?;EE?E/
@antibody_207_multiplicity_51_copy_1-1
GGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTAAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGAGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGCACACGGCCGTGTATTATGTGCGAGATAGA
+
?<<A?B<?BB5DBD5DFFAG>GFF/HIHHH9DHCCGHFH+HHHIFHHICHHEF/HGHF-G,=HHEHAI5IIHHFHIICICIHGFH>IFHIHH.GFEDGDEE<)IGHHGHHHHD@AHD6CH++F5FGEGDF,FG/FBFEGE?E@EFEDGEEGEF@F8//GCFG*E(EFF4E:BGCGEG<EAG?GEEEEEEE*CE0GEFE:G6C;1G/FE?<*:E(E7EAG<'GEC*E*G=;FCE*EE6A;CF?G?AEE**C
@antibody_207_multiplicity_51_copy_2-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGGCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTCTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGT
+
<???5BBBBED-DBDDF6AGGGFH>.FIC,DFHHCHIB.FAIF7=IIHI9GIHIHII*HA,+GHHHAHHBIIIDI-?IH5,EIIDHHBHHEHHH=BFDHCFH=FH<FI,D44F+HHFGH:CCGH)GHE+GFEEGGBGDAGEC(1DGGGEG*GGFFGEEEEC.,GGG(F@?FGEFGGEGG>EG/EEGE;CGGG(GEGGEE8GA*C*(CEG?'A@.G*GC?@B7/C/EA(>.:8C<EC?4:9C:E(?E*>.?
@antibody_207_multiplicity_51_copy_3-1
GTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTCGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGAATCGGCCGTGTATTATGTGCGAGATAGATTCTCGCCT
+
??<?,?BBD<BE<BDDF>GGAG?FI?CHH>IFHAIHGHEFIHEIIIHD,GIAF-GA@HHHHHIFIH5FGEHEIIDHHHIIEIIHIHI7DHH.HHGFFHHHHF<HDEF9@FHFEHCDF6EGH)GEFBGHGFGFHGD@AGCE?AGE;/GE;4AG6(BG?/F#EEEEDGGEG/*(AGEE(A0:CC8ECEAEE.E:E?G*>EE*EG/(EEEF(EGC*0*CEC7:CGC60?:AG(CEGEEC?:=A(;(*C*E6CG
@antibody_207_multiplicity_51_copy_4-1
AGCCTTCTGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTAGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTGGAATCACCATGTCAGTAGACACGTACAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTATTATGTGCG
+
???A?BB?DDDD+BDDGG?GFFHIIII-HECH,HGIHI>CD+HDD)-II@HEGEDFCCFIGHFGEHFHHFIHFH-HH4HFCFHHHI=I@HHH8C-FIF?HH-FDHFH8FGGHHDEG@FFDHDH1EHEEDFH;FDE?FDC:GGGG*;E?FGEE?EFFC:*FG(GCA>E'EG8EFGCG6G'GGEC*G6FA?G)*GGC6/*6EG?:E?ECCCC:A(EC'G:?8*A<G<F.AG:6GEAC(*(AE?E*AACA=FG
@antibody_207_multiplicity_51_copy_5-1
AGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGGGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTAGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTCCAGTACTAACCACTGA
+
?????B/BDDDDDDDBCFGFAFHFHHHHFCIHIAEDIF(GIGCFEHHF9HICDHHI9=FFFC+DFDG>HGHFIHHAHHHH5HHE=FDCHHHIIH=BHHEF#HHHHH+6=HHC@FFDHHFFE1DDGEEFHGHHFGG;DG@EEGFFE;GCGEGCE+E;E.FEGECCC<EF/G0EFF@.G?CGE9:8;GAFG06FFE60FEGGCGC8EG<E*ECFHE(2EAGCC,=>ECC?8;:E:GG(E9EE(1CG'D.C**
@antibody_207_multiplicity_51_copy_6-1
TCACCTGCGCTGTCTACGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTATTATGTGCGAGATAGATCCTCGCCTCAAGC
+
???5A@BBDDD@BDDD/GFFGGHHI@IF?HFHHHHG.9DIHH.IDIIDHFHGD47IA-FEHHHCFEHFFIDIGEIHBIIIEHGHHHHHHI/EHHHI=?EGIGFFHF1IEIHGFE>6HGHFFHH:GD*GEDDEGGGFAGFEGE;DGCEGGCBE@2FGEFGG(:AGG6E;(.GGEG?E;F?:,EF?EC?./8#2A?(ACDECE?A:;EECCHEECCG8G:?)B>6GE84*EEE?/(D?E:#1:EEG2E*/'?
@antibody_207_multiplicity_51_copy_7-1
AGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGAGCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTGCCCTGGGGGCTGGCGGATCCGGATCCAGTACTAACCACTGA
+
???<?BB--DDDDDD@FFCFFGBCFH+HHIIFDFGH-IH.H?ICIHFFIGIEE9GHHGA-G.FHFHBFHHFEHDGHHI5HF+IH>HEH+FHHG/DHHFCH+HHHHEFHBGEGGDCHHFEHH8ED>F;HHDFHHEGGF@EGGGED*F.G8EF(EGCFEEFEG?EFE<ECEG??FFEFBFEE:;EF:GDGA:=6CFG0GCCCAFE*CAHG/A??EG*GEEE.GG:<E6AEE'-(EG*68G*>:?E(:GG-?C
@antibody_207_multiplicity_51_copy_8-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACGGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACTCGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAAAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATACTCTCCAGT
+
A,??ABB>DD@D?BDDG?GGCGHHFEFHHHHHHI?FGHHFFHIGIIIIIIH@HDH>G?H+HFG-AHFHEIIHHI?HH>HH5EIHHHI8HH<F-HFCAHHFHH<FHD(EEG3FHHCFG;FEHGHHBA*E*GGGEG@(;?DEGEGFD86#@FE*A=GEDGGEFF?8EE9GEE?EG:0AA<AEGFE6GEEACEG8;-?GEDE:(GE(.G?C*E(GCE0A:GGEBEGEF:C?F6DG.:G:.8E0#E0?A;GE5E
@antibody_207_multiplicity_51_copy_9-1
TCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAATCCGTCCCTCCAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGAGCGCCGCGGACACGGCCGTGTATTATGTGCGAGATAGATCTTCGCCTCAC
+
<????BBBDDDDDDDDGFFFAGFFHFFHIHICFEH.>9IHIHBHFHGE=IHDHBHAHIHHHHHIHEIIFHFEFHIHEF-FFHH-IDDHCI=HFHHD9HAFEHHH>HFF4GHFEFFEHHHHFHG#HDCHGEE:H-G4FCEGGD@?GGEEEEE(E-(?C?8<EECEE:F?E?*CE?EE(/(EECEGEE8GF?/CGC)CEGE0*FCE**:*6:EEE*E:EG0@::F*EGC?E6CE'*C*0E0?(E.EGG(AE0
@antibody_207_multiplicity_51_copy_10-1
TGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCGGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTATTATGTGCGAGATGGATGTTCGCC
+
?<???BBAB5DDDB<BGGAFGGFHHHEIEIC,?IHGFFHHFHE>IFFH@GEICHGHEHHHHHHHHDCIHIHIHI-HDFFFIHE8DHHHHF@C>HIHI@HG8AFHIFCDHGGHCHHFGG*@H=E2HEGGEEDFFGAE=EG*HDG?@EFG;F06GE=FG'EACGGGE2EFE?FEEEFG.CG?/GCGAEE8E8E('AGEEC;*G(ECEA?EG2GG*@GCGEEDE0EFCD?**E4GEG?86EG*GG((1GA0C0
@antibody_207_multiplicity_51_copy_11-1
GCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTCCAGTTCTAACCACTGAAGGACCCA
+
??=???7-DDDDDDDDFGFEGEIHIHIBHFIDH.HDFID>GIHIHHHDFAGFFFIA+HEHDAIICHBHFFHHFFHIIGCFHHH,?HC@HHHHHHHHFHFHDIGHEDGDHHGFEEFF)GGF:FDGA(FFHHC;HGGC1@EGG3ACEFGEAEGDGA:5AGF;GGBFF*GG?EF:EGE(EAEGFD?EFCG(;D:(CEF6EF(G;E/GEEH<GA6EHCBEG:E7EG:2C(?0F?**/6'GGG/F<=C:G('F:E
@antibody_207_multiplicity_51_copy_12-1
CTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGCTTGTAGTTGGCGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTAGCGGA
+
??=?<BBBDDBDED@BGFFFFFI.IHHFHHHG/HICCHHIHIHGHHHHDDDHH8HHHDIFIFHI5HBEDHAHHHDGHI?IDFHIGFHCHHHHIFH)=HDFGF;=CEHHEHHG-CFFF?G=GCGFFAFGHG3EC?EEE0BGGGEG5GDF2*GGAECGFGEEGFG/GEECEG?CFE?GEEEFEADGGGGDGD*E:(E/E<E//GEGCGF*C;G.E<*C/GGGB(CE*:FEC?EE2;CE.;FCEEE:'FE-EE
@antibody_207_multiplicity_51_copy_13-1
GTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTGTACCGACATTGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCGCAAGCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTCCAGTACTAACC
+
?????BBBDEABDDBDGGCCGGHIHH/?HHCCFIHHFEFHEHIHGEHFIHHHH8HDHHFC5HFFEIIH@EEFHD7EHHHGGDE:FIFIGHBHDHIHFH7H=FIHH+DAHHHC:HDFHGECDFGF7F*FE8*FEHE8#GBFFGGFG?:FGEG86EF??FFFGGAAGGCGEFE9ECGEE)?CE:EFG:G*GEGFD.*:GD(C:CEGGECCEHG:(C'GEGGEEEC2GCAF*A:>'':GCF?1E:AEGACC?A
@antibody_207_multiplicity_51_copy_14-1
GTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGACGGACGGCGTGTAGTTGGTGCTGCCATTATGATTGATTTCCCCAATCCACTCCAGTCCCTCCCCT
+
A?,AAB@B?DBDD@-DFFBFEF;IFFHFCI/CH>=HIGC/FGHIHHFIFHHHIHFD;IHEHHFFHHIHI@HEHFDCCHAHDHC=FHFHHIHEHDHEHHIHHHIEICFCHHH5EHBHGFD@F6F9D:E0GDGEGGGGG?,GGGG<G,GEF@E;C,AF;FFGHECG>6F8CGG:EGCCGAGEEEFGE(EFE?EEG*E*:?:E.8FF(0:GC-C(E7G18CGGGEEEE:EGC(CE6<A8CE0(GE*AG(E.CC
@antibody_207_multiplicity_51_copy_15-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCGTCAAGAGTCGACTCACCATATCAGTAGACACGCCCAAGAACCAGTTCTACCTGAACGTGATCTC
+
???5?BBBDDBD-B?DGGBGACII+HAI@FEH9HHH=DFHHHEH.FHIAHIDIHAIFEHHHIBHHIFH-HEHFHHF*<FAHEFH5HHHIG8GGD;?8FH=;CHFHFHHGDHEFE8GHH:HDACGEEHFGGFGHFCGH8EEDEGGGGEGGEE.GGG?8FGGEEFE((?(8GEE=CC*?GG*EC6>:'EAF?;<GGFG((G6FAE(F0/*)H1EA@GE?A#,E:?C8/A80;?#E/(C:/E?/G'C0G0C80
@antibody_207_multiplicity_51_copy_16-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCTGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATATTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCAACCTGAACCTGATCTCTGTGACC
+
A????/@B@ADBDDDDFCGGFDII>EFEFE7FIHIGHECIHHEIFDHIFHHIHHIIIEADHDGGIFIHH-HCHHC5+I-GFHFDEFBCHFFCHIHFFH,,HHDDEFEEEFHH+D'EG@FDFHE+H8EAFFB@-EEEGGG?=EG@GGEE:.FF(6FG?:0GFC/GGE8FCGGEEGG?GCF*DCFDECAFEDE?GF(E?:CE/C?EA6H?EEA((1CEEG?8B(C:EE#-FAGGG6C:?AC(*))/6CEGC.
@antibody_207_multiplicity_51_copy_17-1
TGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCTCCAGGGAAGGGATTGGAGTGGATTGGGGAAATCAATCATAGTGTCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTGAGTAGACACGTCCGAGTACCAGTTCTACCTGAACCTGATCTCTGTGACCGCAGCGGACACGGCCGTTTATTATGT
+
?95??>9ADBDDBDDBFCGGAGHHIFB>HI=CICHDFIHI8FIF@HHGIFGIE0HDFIFAHFFHH-HIIFIIHHDHFIDEDHEHH-HCI@FHHHC?HI-HEIFIHHHCGHFHGHEEH?FHDHEHFFHDF*GGHDGG)EGEEEE*CGE:GHG>GC*EG)GE*EA)G0GGEFE'<G(EFEFEDEGA(GGG#EA*?E.=GG<AEGAGGCCEG6?AH:FG7EF7?7:EG?#E::/'/CG()?E(C(??88:A'0
@antibody_207_multiplicity_51_copy_18-1
AGACCCTGTCCCTCACCTGCGCTATCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGCATTATGTGAGAGATAGGTC
+
????,BB?<DDDD@?DFFFFFG++HBHHCFIHDDEEH?GIHCHHFH+IFHGHHGHDHFHHHHGIIHCHIHEHHIA>HB4CHHIF+HHH6FGHIIHHHIEGHH,FHCFEEGG@3FF8=@HBFB)F?GEGGGEDDEFGF5BGFG8GBFGEGEEEGEG#DCG6*<DCE*@<:E:GCAEE#E*G+E<G?:GFEFGE#?'EA?GEG(C;?*H?E(8EECC*ECG<9EG8(GG?:E'0EAA*C?A*?EE11::#E.
@antibody_207_multiplicity_51_copy_19-1
CCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCGAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTATTATGTGCGAGATAGATCTTCG
+
?A?=?BB?BD@DDBDBECFC?FIHEFIIEHCHHHIHIDIFH+IFFFHHHBIHHHD5I>IDIBIHHH?HIIIHIIIDFHI,HHHHFIHF=HHIHGHGBHA3H@HG=FHG+HGHFEEHDHCEFHEEDHHEGHFD;;GBFFGFCDEGFGEGFGD@EGEGGECEEGGE*EGF?ECE#GCEEGE?G(ECG/AEEF0GEGEFEACG(GC(EGE?G?EEA0/::CGG;,G((?FCF<AG8GG(FE<E((??/CE?*E
@antibody_207_multiplicity_51_copy_20-1
GGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCGGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATACGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTTCAGTCCCTTCCC
+
???<5=>BDD<DB-BEGCGG>FEGAI/AHHFE/IG@IHIHE.EH7GGHHEHIHIDHHEIFHDHI55I5HIIII5FIHIHEAFAIEFHIHHFHI6FIAE)H=HH*H8IFHHH:BHHFEGF=CHG4H)*9D*HEGFEGGECF;8GD3GGEDCFE@CF?CGCEGA*EGEEEGGC*G8C(G@E?E:GGEE8GCEE:GEGF(?CG0G(*GC*GFE8CH0B?GE::0EA(??F?E9?G*?G)G*GEE0/C;C(06:
@antibody_207_multiplicity_51_copy_21-1
GTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGGTCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTTCCTTCCCTGGGGGTTGG
+
<?A??AB3D<9DDDDDGGGGGFIH-FHHHIFIGFHCHIDG-FIGIIEIHDHFIHCIBIGIHIH@CFEIEHFEIEHHB-HIDGE=DHIFFGE6F4CHFGGH,HIH9HHDHE=+HF=#H<EEFGEHGFE=9HG<GG(GFF6DHADGFEGFF;G@GC<EGFG/EE?CE?;(GACGEGF??EGGEG:E;C0:.G?EDE*GG<GGEAE:0CCCGAAE@E0E*;G177GEF#EE:EAG(6-0EEEC**6?E?*FEG
@antibody_207_multiplicity_51_copy_22-1
GGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGCGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCATGAGTCGAATCATCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTCAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTATTAT
+
???5A>BBDDE@B?B-EG6GFEICHHFECFI.CH@.HHHH@HHFH=F+IGHHHGHF/5HDFHEHIFHH6DCCHIHH+IHIGDHCHFHHFC.HHEFHH+EHDGI.FHHFG@F+FIC@EHHGH+FGEHE+HGGB@GCFEG1G*EHEE>FGGEEGF7E(0G*0FGCGFEE.EE)E8((E;EE:?/2G:FGAF(CCGG?ECGFGEGEEGEA*<H;E)AE<7CEGE/?CGE6?EG?0E#GEC:EG6(C:A*DEE:
@antibody_207_multiplicity_51_copy_23-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACGGGAGTGGATTGGGGAAATCAATCATAGAGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGCATCACCATGTCTGTAGACACGTCCAATAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCA
+
???9ABBB6DD@DDDBFFBAGGIBHHHEI>EHIHHICFHE.CGH.FIHH-HFIHGFE5HCBIH=HE-IHH;HIHEIICHGCFH8IFHFFEHHECHIHHH?FHHEF6DDDHHFCGFCH;FDE+HGCFFG@EGFBFHFG?G),FEB=*E/;*DE1?ACGG2GA'EEFE:EG-EGFG0G'EG8EAFGE(6AG??;?GGGC#C:*G*FG8EGGE*D*G@EGC,GF?*.;G*EGC((A*F=:C8/6:E:0*)*C-
@antibody_207_multiplicity_51_copy_24-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTAGCCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTAGAGTCGATTGGGGAAATCAATCATAGTGGCAGCACCAAATACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGATCCAGTTCTACCTGAACCTGATCTCT
+
?=,??7BBDDDBED<9B;GEGDHFHI>FHCI+GIHDIHIF/IH.EH@FIIHH@FIHF5+HDHIHHHIG,HI4HH=IFDDD=IIDFIIHIIHAHFHEIHHIFHIIC6HGEIHFHHHDFGHFFFFBHEFGHEFE)FDAF*GH*FEGC5?GF;C=EGEEAG;ACGECCGE.(C-,(E*BE?<@CEE-CGEGGF.>EFEGE:*FE1GEEG*<8<EEH0F?.?0)/:?E((EE:ECGG?EE<EGC(C6GE)9G??
@antibody_207_multiplicity_51_copy_25-1
GACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCAGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGTGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGTCGCGGACAAGCCCGTGTA
+
?????BBBEDBDDD-DCFGFGAAICEFHIHHCFEI@IH-I#FHIDHHF5HIHIIH>DHH9GFEIH@IGHIEHE-HHHFIICHHAHAE*II=HFFE-GDH?DHHGHF-HHIF+H3@FCFFBEGGHH*HEDEFEBE+1G2FF0?FGBGDEAGFFEEEEED#GGE?)(A6GCGDE*/CAGFG:EEG2GCECGE9E?CE?GG8:EEFFF//EGHGCCFEC:?',*7E?EAEA;GE(DCF?E#*C#'*CEE*).*
@antibody_207_multiplicity_51_copy_26-1
AGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCCCGGACACGGCCGTGTATTATGTGCG
+
?,??A?-BDDDBD<DDGGGFGCCFHI?ICH+IHFIHHI>EHIHFIFIHCHEI.GEHFFFHIFHFHFIECIHIH?CHH-FHIHHI9IHHFI6DFHH(IGDAGH+DHDIFEEC@HH3*HGFAFFEHB+H@F;E*HEDGFBBGEE7ED>E=G-DCFG?GG2/E?EE9GGGE*?EEFE:/GF@EGFGDE:AC?CGEG?FG.E?6'GGFA(H6F6FEHF*C(CG>GEGG*EE6?*??G80::*A)8:E0*EE*8C
@antibody_207_multiplicity_51_copy_27-1
GCTGCAGGAGTCGGGCCCAGGATTGGTGAGGCCTTCGGAGACCCTGTCCCTCACCTTCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAACGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACC
+
,?<?<-B?@ADDEDD-GEFFBG+IHEIHH-FIHHEHHI*H@IG=G0AAFHHGFHEI-CGHDIHHEHGHHGGHEIIHI)IEHHH/H9IHEGEHEHFHHHFDEH+HHHFHHE+G+HGFHF6C#EHDB;HGHA4D*9HG(DEGFEEFE*ACECEEGCGGEFGEGGGG*FG*(@GFGCC<EFE*+4EGEEG'<EC:E:8EGGEG<EE/*0AEGHEG*<EEGCE.7,?E?C?:C*:FE('G/>?(:*G??E*:8E
@antibody_207_multiplicity_51_copy_28-1
CAGGGTCCCTTGCCCCCCGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGAGCTATCTCGCACATAATACACGGCCGTGTCTGCGGCGGTCACAGAGTTCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACTTGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
??A?A?BBDDB5@D9BC+FCEGFFFIHHIIHHBHF@HHIHHFHHIH5AHFF5BHFGHIIGHHAIIG-HCIEHE#GCHHFHIHH8G-H=IHHH?HH7CHHFH-='-HCH7GF#C*5H/GH.DEHE8FFDECG9DG:EEC>EGEE/FEGFBEGEGE*)?ECEG*F:GGEA;FG*BA6GGGE=DCGC*GC?EGGAGEEFE.*FGGG::G88GHC?@@FA;8EG(E6G?EEGGEEEEC(GA4*?.CEA'CG:FE
@antibody_207_multiplicity_51_copy_29-1
TGAAGCCTTCCGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCAGTCCCTCAAGAGTCGAATCACCTTGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGAACACGGCCGTGTATTATGT
+
???9A?B+BB-DAD@BFFFCFCFHFI8HFH/HIHIIIFIBHIHIFHD*FHDIHGHAGHHICHG?EE-@HIEDIIAFHFF5IH-H=HIHEHGGCIHGCHHHHH*GHAHFGDFFHF?H@*FFFHHGHE@62GGFFGAE+3GEDC+=G?6*@FEGECEEGFEGEEE.CGEDG@(AE/EEAEEE?G?GAGC9C(/GEF(GEDAEGCGCEAHG(AA<AE8FEE(,E/(:G*1CCC(?(GGC:E?:6GEEEGA8CA
@antibody_207_multiplicity_51_copy_30-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCATGGAAGGGACTGGAGTGGATTAGGGAAATCAATCATAGTCGCGGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCCGAACCTGATCTCT
+
?5?==BB?DD,DBDD<GEFFAFCFHHI;IHHIHHIIIG9G;9;FHHGHII9@HEFBIFEIIIHHFHFFIGH5HIGEHIIHIIHFDCH=HIIHHH=ECHHC)GDHFHHIHHGFHEHHFF.,E'F?FGEG@6HAF@GGGFGEEE,8GG0CE:DG:GGFECEGEE**FGGEEG;GC?*;<6EE?GCCGA:EFFA::C;G<:EG2FEE(FF;G?G:;AE7FGECE,EGC(FF:?EA-<(0/FA*0A:AG*EE(?
@antibody_207_multiplicity_51_copy_31-1
CGAGTCACCGTAGTCAGCGCTTGAGGCGAAGGTCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCAGTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTCCAGTACTAACCACTGAAGGACCCAC
+
5??A?BBB-DDD?B-D8GFFFAHIHIHFIHH-7HIFHHHH+BFAFFHGFAIIEFHIFFCFIHFIFEEIIIFI>HIHBHIHHHF+DBIHH9IFHFF>HHIGHFEH<EDDHDHH,DGDEFHHGHEEDGFHEEE+GFGIH+AGC,EDC;FFFEFCEHGGG?F:G0=EG(EG.GFCG;F;CCG0(EEEE:C?D6E;<FG)FCGG?E;9F(C4C?<CHF*E)CGCEAGG0E(G0GFC?*E6//?CCE*CC0.CE*
@antibody_207_multiplicity_51_copy_32-1
CCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATAAACGGCCGTGTCCGCGGCGGCCACAGAGATCAGGTTAAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTTTTCAGGGACGGCTTGTAGTTGCTGCTGCCACTATGATTGATTTCCCCAATCCACTCCGGTCCCTTCCGTGGGGGCTGGCGGATCCAG
+
A,5A?BB?BE-DDD@?GGFGGEHII6HHIEHIFHHIAFDHFE.EIDFH8HF.+IIHIHFHHHG5FC+GHDIIGI?FCH#EDFEECE-=HFHHDEHHGH++HIHFHIH=FHFH5H*DH2EHFCEGF+C*GD,FBG(=GGCEEF;EE=GEAA=GEEE*EF.CG8#?*(CGGFB>CEGGEE?GGEEC)1DEGE(GF(*G*DFG:.*EEGE?EH;D@'(A0C,(*/GG1'E:C?*EC4A/.)AEGE::E:E(GF
@antibody_207_multiplicity_51_copy_33-1
ACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGTGTCTTATGTGCGAGATAGATCTTCGCCTCAAGCGC
+
?????B5<DDDDD+DBGFFG8GIH?IHH+FHHE+IIGI+EGIC@IIGHCIFEICIIIGHIIEGAEE-HB3IHIBHH*ADD-HGIHGIHIHHIHD+6H6HH?HD+HIHH=I@AGH6E8H?2FHHC=HDG-8E@GFBGFHGGHGGEE'GFH6GE*FF;F*GG:?(*G?GE<E?:E:G6:FG:GEEGAA-/CGGE:GE68EEC8'EF6AHA2FE(C:GGE('.(GE:GAA*(0C800(?DGEEE?G6EF*?G.
@antibody_207_multiplicity_51_copy_34-1
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCATCAACTACATGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTTCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGA
+
<<???BBBDB<D?@DDA+6CGGIEEHHE8BIEFGHIICHHHHCHHI=IIA.H>-.FHGHIHG5IIHIHIFFFIHIHF5HEDH=FHBHFHEEFHFFH+CEHGHDFDC@HDH+FE=H+DFFHHGEF.G?5HEHEAAGEE*?FG@@;D.?FEFFED(GEF6EEEE*GGGB>GEGGG:G8?4GGGE?:E;E<A?G(GGGEG:GGFGEE*EF?EE:E.EFEGCG8FG:EF.?E?:E/0:E:GCEE.G8:C*#;CG
@antibody_207_multiplicity_51_copy_35-1
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGTTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGCCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGT
+
<??9?BB<@D5BBDDDGFFGGACCIFEEHFCIAHIFHGHHIHADEHHAF=I>D7E,FHECIF5-B.FHGIGGFHHHFFIHGHIHHCHEH-GHGHHHH<F7IHHFFD;HHIF@HEHFFGHDGEHBHGHFGBFG+:9EE@@*?F?G.8EEGCGEFGGEEE*AGE(GG6C6CE:EACECE((AAGG(GEEA>EE1;E*(GC68*AFCG?H??HEEHEEE:<,EGEE6?F88:?A?F8FECE(GCECA<:6EE:
@antibody_207_multiplicity_51_copy_36-1
CTGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGCGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGATTAAGGTAGAACTGGTTCTTGGACGTGTCTACTGACCTGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTCCCGCTATAATTGAGTTCCCCAATCCACTCCA
+
????,@ABDD-BDDDBCGGGGG>HIHIIFF?I-I/9EGHHCHIIDFBFA@EAIFHH5HHGAIFBIFD6HHHIEHHGAIIE5?G5HEIHIH:@HFEGHHHHEFGH3E,DDHGE*(FFDD=D*CEGFG>EBGHE1E/;G3D+(GE*GGE=6FE:GGGEE#GGFG?GDBG<EB?E?FE:E+CEGGGEEE<8E;GA::8EE6G(D6CFG(#A*?(G8GEGCG,-.(C<:E'GGGG?(?4G?1:CC;?F0(EEGF
@antibody_207_multiplicity_51_copy_37-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTCCGGATACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGCATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCGACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTACAAGAACCAGTTCTACCAGAACCTGAGCTCTGTGA
+
??<??BBBDDB@<DDD.FG>FGFHAFFFFHGFGHII-HHIF+IFGH9HAHHHHIEHDH8HEHIH=IH?HFIHFIBIHDGI+5HH.IEEHFIIIIHIHC:EH+9-IDIHGFHGF@:G)EHGGHEFGHFF?GGGGHGF@GEGB*BG=DD>GAGE2@3G?FCCC?;0<(GDG::4<DGCG?EEEC.EE:EGGG??8ECCE:GCC(EECC.?GFGA8**G;EG:C7DEE(0>:(FE*??EGC(E:#0C*:A;G?
@antibody_207_multiplicity_51_copy_38-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGATCTACCTGAACCTGATCTC
+
???AAB-B=DDD<D9D6GCFCAEEBHH?IHIH>HH0HHIHGCDH=E>AEEGGFHHHCFH+IHHIFC-IHIHC+IH>?IEF?HIHHH@H6HHIFFIHH+HFHDHH7EID?DHD,FHG@HEDH6CBFAH4BFE2HHH(CH@E?GFBEEGEE?G@B*EG?EGE0CE(CE(EE?*F6G(E?G1G/G(C(E;=G6F*EA-GG0ECAE6EA8.E*:C88CE:(GC(*;*EE6CE?**EE8?.AAFCE:E(G?8G>F
@antibody_207_multiplicity_51_copy_39-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGGCTTCGGAGACCCTGTCCCTCACCTGCGCCGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGTGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCTTGTCAGTAGACACGTCCAAAAAACAGTTCTACCTAAACCTGATCTCTGTGAC
+
,?<5?B+BBD??DDBD/7GFFGH>IBHIHIHHGIHIFHEHGGIFI='-AIGHH,HHAFFHE'EHHIH5HIH+DHFDHFDIEHF:H+HIF+HH+IFHIIHHHHH3CHEHDGHGE/G=3E3FEG=EGF?GF*CDFGEGGFF.BEFFEBGEEG(GE:BBFEG<E?E:/G(GEFGG1EEEG?0E02EE?G((?(:G;F(AE);?G:;GGGCF/E?:FGG*E(.G(?F:-FEGGG0E1AE*:/G?F8ED*EEEEG
@antibody_207_multiplicity_51_copy_40-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTCCAGAGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATAACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGT
+
???9?BBBED<@-D-DGCFGGC+BB-HIFHF-IIACHIHHHHHHHHEF-H=HI=I??H5HBFH8FHEIHIGFGDB#+GF-DGHDHHFHFFEHHHH9HHICHGHCHHCHDGHF.GHGE1EHFGDDFHE*GEBEGGFEFGCGE1DEF.;3:EGE=8GF*?FGEGACGGGCG???CEG-FG:GE+EF:AC;E8*:6AEGAEA:GEC=??A(<EGGEAEGF(0A::E?E<?(GF:GAE4E*CF?6E8G/GE(G(
@antibody_207_multiplicity_51_copy_41-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGGTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCTCCAAGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGACCGC
+
??<?</BB-@<?DDDBEFFF;CFHII5IEHAIEFHFFFIFH5HIH=EIHIGHAHDIHEIIIIHAEEHHHGIDHFCCHH>DFH#HGDH7HFIGFHHH3?DHH@I7H?D8HFE7+EHFFDF;GFF.EAGEDH;H30(F@BGGF0GFEF@GGG2EDFEGGC;?BB:CC:.EEGE8GDGA/0A(GCE?0>.(E??#ECC(EDE.?1<?E6EE<(F:CAEEEEE@(G?EAFE*;<6ECC(.EEG(EE60*GFECA
@antibody_207_multiplicity_51_copy_42-1
TTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGAGGGCTTGTAGTTGGTGCTGCCACTATGATTGTTTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGAT
+
5??9?B??DDDDBDDDFFGGGGHHCIHFIICIEHIH=DII.HHFFFIIHIHGHFBIDHF-HHIHDIDF-+E5HHGCAF=IEIF.FH(HCFHHIHFBFHGFHHGFHIHHFHGHGHHHFHFG=BE3GGC,EGE>FHF4GAGB'EHFEGEGE=EFDGG5G(;AGEEAE/CEC?FCEF(*EEG#GEE:ECAACEE::/EF:G:E:GGGEG'8EH6CDGE*;*CEE-GG:CECCG*EG*EE)EGEE*/1GG:8(E
@antibody_207_multiplicity_51_copy_43-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTACTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACGATGATTGATTTCCCCTATCCACTCCAGTCC
+
A????-BBBD?DADBD/GFGFEHFAF8HFHIFFIAII-I@III.HDHHCBGHGCBHHDDIICECIFCHFIIDIHDHI-G>CIIHC-EHEHH@H-FHFHFHGD-FHE>HEHIGGHCHHFGBHEEGEGDG@FFGGG>G(CFDGFGEE3BEEGFE@(?FFEEG;:E/GGGG0E?(A6EG?GCGF+CG*EEG:6ECA?E:0C2:.C>CEG?GEEE?H1@GG(E,1?CCE*FGCG/E?A/':CG':C;*EE)CEE
@antibody_207_multiplicity_51_copy_44-1
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACAGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGCAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCTAAGAACCGGTTCTTCCTGAACCTGATCTCTGTGACCGCCGCGGACACGGCCGT
+
9??5A?BB?DD-DDBBFGFGFFIIIHEHEHCG@HH-IIHIGEII-D@F@H>HI-GHHHFIDHFFCIF+IIIDAI5CCDHFIH+HHHHFC6FFHHHIH9IFIHH@HHE-#HFHGFHDHEG3E+F1GBHEDGGDGEEFCGFBF*;CEGEC;BEECGE/3EEEEAF:G;G/'CCFCE(GCE:EGE4:EG?EBG*G.G(G(G((:CFE#FEAAF#?A/EGGGE@FE6GC:GC*GC?:;*:.EEC?E'GGCEEC<
@antibody_207_multiplicity_51_copy_45-1
ACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTAAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCTCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACGGACATGGTGATTCGACTGTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCGCTGGC
+
<??A??B?D5@BEDDDFFFGC8GHIIHHHHIIIHIIIE>HFEIEHII8FH-HHFFGD-CIH.IGHHDFIF5EH5HFIGFF5F-HIGD?GG<IHIG<HHGH3HIHHG(G*FH6H'HHF*HHFHHHHE.G0FE;;DGGGGDGACG0CGGGGFF?EE=EGA=*GE;GG(GGG:E1EE:GC(E6EAC?GEGGG*GFE6EE:EA*E*::EC**CE:3(EC(:?G0?GG**EE:0*?G1E-G*1(CG:E(#8(6C#
@antibody_207_multiplicity_51_copy_46-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTCCAGATAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGCTTCGACTCTTGAGGGACGGCTTGTAGGTGGTGCTGCCACCATGATTGATTTCCTCAATCCACTCCAG
+
????<BBB@BDDDDDDFFCEA.;HHH;III?IHHEIH.HHFCHDHGHC,HGAHHHF/IF-HHIHD8FH?+FFCIHIFD5F,HHI=FEADHC+C3HFAI=DIGH<FEIHG5DGGHFHCGHFE5FF=)HDH+FGECHGEHG2*(FFG/E2GCE0E*EE*EGHEEG6FG*AGGCGG*EF8GGG?C(FCE?E6:EFEAGC8GF(G6GE:AAAA:?EE@C*(FE7(.'ECG0EGGEE*D?>)GEA*/0ECEGC?A
@antibody_207_multiplicity_51_copy_47-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGACAGCACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAACCTGATCTCTGTGAC
+
,<???BB-DDDDDBD-FCFEFFFIIFHAF?IHFHCIIHIIHFFFHDF,F.EIHHHFIFHDHFHHIIHIHFIDHCHFFIFI+HHHEHIB-HFHI?FIIIHHFHH<HFGEFH>FHH*HG(;GFF@EGFDGE<DGG=HGFE**E=E/6E)FE9C*FEEC(G(EGBCGEAE/GE3<FEAG.AEEEGE8A1ECGEGGG?FCE<ECGEEE;(C??*'GHE*?FEFF9EE0(AEEE//EGG9-GEC8GC.G066(G*
@antibody_207_multiplicity_51_copy_48-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGCGACAGACATCAGGTTCAGGTAGAACTGGTTCTTTGACGTGTCTACTAACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGACTGATTTCCCCAATCCACTCCAGTCC
+
??<5ABBBBDDD<?DDGG,-+CHCIFCHH>HFIHGIAIHHHH,IHIGHHGHHH=IHG8FBCHHAFI.HIHIHE*F5IIHHFEFAFFIIGD=H*HHFHHIFHI-HIFHHFGHHH4HEFHDH*EF+'DEF4E(FE-EDEDAGHGGGGF@DEEBEGGEG**E:EEGGE?:0ED*EAGE?EFE.?GE6F<.G?E(G*GEE*GFE?G?EEGH:EE?GE((?>0:EE:CG*4C0*:G?06*G*(0EECC:ECE(E(
@antibody_207_multiplicity_51_copy_49-1
ACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGCGATTCGACTCTTGAGGGACGGCTTGTAGTTCGTGCTGCCACTATGACCGATTTACCCAATCCACTCCAGTCCCTTCCCTGGGGGCGGGCGGATCCAGCTCCAGTACTAACCACTGAAGGAC
+
??=5?BBBDDBBBBDEF;FGFCHAHHHHFHF9EHA+EHI+GDEHGIHI79HHECHHHFG@IICDFFDHI-HEDIIHIHHIHAHIFHHCIEEI@H=HHFBHFHIHHHEHFHH?+E6FHHFG=HFDEGGC+HHEGH+EGD;CBGEC6EGGECFE?@GEGEG(EGECFEGEG/G:GCE(#=GCEE#GGGCGC?G*.ACGGCCFDAGCGCCGEC:?*:/G*DGEGEE#/0G(D:G.EFCC:*?*CE?CGCC*.?
@antibody_207_multiplicity_51_copy_50-1
CCCCAGTAGTCAAAGTAGCAGCTCTCCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATGTTCCCAATCCACTCCAGTCACTTCCCTGGGGGCTGGCGGATCCAG
+
??=???B>B9BD@5BDGFFGEGHI'FCICFGHCH=IIH>DHFHIF-HBHIIIHFHHHIGIFIFHHHGF8HHHIDHFDAHI-FHHIHGHHIHIIIGGGIHHGEFFGHHH1EH<HFHGHEDFEHECHHGEGEHDGDGD@F;BGGEGABE?EFGGE;=C*GFGCE=;G(E8EFDEEGAG0F(FCGEGGG=(GGG:E6CE6GEGE6A:(F*1C/GGHEGGE*GA*GEE**;:**.E8C*::/AE:?E8*C0EE0
@antibody_207_multiplicity_51_copy_51-1
CCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACATAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGCTGCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGCTCCAGGACTAACCACTGAAGGACC
+
??A??BBBA<DDDBDBGCFG8>AEIHFHFIIIGIAIIHH.H@IEFHHFHA9HDC.BHFH5AHIHH5FGHAHEEFHHIC5HFBFHFGH<HHCIC=HICIFH<H=FDH,6H=HDE8HHFGHE6HDD4G@DGF3GE@BFGCGGEE,GEGE/E@EE?FGBE.ECEF=*GEFGGEE;GFGCECE2EGFGEE::FGEAEGCC</;*EG<CE:H?EAC?@88(GA;E:GGFE?9(CC*-A?D0DCC:G(C:6G>.:E
@antibody_208_multiplicity_2_copy_1-1
ACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATATCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCATTATGATTGATTTCCCCAATCCACTCCAGTCCCTT
+
???A?B9BDDDDBDDB>/>GFFH@FEIFIFHCIICFIEIHHH5IFIDGIFEFHIHBAFH5HEDHEFIBHIHEHIEIHHGHIHCHHHIICFIIHDHIHF=DCHHHHHHGFEEE:F'HDHHFDGEHHHHFD'GFGEDFB6?FEE(E0(DDG8G;GB8GA*CE*::GEEEGEGE.CEEEE(GE6FE'*GGAG0'G?8GGEDFA??CFG/:C00G?HE@(B.?::?6DE*C<E8E(C8EA?*GC6GG0C61(;C
@antibody_208_multiplicity_2_copy_2-1
GGTGACCATGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGCTTCAGGCAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGGTTCCACTAAGAGTGATTTCCCCAATCCACTCCAGTCCCTTCC
+
?A??<BBB-DD@DDDDFFFCC/FIEH8HFHIHHHEHFIFGHFH/>EHHHDHHDBHGHHAIF9HIHIH-IIGFD,GFE;*IFIHH+FAHAEHHFFF.EI=?HHH5H,FH=FHFDF1DHCH*FFFHHHHBG)EFFHG;H7)3EGEGAF;6G4:CFF<EE2GC6?GF:EG8GG?CEG?GEC(AE:E:GGGC(GG2)GG:CEA<EEE;EG6(?:AGC*1?(*F(GE6G?*6GEE1?:GEGGGG6-:0C?;G??E
@antibody_209_multiplicity_18_copy_1-1
GCAGCAGTCGGGCCCAGGAATGGTGAAGCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGACCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATTGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTAGAATCACCGTTGCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCTCTGTGACCGCCG
+
A???,BB>D5<B<DDDFAGFGGHIHHIHI8HIIDHIHD@HFDIFBH+HIH=HGHHICFFBH55GDHFIIHGEHEHI-HGIFHHICEIFHFHDFHHHF?HFH)HFEEEE*HCFEHEF3DHHGE+**GGEHBGFBEHEGBGG+8BEGFG(GGGE>GE?E@FEEE*FG(?FA:EC@GG<EE?CD.(EGEGEGE/A.6*)9AGEE?GG8E/E?A0GC1CCFC,E*4(6?.:DC*.*?(GEE*<*ACG(E?AAGC
@antibody_209_multiplicity_18_copy_2-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTTTCCGCAGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGCTATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACGATGATTGATTTCCCCAATCCACTCCA
+
?????B@BBBBBDDD@7ACFFBAHFHCFFHII.EFH-HHFIIHFGIHG?H@HIDEEHGHCBHACIHIICFCADHHHH5CIHEHHHIIFFHHHDHH8EHIG5=HEH=IHCBFIF8G3)GFFB1*FHGF6EEFFF?GEDG6E-FEEG8FGF6<G=?D()G6EEF2*G(E;GFFGA;E*A:G*A##E:BE;AEGGCGG?GCDG/:GCCACGE?GG@GCE:(GEEEA/D<ACE(?G88?EEGC8:?0E:E6DE*
@antibody_209_multiplicity_18_copy_3-1
ATGGCGAAGCTTCGTAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGACCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGTGTAGAATCACCATTTCAGTAGACACGTCCAAGAACCAGTTCCAACTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTA
+
?,5A5B-BDD@BD?--.CFFEFIII>IHIIFHIGHIIHHGFHHCIHDIIHED@-DI>BH>IIHHFAHDHDHIIFCIDFHD+5GA=HADIHFIH+HCCCFHF6HFGIEHF=)FCFGEBHF7FHHDHFF9GHH=HGFEGGC6*CEAG2E(G;6C,*E'E84B**E*G,EEGGE(::?(?G(0+6C/:/0G;<6??EA1FGEEGAF)E**GG/((;C7CE??GEC6G6C.GCGE?6AAECCECEEC(4FCG0#
@antibody_209_multiplicity_18_copy_4-1
GTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTCGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCGGGCGGGTCCAGCTCCAGTAGTAAC
+
,????-A?DDD<DDBDGGFBGFCI+A-CIFHIAGFIGHAIFI>IIGFHCHIIF=HFCIH>EE,FHEE?IG=DFC5DHG-IDIHH8HIEGHFHIFAHHGHHIHIEI(GHFGFHGDDGHDHDHE)GH?CFFHBFG=GF=ECFHGDE*F?GG=:FE;DDCEGGE<EACB#EFA;F4E?::E*.F:G?A:EFGEECG:F?EFG<**(:E=AGGCGCEEG*GDGG:C:1E(C<F?EGAE**#CGE(G:EE1GDEE
@antibody_209_multiplicity_18_copy_5-1
CTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCATTCCCTTCCCTGGGAGCTGGCGG
+
???,?BB>DBDBDDB<FFGCF,E.>H+EIIGHGHH5HFEAIIHFHIFECFGHFHHFFHHEGB*IIHIHAAHI@CDI-HCC+HIFFHHHAH7HH8HHHG7IHHHHHAHHHH@HF#CHF*GGFHDCHGGGDGGGFFFEGBEF4FEFFGE8GAGB*0EGGCF;=C/G(FCG(GE1EGF2F@?DE+FE6?E*E=?GEAEE/*C0GG;AG(EE?H*GHGE*181GCCE0G?G(A?0?;AF:A?GG2(G.GA6*E?
@antibody_209_multiplicity_18_copy_6-1
CCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGACCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTAGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTT
+
A????>A>DDDE-DDDFFG?FFAIIEIFCHFAIHHGI.HHH@HH/>FFHEG-HHIHIH=5FFCE5IHIIEGHF5GGCIIHCFHI-HHIGH+I?DCC=H8*BHHHHB-H6HHDEFCE2HEFFEEGFFHGEHGFFEB@EC0FAFGE8:G=GCGEF;;?G*GA#EGE(;GEEG<GE6AE?AG?EEG?G'EE(EG(0GE1-?EE8GAF/ECC*?EE(C(GCEDE.CE:A:ACE00G/CE::*E?AA.C)1?CG*
@antibody_209_multiplicity_18_copy_7-1
GACCAGGGTCCCTTGGCCCCGTTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTATTGAGGGACGGGTTGTAGTTGGTGCTTCCGCTATGATTGATCTCCCCAATCCACTCCAGTCCCCTCCCTG
+
?=??5BBBDBDDDBDDFFGF/FHEFFFIE?IHFGIGFG*IHGIHHH/EIII)FFDHHHH5HGH5IHGD/GCHI+EHHEIHCHHHBIFIGI+CFHDEFHGFDHB;HFHEHGHHEFGFEHFHHFHCABFFH*H?G>CEFHFDEECG,GCDGG:E?6GECCGBDGE09GEGG:6AGE:GAE;1?CFEEEGG(G:CGEE.E(G?:(E'DGHG?*(ECF7GB/GA*(G(E?/:A)EE*:EE/CCCCC6*??*FCG
@antibody_209_multiplicity_18_copy_8-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGAATGGTGAAGCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGTTGGACCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTAAAACCCTTCCCTCAAGAGTAGAATCACCATGTCAGTAGACACGTACAAGAACCAGTTCTAACTGAAGCTGTGCTCTA
+
?A?5?BBBDBDDDD?DGF@FFGHAHICHEIHIIGIFIHDFI--IHAFFHGIAFFEBBFHFGEEFHEHGIIIIIIHH,5IHHHIICCBFHHH:47GHFABE-*DIHHGH*GHGEGFFHGHEFGFFGHC9;EE?EF;DFF@F@G:EEF8?C*EGF8CE4EE?G*EDFEF?AGGEG(6AE?E(?:G(?8ECF6EF:68GFG8-G*EF.G.G*EGAHEB8G(EE1?A?DE<?CCCCE0:E(?C*.?A(.'8*('
@antibody_209_multiplicity_18_copy_9-1
GAGACGGTGACCAGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCAGTATGATTGATTTCCCCAATCCACTCCGGTCC
+
?????B7?B5?DB?D?CGGGFCFAHIFFHHGHCIEHHFIIGIHH@GHFFHEIIH.HFFID*EHC-IHHEHHHH-EHG55IHFIHIICGD-HDEFFFFDIHHHEGHHD4HEIFHH+HHB@HDHBFDGHFHHBGEEBI6E.GG.=EG@;FECEF=G?EE:0C*C6EGCEGGEGEEG*E:<6EEF?GEE>*FACGFE:EGEEG:AAG?CADFC5?<C0G*A(GGAED)G2(EFGG0:ECE**CE:G(E*GGCG
@antibody_209_multiplicity_18_copy_10-1
AGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
?,?9?BB5<BDDDDDDFFCFGEIFHAEFI>IHAEHGHCHIHFHI@HHH=HCH07AGCFHAGHHH-G-HHHHBIE5IIHHIGIHHII-AEIEHH5FHHFGDIIFHDFH=AF8GEH=EHBF33GHGHDFEGHFGH*EAEBDFGEC/CEE0FG;FE*EEC(G/'EGGEA;(EEF@((CAEGC/EEG<EAF(AE0A*GAE:EEG2?/8ADEG?(GGEG:?7(?DECGEC<;EGGC*;E:E8GCCGCCC?GGDG:
@antibody_209_multiplicity_18_copy_11-1
CTCACCGCGAGTCACCGTAGTCAGCGCTTGACGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGAAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGGTCCAGCTCCAGTATTAACCACTGAA
+
??AA=>?B?BDDDBDD.FBGFFIFHIHIHHF-CFIFHE.HHHEI-HG/7H+HAIIHHHHGFIGGDGIHHIFBHH8HCHHEDHIFHI.EGHHHHDEHHAGF-HHHFHCHDHHFFHH)GHE7F8H=E@H+DEEEDHHFF=CG*=DEG=EE0GFEGEGBGGC4>GEEGE<EFEAFFE=EGG?GE(EEECGC6AEA8*G(E1C:EGGAC:*A(A?EA'@*B<CEE,#G/GGE*?'E4G0E1:*6EAG/A:6GCE
@antibody_209_multiplicity_18_copy_12-1
GGTGACCAGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCATAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGTCGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACACCAGTCCCTTCC
+
?<???B5BDEDBBBDDCFGFFFHHIFFIIAIIEEDIHEIHEFIGHGDI.ADFHHHH-BFIEEHHHIFCDCHGGHIA-B*5FDF?IEHIG+IHEHFHHH#HIHFFCEHDFGEHHHHH)GGFGFCHDFGHDGGBEBFFEAGHG;GFGFEGC2DGFEG(:E#ECGFG0CEEEAEEEC8C3EADEFCA??CEGC#A?E6C.E*FGE;C/CH;(6EEH7*:CCFCGFG:C(EEEE?ECE*E/#G00EG*G(??C0
@antibody_209_multiplicity_18_copy_13-1
AAGCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGACCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAATCACCAACTACAACCAGTCCCTCAAGAGTAGAAGCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGATCTGTCAACGACGCGGACACGGCCGTGTATTACTGTGC
+
,????BBBBB?DDDDBFFFCFGIHII/HI6I+IAFCHEHBHIIGFGHIIC9D.IIIIIFIIBIHEEI-GHC5F5GHHEHFGHHGHGGHFIHF+G?EH.FCHHDIHHH@+FGF==IHGFFHD+EDFEFAF#E;FF4?EGDE;GHC'G9EEEEFFG*:EFCGFG/>E:CGGGC8ECDECE?G;GEGGE*>;C:G;?6EEEEDA*E(C0EGEHE#H8GEF'()C:'ED0A*E.E/6;0EAGC8G:8EC0?:0A
@antibody_209_multiplicity_18_copy_14-1
AGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGATTGTAGTTGGTGCTTCCACTATGATTGCTTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
?5A?<BB>DDDDED?ECFACCGHI.FI8I,HH>GFD7DFIIIHIGHHHEIIGHFFHHEHHFFEFHHHHIIHHIDGFID=ECIHIGDHEHHIHHCDHHHEHHIDHCHDCIEFAED8HFH3HDHH=?+GHHHFGHGF;FGDF:GGE2GBEFCEGCC6EDGEAG/,FGEGEE<:E*G.6GCFEF?E*EEE)C*A;6CG4.GFE*G82G=?GE*?A@GC(E.,,7A=?G<C(6;E::GA:.F*FGC:9?E:*G?
@antibody_209_multiplicity_18_copy_15-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCATTAGTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTACGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCCG
+
?===A?B5BDDBDDDBF8GGFBHHHIIIHHIIIC?IGIIHHHIFAHHGHFFCH=HFIHDHFDFEFHBHH5GCHGHHCFC)IHCGH-HHH5B/EHFH:HGHHIHBFFHHH<HHHHBFH)>F3DGEHH4HFFF6FECIG=EGC@E+/FEGFFEG)<8G;?GFGEGCG/AG@GEE6(E;E;:AGF.GG;G1DGG?AEE?F(6*GEE*F??CECFE;GC:0CBE?:(EGE-EE:GE*CEGG*:CD**G(E10/C
@antibody_209_multiplicity_18_copy_16-1
CCATTACTCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACCCTTGAGGGACGGGTTGTAGTTGGCGCTTCCACTATGATAGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGGTCCAGC
+
???,AB9?B-DD-DDDFGACFAIFIFHAFF-9HF=HICICCFIDIFAD.EFFFFHEHFFAHGDFHE-HGIHHCHI=I+F,EHGHBE4IHH=HIFIHHIE=H+H4HHBHHFHHD=HFFHE=DFGDGF(EFDFEDDEIHFFF<BFEECGG6?GEFEFE:FGF#E7BGEAGAGEE</GEDFEEGDGE*E0;A*GAE/ECF(:*GEE:GCH<:?G8HGGGC(7G*7:E<#-*(?1(*E6G9*8CC/E?*D:CEC
@antibody_209_multiplicity_18_copy_17-1
TCAAAGTAACAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGAAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGATAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTTCTTCCACTATGATTGATTTCCCCAATGCACTCCAGTCCCTTCCCTGGGGGCTGGCGGGTCCAGCTGCAGTA
+
?<?,?BBBB@DDBDBEFGFGFGBFFHIIIC/FFIFID/IHEICHGGHIFIHIIHDDG-.ED9HHI'G5-FHECIHHEFHHDCH?IIFFIFHAHFHFFDFFH;HHHGFDH.H=DGDBFGGE*EFFGCH;EDF*EDGDGBFFDEGE//GEFEGFGC@EE:E,E>0GEG?C;G*ECG8EGG'ECGC6<EEGG@G?E*:.(DC:AEGFC':CG:0?0ECA:9?.E<A0?E:A8EEE;C?FCE:A'?G.)?C:E'
@antibody_209_multiplicity_18_copy_18-1
GCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGAGGCGGTCACAGAGCTCAGCTTCAGTTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGGTCCAGCTCCAGTAGTAACCCCTAA
+
,?5??B+BDBDDD-DDGGGFFGBFHHHF/8H@HHIHCIAIF=F'@HHIHHE>GFFI=IFAIIEHHCFI@GHFH)FHHCHGHIHEF-DHIHHIHIHC<I+DFHHIH-HFDDH+@FDFFF+F6GFFF:GG9GHFFFFAF?FGEFGF??;GG=BGGGEEG@9'3.EEE6G?BE6G?(CE<E?GGEGE?>6:E?:ECG?*G:??GC/6EEEF6HF(CEEGGG,C7;0E.CE*E*?ECCG*.CG:AE<(:*G1((
@antibody_210_multiplicity_1_copy_1-1
GTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACGGACATGGTGATTCGACTCTTGAGGGACGGGTTGTATTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTTCAGCCCCTTCCCTGGGGGCAGGCGGATCCAACTCC
+
???,A<BBD<DDDBE5CGFC8FAF;?IIIHHHG7HFC/8HBIFHEFHFECHFGHHHIHGH8@FGCIHF-IICIFI5HHGIIAEFI)IIHGHHHI@HHI=IH5=HF+H0HD*GFE*EE#BHFGF*FGGFFHEEHE;EEGEB0EGEGGG7G(*DGEDCB;GG,AE*GECCEGFEAE)/EG;EG?GEG?(:DG:E8EE(?(CGG2C9FC???EG:HEGE*G'EF80(GE*;GC0EEE#A*:GAGEEEADACCA
@antibody_211_multiplicity_1_copy_1-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCACTAGCCAGGTCCAAGAACCAGCTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGCGTATTACTGT
+
????ABBBBD<DDDDDFGFFFFIIHI6CEIHHHEHHDDAHAE/I7HHHGAAIH(HCHIF=HIHEDFIFH.+HE5HFIE-EFCCBD-F,IH?HHII+DHFHHFF@G)GFEGHHHHH)HD+H8?EH5DHE0E;HGF0DFFFG;EFGCEGAG(8G<EGAGGEG7GGGCGA'E(GFCEEF8E()E6(GEG1EEGCGE?GG:/GF/GCEC.?EF?EACF::EAGA8::FE*EG8EE?E*G06:G(EC?6;EA*0:
@antibody_212_multiplicity_2_copy_1-1
TTAGTCAAAGTAACAGTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTAAGGTAGAACTCGTTCTGGGACATGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCTCTCCAGTCCCTTCCATGGGGGCTTGCGGATCCAGCTCCA
+
??AA,BBBDDDD@DDDGCEGFFIAIIIFFHDFDDFE++HIHHHI8HFIHHHC.HEIG>FIHHEIHHAHHIHEFD=FHHFHDCHEH8EECHDI?HHI@HHHHC+@F=HCH#HHBF@HGFCH#FG;'E'=DFH,GG@A*GEFG?EHFFGC8::8EGAE?AGEGFEGEGGEECACEGCBEAFFEGG*E6EGCDCA6'0FF/AAEEF8E6E:C:##/G*G*GEC<1GC1*:'6E?E?/((;C:GG:G)0'G8EE
@antibody_212_multiplicity_2_copy_2-1
TGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTG
+
=A??=A-5+DDEDDDDF-GCFGIFIHIHHFFHF.DHGDHGHAFEI>?F?HHGHFIFIHIF,D9EEEHHGF-AFFFFHHHHFGB+I7GHHFAHHD<IHHH+CHBH,H*H>HDFDFFAFHHDE63*D@HG-EGC6+G;FGGGG)B,EGAGG?A:BC;EE3EEECGFDGG,FEGEE8E0GG/F(CGAF*(?8EGGGGE?EAAA(<GECCHA;H3?@*E/0EC@9?0/:EAG.G:000GEEE*GE:8*;(2CEE
@antibody_213_multiplicity_4_copy_1-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCAGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACCGGAGCTGGATCCGCCAGACCCCAGGGAAGGGACTGGAGTGGATTGGGGAACTCAATCATAGTGGAAGCACCAACTACAACCCGTCCCACAGGAGTCGAACCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCG
+
?????BB>AD@<DDBB@GGFG;AHHHHIFEIEIF/HDHHGBIHIDICFH#HH7I5HHHF--CDIGEFHHI@IHHI-H<FF;DICA-HHI=IIE=HHF,FA*H5HDIHH/DD@FCEGD6F5AEHFEGCGGGHGD.FE*EE3FFB@GEG8FC?GF=C2GEGEBGCE(G:*CE66?CC8(??FEEE?F(CEEA?G?EE?EGA.CE:EGEH'G4EDE@GCB:,,E?*'*E;FCEGG90E6GC6EE(:??0GEA*
@antibody_213_multiplicity_4_copy_2-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGACCCCAGGGAAGGGATTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGGACCAACTACAACCCGTCCCCCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGGTCTACCTGAAGCTGAGCTCTGT
+
<?<?A?+B6EDDDDDD-FGGFEIEHCFH-F=EFEHDHHDHHH?0FIHFFFDIHID4AHGC=HFFIIHEFHHIGIIIIHEEIGEHGHHHD=HEHDHH=EHG6HFHHFFFHHHHC*EHFHEH+=1GEGDE+<H:GEGEG8GGGEF1EGG;G7GGA(FEG*/G;-G#EFCAG<*FGEGCEEEEFEE#E?EAAE:EG:E?GGEE6EC'A:C(G(EEE:E8E7EGGGCE**(#(EE6:06E?EE:E?G>E?C:E6
@antibody_213_multiplicity_4_copy_3-1
CCCTGGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGTGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCGCCAATCCACTCCAGTCCCTTCCCTGGGGTCTGGC
+
=A5?AB?BDEDD=DBDCG@GGFC/FIAC7.CFIEIIDCHCCBHFH9HIIHHHGIHIIH?IHEDHHAHHFFIHHHIAHH-HFHDIHIHHHIHHAIEH,,FFFEHIIH9HD=EGHGFGFBED1HGBH2HH9DBFF6EFGEB*FFFFB*CGAE-CEGECGE?*FEECE*GCE;CCG)'8/@#BG+EEG;GGE6GCEDG:EFE:G*EG0E(:G(EG.@@(E<G@CFF/;E?G?*.=0E6:;8C::60?CCA4G?
@antibody_213_multiplicity_4_copy_4-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCGGCGCTGTCTATGGTGGGTCCTTCAGTGGTTAGTACTGGAGCTGGATCCGCCAGACCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCACAAGAGTCGAATCATCATGTCAGTAGACACGTACAAGAACCAGTTCTACCTGAAGCTGAGGTCTGTG
+
?????>BB@DD<BD9@GC,FGGICHHAFHF.G=HEIIIH/IHC@@DFIGFGFADHHIH#G--I@HBIH>HHIDH-F-FFHHHII/HHIFHGFHFHEHGHH=FHEDHHEI+HHHHGHF:HHGE;BGFEE8D*BGFF+BBD@B=G4'EGEFG;B>AEGGGB)AC?0GG9<0EECFCEFGE6EA?GEECEECGEF;GG:E(CGEG:;AE(?:0(ECG7*?FEFE8CG*A6EAEC(EF;*C;?FCA?(?E*E?E
@antibody_214_multiplicity_1_copy_1-1
TGGCCCCAGTAGTCAAAGTAGCAGATCACCGCGAGTCACCGTAGTCAGCCCTTGAGGCGAAGATCTATTTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGGTTCAGGTAGAACTGGTGCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTATTTGGTGCTGCCACTAGGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGAT
+
??AA,<BBD+BDDDDDFGGFC;CEIFEEIIFHIFHIGFFIFHG.FFHHEGCGHFHGHIHGI-@HFHHH-IHFFDFHHIFIFHFII=GH5BCIDFHH3DF:4BFFFH<+HFH>8E92FFHFGHFHD@FEEHEE+GGEF*EEEEEFGFG=?EFGE<GGCC:G?EAAE>F??<EGE?ECG=E8FA/;EG(GA:FEG(GA<EEEG?CEEGHE8EEGHG:CG;?8C.G?0EFA?A):GCGAAF(E?EE?EGGC2:
@antibody_215_multiplicity_308_copy_1-1
ACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACGGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTTATTTCCCCAATCCACTCAAGACCCTT
+
?????7<BDDDD<DDDEG;GFGAHEHEHFH/IHHHIIHHFEF9F=HDFHFE7IFHDI'HFHHEEHI-FHHHHIHAIFFFIHHIH=HI=HHHFHHH-HHFDE5/AHC?DHF?E@=*DHHEFGHHBGFDEDFGFGGGFHGGEEGGE1GGGGAEE;EGG3/CEF.*EGG*GGGC:GAGG<EG0GCF0GE)'ECCAEEGAAG:1FE?E(4C:GAAGF.GEE(E;C1E#EC?*AD:6:EG:F?CEE(CC*C:EC*
@antibody_215_multiplicity_308_copy_2-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGGTCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTGCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGT
+
??=??BB<@DDDDEDDGGGFGCIFAIIFIHIHDAG0HDCI-HHHHFEGFIIDDHHFFFHDIHHBIDCHFFFG-#DHFHCHHA+HHH?EAIH<HFDFHGI*HFFHFHHHDHGHHGFHDG4EFGF3HGFFBEF0G*H?GFHGEEFE0=?CGBGBG?CG'GE?CGA;(ACFGCFAGCFGEGAA?+E9?(-?GEE?EGDE6G<*;GC6?60G2C<CEGEG(F8G;E:GEF?GEEG(E?0(C:#EF:6?8G::EC
@antibody_215_multiplicity_308_copy_3-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCGACTACAACCCGTCCCTCAAGTGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGG
+
<5A??/B<DBBDDDDDFG;FFFACI+FIHCGHFFCAFID@FHHIDHHHFHE.FFCDFH.IIFHAHHE,HG@I5IIEHGIICE+HHDHAIH/HDHIIECI)H7IHHH1FE-FFEF+.HHBFGDEHHCG@EG@5G@GG*G?DHFGC8GDGGEECGG;F#GGDF6EEAC?CAEG?6EE?E'0AEEEC?G8?G/FE;<(EE?GGGF:GAG:(G??CH*G9G/DF:;?CEA/:E.8CGCC:?E;:-EE*FE:EGG
@antibody_215_multiplicity_308_copy_4-1
ACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGAACTTCGCCTCAAGCGCTGACTACGGTGACTTGCGGTGAGCTGCTAATTTGAG
+
?????<B@DDD<BDBDF>GFFF+IHHIIHHIIIHHFHHHHD9HHHIFF/EIHHIFGFBEIHAIHHH.GEH+GHH-FHGHHHHEHHH-7HF(HHHFDFGHH@HCHFDE5H7HFH6IFH+FFEFBHEF:G2GEAEG6IHE*GEG?CG>GF?C?EGEE?*E(6EECG?EG?GGGCG:FFCECEGE<E*FG/AG<GEEGF.E((E(CC:66EEE;C7D::<7BE0ECE;<CA*CAECG8G*?CE(F;8?CCEF'
@antibody_215_multiplicity_308_copy_5-1
GGTGCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGCCCGTGTCCGCGGCGGTCAAAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGAGTCTTGAGGGACGGGTTGTAGTTGGTGTGTCCACTATGATTTATTCCCCCAATCCACTCCAGTGCCTTCCCTGGGGGCT
+
5??,?BBBD<DDBDDDFGGFGFEFFHCC>CIDHHE9HHH>IHH;IEHEBHHAE,FHHHHHHHIECDFHI5HHHFHGHHHIEHIHHGCD=I+IH)DHDHH=HEHDHGHF=FDF*DHGG=HH;HGGHHF7F?B@E*EAF3FFEG6E20?G?*ECGB8G@GGGG6GE8CFFEAE2:EF?EG.G(E<G(CF?8E*6G*EGD?E)E68GFG:CG??G(EG*(E?::AA(C*(*?E/.G=*E::/4EC.E0(E8C/
@antibody_215_multiplicity_308_copy_6-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGCAAATCAATCATAGTGGAAACACCCACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCGGAAGCTGAGCTCTG
+
???,?<A-DB-DD-DDGFGGGFIIIFFIIFHFIEFHFHHA@IHIIFHHHGHH+HGIIHHHAFB=HHI-DHBFFHCEAIIIEHHEDACDII-;FCC,H/3IHDE=+GFCFEAHIHICH@FH=F(FGBFEDFEHGG2GCE,FG@DG*D+(EEGFGG;F:F0EBEC:?E*E#1;GCEECGFCD<C2:??GE((GAEAEGGE?GFEE/2AE*2(EAAEEE*E:.E8C6E*(CE??CG.E.C68E8G0ECG?EAE
@antibody_215_multiplicity_308_copy_7-1
ACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAAGTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACTTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACGGTGCGAGATAGATCT
+
????A?BBDDDBBDB?FG>GG;8HHFFHHI;GIHIIIIGGEIHHF+HHHHHHIHFF.IIHH--HHIFHHI=IHIH?IDIH-HFIEIFFHEIHFI<<HGHHEIH4H:CHE;EEHHDHGGDEH@HD>(E)E?FG4=GGB+EF<GHGFAGDG(GG=F*CFDC:EGGF8GECG6(-*(GG?F66FGGGEG??BECGECEG<;<8C?<C?:;EGAGE@EEGEG:0EE/<6G1C-AECF(*/6;F/EEF0??/0>?
@antibody_215_multiplicity_308_copy_8-1
TGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGAGGGCTGGAGGAT
+
?????BBA-<-DDDD@FAF9GFIFIHEIFEH@I,HFHGHHHHEIAIAHIHHIFHDAFG5HHHHHHHIGIHDFFGFHEHCEDICHHGHIIHHHHFEEIDHHH(EDFHHHD*9FHD+FHHEGFHE;DFECGB9GBEHG8GEDGFGGGG@FEEC;EEBG?G7*'?G?FFGGEE8A6G**G@FCG(EDEGAGEE(EGFGCCG?(CC?ECCE:F?EEA:7/0E,G..CGGA???EAF0G?E:*G*ACEGG(**C1
@antibody_215_multiplicity_308_copy_9-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACTGGTTGTTGTTGGTGTTTCCACTATGATTGATATCCCCAATCCACTCCAGTGCCTTCCCTGGGGGCTGGCGGA
+
?9=?9BA@D<DDDBDDAFFGFFIEHHIIIFHIHHFHHHI,IIIHBGGEI@@FH@H;HH'HIHFHDHCHFBHCIHH?DEF@FHG-H/AEHAIHHD?I(EHFGGHFDFGGHIH=F=AC@EFHFEE=FF.FGG+DBGGE8C(GBFGGG:*GEEGGG82EE;6EG:G;GEF'GFG0CGG8G(6CEGCD*E(FE1:E?GG9CE:?;*CEGAHGA(?'HEC(:CE(EGE'GC6A*AF?C:*?EG:*GC*G=CGE.E
@antibody_215_multiplicity_308_copy_10-1
CCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCTCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAAACCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACTTGAAGCTGAGCTCTGTGACCGCCGCGGCCACGGCCGTGTATTATTGTGCGA
+
A????B=?BD@DDDD@CGCFGFHIHICHAFE:IIHFHIH0GHH>FHEHGGIDAFCHAFEEHHFHHAIE-GFGD5HHHI=EF,HHFHEHBHIIAEGHFFIFHDH9FFHAEHFHHIC?HFGH=FHDHDHCGHGF=FFE,CFE*;0G9CGGGFGGAE@8G>DE4//AFFGG(E6-E=GGEGECECAGGE(GGCAGEC;::*(;E4?:A;*G2E?F7EE4<E(00A.EG?#/A(?*0E;C*?C80G)?EEC(?D
@antibody_215_multiplicity_308_copy_11-1
GCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTCTTTCCACTATAATTGAATTCGCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCTGATCCAGTTCCAGTAGTAACCACTGA
+
?,???B<BD@@5DD<DGFAGF-FHHHHI/HHIHHHFCHAIIFIHH.?HHDEADHHH=FHA=CIIHH>IDDH5HHHEHHIF-DGEID-IHH=HH<HHHHFHHCIFHHHHFH-FHGHHHHGFEH@DHGGFE@EDECGDGE*D-0GGFEFEDCGG/./GGGE?/GEE2?G(FGCGG:FEGB(:EG(F#.FG':*.*EE8GA:E:E?6G*FECFG/EGGEGECGGE*#6E0**?E?*)CG.:CC*?EF8EC6;*
@antibody_215_multiplicity_308_copy_12-1
GGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCCCCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTACCCAATCCAATCCAATCCCTTCC
+
??<??BBBBDDDBD<-GCEFG>F>HI+HFFGIIHCFEI7HIHF-FF/EHFHHF@H>IHHC;AIIH@DIIEGHIHHFBIHHCFFHH-HGHHHHHHHEHICHDHGAFEGGA@FEGHH;HHFFBCDHHH?FHEE:'GCEAGHEGDGE4GFGE?DFEFEAFFGE*BF*?'EEGEGGGE?GCGGG8:EEG(GEFG4G8GGCG?GEFGCECFEGE?FGE<CC?C,,<:GC-E'(*GEGF6C;(*:EA*E*?:CEEE
@antibody_215_multiplicity_308_copy_13-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCGGTCTATGGAGGGTCCTTCAGTCGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCAGGTGAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCAGAGCTCTGTGACCGCCGC
+
?????B?BDDDDDDDDGG0FEFH-IECHFHFHI/F?GHHGDC9H@HH>FHFH-/H-EIHHF+GD.HFGG=IHEIFFH-HIHIHHIFHEEHIHHGIHDD7HEIFHIH+GHGFGF@DFF6HHGGF>AEGEFG=HGFEGCEB52GFEGG*E*GAFEFGG,E<EDCE?G/(=EABG-'A(GCE':GEFEEEE*E:D-GF(GF;E*E?6EE8E-EE<C:*(FEEG:G??E.ADGE1(:C0#:?C?*0ECAEC:=6
@antibody_215_multiplicity_308_copy_14-1
ACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATTATTGATTTCCCCAATTCACTCAAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGA
+
??=A?BBBDDBADDDDFFGGBGHBIFCHAHH0AH0IDGF;FHFCHBH+HGHHFFICHBIIIFII--HDGCFIIH)FHHGGDCEHHEIFGHFE+EE4F5EHDHHCEHH;F6GHDHDHA=DGHFHHHBHDDB4FGGG?EDCGEGEGGGFGGGEGEEEEGEG,GGEFECG(G;G<0C'G<EG:EEG0/EEG:A'(:EFG(EGGGE('1(HAEHE>@ECC:*CACCCE.6C0G?'E-(E:*EEFC:/'#CA1E(
@antibody_215_multiplicity_308_copy_15-1
CTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGCTAGATCTTCGCCTCAAGCGCTGTCTACGGTGACTCGCGGTGA
+
??A??BB7BDBBBDDDFGGG.GHCFFC>I8GIIGDHI?HFHIHII5HFIGFIFIAIDFICFFIEHCIHEG5HGHHEHFHHIAHF-HEE?EGHHFHHHHEHDFHHIFIHHHDHHHAHGF>HHFDF(=#FHDE2F?GFFGBEEE?CEE;*GCGFG.8G?8E2E(;,;GFGFG<8EDDGGEGFGFCGGEG*EA80CA:E?GC*GE:A/E?#?<E=(/7GE(G@?/CGCEAGEG'CC8(EG:E:EACECGC:GC
@antibody_215_multiplicity_308_copy_16-1
AGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCAATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
,?=5?BBBD--DDBEBGF-AFGIHFIHHF;HGFHHHGE-FF/DCFDHEHHF.FCHH+FFFGIHIHEFIHFEIGH+IHHAG5HHHHDFHHHB?HIIDDFDHHHHD5H?HBEEDHHHG.=EGHFHFFGHG:=FHG;=GGCFHFG@EF*.G=EE6GCGE0E<?GF8EGAAEEGE>GGFEGGA/;G::6GE<EGECEEGEG:6E1GGGEEDEAHEEEGGGGE3ECE(/?GE?6G'?EG??AG(GFECCE?AE)E
@antibody_215_multiplicity_308_copy_17-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCCGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACC
+
?????BB>DDDDB?BDFCGFF@HHHCFIIF9H9H9IFI/FFHIHHC9CFHH-IEHGGIFEDFIFB,CHIDIDIHIHIIHEHHEHIIBFIHH<IHF=HHHGHGHHDHD=G#FEGH(FG@HFGEFFH*GFFE-EGG<8DE@GEFCGDCD*E:E9E;GE<E8GG=BGGEGCG8A@GE?8GE:CGFEAG?G1G*'F??E>GCEEE#(CE?EDGHGFEC0CF*EE2E?C(GFG?AE)AEA*(*E(GCEC*(*G*E
@antibody_215_multiplicity_308_copy_18-1
CTGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACAGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATATCCCCAATCCACTCC
+
,????BB?D<5DD-DEGF>GFFHIFHIHHHIHGHIBAIGHIH9HHHHFEHAHAHHGCFCI5=HGHHHHH-FHHGD-CIFGHHBHEHFGDHFEH;HDHF.EGGH+I;3?IFHGHHEDGHGHB;=HBH.HE9DGF?GECHFBEDGE:BFG#CE=EF(FF.F*;GGG8GCEG*F<CEEEG??GEG0*E2G<:C?CC;:E*E)GEF2.CGE?*#;EHAGCEEEG*,:C?C.A12?G(C(??EFAE.0CC(*0EG
@antibody_215_multiplicity_308_copy_19-1
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCGTGTCAGTAGACACGTCCAAGAACCAGTTCTAGCTGAAGCTGAGCTCTGTGACCGCTGCGGA
+
?=A??BB7B<DD@D<EG;FGGGHFIHHEHH@HH7ID5FFGGHAHGEHEFA9?=HF+F8DIHFGEFEGGHHIIGIHID<EHDFHF)AFFDHFHIH5F4HHHEHHHH<HHC.GFFDHFEBHGH8EGHF?H*)FDG=<ECGDE'GGE;GGEGE<GFEEE0GE7G8EEAEGEE?/E6*(?GGGGE)E8E:GF#AGGEC>G)8CECE;EE?HC6F>EHGGC7E;7*8'EE:CECG?GCEC0(AE0:(G/'EE0A(
@antibody_215_multiplicity_308_copy_20-1
GCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACATCCCGTCCCTCAAGAGTTGAATCACCATGTAAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGACCTCTGTGACCGCCGCGGACACGGC
+
???A?B?B-DDDDDDDFEFCFGEFHHBFFAFDH=9DHFCHFADIH9H?F?FHIH.FBCHHFAHIDI5HBDFGFHF-H?A-DGH8=IHE-FIFGHDHFFGHHH=IGFICG=DHG+HHHF+HHHDDFFHHHEFEEFEG;E,GECE<DEG@GG;FGEGC*GAGDGEGEGEFAFCG*#(CEGECGG6FA/*C*ACD:G?FFGC*EGGGGG:?GHGGF'E0.EE7('E:G((E(AEE:EC2DECCE??C?(ECE:
@antibody_215_multiplicity_308_copy_21-1
AGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACGACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACGACCCGTCCCTCAAGAGTCGAATCACCGTGTCAGTGGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACAGCCGCGGACTCGGCCGTG
+
??????B<D<DD?BDDEGEEGFIHHH>EIIHHHEIIHIIC9IHDDCHG@5H>GHH?EIF@I-IFEIEIHD+ICH>FIII5IHCGE+HHIIHI)HEEFHCCHC7IICFH=DH<H?GA@@H<<EH=HDEEGFFFGFFGGHF'@F8:GFCHG*7#E68ECEG<?CG,*DGGCEGE?.G*G/*E8:EE?G*FCGGE?FFA:E?E:?;CA)E86EG?HD(4?-GF(GA?E6EGG*C*?ECGG.**E(?EC?GGCE
@antibody_215_multiplicity_308_copy_22-1
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGACCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCG
+
<??<AB?BD@DBBDDDGFGG?GFHIEHHIIH?HAEGHH#GHHH(DFIDHH/IHGFFH=CHIIHFIIIHGIIDFHDH-?HHIIHHF@+3DCHA2GH-FFHIBHAGDF5EFH@FHH+,H.;BDHEDDHEGBHGEFGGG@H=FGD;E??F<AGDEEGGGE<FG;C?G;8EC6G6#9AECE<EG'G?EF6EAA8;EEE?FEG8GG?GGEC?8EH(EH@;ECG)G(<CEGG?CFC?EG6ECE(F:'G)G1;CE0E
@antibody_215_multiplicity_308_copy_23-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAATCACCAACTACAACCCGTCCCTCAAGAGTTGAATCACCATGTCAGTGGACACGTCCAAGAACCAGTTCTACATGCAGCTGAGCTCTG
+
???<AB/-DDDBBBAB;GFGFGIFHF;HCCHHH5IHIIHHHH8IIEE5+HHHFHI?IIIACHIIHHHHHEE=IF=IHFIH@HDHFAHE@HGF<DEHIHDFAGG/HHHFIH8;HEHHFFDGHGH4HBGG4*BCFGDEDBGD;GEGB;GGE*CEFBFFEEEEEGG'E;CGE<?E8FDCG;:D?E)(GFEA8;#E(GEE*)CE=F6CCEH?G.G0EG4CEGGG0GC6F0FG8;?C*E(C:#G/*E:EEC;;?:
@antibody_215_multiplicity_308_copy_24-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCGGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCC
+
??<A??@BDDD<DD@DFGGFCFIHHFHHIHFHFHGIHHHHHGH'DIHHHGII7HHH?EAIIGFEIHEHHIF-E@3H5H-I=IHCHHIIH)HHH;/FHE<FCFFGHGIH;+GCIEEHHDFGDEFGEFADGDF*G9EDFEGGEEGEGDAFEGDG:GEECGG?4EAGEG:AA6*GE(CECE:GEEGECC:G=//CEC<?:CEEEEC:FGE0DH0(C'EGCGGE*G0E?A*EGE6CCEE:CAA*?E/GEGG.GE
@antibody_215_multiplicity_308_copy_25-1
CCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACGGGCATGGTGATTCGCCTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGG
+
??????BB?DDBDD+EFFC;FF/H9IFCIEHEHIIH=F*EEIHHHHH-II>GFACGIGHIHDCF.IIAEIFHHIEFHIFGIGIEHCHHHHHGHHIHHHI)HEHGDHHHHCDHHD'DFHHBEFG3AFHHEGH3<EFECE@3EEGBGGEBEEEGG:*8FG,*G#9GEFCG6EGF6E(GEE?/+G*'G06E*:FG:GFEE0CGFAEG*EHE08E9'E:GGAEGE?FG:EEGE.ECC:ACG?/*CF:CCCCA(6
@antibody_215_multiplicity_308_copy_26-1
GTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGTTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACACAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGCGTCTACTGACATTGTGATTCGACTCTTGAGTGACGGGTTGTAGTTGGTGTTTCCACTAAGATTGATTTCCCCAATCCACTTCAGTCCCTTCCC
+
?,,??BB?<BBDBDDDG>FG5GICFE,HE8IH?IIIIHA#IGHCIF5HFHGGHFH-HHHIHFHIFGHDIIDIEIIAE4IHHGBFIIFHHIHFFADHHIIHH@F=8FDFFC5BHDFG=HDGHH+D1CHG@HB#,F7;*DEEEFFCG@G(<?F.:GC?#CG;?:;AGAEGF#C?E*EE?EEEF;EGGG0#:*8D:AG*E;GA;>EG?;AEFH0D7EC1EE1GE??GE6(AAGGE8CEDF*:C(?060E?G8C
@antibody_215_multiplicity_308_copy_27-1
CACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGCTTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGACTGATTTCCCCAATCCACTCCAGTCCCCTCCCTAGGGGCTGGCGGTTCCAGTTCAAGTAGTAACCACTGAAGGAGCCACCATA
+
?==,=?BB<DAD-B9@GGFFGGIEIHIHH>BIFF-HHI-HIEGIHG-FEGHCEHGEEF5HHCHIHHF=HFHHHCFBHFH+IEDE+HHEAH;HIIHFHHGFCEIHGFICHGCHHF7H@G@EED(@<FFGE,BFD@DGFC*EGABFFDEG*F?DG?E3G:G6>:FEC(C#AEE8FFGC/C?80EE-F5:E?6EE?A0EAEEE(6GEGE0(/C9:#F@EGE;:E#G.<(GECC?CE::E(AE/G(?GFFEE?*
@antibody_215_multiplicity_308_copy_28-1
GTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTACCTCAAGAGTCGAATCACCATGGCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCAGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGCTTCAAGCGCTGTCTACG
+
????=>BBDBD@<DDDDFCF/F9AH/E8EIHHFGIHHH@DIHG.FI+HHC=HHBHCCIEGII7DFIH+GHDFFHFHHFC@HEHFGFHHFICFIEHDBDDH/GIF=F+HHDHFGGH,*EHEDHG8@DEEFFHF:H*BE,#@CGFGEEGEGFG8EE?GGE:E?6:C/;EE?EFEECE(GCEG/CGF*6E(GEE(GFCG'*C<E2G;EA<CGH:G:8E??:?1G'8FEEEEE6*A?#EG>*?0GE//'GA;*G
@antibody_215_multiplicity_308_copy_29-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGGCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAG
+
??,A?BB?DB@BDDDDG.FGGFIHII/>>IGHCGHIDHCHHG9H5HHHH,GHFFE@FFDG@HDE+IBDFFI;HIHHHFHFF>IHHEIIH8FHHH*HHBIHGHIDHH1G=HHFHHBE,+DG;GEHDEFGFEG3EFEBEEGE2F*GE@?EBE8E8E?DGG=EAGEFEGG'CFEEAECFGE;1+AE:GGEGEGAGFGE?GC??8GGCD6:?FCCGH**FGEEAE'??GGEGA)0E#(0C0?G#G?FGAGE<E:
@antibody_215_multiplicity_308_copy_30-1
CCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCAATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTTACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAACCCACTCCAATCCCTTCCCTGAGGGCTGGCGGATCCA
+
5??????7D@DBBDD<G,GGFEI;IHIIHIHHE9@HFGH@H8FIH.?G/IFFCFF.IFIFEF-GGA,HHHICHECCEEHFC8HFGCGFHEHIHHFDIF+H#IHHCHHGDGHFHGH@HDFFFDDD=GF=*FG*EEGGEF@F?82GGG,E?E,GGC8/*F?.AG6GEGEGEFEFGEEEEF>G?AE;EF?FCEGFEGE'G(GAFA.E(F<ECE?GH(*EEA?:(8(C6CC*EAA?GC*G>?AGGGEGGEAE0G
@antibody_215_multiplicity_308_copy_31-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATTCACGGCCGTGTCCGCGGCGTTCAAAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATAGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGAGTATCCACTATGATTGATTTCCCCAATCCACTCCA
+
?????BBB<@5DDD@EFGCGF>5AEIHIHFHIHECIHIHH8HHHBIHHIIFDIGFDF7CIFIH=AI-HIHHI5DHD7EHIBDBAHHF?HHI*HH=HHAFHHIHHBA#DFHDH3FHHHCHFHHFEGG#EGE,FEFCFGCG@6.G>EF(EGGHFGE*EA**8E0FGFGEE?AFCCEEG=E?2E?GDGG*6G1?C;(?G'GC</6EEF;A(GE6C((#GG*,G8??CAEAACGEE/?1GED(C:0*>6*:01?
@antibody_215_multiplicity_308_copy_32-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTTGATTGGGGAAATCAATCATAGTGGAAACACCAACTACCACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCATAAGCTGAGCTCTGTGACCGCCGCGGAC
+
<????5BBBD5D5D-@FFCGFGEIEHHIIIE-CHHHHFGICGHDIHFEDH+HHDGHHIHGHIHIGDF1HI-HEHIAHFFI-GGHHIFFICIHBFHHHIHDHHI;GHD=DHIE@FHHFEDEF@,GFFEDF0EEGEEEDGEFEEHFGGEECGGGGGEEEGG/(CEGG';8GFG<:GG8FCE.:DG6AEFGDEGEGCAFCEG:?ECCEAE?F<AGFA00GG(AC(#AC?6(G.9:GEEA.AEGF4GCC*EC(G
@antibody_215_multiplicity_308_copy_33-1
GGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTTTGATTGATTTCCCCAATCCACTCCAGTCCCTTCC
+
,?5??>B<@B@B@-DD;GDFGGHFFIFFCHHEFHHIHH=IIFE5FIHFHIHFHFHCADHFH=HAH@?FHCEHGHHIHDDDAIHIFHCHHHIHIHHHHHIE5DHHHFFEHHGHHDH(HHFGGFAFHH@FG9HGEFE?+GEFE;E@E?@A8GGG?*E<(FGGGFG:C>CE6G6F.EGEG:GGGEG:F?CFG;EGGAGAE?GF=#CAECH?EE<EA*G1B;G@CC6CG4GCCE:GEE:?:6EG(*C?0ACCEC
@antibody_215_multiplicity_308_copy_34-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCACCAGGGAAGGGACTGGAGTGGATTGGCGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATACCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGAACGCCGC
+
<?,??B9?-DDB@DBDFGFGGFHHIAII-IICGIIIH.CHHHIHGDF.DH,IEHHAHFIHFIIHIIHHIIEGHEA?HGAHCBHHHDHHHHFIHEHHAF@5DFGHHH#CA@HEEGH=HGGFD(EHDHEEDFEF#*EFFEGGEGAGE;,DGGG*G:G*8CEEGG(G(EEFGEEECGDG(EAG?6G(?G.C2EG*E#(ECE?A:GGEG?EGGHE6/E:C??GCGGECGE0?>CECCE:?*G;(G*0*E?C*FA
@antibody_215_multiplicity_308_copy_35-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGGCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACCTGTCTACTGACATGGTGATTCAACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATGTCCCCAATCCACTCCAGTCCC
+
=????BB?DDDDD<DDEF8GFFEEIHIII)HDGIIIHG7FCHFHH9FIHFH8-IFIGDHGDFHHEHGH/HAD-GIHHEG=HCCHCHHHHHC+IHHCGBIGH@HHHHE=,HDH*FFCHDHGH8GGHEGEFGHDHF,EEEFE@G@ACGEBHE(GEGDE??GG*G:'E=EGE<BG5E4EAEFA(G*EED(GEGEFEGF8(?.EECEE)E6A?HE?EGG>>G.)GEGEEEFE#G?C?G:AEAG)AC?6A?CE?E
@antibody_215_multiplicity_308_copy_36-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGCGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTGCCCAATCCACTCCAGTC
+
?9=??BBBD@<DDDBDC8F?EFGH8HFIFIH9IHHHFHAIHEEHHHHIHC:IHGHI@-HHIDHIIFFCIH+HHEBHIHHHIHGHAAHECFH5HFIGHFHHHH?HIE@H,HFHEHHF.EHCGFDDHCGGFEEE@E*?G=0GGEG=EEFEGDGEG*GGAEFG7*CCECECEE;E8(EEE?0CEGGEGGE:D?/EAC#GGE;C6CG?DEH-G*DCHC3G?F,G*8CCEC?C*E(:0GEEAEF:E?GEG(C:FE
@antibody_215_multiplicity_308_copy_37-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGTCCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGAGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCGACTACAACTCGTCCCTCAAGAGTCGAATTACCATGTCATTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGC
+
??AA?BBBDDDDDBDDFGG/FFI>HFHHIIHCHHAFCI,HFHDIIHFFFFF7IEAFHHDHHHHFFHHHHHE3EG-DCGHHHIHHEIDIHGGFDAHHIF@H=FHFHHH;DDH+DFHFEHF)EHEG53D+EEGFGE*G?FGEHEE?+@GE?@EE<GAAGECDG*(GE*EFGA0GGEGGGFC(GGE6EGCEEG(CG*<A0F*G-6E(FEHEC?EC::EG:/EEGE:GEC8G<:FACCA::?GEGA1*EG**)E
@antibody_215_multiplicity_308_copy_38-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGGTTCGACTCTAGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGAATGATTTCCCCAATCCACGCCAGTCCCTTCCCTGGGGGCTGGCGGA
+
A?=?<<BBDBDBBDDD>CFFF>IHFFEHHB9HIEF+FEHCHFHII@H,EDEHF@EHHGC?HEHHHIHI?55HFHFEHAF-FHIHHAFFHHGFI1IFIGE3HFHI(5DHDGHHDHE+HHEFEHHDHGGGD)GGEFGEF*;GFHEGFGGEFAG20GDGF6G#8FGE?EGGF0FA.;:F*.;FA:GC*>CFC;FEGE.8;)*G6G<;(C(-E:GGCEBC(G=C.,(*E0:(8?(?1:E6EE;<(6:?(E(*E:
@antibody_215_multiplicity_308_copy_39-1
TTGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTCCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACA
+
A,???BBB@<DDBDBAGGFCDCEECH>C+BEIDHHI.FHEG9AHIG'HGH5HHF,-H?CIEGHG=EFAH=F-CHI5-HIHFIEDEEE?FGIHIHC-)HCHHHHH<FI?DHHHHHH?D@DGGCEFHFFH@GFHEBGEFGFHGDFECEGEG(@D@EG?=E?DEGCG.;CG((GGCCBE(/;F0E1A//E?EGF2E/#G??EAAA0FGCAGEEEE0E/:GEEEEAE<CE.G*E8C*?:GGEEC<?:C/AG)6A
@antibody_215_multiplicity_308_copy_40-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGAACGTGTCTACTGACCTGGTGATTCGACTCTTGAGGGACTGGTTGTAGTTGGTGTTTCCACTATGATTGCTTTCCCCAATCCACTCCA
+
<?AA?B=BDDD5+-5D6CGGG;>IFHBCFHIH9IHHHHHFHHGHHGGHHEGGFHGHDHIHCICDHHIFEGHIIDFHHIAFDHIHCFFG-E=DAEGHIFBDHI?HBHFHFGEHADEEGHHG*HH?CEH@G8EF,FEA?G:FDEEEGGGEEG?EF;FGEE8CFE#G;D(C?:0EFE6EA+'GG;AEC(C(EECA:C6CG8G/A#F.EGEGGEEFH*@</G?FBE0E6?.*C(8#((*CGEAG?6E::)CAG(
@antibody_215_multiplicity_308_copy_41-1
GGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTAAAAACCGTCCTTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGG
+
A???AA>BBD?DDDD<8GAGFFICIHHHIEIIHFAHHFG.AHI9?HBCDEAIII5HFHFEIF5GHCIFGFGHIFH-IIDABF)7F6HIHD=HHC=EF8HHGAGFGDFF7HGD.GEFG=DFEE6HFBBHDHGG6E?FFF3FCFGECCG#E2EGEEG,GG**GGG(@(EGEGEGEECGG:G??;-GFGGEGGEFGCF0CC(*:E)E0CEGE?:GE@E?8EG)ECGAGEE<*E?<:C*?GE?C(ECE*:*:((
@antibody_215_multiplicity_308_copy_42-1
CAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTGTCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGACGGTCGGATTGTAGTTGGTGTTTCCACTATGTTTGATTTCCCCAATCCACTCCAGTCCCTTCCCTCGGGGCTGACAAATCCAGTTCCAGTAGTAACCACT
+
=AA??@BB-DBDD-<DGEC-DFFHHEEIIIIIHIFECIHDH>IH@/F>FH@HDFEIHHIGFHG-HIEHH-IF?IIDIFFEIGIDIBAHH(=-HH<FFF??F8GGIFHHH=CHG55FDC?HCD#*H6EDEFEGFHEFE;E@BG,GG;E,DE(EG(EF6**EEEE;EGGG(A.A*8<G@EGF>(A/('G8)GGEC<GG0EF6'GD*(F'?C#(E(AG*BE:CE(//;'(AEFEEE6EE(E(?E*/EC)G'E.
@antibody_215_multiplicity_308_copy_43-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGAGACTGGAGTGGATTGGGGAAATCAATTATAGTGGAAACACCAACTACAACCCGTCCCTCACGAGTCGAATCACCATGTCAGTAGACTCGGCCAAAAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGAC
+
?,???BB=9DDBBDBBFCFCFFHHHH>IIHHFHGHFIGG9BIGHFHIHIB*EHHHADI+5HHFFAIHAF:CG5HIGEIEC#EGHIEHEAHFHHH<HHHHIH'FIHFFHDH=D*GH(HGD)EFGHDHFHFDGEDDEIGGG*E*BEF9EEFGE.EAGG8EFGFE>)GEGFDGFGG(EE8/*GGEGCGG8(AGG.D(2CE01/(G.GGEE*FE(E:(//G?7;:(AE*D6EE?GF:(E4E<:?(;/8<:?:EC
@antibody_215_multiplicity_308_copy_44-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGGAATCAATCATAGTGGAAACACCAACTACATCCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCT
+
<,??=>BBBDDBBBBDFFGF9FFH6FFIFE@HFH-HHH@-GIFHBHDHBCEDHHIH,DGFHHII.IFHGGHIF-HHHIBH5F-H<ID>AHGHFEHFCH=HFHHHHDDFBFDDHEHHD?3EHF+DHFG+EGGGFDEEFGGG;?,*EG#G8/;*E?CEG*E;G?GEEDG;:G(B5,CE*CE:EE>-GEEEE/GEAG.G<*9C(:G4?:HAE?E.(G8GCGE7GAF;:G:D(C*)EG6*/*AE?*GA(/>A((
@antibody_215_multiplicity_308_copy_45-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTCGAGTGGATTGGGGAAATCAAGCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAATCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACC
+
????AB9>DDBDBDDDFFF>6+8IFIFHIHFBIIHIHHIFCEIHIEEFHHFHHGH+F*HEHIFEII5HH-,HEIDAAHHIBIHIHFIIFHEIGHDFHE-DE5)HHDH6HD(HDHHH=GGF=HEFGG(EH,FC;FG.GF:FG;F5GEG*6EEAE)G?FGEEG@G0GG:GCBE=E<ACF:EGG./?0#EGG:CGCAGC56<EEGF(.0CG?(E/.FC:F(,E:EEE(D/0EAE::C??EG:(G'0)EE:CE?
@antibody_215_multiplicity_308_copy_46-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGCGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTAAAACCCGTCCCTCAAGAGTCGAATAACTATGTCAGTAGACACGTCCAAGAACCAGTTCTACGTGCAGCTGAGCTCTGT
+
=?5???>BDD-BDDEDGFFGFCHEIIIHHIHHCIGH9HGH,GIHIIGIDIHHCCI?IHIGGHDHFHDGEH5E=-+IIHHDGFIHHHHHFH@IEFHH+HCEGDHHEHGD6EFGHEDF566FHCE*F#GFGHGD=EGE*EG6GAFEFG(F+4?GCFGGFEEEEDGEGE0G.G(G0FCFECDFEFEGACG('AECG?/E':E*.EG:?A''GCEA7@@DF7EFC0:?C?(CEEDE2C)C(*CGC::EEE:?G'
@antibody_215_multiplicity_308_copy_47-1
CTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAA
+
?,AA,@B>D+D<@DEBGF.GFFHIEIHFHIIHIIH-ACCHCHIFGHHFCHEHFIFHH-IGIH-IHHIHHCGIHEFD=5HEIIIDIGIHGH-GH6FCHFIFHFFFHHHHHD-H?,HIFHFHFGE5GHDED@GHF>D?GGGF?#CD*=CEGGEEEGE?GGE0GC(EEAFE?F6EEEGFE:?E0GGEFCGE<EE;GEGC(EG=:*FGEEE8G#FGFEEE:D/C*FF(CECC/?F?CE<*8):*)**GGE?.:C
@antibody_215_multiplicity_308_copy_48-1
GCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGC
+
,,???BB@@?BDD<?9FFFFFGICFFHH;IC>IIIHIII-IFHIFHIHCHFHF>IHGHFHFHHCHHIFEIFCCI=HH5FHHHH-HHHFDCIHHHHDCHHGHIHHHHEFHHDFEHF@EEFGFFCD<-FDG;GD2E+GAEE/2FEEE2FGE:EGEGAGGG/EGGG*BG(EACEC*;GEAECGEGF?E(.CG8)G*GGCGG'9AEECGEH:*A(G@F0(G:CEBEECCCG?C'EGE:<CG:F'EFE*C'/A6E
@antibody_215_multiplicity_308_copy_49-1
CAGTATTCAAATTAGCAGCTCACAGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCACGCAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTT
+
????,-B@A<DE@DDD/GFGCGC6EF/FHHHF@FHBFCHHFGHG+-C.HHIIH@IIG-C8HIFIA-IGCG(GIHIIH=IEIIDHIEFGEHH+GIIHIH/AE0HCHG7CH+FFHH,H+FEE.HEFHB;G2@HEBFFG8F,GGECFDCEEGGGGG0DEBEDDFCGGGEG/8GGGE8EGE(??G(8E0E:C.EGG(EG'6E.?E':*4FHEF:(E>7:CFCGG0GE6CC6E6<*F;<GC-G2G06CC?G(6?(
@antibody_215_multiplicity_308_copy_50-1
GACACTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCACAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGAGTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTG
+
A,5,?BBBB@EDDD@DFFFCFCF@FH8HEIIDI,EGHIIIIIHIHHGFCAHIFIIHH-DHIC+HCDAH8?H55=IHIFB-HHIIHIH?IIIHAIHFCH7EHHFHHDHGHHGEFFD;E(DEH@6;9FFDBFFH?HGGAEEGB*BGEEGGE<AECCFEG:G=FC;GA(GEE?EGAGEGAEGGF2C.E0ED?AE(FGG*GGEC*:;C(G?AC6?:@F@GGG?9=,:*(:2(*GA0*EE/E'C.0G?CEE?EEF
@antibody_215_multiplicity_308_copy_51-1
CTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGTCTGGAGTGGATTGGGGAAATCAATCATAGGGGAAACACCAACTACAACCCGTCCCTCGAGAGTCGAATCACCAAGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATT
+
???<=?BBD5DDEBDDG@-EGFIIA?IIIIIHFIHHIDAHEH9DIHIHHIIHFHHHHHFHGF7H?HD>IFHB;HF5GFHFFH5HFHFEGHII<IHDHIEHE,HFH?FEGDHHHHHEF.G*HFHHFG=>GEG(EEEDFGF3;CG3,FEEF6EEFEE:CEC(-**EEEG0CE;EG:F(G8EE?<*GGE0:/C;:E?G(FF49AAG?EC?AE'G':(G.C*?EDEG*GE0EC<GGEE6::CE'CE(GE#(:*?
@antibody_215_multiplicity_308_copy_52-1
TTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCGAAACCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGA
+
?<?A?BBBBDDDD<DDFCFFFF8HIHHFHHIFIHEH*BEGH9+GAHFHIH/FD?H5HFF@>FF,IHHIIIFGIFI>7FH-AHFFICGHHIHHD/HCHFAHDG,CH#EIEI#FHEHFFD+;BGHEGEGEGG+.D4C?3F;EE;GCEGG51G?BE(GBEDGB=GCEGEF*?GEG*C:E:+F?GGEE(AGEGEG(E:EEG?E69**<C:HE?E(;EEGE(E3GB(G(8AC.E-:(4?:EE2?(G?:C*06.G?
@antibody_215_multiplicity_308_copy_53-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACACTAATACACTGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGGTTCGACTCTTGAGGGACAGGTTGTAGTTGGTGTTTCCACTATGATTCATTTCCCCAATCCACTCCAG
+
?A?A?@BB<D<DBDB@FAG?GF+AFIHFIFEFE=CIG9FHHHGIDH9HIHHHGHHIFFCFHGHIHIHIIAHGHIFIHGGHEBBHIIHFFIH7EF7HDHH@#EHHDIGHF)FHBHF3G6FHH@*CF6/GHGHH;FFEF8C(:GFCE<E/AG(?)*EE8EE0CE*E*EGEG<EG(CAEEFEGEE(EEE;G(EGC6((:EGGC2CC6GGECD<:/H>FEG(BGE??G??0*;(ECC*EAG?GAE0DEC?:>?E
@antibody_215_multiplicity_308_copy_54-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAAACACCATCTCAGTAGACACGTCCAAGAACCGGCTCTACCTGAAGCTGAGCTGTGTGAC
+
,?A<9?BB9DDDDBDBFGG.FEFHFHHEEF/FI/GIFFFGEIII.FCHFIHHD-EHHIIIF+DD.HCF+HHEFHAFCF=HFIFHIHEHHEH5EHFFGHHG5GHFDHHFDH6GHFDG9FDHHHH8F>E4G>FGFD@GA*EEGE8GGDE*GFGGEFG6GA?EEG?76E.CEEGE'(;GCE(?@G(GDGG?::GE(*G4EGE(CCCCCEAG?C0E:8CF.C,@EG(E(GGCGAD:G*E?G186E?G#DAEE(G
@antibody_215_multiplicity_308_copy_55-1
GACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGGCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCGCAATCCACTCCAGTCCCTTCCCTG
+
????=<BB-EDBDD<9AFGGGFHH+FFIF@IFIEH=F.IG,IHIFHIGAIEIFHHFCIEH.CIIFE+HFIBFHIBIH5GHIHHFHDIHC>EDE?BHFCGH+H=HFEH8F=HEHFHFHFCHGFBHGEG7F<GFG(@CCGDFGAHGGFCEAEEG0FGG1EGFFG?EGEG.A:G?CG0;EDGF(@E.*EG66FGGE.C?E:AGC54GG</AEH1F:GG>CFCED?C-C'A*9G'E(/DGAE?6EC(#?G:GEF
@antibody_215_multiplicity_308_copy_56-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCATCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCTTAGTGGAAACCCCAACTACAACCCGTCCCTCAAGAGTCAAATCACCATGTCAGTAGACACGTCCAAGAACCTGTTCTACCTGAAGCTTAGCTCTGTGACC
+
5?,A99BBDDDDDDDDFC/GGFHIIFC0IHII>+ID?EII,HHIIHHHIHFH@7H=FIADHAAHA,IDEHCECIB@HHHHF?EGC5HHIHIHI-E,3AEEHGH0FHC(FHGH+HECHHHHGGFFGGFHHH@GEGGGE'G-GCGG=B;1?*HGGEEE=2E0'FGCEE8(EG/E?(ED?EEEFECE(G0:(EA(?9CFGEGEEG.GGE;:>HF(A:EC0EE7?,:E:EA/:8EG/EE-?#?EF1E8??EC/?
@antibody_215_multiplicity_308_copy_57-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAAGTAGCAGCTGACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTCAGGGACGGGTTGTAGTTGGTGTTTACACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCT
+
???A?BB?DBADDDD5GFG/CG.IFFHHHII9HH-.+HFI#HFGFEHEHDFIDFIHHH@FF8G5HG?H>FF>IHHFIAHHF,HHFHECAFHHG8H+HHHHCIHCHFHHGDEID4GHGHHHDFEGF*G<GEGHDF=I/GEF#GFB'BGF;GEECGAGG/(FEGEFEGFEE??E:GG::GGCEAG(:1G.:GGEGCC?<0GGA:CE0?H?6EEG)EG:EG?(E4EDE/GG:GFE*:::C/EEG?EG)D4FAC
@antibody_215_multiplicity_308_copy_58-1
CTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACATGTCTACTGACATGGTGATTCAACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCGACTATGATTGATTTCCCCAATCCACTCCAGTCCATTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGATCGACCCACCATAGACAGCGCAGGTGA
+
A?=,<9B+DD<DD<D9CFFFGGHCIBEEH>EHGHHHHFH>.H9+HG=IIFHHFBIFFAHIDIFHFICIFHIFF-F?HG-FIH(FHIH=+F+EDFIHF?FHHF6DFFFHHFDH*DBH@HH@DHFFEE*GFEEEGFFB(+=GEEGEG#CGG?8=9EFEGF@E:FG(@E?AEE?0G,EF-GE(8G:?AGGAE/GGGFG4?.CGEF*CGE:GEHGGE47**(CE0?D(.?6ACE?*ACD:8G8GE4EA?(CC**
@antibody_215_multiplicity_308_copy_59-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTAAGGTAGATCTGGTTCTTGGACGTGTGTACTGTCATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAG
+
????,<B>E@DBDDDDFG>AGGFHIHCHHIIGEF.FHHHGH@HEHH5EEAFBIHHHF-GIIFF5HFFAIIHHIE#HI5ICCEFA<CIHDGG0HH@GCGH@EDHDGHHFHHH>1(D@CBGFG9FEHFH;=FCEG:GCHFFGDD,EDDEEEA(=DEEB:EEB6FGGGE;G:GGE?G'E:E:FG;G<FEEG6(=?G*:EECEGA?AE4A??(C/GF-8CEGCGGF8EGA>CGG?:1GG?::E:FG:C(C0E;E
@antibody_215_multiplicity_308_copy_60-1
GACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTG
+
????,<B>D<BBDB@DGFGFCFIIIHIAHFGIIHIIHHAHHFIHHIIGGH8HDIH8FGC-IHIICHHIEIFIDDFIBFGH5HGFG7GIHHIHDIFFH?EI*HHDIDD=HHHHED7HEFGHAFFEFHH@*@;+HHDG?F(GDGEF8FEE?4EEF'G=GFDGGEGGEAFFGFE?E3GFGC;(EFC8F?CE(GEGAEGGGEEG?1*G<(E-AH0GEE/?GC(G?EGE1EE*;:GEA(CE(8GA/)?EEC/C*0
@antibody_215_multiplicity_308_copy_61-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCGCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGG
+
?,5??BABDBDDDDD@?>GFGCIHFIHI?IBHIDAHHHFHI=HEHFGHHCDFF+IHIHH-FHHEIIHHF-FD@IGHEIGHBHCHH.FHHIH,HGEHF+DH0HICFFHHFFFG8HAHHFFEE=E(FGFHGGGGDF(G8GEEDG:EFCBEGGG?GA?E(GEGE5EGGEEGE0EG*ECFGE:GC+)?A?GA/;8EAGE6C?-(CE(D:A;6*C(CE*GG?E<CGC8?<GCF6EGE6G6A:AE?(E'CEGA0CG
@antibody_215_multiplicity_308_copy_62-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGCCTACTGACATGGTGATTCGACTCTTGAGGGATGCGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCA
+
???5?BABDDD@DDDBFAFFFGIHIHCFHEIGIHH/HIHHHHH9ADFHFH9HHIGHHHIDIIHHH5H5IEHFHFFIHHGIHHHFHCIDIIGHI=FFBCF,G-FDFHBHHHHDDFHHHG,FGFDFFGHGHDGEDBFG,GFFEEHG)FFGDFC)?EEGCCFAFEF(GCGG>CEGGEEG;<EEG'E6E6(GEE=:;G=(?(GECAA?G(:0;HF9HCBEEAE70GAAGEA8F;G:E:EE:GGCGEFG.8?EE*
@antibody_215_multiplicity_308_copy_63-1
CCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACAGGGTGATTCGACTCTTGAGGGACGGGGTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTGCAGTCCCTTCCCTGAGGGCTGGC
+
,???AB/<DDDBD5D5FFGFFEIHA5.-HHHH9FF.IGAII==H@HHH>GDHHA8IC>IHHFFIHHIH<IF-5GHCDHIF)CIHF+HHAHEIIHHHFH<GHGGHIEHDHHGH,FGFFDHGHDFGHEDEHEGFGEBGF71EHFC*@GEG;EEGF6FFE#(ECG(@<?6GC<CCGEC8EGGG?EG'EDE.DEEGEE6GG?E:E(ECE(E?GE08.G:EBGGGEAG:((*G?E*GFEACE*GEE*GG*/EC*C
@antibody_215_multiplicity_308_copy_64-1
TATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCAGAAGCTGAGCTCTGTGACCGCCGCTGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGCCTCAAGCGCTGACTACGGTG
+
,?<5?BBBD-<@D@DDAFGGCF?HFHI9+BI.H+?FHH=DHCGDFI9GEIFGFGCH+=H,EH-IHAADHDGDFIGHIHDAGHHIAIHAIDCDHD5GFDH-G@EH(HHHDH*HFHGGF=HFEHH@@HFF7DFFEGEEF3DGHDGE+D9EEG<GGH)1GFFG(AEE:('G8CG6FEEGGGCCFE;EE>FEGCD#F*DG.DF;GECE**AGGH?ECE<.G*EGC/G;6?:<G*EFE*AE/GE*E*E:E)?E.*
@antibody_215_multiplicity_308_copy_65-1
TCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTCGGTGTTACCACTATGATTGATTTCCCCAATCCGCTCCTGTCCCTTCCCTGGTGGCTGG
+
?????>=?D<DDDDDDFCECFFFFEFIFFCHHIFIHHAHCEG-H@HFH-HHH'@IEGIHI<AH8GHHIHD>IH@HHI@FIH3HHCH,HGHHHIDHFHCEHFFH4HFHFFCFDD.HFG)=6GGGFIDHGEDEGG*HCEGGG*?7BB2GG5G'GEFEEGEEEGGAEG?FC.E?0FCC(E8GE)GCEEG?EAG#1G?EFEA1EGAGEG:E<AEGCC@0-;CEE?EG/(CGDG*:EC*?::(EECC1.G?86G'
@antibody_215_multiplicity_308_copy_66-1
TCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGAATGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCATGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCCGAGCTCTGTGACCGCCGCGGACA
+
??<??B@?DDEDDADDGGFGFFHIFHH-IHAHIE?HIGIHIIEF9HIIHFHEHDE5II9HFCEFGFIFIIIHHD=H+IHHDE)IHE-GCADHFHIHIHDHHBFFFGCFFH=HD=HHFHDFHF?D#3-HHDFGE18GFCB7AEGEEFCGEEEC,FE,GFGGGEEEFEAAGEE6(BEEHGECE-FEGAEE*EA(?GD'CG??CGCC6/-6*EEEE@:DE'1GECG(??(G:?0E0E:?E?CG*0CFCG?:GC
@antibody_215_multiplicity_308_copy_67-1
GGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACACCAGTCCCTTGCCTGGGGGCTGGCGGATC
+
?????BABD?BDDDD5GCFADFHEIH?I.I+IFIF@EHIAICIFHHFGIIHCF>GFIHCIHCII5AIFIHGHIFIH5FA,DHDHIH7HFEHHGGHHHHHFFE7FH,3HFDHGI*DHHEG.GBH3GFFDAEGFGG*EG1@BC*GC*=;GEGG;GG@FCGGECF<9E?EECGGEGF#GG7FCGEEGAGEFGE?6?E?GFGC0G:GFGGFG(C;G/GGCGA:E#EF:0.6G.E.(G'FGFCEG*(E:GEGE*/
@antibody_215_multiplicity_308_copy_68-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCACCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATATCAGTAGACACGTCCAAGAACCTGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGC
+
A????BB=D?DDDDDDFG>FFG.CCIIH8HH7FEII+HIHHHHHGFFI.HGHFHHHFHCH?HHF.FE5IEHHIFCEHHDHBHFHEABHHFEI@IECDHDCH,HHF-+AHDHH(EFDFF0CHE<*CEBE*EGGEFFIFF6BG.9GEE?G6A/(E?*GFACFG)E?E<;:GAEFCEEG8GE?1F?FGAEEE(AC(#EE:GG*:?GEGCC-?/ACHE:G.GCFGG8(GGE.FC6*F)EEC6GG>:?:*E/0CE
@antibody_215_multiplicity_308_copy_69-1
GGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCAGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGG
+
,A?<?ABBD-BDDDDDGFGF;A>HFHHH?HHCHIFIEIHAII9HHHEEFIHG>H=GFH5GFHH.GIIHIGIHEIHIHICAIIHIHHGIHHGI@6IH)IFHFDHHADHH2H.HHHHEFDEHHHHHHGFHGHG><EGDFE?FDBF2HEEEGGEEFAEE16EG*<*;EGEAEF(G(EG(8CEG>GEG8/C?:G8?4:EG8(/EG2DGGCH(G?G0:D*CEEFGCG8E8ECAFE.EEEAE.:E(EE1(2:AGG:
@antibody_215_multiplicity_308_copy_70-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATTAATCATAGTGGAAACACCGACTACAACCCGTCCCCCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACC
+
5?,??BB?BDBDDBBDFCFFGGAIHIHFH>HIGHH>AGFFFHIDIDHFGEHFDHEIHIEF-HCGDIHFDIHGHHHGIFHFHGHIEII-I@GIIHF=HIGHHCDEHIHHFG+=)H8DGHEF.HFHFH2#GFGFGHHFHFADABEA#FEFEGAEFGE;FF<E?G:#G1EGGG?*1GA1CGG#G+EEG:FEGG.0G<0GAEE:E(?EGEH:EE:AEGGE/E7(E:1CD<?'**6E*C<G401EGA1C?/8CG?
@antibody_215_multiplicity_308_copy_71-1
AGACCCTGTCCCTCCCCTGCGCTGTCTATGTTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCAGAGCTCTGTGACCGCCGCGGACATGGCCGTGTATTACTGTGCGAGATCGAT
+
????ABBBBDDDDDDDCF;FGFCCIFHHCF-IBIF7GIIIHGHE;H@EICHHHIIGDHAFABFE-HFGHAFFH?HHHHIHIHFGHFII8AFDEHHFHHHD+CHHEAEHHEFH4HDH@DGDE+FGH*/EHHGH8CFEEGDC?G6BFD*GFF:,GFGEFG,EGGEG(-AEGFG9EGE??E:G<A(('GEEEF?CEGAEGE(GCG)(FD?)(C(<H)@GG(ECEG(:E?GE.GCCECCC*GC/?EA:EF1CGE
@antibody_215_multiplicity_308_copy_72-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGGTTCAGGTAGAACTGGTTCTTGGACGTGTGTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGAAGTTAGTGTTTCCACTACGATTGATTTCCCCAATCCACTCCAG
+
?5???5BBDD<DDBD?FGFFFFIECHGHFIDHIH=CHIHFHICHDIHHHFFAHEF-IIHFHHIGF5H*+FEHEGEHF-FDGHFE#IFIHIEFHEHIFGIFID7CHFH@F0FHHHCHGFHDE*G*DEHGHH+G@;.GEG.#GEGEA8DGF0=,6G0EB.6@(;6<A;6G';GGEGEGGGGEG'E*GFE6GECGGE.6F:*GCGE0F6*E(H<#HG*FEEGE:?C.#E;EG?C??:C.?EGAC/AA/C:G08
@antibody_215_multiplicity_308_copy_73-1
GTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTTGGCACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATGACTGTGCGAGATAGATCTTCGCC
+
,?5??=B@BD-DDDDDGFGF8FBEEIHHHIFIHFIEHIHIHHGGFFIDHHHHFH-HGGFDGH)D-IGHI5FHHHA=CAFIHIHAHHH@AAFHHFIIFFGFFH,=HCDHEGH?FDD=H3D4CGG.*FHEHEGEBGEGHGFCCEEGFGGEG=F*GE6G*.@#E(CFGGEGEA/GFEFCAE(6GF:E4AE:CG:GGEEEC?C/EE*?2FECCFE?CG(E9EGEC,EAE:.8EE?88AC?8<GE.C*E?.:EE6
@antibody_215_multiplicity_308_copy_74-1
GTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTAGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAAAACTGGTTCTTGGACGTGTCTACTGACATGGTGATACGACCCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCC
+
??A??BBBD?DDDDBDFEFFGFICIHHHIADIICGHHDH>FFHICHHH7D@HH9IHHH@HIFGHGIF.5HAF5HFDG;HHEIFI+FHI.HHI/IHHH'HIHHFHFH@HHHF?HH;H?HHBEC5FCG+8GF.FEEEG>FG(E@;E*BC=G/DECEGE?GF#EGE*;(GCEFC:GEE'GG:G+E?C.8HA4EAFCGGEGF*EDCFC*CCGAEGC@*GA;GFCE/:***E(GFEA:?G?GA?:01FC:E(EEE
@antibody_215_multiplicity_308_copy_75-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGTAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAAATACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTATGTGACC
+
??=?<BBBDDDDDD?DGFGB/E/GI>.HHIIGFC;HCHG9+DIHH/HGHFHHHHAHHBAG.=IFEIIFFDHGGFADGHH@AFIH5+FICHEDH@HI/GFGHHICE;FHHCH+GHHHHDFHHHCFHHE(EGE4FEDIEGGE#FEFDCB:EG8CECGE??EE*4FFE(F8GCEG)*CCCFEGEF?6.2FACAGCEE8.EG;C?G??GFH?CA;(/E9:E(E4?EEG:G(GE:A*1EA/C9C)EF*G?:*4;E
@antibody_215_multiplicity_308_copy_76-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACAAGTCCAGGAACCAGTTCTACCTGAACCTGAGCTCTGTGACCGCCGCG
+
?<??AB=BDDDDDB?DGF?GFFIIFIH?IIFF/9IIIIFIHIGFDHEI@FHHHHF5F8CF'GH-HG+GFFDIEHEHDHFFIA-HHGHDHIHHEFHHHHEDIHCECFHF,DHHFHG?DDEH<HEEE*D>FFEF9FGD8GG;HE:DDGEF(GE8GGE?GGCEEG?EE:GEGEGG;G?EEG?EFGGEFCGF?;AF*E?EG:0EGGE/GGECE(8CH(*EBG?E0EC:?GF2*#G(GC0ECG:8GCEFCE?)EG
@antibody_215_multiplicity_308_copy_77-1
TCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCTGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGGGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAATAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGGCA
+
?????=B<DDDDDBD<FGGCGCHH8HI-CIGHE+.ICHIACGHHHCHF0HHIIDGIIEIC=FHFFHDHDDHFHH5FHIHHGEHFHBFHGFHHHFIC-BHEFGH2+HFHHAF;F=FIDHFH@BEHFD>FEHHGEFHEEE@+EF<*GF)4EEGFF?EAEGGGGGG?CGGG:#GFF-GEFGE=AEG*FEA?A?=2*/ADG6A.6;GG?EC.C*AGE@GAG?E<E(CE0G:**E68G*/:EC?:EG/?1.G/AC
@antibody_215_multiplicity_308_copy_78-1
AGGTGCAGCTGCACGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGAGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCGCCTTGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGTGCTC
+
?A???B/BDDDED5BDFGGCCFEECFIAHHHBHIHEEIICFGAIGFIBFHFHCHHF8HHHG:IAIHF?GEEHHFHCIHFDFHHHGH.HFHFIHD,HIFHFHI;FFHHDFIFHHDGDHGHDB=@HEBEDF@FD=GGFFDG0DC(:EEEE??GECGCG=G*G#F<:EGF4AE;FG<GEG?G(EFCGFGEGEEGEC)GG(E-A.?*#EGCA:CAE8GE#E:G@GFG?GE?G:C:AF?A??GEE?6?C/*CG;C
@antibody_215_multiplicity_308_copy_79-1
GTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAATCCGTCCCTCAAGAGTCGAATCACCATATCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGTCGTGTATTACTGTGCGAGATAGATCTTCGCC
+
???A?<BBDD--<BDDFFGFCCHHE8-IIHEHGIHHIDGHHGHHHFGFHFIIHFFHGFHG=I@HHHAHIHDGIIDHCH-I-IHHFAFIH*FHIHDHAFD*IFGHFHHGFHFFG>6HDFHHFBGEGH#HCBG=FE**;FFEB,2G?=GEFFE4G/EEGEE?FCCDGEEG.0EC:E;CG(GCEAEEC*6CEEE?#*FFE;EEA:'EG:HE:H.G:EDEFE,@?EE?GC/?FG(0*(EG8ECCDECG?*C0GE
@antibody_215_multiplicity_308_copy_80-1
TATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACTATGTCAGTAGACACGTCCAACAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGCCTCAAGCGCTGACTACGGTG
+
??==?BB?6@DDBDBD-CGFGGHICCHFHHICICFB/CG@FFHH#5E-DDHIAEHFFGHI5H?IIG-IHG+IIHHIHII-@HIEHHHEEFDF-FDIHEHFHHEHHHFEHEEHHEDG;HHEC@GDFH@DB(G#G*FEH*GGD3G?EHGEGGG0'FCEEEGGEEGDEEGEEEAGF*.0*GEGGE(G<C?GG6FEEEG?*GGEA6C*;E:?EH<AC@8GEEEEEC:C*6E2(EF?G;C*GEACEEG6/0*GEE
@antibody_215_multiplicity_308_copy_81-1
TCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACCCCAGTCCCTTCCCGGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGACCCACCATAGACAGCGC
+
?=??A5B+DDDD-DEBGCCGGFIEIFHEF+H>EGIAHFAIC*ICIHGHIHHH?F./IHECH'EIF5IIF:IH<HH5FCHFIEDIHE-HIFHGF-EH<DHGFF)F=HGGHDIHGCHDFHHEAGHFG@DGEHDGEDBE*G0H*.GECEGGEG?EE/:9AEGFC?EGEGAEECEEEA:GG/EAGGG?G0E:ECG#FCG?;/GGECC(GEHFGC/E<**89EBG*?GGGE./E((<CC??88/*E:E*?G:EAE
@antibody_215_multiplicity_308_copy_82-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGATTGAGGCGCAGACCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTAAGGTTGAACTGGTTCTTGGACGTGTCTACTGACATGGTGCTTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTACACTATGATTGATTTCCCCAATCCACTAGAGTCCCTGCCCT
+
A???5<B56BD5DBDDGG/ACCIIIIHIE/EFFBIFEHGFIIFH?EH/@HCFH-CHIHHAIIF?-DGEHIHHH#FIE'IFH=HG@IC'HHAHHHHHHC-H=HDHHHHHHHEEH=HH6#HHH*EFF=DEEE,E(DDFH*FFFGGE0GA;G8*E9E:GEE:GG=EGEGEEG6:E06G:G0CF=CACGE6E(?EGE'E.F:EEAG)C(GEG).E?D)ECEG(E:CCFC1G?AEGGA(?A#*?(8.<F1.:E*:
@antibody_215_multiplicity_308_copy_83-1
TTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGCAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCACTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGA
+
??=?=BBBDBDBDDBDCG.EFFIHHEFHHBHIIIHCFAAFH/HFHI9HH?I9GHH/9=HHDFHDC+FHAHIHHG,5F=H5DHBHHIHH4HFEIIH6IIH.FGHIIH.EHHF,GGHDGGHG<DH+@F94EG<GAGG?EGEEFGEDE@E;GEGGGGG#?2/FG?E*.A?E:G*GGE?CFGEECAE:/E:AE?(CEEEEGG?*EA'CG;HE/?8DEEFG:(8G>:AGG(CEGGFC:FG0*EF8.*FGFCE*DG
@antibody_215_multiplicity_308_copy_84-1
GCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCACGAGTCGACTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTTACCGCC
+
???,?BB?DDDDDBD-CFACG>/IHH+IFFG?IDADHIHGI7CHE9HGHHHFIHAHDAGHGIHG3IHHIA5ICDGHEB'(IHFIGHHHHIFDI8HIIEHHFHHHHAACEACEHGBE>H+HGE.FFGFE*2CEGH;F3CGEE*GDFGFGFGFC6FGEEE(EEAG@=2GADFGGGE?CC#:.FGCGECC(GEECGCE(EEA(?0#.E<D.;E8(EEG7.?8(GEAE60EGE.G/:G:G0F*AC:C0(A?.GC
@antibody_215_multiplicity_308_copy_85-1
GGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATACGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGAGTTCCCCAATCGACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGTCC
+
,,A?=9>BDD@<B?BDFCGFGFIFHA>HHFGHGGAHHFGCHHEAHHI4HHHH,HIHHICFFHIHI=FGFIHAFIE?FDCBIIHIGHGBHHHIEGHEH5HIHE=ECFFHHHHFFFE#+H@FFGEG=1-G<GG*8GDCBGGGDFEG8GG;E.F5G8GG=GECGBCG8F:CE*BGFGGGEE(9FF?EG:C.9(CGAGGEE(G/.?'G/FEECEG:C8E?B0CE8'EEGC0CC0EECECEA6>G(:/AAGG#*?
@antibody_215_multiplicity_308_copy_86-1
CCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTAGGTGTTTCCACTATGATCGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGG
+
??=??BAB-DDD<@5DF>GGGGHECFHHIHHHDIFIIHHIHIGHAGDHH-HGH?HIFGFEI8HCI-?HHHHDH+IHGCH5D@HIEFIHIF*IGH8FHCAGHHHHHHFDHHE?*H=DE2HCFH=HGCEFEF3DBGG(EABE8FF:EGEGGE9BDA@:EEGG5GACF;C?EFGEACFG86G(EGAG;E1G:GF?G*EC>/FFGE?0G*(/:H3GHCF*.GG@GEEEEA0*C#F?C0CC:CECAG;:>/?A*:
@antibody_215_multiplicity_308_copy_87-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCAATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGAGCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGCCGCTGAGCTCTGTGAC
+
??=?AB<7D<D?D?@BF.EFCGH-6HHHHIIIHIBHIEHIFDIIF9AH?FFED.EEGIH,IHIHH+DFEIAHA4HGAHED5HHFHIHDHGDHI=FH=HHFG++H5G@DCFFD</GHHD+HGDFGEH@FE,GH1GF=EGEF@GGDGE;GG=FEE<6G)ACEC=CE6GEEF(?GG:@GFEGEEEG1E*#FA?6FEE:EDG?:GE:FFDEC(C(EH(GE*GBC8E:F/ACE;GG1A0(:EEFE0G?/G:G(4:
@antibody_215_multiplicity_308_copy_88-1
TAAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGCGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACGGCAGTCCCTTCCCTGGGGTCTGGCGGATCCAGTTCCAGTAGTAAC
+
?,???B<BD<B@DDD?CG?G8GHFIHIH>HEHHHI+.IIH-DIHHHIHFIHFIFHHIHG-FHGIDEIEDIID?HIHFHHHHEDHH=FHIIHCHC@IG6@HI-I=HHHCHF'EHDHFEE6CBHEH'FGFFGBFH@GG1FGG*G2F?*:ED@GE*?E*G<EE-G/(HGF.EEGEEG?GGCCAE:GECCF;E@EE0GE0EC:60*EF(#E'A(?*:@FEEEG@GE.*CG8/;C<CC*:C*GCAG'C0:?G*(G
@antibody_215_multiplicity_308_copy_89-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGGGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCAACCTGAAGCTGAGCTCTGTGA
+
,??9?BBBD9DD@DDDCGFCAGIHHHCC/HI6GHCHEHGIHIFII-HI+CA@IIIFH5HHHHHDIIIDGF=CEG5AHI?H5EH-DHHIHBGFHCHH-HHHHIHCFHEIHFFHHBHHHEHDFDG@FDGFGG+GFGG3FA/DFE;EG'EECAGGEE*(GGEEEE?;C:A(CCC8GEEGE/?GB+GGEGG?FCG?(6EC?GCG:GG:AE(GE<G.@E(GCG::B7EC?.GE(?C96CCC/CCGG?(8**1C*A
@antibody_215_multiplicity_308_copy_90-1
GGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGCTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTGTACCTGAAGCTGAGCTCAGTGACCGCCGCAGAAACGGCCGTGTATTACTGTGCGAGATAG
+
?????B?BDBDDBDDDG@GCGGIABFI>HEIDHCIEIEHGHH.HFIH@#FEHADIEHIFDAFFIHFBFHIHAHHIIHG5HIFF-HFFDCHGF;IDHEFIHEH+HHIHDFHHEAFEHHG+HFFDFEF>GH<FDGF5EFGG2FFEG2GFGEFGG?*EFEEDEG(GFFG8AGGCEEGCFE(E6F?*GAEEG9*EG.CEGCG.<EEG?A6((8E6GH;G:GE8,EF*E8ECEDE#<8EEEGEE0;G.86*A*EE
@antibody_215_multiplicity_308_copy_91-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGTCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATAATAGTGGAAACACCAACAACAACCCGTCCCTCAAGAGTCGAATCACCAGGCCAGTAGACACGTCCAAGAACAAGTTCTACCGGAGGCTGAGCTCTGT
+
????<B<BDDDBBDADF8GFCGIFIH>CIHGHFHFHAHD9F7FHHH-IHHHHGGCFIEHII>HCIIHIFI4HIFDFIEFG-IEHGH(GIHFHHIIHHGHAEHHD3:HIF)FFHHHFEHHCGBHF2G:HDG(FEGGEHEEDEGGEGGG6GGCE#AG./(GDGG/>GGGGE?2*<GE'EE2C?EG?FEAGF??E?AF/ADGGF(G(GD(E(2(?EGEAE(;=?EGE'EG?/E:GF8'EE(?F0?/G:F:GGE
@antibody_215_multiplicity_308_copy_92-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAACTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTGCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATAATTGATTTCCCCAATCCACTCCAGTCCCTTCCCT
+
,<A=?<B@BDDDBD?AFG+GCEIHHCHHEIHFIHHHI'I@IFH>IIFEIF9-HIGB90HFIFHI-DFHDDI-HHAFHGHFHHGFH)HH5DBIHIHH?CFFFFF++GFH+=1HHFDGFHEG9FFGEEEFFGH,=E3?HEGHFGGEE2>GGEE/::GEE:<:G:?6EBAEG6EE(B.CD?CCGGE)0?EEEGGE*/EECG8?/EG1*GEE:''/HC7.GGGAFEGGGDC:CEEEAAGC?A.EA.GAE*DC'A
@antibody_215_multiplicity_308_copy_93-1
GGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGATCTGTGACCGCCGCGGACACGGGCTTGTATTACTGTGCGAGATTG
+
??<??BBBD+D<D@BDCCGCG;CHI/HFEIH/HHHIH+IH,HHIHIFIBF9,FEGEEIHHHEHFICDHC)DCHIBDIH?-IC-FGHHHGGFCH,HHDHFFHHHEGHHFFHFEHFHF*FCFHGGGGBEHHGDGDH8GGFA2EFEC;<F;FGFEECB?EF2EEDAGCDF,6G:EEEGGGEGEEE./GCAE0C(EGAC;G8?G4ECG0AEGGEAC:CE7G(E-CEEA/8E#A*GEEA?EG*EFE0=GE*-E*G
@antibody_215_multiplicity_308_copy_94-1
GACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTCGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACTTGGTGATTCGACTCTTGAGGGACGAGTTGTAGTTGGTTTTGCCACTATGATTAATTTCCCCAATCCACTCCAGTCCCTTCCCTG
+
?=??AB?=BDDDBDDDF@CFGGHICHHH/HIHHEHHHIIIHHHIIGHFH.IEHHE-EIHFHHHEHGIGGHG5D5IDHHH=HGFH<HHFHFHCIHGH+FCG?HGFHGHCDCE4HHHHFEB4HHDGFGEFAFHDAEFG)B8CEED==1GEE<FA6GGEGD1G(.B?E(8EAAGGG?GGCGEG6?2>;0G(E((E-AGEA#?E>:C*EC(GCEGEH'G0/G7EG8:GD.E'.(E?:1CFECE00EF*EE8FCA
@antibody_215_multiplicity_308_copy_95-1
CTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATTATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTCTATTACTGTGCAAGATAGATCTTCGCCTCAAGCGCTGACTACGGTCACTCGCGGTGAGCTGCTAATTTGAATACTGGG
+
?,?AA9BB<@DDBDDDF/FGAGCIIF+HHF@0HHIGIHBIHIGIHIH=IEH(8+IIEIGIEHIHEIC5GFIAEFAICHI5=H5CHIB@IH8CC8IG/>HGFGHHHHH<HHBHFDHBD0E=GEEHFDEFEH3GEGFDFCE=GFGCGGE6GGAEAEEGGGCCFE?8;GEG:G#.EGCCFGEEFG<(CFGAE4E?EGDGGGE(GE/CDEH;CCG8:8:EG(,C7FGFE?EE?8E;GFF?=EEF0E)?G:0G::
@antibody_215_multiplicity_308_copy_96-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAACATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGCGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAGTCCACTCCAGTC
+
<<???BBB7BBBBDBDGFFGCF/HHIFFFHEHII>HGHGHHHH?9IHIE5IGFIC@HHG5FHHCHHHI5=FHH?II.GHFHHI#H-AEHHFIFIAIGHIHIEFHFEGFHDHEHHEFHFHE=:EF#FFFEE/DGE':GEFEGEGG>??GFGCG,FD-8GEEAEG#/G6GCGC;??GEE8C:0F*8CC?EAG*EEGEEEGC(EG:G6:AEAFGCDGEGC(CGGECAC8*/*D6ECACEE#?*E:E::?:EAG
@antibody_215_multiplicity_308_copy_97-1
TATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGAAACGGCCGTGTATTACTCTGCGAGATAGATCTTCGACTCAAGCGCTGACTACGGTG
+
???AAB/BBDDD-?D@F8FFGFIHI>HHIHID@DC-IDIAIH+IHHCEHHIHIHEHIIFHGFIHHIHGCGH@-H@HCF+IIIHHHIGHHIAEEIIHIHE@+HE3FFHHHHGGH=EDHHHHGH8HH(GHF92FHEFEGE6E@F9GGE?GA(EGHFGGFGG@GGGGCEA6GEE66G(G?=GE?CE<.C:G:0///G#CC?E?F>CG.EHAGEG**C@7GE(0E0:G.:?DE(G?:A?A):GG(E'*8::1(<
@antibody_215_multiplicity_308_copy_98-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGCTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCGTGAGGCACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCA
+
<=???BBBBDD@DDDDFFACGFBE?HHI+I.CCHHHGHHH?GIHIFFHHGHHHIHIFFHGFHHHEECHIIFIECHDH+HDGHIEGHDI;IFGHIIIDBH6-HIE5HGHHEH?HHFEFGDFFGHAGH4H3FH:FHEFF'ACD6ECGGFAEGG:EGCAFE;G3;GF:CAGCE0GEE*EEFG*FE:AAEE*)GG8)FG:18)EF6?CFA':/H=GAC:F/GG8EE?GC:*EA/:8<CE*#E<*CE((86F?.E
@antibody_215_multiplicity_308_copy_99-1
TATTCAAATTAGCAGCTCACCGCGAGTCCCCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGATCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCTCCAATCCACTCCGGTCCCCTCCCTGGGGGCTGGCTTATCCAGTTCCA
+
????AB?@DD?E9?DDFGEFFGI-ICCH/HEGHHDHFHIIDIHE7FBHEF8HD5HADHIEFBHIIIFCF@*H5HI@D>HHHIBHIIICHIH?,D+IBF;HG=DHHCH@EFHHEHGDHGFEFHFFBFEEHFHEFBHEEFFG6EFEABGGGADE@GGEECGCGGGE.F0ECGAE;GGE:FD0(GE<FDF;GEEFCC?E2C/D;C(C?GHEEAEE;:(*EF?EB(AGAECE8E/C*/(?/'(G?EEE*EFGC0
@antibody_215_multiplicity_308_copy_100-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGGAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCT
+
?????BBBBD=DDBDDEFFFGFI8CEHEHE+HIHF'IIHFHI+H@I-FFHIEIIFACIGICGHIIIIIIHCHGCCHAD)HIIIIID,BAH=FIHFIHEHHII=FBEIEG#HFIHDH#D;?HCFGHHFF=E>8ECEFFEG6EGEEEGEE*EFGG?EG,;E?EEC'GGEECEEG?:EGG#A'E+GC=A?AEGE8CG8AGFG>:E;DFF?EFEEAEDG(G8BC((EA(GGGEE1(:AC*8GF)CCA?*<?*CG
@antibody_215_multiplicity_308_copy_101-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTTCCTCAAGAGTCGAATCACCATGTCAGTAGAGACGTCCAAGACCCATTTCGACCTGAAGCTGAGCTCTGTGGCCGCCGAGG
+
A<?=?BB3D@DDDDBAG6,CGFHEHHIHEIGC,IFEHFFFHCHFH>HEAHG-C9DHH>GHIIIIHECFHGH5HFFEHIHHG;HHCIHH=7H/-G*HHD@FHHFFDHHHHDFDEDHFDFDEGHEGDEE+FFEDEGGFFEEEFGFG?FEE=GGGE?EGFGGBEBFG6CEGG(:C'GC:EGEFEEE8FG*CG(FC?CACGG;E#C*'?C:G?HE(A.90*<E(<;AEEF0CEA6EG:F:F(/1#E6>GAC(E/
@antibody_215_multiplicity_308_copy_102-1
GGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGCCTCAAGCGCTGAGTACGGTGACTCGCG
+
5???=?<9DDDD?<DDFGFF8GIHIHFI.II@EIHH9IH-IHGIHII=HFFHFDCC)H5-G.AHIIDIHHIGDFFHEDIIHFHIHIDHHEH7FHHBH16EH)H,F?HHFHH+7F*HEDDHFH*HGH)DH4FG7EGEEF<GEGGE@H?E?EEGEEE8EEEDF4:GEGB/EE)(C(EE(G:;?G#FAEGG:A>GECG(C12(E8-*:EE:CHCFECC**AG@G8;?E.?-:C0(E:*('E:?EF8::F??:=
@antibody_215_multiplicity_308_copy_103-1
CCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTAATTCGACTCGTGAGGCACGGGTTGTAGTTGGTGTTTCCAATATGATTGATTTCGCCAATCCATTCCAGTCCCTGCCCGGGGGGCTGGCGCATCCAG
+
?????B/BDDDDBDEB>FGGCGHHCFHI@HEHDIGIHGFHCIFGHFHIHHHIGEFHHHHHDIGFHIFFEHIGHDIEHHBEFICHEHHIFAHH-C+H.F@F+1HHEHHHF-BH+EGEH5DDC*HDBH*DA?FBBEGF@FEFGFDGHG5G*D:AE#EEGEG.GEA((6E?G(GEE?CE;EE?GFE?F/GEEGECC(CC1*E'/EEFGGC/C(AAF#EC*E/FCG:GGF?(G*((EEFEE:E.:1C*08E:GF
@antibody_215_multiplicity_308_copy_104-1
CAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCTACTCCAGTCCCTTCCCTGGGG
+
?A??<<BBDD<DD5DDFCE;;.HIAI>HIFH9F=IHDHIIF>I?AGIHHEHHEFHFAHIIBH*GHHIIGIHH-HIC?IIHAHHG5EID/ICDHCHCIH.FHHCHF+HGHHF+FHFGBFHDE#FH@@+?H5FEHG@DG3GGGCGE@B*EFGF,G9G,CG?<.GF(EGCE*A=GE(DG?E?#CG*>/(AC'EE*CC.0?CEAGGAAGG;8AE8FD:*E;C0;*G?C:CEE(?(F:?82:C?E.ECEGC?8*C
@antibody_215_multiplicity_308_copy_105-1
TGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGGGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGTCCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGCTCTTCGCCTCAAGCTCTGACTACGGTGACTCGCGGTGAGCTGCTTATTTGAATA
+
?????B9BB-D5?BDDGGE-FFFHIIHFICGEHHIGH9II=FIDHHHFG9F>HHHHHAIHFF#I8IFH-CFAHFF--BGGDIHIHCGHFFDHHDHHD4FEDHFHDHHDHEHBCE4HFFFHHGGGHEF>E)EGGGE5FCDEF6GGEGG*E?GCGE.G#F)EFE6EBEF#G)EE8CAE=6EECE(?</8>G:FCEG**CF*AGEGG(:E>A;#FH(.8/<CGC:A:-C?D:?'**G*//EAC(A?(AC6EGE
@antibody_215_multiplicity_308_copy_106-1
CTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTCGAAACACCAACTACAACCCTTCCCTCAAGAGTGGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCACTGTGACCGCCGCGGACACGGCCTTGTATTACTGTGCGAG
+
??<?A??BD?DDDDB?FE?GGGHIFGHIIFIHIIIIDCHIF@HIHIIAD.I8IFIEIG.HIIDIICH?F-IHBHGIHF-IGIIGFHHDFHIEHD8HFHHHHHFHEHHHEHHHHGC6FHDHHD+FF;0HGGFFE*EGGBG@0E(G6@GE??CGEDE(EEGBBEGGECFEEDGFGGE((EE<FG::?E<G8::EF*AAC*G*CEGCCACEG*GE()GAE*:G:CA*DGA)G?/A/'GE>?86A*FC/E(GE8
@antibody_215_multiplicity_308_copy_107-1
GCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGAGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGGCCCTTCCCTGGGGGCTGGCGGATCCAGTTTCAGTATTAACCACTGAAGGACCC
+
<?,?A=BBD9-DD-DDGGGGFGHFIIIFHIFIHFHHHFHAFHIIHHHGGFG+E0F9+CGHBHHH;EFHHIHIFHIIFGGIIIIB-FE-HHHHHGGHHICFHHECGCBIHHHGGHHG=HGGGFEDHHHGG34FHEGEFHECFDGB;EGBEEG?8CE2?CG(EGEECEG'EEA.G8B'F??:G?C*EG:G?)GF(E:A(8ACEEECGGCE:HG8/:<F7CECEE:E:A':E?F?*?G(??EE:AG?E68(E(
@antibody_215_multiplicity_308_copy_108-1
AGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTAGTTCTTGGACGTGTCTACTGACATGGTGATTTGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGT
+
?????B?BEDD@BDDDGFFFG>H+>IH8IIHDG9HHIIHIGC>HHHFFCIII-FI?EGC@GHFIHIGHHIH;AHHHD5AFI,E-GDBHHFID#D=H?HEHHHHHGHFHHGDHGFH1HHHFDHGD(HH<EDHH@GFGE4E@FGGCCFE+E@EG(C;*:9;EE8EE(@CECGG1FGD(EG*/.E(/#866AAGGECCEEG./GG:EEEE6EE;E@<G?C(CG??EGE2AA*CDGCGC6C*?.EEF-*EACE)
@antibody_215_multiplicity_308_copy_109-1
GAGACGGTGCCCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGTCGTGTATACTGACATGCTGATTCGACTCTTGAGGGACCGGTTGTAGTTGCTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCC
+
=?<??BBBD-<@DDDBFCFGGFHFIEHIHFIIH-HIHHFHHGHEFFHIHHIHFFIBHF?DHI@G+HFHEH+IAHAH=HGHGFEIHD9FHDHGCHIDFEHH-HHCGHHHFCEHGHHEHHGF=D,EHIFEDD/E9FFFEB?GEEG*@FD6E*FGAG/?GEE0GFE1C*FGAGEGECGF(:GE;EAEACF60C=0.F;CG#:0GGGC:F:?G.G8E@E*GC:GGC*(<?C0?E::E:FG*(8)/2:GC)(?C:
@antibody_215_multiplicity_308_copy_110-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTTGAGTGGATTTGGGAAATCAATCATAGTGGAAACACCAGCTACATCCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGGTGAGCTCTGTGAC
+
9?A??BB?DBBDDDD?FFG+FCHIHIIIFHGHIFHF@DH.HII)HHAID8IHEHFIFEIHIDDHHIAHCHHHHHHDGI=HIIFCHI.ICIHAAIIHI9F?H=HHHFHDEH+CHFEFEFEFE;GF7GA,GF@FGH?EE#GGGGHGBD>FGE=;FGFGEGGAE*G;*0FE0EA(AAGEF'?EEEE?AA/G:':F*6G0;EEA2(AC?:/*:AEGH;/<E::G:CE?EECG:6??:EGE(*E:C:*?C8E:C*
@antibody_215_multiplicity_308_copy_111-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAAGTGGTTCTTGGACGTGTCTCCTGACATGGTGATTCGACTCTTGAGGGAGGGGTTGTAGTTGCTCTTTCCACTATGATTGATTATCCCAATCCGCTCCAGTCCC
+
?=???BBBDAB@DBDDFG.GG@IFHEECHFCFHHCDFICF?HHII?HE+HCHIA-FFEHIHIFFGGHIFH@GDHG5HCFHIHGIHHFAHIAHHGIEIF=EBDHFHCGHFHEFFHD=EFD?FEGEHFGG3G;C+GFG3=EE,GGEF8F*FG=ACGF@EC1E8?G;6E1?GEFGEEB;G'?EGCG?ACEGGEEGGE6*.=?GG-FCF0EC0#(*CGBG:'F,E?*EG8E)C*#A6E''GEC*EC0/>C(ECG
@antibody_215_multiplicity_308_copy_112-1
ACCTGCGCTGTCTATGGTGGGTCCTTGAGTGGTTACTACTGGAACTGGATCCGCCAGCCACCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTAGTACTGTGGTAGATAGATCTTCGCCTCAAGCG
+
?55?=BBBDD?D<A@+GFG;GF-ICI/F6HCHHFGIIEFIIHE7HF8HHIHFFHEHHF,HICFGGHEF+HE#AH5IIAHHIE?F5GIHHIFHCHAHFG=F=FFDHG=HHHGHHH,+9+GH+*FCGGH9?*FDE*FDEF;@DFGCDGCEG*D(.G@GF:GG;E:EEFG*C/?GG:.:6CE2E+6E(CAFE;EGEGC:EA<GCEF<FGCG=0*G::B;EE):(E.ECC#*G:*?GGEEE0C*;EGCG:GC*(
@antibody_215_multiplicity_308_copy_113-1
AGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACCGGTTCTTGGACGTGTCTACTGACATGGTGATTCCACTCTTGAGGGACGGGTTGTAGTTGGTATTTCCACTATGATTGATTGCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
????<B>BDDDD@-AD>FCF/GI8/8;HFFHIIAFIIHHIIFH=FHHFFH7FFIGFIHIFIG8HHFHHIEFHHIIIHFF5?FHHE**EHIHGFHC++IHHCHHHHFHGH4G*F;GH=F.GFG@HDEHDDE?EEGC@B(F:1C;EEGEECEAG2EGDGFF6;GEEFGG(GE8(GAE?*(GCE0;EEG(CEFEGE8CC.?C(GE(EGEH(EHC6HEFCEF#@DC::EFEG*1GGF'EEECG<?:C<*<GE0G
@antibody_215_multiplicity_308_copy_114-1
GACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGCAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAAACACGTCCAAGAACCAGTTCTACCTGAAGCCGAGCTCTGTGACCGCCGCGGACACGTCCGTGTA
+
??A???BBDDB@DBDBFGFFFAAFHC/IIHHHIH+HIHHFHIHIBCEH@H:HICIHFIFFFCIDIIIHHFB5EH5FIFI+C-HAEGHHFC(HFI,DHI+FFCGHHH=HI4H@=EEFH+3BB3HF(*GH(GDE)G5GE?FDCEEEGGGFGGG8'GF(GEGGA<BA)D>EEGGGCCC??;G:6GA1E(6EE*CG?G8?:CGGAEGG-;*AC(EEHGGC((,E*EA??EEE*CEA9C:?E?E:??':?EG?F'
@antibody_215_multiplicity_308_copy_115-1
GACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCCTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCAGAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCA
+
A??A?BBB@DDDDB-BFBGFFFIHHIHHFFFFIIEFHIHHHHHA+HHHHE=DHIIFHH@/.GFIFHEIG-HAHEEHIHEH?F+IFIF)HG5HIGHF8IDHIHHH@+G7HHHHDHHGHDGFGGDG;HHBHBGH7FFBF@DE3?EE/CHGEEE@BGGEGGFG/EF;(CEEEG(G(C60F6*?GEE*CCE<?6)CEFEE8*?GG?EGGG*EG0GEEAG7G?C0CCD1=6GC:6A6C*1?G:GGAFE66A?*F'
@antibody_215_multiplicity_308_copy_116-1
GGCCCAGGACTGGTGAAGCCTTCGGAGAGCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAATGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCATCATGTCAGTAGACACGTCCAAGTATCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGG
+
???5?BBB@BD@DDBDFG8EFF?+HHHE,FHIH.IIIIH?FEF=-HHFGHH?FH@8GHFG5IFHIFHHF5IHEBHFHGHDDFFHAHHHC+=EIHIHHHGCHFHIGGEDI(FDEHHFEF=FFCHEGG>FEFG+'F*E<CG;CBEF9B@EGC*EEGGCF(H2FG:FE;<EE(GG?:ECEGGA6(GFGE2EE4FAGG*C0?(E?GDE(**EG(G*(EGG?(E,0?A/;CCAGE/0AEFCEG*EG(E(EE(.EC
@antibody_215_multiplicity_308_copy_117-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATAATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGATGGCGGA
+
<<??A?@B9D-DDDDBGFEG>FHCIIIHHHIIHGCHHHGHFGFIDHBICFIEIGFHFFE+ICIHH'BCGHIIICHDIID-E=EEHH=IAFI.HHHCHHFEFD?FFHHEHHE.HHEFFFFGHEGFBDG*:,DEDEGGDE.+BE6?8EGEG==GEGCG;,GA6<GEFF>'8A*EF:EGECEEEEE:EG-FHG(09GEGEGGE6G8G0GHG?<CG#(8CG<:G;=*C6E?EC:CE:EE?EC:(GE#GE0?EAE
@antibody_215_multiplicity_308_copy_118-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGCTCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCATCTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCAGAAGCTGAGCTCTGTGACCGCCGGG
+
?<<A?BBADDDDDDDDGCFGAFEIIHHIFHIII0IHHFIHFHFDHI>F.H>CFF-EIHEFEDD=EBH-HFHIII-GHAIII+-DF6HEHIHI?I7F-HFHI,FIIFFHGEHFEHHHHD4E@GEDFFGF9=B8@F,=*EGEGE*@AGHG*/E?GGEDB?*ECAEEGEGG0FEGAE:EA:EC?GE*G/E0AEEFG/?GE/FGG?G6G(F::?EC@:E0?/:EEGCE(G?E(0EGAA*?AGEE6;8CDGE)**
@antibody_215_multiplicity_308_copy_119-1
CAGGGTCCCTTGGCCCCAGTAATCAAATTAGCAGCTCACCGCGAGTCACAGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGGTGGTGTTTCCACTACGATTGATGTCCCCAATCCACTCCAGTCCCTTCCCTGGGG
+
??????B?DD@DDE<DFFFED#F.IBHHHIHGGDI0HHF@5HIIH9F5F-EH,HHIH@HG@5IHEIHHGIIHFHFIIH*EHFIHIHHHHEEIFBFH+IEGHB*EIFDH=DAHG7HGGFEEGGD*GGFGFHDE;DG9F#(GA=GGBEEGGGDFDFF=BC*GACCEF9EC9E?CG(?*EE(ECC8G.G*C:0AEEGG:GEE00GEG(G'ED(*'C:GE0G(@*AGE8GG6AC?DCGCCFC*;C1<*A8EE1E
@antibody_215_multiplicity_308_copy_120-1
TGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACATCCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTACAAGAACCAGTTCTACCTGAAGCTGAGCACTGTGACAGTCGCG
+
,????7BBDD-BDDB-GGFFCCEFBHIFIEG7HAF@D/H9IHFHHHHGHEHHF:9HHIIHEFHIG+:H5HHIF=H-HHHEIF2EFAI=AIHFCGFHHGFHD7GHCEHHHDCHGDHIFH8FGHHHEEFHHHE;*HGACE:6GDGCFGC,FEFEBECF*GEGG'.G#G;?CCC8F:ECGGCE;/*EFC:GCFF?FG?FFE(4GC?EEG(EEC;GE@B?FE78?GC1FGGCA(E?A*(/G*ECC*A6A'D:CG
@antibody_215_multiplicity_308_copy_121-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCGGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCAAAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTTCAAGAACCAGTTTTACCTGAAGCTGAGCTCTGTGACC
+
A=?A?9BB-+DDDDD<>GECACCHFB>HHIIGA?FIDIHEIFHH)HH=FIEH@GDGHFD=E,GF>ICEHHHG+EI+IH?EGFIHIA@HHFHHF@CGIFHH(E=+H:,FH@HBGHHFHH.EDG9GHD;GFHEFBFFGFGDDG;EEGDGFB)#EG5?EDCE*AGFEECC<3GE(G:EGEDEGEEC:EEG(.?.C;GGF:A(A8EA6GG'A?C;G#F.EC'EE<E(DD(?G??6E*EFGCF:G:EE:?GGGGC
@antibody_215_multiplicity_308_copy_122-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGATGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGAGTGTTTTCCCCAATCCACTCCA
+
?,<?5B?BDBBBBB@DG8FFGGFHFIAEHICIIEHI,.HHG.IHF=HFABII-BHE5HHHHHHGIGFIG5HI<GHFHFHHHHHHHEII/HHHDE8CHGCDHHBHDH.HEHGHF@FCFF2FHG?=HCEGGF)BD@GE0GDDGGB<*GEE<E(29;?8EEG89GCE2?(;:BEG;G1?EEFG'GG1G6?CG:EG0GC;:CCCG*A(GC>E(*?*H>8GCC:;EG:GFE/(0EA(EG(E?;4A?CC:GE0A:?
@antibody_215_multiplicity_308_copy_123-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGCTTCGACTATTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGGTTTCCCCAATCCACTCCAG
+
5?<AA<<BD@DD9DDBF;GEFFH/HHHHH9BHHFHHGHH9IHIIIEBFF>HIH9IDHGHCHIIDDFIH-GHIIHHIIIEE5ICH+C-HHIIDIHG==FH@HF+H3HHIHIDHHFHHGHGEFFFFB(FEEDE=GEHGDFG:F3+EEGE?E/E.E3EG649EEEE?7E0E?GEG*FEEEGGG(C(EEECEEE66:GAACDGFCEEE;06F**E/CEE*?8F,FG8*FEC:/?(EGE18G?(#AE*(AG*G-G
@antibody_215_multiplicity_308_copy_124-1
AGGTGCAGCTTCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGCGTGGATTGGGGAAATCAATCATAGTGGAAACCCCAACTACAACCCGTCCCTGAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCTGTTCTACCTGAACCTGAGCTC
+
,AA?<?BB@9-BBDDDFGFCFGHEIHIHHBHHBHIFIHI@HIFIHDF=-IEFIIHHFHFIH-HIHFCHIIHGI-FGEHHEHIHHIFHFIIEHIHHHDHA=HHHHHH@@HHFFH?BGFHHFGB@F,G=DFDEE:#6#GA:F)F8FGCBB)=GFEG=EGCGCF9GG9GG0<GG?EGGA:=E;CCGG?.A.C/E0=AGC?FEEE?G<:GEC*:ECEEB(EF.7GE?1(:E?*6GFCF*GEE:E():EEEE?CG
@antibody_215_multiplicity_308_copy_125-1
CGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGATGGAGTTGGTGTTTCCACTAGGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGTCTGGCCGATCCAGTTACAGTAGTAACCACTGAAGGACCCA
+
?????5BB<DD??DDDFGFFGFHB8>HHCHIHHH*IHHFHFIHHGHF+HIFGFIHGIC?CI5HHHHG=EHHHHHB=CH>HHHDIFIFF5HH(HDHAI3DCHIHGG*HHHHF=DH,GGF+GHFGFHDGGDHH@HGFEGBAEHGE@EEG4)GG(EEECGB-6A#BAG(GEA*GAGEE?(DC*C:-GFE?E(AE?AGE1(CE?CEE>1:E8E(;*:A)#*?C.E0C//*:0C(C*E0?G?(**(?6:F::GEE
@antibody_215_multiplicity_308_copy_126-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACTGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGGGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTATTTCCACTATGAATGATTTCCCCAATCCACTCCAGTC
+
?,????<BBDD@DDBDEFCGFG9FHHCFEHIIHIEIIFFFAHGIDIEGEGFIFGDI+FCEI@CHIFGIHICIHHHHG-EHHHHIEIIEF5HFCHI8DGIIEBHHHHHEHI6?HH;+HHE?,HFCGFEH(DHDEG=DEGF*GF=EECE>BGDCGGEEEGEE@EGGCG,GGEGEC(:GAG(EFCGEAE?GEGCGE;EG:EE*?EEEEGEGEEEA)C*C.??E:FCF**E;EA?*).GE(?CE*00.E8CGE(
@antibody_215_multiplicity_308_copy_127-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAATGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCATTCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGACGAAACACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACC
+
<????<BB@D@BDBB5FGFFFEEE>IHHFHIH6HBIHHEHFG.HHEHFEDIHGA.HIHCFF+IFG?D)IGHDIHIH5HIF)H?GIC8IIEEDEEHHFIHEFGGEDFHEDHHDGHHFHHEH;G+EHG=EFHFHE=CFF9HGGF=EEG(EGE?G2AC.GEEEE2EG?GEGGDGG*(CE'CGGG8GGC2(CECG/ECGG:CG6GE(GECCEGCCEE@E*CEC0*C:EG:C6E??C)ACEG*AEC(?0;*:GEF
@antibody_215_multiplicity_308_copy_128-1
AGGAGAAGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCGGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGGCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAAGCCACTACAGT
+
A?A??B+BDB?DDDDD>GGGCBE,FIFIHHHHIHIFFIFFFGHIIHF-FBHHEIHHH-HFHCIFHIH,I#EDF-5FHGF+HAHIADHIEFEHHEADCHE7HHEEHFHDH8DGDHFE2BEEFG:=HDE4:G?HCECGGH5G,DEC?GFB6*EFFGGE(?F8GG6:CC+AC:9DEEGGEE*EEE?:C1GCACE??FCE6E(EF6(?FG-:=2GGH0*<;GEE??(E/C?:*?GGCG0;E:C(A?G<C(EGGA
@antibody_215_multiplicity_308_copy_129-1
AGGAGACGGTGACCAGTGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCCTCAGGTAGAACTGGTTCTTGGACGTGCCTACTGACATGGTGATCCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGT
+
?==??BBABDDDD<B5+FGGFGF>IHHH8IHHAHAICIAHFIIE5EF5I?HGI=HHHDFHAIFEHG-HEBEH=DIBHDDFF*IE=H>HIGHIFIDIEEHHGIDHB@HHFI:HH+*4G=HFGEEHDGHFHFCEEE*FFGC*GEGFEGG2GFEE7'EEFC.FGC:CG;(EGCEFGAD?4?C*GGE*G0EEEEACGEGGFG?F:GC);G?A:EC6E.:E:G?FCE:A>.:.(EG:C?<G?E:C?EF0G*G0'8
@antibody_215_multiplicity_308_copy_130-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACGCGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCTCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGACGCTGAGCTCTGTGACGGCCGC
+
?????BBB@5D9-D5D>GAFFFEIHFHHHIHFFHCHI-HC=FE@EEHFDIIHF=G8FCHAAEHFHHCHHHIH4CIFGHHHHHFIHI/85HDDIHHHFHG<GFHHHHH=FGHH=BHH.#H=G8EFHHECGGECCBGG(F*EBGEE,D=8D+A*:EF(E(ACGEE:GE-G81CC#GG*6(:E.EE<.;?E>E*6:F?/:C(AECGE:EEAEHGG@C*AEA0)':88(D?8(AECGA/*0EAGE?E(#G?E8C
@antibody_215_multiplicity_308_copy_131-1
GTCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGGGGGACGGGTTGTAGTTGGTCTTTCCACTATGATTGATTTCCTCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATC
+
?5A<?B<5DBBDD-D+FG-AFGI-HH>III0HIIHGIIHIAHFIHEI;CIDHH>H:HI5GH?=H;IA,HHHIFAHBFHDHFGF/HCBD:DHIFHHFHHGFEECHFHHHF=FHGHHC++F;DAHF+F,GDF9FGDDA@>,FDEEGDD=DEFEFGEBG,CECGGGF.AGAE(GGEDGGG(?<EGGE?;CCE(FEGF<G*:8E:6CGE<EC>(E#HEC8GGECGA.E0?E:EGGG(:EEEA.GCGG?CAE??:
@antibody_215_multiplicity_308_copy_132-1
AATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGATCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCACTTCCCTGGGGGCTGGCGGAGCCAGTTCCAGTAGTA
+
??A???BBDDDBBBDDFFFGGCAIHIFCE.CII9GHGFFDCIHHDG=HIFHHHHHCG,FH.HHIH.HIFICHHHB-CEH5HDHEIFHFFICFFIF#IIIEHBHHH4H2EF?-GHEF@HHFG;H=HC=H=;AHD9F??DAEGEFDAGGEGGGEGGFG8GGA(.AA;GEC?GG(8ECCE?GC0GG*FE*GEG:E(DG:CCEE8EEA:.HF?E6CC1E;GE7CE?*EG(G>CE*E:F*AGG::CAG/EAAC0E
@antibody_215_multiplicity_308_copy_133-1
GCGCTGTCTATGGTGGGTCCTTCCGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACGTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCAGTGTATTACTGTGCGAGATCGATCTTCGCGTCAAGCGCTGA
+
A??<?<B3BDBDD?DDF;GGFFF-HH+BHFHH?CIHFGHHIIIF?HIHHHD(@G-H>-HHFFGGHE-HHHFHHFIHIHFGHHGH=HEDH6-IFHFIHFHH:;@HF=HEHHHFFD?GHFHEFHDHEFHBHFG1GHG>*EEHEBEGEEEC*CFE=GEEEEGE.EEGEE(EGEECG#?AEGFE/C:?CFGG6FE;C6.GE/EEE-(C-?FE-C?8HEC?<C?C:GEE*GEE(0AE:C-?FG*G?A0?*EG>66
@antibody_215_multiplicity_308_copy_134-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGCAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGT
+
????A>BBDDD@@B<@8CF>FFIIHHHFIF0FAFH/HHIFIIH@=HEAHHDF59=HHH:G+AH@GFB#I-FHIIIIHE<FIFHIGHH-GHHGIEHFHHFHHHFHHEH@GHFF.BFFI7FFH3HHEF@2DFF6DHGICE3G6FC=GFFGG?@FB;EFFFG'AD3ECGEFAEEC?GE*E?GCE2*G?EE(??(EF6:0*FGACAGE;AHGEE::H@*0GE8:G:GEA*GCGEG:*E(?1G8GCC0?G8CFGE
@antibody_215_multiplicity_308_copy_135-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTTGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCAAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTG
+
??A???BBD9DDDDDDGGFFEFCHHHHCHH-E9IIHDHGHICEFICHH+FAEIFIHIGIG-IH=IHI*EEH>GIFE>BI?H-FHFEDFH7IHIHIH@HHF5FHHFIHF>HHHH*D@EFF6FEHFHHD8F2FGE2BG+2E=G*GF*?GDFCEBFCGF>:GG?CEGEGFEG/FG4EC:G>EEE(G?CE(EGGE0:)GEGE6FEGEGC((?;EGGEE:*C:E@/:C?<A(6(6(E*CECEEGG:FF(C*.*<G
@antibody_215_multiplicity_308_copy_136-1
GGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAAGCCGTCCCTCAAGAGTCGAATCACCATGTGAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGATCAGTGTGGCCGCCGCGGACATGGTCGTGT
+
,A??,=?=B?A<D<BDGCGEGFHIIEEIH,IHIH>.HGC5HGBEHF@FH9HEGFCEHG9DHIIHGIHAFHCI@FAHHE-FFHHI=ICHFEIIEHFHHII@H?,HGCFDFFGHDDHE?H6FC4FFHHDGGAGEDGCG7G.FAFEEG=G15GFC'1GGG6FGCE?FEEEE?E:E?E(;GGAGG#?F.0F*<CGEG*?CEG(GC:CFGC(E??E.@GGC*EC@(?((A<A*6C(EEACE'C<:G)A:(?E/*:
@antibody_215_multiplicity_308_copy_137-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTGTCTCGCACAGTAGTACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGCTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCTACTATGATTGATTTCCTCAATCCACTCCAG
+
<??=?<<?DDD<DDDDGFCGEF;FHCI-/H+CCHGHIHIEDHFIFIH/DH+G=9IHEHHFHHHHFIF@FFFHHHGCH/DIIDFIFFHHCE#HIHFEFHFHCHF#HHCCHF4HHFH0HEHHGGGGD=HGHEF=BH>GGD(GG3FEEEEDGCDE*01B?,(?EECFEEECGE:GEGA<;GE(>(C?/EEAEEE0:(GFEC/EG?AE0EHAECAGCG:ECG(.EE:FE/C;CEGC(:60(*CEE(C2GGG;E'
@antibody_215_multiplicity_308_copy_138-1
CCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTACTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCGACTCCAGTCCCTTCCCTGGG
+
?=A,A/B5D5DDDDDDFGFFGGIHIHHHCIHIDHI@HGC9HHGEFCHH-EIHDHD/GHHHHDGIHE-CHCECIHGBIEIIHHHHHII;HHHFHDEGGFHCHIFFHHGH?FGHBDFHBFHHHGDGHFBEHHFEGHGEGE.HGFF(GAG*FFGFC;D<GEEFE8:A0(GGEGG@EEACG0CEGA:/EE??:G#F*6*88G0EF*#<E?EEC//:C@@)GE?7E?GEC(GEG*AE0A(GEEA6GEA<(G?(EG
@antibody_215_multiplicity_308_copy_139-1
CGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCAACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTC
+
AA???BBBDBDD?BDBGFGFDGFHH8HBFIHFIHHGIGAIHIFIEI9EHHIHHEFAF-EHI.IHHHBGIEEHDHGHHHH?FHII-F1FFF7EF5,IHCFHGHDHDHDHE+'HHHGHDGBF*DHEEHEH7GFFEGDGEEFGEFEDE;<GGDDGF?B(8FG?EEGGA:FGFAFAG?EEDG??;E0GGCG(6G?EC6EF??E*E?AEE*..GAA1(D*G'('0#;GACC8GGGGC6:.G?8(:E?CE(CE(EE
@antibody_215_multiplicity_308_copy_140-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGTTTGTAGTTGGTGTTTCCAATATGATTGATTTCCCCAATCCACTCCTGTCCCTTCCCTGGGGGCTGGCGGA
+
??,=?9<B?DDDDDBDFCGGFGHFI6FIHHIEGIGHIHF9AEHHBIFHADFHIIII*FIHIHIEHFIFIEH*H9HHI-F@EHHCHH;H(IFIHFCBHAHHF=HICDHCDHEGH+HFGHDGHGFE+GFGHBEDDHCE>GGEG4'F8G8GEDED*(G.GEGFF=((:AEC<BG/EGFEEGC:<GE?GCAEG:?EC?EEE<(GEG'.EEE?E-EGH71GEDCEFF::0#GG:'EGGE(EAE(-GC(GE0EAE4
@antibody_215_multiplicity_308_copy_141-1
CAGGAGTCGGGCCCAGGTCTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACAACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTCGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGAGACGTCCAAGAACCGATTCTACCTGATGCTGAGCTTTGTGACCGCCG
+
<?=5?B>?EDDBDDDDG/BGGBI8EFFCHIEHHGIC>IG>HFGHHG@FGEEEF>FHFHI+H?HHHHHHH=HEFCI?H5H>FIFH#IGGHFGFGCIIHHHEHEH=GGD@HHDHHHHHFC=?FFF,GE,F+GGG(EGEH0FEGHEEFCB@EEE8*G;GD?DEG?=GF.EF::?/8GFG8'0FCEGDE(?G?FA:(E6EEECGGE((EEHEE(C6E@E*?((EFAGG(.CEE(EEEEE:?C*/CC<1G*::-:
@antibody_215_multiplicity_308_copy_142-1
TTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAAC
+
<??,AB>BBD@DDD--FFEGF@ECHIH-HFHIDGICIIHDII=HH@HCH7IICAAHIHHHAHEFI7HI-D-I@@HHDGIIHIIH-8H)IFHIIHEHIHHI.HHCHHH;.H,GHHEH.HHHBEH4BBH=,F98D*D?FACF:DBGCEFEEECFG>G6EFAECCEFDGG)::FAEG?GEG?*EEFCGEE;:GFE=A<E?0FE?CGGC1E*0(0EEG0ABEEEEA:GGCE2E?E*GEG?FEA(EEE:CGE*C?
@antibody_215_multiplicity_308_copy_143-1
GGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGTTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGACACAGAGCTCAGCTTAAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTTAGGGACGGGTTGTAGTTGGTGTTTACACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGC
+
??<<?B/BB@@BDDD?FFFGGF>H0FFIFHIIAIIHI-FDDHHIC@.HHHHE.HI;5E#F-IDCIDHHDIIFHHFHHFFDI3HIIG<IH<EHIHIHHHHIHHFA=HHH=D'4EF3?H@.HDEFBHF+G;FFGB3GEGG7H*9,DF:EFCEEEGGGGEGEEE;CG?@66.?36C:E,A(FEE8>E/.CEGG6C1E:CGAEGEE)*GE0:EHG6*:E8?7F;0GF;C(E;A;8*):0'G:8A94E>?ACEE?
@antibody_215_multiplicity_308_copy_144-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCATCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCAACATGTCACTAGACACGTCCAAGAACCAGTTCTACCGGAAGCTGAGCGCTGTAACCGCCGCGG
+
?<??<<>BDBDBDDBDFEEGGGFHIHCC+FIIHHHHIIGH8D7HHFECHH-FHF+F9BH>HHIIDHH>F#IFCI-IDF-II5DGGEIHGGHIIHIDCHFHGD+H@5HFFHDEHFHCHGHB6F?2;6DDFFH;GHG))EEE0FFG:E)G3G2=CAAECEGG?F64E#6FDE0E;GACAC?C:CEEEG'(EG(FE6G86*GEE'0GGC:6GCE*H:EE7EEEBEC'GA2(C*E/*E(G::.0EE9E*G:8CG
@antibody_215_multiplicity_308_copy_145-1
AGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTATAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGAATTCAGTTCCAGTAGTAACCACTG
+
???A<B7BDDDD9D@DGGCFGFHI+/8AH>IFHCFHHGEEFCHFIIIHH:5FGHDGHEHGFGIIHAGFHHHIIDEI=BHHDH-HFEDAHIH)EFIIHED=+H#H-DH@FEHHIHFE@GFHF;HHFGG:H(CHGBGGEF)HHGFGF=CGGGFEGEAE1*E**G*G8GFFEGFEECEAEG=EFGGEA::E>GEAGE:GE#E6FAEAG<EA4'GGHGE?*GG@FAEE*'EE':GEEC/CGG#*GG(GEE4GC*
@antibody_215_multiplicity_308_copy_146-1
GTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCAAGTAGTAACCACTGAAGGACCCACCATCGACAGCG
+
,???=BBB@D<A@DDDFEFCGGHHICHEE-HFHIIHHHGIFH@H.HEFIIHIHCGHFDIHEHIIFHHAE*-HHBBHHG,HFHHIHCHCGFIHIHHEH?FH@GGHHHEF=FCFIHEH+HIFDHB=GGECHH:-EFG+D9EEEFGEECCE?B0E:BEG0-/(G>/CGGE:(GEEEE*?GCG*EGEG<6EA;GC;(CEGA.*C*E'F<*(0CH:0HF(0'EC:CGCCA0AG:C:?::0E?6EG/*(*G*6GEF
@antibody_215_multiplicity_308_copy_147-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAAGTACAACCCGTCCCTCAAGAGTCGAATCAGCATGTCAGTAGACACGTCCAAGAACCAGTACTATCTGAAGCTGAGCTCT
+
59???B9B/@DDD<D@FGGFGGFIHIFFHFHHHHF9;G+AHIHE-GGFACH@5.IGIEIFHHID5FEAHEEFD-HEGAHHFFHFGHIF,IHHHHIHBEHIH+FH.+?GCHDGD+IHHH=HHHFDGFHHGFHEFCBFCDAE=E.EE,:A#B*G@E2*.G(GEG?<<EGEG8)*E1E8:EC:GE(6*0:6/<(E:?GCGGGE'(FE6:H?G;EGFE(GE:,GC.DEAC8:>8(>:E(A)GG#0?F(*GGE/(
@antibody_215_multiplicity_308_copy_148-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGCGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGC
+
A?=?ABB=B<@B-DDDGCEFF-I;EAF.IIHIFIHEHGFIHHCHFHFAIHHFHHFIHHIHHHH-HEE-HHIEB-IHHCHHIG4H<HGIEFHI:6'HFDH=HHF3HDHFFF3DH=HHGCHHGDHGEHEG=8G+FC9CEGFG8G=GGGGE;FEG(CED?G;C*,EFCE(GAEGDCGC?GAG-+<G*ECEGAE:CFE4/:6GEGF'<ECEEFAEGEEG:*C,A0:GGG(*06*E*GE?C0'0'?GG*CE:E:?
@antibody_215_multiplicity_308_copy_149-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCATCAGTGGTTTCTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGCTTGGGGAAATCAATCATAGTGGACACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCTC
+
=5??5ABBD-DDDBD?GFCAGCEEH@FHFIFHIDGIHFIGFGIHHIIGF9HCEIGHIIHFHI+H8FHHHF--IIHHIHABHHF-HIIHHF-GE.<FGH/CB=D+9#HHHH;EGFFDEDH0GHF+*FEFEFGFFHFGG@FE,GGFACGEFGFDG=EGGGE;D6F**AGGEEEE<EAEG?/E:GG/G?*G:E(EEFEE*CEEG;;8FEEEGH..E(:E?=BDGA8C4G2:AGG?04C#F:CE/EGEE*;*?E
@antibody_215_multiplicity_308_copy_150-1
GTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGCTCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTGCTGACATGGTGATTCGAATCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTCTGATTGATTTCCCCAATCCACTCCAGTCCCTTCCC
+
<????BBB--DDDDDD@ACGF6HEIHFFH.HIGIEHHABHBHFHHAHHEHGHH>HHICIHDHEHHHFAHHHIC@GHE-FHHIAHII8HC5FFHH3CCFFHI=H=D@HGCC7H+DFHDFHFG=HDGHEHEGGDHEE<FBFGEGGE*BEAGBFEEEF?E<>G(*<GEE/<GG,CEGGE8CG(FED6::CFCEECEGA;ECCC<EGGCECE0?EG'/(7?CGF.E:GCE.(/ECA4;:E*F;80(.000?CE?
@antibody_215_multiplicity_308_copy_151-1
CTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGCGTATTACTGTGCGAGATAGATCTTCGCCTCAAGCCCT
+
<?<?<B?BBDDDDDBBFFGCFF0GCGBIHEEIHFFIFHFHCHCIFGCIHIBFFCHHHIHFDHEIAHHF5IADHFAAHF5HED(HGIE?HIH-HHIHFHEFHFHFHHGGAHAFHAAE)FFHEHH+GGH?E=F6FDED<*GDF+GE@'G@EA/G@GG*GG=>GGBE:GGCGFFEGE((EG?(6AGC?GC*EE?EEE*ECG*AEFGC?GCGGFG'/FBCEGD1CGE*CGF)EGAAE?G(;?G00E0;CCG/A?
@antibody_215_multiplicity_308_copy_152-1
CTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCCTGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGACCGTGTATTACTGTGCGAG
+
?A????/B@EDDED5DCGGACFHHIIHHFH-DHHIDHI=IIIHIEHHGFFHHIE/HDHFHGGIBIHFHHGHGECEHII-BDHHCIHICHFI+IHCHFHG+I6GEDHH8HHDHF(=FH9GEFFEEBFBG/GG,G?D,H?;F6EEFEF8@GGECAGFEEG8EEGEE(GE#:FEA6:GEG0GEGC(6AFEGEGC?E(GE(?E:(?E6DEFAEE.E*/ECGA?C:EGGGEEG(>*(EE666(EGEEAEG80EEC
@antibody_215_multiplicity_308_copy_153-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCACTCATAGTGGCAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCCAGAACCAGATCTACCTGAAGCTCAGCTCTGTGACCGCCG
+
??A?,?B?BDBDDDD-GGGG+FHHHC>FHII+EIEE>EHGIIIHHFHHFGHFCD*IF=FIIEIC=CGCFIHFIH5HIHCEEHHG3HFHHHFH+FI?HFEIFIEDGFHFCHHFHF*H9FDHBGGB6FEF*GFEFHF>DEFEDD*8G.GGEAGF#EG00BG6'CEF@:GEEE9GG</E?+EG?CE?GECGG8/GEEEGGACCGECFGEC8E*(GCE;?/E?#GCGA/?:(FECEA(C<D(C:*C8C6CG?::
@antibody_215_multiplicity_308_copy_154-1
ACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTGAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCGGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGTCCGTGTAT
+
?5????BBDB@DDDBD,FEGFCIBIFE-HII99HFFI)IHFDCAIG3IIFIHHHHFCIGIIFIIIFEIFEHHGHHFEIFCCDHH-HDEGHCF.BF-HHIHIGGFEEHGCCHFFFAF*EHF5HH=5>@FG2EGFH;GDHEE??GFG8:GEG?EG*GG;GE#*(FE'GEAGGG.8GFGGGEEGG0EGGE0G01G0GE1F(CE'AF4:D*6CEE:EGGEECEEEGCFF*GD-A:.G*:*C?:*/(:GG8?CE6
@antibody_215_multiplicity_308_copy_155-1
GGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGCAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGTAGAACCGGCTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTTCTTGGTGTTTCCACTATGATTGATTTCCCCATTGCACTCCAGTCCCTTCCCTGGGGGC
+
????A/B>DED@?BDDFFFGGGIEHFIICFIIHGHHHIHIIH@@IHHG.FFI>CBHH@HHHGHCICHFCGEC5FE+I-HIGIIH8*DHAHFHD-I@DHGF3HH?@I@.'H'FGH+GHDD#*GGDGFEH?HEBF+EG#EG(?GEGFEDEGFEGCA,*GE'(CD?*EEGE:GECEG6CEEG;:E(EG-EEEEE#(G*EEG(GFC9ACAHGGF80@:E8??GG'EG(C(C6'E(E*80DE(CCFEE6*AA?G?
@antibody_215_multiplicity_308_copy_156-1
ACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGATTCTTGGACGTGTCTCCTGACATGGTGATTCGACCCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCGCTTCCCTGG
+
9<=,?=BBBEDEDDDDFFGAGGIHHHHIIHB9HF9AHHHIHFIGIECGI>HH+HFHA-G>HHCEIDFGI-FGFEIDHAHHDFCEIHI=HFDD*FHIHIGHIH*E@IHH=EDFHFGG@FHHHH8HEFH(FEFEBFGEEE;FFE*DGFG8@FH;F16(F*(@EEFF4E1EG?AEFC*F.+GAGGECGECEECG8)FG8?(G<?:G*E(HE.E*GEE@C:F:G::0?(*C:*?D?ECC:E:(E)*ECE(0GEA
@antibody_215_multiplicity_308_copy_157-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAAAACCAACTACTACCAGTCCCTCAAGAGTCAAATCACCATGTCAGTCGACACGTCCAAGAACCAGCTCTACCTGAAGCTGAGCCTGGTGACCGCCGCGGACACGGCC
+
,?A??5BBBEBDDDDDGGC/G>CIFFEIA>EDGDIHEIEHIHFGGC@FAFFIFHHHI5H5CIEH7EDF>GII-EFGGHHHIBHEHFAHFHHHH*CHEF=FH8FIFHFHEDGDF7G?FHHHFFFBFGHH.9CH@FGFECEGE+(G;E4EBGEGEG(6E(#E8?ECGEG?GE(CE(AFECAGCGFGFF(?G)GG?E?6.?CGGC??CE*/*A*C8GBGEC:@C:?GGE((#CGE':0CG:E(EEAGCGG0?0
@antibody_215_multiplicity_308_copy_158-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAAGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACCACAACCCGTCCCACTAGAGCCGAATCACCATGTAAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGAC
+
??==?B+BADBBDDBBFCFFGEHIIFIIAA9IIF?D/?IF+CHHHII@.GH-HDIGHHEHIFHIHH5HIIII5GGHFFHFIFFHHF?ECF<AHH-FH=-G'IF3FHHHBFB+HGGGHHH@?*EHHEDEEEGEDAFG.BFAGGBGEGDDFBEGCGG9A,EGDE?GEGEF/:#G'?EC;'GG?CFE?EGEEAA(GEGCCA8EE8CEC1(E2HEC:A.EGG8E:EE*:ACFGE?AGG)A**68'GE8:GG:F-
@antibody_215_multiplicity_308_copy_159-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCCGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATACTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTAAGCTCTGTGA
+
A5??,BBABAB,DDDDF;FG;FEHIFIFIHFIIAHIHGCIHGIECGDGHIFHDHC?'-HIHHIGIFEFHGCGIIH5FIHIIIH=HHDHIHHHHF,GHEHGH6IH5HHGHFFGE2HHHHFGGHDCDDG(FFFEFE9G@GBGCGEFG=EF0HEGGF#?(F?EAG.GA;FE3(ECGG*E6EA<EG(EE(GEF*:(G?(2DFEEF0*E.16:FCC?@CGGDEB;FE?EG?GA-C.GE8AF?E*00DCC0A?E8G
@antibody_215_multiplicity_308_copy_160-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCCTGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGATGAGCTCTGTG
+
??A??BB-DE@B-DDB8F28FGIBFIIF.FEFIEHEI.FG-HI.FHEGFEGICFAHD+IEFDHFFAHFCIICFHDHGHCIIHI-;4HF6HHGHBHDEFHGEGHH@IFHFHGEEFEFFHHFFE0DFHFHD=EFF8CG1FEEBGGFEC1GAGEG@E0GEEFGG*ED:F=?CEGEEGA*/C(C?E6E6<AEG*EE0G/?EAE((CFE;*EACEFG@GBC:G7/GEG(E'?;?G???/*E8G.ECGEGG*A/GE
@antibody_215_multiplicity_308_copy_161-1
GACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCGGGTAGAACCGGTTCTTGGACGTGTCTATTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGTTTGATTTCCCCAATCCACTCCAGTCCCT
+
???A?<7B@DDDDBBDGFFGFFFIIHEFHFF;.HIII.H.IFIFHBCHHHGCEH99HFFCHHEHFDHDE@ECFAH+FHHIF=5HICHHHCHEII=EDHHGHHHE(DEEIHCFID4HFHFI.=DH<EDE8GGHGFBFGE*GEA@EECD(;G(?GB=0FEEGBCG(G*FGEGE.(GEE8GEAFEEFGGGE>?CEE<EE?ACG1*)6GEF.E?C?'*)GGGE17)FG<ACEG(E(*E6*:'0G;E6;E::E1G
@antibody_215_multiplicity_308_copy_162-1
CCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGCATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCTGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCGGTGTATTACTGCGCGAGATAGATCTT
+
?=??<?BB<D@DDDDDCFF/>GIHAHHIHE@IHHEHI9F-HHHDDF9FHGFHFEDHHIHFBHFHEHCCHHDF,IHDCHHIE5HHFIDCIHH-FIHHGHIAF@HFIDHC(D<DEHHHHCHG(FGEED:H?*+F?FH=GEDGGE=;C;G*EGFEBBGFEGEG#EC:?AC6GF(F=;GECGEGE?:GE(E:(6((GC9(EE8E?:?EC8.G'EEE'GCEG.GG;GG-:/0(E?E(EGC*0EG0ACFA?;*:A#
@antibody_215_multiplicity_308_copy_163-1
TTCAGTGGTTACTACTGGAACTGGGTCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACGCGTCCCTCAAGCGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGAGACGGCCGTGTATTAATGTGCCAGATAGATCTTCGCCTCAAGCGCTGACTACGGTGACTCGCGGTGAG
+
?9?A9<=ABB5DD?,??EGFGGHI.AHFHAFHECGFEHHHIHFHIFIIHHGGFIFF5IIH,DDEFHHHDED5-HIIIHIHGF-IFFFGEEAFHFHI,CHEGHFGEDFD#FHFHHFCCHGF=HHGBEFCF.F:GGF?8:E8EAFE.1FBGCG,;FFD8AEGC;G:.EC<FGBA.'F9.CE(FA/G(G?6/GGC6GE;C*C:GGE(G?8GEE'C(.@)GE:,E7EG*:/C?EG:A?:<EC:?6:G8A::?*C
@antibody_215_multiplicity_308_copy_164-1
CACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTGCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGACCCACCATAGACAGCGCAGGTGAGGGACAGGGTCTCCGAAGGCCT
+
???,?BBB-D<BDDD-FFFAFFIFBFFEHF/IHIICHH/H-AIHHHHCIFEHHBIHHE@AHC,FIIHHFH?FH=AEHIGHEH=IIIHHEIHI=HE5HHH+FHF+HGEFFH+HG?HG=FCEFHEFGFFEECEGHGGGD7BGGCEEEB?EGE)AEDG=(EFEF6=FG(EB8G80/FFE(G8GC:0GEG*ECF*:G?GG?C8C;?EA.?H0;.(E@0CG/EDE?EG6GG*:;:FEEA(EE'G**'E?.:?:'(
@antibody_215_multiplicity_308_copy_165-1
GCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGGCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGATACGGCCGTGTATTACTGTGCG
+
=<,<AB<AD=DDBDDDFF;GGCAFCEEFIIFEIFFI/HCHH.FII-HEFIEA9FGDHHHHHIIGFDEFHFIEGBCFCIHHIIHIEDDIIIHHHHIAHDHFHFH?GIFHH6DHHHHDA+C@HHGGEGH4HEFFGDFDB;1?AD*@DGEEGFFGEDEG*E*GGEEFG;*9C8CEECGG>BC1.2GEECEEGEEG?(E::EAEGF:A8.;CCEEEHC;A(G(GECG'E?6G*EAG?E:DGC*;:E'08:C:8D
@antibody_215_multiplicity_308_copy_166-1
GTGACCAGGGTCCCTTGGCCCCAGTACTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTGGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGTTTCGACTCTTGAAGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGTTTTCCCCAATCCACTCCAGTCCCTTCCC
+
<???ABBBDBDD@-DDAFFGGFH>IH+H>CGEIHHI@FHHHHFHHIFHF0HCHIEFGEIHGFIE=F5CHHIEEF=IEHHHH5IA5DHHHHDII:E*GFDC=@GFFHEH=HGHHFH'GEG@HH@HHFHEG0FHA8EFGFEGE*EEEDE:G.CFGEEGHC:GEGGFG;CEGGECG#GCBCE1EGGAC?0CE?<6.*G(;:E6/.E(.DCCG(EAHCF?FGFC:,E?0C?AF*EG08(:EAEEC?0AG(GE'E
@antibody_215_multiplicity_308_copy_167-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGAGAAGGGACTGGAGTGGATTGGGGAAATCACTCATAGTGGAAACACCAACTACAACCCGTCCCTGTAGAGTAGAATCACCATGTCAGTAGACACGTCCACGAACCAGTTCTACCTGAAGCTGAGCTCT
+
<???=?B?DDD5DDDD8G;FCFIHC.II5HIED.HGFFHI;EIICFHD9IIEGH.HHHHHGF-HFH5H=HHCIHA?5IFAICGFIH<HFHHH=HHHEHEFEIHDHHEHHHHGHEHHH*F@G+#HFFEH/GCDFGFDEG*=FGGEAFE1FGAD(A?EGEEGAG=GEGA.FB?C?(GEECEAAGFA8G''EEGG;.GGG6GEE8)G8(?GAH:EHG/*G/,CE'AG*:E(CEE(GEG*E1'004#*1*0/9:
@antibody_215_multiplicity_308_copy_168-1
TGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGGTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGAAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACGCGTCCCTCAAGAGTCGAATCACCATGTCATTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTA
+
?????<>?DDDDDD-9;EEFFEFBDIE>.EHHHIHB+HHI=@HIHI.H>EIHHEIH@?ICFHI5GFCGIHF5HD-E-;IAFII,BHIEIHGDFFEHHGFHBHHI+HD3HADE+9EBHDFG+HHEECD2GFGHEFGEE8EECGGDG8EGD,EE*EGDF;EDGACAG<GCCCFE8E(*EEG(E?CFE@1AEEGAG1EGAC8FGGC(CC..*H0F:ECG'E?C;/G::E-E.;A(:G*E?1GC/*:?EF<EAE
@antibody_215_multiplicity_308_copy_169-1
GCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCAGGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCC
+
,???A/B=@DDDDD-<EGGGGCHHHECF>CHCIIIIIH>@>9HIHH8HFHHD(DHHGI-H?GH=FH.DDAFFDIEHFFHHCB-CFHHIHHHHEFIHIIHD=CHE,H6FCHDFHEGC:EBH@HFF@F=@E'EF@HGBGHFHFHDECGFECG@EFG(GB:*G:ECCC?E;?A:GAEAEEG/GGAAE8CCEEC?FGE.AGEE8*F-AAC*GA8F;E7GFE:;0EEGE:(*:EEAGCC:G(?F?CDE0FC(?G:
@antibody_215_multiplicity_308_copy_170-1
TAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGCCATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATGGATTTCCCCAATCCACTCCAGTCCCTACCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACC
+
????=BBBD@DDBDDDFCGCF;IIHHFIHI>HGHFH=IHHAIGHHF.EHIGIIFHH+AEHBF-H5FCAEHHFHDIEHIH9I5,HHIEH-H?C+BH8GIDHH+DCDBGH@5HI@HHHH+DHGE,GFHG+G)GE*-FCA<5DB*DEG58G:DFGGFEBEACDA;GB?EEEFFG(G?DGCEEEG;AFGG*E6CGCEGGGACC18?6GEEF(:?E8E##CG*,(C(C6G;0:EEAG(EGE:EEC*:EE:E12G:
@antibody_215_multiplicity_308_copy_171-1
GAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCACCTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCATGAACCAGGTCTACCTGAAGCTGAGCTCTGTTACCGCCGCGGACACGGCCGTGTGTTACTGTGCGAGATAGA
+
?<A?=?BB9DAB@BDDC+CFGFICIHFICEBHG/HHFAFFIHH>ID)+CDG-HFDHAHHFIH5DHHH5HAGHH>HHEHHH/-HHGHHHF=IDH5GHHDHGF@B=DIHGHD:HDHGHF?EHDE47EFG:GEF=FGCGGGEE=EEE=1?F@EEEGEEC8CEGG*0CGC<EAE:E9EGCF:(GFECE/*(<CE::E?ECEG((C9EEGE(EE*CCE'7E*8(CE8E;C?E:6E<E(G?GA??8AGE*G(G)2G
@antibody_215_multiplicity_308_copy_172-1
GTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCTGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCTTGTCGGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACT
+
,?=A?+BBBDBDD<BDGFFAFAFHF8ICCIHEHHA=HHI9H9HIBIFAEIEHIHEEHEGI@*?HHDIGIHHEHCDIAH-FFFCFIHHHICGICHHIHHFHDIHI=@HDHHH?DHGAFDHDFBBGGHFFFHBGG;G*CFC)E'=GGG*C(GEE(G5GFFC?FE)EGGE*EG.(G?GG(G6(FFEFEEE<?GE(EEE?A:AG1CG*FFHGE*GAHA7?(EE@E7A:F)E1:((ACGC<EA0?C*G?A*GCGC
@antibody_215_multiplicity_308_copy_173-1
AGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCAATATGATTGATTTCACCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGACCCACCATAGACAACGCAG
+
?,??<?BB?<BBBDDDG+GF69IHIHHFFH9EHGIIHHEIHH7IIGFIGBGHDF9<HHGDEHGI'FIHI5GHHHHH-IFHAIAFEDH>IIFCHICHE'DD6HHHDFDEFHHGF.IHDFH@FDE,;FFEFGGFFFDG*E?E?9,F>*EEEEF*F*2GEG@8EGG=E.0EEA.GE6EE:/:FEGG;GG.EEAE?ACEGEEE8'E*CGE6(F?G?:EE2EEE:*?ECG/A?F(EFEE:C?AC/G?A.**:EF*
@antibody_215_multiplicity_308_copy_174-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTTACAGAGCTCAGCTTCGGGTAGAACTGGTTCTTGGACGTGTCTCCTGACATGGTGATTAGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCC
+
??A5?B>+B-DD5@DDFEFGGGHCAIFCHHFHFEHCIHCFHIDI.8HHFCGDCIFEHHHGEIIH>HH-EIF,HHIHHHFIHIBIIHFHEI=HH7DHH*HHICHHHHGEEHD;HF9H+FEEDFH#FAG?BG,=GHGFGEH*DB;?GAGGFC8GG1GCBGEEEEFEEE/A(*BCAEE,GEGDG'CF/C0C;EGG?E:G<?:?CEEF.<HGGE?FEGCG:E;C?:<EGCE:GGC=A:.CC(A?EG4CEE?(?E
@antibody_215_multiplicity_308_copy_175-1
CTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTAAGTAGACACGTCCAAGAACCATTTCTTCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTCTATTACGGTGCGAGATAGATCTTCG
+
????=BBBDDDBDD@<DGGGGFI8HI8IECIHIDFCC9HI.FAI@EIFII@HDIIHHIHIAHF@IHE-HIIID-HFFHHFGIAHH-HGIEF?IHDHHHHFGHCHHH6=FHFHHGGFG=#GEEGDB*6GFH6.FCGE8GEEF#EEF*GB;GGECFGEF'BAGECEF:GG*ECGEG;/G:C*6AEE(E*FEC*CGC(EEGCECGCGEE)EGCE*F:EGGEE@.EGG0GCFG(C:G):CE;*EFEGE*AAG00
@antibody_215_multiplicity_308_copy_176-1
GCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTTACCGCCACGGACGCGGC
+
??????B?DDD+D-DD?GFF8AHEIFFHFHHHHFIHHIIFHIFHIIF,HIHH9F.IHFHBC>IHFIFIHFFFDH>AHGBFFI@GDCGIH)AI=-HHHIGHDH+GH?HDHHG*HHFHHHHFH,F84HFHH=F=)FFFGDGD<EDG=GG6GFFGG;GG9EG*GC;GGGCF;<(CEC>G?(G8FE(CG(?(E/*CC??C6E/AG4FEE(CG*C)G0-;(/E,GE7:8CEEE;F*:#GGCG??)GAG)C0*EF4
@antibody_215_multiplicity_308_copy_177-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAACCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCTCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCGGTCCCTCAAGAGTCGAATCACCATGTCAGTAAACACGTCAACGAACCAGTTCTACCTGAAGCTGAGCTCTGTGA
+
?????BB?B+DB@DDBGFFFG/HI.HIH;FIH,DFII>9F?IHEHFHHHCIHDFGD=E*CHIHH-IHI+HE>FIF-E,H=CGHFHFHIHH=EHHIHHGHH;HHGHCG=C=DFG+HFEGEHDECH?BEGGHFGGDDFEGFG*G<FG**CFCAGGEGGF:GE0B?GEEE:E:GE6.6/6:CGEFFA:E@GE6CFDEE1;6?FA:?C?CECE*;:F(E(C#(8/A(E.EF?G/1:?CEE(?:EACG:DC:0C=
@antibody_215_multiplicity_308_copy_178-1
ACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGAGGTGTCTACTGACATGGGGATTCGACTCTTGAGGGACGGCTTGTAATTTGTGTTTCCACTATGAGTGATTTCCCCAATCCACTCCAGTCCCTT
+
?????B5BDDE?-@DBFFAGFGEII+IIIFFH-EEIIFHHHHHIH9.9HBH=I=4H=IHIFIHF=I?ICHFI@,HI=HIIIHIII-HIIDIE>HHDFHCHFHHGHEEH@DH@IG<HGHHF,GH@BEEFAFBF@G4G;EFCF@EFGEEEEB(E#GF?C*GEF66GG=F0ECCCEG(CEEGGGGCGF*.*1GEG/FE*#C6EGE(AE*H)EE'CCAB:CC?EC(CEE6EEEGACCAG*CE08?0E(D1:/EE
@antibody_215_multiplicity_308_copy_179-1
AGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCGCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCGTGAGGGACGGGTTGTAGTTGGTGTTTGCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGGTCCAGTAGTAACAACTG
+
???A<BB>DD@BDDDDCFFF>B8FFICFHIIHB.GEHCGFHHHDD>(GHEHHFIIIHABEIIH@ICFHFHIIFHCHHC5FGI-IH+IFC)HBIGEIHHH2GG*H?CFHFGDHFDH@DHFFGDFGGHFEF=F,FFGGGEF=GG7E;(EEG9GEEE;=EGF(G?,EG'CEC/GC'GG8GCEEEE4G(?8C4GC//EFGE6CG;;A<66C*E*E*EG)E::,@/DC:.:6EAEEE(**18C:FC*G1'(G28'
@antibody_215_multiplicity_308_copy_180-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGGTCAACCTGAAGCTGAGCTCTGTGACCGCCGCGGAC
+
,????BBBD+DBBDD@FFFFGCBFFBFIC>HEIH9E/H/HHHI7-HEHCIDI/FFFHHFHICIHH-+HH.FHHFHH3IEDHHDIIHFHFHEDIE-HF.EA=HHH.FG=EHF6FGHFDDHG+DH(FHFHHH.4FGGF?EGE@?EFGE,*G(FGAEGGEEGEEGE*EEGGGEA8GGGECGE<GA,8GG(CCGGGEEG<*E/G?C0*AGEGGA*FF7#E/(7EG0CCEAFF/GFA?#CEG:EFEECA#C1*E?
@antibody_215_multiplicity_308_copy_181-1
GACTGGTGAAGCCTTCGGAGACCCTCTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACTACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTA
+
???A?BB><<B<DDBDCGFGAGBIE.F+HH=FEHEHBHIEIDFGHHCIHHHHEIHGIHGFHHHIAIHEHGHFHIIGH=F9HAHI4EHIA#FHH>HH68.HHH=CG+H-=2?HDHHDCDDEDG7HGFFHGGFCDGEGG8GG?(FEGEG;G(E,FEGEAEC(AGAEEGCCG?<4?GE:C?C8AG;(E8DGGGG*F8ECG*GG?((EGEH?G6C:*E;EGFCEEAGAECGEDECGECCE6;(0CCAE:E;:CG
@antibody_215_multiplicity_308_copy_182-1
ACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGTAAACACCAACTACAACCCGTCCATCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACAGCCGTGTAT
+
A?A??<B5D-D?DDDBFFFFGEHIHBF8IHEIABHHEHHHHEI(DHDHGH=D9H+HHFHH@IFD7IHFFD-IGIIHH@FCIFF-=FHIHFHIEICFIIHE>HBHH0EFCHG?6*ABFH=DAG@FGEHFDFGEEH*6+DEA(:E5;ECEEEGE8(4GC#CFE8.(606;EEEEGGEGCGEGACEECE?GEEE:GE<GEC28*EEGC?HG:CGEH@.?GA8E*EGG?.F-C';EE(C*<A*C(G6G6;91EA
@antibody_215_multiplicity_308_copy_183-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCGGCGGCGGTCACAGAACTCCGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTGCCACTATGATTGATTTCCCCAATCCACTGCGGTCCCTTCTCT
+
??=<?BBBBDDDDDDDFFFGGFECE+IHIIGHFHHHFHGHHF-9HGHFA>A@GFEHFDEFCHIGFHDHEHDI)E*HHH@IIE-EHF66HFFH=FDF+G8E@ED@HDIF#;EHFE?6HC@DGF4GHE?#GCDHFF;@G2FG?GFFBGFG2GBFEDEEFEEEGGEECFF?GA8(;GEEFCEG?GEF6(:GEEEEE**GFF:E*AE=:<F(E:GG*CE:CG48EEF8EG0CE?/EEE*)*G*E/#E6??A(?E
@antibody_215_multiplicity_308_copy_184-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTCAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGCTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGAGAAATCAATCATAGTGTAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTG
+
??A?,<BBD@DDBBE@GGEFGFHI>FIHEEDBHDIHFHHIHIHIEHB+GGHDID>.GIHHCHIIIIHDFD,+CHIG=BGHHAIHFIHIICHBIH?HHH7I5=IDHIHH?CFHEDEHD(HCAFE;AFHGE.GE?GGGGEFGF3F(E(GF(EG?'AC=GC(:DGEEEAE?F68C<GCEG:?GF8.FCCG;GGC:F(G?A<E/AFEEEG<C0E?GFAE:GDCECGG:(EE?(8CA(*.E(?-0)A*GGE-G:E
@antibody_215_multiplicity_308_copy_185-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTATACCTGAAGCTGAGCTCTGTGA
+
??=??BBBBBBBDDDDF-ECGFFH-HEHIHFEIHHH9IHGAIHHHFDCFGF@=HH>EIHCFIFFFIIGIFIIEHHHIIIFFFGH=AHF.FHFE+HHIHDH==HFHFBHE@3HFFDGGH'GDF=GFHEFFFEGG02EEB?GEBEGGGEEGE=98CGGA8CGFFEEGFG?G6*CCEA;EGF?CGCE;;?ECEC1C*E:FEEFEE1*:C?E?((FHC@:EEF0B:<G;G/*AEG/:(9CCC8GE:ECE*GCEE
@antibody_215_multiplicity_308_copy_186-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGACAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCGCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGATGATTCGACTCTTGCGGGTCGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCC
+
?????ABBDBEDBBDDFFAGG>HHAHBFHHICAGHGI.9DG7IHGEG-HHHHHFCHIFDF>.HDG5HD=HFGHECDHHEFD-'IGCHEHIHH-DIGEHHFE=H:F4EIHHFIHFH6GGE>G3HGDG?FDGHF#GGEG*EFFGEC;EDG=GGGGGE:EFFGEECEE*(A/CGF:E(C.C6?;+6,GE<?C'*)ECE0CECE/C??'AE*GHA*HE7F;C.EC4F0EC;.4FE;8.E8C?<?:EC:>E.E89
@antibody_215_multiplicity_308_copy_187-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGATCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGTGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAG
+
,??A?B>9BDDB@9?B>FGCGGFIIIIFHIHHGHHEGIFHHI5IICA,IIDHIHEIHCEA=IHHHFHIC5HIIHHIIIIHH=EHHHGEIHGIHDGEHDDHEHHDHF8FDHD+2GGHC9:3HF+FHFHEG;D0(*DFEE.GDCGEGEA8ED?CG@GGGG@E(EE(EGE/CFGF(E:G'D*EG?GGEGEAFGGGCEG*CC8G2(E8EG0E<:1/C*G.GCCE??CGG?GAG.:(0G6FE?A*DE50E0:EEF
@antibody_215_multiplicity_308_copy_188-1
CTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCATTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGCAACCACTGAAGGGCCCACCATAGACAGCGCAGGTGA
+
??A<?.<?DDBD-DDBGFFFFFE+HFHHFHFI=E0HECI+IFHIFDCEHHHD//DGFH>IFFHHHIDI-DIIHFIIH-CCH+GH6HBHGEFIHDFE<HB@I.6GFHF+IHDGHHDHFEDHGGHEHDF.HGAGGDECAGC@EEG?C/GGE@F:GEEGG3'GG>EGE*(GGC#DGGE?GE(CGFEG;*F*8FG-'CGEEG?C:?G80EC)8CC*:(GC.ED<B?AAG:(A0;'AEGEFC/GEE;GG?E?C?(
@antibody_215_multiplicity_308_copy_189-1
AGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTATATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTGGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTGTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGC
+
A????BB?DDDBDBD-C?GEFCFHCHHHEIIEHG+-GHEFHIHI.F-DFIGI0IHDFDIH?IIHDIHHF,IIHHIIII5DHHCHGH5I-,GAIFI=CHHHHHFGCEE*CFDH(FHFDHEDHHEG;DGD#FHGAD@EFEEGGFGG;EEEDGF=E8GGEF-E?G:EACGGGAGG(EG:;AEE6AGGCEEGCECEEE2G')GGAGGCCEEE*;<:E.(/GE,:8CGG0*F00E.CC#((EEEE(*(E1*E*EG
@antibody_215_multiplicity_308_copy_190-1
AAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCAGCGGACTCGGCCGTGTATTACTGTG
+
???A?BBBDDD@DD<+FE.G8CFII>HIHHHFIIECFII>GHEF+FFFHF/HHFGFFAF>IIFHIHICHHE5EHGEIIHHDHCI/HEHIHHHH+HGHGHEDHFGFHHEHFHHC0HDH9HGHEEEEHH7DFEFEG5GFG@DE4DF<<GGBFE*0GEEGCE,G*EBGF?EFEG6EAGGEGFGE?GE:?*GEE*EFEGEC2:1E8?:D0((GFGA*E';G*;EF?8C*/6C:AE#E*814:6.**C0ECAEEF
@antibody_215_multiplicity_308_copy_191-1
CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAGGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACGGGAGTGGATTGGGGAAATCAATCATAGTGGACACACCGACTACAACCCGTCCCTCAAGATTCGAATCACCATGTCAGTAAACATGTCCAAGAACCAGTTCTACCTGAAGCTGAGCT
+
?A???BB9DD@DDDDDFGFFGGIIEHIHI(CIIHHHC#IIHII>IFHFF/IEIHCAC9HC;HI-FHHGHHG)HF>FHHHAHHFHFHIHHHHHFHIHDHBHBHHH)H4HHHHFEF=H,,BHFHGHFFFG;GFDED*E?/AGG?@AEDGFE:E(*0GEEEEGC#*GA.?E:EA*FEAAG>'ACDACE?06GEG?E#6G*CC<GF?E?E(:G(E?C'G*?#::D7E02F*:9CC6;GGEE''C)C#CCEE(E'
@antibody_215_multiplicity_308_copy_192-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGGACCAGTTCTACCTGAAGCTGAGCTCTGTGTCCGC
+
<5?A?AB?D5DD@ED<FF/GGGFFHFHHCHIFHFFFHAHFC7DF/AGHHGHGEIHHEFFGICIHHAIEEGHGHHIHIEDGHHI3HHIICDG?FEHIGHDH+HCHH+AHEF1.C,=HHHH+AE@FGHF;EGGEF2HC87GEEGEGGEFGEEGGG*DEGGF?GEECEEFGFE;@EF*CAF?G?6F680F*.C?G#G>EEGC?DEE'?ECECEEEH@G*CE1E*CC*CEE*E6A:G*:6GEG:AC*?G*A?EE
@antibody_215_multiplicity_308_copy_193-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCGGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTATGACCGCCGCGGACACGGCC
+
??,?=B>?DBD?@BBDFCGCGGCIIHIC8C@HHCEHIGIHHFIIH?GCFDFEIHDI+C@8FDHHFIGCEFIIHHIFIFHCHIGHFHHFIHHEHA8D+HFEHEDG):HHFF+6DFHGC?3=HFEFGFGG*C+GFDEFECEGFEGGGFE;GFCE?G:G?GFA?G;G/ECEGGCE:CE6'0AGGEA(CE(EEFGFE8EEGG6EEE?GGG(G(?FF*.GCEG4/E0G6?AG1?*G(E:GE0'C0=?(?CG'0E/
@antibody_215_multiplicity_308_copy_194-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTCTGATTGATTTCCCCAATCGACTCCAGTCCCTTCCCTGGGGGCTGGCGGA
+
????9BBBDB@<DDD?GGCGF0HIECIAHHE@IHG.F.GIGH=CFHFDFGCHHHGH+FIHICHHH5I7?E5GIAHBHIF?GHI.FFIFHHIHIHGHHEHHHHFF,,HH+IHGGHG(AFFHDEGC1;HGEGG)G+EG3)E9(EFECBEEG*E'E9@EA?CF**FG/:E;;,B;E(GGADC-EG.G*ADAEG.EGGC((G::(ECEE?EGF#*<H4:(CF?0ECGC?:D?6FE:?0G*CA):A.E?:G?GEG
@antibody_215_multiplicity_308_copy_195-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGAAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTC
+
,=???BB<DEDDBDDD>FCGGGFIHCHFIHHIIAEHIHHIHEFIH5HHF-GCHIBE=HHIDFI5H5HHHEFEHIEEI5:E5HGIHHDHFIHHFGHIHEFCHHG=HHFGHFHH4EHG**CEHHHDDF@GHF'EEEF+CHF6EE*EGG9GGD>G=:8EGBAEGA0AGFC/EG<.C?E=1F.'6?GACGG:?0G:CGD:EG??GEA:G(CGFE#GHG<AG0E.;C?ECGG6E:CCGGGE(?EE(EE(C*??:*
@antibody_215_multiplicity_308_copy_196-1
GTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTATTGGACGTGTCTACTGACATGGTGATTCTACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTAGGATTGATTTACCCAATCCACTCCAGTCCCTTCCCCGGAGGTTG
+
?,A=?BBBD@DD+DBDGFFCFGFH?HFHBHIIHI.FHHHFIHIHICHHH5IC-BH@IAH-IHIHHIICGHHDBG-AHHICHHFHIAIHEHHAGHH7HHE*=HDEEEFHHD>GHGDHH?FIHE=DHHEFEGFEEGGG2@G#EGEEEGC:*G:GAB>A6EGEACGG:GE?'D?EAG(GFCGGA0EECGGEEF*G/(E?GAEGGGA:FA(CG(?00(FE#E0CB8AD:0G-CCGA?<E/EEECE)EG*CA*8E
@antibody_215_multiplicity_308_copy_197-1
CGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGCGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCATGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTC
+
?<???>A@D@-DD-DDAFFB+CB/H-HHFIIEIH=EHGHHHHGAHFHHI.I+D/.H5HEFG5HFHHHCDCHIHAIFHHAHH-HH=HHCEHHHIE@F8HHEIE@HF==(HDGDE67FGGGHECGDFHGFFDHFF2C9@D8GFF;GGAEEG#EA?9EG(ADEEC:?EDCEGEEE<FC(GGEGGG0**EG*G?EEEGG/?>G4GAE*.*.*GEGFC*GEGFEG*AAE<;GEEEGA*CC6CE:C::<G?:A8*6
@antibody_215_multiplicity_308_copy_198-1
CCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCTCCAGGGAAGGGACTGGAGTGGATTAGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTGGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGCGCGA
+
?5<5?AB>-DDD,ED@FGBFGGH,EIEFIAADEEFIH-IHHHDHHHI7H>HHIAH9IIGIIH5CIF-GF+@AHFIF?IFH#;FIDIIDHG=H8C*IH-GI.H5HI#=4HGHHHDHH@G=H;CGBEG?HGFGGBHF?HGAGC8GHDEGE;*EBABEF/FFGCEGEEEGE?(AE8/EEEE*GEE.GGEDG?6GEEF:::(ED(*/86EEG6FEE@EC:?(:E20<GGC01CGEE(GG1CC(E?DAF;(*E)?
@antibody_215_multiplicity_308_copy_199-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCATTCAGTGGTTACTAATGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGATTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGG
+
????ABB?D?BD5DD5FGBEEEEIE.EFHIFD=CH+HHEGHH*HFGHHEI9H@EFFEHHIF?=GEHG+5HFHFFFHI5GAIHH/I.GCHE>/FDHHH+HIH7H=GHHFIEGHHDHHDFHHG4*/DFG=FE/DEFEIFBDFEGEE>EAEG@EFCEFE*EGEGGG?EC?8FEGAE?GGG,?GAFCE;8??E0GC(GFE?#F(EC?8G6HE::CE(G::.EEFEC:EC(?G(*GEE:GAAG.E*C</CE?E:*
@antibody_215_multiplicity_308_copy_200-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTCGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCGCTCCAGTGCCATCCCT
+
?,???AB+D-BDDDDBG@GFAC6HFIF6HHDFHHII7EIIEAHIHIDH-IDA>EHG>IHHFHIIFIHG5HFFHIFHHHAHHFIHHHAIHHHIFHHHFHFF=HHHF:FCHGICHHHHFHFHG3H4FFH);DECHB9EDEF(3F?/E+GG*BGFDEG(?F*C(EEGGGC/A*2CEAE:C?0CEG6GEG(GE*;FEGF?E0C(8ECGGG*?:6FG0GGEGGEEGG?CF.GC:;CCG*?G*A0:E(6G#.DG):
@antibody_215_multiplicity_308_copy_201-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCTCCCAGGGAAGGGACTGGCGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAATAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCAGAGCTCTGTGACCGCCGC
+
A5???A9BD?BDDDDDEGFGFFHFFCF+IA@IEHHH>HDHHHDFCIFFIHFE9IHF@/F=CH-FEH>FCFIIH@EI?HF=EHFFH7HIADIFH+H)HHFHBDHIF*HGHEHH44DH?3GDDGG*GE*DBE,EFGE2GBFEEBDFDFEEF;G(GE*EG/G*EGE:EG?C/GGE8;AEGG(EGGEG?E?0G/:?GECECF(EEG;G.E?(CAEA;;:E(EEFEG*EEC;.<=E(8(G?E2?*E)CG;FC<?:
@antibody_215_multiplicity_308_copy_202-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAACATCCATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACTGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCGAATCCACTCCA
+
<,??,B=BB@DD9D?BGGCEDFHIHIBIFCGHEIIFHIEIAIIDHIGEIHHA@?IH98HGEI+HHHIEH5DII--FIGHI?F5EG+#H=H+FH-IEHHHGHHEHHF?HHHH)BHDGHD@,HBFECEG-?EF*CGG?CG3=GG?GGEEGGGGFGC/=FGAG?GGEGFF/EG?AGE?E'GDGEACEEEGAA*?EG:6EGGGCF/GDE.6EGECE'G/EBG,F(?AGEEECCC*:EGG<**((EACE<E?EEA
@antibody_215_multiplicity_308_copy_203-1
ATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAACACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGAGGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGCTCCAGTTTCAG
+
?A????B?DDD5DDDDGE8BEFHCFICEIEIDFDIIHIDGFIGEIEIHH.IIGH-HGC=EHIHHBFHHCI-HIHIHHIHFIHCFCDDHGE-IEHHF)F.DE8HCHHIFFGHE4HHDCH#GD+GFFEHFH#GB3FEFCE0GGG;(GGB(GBF8CDEGGEEGEE(F/ECCGE;GACG2?068CG?F=GF1E?G6FGGGC;?<FE**GG::(AAC:E:DEGE::EA*E;G*D:?>FAAE?E'?*?G?/0'G/E
@antibody_215_multiplicity_308_copy_204-1
AGGTGCAGCTGCAGGAGTCGAGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGGGCTG
+
??AA?BBBBDDDE79?GGGF,GI>FFCBIIFHEDHH+FFFIHIII+-HHIAHHAH+F'BFIG-CHHIHIC*IIIHIIHGHHHFEIEEEDGHDIHGHEFDDHD=GDHFAHHHEFDGEFHGHED*D)FHDG@FEEGGFEBG;9FEFH-*EGFCC(CF*GECEGG*?EGG:?GBCEG*EG/*GGA;GFGGEE::?6<EF:EGC??GG0GA)*CGGH7EE/E0EG?()EDGG.FAC/??:<G?A:;?4C/FEF(
@antibody_215_multiplicity_308_copy_205-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATGCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAACCACCATGTCAGTAGACACGTCCATGAACCAGTTCTACCTGAAGCTGAGCTC
+
<????B/BDDBDDB?DGCGFGFIFFHAHI-.IIFFHIFDGCHFHIGEHH-@HFIIHF-ED.ECIHGHHHIIIFFHDHIHHII?EI-.E4FH=HH.DDHH+HH*I=HDHG+FFHGHHGH;G=GHGEH(FFGF:FF9GCDFGE3CDF,=BGBG*GGGCEG';EEA?BEGEGEE<FGECGGFF/FG*DEC/CC?.0EAC*?/G'E0EAF2;EH(EEGE*C89GEC(G1?<:EA0E*;CC*EFEDG:8E*<4:C
@antibody_215_multiplicity_308_copy_206-1
ACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGTCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACCCCAGTCCCTTCGCTGG
+
???A<BB><B@D@BD,FGGC6EEFHHIHFGFIFHIHHGHHHI9IAIIHHHIHI=CGH=A.HHIIBHFH-IFHHFGIFFH@IGIHHBEDEFEHI@H4HIHHI9GHG+HHED*DHH+E=DFEGHBFHHGGHEFGE2E*4;GEEGG8GGE*,GEGGECFE(CEEG?G*G(8GGECGBEG2GG:G<GEG?AC?FGGF0GGGGGGFE?EGGA-G8?EC;C?EGGGEEE?GD2F?0E0E*FE'4GF?6CGC*:/G.
@antibody_215_multiplicity_308_copy_207-1
TTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGTACGTGTCTAGTGACATGGTGATTCGACTCTTGACGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGGTTTCCCCAATCCACTCCAGTCCCTTCACTGGGGGCTGGCGGATCCAGTTCCAGT
+
?A???BBBDDBDB<DDFGCFEGHHHFAIIIFHIIHGI+IHHFHIFCFH@GEFEHHHAIH=IAHH-F-IFIHIDEHHGIFHGHIHFHHHHFHHHHEHHEGAE7IGFH=HHFF=@FHGBF@HHHFEEH)AAEEEFD)G'9GFF<GGEFEG<EG/ECEG?E*E(CGEFGEG2ACGE;E)G#G.EE8(GEG:;GE??EG*ECGFF:E;C/?A/0CEEEEEBEGECE(G:GGG?EE2(0AC:FGA(?0E/GACC?
@antibody_215_multiplicity_308_copy_208-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAAAACCAACTACAACCCGTCCCTCAAGAGTCGAATCTCCATGTCAGTAGACACGTCCAATAACCAGTTCTACCTGAAACTGAGCTCTGTGACC
+
?9???BBBDEA<BDB<FGFFFGFFHFAHHFFFH.CIIIFHIHHA/;DHIIIGHEHDHIIDEAHHCHH5HIHEGFGHGHCFHBIAGHFBHEFIFIHHHFHEFFHHH-FCHGHDHFFDDHEH7HHFGG8F,GGE;ECGEF2@AFE(AGAEGFDGEAEAGEG(BFEE4FBECDGE8CFCAGG6E?*0EECE(?EA'(G/G6F:EEGG(E:?E0C:CEB**GE/0:C0<?;/C*?6E:(EG:*C?EEG80*<*E
@antibody_215_multiplicity_308_copy_209-1
GCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCAAAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCTCTGTGACCGCC
+
??9???BB6<BDDDDDFGFGFFIFIIIFBEHHAHGHIIGIIHHIG8HIHFIEIHHIHHEHIHFIFHHCHA=HIHFFH?FHGDIG.HFH>HGIFIIHHH)EH=HHHE=HFFCHH9EHGHFGEHGGGFFFCFG+GGGEHG6EDCC*EFG*EAGG=EE(38ECFAED(;G(.*CCCFEGC?GGEEEF6:F?A?E.E1EE?CECE.GGG?H?EE6:AG'E*FGC*EEEF.>0E(E1.C0(G(;CECF6?GGCDG
@antibody_215_multiplicity_308_copy_210-1
ATGCTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTCGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTTAGCTCTGTAACCGCCGCGGACACGGCCGTGTATGACTGTGCGAGATAGATCTTCGCCTCAAGCGCTGAGTACGGTGA
+
?=?,AB<@<BDDDDDEG/GFF./HFCH>HHHIIFIII9D.G@H@H=>G@I/GI9.DEHFHH5HGFHFEHHF,HIACIEH;=HHIHHC>FHIIHHFI5HDHDHHHFH2F?HFDF5CDHFE=HD/FGEFH?GFEDDCG=D>C/FEEGGGE?AF:EFFC;>=CGGGB.(6?CAED(:'G#GA:/#BEE.'G?:;?'(E**GAC/GG66G(6F?AG@FD*GD(8F:CF:6G?(:G0:E?AE?EAE*?0G':FC:
@antibody_215_multiplicity_308_copy_211-1
GTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGGAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCCGAAGCTTAGCTCTGTGACCACCGCGGGCACGGCCGTGTATTACTGTGCGAGATGGATCTTCGCCTCAAGCGCTGACTACGGTGCCTC
+
?A?5?BBBB9DDD5DBGGFFFGFHCHI+IIFHHHHFGICI/HFIH7EGII.GIF-/;I5'HFHFI5HF.ID=HH5EHFHHEI?CDCEF-FFHHH8HIH@IHF7E+@HHGFFHCF,FGEHGG;EEHF8HDCG2FHEF:#EFDGEECE*GGGFEG2GGE*GGAF(GFDEGC'EGG(C.ED*E?G(:GG6E(#C?EC;CGG;?GF6EGEFC*HG?E(EC'F,(FC?C(EGGC6:?(A*G*G:0E8C?90':(*
@antibody_215_multiplicity_308_copy_212-1
ACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGGGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGA
+
?????BB>9EDB<DBDFFFGFGIFEF8HI/CIIIHDGIGHIII=F@HIHFHC@HGF@HI>H-IHHFHDFBHF(HGFHCFHH@HHID-*HI>FI+IHFHIHHHDHEHD4HHGFHE?GGBGE7HH*GGGBFG2EEDDG,FG'@EE#GFFCGBFG*EGGBG.GE:?GEEEE:DECG*CEF+GEAEEC:E?E<ACFEEE)::ECE:GE>>6(?0EEH07*ECEGG,EAE?C(E.C:??GEE*E*::F.A)84CG
@antibody_215_multiplicity_308_copy_213-1
TGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACCCCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGCAGACACGTCCAAGAACTAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTA
+
=????BA?-DD<DDDDGGGGFFHFHHCFBIIGHFEHIHH.HHAFCHFIFEHHHF=DIEH@DGHIIHFIFCIIHIEIHHIIIHHHIIIICF=FIHFHFHHH+FHHFHH0GG0F@H;@HH>HEDEDHG+DFF(F*FDEF#E7EEFGEGG<F.38CEE>;EEF6EA::EEFE:G<GEG;<GCG#E/?GEE6-*G:E:CFG(ED:AF(GF:4EE0E7:(1GE?GE:6:CE(?ECGG(EGGA0*/G:G)CG6?AC
@antibody_215_multiplicity_308_copy_214-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGTTTCGACTCTTGAGGGACGGGTTGTAGTTGTTGTTTCCACTATGATTGATTTCCCCAATCCACTCCA
+
?5???BBB?DDDB9E,GCFFFGAIHHBIEHIIHGGIFFFGIEIAFIA)7HHGFHF/;GIFIHAHCHFGIHIHIHIEHIEHHHCIGH/H-II(H-H(HHGGHFDFD3HH2+HHHHGEEGHEGGEFGHFEG(HCE;GG@EFBEAGE.EFEAEGGC?E88GEGGE:EEG8GCG/G)(C0E+EGECG#E?0F=EE<0GEFFGE8EE6EEEH=EA6<H(<C?A:E/GG:EE(CCEE6:G#(CG:/:CA/CECG8G
@antibody_215_multiplicity_308_copy_215-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGACTGGATTGGGGAAATCAAACATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTAAGTAGACACGTCCAAGAAACAGTTCTACCTGAAGCTGAGCCCTGTG
+
??????BBBDD<DD?DGG-CGCIHHIIHIHFCHHHIICHDHIFFIGIHEII>-HHHHGFG@HHHGCGFFIHIIIDHF:GHIGHIDFHII=G+I@HFE7HH(FHHEHGHHIFHFDHHGGGFG;FFC@HFCFCC)G8DGF6FEEF+GEGE4E*GEECGG?C,GECGEE?A-C(EGEFG8EC?GC*C(C;GEEGE??CGFE0G*6E(G<H#G::EE@8FGCEC.D*AGC:E6AC:E(?A::A/CEG:./*(DE
@antibody_215_multiplicity_308_copy_216-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCTACAGTCGGATCACCATGTCAGTAGACACGTCCAAGACCCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACAAGGCC
+
?A?<ABBBDBDB<DDDFGFFFFF>HHIEIFFHFIHEH.HFGHHHDH@HDH?H.FHGCHHII>GDIAGFBDHHHF9-IDHCIHHIEGHG9EG-FIEE7HHD,FHHHHHH?G--EH*GDF7EHFF>FGEFF=GFFFEEFBCGGDG=?GGECGG6EDAG9FEFGCAE-F#F(ACGF;(G)GCCFCE:GG8GEFEC6GG:EGGE=?E#EEHEC?(:EECD?ECGB7?E2?GG;EEE/:EEGC??GAEE*/9?GF
@antibody_215_multiplicity_308_copy_217-1
TGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTTGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGTTTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGAT
+
?????BB?@DD<,D-DCCFG?>>FIH.HFIHHDCCHI@IBIHEIFEHHFIFH.FIIIIHFHA5IFEHEFHFC5H+GIH>FHGIHIHHIH=EFDFFHHIHIGD@HHB.HHACFH=BGHHFFHHH;:DGGDFGGGGDG)EEGEGDAGEGGCCD?8CC@F*GGEFFCE.0EEEC/DGAAC:8FEEGEG?GEAGEGE<A1ACEG10#EG?HAD00*E0FECE8GEEG:)8AAE0;G::C:ECE6EG:?*-*CG:
@antibody_215_multiplicity_308_copy_218-1
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGAATGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTTGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGT
+
??9??BBABDEDDDDBFGGFCF>-.FEFIIHHGHHEHIHIFHHI/B?FIIHCFHCFCFH?FGIHDE5I@HIGEHFFHGHHGGIIECFGHDH+HFHIHIHHHHEHDHC#BHHHEHFGHH9F=GFH7EGGDFFG@HFEFGEGG>E<G*GGGGD7EGGFCGEEC:EE78GG)CEGE9(E;GA:FFAAE?.(.EECG/GG<GF??C6GE9AG)F.GCC88F=:GGG?E(?E<;CEE(GCE*(C/FE(<06C(CG
@antibody_215_multiplicity_308_copy_219-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTTGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCAGAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCT
+
??9??9BBDD<DDBDDGFFGGCHIIHIHIEAHHEIGFGGEIHBGIIIHFGHDHCCHHAFHFGC5HIGIFIDFFFIDFIIHFHICHCIGFD>HHEHFEEFHCHBH#9HF)H=FD=G+DFFGHGEEHCGDF;*GG@DGC:5CGAG@DDAFGGCFEG1D'GFE*FAGGEE<GEEFG?G?E<GE(?<D*AG*>EE??G/:EECC>'68=0C#ACEAEGGG:GGCBCGEC((.EAC'AE1EGEE:.?EG8EEACE
@antibody_215_multiplicity_308_copy_220-1
GCAGCTGCAGGAGTCGGGCACAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTCTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAATGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCACAAGAGTCGAATCACCATGTTAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTG
+
?<,??BB+DDD--DBBCGF,F?HHFIII8HFHIGHIFHIIIFIIIAD+II-EIHIFGHEHGHFF+IAEFI>FEIF==H=-G@FGIEIGIB.FHFHHFI=HHDB=CHDEDEEHFHBEH,HHBHE*D?HF6HEH=F4D;DFDF#5:FCEFCCEE=(EE;E2ACE?E/CG?FEECEGE?*)GCCE#EEE.G(:/CFA'GFG.CCFG.E?AEAA(F((BEECCEEE/C(/?E*C6D:(EF?.?ECACCC(:6CE
@antibody_215_multiplicity_308_copy_221-1
CTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGAAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCACGAGTCGAATCACCATGTCAGTAGACTCGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCG
+
??A??BB9EDBD<D-DGF-FFFHFEHH>;HIIDIFIHIIHIFCIDDG7HGHDICH=HECII?H?I8+HIIFHEHHHHCHFHDHHFEHDHIBHIIHI#HHIHIHHGGFEH*HFDFHGGGHCF3GEHEEHHHHFGGFEDHG*'EEAGDGEGGGEGEGGG?GG;GE.F)E((=*(FE?EG;/G+G?'A6G:CG*EGEEDE:EECEE1/(E':HG?E0@*?:?E/A?G(*AE:(;EE)GF*EF:CEE:G)?0:E
@antibody_215_multiplicity_308_copy_222-1
AGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTTTACTGACATGGTGATTTGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCGACGATGATTGATCTCCCCAATCCACTCCAGTCCC
+
???A?BB>DDBDDDBDFFGEFFIEHHIFHBHIGIIEEHGC9IHHF>HIHFDEI.HFGHI9HGIAEIFHGHHHHFFIHIIDE=HABCHHHGHGIHHCHIH=HFHEH,DFH@HDDCEFFH<?FHFEGBFD@CEHF;CE>EG8FEDHFGE7GEB>EGE859EADG?*,EE?/CCGGGGEE<F?G(E:G/A*=GAEGEFG8?1?FE/E?G:G6(:')F:(GE,1CCG;-E6;(?EEGEA:EE8'EA'F96F0GG
@antibody_215_multiplicity_308_copy_223-1
CAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGAGTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCACTGTGACCGCCGCGGACACGGCCGTGTATGACTGTGCGAGATACATCTTCGCCTCAAGCGCTGACTACGGTGACTCACGGTGAGCT
+
?????B?BDDD<DDDDFG/-CCHF.HEHI0HGI/HEHIIHHHHEHD-@@7AFDHHEA,H55FGIGC=BCIHHHGIAHIEI5FCFIIHAIFD-HHIDI)F<I@HFHHHEHH?HDE@DDHFD=GDHEB=DBFE;F?FCH=FG+GEC5GEEE*FFFGE*<GCEAFE#G9AGCGECE<FGGC:ECG:.GG6*EEEG?*G:;:0E6F*G(GE(8HEEFFEEEGE;C::E?6(EA/:EG?C(61(?*C*G?GC*E:
@antibody_215_multiplicity_308_copy_224-1
TCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATTTCAGTAGACTCGTCCAAGCACCCGTTCTACCTGAAGCTGAGCTCCGTGACCGCCGCGGACAAGGCCGTGTATTACTGTGCGAGATAGATCTTCGCCTCAAG
+
?????+B<+B@<DBD5/F.GGGFFH+I/CEHH@ICGIHHIIH=F9IF@DF@AFGG.GF9HHHEHHFCH(HHIFHDHHHHH5HIHEGHHIHGHEHFICHHCD@-HHDCFHHCIG@FHG/GFG78*HEH*HF@@FCGEE+GEG8EECGEG#*EF9EFG)F(G=?;GE*C(4?E(CGEFGGEG(6E6F?6G(8G:C#/G)DG8GC::?GH1FE(FFEGEG/?G?40E1:E:FEAE*EG?CGC:AC.:1-G*9:
@antibody_215_multiplicity_308_copy_225-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCCATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACATGAAGCTGAGCTCTGTGACCGCCGC
+
5??,?BBB6?DD-B-@CAFGFFHIIEFHHHHICAIIIHHII-HIFH5HIHFF5.AHEHF.AIIE4H.IGHIEHHB5FDHCI*HI/HHFDAFF<EHB8HAHF@H;H,A@DHE=HH-HFHBHHG@1HHC*FEFHFE/DE@EG(GGGFGFBGG/GE@GE01EFE*E*EFC(GGGGGFGEFDGE?GAG0:::?EGGFEG>?<?;86;GG*CEC::G/EE:FGC.ECG?)GE?.(E<6G:0(FGC**?8E*CA(*
@antibody_215_multiplicity_308_copy_226-1
GCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACATGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAAGCACTGAAGGACCCACCATAGACAGCGCAGGAGAGGGACAGGGTCTCCGAAGGCT
+
<,=?9BBBDDD@9DBDGCGGGFHHHHBHEAIGB.CEGHICEIFFHHHGIHEIIHFGFH>HHI5IID/FI(HBHIGEHEHHI5HHIIEFGF+AE=IDF+HD+DFHCH>HDHG2I7HH+3CFFDGGEGHGGFHGGEE.DFHEEEFEFEEFEF?GGGFAEFG=CGG=CEAF4@=FGG?E?F:GCCGA?DEG:E*EE(F'C*EEAG?:GEF-A(GGCE:F8GEAEE(:EF::GGG:G8CEG;G:<E/FA?CE;:
@antibody_215_multiplicity_308_copy_227-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGCCCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATGCGCCAGACCCCAGGGAAGGGACCGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGACTCACCATGTCAGTAGATACGTCCAAGAACCAGTTCTACCTGAAGCCGAGCTC
+
????A9B?B@E@BBDBCFFFAGHAE,EAHHHCEHIDHHHIIH@CIHF,DIHFHCG.CHCHFHIHBIIHHFHHIHIHGEHH@E5IHHIHFAHHIHG-FEH=HFHH=HEHH+EHEFHH#HGE#@BHGGH?*GDG+*D>FFGEF.EHEBGE8EG8F/(CGGEGEGEFGGGDEEG6F?4:EGEEDEG/EGEAG)9CGF/FE#8.E*;??AEGA6DGE@(?9CE(DGCAEE6:E??8CEEF*0EC?8?*E?AG'1
@antibody_215_multiplicity_308_copy_228-1
CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGTGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACGACAACCCGTCCGTCAAGACTCGAATCACCATGTAAGTAGACACGTCCAGGAACCAGTTCTACCTGAAGCTGAGCT
+
?????BBBB@DADDBBFFCGGC?FFAE?EIIHFEI?CH/HHIIFHAHCHICF-EHFFIGHIFECHEEHHFEHC=IHDHIIF@FFF-II(FHHHH,D8EIHHEFHFEHHHGGCHHG?HF(HHFHFEHGE@GDGHGGE(E*GHF*FEFGE3GEGDCCG?,=EGEAG?*9?D;1CG7/EGG*GGEG:(6#;;:E(F#G((G?C8CG*E(EA(E?G:7*:?*CE::E):C*:A?FEGEECE:GF':E6CECGF*
@antibody_215_multiplicity_308_copy_229-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCTATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTTTACCTGAAGCTGAGCTCTGTGACT
+
?<???=?B-<DDE5?DBGGFGFII6FHIHIH..HHIH/HHCHHAHHIHHHDHF-FFFIE+II-IHHHCHFIIIH@FF+5IIFGEFIHHH*HH*HHHHDHFHHEGDFHHFIFEEIGHHDFGE?EEHHHE2FGGD=BEF9829FEEF(;ECE?FGEGFCG;EE(<G:EBGEEGF6A;GACAEGE@F.?CD9EGEE8DGEGE:?E'CG:;:EEGE3<@:EFFGBEC*#*GEGEG82GE..(?EE?<GEE/:C'
@antibody_215_multiplicity_308_copy_230-1
GTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGTTCTATCTCGCACAGTAATACACGGCCGTGTCCGCGTCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTG
+
A,?A?BB?DB?<BDDBFGGCCGIHIHIHIFFHFHHHEHIII@+=+HFGHFHICGH*DEG-HHHIFHHH'HGHHGIHDEDIHIHIFFIHHFHEAHDG+I3+GGHD#HID+CAH=HGGDFDHHHCHFFEFEEEG)D9)*1B-CEGEEC*GGAFE?GEFCG<GCFEC*GD/GF:;:GEE?FA(G+E:G*GAG66AGGGGE;*C#:E68AHC-6C*:*@:1;E0CFC?E??:E?EEEAGGGE?(GG..(A?0E)
@antibody_215_multiplicity_308_copy_231-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTATTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGCAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCGGTG
+
??A=?BBBB@?D@DDDGEG+GAEF+86IAH7H./IHHGFIHGHH8FFIHDIGF;HFAIEEFFIFFI+IFEHIHGHHH4HFEHIHHHIHGE8HH5D.ID+DHHCDDH4+HHFDDDHHHHGE=HAGHEHGFG0?FBEG;EG3BDCEE>EE*;G;G(GGEGE/FF@CGF?2?=<EEE.:GEEGFEGEDGEGG4(CG?GG(.G??8GGFG0DEH?;;@'F?CE.EEEC*A?/C?AGC?G;<)GGG:10E4((EE
@antibody_215_multiplicity_308_copy_232-1
TGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCGTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATCGTGATTCGACACTTGAGGGACGGGTTGTAGTTGGTGGTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCGCT
+
<????BBBDDDDDDD@GFFGFFIFCHIHFHHHHGCGIIIGGICEHIGHF-GIHFCH-IEFH+IEF-HFIHHCGIGDIIIAIF,HIDFICHDIHAA?CHG+GEDIDHD3H=DHFDDEFHDGEFF=GGDGFGG*+9)CG@DEDEAGGE@CAEGFGEGE<1EFGCGGEG;C(EGC8:?(FEA('AFGGEE*E/GECECG?E??:<ECC#C:CH:C0GC(C/,7:GEEA8EEG-*0?FEGF*/;G?G*??.'C6
@antibody_215_multiplicity_308_copy_233-1
CCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGCCTACTGATATGGTGATTCGACTCTTGAGGGACGGGTTGTCGTTGGTGTTTCCACTATGATTGATTTCCCCACTCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAG
+
??????BBBBDDDDDBAGEFGFHFEIF>,AFFHA=EGHIIIHHHFE>G9FI-HHFIFH8GIFHHHIHIHHHHEFFHHG=HI5HHHBHCIHHH8GEHE5HIHEG=HHHFEHBDHIHH?FH-4FH@+=GEBEC*FG>DFHG(GGAGG0E*EE4E,GG32EECGFCEEEG:EE:CED:DEFE(:EE<ECBE(G(GECE0'C?D0DGEG-6CGEE)@9@GEEEEEEE:/6A/EEEG:CC:EEFCA?EGD(E:EA
@antibody_215_multiplicity_308_copy_234-1
ATTTAGCAGCTCACCGCGAGTCGCCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGCTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGTGGATCCAGTTCCAGTAGTA
+
?,???><BD-DDBDDDGGGGFD-HFFHFIIGFII9I.DHIDAFHHAFH8CEHFEFHHIAHIHIIFIHFBFCFHGIDHEIHGAFIGHH=HIHHFHHHHEDHHF?DH.FGEEEHFHHHEF+.EGGGEDFHFGGD@GE8GHFBCG1GFGFHBF*FEGEG.*GFGEG*EE:CEGFGGGEEE;EGGEEC?(?C-8*GF*(:E:E*.?GG0CCEEHEEC:*F<A7AE;???AE'E:*FEGEG?8C*0:EECEAG4E
@antibody_215_multiplicity_308_copy_235-1
GTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCATAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGATTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGGCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAGCCACTGAAGGACCCCCCATAGACA
+
???<?BBBDDD@DDD-FFEEFC@?CHHFICGGIDHHHF>GIHHHF.HIH.E+CF>F/HIIIDFHF'F8FHH=<AIFCHFHHHHI5IE?H@=GFHEHHHHHDFIFGHHHFCF;HDHHBD.HE@DGGFFDDE;FG9GCHF(EGEEGGEF#GGG9G3GFFEG(G0EE<EG:>GE6C/G<EE<AC+EA6C*GG(GE0E?A*9E?/1CE;AHG(*:C/FG<8G7,(/F/E*CE:**A:C)CGG?'#E?*C:?E:E
@antibody_215_multiplicity_308_copy_236-1
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAATTCTACCTGAAGCTGAGATCTGTGACCG
+
???9?B=BDBDDEDDD8GFFEGHCIH8(FBICH?FEHGCGIHFIHEGHCHDGHHHGFHGHIFIGGDHCHIHGHIEADHIGH5IDHHHCFDIEHIH(CHCHFHEIHH?,FIF*,FDH4I+FB*GGHFG?*H*EGEEFHFFEE8EFEFEFFE8GEGFECEFDDFG;/BG.GCEEEG60EEG?8G:FGG?6?(EFFCGGGEGF.C<EACF(-E?;CD(:B?CE?(C1CA*>/*-:C?G#GE((9<:EG>*;EC
@antibody_215_multiplicity_308_copy_237-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAAGACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCG
+
A=A=?BB?DBDB<DB5FFCFCGH6HIAHEHFEIFGFIIHICADEHHFAIGH.FC;5ACHGIIHID=DDII55(EFHHHIHCHHHHHHIIFFIE=HHC5H?IHDI8HHHDHFFCB6IHHHH;EHEEGHGGGGGE*FFFDEG((C@>E?:?;2CE#GGFFEECE?GEGE.AGGAG?E9FGAGGC?CC(C6F/E/EG#*GC6:C/ECC/E1GH.GAA@GCG(9'E?EE?EEGGG:(AEAC;EC:E?E1GCEEE
@antibody_215_multiplicity_308_copy_238-1
ACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTTTCTACTGACATGGTGATTCGAATCTTGAGGGACGGGTTGTAGTTAGTGTTTCCACTATGATTGATTTCCCCAATCCAATCCAGTCCCTTCCCTGT
+
????,B>B9?DDBBD?A88F?-IFIHIFHIHFH7HIHIHH,AFFFCFGDG-FG+HEHHHFHDHDEE+HCHFCHHH5IIH=FHGIHEDEHHHF-DHEHH;HBFHH=FIIFG7H@GHHHH2GHGHHHF?E;C8DG*?GE9GGFGFGEDFCCGG:EG(CE;FEEGG:G4)A?G4GGFG?/EEDAEEFEE/)GGE?FECEFEG(A*(:GGEGC6AGH*E?EEBEE/G?F?GCGGE;(ECGC.E*:6G0:CC*:*
@antibody_215_multiplicity_308_copy_239-1
GACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATTCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTCGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGGCGTGTATTACTCTGCGAGATGGATC
+
A??A?BB?DBD=<DBAFEFGGFAAEFCDIHDIE9IIHHDDIIF/GHEHIHGHAHIF+7HIHIH-IHIHE@IE?BEHIHFHBIHEHGHHHEHE@EE,IDHDFGGGHH9GFGEGFHH*EGGHH2;,EE5DGGF+B2EGGFEC;GGFFGFGE?GCBGDFCE(*?E0EFECE?GGDEG*:EF2.GGC=GGG:A(=EEA2?(EG?AGFGEG0AE;CD8#G*GG;9GEGA#(E(EE<(C*(;#/ECA:*E:'E0E.
@antibody_215_multiplicity_308_copy_240-1
CCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCCATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTCTCATGGTGATTCGACTCTTGAGGCACGGGTTGTAGTTGGTGTTTCCACTATGACTGATTTCCCCAATCCACTCGGGTCCCTTCCCTGGGGGCTGGCGGATCCA
+
?<???<BBDBD<@-DDCGF+GCHEF+FIHIHFCEIHGHD9I5CI9IHEHFEHHIIIIAHHAE+EH(IIGCIEDACF++HHFIEIIBIHFHGGHHHFGHDIIDDDFFHFFB?H6FHHGGHHDCE4GAEBHGBHHE@EHGGEGGC+E:'*GGG.GE:FEEGEC8EAEGFEEE*ECCEGEEGAAGC@?E(G:GEE01GGGEAE*C*CGEAA?:EE18)CG-B,*'E:/D(*0AE:GEEE?00EA'AE0C/)EC
@antibody_215_multiplicity_308_copy_241-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACCGGGTCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATAGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAACAACCAGTTCTACCTGAAGCTGAGCTCT
+
??????<BDDDDDDDDGECFFFII0F.CFIH9HIHIDIH7HFHDCHIIH@FFHFDHHEI5AH@IHIIHHFIFHHHIBGIIHFFFHH?FI8G.HHIDFHIBDHG-F?(HHHGDCHGHFGDFHGFFDEGGCFHEEEFGFEE=E+EFG(EEFGGEEEGGGFE<BEFGGAFEG:FC<8.;8FFGEFC8:C*8*ECC:0:6CGE?.CF?EGEGE?E0*/@?CACE/G(?*:CC6:G;EEE>C:0*EG:E*E*C*E
@antibody_215_multiplicity_308_copy_242-1
CTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACTGGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAACCCACTCCAGTCCCTTCCCTGGGGGCTGGCGG
+
?9???BB?DDDB@?B@FFGE.8HICAIIIIAFIHHF+DHII/D=CHEHDBIEDH5FHIFGHGIH+H5+HHIHH=HIH-GICFDFIFIHED2<HIHHFIHAHHHEHHDFHHFH.GEHHBFDEFE:EBGH6F*F=GHGE?B8GF##CCGBEEEG(G*E<GBAECGE<GEF:FG3CG2F6-(EEEEEEE(GEA/GE/EG*(E?GCC9?EHCEH.8EEF7?G(G4/GG:CG?CCE<'.C:ECE?AGC*D?:(8>
@antibody_215_multiplicity_308_copy_243-1
CCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGTACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACCTCCAAGAACCAGTTCTACCTTATGCTGAGCTCTGTGTCCGCCGCGGACACGGCCG
+
??5??BBBDD-<@D+<FFCACGFIHE>FII;IGCEIIBFF,FGCHFEE9FFEBH9H+BAI-DHGFIFCAHHAIIFHFHIF-FHDAI5A+DA5FIHHIH(,FGCFFG.H=+D@FIEFHFGHGHH2GEHFDHFGEG/GE6FE;GFEG/2GEGE=EEAC':(A*F'EE,CG;(ECG:GG?(EGG?'CG>GGCG0EE0'6:A0CAEGAGF;*FHGE8G.)7#GEG)1C64EACFG'?E?:AE;:C8GF/*G;*G
@antibody_215_multiplicity_308_copy_244-1
TAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGACCCATCATAGACAGCGCAGGTGAGGGACAGGGTCTCCGAAGGCTTCACCA
+
=????BB>BD+DA@D=CCGCAEECI->IIAI;HIHIHECI>CFFF.GHDAHFF5HF7HFIIF*E>HEHIFHIHIEIIHHAIEHFF>HGH=FHGFIH(CCHHHHCG@?FHHGHH7;EBHH)HBGEFFHFG;EEGDFEEFGDDD;CEBFF8EF0FCEBGEGFEC(DFEG>@EEE'G(E*F8::G?G:G:6<6GGEG??C/EFF:CF(C:*6A<A<E@CBEEEFDE?AGEG);EFC6CCEGEG:(:CCE0*:G
@antibody_215_multiplicity_308_copy_245-1
AGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGTAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATGTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTCGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGT
+
5????=B5DDD<5D@BEGGAFFIIIIH9;HECEI-HCHI+FH?F+FHECFFHICHII>I5HDDIDDHFIGFB-GH5HAF'GHHFIDEIFE++GDIHHH5F8FH?I4CHDGHHEF8DGEDHGDH:FHG*FHEFEHGD+*,BEGHG?2?GEEG6GG?@G,ACGF(AFGEGGF(EE(CF2EEE1CFG8'1G*C?(6?AG8(E-EEE;E((GEECG(:E::G8@>C?CGE?*F(6CEFGAGG:CCG?C*/G=).
@antibody_215_multiplicity_308_copy_246-1
ACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTTTCTCGCACAGTAATACACGGCCGGGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGACCTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTGGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACACCAGTCCCTTCCCCGG
+
?,???BB?DDD-BD@DGGG@FGFHI+IEHAFICIBHH*HFHFF7.HHIFFIHFFFAFEGIFIHHHI0FIHHHAAHCHF05I-HCFDFHHHHIHGGFFGHEEH#FHHHFCHF+HEC@FGH*EGH0;EFFHDG@GGFFFC#G*EGGG/GCFGC.EA9FEE?EG/FGGCCEFCCFG<EF@E(GCC*'E:E?GGGG)EE(G)EECGAA:G*DC0CGEEG:GEEEEACE(6EG::EE:(/C(8*A?C?(6?8**G
@antibody_215_multiplicity_308_copy_247-1
GCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTAGTTACTACTGGAACTGGAGCCGCCAGCCCCCAGGGAAGGGACTGGTGTGGATTGGGGAAATCTATCATAGTGGAAACACCAACTACAACCCGTCCCTCCAGAGTCGAATCAACATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATCACTGTGCG
+
?????B?BBD@?DDDDGG8G8GIIIIHH/5IHIIIGHCF+HHCH,HDHGEHH-GFHF9GFAFAID>FIEHI*E5HEHH-C>HHADDIHEG.GIDF@EH-HGIHH,C:HI=H=HGD*HDG>GGFGH*GBGGGDGE;GFAEFDEG?2,@GCG3.EFFEFEFEAEG.)*GFAECFG:G(>4GE(-EEGC*EGF.:?'?A(:.?EC*EEGEG.EE/E:ECEF,EC4FG2*:::?E(GEEEE:CEG0GEAE0/?:
@antibody_215_multiplicity_308_copy_248-1
ACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCCTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGTGGCTGGCGGATCCAGTTCCAGTAGTAACCACTGAAGGA
+
?<,??=BB+BDD-@DAGFGFGCEFE,IHIHIHHIHGBIIBEI@E>+G.GEHFGIHHIHCHBCFICIDFIBG=5HFBHIC5CHFHHDGHIHD)HHI+H>FFEHFFFHG*HH7HGFGDH+HFG3FFGEF@FHFGG*B;GG;FEBE9G;EE?A3GCFD(:G>GGGEEGGFFFGA?6GCG*GD?+E8C<ECCEE:ACGG?FE(CE?EE:0E?G0E(EGC(BGCGEE?/C?A?)AGEGE?*E*AE8*E(G:)<6C
@antibody_215_multiplicity_308_copy_249-1
TTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGATCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGAGGGGTTGTCGTTGGTGTTTCCACTATGCTTGATTTCCCCAATCCACTCCAGTCCCTTCCTTGGGGGCTGGCGGA
+
?????>BBDDDDD-DDF;FFG7HIHHHIAIHHCC@HF?DEHI?HIHIEHFHHFEGCIIB+HHHIIHHCIIFGHHIHDI55FIHHAE++EC-5IH,HFHIEGFHEHH-@H=D,H+H6EH;G2?GHHGGDEGFG*D@G,A2GDDGCDFEGEECFF*EEGCG:(C.,F@(GE2EGEB<G(EEE:G<G'GCG;?G?E*AC?A:GEFG'0*H6ECFGA*GAG?88E7C?:GGE;*CGG>G(?E600*/C.**.?:
@antibody_215_multiplicity_308_copy_250-1
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAAGACCACCTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCGGCGGACACGGCTGT
+
?A???B/?D@DDDBD@FFEFGFHFHHHFIFIHFHFHFFICHHIE@HFHDH@I:HFH-?+HG)GHHHG/>GDHC@IEHF)I?@IDHDHHFHHIH,HHH=HIHHHHIG4HH5G+CFDHG-G*HBHGCFC+FGH=GEGG+'DG1G#CDA?(CG*;.GGCC7CG(C9FG/EG/GG:GGE28F6EE:EE.E(EECEEFECEFGEGFC*ECEEE?H*G*FE1?EE(*7EGG:CE6/C(EEC*6:EC/FA6C0?'G.
@antibody_215_multiplicity_308_copy_251-1
CAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACATGTCTACTGACATGGTGATTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGTTTCCGGTATGATTGATATCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAA
+
?????<5B6BDBDDDDFF;GFFIHFCI>EFHII;@GDC/EHIHFFGIIAIHHHF@IH>+IGHHFHIHI+I=HHHI7@H*EHHIF83FHCFHHIF+HCHFCHFHF<HGDFGGE@FHDF.HGEFEDHEH8?BDGG2DGGG,@DFEE.AGECGBGCE,@'GC;:F*GGBFE:GGECA/DEG*GEAE''F<(EE:G?;F.ECEF:C?EEC*??/:(CG)CE?C@'E:<'(AEA*?ECE::8?EDCGE*GECC**
@antibody_215_multiplicity_308_copy_252-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTCGTGTTTCCACTATGATTGATTTCCCCATTCCACTCCAGTCC
+
?=??ABB>DBDDDDBDCFF,GGH>IEGHHHC9IHIIIAIIHIFFIH/@FG@CFHECIHHGFIHAHFIGGIFIIHFHFFIHIIIEHCHGIFIDEHFHHEFFDHE.FHHH@HF/GEECFHGF@GGF?*D+DGEFEGFGEDEE'HFFD(GGGEC*8GEB'GCCEGGGEEEGG:EG::EE;AC.GF0GFE?FEE*(CGGGCEG?GC8(EEEG('(GE1GCG38@G:??:?<E':)FE:FA(??(??G0CEEA(G
@antibody_215_multiplicity_308_copy_253-1
AAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGCTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTAGT
+
??A??BBBDDD=EDD@CFFGFGEHAEHHEFI-HIGIFIHIICIHIFI?IEHFD5IFEH?HIIHGH.F--:IIDHH@AHD)I5GDAGHG+H=IHHFFHHGHHEH=+EDBHFBHGG=H4HB:FD+=0EFHA)G/DE?DGEEGGFFECG?EEEE(FE;G(GF?GEA*GECFGGDGE/CGGECC+GCGEEEEA?G6G6:EEECEEGE:GG:GEE;EEEC0B-EFBEG:E6GAG?*A:EE8EG-6C?G61??CC0
@antibody_215_multiplicity_308_copy_254-1
CCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTCATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCATCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACACGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCACTGGG
+
=????B9>BDAD@DDDCGFCGF8C-IIFIHF8I.FHHGIIF)FHHAGH9II+H0BHI>IHICIHDCFIHCHICCGHFIHFIHGGHH5HH#FHDDFGGHF0I?#AEFHHFF?EHGHFDH;(HFF4G#FAGHCG*CHEGG.;C@EBGCG/;G0*EF8?FFEEEFAE#?GG/)GC?CF/FE:GE?GGG.:EGE:AADGAFG0GG*;:CGA:CE/(H*(G7:E'GF?;:;E(:GG:G1CA0GEEAGE?#G:/*G
@antibody_215_multiplicity_308_copy_255-1
CACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGAGGGGTTGTAGTTGGTGTTACCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTCGGGGCTGGCGGATCCAGTTCAAGTAGTAACCACTGAAGA
+
,,A<?B>?D5DBDD-DDF+GFFFCIHIHFIIH+HHECHH>I>FHHFFH,FGGIHHHFGBHHIDHHIHIHDIFFEIIHEHHHDCH-IFFFHCIGFGAEDIHFIEHDDHHGEHDGHHGHD*6HB*DGFEHGEG:E3GFDEFGGA6E.(*GB,G4AGDGCGG.AE=FF0A*EGGE8(G>*((A/GEAGG?8F6=)GDFEE*E;(EG8EFCEGC(GAC@8BEB8GE:E4(:F/G*0AG?*EGEC>FAE?G)GC?
@antibody_215_multiplicity_308_copy_256-1
GGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGTTGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGCTGCTTCCACTATGATTGATTTCCCCAATCCACGCCAGTCCCTTCCCTGGGGGC
+
?????BB?DBD-B?BBFFCGFFHH/IE;HIIHHFH=.HFH?HHGIIIHE.EIHIEHHHHGFHI5IHAIFGFHCI';HIH4IIIGID-HHHBEEAFAHG-EIFH@FHD@HHCGH?,GE6EBHFF6GGCFDDG@GFE2EFA@EEGCEG###C>GGFGEE:.GEGG:EB?7GECEG>GE6GE69GG*DGEG(EFDEEE:(GA(CGCC*?*:/EA?C@B(:(';EEFAACECA*CGG(?(>A8C/EGE*:E::E
@antibody_215_multiplicity_308_copy_257-1
AGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGACAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCGTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
?A???-A?BDDDBDDEFEAFEGIHHIHHHFHGFFIIFDCH9H9GDHGH.HCEF+I+HFHFH@HIFHIHI-DIHFFI5HH@FHFHHFHHHFIFGHFHFDHBDH2H9FHBDFEG:HEH=,EHEEDH,FGEGBF8HF*3+GBB@FGDE??EAEEFGFE(B;E:DGACEBEF;GGDCGGG*'AAEFGECDEFE(G/(;EEE)AGG?:>8(/;)CEE:E;E*GCFGCG(EAE<C*/???EEAGGC?C6E0C?:AG
@antibody_215_multiplicity_308_copy_258-1
TATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGACGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTTTGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCA
+
?A???5BB-DBB9DD+FFG+G>IIIIIIHHA@HIFIIIHIGIAHHIG-EE-BFI@BHIAFGEGI5IIIHFICE'HIICIDGIFHIH*HGBBIFHIHGHGD=EFFEBEDFDFHCHH<EGHHH+HDGGG@EBEFFHHG8C:EEFDGE*GGFGGEGEGEBEGGG?BE:ACAEEG>28(E:GEGF?EEGA4:GG'G2???EEE?6CE?EEHGECF?E<GEE/GE)GC68GCGC69EEG);A(1*A(A6:AG(CE
@antibody_215_multiplicity_308_copy_259-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTTTACCTGAAGCTGAGCGCTGTGACCGCCGCGG
+
<A?A?5<BDD-DBBBBGGFGF.IC;/E+HHHIHIIHIIGHHHGHHH.HHHF>HEEHFGH--EIG5HEIHHH-AIIIHIGCGHEC<HIG?HGAIFH-IIIHHFHHFFHIE;CHHF+#<HFDGHEGC,GBHFGF5EDEGHEA0F5H>9HC5EEGCGEE)3G'GEEG0GC(GGAGECGFEG(ECECFEG?E(0EFF:EG2'G*G:*AE)*:(0GCFA8?<C(@EE/CGE?*F:0EC8)6:/A;:?F*G*A/CC
@antibody_215_multiplicity_308_copy_260-1
TGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTAGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGAT
+
?,???B??BDDDDD@DCGFGGF;HFHIII8HHAIBFHGHIAHH+FIHHHCGEHH+@CI5./HHCGIHIFDIGHHG5F5HIDCE-HECIEDIFHHHDH/DIE:FIHH4+IH+DHEDHGFGHGF@FEGG)GH(,2E+GD4GDGGFG6GEFD;E6GGE6EC8?B:ACEC6GEGBCFG>GGGE?'6CGG'GCA*EE;G*G?:GF4:6G6CE*:??:CE)AE'F.*CF<AG6E0*C<:E9C0(C?:#EFEE8AE*
@antibody_215_multiplicity_308_copy_261-1
GTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCACAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTACC
+
?,?=??BBDDDDDBDBEEFFFBHII+HIHHE+HHD+IIHHIDGGH.HIFEDHFHHEH=ACHFDG-FGIDIH+CAGHBDHHHIFIHIEE-GHHHHEH@HHFHHFHHHHH1DFG7HFGGHHGDFF=@G(EFGGDE6B3GGG(=CEB*;GF(GECDGEEGEGCCEFGFGGFGGF*9AC<EAGE;CGEAA:8G1E:G<'E:G:/EG:G?E1GG/?1E8FGE(0A0EEG(EC:CE?:EE6*6?G/C::*C/**08
@antibody_215_multiplicity_308_copy_262-1
GGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCGAATCCCTTCC
+
?=,???>B<-BDDDBBC8GFFGHIAC/GHH?FIAHHFIHGIHEHFHIHHHBIHHHHIHCGHEHGFG/HFHCEFGIH5IDHHFH?:HIIF-GIEDGHHHG3=HFG<DBB;FHHHHHHDGHGGDGHF?GCG?DGGFDGGE5*G.FFGEE/*EGFGEFAFDECEG;CEEBCGEEGE0EAE:CEE:?CF'EAC;F'-GCECF(C:C?FEG/0.EEFF(7C)GGC/EC:EGG-EGCG?GE*GG6(?(E6*(E*GE
@antibody_215_multiplicity_308_copy_263-1
ATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCGAGCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAAGTGGTTCTTGGACGTGTCTACTGCCATGGTGATTCGACTCTTGAGGGACGGGTCGTAGTTGGTGTTTCCACGATGATTGATTTCCCCAATCCACTCCAGGCCCTTCCCGGGGGGCTGGCGGATCCAGTTCCAGTAGTAA
+
<??<?BBBDDDDDDDDFFFECGHIHHIIGF?HIHHGFGFIIAHIHFHEI-H0HE,EHIEEEFI5-HGF>IC-IIIHFH0BHHDFIEHHDI3HFIHFH.HHHIHHHHHDEHF#EGFDH>49==GF;BHGCGF=FD*E-FGEE>EGGG*F'6G9AEECFE:G@F3G*:E2G?E?EG'?G((G6G#C?EG(:(GEE*CF:GG/6CAECAH;C#/EH/)7FG7(G1CE:G?CG;E*E*E8AECGEECCFEECC)
@antibody_215_multiplicity_308_copy_264-1
ATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCAAGTTCCAGTAGTGA
+
??<A?BBBDDDDBDDDG8FFGFIIEIIH>FEHHGHBIIIHHII=HHHFI=HHHHFIHFGHHHCG?HHIHHGFEFFID7F@CAHIIEIGHF=F7EICIHBH;HHF;EEFFHFGHEFHFE?DGDGGFFHF@:9DG*GGE*BGGGEE/GBFAEGGFEFB>FGDGGFE(DECEG;;EEGEE.?GE:G>GEE(>CC/C6FCE<G**/?EF/??:E8FH)*EEEEG00)E?F/G*)*60?G'C2:EGCCEEE=:?*
@antibody_215_multiplicity_308_copy_265-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCGCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACAAGTCCAAGAACCAGTTCTACCTGAAGCTGATCTCTGTGACCGC
+
??A,AB79DDEBDB?BFFCGFGIEHEFIIHHH;HH-IH?H@=HIFIEHFHHICF5HHFHG8E-BHHCHEEEFF+FHIHHFD5BFFDC+HIHH=HIIC6HGFIHHIEFH#ICD,EHFGHFDG*)HFHGGHEDEE@4DEE=EEEGEGE*EBEF#EFG:EEGEG?GBD.EGEGE6?:F*EGEGA:GGGF.E?*9<?8EF<;EG/4*A?GC#EHGG0FG*C#EG)G.?(E.<(G:/(?C?0(?E(:E0*D9ECG
@antibody_215_multiplicity_308_copy_266-1
GGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAAAACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGAGACGGGTTGTAGTTGGTGTTTCCACTATGATTTATTTCTCCAATCCACTCCAGTCCCTTCCCTGGGGGC
+
,A<??BBBDDE?BDDBFCFF>-EEHFIFC/HC-HHHH.GGIFHA#FFFH-IH.>IHGH2HHHIHEFFHFICDDHFCBHHHHFFIHFH++HHHDHGHIIEEHGGIDHCFHHBFBGEHHHHHFEGHH?EG3F9G4FGDE(G@GHGGE3FE*EEEG<EGCGEEDFAEC6GG6E6GEGG?GEG(#?EGD0EGG:?AGEG?FF:GCAG.:F?:?4<?C'4#/FG,(7A#G<:E*CCCGAE66)AC6EGEE.E'GC
@antibody_215_multiplicity_308_copy_267-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAATTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGAATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCCCCATGTCAGTAGACACGTGCAAGAACCAGTTCTACCTGAAGCTGAGCTCTG
+
?????BB>6<D9@DDDFGGFCF8ICIIHHIIGHHHIFHCFH?GHHAHFIGIC@I@EH5HFIHIGBHGG-HIHHFFGGCHGHHHHHH>FIIHHGHDHAH=CD#HIEDFHFDE=HIHGH-*GHHEEEFHFD8GF8FEEG'CCBFEAEDGEEG/CFEF8:FFEGE(G/ECGEF?GAF/G*GCEGCGEGEF0?DE9#E6.:E*G??EE(FE*F(EECC:C*(EAC:ECGFE*?EGE*CA*?*60/GGE://?1F
@antibody_215_multiplicity_308_copy_268-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGCACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACTTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTCTGACCGC
+
55??=B?BBBBDDBDDFFAF8-FFI/HFHFHHH9IHICF8HHI/IFHH-HD=HGGHH--AGHIIIHHHIIHGHHHHI<C(HF<HIHDHHDH=(G=HEHFDH=HFHDHHE@H?GHHFEH0*@G=@BC(F+EGGFE@CF8GHCF:GEGEGGEGG?G:E?:GAEF3;8AEGECGG*GEEG0AEE6EG1F?AG?EE'GG1/<GEEG?GF(>E0E;FFGEGE(?E?(:?G*C(?CD*<'G/(4F0G-(E*EEEE)
@antibody_215_multiplicity_308_copy_269-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCGCCAGGGAAGGGACTGGAGTGGGTTGGGGAAATCAATCATAGTGGAAACACCAATTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTAAGCTCTC
+
,??<ABBB@BDDDD5DFGFACGIIH/EFIBEIIHIHGHEHIIGHHHDEGHFHHEHCEIHA-I*IFIHIFIFDHIIEF@HII-HHFEHHBFHCCH.HHHGDFHF=HEFCF,>E8HHF.G;CHHE?GFGF6CGF:DFGF222;@EA(AF/GGCGGGGE?G:C((G9AE*GF8(GCD0CFGEEEGCCEA(G6:68:*AEECC?EE8('?CE0#<GHE:A*<::CAAECG:0:FCG;EG;(?*0??(8*:E2C(
@antibody_215_multiplicity_308_copy_270-1
GAGGAGACGGAGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTGCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATCATTGATTTCCCCAATCCACTACAG
+
?????BBB+B+DBDDDGAGBGFHFIHIEHBI>HHHI9=F=GFHHH/DGCCH>HDFHHDIGFIH-HCIHEEHHHDGFEHIGIHHHH8EHFC.H+HHHHH=@3HHH,F?E6+H)GFHDF#HH@HGBFEGEBGFDFE*FG:*G=GGGDE)GEGGGGEGCGFF<E@E?FEGEF'AGG;E?GE;CE+6?E0EEGCFCE>EAGEGEE:CEC*H:E/E;8FEFG??FE.:C?(G:EEF?(8(A:GE**;<:/(**<A
@antibody_215_multiplicity_308_copy_271-1
CAAATTAGCAGCTCACCGCGAGTCGCCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAATTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACCCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTAAGATTGATTTCCCCAATCGACTCCCGCCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTTG
+
??=??B@BD-BDDDDDFFAFFFIH.C>B>HFICHGICHHIHIHHH@H8GHH?DHHEHHFIGHIHFDHGICFHAIEH>IHHHFHIIGAHEHHHFGFHHICH;HEDHHHHGHE?/7)(F?GHGDG.G+GEHH8.FED;1AGFG@G*CG*GGGGF*DFGEEAECCEGGG-G*GE(:A*E0/C*G8FGECF)G(DAC'><GA:G?FGD/((:/C?(E*G:CE;CEFG4F/CECECGCC?ECAGEG8EC:EFG?/
@antibody_215_multiplicity_308_copy_272-1
AGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGCACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACGATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTG
+
????</>BDDDDDDDDEGFE7BHFEIHIIIHHHH9IHEHFIIIGGGCHEGIFHHHIHFHFDG9IIBHGFDHECHHH=IFFFFH@.G7HHI-,F@IEEHHHHHIICHHEH#H7EFCFHD+G?3GFBGGFBFB+;@*DGFFEFDF*GGEF=EECE:GGGFB*AE5DG:GEGC=EFGEEG(=GEEA.G:GEG:F:GGEE(C:GGCCEA(/6*A6E*CEGFEEEG>GE6E::(C0G*EAAECEE(G?*?0(6GD
@antibody_215_multiplicity_308_copy_273-1
GACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAAGTCGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATGAGACTCTTCAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTG
+
=A?A??BB-9D9DBDDFFGGGFF.HFFIHAIH@DHIHEFHF@H0GGHIIHHHI.HHFDHIFFHHHCE5GHHHHDIDHHAHCIFCIDIFHFCIHHFFIHFFE.C2E+E-HFHHE8HDEHGHBHGHF=EEGGG:G(@;+E>FGGECGEEC??;E(GDE,F(GEG(CG=EGFFEFE('ECEGEG+*G(CC*:CGE?(*2:E*(:EEGEEA/?<F3@G(A>CCCGC:6C=?FGAF0.C(G:?(DEEF0EGC(:*
@antibody_215_multiplicity_308_copy_274-1
TGAGGAGACAGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTCACATGGTGAATCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACGCCA
+
<??<?BBBB-BDD@DDGGFGFFHHFE;EIHI>HGDCIDI@ECHIF7IEIE-DHHHIIHDIFAIIHC=FFIGHA-HG=GHIHHDFHIEHHHG6HGICH7H178HD=EHDHFCFEFHHE?F+GH9EE7F*@?3CCGEE.AFGGGE1CAGFEEF2CGEFG.F6?GCEEGGF:EEGEG(G:(EEC:EG(8EG?;.E*E.EC)AEEGE/GEH*EAE/E@GEECEGEEAF8CCEEG::GGAEC?F6EA??G:*AFE
@antibody_215_multiplicity_308_copy_275-1
CACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCCTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTGCAGTCCCTTCCCTAGGGGCTGGCGGCTCCAGTTCCAGTAGTAACCACTGAAGG
+
??<A?BBBDB99DD9DFEAGGG.IHF>I>HHH>IHHHHCAIEDHIEFEHHCDCCAIHDHHHFFICIHIHHIFIDIHHD?5HEF+HHI=HHHHIBF>@IIHHIIGCHEH6FHHH<HDGHEEE@HDEDEF>E<GE;BEHEB+**GG;G6GFE:(F*B*BFEE0F?EGE(G.@G1AGGEE+?AECA?EEAGAG?CEEGD*G?1<:<E*:1E;C*GHC7C.E;CCE#02GE:G)A6:EG?')/:C80AE?'G(:
@antibody_215_multiplicity_308_copy_276-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGATCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTCGACACGTCCAAGAACCAGTTCTACCTGATGATGAGCTCTGTGAC
+
?,???<B9B<-DDDDDGGCFFFFFFHCHIFFGFCI@FGCHHE/?AHIIH/HCHIH-HHHHAI-H5IHFEHIH-+ICIHBFIHHHHDHF+A+C-4H=IEGA=FIAFHEEHFHGDD;+FHFFHFGHFEHEGEFGHFHEECF2GEF8FG;?EEFC1E?EG?/EFFCE?B*EEGGE:CEG9G/ECG#E=:8/C?E6G(G:AGG(EEEG*8E:(HGCEG((07/ECFFCGEE5CE90:F(?(FE*ECC?CC?EEC
@antibody_215_multiplicity_308_copy_277-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTGTATGGCGGGTCCTTCAATGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCCCAAGAGTCGAATCATCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGTGCTCTGTGACCGCCGCGGACTCGGCCGTGTATTACTGT
+
A???=BB?DDB-DDBDFCGFFCHHIHHCIFHIIHCI=IDIHH#7GFHIHGFCH+HGFCHFHFCEIFEIEGII5IIHEGHIII5HIHAFIHHHAIH+E6IHHHFHHEC;HHIHG3EFHFHHEGDFF;FHBEEGEGEB=FDGCDFGE,EAED.G(DDEEGEGDGEGGG-#EDGGGEG:F?E?EE:EGE?DEF;GEGGEFGE<?C60/(?G?H0(@@E?((GEF.DCG?(E:C#E*/F100*A(2C?C:EE:E
@antibody_215_multiplicity_308_copy_278-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCCCCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACAATGTCAGTAGACACGTCCGAGAACCAGATCTACCTGAAGATGAGCTC
+
????A=<BDDDBBDDDFCFEGGHHFHI+FIIHFFGFHHC>D>GHH5DFDHHIF?GHHFH-FGHHHAIDH5FIBHFIHHE+CIIH(FDHHIH6FHH=HHFEHHCHFHHBB5CFH;HHFAGD4FDE**FGFH*EFACIG,9H;DD8EC3GEG>ECE*CEE,=E2E4BG.8G=6/EE<(GA'A8:GEFGG?EGE6*/?CGAEGEE(::;:*E:AGC@@:?8C#7,0:6CE6G</C*1E<A)?.:G'G6:*CCE
@antibody_215_multiplicity_308_copy_279-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAATCCGTCCCTCAATAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACC
+
??A?<B?.DD@BDDB?CE>6CGFAHHFAHIHCFHIGH7GGHHHFAIGFCHFFEHHIFH)IHH>IBIFHIH5HFHIHHFIIIFEEBIBHHBGFHHDIGHHFFH,HFIE1FDHEGCGH-HDHHH0GEDFGHBCCGD*CCEDFFCHCEE3EDECC;D*EFFCEGEGGGG1;AEG'GGAAECGGG;;(E?EAGG#GEGECGGE6?E8/CCCGG?GFE*G:??E@;E:GC':?G(C0CE:(:E'8/F*EGG*::E
@antibody_215_multiplicity_308_copy_280-1
GGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGCTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGATTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTAC
+
<????BBBB+DD<BD+BGFFGCBIHEHFFFIHIH0F@HIGHGEHHDHI+AGIFHHHIFBEIAIIHICIH-EBGHICHH5HHHHBDF)>ICFHFDH8=HIHHDHDHHFGEFE=4.DDFDEEFH7H+GH=EGGC8FEGCHEFEGGEG*GDDBGG1GF8EEB(E0AEFGEGG'EAGAGFCG0G+GE6E??;GE<AFEGCACC:C(E?AC*G:8E?*:CFEG,CC?G:GGE;?8CG:-:EC>CGC/0E?EC(CC
@antibody_215_multiplicity_308_copy_281-1
CTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGAATGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTCTTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATT
+
59A??BB5DD?B+DDDFFGFFFHF/HF-FHIHIIEHHIH>HIFHGIFIFEEHHH8HFFHIDHF=FHHIHE,E5F5HFGFHHHFFGH9I(HHDFEFHI(HHEHHF4HHFFECA+HGFBGFBFDEHFGFFG@*/GGEGGDD<FEDFAG?EEFF,G0GEGEGEEGFEG:DEEGG<C6GE.86FGGGFGE:F09CF6/<(?EEGEC*#E(EE:HA*E7GDG-?(;EFCG*C6G0*?D1?68*GAG<CCCA0ACC
@antibody_215_multiplicity_308_copy_282-1
ACGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTCGATTGGGGAAATCAATCATAGGGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGTTCTTCGCCTCAAGCGCTGA
+
,=??=B?>DDDB?@DBGGGAGF?HFCEHEHDFIHIIF.CCHAFIFCDE@BF>HGH8H.HIHHEFG5FH=HIIHFH*HIEH7HHHDHIIHGIEB@HHC,FEHF=DHHDEHGHHDHGFEFF'(DD@EHGFHCHFF.GEG+FFFFEGE:EGFGGF8.GE)G?((:EF?C06EGG.E?GGCCF8:EGAEGGEE8EEA>?EECF6:E;EG:E<EACGH@8E879G?GAE6E?G0/*?E?0CEGG::?/6E?F)C*
@antibody_215_multiplicity_308_copy_283-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGCCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGCAGTTGGTGTTTCCTCTATGATCGATTTCCCCAATCCACTCCAGTCG
+
,A???BBBDDDDDDDD;GGEFCCIIEIEFHGHHA/IIHGHCFHI=FHCFHGHHHHHIG*E+FHGHIFFFHIHCGFEI'GDHI4FHH5GE6HEGHHIFAFHIED=HHFHHHHBHHFEHGH(GFD>;6<FCFC@GEDF4GCFF@GE>EGG,EGG4?G?C*GEE(GEE88EGEAEF=GGFEGG:GE?(CEAEAG0AFEGGFEG<GA(4>HGGFE6E7CEE*G7CG?GE(EEF<C*:G*?6*:1G(??0G)G*(
@antibody_215_multiplicity_308_copy_284-1
GACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTACCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTTCAGTACCT
+
?????AB?EBB5BBBDFFFFGFCI.IEHHEH/CAFHHDIHH9HIFIH(DBF>HHIHF@E9FI@H*F?GHIICIG-FFHFHHHHFFH#HHEHBCIHCFHH+HHDH=D5FHF7GCHHGFHDBC:EE.1FEHCEFGGE(HEEGGEE8EDFGB#*E6DG;EEECG8*FGEFGG:EGG*G:CE(FE-=GD:GGFEAEGC8EGGCG*6EG:E(E;*CG7EEEGEEE?,11C?G?:?6<CG6FA:CE?(ECEA:E8(
@antibody_215_multiplicity_308_copy_285-1
TGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTACAGTGGTTACTACTAGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACTCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACTTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCCCGTAGTA
+
???,?B=BDB<D@DD?FGCCGCHHEHH,FFCI=IIHH9FEFGIHIHHDFIFF/I.EHHF-+HI=FIH+I+DEFDHFHGHCF*HFIHHHE/HFHHF(G@+FADHHGGHDIFFEF+HFGF:HFHE+EG+GH0C+DHFGEE3E*EGEEE(AG8@CGEDACE7=ED?GCGFGCGAEC.GGE(<C6EF(*6?CECE4GG(?GF6:ECE(EE(0E;EGF@GGC;;0FG<EG?(E04'FEEG:AGA16**)A*G(?8
@antibody_215_multiplicity_308_copy_286-1
CTTGGCCCCAGTACTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCACAATCCACTCCAGTCCCTTACCTGGGGGCTGGCGG
+
?=???BBBDDBD<-DDGFFCFFIH;F,HHCDHGHIHFH@?HGHHGHFF+5HHHHFHIFAHHFDII-HEHHFFCICHGH5GHH@EEH+EICIHHCHGDBHIICF@CHHHDHBHGEDHHDBHF?D'EGFFHDFHEH.FEGDGGEFEGGEF@EEFGGF6E=FEE?E(<EFGE.EAE?GE<;=EGF:EEGF60DFEF:E#FAF;C?E/EAEGEH?CEE/:CGBEB1<2?(16?GAG:*(GCEF/D0E:EGC:E*
@antibody_215_multiplicity_308_copy_287-1
TCGGAGACCCCGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGACTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGAGCGCCGCGGACACGGCCGTGTATTACTGTGCCAGAT
+
A???A<BBBB-D@-BDEG>FCFC0IE>HFHIFCHICHHI-IIG@IHHEFHIH=/HIEHHHFF5HIIHGGHHFHIHHHDI:-HH@HF=8AHHHIH8HHHEDFHH.HDHFFGGFDEG)HH7HEHEEGEBECFGGEDG@FEG,GCE>F@?CHC;D<EGG'GC@E/GGEF8(8G/0:FAGGE8GGA?(G-GG*A8EC6EGGEG*E*8FFCEE*HEG4(#*.G(7?2FG?>E:(E<EGC?E**?/G***-*08*1
@antibody_215_multiplicity_308_copy_288-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTCGAAACACCAACTACAACCCGTCCCCCAAGAGTCGAATCACCATGTCAGTAGACACGTACAAGAACCAGTTCTACCTGAAGCTGAGCTCAG
+
?????BBBDD?DDBDDCFGC.EH>IEIIEH=HIHI@BHH+GHHEIHHCDHFEI?FIFAIHHIBHH@HHHBH(HFEH--IEHFHHHIHI?HGHGHF-H7HFDGF+IHHIHHDF@H@GHHFHDHGGF?GECFGE,4E'GDHE;AGC12'GGEG:EEG.GFE)?:EA?/B(EAEEEDGEEGECECEG'E*F:EGCEAGGC4GGCCE*GEECC?G(EE(E**C;E?F:EE86F80:EE?E:.8FA6G6EG(G'C
@antibody_215_multiplicity_308_copy_289-1
ACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTTCACTATGATTAATTTCCCCAATCCACTCCAGTCCCTT
+
?,?<?B?.DD<DDD-BCGF>FGC>)FCIFIF>IIEHHHHBGHHHFHAHHHHIFI9EED=H9GHIG,G?GIEIHIHIHHH>FE=HCC-HG@DHH,H4.ICHIFFFF5FHH(+DD?HFEI+H;DEGDHGEGHHGEDBGEFFCFGEGGEE@EE*FGDC2@:E38CGEF7C2G*CEG#EFEGG*E(F?C.CE;GGC?EG(G?0ECE9:EE'.EH66'GCA(G,:FGE*EE.C*:6CGAEA/ECGEE)EEC1E?:
@antibody_215_multiplicity_308_copy_290-1
AGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACCGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCATGGGGGCTGGCGGAGCCAGGTG
+
?????B<BDDBDBBDDFFFGFFIIIIHIEIA.FGHH@HFIFHGH0FFHIHFFDBEC>I?FHDF.H5HHIIHCH-IHFEFF-HHEI(HIIHFHIHHHHFEHEHHIHHHE+4H2HEEGEHGEFH0EGHHFBBDE8BE*(@D*C*6+EEFGCA3G?;=G*6E@CGGE;AE<EG?GGCG?GE*:G:(*A<-CAEEFEE:GGE/?EA9EF/HEEHGE/GEC7FGECE?66C*(:8?GEEAAE;*A:(*?GE(/C(
@antibody_215_multiplicity_308_copy_291-1
GTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCGCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGTTCCAGTCGTAACCTCTGAAGGACCCACCA
+
==???<B3D?BDDBDBCG?GFCFFH.HHEHHHHEEAGICD@GH9HHFIGGHIH;DF>HIFFHI-I5BD/FFCHCEFHHCECICI2GECEDHHHFHHGHIG?EHHGIDEHFGHFHHFD)GFC@?,FGG)FFFGHAFE=GGGBDFF=D:ECG*EG=FE(CEEG.DGA*CEG8A:EGGF?(;EG=?GCG?D?G6?GE:<EEFEG.F?)E.?E?(CE<;*:EEECEGC?1E(GCDEE?(E(.-EA/1*AA0E/E
@antibody_215_multiplicity_308_copy_292-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGGAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCATCCCTCAAGAGTCGAATCACCATGTCAGCAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGTGCTCTGTGACCGCCGCGG
+
???,?BA-7D@DDDDDFG6G-FHFFHIIIFEHDIHIIIIII+IHHEE/BFHCHCHAHE.HHECIDHHAHH@HHI?DEFEGH,HGDCHIHHHB#HIDHHFCCGHHGHHHEDD*DHFF9@FGH*HHGG9DEEFF*DDEACCEEEEGE.BE@F@6G*#EG3GBEEGEGA:(EEE6.6GE;:;DGDEEEE<AE8E?EEGC#6CEE(FF8EAAGEGG*CEE*G(G(E1E?0.??E((EEGGC6:?G6:(EGCGEE
@antibody_215_multiplicity_308_copy_293-1
GGAGACGGTGACCAGGGTCCCTTAGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACAGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTC
+
?????-B?BBD<@ADBFCF>?.I/HH0HHIIIHEHFEIHHCGHFHDH@F5DG98HGHHEDHECEHHHHHAEHHIAC?HFHHH4IHHGFDHHI(HBHFHE+HHHFFHHGHI7FG@FBHHF+F>HFH28EGEEGH>9E1GGGG(AC;FEGE-(3?GF:'GEG=GE83EE<CEG8E=EEGGEC)EE=E;CE*(A?GGC*EG?GC?2GEEECE0GEFCG>EAGFB:*A4CCECGE'0GGECA61E/G?CGE;:E
@antibody_215_multiplicity_308_copy_294-1
GGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAGGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGG
+
,???AB<BBDDDD?<BC?B0FFCHEIEI?>ICHHHHGHEI@DEHFFIGGIHHEHFHHHFHHDIHHFC5IGI5HAH)HGG-G-IHHEFFIH+H(IEHCGHAIHDHHHHEE@EHCBF*FHEFGEDGDFEE,=F*GGFEFCGHE;GFDCFG@0CGEEFG=.<@?GA#EGEB?BAGE.EGC8FE?/EFF=EGAE:EEEE8D/EGCGE(#*HA:E(CEE:CGFC;CEG*:C:FEGE/E80E:*.CE0*AG?(E2C
@antibody_215_multiplicity_308_copy_295-1
CAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGAGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGAGGCGGTCACAGAGCTAAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGATTCTTGAGGGACGGGTTGTAGTTGGTGGTTCCACTATGATTGATTTCCCCAATCCACTCCATTCCCTTCCATGGGG
+
?????BBBDDBDD<DD8GGGCGAHIIEHH>B=GHII9GHIIIFHI-FII@IAH0HH+5DHBFIHIHF#AII5HFHHFDHEFHFCHEIHF=GHHE5F+GFBGFDEH4+2EHEHFHH=:GHFHE#DF/GFF=G*E2DA;DCE6F2EEGFEEE.DG-FE8E;FE'F0.*B?CEFEAG.GFGC@AEF<ECGFG#CC'8E*;G?EE*:GG?EE0.GCEEF8*EGGE??EEGEGE*C;0G6*6GE?)EGE:EG?:G
@antibody_215_multiplicity_308_copy_296-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGTGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAACCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGATACGTCCCAGAACCAGTGCTACCGGAAGCTGAGCTCTGTGACCGCCGC
+
??==</BBDD@BDDD-G.GG>+IIBEIHIIHCHIGHI7=GHEI0IE9HEIHFIFD:H?HG9FHHA-=->CGHFFHFHH-IHHEHAHHIHGFHHIEI-FI@HFH+HGEFDFD#5GHC<F4HHEFGEHFEDFFGHEGGGB7:FE;GGGH2B.G;EEGGCCCFGGEGAEE;GGCC:E:8B:?E?:GFEEE**(F(G?G<GECEAG(EA:FFA(AE::CGG/()/E**-'?GCGCGECC/F:G8<>GCE?CECC
@antibody_215_multiplicity_308_copy_297-1
ACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGCACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCACTT
+
5??A9B=BBDDD?DDDFFFF@FHIFCEHF8EHHHGHHH(IGIGHH=FCHIHHFDHHFIGHIHCFEH-HD-HHI-DHAHIHHGFIHIHAIEIH-?DEHE=IEHHEHHIHFHH2E3.,0HBH@9GBCHF'BFHFEFG@EG;HFG*(G6,GGAG;CECEEGEGEEC(???F.CFG<GG6GG1G6((EEC4>AG0GCE(EG;CGE/EGGC*F?8EC:E)G18:C(?CAGC/EGCECE<AEGC?6E*E*GG***:
@antibody_215_multiplicity_308_copy_298-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAAAACCAACTACAACCCGTCCCTCAAGAGTCGAATCACAATGTCAGTAGACACGTCCAAGAACCAGTTCTAACTGAAGCTGAGCACTGTGACCGCCGC
+
?????<BB-DBDDDDBCFFCFGHFCHFFHEHHHEIHFI-FHEIF@GHEI7GFIDH?IIGHDI'IBIFGHFIFHHHH=F++FHFFH+HHIIDDID5=DFH+HFFE=;3DF7DHGGDFGH6GHEHGFHGGDEG,G@EICE@GEEF>2GEGFFDE*>9E6GCEC;E?CG?FCEEGG06*(FGFE:6EC?0E=E#EEDG.A8GFE=EEAGECEE0/F<E7EFEG?EE*9C0EE(AA:6.E*G0EA;G8ECA:?5
@antibody_215_multiplicity_308_copy_299-1
CAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCTTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCTTCTCTTGAGGGACGGGTTGTAGTGGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGTCTCCAGTTCCAGTAG
+
???,?BBBBDEB5D@DAGGGGFHIIFEHHHB>DG@HIHFEHFHHAHFEG@IDGH9F9E>HIDH@HHHHGII=CFHF#DHGFHHIEICFCEI@HHDCEIHHHHH,IHFIH,FDHD?H=EEEGDF@HGEAF=HEGGEGEGGEGAGFEGFFA'#GCE.?=EEGEDAD?G;GFG?F<(AGGGC:GC.?G8E/EGG=C>EE.GCGGFE2FGHEG?GGH):E:FGGFG66.GG:G?-E/E##EGEC:EA-EEG)CE
@antibody_215_multiplicity_308_copy_300-1
CCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGGGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGTCTCA
+
=???,<?BBDBBD9BDFB>FFFH;IIHIIBDD7II9ICHFIIHHII?H9DIHHFHFFAFFFHHFFGGFH(HHIFCHEEFFHEICHHHBI-HDHCH7H3GD4@HHG,HHE8=HE=44HHDGHHHE(FFFFHHF8GFFGCD<EE.GF;GEG4;FG4*GEEE?EEGEAE>3GEA>1C(FEG;C(C-GE4G8EEC:(AG?G*CEEFGG6(EEGH6G::GGBF(0;C??G:EE?6C*(AG4CCG?A/?E?:CG*D
@antibody_215_multiplicity_308_copy_301-1
ACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTTGATTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCATGTCTTACTGTGCGAGATAGATCT
+
<?<?5-BB<ADD?D9DFGFBBAHFEEHFHIHIEHHFHHDIICHIIIHGHFHIHFEHHH>EHHB-FIFCHH-FHHFHHB-FHHE>*HIHFIIAH+C@IHEG?FHH@CFHEF?H=F,>*HHEHFFFFGGFD2HEEGDF*GDE?EDDGEEHC?EAGGGCFFG*GGE;FGGGE:9GFE/EGEE>G.EE*CGG.GGGFA*C8G:F*CEGGECG:6/*<EEA.E:8C/*:C0EE)(C.A*G?EA:(EA.(0G?:CE
@antibody_215_multiplicity_308_copy_302-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGGATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGAATCGACTCTTGAGGGACGGGTTGTTGTTGGTGTTTCCACTATGATTGATATCCCCAATCCACTCCAGTCC
+
???,?BBBDB5DD@D-FFGF/EEEFFH;BE-I@EIHDIGHCHD.HH7.5HH>5HFF8IGDAGCDHCHI8CHDHIEFHFFHAIHDHCHI.<?CHEFFGCEHFIH=H=GFFH@HHHHH?FGCFGE?+HFF+G9EGHFF,.(E*<;H:)FBECE,,G?3GGEGEGAAFGGGGGAG*EG;EFE((+..'?:G.GEEEG#AFG8EFEEG(E*EAEECEEEE)GC0E0GA*GGGE)ECC>?E*C4A/F(GCCCC?/
@antibody_215_multiplicity_308_copy_303-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAACCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGATCAGCTCTGTGACCGCCGG
+
<????B+BDDDEDBDDF/GEFG>+AHHEI.IAIHFGIFEHFHH.IFIGFHHIFIIHGFHFFHHDDIH5EIHHHGHGIGIEAHDHHAC=HIHIH4C(IH6DHHHFEFHCHHGIHHGDHHEFGHEFHFFHEF;BEGFGBEH3EE0*BFB;EFE<E#FEE?C(GE?ADG0FC0GGEGGGE0*(GE:?EGF<66?(EEA/CCGGEEE:EC//E84AHAEE?CGCE0C?EGC1?<*((E8C8?EGCG:A:**EC(
@antibody_215_multiplicity_308_copy_304-1
CGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTCGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTCGCGGATCCAGTTCCAGTAGTAACCACTGAAGGACCCACCATAGACAGCGCAGGT
+
?<?AABBBBBDD?DDDGG>7GFHFIHACIHEEI>EI=HHHIEBAAHHIFI.DGGHF=HHIHIEFIHE-DIGDCHFFCAFH+FIHIHI-EH-HFEDFHGF3FHEHGH+HHFEHH@FHGEHHHHGE?(GHF6+HHEFE-F>G)EGGF@EDEDCE?6GD8ECEFEEFG;;GGCGGGEFEG?(EEC(GEG?EEF??8G('/:GGEEGEAE::G<ECEFC:EFG:C:EE6EE>GE<C?1*EE;)CEF.>CCE:?C
@antibody_215_multiplicity_308_copy_305-1
CGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTCCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGTTTGGGGAAATCAATCATAGTGGAAACACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGAGCGCCGCGGACAC
+
?????B>BBBDEDADDFG>FFGHFHHIEIFFHIIHHIHD=I/9HEIHHHHE+HIF>FDFFHH,HHG+F@DH-EHIHFGF-BH-HGGIIHDCFICIGHIIH=FHF*HHFADFEHG-EHHBG=E*,FHFDGE0HHHDGF@EGEG;DE?FE2G8?C:BG*G;GC?G?;6;GCEEGEG>((GD6GEC;FE6GEAEGEE9GECE((AGE:6E:4*A-EG@CCD;,G((EC8A6E0:EC4<F?'*C*CEE?*8GEC
@antibody_215_multiplicity_308_copy_306-1
TTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATACTGGAAACACCAACTACAACCCGTCCCGCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTACCTGAAGCTGAGCTCTGTGACCTCCGCGGACACGGCCGTGTATTACTGTGCGAAA
+
A?<??BBBDDD@DDDEFGCCFFHIIHI.8HH7FIIIDGHI+FAIEHIIGAA9HH/FFIFFH2GIIFH-HF*HHAHIIHIFH5GFIHHEGBHIDDI5HH=E->,HDHHAEHG3H,FGGBH+EF+FHHGEFGFFHGE@E8DGGGGEHB2EEGEGEFEEE8G?GEGG;A,EEEC?C>FCEGH(GEGC?CGGEE6E:*ACCC*GGC6?FGE<FE?E@:*EE'E:EFFGG0?;EA8DG?GE<E(/A<FGEGC<'8
@antibody_215_multiplicity_308_copy_307-1
GACGGTGACCAGGGTCCCTTGGCCCCAGTATTCAAATTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCGCAGAGCTCAGCTTGAGGTAGAACTGGTTCTTGGATGTGTCTACTGACAAGAGGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCG
+
5???,BB?DBDDDD@DGFGGFEIHEHAHH-HIFCHFH+HEFGIEI.HHFHFIICHDIHHHHEF?GIG@I?FFHDHFEFIH5FG8H?FGIC<HHHHIHD7GEGHHHFCIHCHHG=H6DEF8FGG*@EHGF,@HF,GBE*AC@G?G'<GAEEC*6,*BE*(60>1EAGGGG:2;(A#*EG@(AE*CF1F;8GB?(EG?CG0C(;E.EE2/DC1G4:@GB*7EGEGG.G:DE?(FEEG:?*?GCCFEG/E::(
@antibody_215_multiplicity_308_copy_308-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAACACCAACTCCAACCCGTCCCTCAAGAGTCGAATCACCATGCCAGTAGACACGTCCAAGAACCAGTTCCACCTGAAGCTGAGCTCTGTGACC
+
?????B9BBBDDB-DDGFFGGEI;IEHHIH-CCHHHFHGHIIFDIEAHIHFH*FIIHFHGIHH-FDHHI?FI,HBI5EH---H2FH-I+HGIH=IIFHHEHIDHHFHHHFHHFGHHDHHDGEBAF=3GGF?FFEEDG8;FEHE.FCGGAG?G<E8FE?ECGFGE8BG*E*F**86FE/EGGGF0<GGG-A;'*:E:EC>(E'.E6:?E?HC=F7C)*:G0E01E?E#G6:(E:.>A?E0ECE*?GCAGG?
@antibody_216_multiplicity_2_copy_1-1
GTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTAGTTCTTGGACGTGTCTACTGACACGGTGATTCGACTCTTGAGGGTCGGGTTGTAGTTGGTGCTTCCACTATGATTAATATCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGGATCCAGCTTCAGTAGTAACCACTGAAGGACGCACCATAGACAGCG
+
???A?BBBDBDDBADDFFFG8GFFFIFHFFHAHF9/FIHHCCHHFGA+IHH5FAFH*HFF-IHHDHHHFFDHHI?IFEIFHHGDII(IHFEHEHDHFI-HFDFHBHHHHH)HFFHFEHDHDFFFEG=GG@G+E;HFGGAEFBA?G;F21G'DEE'G@:GGCE(GE#ECGGGE(:FGBAGD?GGGCGGE(EEC.E;FEF/EE*)E<FCE/?/A;(:EG*BGE/?FGECC?E*'F/D*G*E*?GCE'GAG''
@antibody_216_multiplicity_2_copy_2-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGTGAGCCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACACTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGGTAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATGCGACTCTTGAGGGACGGGTTGTAGTCGGTGCTTCCACGATGATAGATTTCCCCAATCCACTCCAG
+
??=??B>BB<BDDDBDCGGGF6HHEIIHHBIFH@ACHFHIG/FIHHGHGDGIE8GGIFDGH>H5CIEHA-HH55FHHIFC=I=FIHIH-BDHEIHGHIEI#+H4<IHHH6(HH<EHHDGHFHEGH:AG4EG4EC>F@GE*GEGGEBGCEE.(CEG?EGGFEEGGGGE8G*:GE6F0CEC(GE*?(GEEFEA::6802G?(GCGAEED.6H00C8CC(*0FEC(GE8'G(:GGFE;A?GCCGEE?(:G)?.
@antibody_217_multiplicity_1_copy_1-1
AGTAGTCGGGCCCAGGACTGGTGAAGCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCCCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCGTAGTGGAAGCACCACTTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTCCAAGAACCAATTCTACCTGGAGCTGACCTCAGTGACCGTCGCG
+
,=,??<BBD<DDDDBACGGFFF/HHIFC8IHA+IHHIC5HFH>'FFDHFI=IG@G>IHF/H-BHIICH+DCEHEECHHH-FIII-F3-DF;HFEFD<HI=HAFHFHH?DHBHG0HGFHGG:GFFHHG4EGADHFHEEGEFEFE(G,E?G@GGGCEG??*F(@(GG(CAGG'@ECACEGE?:E:6GE02G:GGCGGCG<FF6F*F4A6E?FGC@/E:FG?E*:EC1E(.GEG.C#GE?*<EG::8A(A:GG
@antibody_218_multiplicity_2_copy_1-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACAGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAGCCCGTCCCTCAAGACTCGAATCACCACGTCAGTAGACACGTCCAAGAACCAGTTCTTCCTGAAGCTGAGCTCTG
+
5=,?9<?B/BDDBDDDFFCF/FH>HCHCA/IEEIHFIIE+?IIFHHDI/FG:I-CHCHHFIHHAFBGFIHF;HEFDHHCI;HI5HAHIIGEI)I,F+HH+D6=HEG>?CE#D+HEH7*G6FHHFH*HHFFHGF(G)EG;G=;*@6EG?EFCGFBCEB?CGG?FE?DEG?FEEGEF#(E:EAEA(GFE6(G(G6FCC9G>CEG'EEEEEAF*F@CG0:??::?/A0CG?C0G8*GFEE?8*1:GCFEE***
@antibody_218_multiplicity_2_copy_2-1
GGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGGTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCGGGATCCGACAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCAGTAGACACGTTCAAGAACCAGTACTACCTGAAGCCGAGCTCTGTGACCGCCGCGGACACTGCCGTGTATTAC
+
?<??5<B<DD?D-DBDGFC?FFBHFEICIIGGIII+IHAH+EF/.HHI-H#HF@DHFDIE-FHI@HI-#=H+F#5FHHEHFECHFGHIHGAHHHHIFHIFHHFBHFHD0HHF@5CGFHFDBF+*EGHGEH;DFEEBH,E(GDE5EFF)E;CEGCE=8E#EE8G9EECEEGEE?.EGF?G6E/F;CCCE(C?EE;F?E4G;*EFAE?1AEHE3*@BEFG:FBC?)F/?C::F?GCEC'#'EGCG*(:EE8G
@antibody_219_multiplicity_19_copy_1-1
TGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTTAGCTTCAGCTAGAACTGGTTCTTGGACGTGTTTAATGACATGGTGATTCGACTCTTTAGGGACGGGTCGTCGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACGCCAGTCCCTTCCCAGGGGGCTGGCGGCT
+
A?=???B<D@DDBDDDF--FCAHHIFC+IHIIA7FIFHIIIHHBFFHHFH@HIHDH=FH-AHIEHD5-IIIHGHII?HHHFHAFGF8HIIH(GHE@HFCHFAGHHFH+ADGG#HHF7+0HHGHEBCEHFFFHG;GGFEGGFCEF#D>1EA*AG(E:@-8GFGGEGEAE0*CGBGEB6FDE(EG#EC6GE?E;0EG*;0EA8(:EGFH'EAEEHAECGF:@.(E:EC?GE):G*C?#;<'GECCE(/0G'A
@antibody_219_multiplicity_19_copy_2-1
CAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCCCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGTTCAGCTTCAGCTAGAACTGGTTCTTGGGCGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGACCCTTCCCTGGGG
+
A?99?B>>DDB+DDD@F-FGE/IH>ICC+IIII?/EHEGHCHHIH,?A-H=EHIIII==I8=IICI>ICHGFC+EH-FI5C+FI)EIIFIIH8HFEHGCH)HDCHGIHHHH=H>=HF*HH(GE4FGEBCF3C@DEGGEEGDDGBE*@G*2G,G=:CGEE=/FEAGG:GCGEG0E*EE?EECCE<EGEEC:GEG?GG<'FEF?CGGECCG**?CFE/E:E,CEDAG??6?.G1A?*?(CFGEG86EG?;0/
@antibody_219_multiplicity_19_copy_3-1
ACTGCTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAACGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTTAAACCCGTCCCTCAAGAGTCGAATCACCATGTCATTAGACACGTCCAAGAACCAGTGCTAGCAGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTAT
+
?,?<?B@BDD<D<<A+GGCGGFH/HEFHFH+IHH7CHGIFC85ECEDAIGIHHFHGH,-IH-IFHIHEFGHHHHHHI-IIGHHFCEIIEIHIIHEHHHI+EHHHDEGBEF3HAG@EH*BBH+@GGFEEDEEFH(EAD(EFEEEF8F#*F?@E@EC(GGE=?GG?G?E??GGFCECE6CEGEGCG:GG2EAAG?88:CEEEECC(GGE0:.(GHCE2?E?)GE(:G6C?G**CCCCCA*EE6EC0::?EGE
@antibody_219_multiplicity_19_copy_4-1
CCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTTCTTGGACCTGTCTAATGACATGGGGATTCGACTAATGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCGAATCCACTCCAGTCCCTTCCCTGGGGGCTGGC
+
??=?ABB?@DDDDD-DGGAFFA+IHCICEIHCCHHADFFF9CFG,FAH.EEFFEFAFFFHDHIFGHHHII-I5FF;HHIHICBEHHGIIHHDHHH5CCH+?HICBEEHHDHHFH.HEFHEDGFHEDHFEGFFFEGGG5FGD@EG(EGD6FGEDCBGEAA5(GFECE?<EG'(/EG06EE?<?EEE(A??ECAE9GGF:0C.1C:E<?GGH0.7GEGG0::GEE?GC<EFC-GEC/?GC:E??GE:EC8GF
@antibody_219_multiplicity_19_copy_5-1
CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTTTATGGTGGGTCCTTCACTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAAGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGGGTCGAATCACCATGTCATTAGACACGTCCAAGAACCAGTTCTAGCTGAAGCTGAGCT
+
??????BBDDED?--D8GGGFCEFHHFH8FGIIIHH.FFI+FHAFH.FHHDDIGHH;'@BFH'FEHIFIC>(HIAIHCFCIHFI=-HC-HFGDFHH*HH)HI)FH@FFEHHDF,BF4HH;F9FGFE@F.(EHHEEGFG=*FGC1GEFGAD-FEEDG(EE0E'*EEEA<AE?GAE,:/F6C.:/EGEEG0*#F**?EEEGG0.GCEGEGEH8G(@BGG'F(*FF/G.EAEE=GE8?A8*:#GCE(G1GE1E
@antibody_219_multiplicity_19_copy_6-1
GGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTAACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTACTTGGACGTGTCTAATGACATGGTGATGCGACTCTTGAGGAACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGC
+
<???,5B?DDDDDDD<CFAGGF/I=HHH?HFFFH.FIHHF-FHI'EIDI9IHGIFHH,;HHG@-CAFIHIEHE*HEEHHAHGI@GFHAFHI3E<8GDFGIFHHHHD*+HGCF02FFEDGH:GHEGHH#EEHG:FEGGEGG*8;3>FEEHBC4G;EF.EFEGE:GAEG?*G(.G::.GGFG/+'(:EF?GCFG)GFAEEEEAEE<GGAFE*EG3EGA7EE2(C#-CEC(>0EEG>(E:?C(C0GEGE0*?'
@antibody_219_multiplicity_19_copy_7-1
ACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTTCTTGGACGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCATTCCCTTCCCTGGGGGCTGGCGGATCCAGCTCCAGTAGTAACCACTGAAGGACCCACCATAG
+
??AAA?BB--DBDEDDGFFCCF-8I/A50HIH>IH<AFHCFHGEGI=EFHGHAGH-HH8HGIEHHIHICF5HHGHDFIHHG+EHHIH8HHH=HIHHHFFIHGGF*EHFCD?HDFEHD(HHHF*FFG)D+EDGHG?'6GEC4E(DGC6BCG=6E?E*GECG0EF.DG/EGEGG*G<*<AAEAEFGFAGE#<E.GA8?;?G(GFGGE6HGC?CGH:EEEE?EG,EGAG6E:.E*GE(EG(C?:*:8?*G*E:
@antibody_219_multiplicity_19_copy_8-1
CCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCTTAGTGGAAGCTCCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCATTAGACACGTCCAAGAACCAGTTCTAGCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGGGGGAGATAGATCATCGCCTCA
+
<??,?BB?BD?DDBEDGF?G6FIHHI-I6IIDHHDCHHHICHH7IHHHEIFFFF/IB5ID-HGHFHIIFFHHIFHI+FHFDIHHEHHHIGHI@CHGHFFDH+HHFFFFH+H3#FHE@EH)HFHHGEEFGGGFGF@=3FEGFCHFFF*G*GGGEGG=><G*GFEGCGGEEEC;GCGE6GC:GA*<6GCB*AC(**GDGF(C?CE0GEE*E1;AD@EE:1/;CE?EE6.E(0*;EECC;6EG?#:':(EC1G
@antibody_219_multiplicity_19_copy_9-1
GGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTTATTGGCCGTGTCTAATGACATGGGGATTCGACTCCTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCT
+
??A?5<BBDDDD?-DDFGGFGFEHCHIIHHCHI=I/DHH+F=IG@EIH@HB0FFHH5HHH=H@5I=?+HH+=HIHIBHHEEHFHD>FFHIIIH=IGD.GIHG7FFHCGCHHFGCBHEFB2E@H+DHFFHHEFEFHGB?DE*<GFD8EFFGG,GF4?EEFEE=:#G8G*C6ECAD/EEEC<C6?AGCEC(?(EE9EAACCFEG6GA;E'GH:?/EE((<C,ECE6E<D.E(G<'*8?;G?:FEE'6?(8EA
@antibody_219_multiplicity_19_copy_10-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGCACTGGAGTGGATTGGGGAAATAAATCATAGTGGAAGCACCAACTACAACTCGTCCCTCAAGAGTCGAATCACCATGTCATTATGCACGTCCAAAAACCAGTTCTAGCTGAAGCTGAGCTCTGTGACCGCCGCGG
+
??A??B/BB@DD@BD@GCG+CFIIHIIIIFHFIHBIBCHHF99HFIHF>HFECDBH--HIFADFHFAHHHCIHEGADCHFIIH?DHIDIH>DHFHFHH=EFEDBHHEHHHBHHHH,GHDFFEGDGDGF0GGE7.FGG#EFGGEFEEG?D/FGEE?AGGGGFECGF(EE)3:GGFEE:CFEECE(GG?EF0ECGG=EGG(#G:GGGE?/)*EEC;EA*G,G.E:GCDACACA?E?:E(EF*ECE:G>E(;F
@antibody_219_multiplicity_19_copy_11-1
CCCCCAGGGAAGGGACTGAAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCTTTAGACACGTCCAAGAACCAGTTCTAGCTGAAACTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGAGATCTTCGCCTCAAGCGCTGACTACGGTGACTCGCGGTGAGCTGCTACCGTGACTACTGGGTCCAAGGGACCCT
+
??A??B>?6DD@BDDBG0.GGCCHHI/HHHEIIAFH@HICFHFHBHIIIIHH5IFHIFDFIGAHHHFH5DIFHEII5HIIHHHHH-EHGHIF*=<HHGEHHD.GGIFGHEFFH?=GAF?GH9HHB.FHFHFD;FGFFC?DFFGFGG?*CDFBEEAFFGE?G:EGGCECFGGCEE(CE;CGE+8*ECGAAAE8E:1AEFGAEEF.8FCE(HEEHFEE:C,EGEGC#(GEEE(?:FCCC(8EGG:GE(C(CE
@antibody_219_multiplicity_19_copy_12-1
GACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCATTAGACACGTCCAAGAACCAGTTCTAGCTGAATCTTAGGCCTGTGACCGCCGCGGTCACGTCCGTGTA
+
5????BBB9D@EDDD5C8GDGGFHF8BIIHFIHHDFAH@D-FCIIHICHIFHIHFDIHAHFFHI-I<AFCFFHHFGEEH=C<I-IFEIIGHEID;I-C-GFFHHIDFDG3FH@DH7G.HFFFHEGHDG;DAFG:EFEGGGGCF3EE?@E8G*EFEBEF*G(@AGCGEGECFEFDEAGGEC(CEE0GGFE(EE?GCEEGD;?;G(EDAEA(.CCE*ED(B7*#G?G;*C6EECGECE0(:D*?*C*01E6D
@antibody_219_multiplicity_19_copy_13-1
GTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAATCACCATGTCATTAGACACGTCCAAGCACCAGTTCTAGCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGATAGATCTTCGCCTCAAGCGCTGACTACGGTCACTC
+
5A???B/5B-D@DDDDGGG6FGHHIH.HEEEGDIHGHHHIHCIHHF.FE-FHH.DHHE8IHFEHAIBHHHFFIF-FH5H-8AHIC,HHEHHHIIH6IHHHF5+DF.HC=FDCF.6H4GFEABC:@G@9FHGHHG@EGGFG@G;GGAE*G*E*@F:EECE*?A(;*;EG*<G@0G-*;E0*EE/G:??FEGGG8G/:(E/*GGA*GC61*<:EH@E.EGG@GE:(A?:C.AC*?'6>A?CCEE:C0#EGGC
@antibody_219_multiplicity_19_copy_14-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTGACCGTAGGCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAAGTGGTTCTTGGACGTGTCTAATGACATGGTGATTGGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCA
+
???A??BADD@BEDDDGDG;GAIFHAIIHIHIHIIFCHHHGIIFHIIF?HF8IFFGGCFCC+CIIAE@I(HEIHHHHHIHFFHEHDIFGDHHDHHCIHEHH.5HHHEFFD=HGHCF@+HGDECF,GGHGHGF*GDGFF@0GDHEC?(E@G.E2BG:6E0GEGCEEFE:CF?C*?GCEGGFFG:G<:(CG0:CGE/E?EEF?(0A;*FF(ECFEEEGGE?FGD:F2?<C(*;;*AE?CC/E6E?G?-G:F4
@antibody_219_multiplicity_19_copy_15-1
GGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTTCTTGGACGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTC
+
????=>BBDDDBDBD<FGGF;FHCFIHHFACIHHDIIIFFFIHCCHEHH-/HGGHHFEFIGHH-DII*H@E--IDDHHIAHIH,FHIHIEHFIFFACCBIEGIFFDH7HFDEE(EHF?FEF@GEF9FGDGFF;FHFGFFF(GGCGB*EEEGGFF?@GG(0EFFEBF<<AGGAGGEG-FCE=AC'(E<GC?GGGEC?AEEEEC(E:EC?AHGE:<E:'G.A:,?:EGE-C0F6EGEGC86G/*C??:E?8F
@antibody_219_multiplicity_19_copy_16-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCGGAGGCGGTCACAGAGCTCAGCTTCAGCTAGAGCTGGTACTTGGACGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGTTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCA
+
?,?9?<?AB?-DD5DBFGF/A/E.BCCHHCIIEH>9HFG=HGI.HFFAEICFIFF9HHHEIHE5?F@IHHIEIHEGAHHFHIHGFEHIIEEHHHHIIIHHFHIFGEIHHH3FFHHH?FH*G(GFFFEFECDGHDDEFA:EG@GC8G4ABGB*G*EEE*(GBAGAE6G:CGF?:EEAEFEGEGGCGCGECGCG:?.GCG(GGF0.AFCGC(E*HCCGGAC@<G0C::?E8AC.1E8CAEA(E/*EDCEC(0
@antibody_219_multiplicity_19_copy_17-1
GTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGTGACTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTAAAGAGTCGAATCAGCCTGTCATTAGACACGTCCAAGAACCAGTTCTAGCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTGGTGCTCTGCGAGATAGGTCTTCGCC
+
?????BBB6DD9BDB?FGFFFGICH>HHFCHI=GGICFIDCHFHHHHDFEHHAGIIHGHIHFHIHAHIFG>HCF@H#H+F=H5DDI=IHHHDIH5HHHH=BHHF?H@?HBGHHG+;G=H:HGEGCEFH>9*DGGG#FG9C*F2GB8*G@((*FCGGGCG#EGCAF*ACGEFG6GGCGGA8GA:EF)EEAEEGEG6>GCEGG?G.0FE*EH:E:C@'C(DGE/F6*#C*A0#ACGCED.E:)*(:C<:*?G
@antibody_219_multiplicity_19_copy_18-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGCAGCTCACCGCGAGTCACCGTAGTCAGCGCTTGAGGCGAAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGCTAGAACTGGTTCTTGGACGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGGGTGTAGTTGGTGCTTCCACTTTGATTGATTGCCCCAATCCACTCCAG
+
?????=>?DBBDDDDBG>CG+GHH+FIHHIEGGHHBIIHHEIGIHIEGIFFIA@HAFGH5GIGIHAIHIG,CEF?IEFFDHHDIII>FFIFIHIHH+H:(?=DFHEDHHH=GFEFDCGGGF+FDHAHHHHH*,>EFEFE@CFGFGB)=GFGCFCFEEEEEEEEEFG6?EEEG=?F;EFCDC?G0EDG8'CECG0GE*.'EFDE'GC:A6EGEHEFE7EE7'AE#CEEEEE?C9*C*CEAE?<??*0(:EE
@antibody_219_multiplicity_19_copy_19-1
AAGATCTATCTCGCACAGTAATACACGGCCGTGTCCGCGGCGGTCACAGAGCTCAGCTTCAGCTAGAACCGGTTCTTGGACGTGTCTAATGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTTCCACTATGATTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGGCGTATCCAGCACCAGTAGTAACCACTGAAGGACCCACCATAGACAGCGCAGGCGAGGGGCAGGG
+
???A??BBD<DD@D9@FFGFGCHIIFIHFFHHCIH,DHIHHHHHHHIIIHHHI0HHFFEHHIHIHA'(H(HEHC5DH0CHHHHHI;GFGH<EHHEFHEFFE4HIDHC-HFHHCEE,FHEHFFB(3FEHGGD7G*.*GB2FFGCG@FGFDCEGGGGGA?G2G.=F3AFGEGE@FG;GE:E(E;GC(F??#.CG8EE?#?<E6GGGG/HC?ECGHA@G7E87EE.G?E:?*CG:CG8A(0'<EC:E#EC/:E
@antibody_220_multiplicity_1_copy_1-1
CACCGCGAGTCACCGTAGCCAGCGCTTGAGGCGAAGATCTATCCCGCACAGTAATACACGGTCGTGTCCGCCGCGGTCACAGAGCTCAGCTTCAGCGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGATTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTTTCCACTGTGAGTGATTTCCCCAATCCACTCCAGTCCCTTCCCTGGGCGCTGGCGGATCCAGCCCCAGTAGTAACCACAGAAGG
+
<A,5?BBBBBDDDBBDFGF/FGHCHIIFHCHIAH-HHHIIIGHFHHIEGFFIFIBIH>FHFIGGHGID=IC#FHF5HFF-HH)=HC6HEF-HFH=I(7@<IF<E7FFHHHHGFHHAHHG@AGHFCHEC)FEHHEC)HFFGDCEGG:*GGF(8EGFFG0GGFCGEG,EGF?E0E'GE6'C.FC;:<GG('GGE=E?-EGGC:CEGCEAEEFE?:#CCGCDGBAEE*GGFGE:*2GGEA::*/*??*'G(?A
@antibody_221_multiplicity_1_copy_1-1
GCCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAAACTCTGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTCCAAATGGGCAGCCTGAGAGCTGAGGACATGGCTGTGTATTACTGTGGAGCTCGGATGCATGGATATTGTAGTAGTACCAGCTGCTATGCATATACGCCTTTCTAGAACTACTACTACTA
+
???A?B?BD5DDDDDBFFAFGGHFHH;H8HGHIIGHFHHFHGID9FHHIH>HGH-=C>HEHCHH@>FGH*HGFHHGIECI+EGG8HHEHFHFHFCHFHDCH,H+HEGGHHFH+H>;EHF(@*EHEFFGAG)GGFGE*D+F4EC:DEAG?FGDF<;.GGG(EGGCEFGE*GA:CEAG1EEA?AF(EG.AE(A<G:EEGE8#EE6G6CF?/?EAECB:BCE-D(?C8**/E:/6F<6(G(:(?)?.AG?GA*
@antibody_222_multiplicity_3_copy_1-1
GTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGATATCTCATATTATGCAAACTCTGTGAAGGGCAAATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGGGCAGCCTGAGAGCTGAGGACATGGCTGTGTATTAATGTGGAGCTCGGATGCATGGCTATAGTAGTAGTACCAGCTGGAATGCATATAC
+
????,>B@DD-A?B-DFF+BG8EIHFFF.HEIIIH+CIFIHFAIHCHCHHFGIHFFIHI+F@IF@FFEDHCI5FHHHHIBFCHEH5HHHHHAHHGIIHCCHF@HHIEEGBF#E?E=C8H*GG@FDGECFFE-(FFGEH,3;E4EFEFGEEGA?1GEG?GAG=CGG*EC*FE<;EGG(EGE+FG?GEGEGEGEG?EEA8(CGCE.*C(-GHE(EC<A1/,,E(FE=?9EC:0AEGCG;C(:AE:*2EA?EC
@antibody_222_multiplicity_3_copy_2-1
GGGGGACTTGGTCCAGTCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGCGAAGGGACTTGAATATGTTCCAGCTATTAGTAGTAATGGGGATATCTCATATTATGCAAACTCTGTGAAGGGCAGATTCACCATCTCCAGAGACATTTCCAAGACCACGCTGCATCTTCAAATGGGCAGCCTAAGAGCTGAGGACATG
+
?=?,A/BBDDBDDBDDFGFFFGIFHFE0IIIEDHF?IIHFEIHHEEFH7IFHHE@GHFGHFGIHCCHIIFDCEIIHEFDFFH5AIDHHHAD,H=HHEEHDH#FIIEGDHHH+EH@CHHHFH'FF9CEEF7FB78@4EGD;E*?GGD8F;GB0GGE*8GEF06G;?6AFGFGCF.?EEC<EAEF=CA?EAG?CG;E8A(G;EGECGG(AA:(FHF*:3AGD87*0CE?GF:/C.G(*G*A::C*/:0?CC;
@antibody_222_multiplicity_3_copy_3-1
GTGCAGCTGGTGGAGTCTGGGGGAGACTTGGTCCAGTCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGCCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGATATCTCATATTATGCAAACTCTGTGAAGGTCAGATTGACCATCTCCAGAGACAATTCCAAGAACACCCTGTATATTCAAATGGGCG
+
,????BB>DDDDD<BDCG8GFGIHFHHIHECHHIGDGGG.FBHHEIHFHHDFGAHHIEHGHI8=HHFCIHDCIHI>HHHFFHHIIHHIHGEFEFG-IHDHGF3EC.FHH(@=HH#HEHG?=HFEDHFAGG,@@:EE>H?GHE*G@*EEG;GG,ACC?GEGEE8GGF;GEDGEGGE*G(EF:CE<F(EGG;GEG*?EFEEC#E.GCEHCEE8G(G*FGEEF(E>GEEEC6:'6G*):E#F:C(/CG:?G*/
@antibody_223_multiplicity_1_copy_1-1
GGTCCAGCCTGGGGGGTCCCTGTGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGGAAGGGACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGTAAACTCTGTTAAGCGCAGATTCACGATCTCCAGAGACAATTCCAAGAACACGCTGTATATTCAAATGGGCAGCCTGAGAGTCGAGGACATGCCTGTATAT
+
??A??B?BADDDD@B5CC-EGFHHHIIIEEI-CIIHIDH0HAHGFIHHCHI=IHHGFFEHHEHI=HHIHEIFFHIHHFEII>IHHHE0IHHHHFFIIIHHDHIHFHF.BHH7HHHFE<FCGBHFFBEE@B4E+02EGEE,6E;GB*DE:GGG0FCFGF6.G>E(AEE:-.?:EC/GCDCEA?CCGG/GE<GEDEEG/*':8;CFEEE0((F?@:G?(G:D88*EEECGEC*#GCEC*:E*>AAEE:*E:;
@antibody_224_multiplicity_1_copy_1-1
GCGCACAGCAATACACGGCCGTGTCCGCGGCGGTCACAGAGGTCAGCTTCAGGGAGAACTGGTTCTTGGACTTGTCTACTAATATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTTGGTGCTCCCACTATGATAGATTTCCCCAATCCACTCCAGCCCCGTCCCTGGGGGCTGGCGGACCCAACTCCACCTGTTACTACTGCTGATGGAGCACCAGAGACAGCGCAGGTGAGGGACGGGGTCCCCGGA
+
?=???BBBDD@DDDD?GEFG.GCF;FEIIHIFIGDEI,@HIF+GCHH,.IH5IIFIEHI=CHFICHDAHFHHHH5IFHIGHHHGGIGHHFIH6FHDIIFHD<DHHEHDIHHGCE,HDFFHHEFHGA@G6FDDGFBEGHGGFEEGGEE6G*GGEEG9EGGGE60?FCGEBECG/GGG?B.>C(/GCG(/GGGA#GEE?A:EGEE)CC(FG0(:30/E)0EG(E;(EGE'?(E;E??0GA'EC()E10?:<8
@antibody_225_multiplicity_1_copy_1-1
AATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCTCCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGTTCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCTAGAAAAGAGTCACCCTTACCAGGGACATGTCCACAAGCACAGACTACATGGAGCTGAGC
+
<?AA?B+?DDDDDDDDGFCCGCFHHEBHHHIHFIHBGHFBCI>IDIFIFH9=HGHFHIBFGB-H5HIGFEHH?HHFHIE#HF=FIHHHHIIA?IICHHHIBFGE=+HHIHHGEHH@GHHEGGFHGE)DDGDE1GG?GEGGDFDFECG?*EEFC(EGEEAGAE@CC*E?EE1G:EEFGCGG(EEAE0A(EEGG:*AE0GGEC*DEE*AAC?;CHGGC(8CEG:E.?*FC(E6AGE.AFCG:G2EG*E:/GG
@antibody_226_multiplicity_5_copy_1-1
CCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGGGACAGGCTCTTGGACAACGCCTTGAGTGGGTAGGATGGATCGTCGTTGGCAGTGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACAATTACCAGGGACATGTCCACAAGCACAGGCTACATGGCGCTGAGCAGCCTGAGATCCGAGGACACGGC
+
=?<,=<BBBDDBDBBDFGFGFGIFFFFHFHHH+HHDIHICFIH+@HGHGHH7HFFIHHF5D-HDHGGHCGIGEFHFA+BHIHHG7@GHIIHBIHFH)IFCFCHHHC+HDCF.H<G(D*H?HFEG5GE8FGDH*HFF?FDEGGEGG*G3.EAG0EG;C?A(*E(/EEFG@,>8GFGEGGGG?+GCEEE*GG*GE.(5FFG*G::EG8?FG0E<:CEG/?(#:,GG6G('E(*C::18CC(AEEF'6CG>GG
@antibody_226_multiplicity_5_copy_2-1
GTAGTAGTTCGCGAATCCCCAATTTAGTAATAACCACTACTATCATACTAATACGGCGCCTCCTTAGTTATAGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGCTCAGCTGCCTGTAGCCTGTGCTGGTGGACATGTCCCTGGTAATGGGGACTCTTTCCTGGAACTTCTGTGCGTAGTTTGGGTTACACTGCCAACGAGGATCCATCCTATCCACTCAAGGCGTTGTCCAAGAGCCTGTCC
+
???,?>-BDDDD?DBBFGFFGCHFHHCIE,EIHII-7IHIH=HHI95E.HHHIC5FHDF-EHIIHIIHIFFGH?CGCEHDIF+HH:EFFHGHFFHIFGHDIIHF2IHDDHFC+F+GGE+H.FFFH=EBF'EFHB)*@GCEEGFECFAG)BG0GEEFF(GC(CGGEG(GGABC3((EF?CFECGAGC(ECG#D?GC'GDGGG::G;;C#EHE0;EC9(EGCCG'GFCGE(FCG)FG;*::E8*GCE?EE(E
@antibody_226_multiplicity_5_copy_3-1
GACGTCCATACCGTAGTAGTAGTAGTTCGCGAATCCCCAATTTAGTAATAACCACTACTTTCATACTAATACGGCGCCTCCTTAGTTATAGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGCTCAGCTCCATGTAGCCTGTGCTTGTGGACATGTCCCTGGTAATGGTGACTCTTTCCTGGAACTTCTGTGCGTAGTTTGTGTTACACTGCCAATGACGATCCATCCTATCCACTCAAGGCG
+
,??????BDDDD@DDD>GFFFFHHEFIHH@@IHIF+@HFIFIHHHFII-GCH+IFEDEH-FIHIHAIIIDIC<FHIHHHHBIFCHIG7BE=HCIGI6EHIHH=H-HGHGDGHCHH+HE:*GCFH=+GBEF;HDBFE3;;FEFEFFCFEFGEC*8>=;*EEFEE*G6DGAEEG?GEG?:E(((B.6E?AEFGA?CC4EG*GCEFFE:EGC:(C;AEC(GGEEG()=A8';:GF(ECEG<E?CEGG*C?.A:
@antibody_226_multiplicity_5_copy_4-1
CCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCCGTGGGTGGGACAGGCTCTTGGACAACGCCTTGAGTGGATAGGATGGATCGTCTTTGGCAGTGTAACACAAACTACGCACAGAAGTTCCAGGAATGAGTCACCATTACCAGGGACATGTCCACAAGCACAGGCTACCTGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGA
+
<????B?B=BDD<DD<FFAGF>IFIIHHHCHII-HHHIDIDIGFCBFHHHHDHHHHHEEEGI?F+H5HHEHI55CEDH,IBH@IFHGI;HDHHFIH?6HHFDHFEHHGGHFHFGFHE)HFH=,FF+EF:HEE@9HE(F,EEE@G1GGEGGGEGH;C*E(:EEFGEE@E?C5FGBEG/ECG?BC6AEEC:EEG(<EEGG:6:AG*FE*G*CF?H:C:G.E.E:GFCCAA?EEE*CEG/FE8:AD6E0AE:2
@antibody_226_multiplicity_5_copy_5-1
GGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCCGTGGGTGGGACAGGCTCTTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGGCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACAC
+
??A????<D@DDDDDDFGGGGFHEI/CIHIC/H9I9FAC0FHG@GGIIFIHFEDHEEH.IHCI>EHCHIFHCI=FFHEFIC?FGF+HHIHHG(HHDEHHC?GF:HHG=+H4C/FHFFF=EDGHDDEFF;EGCGAEEHGE(GF@G.GDECEGE?FGE*C8:GGEE:G)8FE:E<CE?AGGECF?EA8:CEAEA?*GEG(EEEG;G<G6EF(?8FEG2G/EAC:FG?F?:G.GA(6<:*CGFC:*>G(CE.2
@antibody_227_multiplicity_4_copy_1-1
GTAGTAGTAGTTCGCGAAGCCCCAATTTAGTAATAACCACTACTATCATAGTAATACGGCGCCTCCTTAGTTATAGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGCTCGGCTCCATGTAGGCTGTGCTTGTGGACATGTCCCTGGTAATGGTGACTCTTTCCTGGAACTTCTGTGCGTAGTTTGTGTTACCACTGCCAACGACGATCCATCCTATCCACTCAAGGCGTTGTCCAAGAGCTG
+
??,<?BBBD@DDBD?DGFG.FF/HHIH@>HHHHHIFDH0+HHHAGHHFFGGH:GFHE?HFIFAE=,HFHHFFFIHIHDDIHHHIDAFHE8I:G@FHAIHHHCCH8HHHHHHHHEGHF#FH4EHFFB4G;HFF=GEBE@GD=E1GGFGDF?6GFGB?:DGACEGE:EGEFFGGA*G<FEECGF:CEEEGGE8?62G?EEGAAG?E'0HEEE6D@A((GEGG?.6C:*GGEG>*GEGGGFCC?F/E60G0GE
@antibody_227_multiplicity_4_copy_2-1
GAGGAGACGGTGACCGTGGTCCCTTGCCCCCAGACGTCCATACCGTAGTAGTAGTAGTTCGCGAAGCCCCAATTTAGTAATAACCACTACTATCATAGTAATACGGCGCCTCCTTAGTTATAGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGCTTGTGGACATGTCCCTGGTAATGGTGACTCTTTCCTGGAACTTCTGTGCGTAGTTTATGTTACCACT
+
?,A<?-BBD+DB-DDB.GFFFBCHIBHH/IGF.FHIF,HD-HH5?CFA>IHHIIAH.HF=HHGH=IHGIEHIHE-IGG-HEHAEHF>H>GIIDEHEDFHDHGCGHDFDHFH*BIEHEFGFHFE9G*E+EBC9GEFEFHGEDEEEEGEG;3C,EF;CFEE1GF?E6G.GGG?;CFGGD?GEC8FGGGAEEGECDG(EF/CEGFF?CE?GG4E:@@:8:EEGBA:G=:E*A.E?GAE?**?#:*6E?AGE/E
@antibody_227_multiplicity_4_copy_3-1
CTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGATGCGACAGCTCTTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACAAAAACTACGCGCAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCAGAGCAGCCTGAGATCCGAGGACCCGCCCGGGTATTACTGTGCT
+
????<B=BBDDDBDDD+FC8FGCEEHIIFIHIFFGGDHCHGAFHHFCHIFHGAHHFEGFHF5HHF.5HHD55FGHIIIHIFDFH-8IFHFIIGHHHHHFEIGFEICEHCHHG6H5=,+FGEFGH,EGG.6**FEEFFFDGE'DFGEG*EAFGFEGGGEEGEEG;G?GEG8CE8G<6<):FAGE*?DG.'AGEGGGG.EE*FGEGEG.GG<E<:A@EG:EGEECDC?CD()EF(?EE:GE:6ACAG(*G6E
@antibody_227_multiplicity_4_copy_4-1
GTCCCTTGCCCCCAGACGTCCATCCCGTAGTAGTAGTAGTTCGCGAAGCCCCAATTTAGTAATAACCACTACTATCATAGTAATACGGCGCCTCCTTAGTTATAGCACAGTAATACACGGCCGTGTCCTCGGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGCTTGTGGACATGTCCCTGGTAATGGTGACTCTTTCCTGGAACTTCTGTGCGTAGTTTGTGTTACCACCGCCAACGACGAACCATCC
+
??<??BBB@+DB@5D5CFGBAGGEIFIFHIIFFIDHIIE0IHF?HIAID+>FIHHIIFDGF.IHI-EIIHIIDE-+ACIFC;HBHG5HIE+CFIHFI=CHH<HHFHHG3HIDIHFGCF@1H@D@,6FH@GGGGFGCEFGFEGGEFD:GGCGGE;GEAEEE?CB2**CEF?<=.6GFEGEC;E8FE/?GEGCG:G'?GAGEE0GF<ECGC*:EEAC:EG87EE*GC*6?C/G0:EGC???GCEE*.6<E*C
@antibody_228_multiplicity_3_copy_1-1
GCCAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAATCACCATTACCAGGGACATGTCCACAAGCACAGACTACATGGAGCTGAGCAGCCTGAGATCCGAGGACCCGGCCGTGTATTACTGTGCTATAACTAAGGAGGCGCCGTATTACTATGATAATAGTGGTTATTACTACATTGGGGACTCGCGAACTACTAC
+
?<,?=<BBDDDB5DDDGF7-;+EIIHHHIIHH>ICFIHIIAF>CIHHI.HI?H9IGHHIHHHEHGGIFAIEEAFG+I=IIHH<HHI-HH-BCHGHDIHH6HIFHEHHDHHCHFEDDEDHHEH=9E(EEG+EEHGDCF6EEGF@@*EECGAB:?EAEEE#AFEGF=.GG;EA(:E?;*FEG(G(;??GGGG*EAG?EG?C8FF:G?D6A<F;?E@E(ECGECG:GFEAE#G(EE9E(EG?*EEA<).?EE6
@antibody_228_multiplicity_3_copy_2-1
GTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGCCAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAATCACCATTACCAGGGACATGTCCACAAGCACAGACTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGAATTACTGTGCTATAACTAAGG
+
?????BABBBDDDBDBGGFEFFICIHH./HIG9HHHH9EIGBHIFHCFHHHCIFFH.IH;HHGHGCF-DHIHHHHBBHGHE5IDHE-HBIHHH=G8EH@HG)CDHHFHGHFH*F;FH?0H+GGGH8G:HGFEGGGEF;C@5G48A?FGDFGEEE*@EGCEE**EGG*EGCG*8G:C2GCEE<G(G(>CGE(CF*(EG*:GC(GEG*(*GCECEECCEFG@CGG8(GGG(.EA/C**E/2CDF*;?EG(?F
@antibody_228_multiplicity_3_copy_3-1
AAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGCCAGGCTCGTGGACAACGCCTTGAGTGGATAGGATTGATCGTCGTTCGCAGTGGTAACACAAACTACGCACGGAAGTTCCAGGAGAGAATCACCATTACCAGGTACATGTCCGCAAGCACAGACTACATGGAGCTGAG
+
?????BB?BDDBD-DDGFGGFGHHHHEAIFFEHIHIHGCIIHFHHI8HGHHIHEHDHIFHFHIIGHID55CIIHHHFHFIF5IIFHC=HHHIEHHHGHIHHBFHH+E9HHI7HH/4EDBHH+H5HFHEEGH;HEGFE.G2GG>EEAE#EGGCGFEFCB(F4GG0AEGFFEGE@'GG?EGG?G6*EEFGGFE*EC8'*GEFDE;GE:EGEEE(CF.*BG'@EEC?(E?*E-G0E1(4?E(0?E6(A<*G8*
@antibody_229_multiplicity_5_copy_1-1
CCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAAATATTTTAAGCATACCAGCTGGTACCAAGACAATATCCCCGGATTATATCTTGCACAGTAATACACAGGCGTGTCCTCGGGAGTCACAGATTCAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTGGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATACCACTTGGACCTGCAGTATGTCCTTCCCAGCCACTCAAGGCCTCT
+
?<??ABBB++DAB@@-GFGF>GCCIEHBIHHFHDHHHHHHHII89@=IH0FH+HIIIF4H-H5HIIHHHIFEIEFIFFH=GDIHIIFHFGGFDHDCFHHHHCBHFGHHHFIFHHHFHEDAHGF.CHCFF2EDCFGG=EF6GEEFEE;CGEEF:4GDG*'E6EGC8F6A?GE<B(GGE(8CEE8EGG*F(*=6E*EFGE*.CE?GE:E.:HEFEEB?EC/EEAG1CCG?:(AECGD/*::=6G/FEC1?.;
@antibody_229_multiplicity_5_copy_2-1
GCAGTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCACCAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAAGTCCAAGTGGTATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAACCCAGACACATACAAGAACCAGTTCTCCCTGCAGCTGAATCTG
+
,??A?BBBD<DBB5DD>CGFFFCH+IHHIHHIG@IIIGHFHFHIF+GGBCIHHBEHIHBHFHHHIGHHIG+FHHEBHHHHIHHHHIFHHHH8FCIDHHIH<*IHHE-C5HH4DFH2E=H6GE@*F2D@GDGGDGGG*G38E.?GEGG'6F2G#AGEC1F/CEGF?EEACFCGGEECEDCF/EE.GAE6EA<GG:E/G8C;GG1EDF*4:CG?(CCGG0(AC:>ACGC>/(E*GEEACGEG?C:?*E8*(:
@antibody_229_multiplicity_5_copy_3-1
GGAGACGGTAACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAAATATTTTAAGCATACCAGCTGGTACCAAGACAATATCCCCGGATTATATCTTGCACAGTAATACACAGGCGTGTCCTCGGGAGTCACAGATACAGCTGCAGGGAGAACTGGTTCTTGGATGTGTCTAGGTTGATGGTTATTCGACTTTTCACAGATACTGCATAATCATTATACCACTTGGACCTGTAGTATGTCCTTCCCAGCCCC
+
???A?-7BDD+DDBBDCGGFFCH/IHCIFIHCFIAIIDFI/FF+HHGHHFF=HIAHHEFIBICGHEFHGHFH3HHHH#HDFIFIIHHHIIH+HHGG+H+GGF.HAHDHHHHIHEHGHFBGDGG.F?FFHF*EH2(9FBGC.GCG*@EGFEEGC@*GEECC6CG.EG<:6(E;GG(G(EFF/?EDEFAG?FAC1;EE/FG<G?CE4EC8(8G/CEE*?',EEC/GEECGC?0:EEGG8?0:E*?0E*:.*<
@antibody_229_multiplicity_5_copy_4-1
GTCAGGTCCGGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCACCAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTGCAAGTGGTATACTGATTATGCAGTATCTGTGAAAAATCGAATAACCATCAACCCAGACACATCCAAGAACCAGTTATCCCTGCAGCTGAATCTGTGA
+
,,?<ABB@BDD5DDDDCGGGGFCICFHHCFEEGIGFIIHCH.DFFH.HEIE>EG7GIHA5CFFHDHI5HHD-HFFI5FHFFIGHFHDCFFEHHHDIE?)HHDHDHEDHHH=?HGH+B+DGEFB68E*EF+CBC?EIEFFAEGE=E@@FBEAF#EG2GGEEGGG9#<6EGGFCF6E6CGGE?/A?E6CE#G*GFG(F*6<G((AE8GHEGE<.HEBCGG(GG,EEGF?(#E((E?EG?EC2?G:8CEEAEE
@antibody_229_multiplicity_5_copy_5-1
GTCAGGTCCAGGACTGGTGAAGCCCTCGCAGACCCTCTCACTCACCTGTGCCATCTCCGGGGACAGTGTCTCTAGCACCAGTGCTGCTTGGAACTGGATCAGGCAGTCCCCATCGAGAGGCCTTGAGTGGCTGGGAAGGACATACTACAGGTCCAAGTGGCATAATGATTATGCAGTATCTGTGAAAAGTCGAATAACCATCAATCCAGACATATCCAAGAACCCGTTCTCCCTGCAGCTGAATCTGTGA
+
???5?BB@D+DDD@E-FFFFFCHHIHIHICIGHGHF9BHHCFFHHFHII@EGFI5DHIIFCHHH5CAAFIHGC-EHF-HEBIIHIIHFIHH7FHIFH,H-HDH-DHHHHFH+EHGAHEGGHEGDHFGFFBFEEAEG*BDGFCGH7E;GGGEG;2.0FGFA#CFEE?;EEEE<GE;((CGG:?EACFD.E:CEE1#;A9GGGC8E(CF)GEG*'ECA?GCG7G?G*?-CE*C?CE/D0GE)EC.E6C*CCE
@antibody_230_multiplicity_2_copy_1-1
CAGCTTCTGGATTCACCTTTGGTGATTATGCTATGAGCTGGTTCCGCCAGGCTCGAGGGAAGGGGCTGGAGTGGGTAGGTTTCATTAGAAGCAAAGCTTATGGTGGGACAACAGAATACGCCGCGTCTGTGAAAGGCAGATTCACCAGCTCAAGAGATGATTCCAAAAGCATCGCCTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACTAGAGATCTAAGAAGATATAT
+
,???,<BBE<DDBD@BGGFFGGI>IHEIHEDHHHIHHHHHIIF7HGFFCH.IHH-FGDE-HGHEIH+GDH))GE55HFGI>HIHFIDHDHIH,H.I54FEHFE7HF@GHHGH@FHFFHDGF=FFGFEGFH*?EDC;FEGE/BEAG<G?6*GE;D0GGEEEEEFGGH*ECG:E*EFGGE(GEGEF?EE<:6GFGEEFDEAGCECC::?(E?';@C(E7EGAEE/D:E<FAEEG<8ACAFE64ECC6C8?06
@antibody_230_multiplicity_2_copy_2-1
GTCCATACCGTATAGTAGTATTATTTAAATGTCCCGGGCCCCAGTTAGATATATCTTCTTAGATCTCTAGTACAGTAATACACGGCTGTGTCCTCGGTTTTCAGGCTGTTCATTTGCAGATAGGCGATGCTTTTGGAATCATCTCTTGAGCTGGTGAATCTGCCTTTCACAGACGCGGCGTATTCTGTTGACCCACCATAAGCTTTGCTTCTAATGAAACCTACCCAATCCAGCCCCTTCCCTGGAGCCT
+
??<=A?B<EB@BD?DDEF>FFGHIFFIHIIFCCHF@IHDIIGBHHI>HECDI0IHGDG0-FFDGIHHHEHGECHHHHIHI?HHCHFHIIHID@DH,HEH5<CEEH?+F3GDBDHEHD-H@HHEH:9HHEGHEGDGGEG0EDCFF@4FE;EFGE6GE?GEFEE;CG(4>G;G?EEGFEE?F6'FE/E:ACF(G::A#:E:/E(A;C?(.G?G*@EEC9GGEEGEG/*G?E.C?/GEE:EE0(E8=:(GCGE
@antibody_231_multiplicity_3_copy_1-1
CAGCTGGTGGAGTCTGGGGGAGCCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGTCTCCAGGGAAGGGTCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGTTGGGACAACAGACTACGCTGCACCCGTGAAATGCAGATTCACCATCTCAAAAGATGATTCAAAAAACACGCTGTATCTGCAAATGA
+
?,????<BBDDDDDDBGFFFFGIFH>IEF6IIAIDF.FIFAHHIIEDHIHFHGAIADHFHHFGICHCD-AHCHE-HHEFHIH5FIIHDHIHFFEAH(EH.GFDBHDHDGEHF/HH(HFCFF*HHDHEDDDEGFFHDGGFE4EG<DG=AAEGGEEEGE*1GCEF#6EB*DGEECDFG=G*EAG?FCGE(GEG?6E??:EAEEG;*?(HEGH4:FC(8?E:<:7EAFGE*C0E6**:A*/-(*::GE>//(?
@antibody_231_multiplicity_3_copy_2-1
CTGGTGGAGTCTGGGGGAGCCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCCGCCTCTGGATTCACTTTCAGTAACGCCTGGATAAGCTGGGTCCGCCAGTCTCCAGGGAAGGGTCTGTAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAATGCAGATTCAGCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCATATGAACA
+
5A??AB<9D?D-DDDBG6GFFCEFBHCFEIHFIF=IDDIHFIHDF?HCAHHHH5*IHBC,AIF@DFIGHIAIIICCIHFAEDH+EHI8I>=7,GCEHCHG=HFIHH@HFGHHHHH.FG=EGDEGGF+FGG/HGEGE?*BFE?CDG*EBFEFEG,;EF?,E*8EGFA@GCEEGGG?EGFGE=EG*E6EACEGCGA<CEEA*0G(GE?EE(E:;78@GBG:GE1>?CEG81::</;:GEGCEAF(E*<CA:G
@antibody_231_multiplicity_3_copy_3-1
AGTCTGGGGGAGCCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGTCTCCAGGGAAGGGTCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAATGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAAAGAACAGCCTGAA
+
?<,???B5D@DDD@DDCCFGFGEIHI8HHFIFHIH.CF=9HHHGHHFIIIIFIBEFIF5GHIHEIFE-HF>A+IHIGIHFIHHHIIAIFCF4ACE+HH5CICF'4IHHHHHHEGEDGF@HGF)HGEHDHHEH<GHAGGGFEGEGDG2GBAG)GGGEAGG?GA;G988GGGECF*:*G@(6EG8CG*'8GGCE6EE?FF?EE#.C(?DGEE(:D:EC?EE8C,GEEC*C:?:(??AAE(;?D?E0E<E(*;
@antibody_232_multiplicity_1_copy_1-1
TCAACTGGTGGAGTCTGGGGGGGGCGTGGTCCCGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGCTTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCCGGCTCCAGGGAAGGGGCTAGAGTGGGTGTCACTTATATCATATGATGGCAGTAATACATACTACGCAGACCCCGTGAAGGGCCCAATCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGC
+
,??<?/BBDDDDD--DFFFAGGFHFHFH6EF?.HEGIEGHH9FC=FHHICHII5HEHIIHAFHB-,HIDIEI-H@A?HH;IG+IHHDCHCIHGHHHHFFIFHHFE+HFHEGHHGHEBHFG,EEF4</GFEGG0FDEFGGE=E=(.GDBGGGGCCCEEE?#GGGGE:C:*?E=FG>GEE0CE/<GCEBG(EGGEGG0#:?(D#><GE/C8:GF@8EGG.EGEEG?CECCGGCCGGEEAG6E10AC?1?::6
@antibody_233_multiplicity_3_copy_1-1
GACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAACCCGCGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTGATGGTGGCTCTGCCCTGGAACTCCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCCAAGGGCC
+
?????>@B<DBDDEB@GF>GF/HFHHHHHHH>EIIICCHFH7IH/CHHGIHIIBEFII8GFHHHHFHIHDAEEIIFAHAHHHHHII8HHBDAIHHHCEGHHH+HHIAHHEFFI+AHHDGGEHHEGFHGHEFE-FCFFEEEGGGGG2EGC?EG0E6G(.EGE;CEGE?C0FGGEFEEG9E8C+GEE/<E8GDE/G>GEE?E<.EGG0EE?)GE/G:EGC8/BEGCE/C6EFG(GAGEDC?#C:EE*(?*CE
@antibody_233_multiplicity_3_copy_2-1
TCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTTGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGGAGTTCCAGGACAGAGCCACCATAACCGCGGACACGCCTACAGACACAGCCTACATGAAGCTGAGCAGCCTGAGATCTGAGG
+
?????/BBB@DDDDDDGCGGFG?E?HH8HF9I7HHHHFF-H.HIH9HFEHCHFEHFIEGHHHFHD>BIGGIIHGIAHHHHDHFHAD+8HHHC@IIF=3EHHDH6HGDCBH+FHFIHG*HCFFEGFD.FEE@HFG*BCBEE8EGGGGFEGEGE*@>EEA=GEDG<8GEE=GGCEG:CGG(FAG:C4C'FF:FAEEEGE*;G*::E*CHG:(EEHG(*:(G(:E?G:(EG*(E08(E<AE6EEG>EE?G'AE
@antibody_233_multiplicity_3_copy_3-1
CCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTTGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGGAGTTCCAGGGCAGAGCCTCCATAACCGCGGACACGTCAACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTAGTGGCCGAAGCTGGGTATAGCACTGGC
+
<,???A<BDD@DDDDBAFFC/EFFIFICIEI9FAFIHHHGIICHGIIHHEHHH@IGFIHE>GFFHHF5B-G5IHHEHHICIHHHIH-EHHHHDI-HHFHHFFIE-HHHDFHCCGH.DHEHFHFGHFFFHEEEGEFG(BEAGEE(1?.E(E@ECF?@?GG:=CE(F?GGED(AGEB#FCCFGE<:AEDE?AGEF?ECEC;0G?CGGGHE<8;0HE@:*GGA:EG((CCEGFEG.:EG.AC?EGCC?(GCGF
@antibody_234_multiplicity_13_copy_1-1
GTGAAAATCTCATGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACAGAGCCTAGATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGGCCGAAGCTGGGTA
+
???A?BBBDD<-DBB?FFGFFFIHHHBEIHFFIIFHI8:EHDEGHHH@IGHF@FIHC8IAHDFH+HDHHF5FHFI5IGCIIHFAEEHGFHH+I+HIHHHG@HHH@HH@DH<DHFE*HAF@H,BH/GGGFFCGE;EEG;F;5GEGBGG*HC@GEEFE>E@G(EECFGGE6EG?C:1EG(FGCGGGCE?E-EC0.(EG'CA0*1AC?E0?EH?GH8F:G*GGE?*EAECA*#C/.(EACFG-E0*C?GG8(G
@antibody_234_multiplicity_13_copy_2-1
CGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGGTCCATGTAGGCTCTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGCTCAACAAGTCCCATCCACTCAAGCCCTGTTCCAGGGGCCTGTTGCACCCAGTGCATGTAGTATTCGGTGAAGGTGTATCCATAAAC
+
?5A?<BB3DDDD<D?@FGCFGFHHF.IIHCI=FIHGHHHFGEIHA.HHHICHEHFHHEGEHFFHB+DHHH5II#F4-BHH9IHFHIIHEGHHIBH+CHHHGHHFH;FHDDHEBEHHDHEF@AE+EH,FGGCAGGFF*4EBDCFEFEEG5GEB/GCEGDGE@?F(8BF:E?EGE6C?EG:EGFGGE???F?G(EE)EGFG?(A6EEEH/C*G:FG/?0AEGECG;(((GEG:E?A?#*:*C<GF0E'C'?8
@antibody_234_multiplicity_13_copy_3-1
TCAAAGTCGCGAATGCAACTCGCGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTCTGACTGTAGGCGTGTTCGCGGTTATGATGATTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCACGCCCTTTTCCAGGGGCCTGTTGCACCCAGCGCATGTACTAGG
+
?????7?B-DD<DBDBGG?@FF/.IHI+FIGIHICAIG?IIH-HIHIHG8HIHHIHFIHIH-HFIIFHEHHA>HH.EHHHIGHGEH7HHHHFHFHHC<FGH=HHHFH=CGH,IGFDCG*HDG@+(HGAH.GF?ED*G;:*F*0FEEGG<HEEFGEFF;GE?E?DGEEGGEGEEG6<E1*F0E8GEEC:GAG2G*EGE(ECEEG?C*E(8EE?@G0GEE.C'GEG*:GE<E6(6/?E8#EACAF(?(G*C*
@antibody_234_multiplicity_13_copy_4-1
CTGGTACAGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGAATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATACCCGCGGACACGTCTACAGACAGAGCCTATATGGAGCTGAGCAGACTGA
+
????,BBBDDDDD@DDGGG->GIAIFIAHHCIHIFHHHCHDIC08IHIHHIIGHID5IFHHHH,FHG,HHHHHHHHHHHFDFDHCDID=FIHIFHFBCFHHHFFHD:DHHH.,HHC:HFC@DH9GFFGGGFFGH1E?=F*GC1G?G1CFEEGGEGE*ECGAGE.GEE/G/4EC;DE/EGF0DE(GEEGGGG?G?AFGGGEG(:?:EH?:H.A@EB::'::G,CGAGE<FC(EC8/E'*.8(9E?(*E:*(
@antibody_234_multiplicity_13_copy_5-1
AGGTCCAGCTGGTACAGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGACAAGTTCCAGGGCAGAGTCACCATAACCTGGGACACGTCTACAGACAGAGCCTGCATGGAGCTGAG
+
?95??BBB@?DDDDBDGFGDGEIIFCIIEIAC4DIFAHEFIBIHHCGFIDHHGHGIHEH-DICE=;HDHIHHIG?HHH-HHHCEFHB?+ICDHFHIG?BDIHHHCHGHFGFDDGGGEHHEGHFFD9EGCFH@CG:EFFC2@FDECG8EFGGBGEG,F;GGGG6(E?E6GG>9EEFGEGE:FCEE(?EEECE<:F?E(GGGE//6EG(<EDCA((G(?CEGG?/1*AG/:F*GG8/E*1(EEC6EC0F#EC
@antibody_234_multiplicity_13_copy_6-1
CAGCTGGTACAGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAATAGGGCTTGAGTGGATGGGACTTGTGGATCCTGAAGATGGTGAAACAATATACGTAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACAGAGCCTCCAAGGAGCTGAGCACCC
+
????,BB?DA@DD5ED;GFFEGIFHAHHI8IFHHAHHIIED.IH=IGCHIH+HHEEIHHHIH@FFDIIDHDFI9=IIH?HHIHEHIHHHFFH6GIHHHGIHHFGHFFH7GFHF+HB#FHGH0D(F@FB,*<GGEBFHFD,CGGGGF*G?GE:GG:CGFE(FGGE?(.=FEA*:(G#FGGGE?*E*;G)GE*E?G2EG:GEE.EG0EHGCEG8(GF/0E7.::FC/G.)6GEG(?G1(E*CCGECFCE(8'
@antibody_234_multiplicity_13_copy_7-1
GGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGGCGCGAATGCAACTCGCGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTATTACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTCTGTCTGGAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACGTCTATGCGTATATTGATTCAGCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCCAGGC
+
?A?=<A<BDDDDD+BDCCFEFG-.CHFHH+HIIF+@HA9HIICHIGGAH9FDHFD-BHHHHDHHHHHDHIIHH(DHGHI5HFEHHHH(DEHIHEH8HEFG@ACIAFHH@HHHH+GHGBHHFFG(GD6FFE;GFDGGGEEG*3G#8EGGFEE:.C:GF@ECFE6AGG*FAEFAEEAF*2CFF(GGA*E*?6C(FEAFCCCFG8*CGC6GEEE<EC**EF1GGE(E0?AEGG?E0C8'G?GC*AGE*(GEE*
@antibody_234_multiplicity_13_copy_8-1
AGTAGTCAAAGTCGCGAATGCAACTCGCGGTACCAGCCACGGCTATACCCGGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTCTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGCAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCTCTTTTCCAGGGGCCTGTTGGACCCAGTGCATGTA
+
?=?A?B?BDDDDDD<BFCCFCGIHIFIHHBIBFFAI>GGH9IDIIF8FHE+HIHCI=AHHEFHHHIHIFIHFIHDI?ECHHCFHIHH=H?H-HHHEFDCHDH@@HFIHHCEDFHHFDEF'FD+HGGDB*EHCB:EGEEE>EGE'EBEGEGG*;G(GFC;FG:G.ACGGGC(C?ECGGGFBFECGDCG6F.GE<GEE:EA*(AC?GG8EEH)CCCB(G<8EB-?E'*::EE;E*F.(E:E?:EGF6:G0C*
@antibody_234_multiplicity_13_copy_9-1
GAGGTCCAGCTGGTACAGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATAGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGTGTCACCATAACCGCGGACACGTCTACAGACAGAGCCTAGATGGAGCTGC
+
?????-BB6DDDDDDEEFFGFGIHH.IHHHDFHHHCHHHH9DHH=EHFHIE.HDHCDHIIF=E.HICFGI5H5HCCIIHHIIHH=FHFAHFHHHHGHHHIHIHHHHIHHGDFFH*FDHHFED*@HGGEEEE@EH',FHFCEGGHGGE9EEE#FE;E@GGGCCGG@GGGGE@EE-EAG+EDE.C:FEG'EFFG0FECECAE)E:EGFHEGC4?DEE:>A:G7,E?F?ECG48GGACE6AA*GE?A:*EEA*
@antibody_234_multiplicity_13_copy_10-1
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAACTCGCGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTCTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTACCATCCACTCAAGCCCTT
+
??,??BB3DBDDDDDDFGFFFCHHFEEIFI.IH7HEHEFCHIIGEIIHIGIFHFI=HBI-IIIHIFIHHCHB-HHFHGIHII'HFIHI=H+;HHHHDHAHHI.HHHBF=@H4=HHFHFF)=F9GEHBFEEEDDF9)?CEDEDEED;.AFEAG*CED>F(F*EGC*1C?CGEG:(EE:EGG/+E4C0EEGEAG*A;1CECGC(GE*>8:G(/G-F/EGE:E<EEA*GCCE(C*)?E.E'?C(CC.<EE:?(
@antibody_234_multiplicity_13_copy_11-1
TACAGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTGGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCCACAGACAGAGCCTACATGGAGCTGAGCAGCCTGAGATC
+
????9?BBDD7BED5DFFFGAFBE@FGHH>HEIFI9HGHBIHGIFGHIIBI0H/EHFHE-IIEICCIHHHIHDFHHIFHHGHHCHAI-IE6HCFHFHH5B:IHFDE)7HHH@?HEHHEHGGHFGB>=GGBHG=F=E(;EFGDGG*?FGEEE;A3GE@6@GC=GEGGGG4EEGGCGGEEF:(?C?CAGED*EG?CA:C?1EFFDE8ACGG8*'CC<GG.E@7<6CFEE:GGGEE?>GFGEE*FEC:-C/81
@antibody_234_multiplicity_13_copy_12-1
AGTCTGGGTCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATACTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTTCATGAAGCTGAGCAGCCTGAGATCTGA
+
?,?<?<>AD<E?-DA9FCFGFGHIIAF5>AH,C-CHBFIHGIHGFIHHA0HGHAFHEHHFIGF-HHHHIHEEG-HIIDHAEFH=H9IIIHDHCHHHCFF5IHFFH:EHE+HHFGHHGGHFE+@FGHDHDFHBDDF(EHFG'EEE8AEGG?@@AEGGC,GFFGG*7E*EEGCEBG#E.C=#EE<GG*G?0FGGEGGFC'?(FEE0EEEE(HEE@GE>'CE/:E(GCGE#G'(EECG:0CG1?CGGCA0C)G
@antibody_234_multiplicity_13_copy_13-1
CTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACAGCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACTGTAACCGCGGACACGTGTACAGACAGAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGTCCGTGTATTACTGCCC
+
<?A?=<BB?DDD5DB-FFFFGGEIHHIICIFFFEHHG3@HH,*HHEHIHCGG,HFHCCFF.HHFIEIFF5II5IGHC=HIE-FEHII+7CF?I@HHFG@HH+HHH;D7CH+FHFHHDHGEH<FGD+FGFGE.G5GF@HGEGGGFAGEEE3GD?E;EEG='EF-AGG##FGCEEA?G0ECEGAG(G6E<GF>CCAG:0G:GEEC6(F(0CCE:FE<EGGGGE/?/C1?E(ECC;*E?GFC:::C**GE(FC
@antibody_235_multiplicity_13_copy_1-1
CCTGGGGCTCCAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGGC
+
???,9B<BD?BDDBDDGCCFGGHGHFFHIFEHIHHIHHHFI.EHFID??GG8FDG@HHHFCII0HH+EDHH3HIH=IIDIFH-HIHIHFHIHFIHIGHDHFHHAHFDHEFHHDHGCCFHG+GBEGHE?FFGHEF8D)E(DGF88CFCE=6;@GDFE@(GGEEG/=GD??EE90F?CCE#EF8GEEE;GE(E8EC?G?F4E8GG?E.F(FFECHE7C/A?EC,G/C6*GG8C0(:CE?:E0*:E*GGC*?*
@antibody_235_multiplicity_13_copy_2-1
AGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACGGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCGCTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTCGATGGGACTTGTTGATCCTGAAGATGGTAAAACAATATACGCAGAGAAGTTCTAGGGCAGAGTCACCATAACTGCGGACACGTCTACAGACACAGCCTACACGGAGCTGAGCAGCCTGAGATCTGA
+
??A??5BBD-DD@B-BGGGGFFH8HF;CEHFHEE*HFIHI.GHDHHGHHFG?IIBEFDGHHIFI>FHFFDEFHIHGHABFHHHFHHH#IDHH=*HDFFHHHICFHHHHII2GHGHDDGDDHH**HGCD=H0GGC@G2(E.'EFF0EGEA<F</F?HEEAECCE;EEGFFCGFGDAG(?C?C+DEGEE;8GGE:AFG(FEE0CC(GF'G*?:CCE*:BECECA8EF(EGE:CGE('EF(EG>G?GEC**0C
@antibody_235_multiplicity_13_copy_3-1
GCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTAGAGTGGATGGGACTTGTTGATCCTGAGGATGGTGAAACAATATACGCAGGGAAGTTCCAGGGCAGAGTCACCATAACCGCGGGCACGTCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAAATCTGAGCACACGGCCGTGTATTACTGG
+
=<???9BBDDBDD@BDGGFFCG?FHE?E+F/EHFH7HGIDC?HIE+HBI.H@IHGH8HI=IIFFD>FHHCIHEHHHHEHHFGHEFCIGHHHHHI-H)GHHHFEI-HHHDFDGHHHD@HGHFCG-;GH==EGGG(GGGEF>GGGGGF((EFGGGEG/BG?ECGB<G:8GEG0EEG=EE?E.GE(G/((CG?G<:;C:CE/*A:E(8GDG*(G*CG(E(*,G?(6E:EGE?#FE8?GA0?:9A8;(8?E8AF
@antibody_235_multiplicity_13_copy_4-1
TGTACAGTCTGGGGCTGAGGAGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATACTGAAGATGGTGCAACAATATACGCAGAGAAGTGCCAGGGCAGAGTCACCATAACCGCGGACACGTCCACAGACACAGCCTACATGGAGCTGAGCAGCATGAGA
+
????=+BBDBBDBBDDGGFF.FHHFCHHH?EHIII7IGIHHEG.GEHDDFHE-CIFFGI/HDHGCFHCHFHGHAH=FFFHH-IHDICHGBH<FEHHHAHGHGIBHFE9HHHGHHFHHFF@GDD:FHGD*FGF+GGG@*G*FFFED(C.EG@B;EEGC9(DFGGFEFEFG?GEGCG>C:A#/E??/F(EG*GEGG?AEG1C*GGG?G:E*EE61*C;FCGEEF;CEEGAA*GC(GC?FE.G;G*C(CGF/E
@antibody_235_multiplicity_13_copy_5-1
TCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGTGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTACATGGAGCTGAGCAGCCTCAGATCTGAGGACACGGCCGTGTATTACTGGCCGAAGCTGGGTATACCAGTGTCTGATTCCGCGAGTTGCATTCGCGA
+
A?A??BBB@DB@DD=DFG/FAFIFHIEAE+AEH=IIHGHHAHIHH,.A+9H@GHG>HHDIHF?EGI.IFHHGDH;HHAIHDHHHDDIII?HHHHIIH,I6HHHH=HHHHGE)=+HEDG@CHHHCGHAEH8FEF2DGGGEEEGEEGBG0G2CFG?GF468*?FEGGGFEG='?)EGGGGGFG?AGE?EECFEEC;E8/?EGEE6E:(C(GCFFH0E?C:(GGEE?(6E/C:**(:E:;::1E*(E:E)EG*
@antibody_235_multiplicity_13_copy_6-1
GAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGATGTTCCAGGGCAGAGTCATCATAACCGCGGACACGTCTACGGACACAGCCTACATGGAGCAGAGCAGCCTGAGCTCTGTGGACACGGCCG
+
?=?A?B=BAD9E<DD<G?GF,FHIIHIFFHI7HH.FGCIHH.HHGHIFHH8HEHGCAGHG'GHHBH-HHIDF-I=HFII?H-H7HFEHIIDIFHHHEHAIHFFHDFBHF@HDCGEHHGGHFHGHFDFHHGGF0BADFEH9EGDGEFEDC?@G,GGFBCE?*DG5E*ECEDE(<GGEEC(GE?GE=EAEGGG(?E0'FEA:(G:;G(HCCH?(:0ECF*0E((E?EG?CCEECE(GC)E#AE:C)C:C:?E
@antibody_235_multiplicity_13_copy_7-1
GAATGCAACTCGCGGTATCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGACCTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTCCCAGGGGCCTCTTGCACCCAGTGCATGTAGTAGTCGATGAAGGT
+
?<??<B5BDD@-D@9@GBFFEDIHCHCCFIII7HDDGF@EHFEHGFHGG=HHFHFGFHHIHHHHDIHHBIIICCGHHE=4FIIHHEEDII<FHH*HHHGHHFHHHCG;FHBHG+GEEHFCHGGFEGD;EGH=?G-GGFGEB*CG,G@DGGEFE@6GGE/C?.ECGE8F?(1E*CC0AEE6C0GGAGG?A'FE*?(GG9E8:EE<40ACFHE:*C7CB.FG.CC8GC.FEE(#AE:EGE0EEG'E<06G:*
@antibody_235_multiplicity_13_copy_8-1
GTCGCGAATGCAACTCGCGGTATCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCACCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATGGTTTCACCAGCTTCAGGATCAACAAGTCCCATCCACTGAAGCGCTTTTCCAGGGGCCTCTTGCACCCAGTGCATGTAGTAGTCCGTG
+
<9?A?BBB?DDDBEBBGGBGFFHCHIHHFCIHFFGHA+HFHEIHEF9/CDIHHF-ECHIHIH(DIFH?FEFIHFHHHHIIIHHHDH6FH#IGHIHHFHHHHDHEHE=E3IC,HHHIHHECHEGFDEDFH9EGD..GE>AE=EEGECG8;DC*F,E#EGEE*(:C0>AEDEGE)EEEGEE(GG*E(EEEE?GE?0*CAAGG#GC(C*C?E.?E*A://GEF7EACFC(2GG(GGC(?CCE6E*FEC*#E(E
@antibody_235_multiplicity_13_copy_9-1
GGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTTATCCTGAAGATGGTGAAACAATATGCGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCATACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTG
+
??9?ABBBD@D@DDDEFFCGGGHI+HFHH>IHHIHHIHAGHIHHDAHIHHHEH=DHHHFEHE+EDHH5-IHHHCE)EIIIHGBFHFCF.HHHIH=?AHDCHHHGHCGD3F?HHE?FHEHHHEFH*G(?FBEDHCGGEE9EGCBGEE?CG(8GEFEEDEEGG'CG?>GFFG?E:EAG(E8GE?E((:CCG/CF0FEC(A4E=C?C(E?(:CGGHAGGE?<CCE:ECG*C:8:EEE.E:AFC(E?G.:EFE*
@antibody_235_multiplicity_13_copy_10-1
GGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAACTCGCGGTATCAGCCACTGCTATACCCAGCATCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAATTTCTCTGCGTATATTGTTTCACCATCTTCAGGCTCAACAAGTCCCTTCCACTCAAGCACTTTTCCAGGG
+
?????B+BDDD<DDDDECGGFFHHHE.IHIHIHAHFHHHIFG?II/ICEI9IDHFHIFHHFDH-F=FIH;IIGIIF-HHFHHDIFHHF=F+HHHHIHIHF.HDHH4IHHG4EDEBHHH46D8GHGCHE@GGBE,G;:GGGDHCFCECBDEDFE(E??EFE8EFEEEFF?EEEEG?GEE:G(EEEE1GGEE?F((?EE)AGE*C?(F:EACAA((GE0ECE:GC<GG#AG?;E?GGCE1**EACECA?E:'
@antibody_235_multiplicity_13_copy_11-1
CAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACCACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCATGAAGATGGTGAAACAATATACGCAGCGAAGTTCCAGGTCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTACATGAAGCTGAGCAGCCTGAGATCTG
+
<??A<?B?<D5D@?B<GFGCGFHIFHIEHHHI>GIEHIGHFHHHHIHFEFGEII=AH7FFI>FIGDABIHIE5HIHHG-IIH?HHDICEFHAHI0IBCBAH8GHHEHDHH=H>DFGFEHHHFHDEHDF@EGHE@GBEEEC*F*<GEGCGF:F30GE/@-AFG??(/EEE'GEEGFECEG@:+(?1(G;?GE'FG:FGF=CF1'A*EHC;HFCHGG*GE?0EG0;EA*E0?*GC*<DF:**/GC*E?/D*A
@antibody_235_multiplicity_13_copy_12-1
CAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGTGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCCACAGTCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTG
+
?5?,?BB<DEBDDDDE+6FGGG+IIFHIH>HFDFGI=F-IFFHIDFIDFE?A>@-IFHHCHDHIHIIHFIFHCIGFEFHHHHIHIIHFHFHFH@EC==HFID4CCHHFHEDG?=D6,HFGE,H(@BBDD+GDDGEEE8(CE@GFD=FE8=*E@(EE?FGEGEG1BDEFEE*(GGE?0CE>EFFGG=?('*EGEEGG'EEE:EE/E>AFE*):HG*E-AE.C?G*GG(G?ECE?/E*A0G/:G?/ECFG(C
@antibody_235_multiplicity_13_copy_13-1
GCAACTCGCGGTATCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCATCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCGTCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCCAGGGGCCTCTTGCGCCCAGTGCATGTAGTAGTCGGTGATAGTGTAT
+
?????BB<DDDDD@DB0FE/GGHIIIFBIIDCCHIH@IHHHHCCHHFH#HHIFFH@C@E5IHC=AAHE-FIHI-IHHFDH,)HFFFHHHHHHEHHGIDH*HHHFHHHE1B.7BHFF6H3GHG@9FGFE*DEFHB*FHHG*;G8DFEGFEGEDFEE:C0EDD3(BC*GB(GC:GEEC2C8FCE0*4E:EFGG6(GEA(CF*:0:(EGCG:EEE:EEA?'G,GG:GGF:G6*(A6:CG*(E:E:(#(E><E:
@antibody_236_multiplicity_1_copy_1-1
TGAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAAGTCGCGGTACCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTATAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGAGTATATTGTTTCACCATCTACAGGATCAACAAGTCCCATCCACTCAAGCCCT
+
,???<B>B?<DDD@D-FFFFDG3IIBAIHIHHFGIHDCEFE7?IEHIHEFAHECFDFFD-EHHHDH5FIFH>FI-HHIFIFHGHHII?EAAHIICCHDHGHFHIEHHIHHHHFFGDDFEGGF@FEEG*FEE=G74=GF:DF8C8EGDGEGE+AFFF)EFEG?GGCGG0E0E;=GAGFFF4E;:GGGDGA;E?EA*G>('G6C*A=C:(6'3E:@C1:#/E8EGE/*EA.E<:.AE?G(A*(EE:*:A;:C
@antibody_237_multiplicity_2_copy_1-1
CCAGCCACTGCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGTTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGTGGTTATGGTGACTCTGCACTTGAGCTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCGCTTTTCCAGGGGCCTGTTGCACCCAGTGCATGTAGTAGTCGGTGAACGTGTAACCAGACACCTTGC
+
??<??B??DDBDDBBDGFGGF,HFHFCIHFE8AGHIFH.DHF9GHFIHIHGHHCIEG-A8GFAHHHFAGFFIHFGGHF@HBHEIHBEECFFHHHDHDHHH'=HHG@BEGE=HHFHHGH,HEFF?#GGCDFHDFF,AGAEDEF8E6G@FGBE8GGBGF1((EGCBECECE6G>GGFGG#EE?:E)6(GG/GGGG>0CEEGAGEEEEAE?A?GECEFEEEEFBCD:GEECAC#:0E(E)E.A**0CE(:;C(
@antibody_237_multiplicity_2_copy_2-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAACTGGCGGTACCAGCCACTTCTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGTTCAGCTCCATGTAGGCTGTGTCTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTTGAACTACTCTGCGTATATTGTTTCACCATCTTCCGGCTCCACAAGTCCCATCCACTCAAGCCCTTTTC
+
????<?BB@D@DDDD5CGCGE/.H>FIHIH=HAH=FHI.IFEHI.DIDI?9EA>IDGIHFHIIHFIIAI#7ADH-EI+HI@H?EH@HE/FHHBGEHFDHDDHFGFFHDFE=GHDHGEFHFHF,HHEFEFBFG*HEEE>FGEGEE/C8EG*GEEGEEB)GG?EGAE?FGDEFG?6DCEEG>EFG:EAG#CEGE:FGE(EEC6<CCCGHGCE66A(B*B8,FG)C/GAGG1A??EGG0EE-:?:CE>(GE1*
@antibody_238_multiplicity_1_copy_1-1
GTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGCGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTTAAACAATATACGCAGAGAAGTTCAAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACAAAGCCTACATGGAACTGAGCAGCCTGAGCTCTGAGGAGACGGCCGTGT
+
=A?AABBB+DDDD@DDGFFCBFII;HFHECHHCCG@?FI@CHHIHGHGIEH@HH.H=FGFHDIIFDIGHIHHFFH>IFHIHEIFI+EIHHFB)CIFFII-HGHCHFEHHHGFCGH9G=8:HFDHGDE6@B;#GH@FEED;EHFFEEG=EGCECEE*GG8*,A*G?@EEGGGAGC(CGGEEFG*.EE6CB?CCEE?GGFEEE?(CG(HEGE:EC@E*GGC@8GGGC/E?G:*CE**A.*6(ECD0G?:G:E
@antibody_239_multiplicity_8_copy_1-1
ACCAGGGTCCCTTGGCCCCAGTAGTCAATGTCGCGAATGCAACTCGCGGTACCAGCCACTGATATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGATCGATGTAGGCTGTGTTTGTAGACGTGTCCGCGGTTATGGTGACTCTGCGCTGGAACTTCTCTGCGTATATTGTTTCAACATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCCAGGGGCCT
+
?,???BB>BD@B=DDDFG?GGGEHHIIH8FIHGF.H@HIHH-HHHHECHFAGCF.HAICDE.IHFIFGHDI?EHHHF-I-F@HHHHEHHHIHHHHIHIFECEFF,CDFDDFHE+EHGGF@=F*GEFF+F#EGDG;E*EGCFD#GECG*GE?6G@GBGECBEF(GE89EE(G8CG6F?#G>C(BC?9E/E*C*GCGCE(*8((AAGC6:C'CG(G@?/*CE7GG(?EC(EC:ECE6C0?GE??EA:*FA0:
@antibody_239_multiplicity_8_copy_2-1
CCGGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTAAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTTAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACACTATACGCAGAGAGGTTCCAGGGCAGAGACACCATAACCGCGGACACGTCTACAAACACAGCCTACATGGATCTGAGCAGC
+
=A????B>D5DEBDDDFGFGGGIHI/FF@IIFIHIHIHIFIIFAEIHHHEFFDEI=FFFGEDHCIHIHGI(EHFG-DDHIHCEHHEIIHEFIHC=FI5)FI)HHF=HGEGFHHHGDHF@FHFFDGFGFFG'FFFE*G8F;F**EFFFF;G@GEFA:AGGGEGEBEGCA/#EG(E;G:GCCGEA<CECEE<E=*<EE:#G?'A/(G?H1<:E/HGB?EG,:/FC8*0G;0EE00F6.0):A:GE:F*E?'F
@antibody_239_multiplicity_8_copy_3-1
CTTGCGGTACCAGCCACTGTTATACCCAGCTTCGGCCACTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGATCCATGTAGGCTGTGTTTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCTCTGCGTATATTGTTTCACCATCTTCAGGATCAACAAGTCCCATCCACTCAAGCCCTTTTCTAGGGGCCTGTTGCACCCAGTGCATGTAGTAGTCGGTGAATGTATATCCAG
+
,,,?A<BB69DD@DDDGEC+FF>IHF>IHHHHHH=HHH#HHIHHI8HHFIHHHIH:CI=HFHGI?HGH-GGHG>GFCCCH>*FHICHA5IIGGFFHIIF*FHHHH=D:EFHFF+=ECHFDHFGCH=GH,=HEHFDGFFH**FEEFFGGEE;CGGEG*CG6EFEE?GCGEC(E'E/E8#EFCF(?EE:FGGGEEC(GCCG#FGEGCECEE*A0HCCC*E7,E,E?CE:'*8'G0CEE:0<*8E6*8EC:AF
@antibody_239_multiplicity_8_copy_4-1
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTCGCGAATGCAACTCGCGGTACCAGCCACTGTTATACCCAGCTTCGGCCAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGATCCATGTAGGCTGTGTTTGTAGACGTGTCCGCGGTTATGGTGACTCTGCCCTGGAACTTCGCTGCGTATATTGTTTCACCATCTTCAGAATCAACAAGTCCCATCCACTCAAGCCCTTTTC
+
?????BB=D@DBDEDB/?FCAFIHFFAIHE9IHIGHHIHF7CH-ADFCFIFGEFIHH8HFFHF5HHHDHEHHFEHHH+HIICFCHEIDFHHHEIHIHF?CHHH2+FHGFFFEGHFA,FFEH+8CHH;FBCGGHFG**EFE(*GFGEGGG@AGAC,@?<GEEECE??E@G/GG6EEG(AGGE.EGDG4FG(;CEEGGGC;EE(EEE/EECCE*E@G*0/G/1.EGECGE(.<C0G:G*(ECA:E*EE6GF.
@antibody_239_multiplicity_8_copy_5-1
CAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGCATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAAACACACCCCACATGGATCTGAGCAGCC
+
???,??BB?DBBDB@DECGFCF?HI>FIFII@CDCHHIIHGB7IFDHHFG9HIC9HEFHHCHHFIIIFIH5DH@=CFIIHFIFFCGCGHIA,HIFHIDIHI+)H@=HGIHDEHGHI+HFHHGHFFD.EF*BE*B@?D8FCGHFGEDGFAAE1GDEEFFGAF:GGCGGG2E0/EGG;:EGCGCEGG6?EG<GECE?GE=EFGFGEEFHFCE9A-F:GGECGG<A?GE6E*G?(E6E6(A(A06G:(08(EE
@antibody_239_multiplicity_8_copy_6-1
CAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTCGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGCAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAAACACAGCCTACATGGATCTGAGCAGCCTGAGATCTG
+
????=BBBD?DDDD?DEFFGFFHEFH8CBHG-F6FHIHDIIAHHIH7A>H5HDHIHFIHGHCH-DIHCHHAFIHIHF-IGHICIH?HI=EGHGIHHHFIEA5H.HHH?HHHFHHEDHHC+BGHGGGEE8EGCEED@::DGGHBFGFGGE:GGGFEECGGEAFGF;-GB=?;6?EF-8EGFGEEE?(5EG.4:GGG('GA:8EAC.0E;GA(E)E@?EC(CE4FC*EC*EG?GCE?EGGGE?(??CEF4:G
@antibody_239_multiplicity_8_copy_7-1
AGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCAAAACCGCGGACACGTCTACAAACACAGCCTACATGGATCTGAGTAGCCTGGGATGTGAGAACACGGCCCTGTATTA
+
A?????7BBD?DDDD@CCGCFFIEIHHHFHHF9GIGH9I9IAHFIAH9FGFIID?HHHECDIGEEHHIHH-GIHIHHFH4I5IHF-HAHHEIHHD(EIIIH+FGHCBEHHFG*EEEEHF/GH)EGCEHBEGHEBE,EFD2EGFE,*GEGEEF@E6GGEG#(GGE'AEEGGEDF;'G?G:;AEGE8(EGEBGE6G068EE/E8E?CE0EC?GG(GC:G(8CB2/E*:E:(??EE())C1E.CE*CCCGAC-
@antibody_239_multiplicity_8_copy_8-1
GGGGCTGACGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGACTACTACATGCACTGGGTGCAAGAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATAGGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAAACACAGCCTACATGGATCTGAGCAGCCTGAGATCTGAGGACA
+
??A??BB?-DDDBBDDFFGFG>HIIHFCFF/II/HHHGIHIH>@II.HGIDF-HCIGHAIICIIDFFHIEFHIFHIFIHIHHCHHFHBII=H@(HFF+?EEGIDHH?DHH@FFED<H4DG*EF?E5FG9F:E97F*GGCEEEHHGB5ECE@DGFE?G-,GF<CGA(G<G<GAFG?E(C0CGBGE.AGGCGG66:(C:GE*1CAG:EA</DEGHCE(GCG<BGCE*C*?AGAE;GCCCGGEAEE?0:A*GA
@antibody_240_multiplicity_1_copy_1-1
ACCGACTACTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACCCGTCTGCAGACACAGCCTACATGGAGCTGAGCTGGCTGAGATCTGAGGACACGGCCGTGTATTATTGGCCGAAGCTGGGTATAGCAGTCGCCGGTAACGCGATTTGCATTCGCTACT
+
?????+/<@D@DBDD<FFGGFE>B?IIHIHIHGIHDIHF-HHIIDF5IIIHFBHGEGEIEIIHDHGGGCHGIEGHHIIFHH5-IHHDFH=HHIGIHIE=?<HIF4HHHHEHFEHEBBFF*GBGGGFDFHEGH#GE.EA#7EFEGCG:EEFE1G>FEG(6FCGFCE(E(AE8G/FGCEGG(EE1EEG/CG;6?.GEEG6E6EG*FEG86G0:EE@/?::G0C(CEG0:E?(G(G(FCG(EE0G?G:C1CE*
@antibody_241_multiplicity_1_copy_1-1
GTCCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCTACAGTGAAAATCTCCTGCAAGGTTTCTGGATACACCTTCACCGTCTGCTACATGCACTGGGTGCAACAGGCCCCTGGAAAAGGCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCAGAGAAGTTCAAGGTCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTACATGGAGCTGAGCAG
+
?A?A?BBBBDDDBBDDGGEGGC-;HIFHBBF9AIIFGHIHGIEHD-HIIIHH.IHHHAFHEHIFFIHIFHHIHIHII@HIIHH+GFI?HBIIHHEDH5=IHHHFHFDGG6FFH1FCFEE*FDHE#=FFBGF*EEE4GGFCG9GE?DGFF:F?DEEDF8#GGE#AGECG>.1/<GECAE0(EG?(CGC0'C.G(.6(EEGGEGGGGEA:0C>F@EGEC>GCF(?G.CGE/ECGECFE44G<E80*G*G:?E
@antibody_242_multiplicity_1_copy_1-1
CTACATGCACTGGGTCCAACAGGCCCCTGGAAAAGGTCTTGAGTGGATGGGACTTGTTGATCCTGAAGATGGTGAAACAATATACGCTGAGAAGTTCCAGGGCAGAGTCACCATAACCGCGGACACGTCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATCACTGGCCGAAGCTGGGTTTAGCAGTGGCTGGTACCGCGAGTTGCATTCGCGACTTTGACTAC
+
,?<<??9B-DE5DBD?CFDFFFIFCIIHHIDHHFIHHIGHFGHIHC+IHDGBIDH:8FHHDIFIBCFH8HFGD5EIEFIIHF=GHHHH-DFE:HADIH+/EFGHGHGH@FHHHHCEFH+F,EG=@HE>EEBGGGEDFG2GDGE6EFE*EEEEGCF6A8AFEEEC?GFGGGE:E)?<FG???GG::EADFE:A6FFCEE<DAGE(G(:EGEG.CG@ECE1:?AEC1?(GG:?;/.?*0EE(6E.ECA?*6C
@antibody_243_multiplicity_3_copy_1-1
AGGTGCAGCTGGTGGAGTCTTGGGGAGGCGTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCTCCTTCTGTAGCTATGGCATGCACTGGGTCCTCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGTGAGTAGCACATACTATGCAGACTCCGTGAAGCGACGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCAGCAAATGAA
+
,????B+?D<DDDDDBFFE?)/HHBHIHFIIFIHAH=AIIEHG@CDFGHHHHHAGIHEFIDFE8IFHIHHIHDFIFHFIG-HEHHHHE/:CEHGFFI@FGHED,HCFFGEHHH6FFH4HH@(BGFF,EGEGFG;FED*GGDEEAFGGE*EE?EEG5?GEGCDE,E/EG2?GEGCGECE/C8EEG6EGCECCGGG(C(EA0G:EEEC:((?C8H/(.EGC;BG:<G;EGG/*E?E?(6E)8*CA(EC-?AE
@antibody_243_multiplicity_3_copy_2-1
GCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCTGTAGCTATGGCATGCACTGGGTCCTCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTTTCAGTTATTTATAGCGGTGTAAGTAGCACATACTATGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTGCAAATGAACAGC
+
?????9BBD??DDDD@EGCFGFIHHBFEFHCH?IAI=HIIHIHFHAHIIHFIFAG?EIFHFHDGHFFHI?HH5D-HFHHEG@CIEH-HHGDI*HFHIHDHHHFH,FHF<FHGGHFHGFF=HH+HDEF=8GHHFEGFGE-G*GEFF*ECE8EEGEE;G7C+GA'EFG:EC?EC(*-G1E0FGE?F1GG/(<8GE:C<(EGCG?GGAGEEEH;CCE8EC/EC?GA(0G:8C.ECACAGA0A.*EDC?G4G((
@antibody_243_multiplicity_3_copy_3-1
GGTGACCGTGGTCCCTTAGCCCCAGACGTCCATACCGTAGTAGTAGTAGTAAAATTCCGGTAACCATAGCTGTATCCATTTAAAGGGTCCCGTTAACTTCGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTCTTCAATTGCAGATACAACGTGTTCTTGGAATTGTCTCTGGAGATGATGAATCGGCCCTTCACGGAGTCTGCATAGTATGTGCTGCTAACAACGCTATAAATAGCTGAGACC
+
?<??9>B?DDDD+5DD-FGGFGAEIC8IHHHEIGIIHFD.@AI@CFID-HCFFFHCGHA>FHFEDCDIGFIHHIHHEHIEGCHIHEC/IFCF?HHFHIDCE;HHIFHDBHGHHDGFFHFF=GHD=FFHFG*GHGGGCE=E8G:(*GEEEG:GE4*FGFEAEE8ECGCFCE:ECAEC2G'FG6EC=E8(:F?FAC;GAEEG;E?E*G*8G*GF:C:C*AE;7G*E?>AG(#E:E('FG)(E/(C?CE(C6C
@antibody_244_multiplicity_1_copy_1-1
GACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTCGCCGGCCTCGGTACCCATAGCAGCTGGTACTATTACAATATCCCAGGGACACATGCTCGCACAGTAATACACAGCCGTGTCCGCCGCGGTCACAGAGCTCAGGTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGGCTCGACTCTTGAGGGACGGGTTGTTGTTGGTGCTTCCACTATGATTGATTTCTCCAATCCAC
+
???,?BBBBDE@B<ABGGF>A>IIFHIEHHIDIIDDH/,II+5C=EGI5I.CII.EHHHAFHFCEHFHHFHFFHHHI-G+IGCIHEB.=HCGDHHH59EHGI,IHHFGHHGGFHFH4GHAD@GFGE,GEEEHCEGG4DEGB*DFGGEGEE:FGG@E<BAFFFEG:EG@G?*<ACG;:E8E6A@G6ECAGE(ECEEE<AG:E#C(AA:EGA:0EE*G0C;,:?EE*8=?E:E::*:EAC:A(CEE.EE::*
@antibody_245_multiplicity_4_copy_1-1
TCCCCCAAACGTAATCATAATACATGTGATATCCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAATGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTACCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGCCCCAGTAGTAACTACTACTGCTGATGGAGGCACCA
+
5????BB-DAA@DDBDFF7GFFIHH.ACFFHG/FEHIIHH.IHHEI=HFAHIHHHCHHF-=-GAFHHDGFHHEFCHFEFHF?HCHEFH/HHAHIEDH.G@GCHHHHEI@HHGHFHGH??HHGHGGBHDDEEGF;EC)G@=EHGEEE38FAGFGGEE.EGCGC1EEEGEE/G(.EEE0EEGGEEGCGCECAG?F(G?EFG*GE/G:EC?80:*EFG7E?E1EECCE?F:0E?*?C*D0C'?E4AA(?EEE?
@antibody_245_multiplicity_4_copy_2-1
GACGGTGACCAGGGTTCCCTGGCCCCATTAGTCAAAGTAGCATGGATAAGATCTGTAAAAGGATAACTCCCCCAAACGTAATCATAATACATGTGATATCCACAGTAATACACTGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAATGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTTGAGGGACGGGTGGTAGTAGGTGCTCCCACTATAGTAGATAGTCCCAGTCCACTC
+
???A?BBBD@DDDDBDFGGGFGIIEHHHHHHE:0DFHIED@;IHI;HDIFIC=I+FFFII@FACGFHDEIFFIEIHFGICHIFIHFEDIDAIHEC@HHFIHHEF-DCFHAHG=#FHEHBDHECFFEGD<5?GGE?GGDDEEGHFGEFD;GE6:GFGAE*EE?8EFACEFFG?FGGEAE(ECEEEEAAGGC?CECGCF;GC(GFEEEA-:CEE/@7EEDCE'G(E:G.*1)C6G<GE):E:E?#GE/ECE1
@antibody_245_multiplicity_4_copy_3-1
CTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATGTATTATAGTGGGAGCACCTACTACAACCCGTCCATCAAGAGACGAGTCACCATATCCGTAGACACGTCCAAGAACCATTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTAATGTGGATATCACATGTATTATAATTACGTTTGGG
+
???,A7BBBDDDDDBDCF?FFFIIFEIECIIAHHCHH+FIG+EFHH@H?D5HIIGE8FHECGFHIHFFHHE-HHFDBHIEH4IHIGI*HHEIIHHIF/EIHH+FCFHFHHHHHGEH+EGHH(HHGFG8F*3EF7GGEEAE?G6GEEFEGCEEC?E2G6>C8AGGCEFG0GCAGE?CGG(F?CAEEGFCG'G.?EGF:EEAE*ECE(HCGH;:>EG(CECCE?E((CF:.CEEC?./?(E=G(E6EC84:E
@antibody_245_multiplicity_4_copy_4-1
CTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATAACCGTAGACACGTCCAAGAACCATTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGGATATCACATGTATTATGATTACGTTTGGGGGAGTTATCCTTGTACAGATCTTATCCATGCTA
+
??==?BBBDD<D@9@BCFGFGGFHFFECIH-FICHHH@BCHE?IFEDGH=9H+FCFIGHHIHIIHGFGHGHFHHD5-GHHHHEH8HIIIHHI=HHI=@FHH,,FHDFHH,HEHHHHEHHEEEDFH5E3BGGGGGCF8GEGG0>EH2BDG*GBD*GC85ECG?@E/E<<?F/*G?EGCG8AGGE?GCE0E6EACG(E?:FEGGEE6<CE0EG*EE@E(*EC::GE*G:A6**0GGG//?E:*E?E:E::G*
@antibody_246_multiplicity_1_copy_1-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCCGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTTCAGCCCGTCCCTCAAGAGTCGAGTCACCATATCGGTAGCCACGTCCAAGAACCAGTTCCCCCTGAAGCTGAGCTCTGTGA
+
?????/73D-DDDEDBGFEFCF;-;HIFEFGH>IDIIFIHFEAHDI.-DFGGHHGI=DDFHHIHHCHHGF.HHCHI-HIEIFHHIDH6HHGBFGI)HGH=HHHGHFFHIEAHHHGG?=HGHBHEGGEDBHE2FDFEGHDGCEF(EAFEDEACF0FCG1F.-3:FEG8;GEG**E.EGG0?;CEGD?;ACGCE*E:EAAF6GE:#??C:/EC?(/;CCCGGC?AC(E*?*GC(CG(G0C0:0EE6G(E:CE
@antibody_247_multiplicity_1_copy_1-1
CAGTAGTCAAAGTAGCATGGGTAAGATCTGTATAAGCATAACTCCCCCAAACGTAATCATAATACATGTGATATCCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGTTATGGTGACTCGACTCTTGAGGGACGGGTTGTAATAGGTGCTCCTACTATTATAGATACTCCCAATCCACTCCGGCCCCTTCCCTGGGGGCTGGCG
+
?????<?A<DD5@<<@FFCFFGEAEIFEHIICHCICF=HGIFG-GHC-+FHH=IHFH;HE5FGHHDIIFFEBHHCCFFDFHIIIHHDFHHHHC>GHFFHHHIHGH.H2FHFBHD,FHDHF,FEDFG+H=GFHGFEEF8E*2G@G?BE1E@FEG(GCGGC'E(GAEBF8E=:E6CEAFGC<21GG2E:'EE(8EGD6<:?FCE?E#G'EECGGEFEEC(E,EF:8EEA((EEC=/0=(0*EE(C8G?):?F
@antibody_248_multiplicity_1_copy_1-1
AGATATCAAAAGCATCAGCATGCTCAGGCGGTATATTGTTCCACTTGTACCTACGTACAGCTTACAGTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGTTACAGCGTGTCTTTTGAATCATCTCTTGAGATGGTGCGACCGCCTTTCACAGGTGCCGCGTAGTCTGTTGTCCCACCATTAGCTTTGCTTTTAATACAGCCAACCCACTCCAGCCCCTTCCCTGGAGGCTGGCGGCCC
+
,????BBB6BDDDDDDFFG;GFIIBHBHIIGIE.H+I9HIGEIE9H'H>HHI>HHDFIHFHCF-CI-@.H?GIIH+HHHHGHHHFFIHEH>5HF=+FAAGHDIHDHHHFGG':DGFGFDH=E(HG:HBC;G3EFGFEFEG=;GCEEG*+'#>C(::6:CCA0EFGCC<(G6:.*EEE?EE?EGEE*GE:8/E?E;*#E?(EC8EEE84GFG:@FGGGEE,GEE6?G:?CE?1*EGE;.G:GEC9CA1?4G
@antibody_249_multiplicity_4_copy_1-1
TGCGGGAGACTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGACTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCTGTCAGGCTCCAGGGAAGGGCCTGGAGTGGCTTGGCTGTATTAAAAGCAAAGCTAATGGTGGGCCAACAGACTACGCTGCACCTGTCAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAGACACGCTGTATCTGCAAATGAATAGCCTGAAAACC
+
<??<A>>BBD5D@D+DCGFGGFEEFHCHEHIG9HH0HHIIF.GHIGC@FH(FIDHEHIIIHIFHFIHIHHI5HFHHIHHEFHHFIFHHEHHHF8GH.=HHHHHFIF+HBH;GFHHFBFCF;HEFHGD+HHGFFF,E0.DAGEGEBGGEC8GE*C#*6A/(?GFGEFBFGFGF8G/CE(GG8GA::A=AEACG?.EGG(EEFECGAE?GE;GE8:(CE:G:E:1(?GG8GCGE/?ECG(CC:?:CE:):CG
@antibody_249_multiplicity_4_copy_2-1
GGTGAAGCTGGTGGAGTCTGCGGGAGACTTGGTACAGCCTGGGGGGTCCCTCAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTGTGCCAGGCTCCAGGGATGGGCCTGGAGTGGCTTGGCTGTATTAAAAGCAAAGCTAATGGTGGGACAACAGACTACGCTGCACCTGTGAACGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAA
+
<?5?,B79EDDDDDD?>GGFCFE.IFI>E/HGIH.IH?IH-IEIFIIFHII+HD-FHIGII?EIHEHFFH/FHFEIFEF9CF;HHACD0H/+HFHHHH+-E6FHFHHH)BHCFHH>0?E<HE>GG)DEFDEHEHGGFFEFGDGCCGED*GEGAFE)FGEA=G;EG'CEEG:CA.FEG:(()EG?8EAGCG6EEA;EAE('E:A(?0E;?E<A:9EAE/<0GCFEG*6:E8:AAEAEG/*6G?E*E?C?CG
@antibody_249_multiplicity_4_copy_3-1
GCGGGAGACTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCTGCCAGGCTGCAGGGAAGGGCCTGGAGTGGCTTGGCTGTTTTAAAAGCAAAGCTAATGGTGAGACAACAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATGTGCAAATGCACAGGCTGAAAACCG
+
??<??B<<DBDBDD5DGFCGGCI>I-/IIH9HICHFHIHHCGI0FII+F@H@FHD@HE-GI8IHEH.IGHHHIGHDFHEIH5I?HDEFHEIFFH4HH=H'HAHHHFH),=HHBHHH4ADGF=HHH+EF>.EGB@EGFBGFEGEEEDEFEGA*G@GGACEECGAE:FEG(CEC.G(E?EAGAEG?GG?81FEEFG9GEEFE*806/6HCE8?.H:CE*EG9CEF:E(8<E'*F18';?GE0*.:G?EEACE
@antibody_249_multiplicity_4_copy_4-1
GTGGAGTCTGCGGGAGACTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCTGCCAGGCTCCAGGGAAGGGCCTGGAGTGGCTTGGCTGTATTAAAAGCAAAGCTAATGGTGGGACAACAGACTAGGCTGAACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTAACTGCAAATGAACAGCC
+
,5??AB<BADAB@<?DFGGFGCEHHFHH,IF0ICIIHIGIIH>+HDG9IFHIHIFBEHHFH+FGBDEHDHH-FH-A)HDIIIHHHAH8IFFHFHIH.EFE+,EFHFGHHHHHHFFFG=FGFH@HG@FGEG0EHEGGGEEGBCFGG0DE?G=GGDFEE:C**CEGGDFEG?C9E)/E4E(AA;/4EGE:G(;'CGG>:EG0G??E?C)CG*G;@'CGF01E8AEE8E'AAGEA8#(E?*.<1(EC).CG:E
@antibody_250_multiplicity_16_copy_1-1
GCAGTCTGGAGCAGAGGTGGAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTATTGACTCTTATAACAACTACCCCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCC
+
=??5?B9-BB5DDDEDCGF/GFHEIHH+8HHFHCGIIHI9HIIFFIIHHFHGI@HHHDHHIF5FGGFEICFHBEIHDI=IEHFBIBIHFHEEIFHFH5HHE.FFFFIHF:GHHHHH<GCFDFH=HFFGF@EHBGEFDE@GEGECGA#GG?D=F?CEGGAE*GDAFGG*;6GFG=(EE(EC>GE'1#EGGGCGEG:?E/CG;:E8CEH'EAC(>-(C-EBGCGG8F*DC8(AC:.EEGCEC(6C:;EFA::
@antibody_250_multiplicity_16_copy_2-1
TATACATATAGTAGCAGCTACCACCACTACAATATCGATCTTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCACTGCAGGTAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAAGGACGGCCGGTAGTTGTTATAAGAGTCACTAGGATCAATCCTCCCCATCCACTCCAGGCCTTTCCCGGGCATCTAGCGCACCCAGCTGATCCAGTAGCTGGTAA
+
<????B7BDDADDDDDGFE@FGFHHHHIBHIFBHDIEEH@IIIIFFH>I-DEHH0HBHGFEFHF?IFFAAG5?FIHHHHHHI-HH?<HHH-6IHG;HHFHIHH=EHH4FEHCBHHHHHEHFFHE?EFG@HF@GED?>HBFC0GEGE=GEEFG*EC>GG(7GECF'EG:E:GG?FD;AE6G=GE?C(ECGEEE4GC6E?A:E:8GGE*??:/E/GGEGA(F(EC0CG<*;E;GGCEG1F:C*?*1:(F1AG
@antibody_250_multiplicity_16_copy_3-1
TTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCACTGCAGGTAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAAGGACGGGCGGTAGTTGTTACAAGAGTCACTAGGCTCAATCCTGCCCATCCACTCCAGGCCTTTCCCGCGCATCTGGCGCACCCAGCTGATCCAGTAGCTTGTACAGTTGTATCCAGAACTCTTACAGGAGATCCTCAGAGACTC
+
??,????<D+BDEDDBF>CGCFII>EFFHHFGHGEIHH0CHFIHHGHDHI-HF-HFD-IIHDFEHHCE:DGHHF?FIIHFHH?AHHHIHHIHHEHEH-HIE=HHGHEFGHHEGHFEH8DFFC=DF#FE+DDDEGBIEED/E@E8?GEG(GEEGFGEFEGGG80?(B;EGEECG*E*G#(GFEEF?E:(..GG;G:<:CG0(CEGE*HE*'DGE0EGEGGFGFF8E(CGC?.CGEAAE?(G?CE(E?(?:(
@antibody_250_multiplicity_16_copy_4-1
GAGACGGTGACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTATTCAGTATACATATAGTAGCAGCTACCACCACTACAATATCGATCTTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCGCTGCAGGTAGGCAGTGCTGATGGACTTGTCAGATGAGATGGTGACGTGGCCTTGGAAGGACGGGCGGTAGTTGTTATAAGAGTCACTAGGATCAATCCTCCCCATCCACTCCAGG
+
???,?B@BDDDBDDBDFFGFFG/I.FHAHIIHFCHIIIHIG>ADHGIIIHFEFGCFHIHHHF5/HH.FGHAIHE?CH==HHH-A+DHI=<GIGHII@IEHGGG=HHEGHFDFHEGHFBHGDDFGGEGHE+FGE3#CGCGEG5HFEFFGGEE6G/GEEEEGF:G;?GE#0AEGDEEG0?GGGC.EEG?(EGG=*EC?C#?E?GCF?*EC?CA6HCGAC7B/.?A6*GCCGG1:EE**EEC.6(</C8C.?)
@antibody_250_multiplicity_16_copy_5-1
TGAGGATCTCCTGTAAGGGTTCTGGATACGACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACTACCGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCGATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGCCCTCGGACACCGCCATGTATTACTGTGATACACGATCGAT
+
A9AA=B=@BD@BDDBD.FGFGGEAI/FE?+H>AH7FIDHFIIHEH+IHHH+EGEFFEHHFHEHIHHDHHIIHHHIFHH-AH-G=FIHHHE/GHHFE@HIIGIGBGFG?BGEHGHHHGFFEGGHDBCFEGFCDFGE0>*@DFE:AC*?GEGC;E<EEE('AE?E7(9=<<EEG'F/AGA?=/ECEGG:?G:EEC;EECGFE?AC?0EEGG(6*EEECCGGA*AGEEE//CGFG::8A#G?G#C(E:E0EC*
@antibody_250_multiplicity_16_copy_6-1
CAGCTGGTGCAGTCTGCAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACTACCGCCCGTCCTTCCAAGCCCACGTCACCATCTCAGCTGACAAGTCCATCAGCAATGCCTACCTGCAGTGGAGCAGAC
+
?5???B=>DDDBBDD?.FGCEFHHHIHIIHIHH9IF0AHIHICIFH0FDIHGFDCICIHBGHH?HHGHHIHFIHDEFEHHEFCHHFHIFH+H6HIHDFFIF*EEHHHDHEHCH;HFFGDH=DGBHGH@1E=EEEG?,EEGGD;EE6GGGAGGEE6E;*F?EGGGCE(E'ECGGEB=EA;CE)A8EEFFEC('AGGFAG8A?E6.6E?GGE?CEEE:8A(FG,F:GE(9C6EFFFG(?:G:G6ECGCG/(G
@antibody_250_multiplicity_16_copy_7-1
CTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGACCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACTACTGCCCGTCCTTCCAAGGCCACCTCACCATCTCAGCTGGCAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCCGCCTGAAGGCCTCGGA
+
,??555BBD<DBDD<DF@CECGIE+.EHHHAHFHIGHGIHHHHDFI?IIFDCD5FD<HHHDIHHHEIEHHHEGGGHFHHFI#HC6)GCH?IIIGHGHHHGEFHHIEHEHEHHEC,FBFFHGFHF'F*G*GDEB1;=DGEB,49EC=GEFDEAGDGGGGFGF'AG.D-E8EF<EGEG*DEFGG(GAGF=GC:CCDAEGC(.(F?EE'EEC0C>/C-CBGF7:(EEC(<CC?EC/#6F(GC?*(E1CGE(EC
@antibody_250_multiplicity_16_copy_8-1
GTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTGGTGACTCTTATAATAACTACCGCCGGTCCTTCCAAGGCCACGTCACCATCTCAGCTTACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGG
+
<??5?BB@DEBD,BD@FCFC?FIHIHFHFFHHC/HIH@F=@H+?IIEH.IHAGHHGD-.HFH#HHHGFHHGHGGIFF@IF-HHHFD5HE=@HH@CHHHIEGF+IHHFD(FH.;DGFFG-HHAEFEF?HD4DGEDGE>=F>EBAFEG:#E?GCD<GFG6F6>(GFAF/EGFFE(G:EGAECE?GGEFE?GCC.CCGG6G?.E(EE(G:G0F?E//EEG?(EGCG<GE/*EA6<CG*CE:AF.GC:(6'GE(
@antibody_250_multiplicity_16_copy_9-1
ACGGTGACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTATTCAGTATACATAGAGTAGCAGCTACCACCACTACAATATCGATCTTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCACTGCAGGAAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAAGGACGGGCGGTAGTTGTTATAAGAGTCACTAGGATCAATCCTCCCCATCCAATCCAGGCCT
+
?=???B>BD@@DAD<B.G@FGGIHHFHFICIHGHCIIFIHH9EHHFIHB8@/I8GHF5IFDI@HEEHAHGHAHIIDEIIGI-HIA-HH;HIFF<IHFHH+-FAHF+HHHH@HHHHHHBFHGF=,F5GHFE#GH=DD?;*,G>GGGEFEF?DEFEEBE;A@EAGEEAGEEGFC6E6(*GEG+(:GEE.6GBCEEC41E*G8(EE8-E:2EHGEH2CAGCEFG)?ECCF8EEAE0*G:F0A?*?*GDC?C/(
@antibody_250_multiplicity_16_copy_10-1
CAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGACTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCCGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACTACCGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCAGCAGCACTGCCTACCTGCAGTGGAGCAGCCTCAAGGCCT
+
A??,A?BB-DDEDE@DCGFCGGIHIFE0I;HHI'IHFHHFGDFIDHHFFCHC=FI+HB5HEHF.H?HIIGEDHHCICHEHIIH6DH8#IAHCHIDF),EHHH4DEDBF.F3+EH9GGAGFE?G7+HF,*GHFEHGGA#ACECCG=EEGE*CG=/,@.EB1C?FG<EEEEGGG:0GCE?::?E6EE:GFG/G:AE*E(E(EEGEFGA8CEAE#HGCE/;?GB86FE:?F(A?C:G?8;CE((A((?CECG*
@antibody_250_multiplicity_16_copy_11-1
TGTAAGGGTTCTGGATACAACTTTACCAGCTTCTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACTACCGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGATATAAGATCGATATTGTAGTGGT
+
??5A5?BBBBD@B9D<GFGCGAFF/IHFFIG+IHIIIIH@CHEHHIHFFHH.HIFHIAAEAHEI5DII?HIEAEHHCGCH0IHHHIHHAHIEFDDFG=EHHDHHGHHH=HDBHH#FHG<HE,DGDF:GFEDEF>DBGHHHGB;E6;/GG>G7A;GEFGAACEF*G(AE'AEGEGEFGEEFGEG)FEECEGG(ED/ADC(EFEA?CG(ACE/::(@*EGC@G?ACGCG?(GGEC;.(8/AEGD(/E?8<:F
@antibody_250_multiplicity_16_copy_12-1
CCCAGTGCTGGAAGTATTCAGTATACATATAGTAGCAGCTACCACCACTACAATATCGATCTTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCACTGCAGGTAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAAGGACGGGCGGTAGTTGTAATAAGAGTGACTAGGATCAATCCACCCCATCCACTCCAGGCATTTCCCGGGCATCTGGCGCACCA
+
<???<BBBBDB-DDDDF-FF8EIIIFHCHIGHHIIHGHHHEIHIICH@CFGDHFCFHHHCHIIEIIIFEH@HHIHF=DHEH-HDFHH=HFEEFAHEIHHDBHHHHF=HHHBDHHF;FBCAFFFHG0>FFGHGGGEE:FDGBE(GCE/GFC,?GE.EE?;?32*GGEA(:EGD:GCEAEC(GC?E(A6EEAGFD#EAEGCFE:8E*E:A.ECG*EE**FEE0ECEE)):GC(CE88FGA8(*EG0?C:C:*
@antibody_250_multiplicity_16_copy_13-1
AGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATAACAACAACCGCCTGTCCTTCCAAGGCCACGTCACCATCTCAGCTAACAAGTCCATCAGCACTGCGTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACCCC
+
<A???<BBD?DD95D5G/CG@GHHFIHCIIHII+FCAIIH9HDAH=DF@F/DCGIHDGH.FEICEFFFEFIFICGHEHIF=IHEFHIH<HHG-HHF5)HFFHHDHBHDHHHIGEE*HDG**FF2@;EC<@FEHCGGEE3D?GCG7FG*GE/G(E(=FEEGE*CEC0EGEE8GAEFD6EE*2E(26(AGEGF6G/F;::*GF:G.FDEG.*G:E(BG*FFEECECECGGEGGC1EE#64G;:GC(G*G(GE
@antibody_250_multiplicity_16_copy_14-1
CCTGTAAGGGTTCTGGATACAACTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGGTCCTAGTGACTCTTATAACAACTACCGCCCGTCCTTCCAAGGCCACGTCGCCATCTCAGCTGACAAGTCCATCAGCGCTGCCTACCTCCATTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGATATAAGATCGTTATTGTAGTA
+
?????B=BDDD@D-B?FGFEEFHHHHIEHCHFIIIHI+EGHDH=DIDIHH@IGHF@DEFIH.EGIAAIAFDHHIIIH@HFIHFGGIHHB)HH4#@+AEHEH2=EH)<H?H*9GFG-D@HF@F=CFDDGF9HB?4E.4FFAEFD#8G*E/GGAD*EGBGEGGE6-FF8GBG(GECGE?G.CF'E/(8(AGE;G:AGG*/ECGF:C2(1CG:GE:EE?EEEEBGEE?DEAE;GE*.1:/=E(EECG8::)*(
@antibody_250_multiplicity_16_copy_15-1
TACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGTTTGATCCTAGTGACTCTTATAACAACTACCGCCCGTCCTCCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGGTATAAGGTCAATATTGTAGTGGTGGTAGCTGCTACTATATGTATAC
+
A?A?=BBBD?AD@DD?FGFGGFIEIIBHFIHEHGHHIGFHHH>HAHIHGCHEHHHHGH?HHH5D-HIIIFFGIFD-5<HHEGIIAGHHCHGHFH5F7.D-FHHD#HE6H8H@GF@HHHE=GHHHE+EE6FEE@,G@G*CF8GGFE,EDGGEEFEE,EGEEE*6F0GGGG<E(8EFEE;GE+E*F'EGECA:GCAEE:ED1G88(FGEC6E(:**(-EGE.:G*E:E:C?EE8(G:FGG8*A::C;=E)8?
@antibody_250_multiplicity_16_copy_16-1
CCCAGTGCTGGAAGTATTCAGTATACATATAGTAGCAGCTACCACCACTACAATATCGATCTTATATCACAGTAATACATGGCGGTGTCCGAGGCCTTCAGGCTGCTCCACTGCAGGTAGGCAGTGCTGATGGACTTGTCAGCTGAGATGGTGACGTGGCCTTGGAAGGACGGACGGTAGTTGTTATAAGAGTCACTAGGATCAATCCTCCCCATCGACTCCAGGCCTTTCCCGGGCAGCTGGCGCACCC
+
=???AB<?ADD<DDDDFGGDGGFGAI>HFHHHEHECHFHH,CIHHGADF=GCIIH-HHH5FFHHIIIFAE5BGIH-FIEHIHIIHHIFEHGHI8EHI;D0FEDHCHHGHBEHHDGGHFH73FG+F*HE;6FFEGEFFB;EEE?EFGGECGEEECEGDCDEEG/GFEECGEG=.(EGGEA:EGEGA-GGCAAG?CFGG:?EG6GG8EF*8/:F.GEC'E:A(E??*0<(?EE:GE:*:*/C6?:<;*G;E/
@antibody_251_multiplicity_1_copy_1-1
AGCTGCAGGAGTCGGGCCCAGGACTGTTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTGCATCTATTACAGGGGGAGCACCTACTACAAGCCGTCCGTCAAGAGTCGATTTACCATATCAGTAGACCCGTGCAAGAACCAGTTCTCCCTGAAGCCGAGCTC
+
??,A,<BB@DB-DDDDGDEFCEHHFIF/HHHHIHHIHIHIHII-HGHFH/HIFGFHFHHICGG-<IIIIFHHFHHIDFDIF-IHHEHIIFIAHFCHF=HEHGHHEFHGH)G6.FHGGEFGGFGEHHDB0(FFFEEGGCEECGEDDD#(FEEC(CGGC/2D0E*E'EEGGG<=GGE>8E?G:G;:=(/E0:(:G/GGEAEE?GG:ECCG1FE?EGEG(EE0GEAGE:ECE?0(:*:'CFFECC/:CE:CAG
@antibody_252_multiplicity_2_copy_1-1
TCGGGCCCAGGACTGTTGAAGTCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTGCATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCACAAGAGTCGAGTTACCATATCAGTAGACCCGTCCAAGAACCAGTTCTCCCTGAAGGCGACTCTGTGACTGCCGC
+
5????BB9EDBDDD5B.0GG>G8BIEHIHEAHHGGIIHIIGEHFHHHHHHFIEG-EHHBDIEIFHDEH+CGFGCHBIHIH;FHFIHHHDIH@@HHHIHFI-HFG8BH(HGHHHDCHHHE8GBCHHGGHF:GG*@@:EG98EGGE8=?'0E3GGCFF8CEGECEEEFFGEG2*F/EG?FGC?G:*?GFC??<GEFC?C/>(GC-EDEEG>A9E@AEE?C7EFCCC8GFE)-E(CGE*A:GEE0?.D*G(C*
@antibody_252_multiplicity_2_copy_2-1
CGGTGACCAGGGTTCTCTGGCCCCAGTAGTCAAAGTAGTGCAGGGCCGCTAGAATCGTAGCCACTATATCCACTGCACGGACTAGCTCTCGCACAGTGATCCACGGCCGTGTCCGCGGCAGTCACAGAGTCGGCTTCAGGGAGAACTGGTTCTTGGACGGGTCTACTGATATGGTAACTCGACTCTTCTGGGACGGGTTGTAGTAGGTGCTCCCACTGTAATAGATGCACCCAATCCACTCCAGGCCTTT
+
=???5B<BB@DDDD+-F.EFEGHIHFIHIIA@HGIH-IIFDG=HI=HA@*GFI-EHF@FEIHFGIE=IE5FGHFCFGIGHII-I+FHGG-HFH=IHF#HH7HCHEFHHEFFDFFCFHHHEHFGFGG+1GFGGEHDGDBFFF:G3F;EEGDGGGEAFACFGGEFEE*AGA(E(8C6GEEAE,6C*FFF(*C((#EECFG;/GE6)6?HG(8A/@G70EG8EB8FAG<GE61G.G*1.A*'A:?DE:GG'F*
@antibody_253_multiplicity_4_copy_1-1
GGCCGCTAGAATCGTAGCCACCATATCCACTGCACGGACTAGCTCTCGCACAGTAATCCACGGCCGTGTCCGCGGCAGTCACAGAGCTCGGCTTCAGGGAGAACTGGTCCTTGGACGGGTCTACTGATATGGTAAATCGACTCTTGAGGTACGGGTTGTAGTAGGTGCTCCCACTGTAATAGATGCACCCAATCCACTCCAGGCCCTTCCCAGGGTGCTGGTGGATCCAGGTGCGGTAGTAAACACCACT
+
??A??B@7<DDD5DDDAGFGF+H8FCIIHCDFI@DHHHHIDIHEHDAH8GHHGEHIGHH*HIFHIH-H=HFEGIH=AHIDDHIHIHHFDEFICHHBEHHF=DHHBDHE#GGD?FH+@GFEHHE9FHDGE1@FDG@E=GG;EEEFGEF,(4EGGG*EFC@:DEGFCG<EG(FCC6(AEFCEGGEFEE:AGDEAG?*A:?G/?ECGGE0A:EG.CCG.**C(E,?D?AGEEGE/C:#AG.G.EG:0:0:?:G
@antibody_253_multiplicity_4_copy_2-1
CAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGTTTACTACTGCACCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTGCATCTATTACAGTGGGAGCACCTACTACAAGCCGTACCTCAAGAGTCGATTTACCATATCAGTAGACCCGTCCAAGAACCAGTTCTGCCTGAAGTCGAGCTCTGTGACTGCCGCCGACACGGCCGTGGTTTACTGTGCGT
+
?5?AABB?DDD--DDDGFGGFGFIIIICHH-IHHIHFHH,=H.@EHI?FI2IHFHHEHHICHIHHIEIFIIGHIHIHHIIF*H@GHHHFGHHEHFHFHHHHHE=GHI?FH=HHHHEGG>H7HFEEH=GEGF*EG<GG3#;*8GG/GCFEEEEC1GFG8ECG(CAGE:EF:GFAFECE(*2EEFGFFEEG(.G(E6G*?DFE<CG(6:E8?FE'EEF<.C80E*6/:.8EE(0GC('E:EGE?EE(8?:?(
@antibody_253_multiplicity_4_copy_3-1
CGCTAGAATCGTAGCCACTATATCCACTGCACGGACTAGCTCTCGCACAGTAATCCACGGCCGTGTCCGCGGCAGTCACAGAGCTCGGCTTCAGGGAGAACTGGTTCTTGGACGGGTCTACTGATATGGTAAAACGACTCTTGAGGTACGGGTTGTAGTAGGTGGTACCATTGTAATAGATGCACCCAATCCACTCCAGACCCTTCCCTGGGTGCTGGCGGATCCAGGTGCATTAGTAAACACCACTGCT
+
A?A?<BBB@-AEDDD+GFCG,?HHHII/8FH.CHHFFHIHH=HFGGFG=HD>HHHFHHFH*IHAGFGH*FFHFI,IFFFF9HHIFED)IHHIHG52IHHHHBGD+G@FIGH2?EHFG@FFHCEFGFFF*EEGF#;FECGEGGEG6EEFF(AE@FGG=EE?G*7E*?(EEG.CFECG:GEGGGC2EC/GGE(GF8;FC?A)=CC(0GH?FD8EAEG'(#FGEGF?(*1C?CCE(*E0'ECE6E?E?:E?:A
@antibody_253_multiplicity_4_copy_4-1
AGTAGTCAAAGTAGTGCAGGGCCGCTAGAATCGTAGCCACTATATGCACTGCACGGACTAGCTCTCGCACAGTAATCCACGGCCGTGTCCGCGGCAGTCACAGAGCTCGGCTTCAGGGAGAACTGGTTCTTGGACGGGTCTACTGGTATGGTAAATCGACTCTTGAGGTACGGGTTGTAGTAGGTGCTCCCACTGTAATCGATGCACCCAATCCACTCCAGGCCCTTCCCTGTGTGCTGGCGGATCCAGT
+
??<??<>>6?DDDD<@GGFEC7CFEI-HIIIHHIEF?GHBHFIGI+HHI?-.ADFFAFIAFII5HAFIHI-?DIH?IDIHFIIHACIEHIGIHFIHGFF,DGAGFHHFHFDDE6HFDHHHGDGEFGH,4D4DGCG@#EFGGGBBG,G@GE0DGGFDEEEFGE(FGGGG?EG:C*EA6?EGGE?EE*/0EEGE6G;(E6G'EE8.FECGG*GFF7C?:ECG8<CA1EAGG<GE(*EFE:EE<CC/E*A*E(
@antibody_254_multiplicity_2_copy_1-1
TCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTATTACATGAGCTGGATCCCCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGTCTCAGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTCTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGTGAGAGCGCCCTCAACCTG
+
?<A??5<BB@@BDB@DGFG>FFFHH>AHIEGHGFH/GHHHIIIICCG9HDBAHGHFHIIFBECHHHH-HFHFCHDFIHGHIHHHAGAHF-CHFFBIAH+H>H6EFEHC6=H,HFHHHHGEHHHD@+DEGD#H*1CEEHEE3CEGGCGG?E-<?GEE'GGG6GG9G6EA06G;EC.?FG(G?.0E)E'*CGGEEGFCG?F(CE<GGA8E:8EE@F/?B/CGG?AC66(/CG6#ACGAG*//:EEECG*(*C
@antibody_254_multiplicity_2_copy_2-1
CTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAGTCACCTTCAGTGACTATTACATGAGCTGGATCCCCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGTCTCAGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAAGGAACAGCCTGAGAGCCGAGGACACGTCCGTGCATTACTGTGC
+
A????/9>DBBDD<DD+GFF>GI;IHI/HI@HFHIIH9,DFG7EGG,GFF>FAIG?FFB.FEHHHHHFHHH-+HEG?EIGH=II-G+FICGEGA,DHHHGDBGDHHHH=HFHHEHHHHEGHHHEHHGGFDCGEG;CFG?GFFFEGDEG8GD1ECEEB>CGEEGGCG?)GEGE6C./GEGG?<(GEEEGGGG?CE?GEEGE-F/:8:?#F8G*CG(*CC(@BGEGE(G:EFGEC('E9;E)CE/*E1/:E0
@antibody_255_multiplicity_1_copy_1-1
ACCATTGTCCCTTGGCCCCAGATATCAAAAACATAATTTGAATCGTGCACAGTAGCAGCTCCCACCACTACAATATCCTACTAGTTGAGGGCGCTCTCGCACAGTAATACACGGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCCCTGGAGTTGGTGACTCGGCCCTTCACAGAGTCTGCGTAGTATATGGTATTCCACTACTACTAATGAATGGAACCCAC
+
??,A<-BBDBDBDDBDFCGCEFIHAH0HFH(II+H@.HIHIGIF+CHFFHHHAHDECEHHHHFHH=IHHHGH5F55HIHIHCGHHHI+8HHIGIHD7H*HDFGDHHFFFHDI.HHHFGHGEFFHF;6FG8EGFG=EEEGGE)GEGECAA=GFFCE8EEF:G.*BG=FCFEB8E?E@GGE86EGGGC'?*EEGGE8FGG6ECEE(GA?E?HGCAE@:0?E:*/*GE:EC8G*E?GE68*#C)G.ADCEFG?
@antibody_256_multiplicity_3_copy_1-1
GGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTCTAGGTTAGACGATCTACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCGTTTGAAGATACAAGGAATTCTTGGCATTTTCTCTGGAGATGGTGAATCTGCCATTCACGGAGCCTGGATAATATCTGTCACCAGCAGTACCAATAGCTAAGACCCATTCCAGACCTTTCCCTGTAGC
+
?5???+?B<BBDBB<DFCGFF/IIHH8HHHFCIHG/HHHHI.H@EHHIIFHFGFCDIDIHICHHHAIFHH?HHHHICFH-IFGFHHHHIHDIHIHHAHII2-HHHFFHHDHHGF5D:GH0BA(H@GEDDECDEGH/BEH0FGGCCGEEEEEGFEFG@6?EEEGGCGGE@GF'GEA:CGE(C6G8EE0GEAD6GA*?:)'E(FEG?G*FFEF:HECD1ECG(((G?.:E1:66*E*?E0/AG#EEC8;EGG
@antibody_256_multiplicity_3_copy_2-1
CTTGGCCCCAGTAGTCAAAGTAGTCTAGGTTAGACGATCTACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTCGAAGATACAAGGAGTTCTTGGAATTTTCTCTGGAGATGGTGAATCGGCCATTCGCGGAGCCTGGATAATATGTGTCACCAGCAGTACCAATAGCTGCGACCCATTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGT
+
????<?BB-BDDDDEDFGGGGGHIIIEAIIHHHFFIH=GHG+H@IH.EFID5HH.HGEIFCEHIH>HDC5IH;FHIIHDFHHFGDGDHH4.IFHHIIFC@G,HHFGGFDHH+EDFFHHDFHEF@@C=<GDDAE+GGEEBG?1GECE8*9EEGGG6G?A4GEC9(E#G(C6GE<F:E6AE?F0;E/AEAEE??(C?EC8EG?AEE0E1<(FEFHG@(:GBGCE:C8C*EEEE.*0E6GGC#E/EC(/E:(*
@antibody_256_multiplicity_3_copy_3-1
CGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTCTAGGTTAGACGATCTACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCATTCACGGAGCCTGGATAATATGTGTCACCAGAAGTACCAATAGCTGTGACCCTTTCCAGACCTTTTCCTGGAG
+
???,=?BBDDBDDDDBAGCGFFIIH.FIBH,HDHHFIFDGIHCHHI7HHEHFIFCHFHFHEGCHIHIH=<C-HFHDCHII;GD,IHHF>+-FGDIFIHD<IF@HHHH*HHHHDCHBHFGHFGDHHBEH*FHH*;FG*DGG5GED)DEGG:E?GG8F*EE..E(0FEGGGGE.E*CECGB<1GDGGEEG/<G:GG?EE<AE*GEEG*<A*EE8E03AFG;G-:.#8ADFE#?GG(CG.F:5A(?./EC'AG
@antibody_257_multiplicity_1_copy_1-1
GTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTAGCTACGACATGCCCTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAATGGGTCTCAGCTATTGGTACTGCTGGTGACACATACTATCCACGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGTCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGGCGGGGACACGGCTGTGTATTAATGTGCAATTAACATA
+
55?A?B>BADDDBD@DFFGFF/BFBFF6FFCGHHFH>HAF.ICEHFI0IHHEHHHHC,IGFIIIGCHHHHIHH5-EFIFDGIH?HCIICHGHHFHDHDHE,H3HH=;>(FFFFHGB=F@EDGH,*FDFG,HGG'FE9GE8?GFFGAG*G*D/FC8FGECFEAE;A?EC'>E<;:G6DG:<GEAEGD:GGEECG:E6C?ECE8EFAEHGA//9ECEEGGEGD:>AC#E(::CGA:EGGCE:EGC??:0?:F
@antibody_258_multiplicity_1_copy_1-1
ACGAGCTGCTAAACCATATGTTAATTGCACAGTAATACTCAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTGCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTCCCAATAGCTGAGACCCATTCCAGACCTTTTCCTGTAGCTTGGCGGACCCACTGCATGTCGTAGTTAGTGAAGGTGAATCCAGAGGCTGCACA
+
5?5,?BBBBBDDDDDDFGCGFDIIE6FIIFHIIHIF(GEFHBECIHHGGIFIAAHFC-F-FHIFEIHEFIH+AIC5HIH-HIII5HFEHHEIGEFHCB-GBHGEGHF6GH=EH)DHFGB5DF0GGFEHFFEG@*:GGEGDEGFCGGAEEEEGGFEG8(GGE@EFAFE,?ACF?4*?.AGEGCCF*(E:(?(EEE?GAGGE8ACCECFEGE<EHF@)FG;G8>AF(FE?EE*G-C?E*2;GEECE?GG9G0
@antibody_259_multiplicity_12_copy_1-1
GGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATCCACCTTCAGTAGCTACGACAAGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAATGGGTCTCATCTGTTGATACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACAATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGTCTGAGAATCGGG
+
?A,?<BBBDDDBDDDDEGFAFFCFIIEIFII'IIG.I9GHHCIBAHHFG-HIFHC?FGIHFIHFHCFHEHEIIE==IIHEI-DDHGFCIE)F@HHI*+GDHHDH/EHH@FD'FFC@HFEHHECHAHHBHEEG@GEB*C=?FE?8GECG(FGG,GGAGGEG:GECF#EGAGG(?:6;ED.E6GE:GADE6#EA#*FE*ACA:CACEEE;(HG6ECBCGG:(GF?GG*EGC.;ECE98;(C?GACC#)*F(<
@antibody_259_multiplicity_12_copy_2-1
CAAAGTAGTCTAGGTTAGACGATCAACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCCATTCCAGACCTATTTCTGTAGCTTGGCGGACCCAGTGCTTGTCGTAGCTAC
+
?,=A?BBBBDDDDD<DFCFADFEF+FH+>CIGDCFHIIGEHF.DC@HHF?HHHIIHEFHFHHIIHCGH5IIHCIIF5HIFHH'EHIIIFFEIIAHHEEEFCD.FCHHDGHHDEHGHGFHHH<HGDGEF(G*@H2F<*EEE;;GEGEEEGAEFDCEF.GA0EBAECGFDC:(EAG(:CEF?F6'1ECGE?0EGC(DGG:??A?GF;GHEAE#0H'<?C0GG:EEEE:EEC''G;GEEEE:.?::6:CCFEC
@antibody_259_multiplicity_12_copy_3-1
GCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGTGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATCCACCTTCAGTAGCTACGACAAGCACTGGGTCCGCCAAGCTACAGGCAAAGGTCTGGAATGGGTCTCATCTAATGAGACTGCTGGTGACACATACTATCCAGGCGCCGTGAAGGGCCGATTCACCATCTCCAAAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTG
+
?,??ABBBDDDDD?<@CGGFFFHIE>>FIHBHHHIHGIH-IEGFFHGGFFII+HHEHHHGFHIIGIGIHIIHDFIHIF=EII>IHICEHHH-GHIIHFHEFHIHIHDHFE=DDD=H9D@H.HHFGGFBBDFFHECGEEGGGG.8;?(AE<0E4G6GGEG#GEEG*GGECEA<ECCFEC#4E,FE(GCGDCGCGC?(A6EFGG(??A*GF*-?0G*8EC(7#GEG;((E0CA(CC=GG?FECG*EE.GAE(
@antibody_259_multiplicity_12_copy_4-1
GATCAACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCCATTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCTTGTCGTAGGTACTGAGGGTGGATCCAGAGGCT
+
??????BBD-BDDD@B-GAGFCHEIFFFBFFHIHHHIFHFFHA@FEFF8HEGHHHHAAIFHE5FIHBHIH5CFDEHHHDHEH=,EIHG-HHHHHIHFAGEHHG@HHHEGAHHH(H*HFFHHDFG;FEFFHGEEEFA?EEGFEEEEEECGGAG;GEB?*GGGGAC8GECC8/*EFE*6GC*GEGGCE?EE8EEGGG/EEC*FE6A?ECCEHE?CC@G*EEEG.:GG:'EGCEE*#*?ECG6?AEG((G*EA
@antibody_259_multiplicity_12_copy_5-1
CGATCAACCAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGCAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCCATTCCAGACCTTTGCCTGTAGCTTCGCGGACCCAGTGCTGGTCGTAGCTACTGAAGGTGGATCCAGAGGC
+
,????BB?-DBD@DDD6G.FGFIEIE=H.HI;HHFAAIGCHHIHGHFGHFIFHHHH5HF=AEBIIGI5EFDHACFHIH?H==IIIHHIDI.FEDDDHCE(HHHHHBEHHFD+GCHFHFFHFFDHGF2EGEEDH?+FDEDBGFCEGAGEGCEDGG?ECBG/FBDEEEBGGF8FAE:8F.FEC?G:08FEDEE:G(GCC:AAGE.;(>CFA8?GC=*ECF1(CF8AG*G><:E:GGCG0)EC9)?E<A?G:E
@antibody_259_multiplicity_12_copy_6-1
GGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATCCACCTTCAGTAGCTACGACAAGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAATGAGTCTCATCTATTGATACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGCCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGT
+
??,=A+BBDDDDDD<BEFCFGGHHHFHI?EFIHFAHFH=FHI.IH@D-HFHH=CFHH.FHFHHI>HHGFHI)HIIEICEHHIGH6IEHIHFEH,DHHH9DFHDHHDCHFFF,E)HFH,2HHF5DFDHD3*FEHGEF*FEE,GEEGBGGCGF8CGEG0C5;CEFBE.(EFEGGCE8CGG=/GG<:EE(G,6(EGEG?FGGC?F:F:A6(AA1;@AC*/DG:EGEEEEGACEGGC0EEEGG):(:E?GGC?E
@antibody_259_multiplicity_12_copy_7-1
CCAGTAGTCAAAGTAGTCTAGGTTAGACGATCAACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCCATTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGGGCTTGTC
+
5???ABB=E?DDD-DDF/CGFFIEFIAIH>IHHEIGHIHH-DHHDFGHFHHI=GDGFFEIFDHIGGFBFIIF@GCFIH,DEHCF8GIGHBFDFI?HFG+HFHBHFFHCIHFDGGGG3F:HGF35EBHGGHF6GGF@=EE;EGE+E5FEFGDCBEEGFCECC>E=)9E;FGC?EG@6G(EEG.G0EAG?FDE1F:AFAG'/EAAA:ED6E:FD@EEG.E8G*G)G/AEC:EEG(*=:EGAC.:*A)E?0?E
@antibody_259_multiplicity_12_copy_8-1
CTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCCAGTCCAGACCTTTTCCTGTAGCCTGGCGGACCCAGTGCTTGTCGTAGCTACTGAAGGTGGATCCAGAGGCTCCAAAGGAAAGTCTCAGGGACCCCCCAGGCTGTACC
+
,5?AAB<?D<+DDDD9>FGFFFFHHH-F.HC/HHIHC/IIAIH,FF=GHI?FGFII-IF5HH=D5-ID5I@CIIDECFHICICHF;HFIIFHGHHHHHHHHHHFH7HHFFHGE+DH;H19HFGD*EGF,FCFE8*B@F=F>#AE*EB:DDA;GGEGA?ECGGG@G'E,FFFGFGEFEGGG::(*-CGAECFE:EG*E?6C)GAFGGE?EC8GE:(FE#1ABG#EEFE?/GG6G:(E6C*(*:GEC(C:(E
@antibody_259_multiplicity_12_copy_9-1
AGACTCTCCTGTGCAGCCTCTGGATCCACCTTCAGTAGCTACGACAAGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAATGGGTCTCATCTATTGATACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAATTAACATCTGGTATA
+
??<A?BBBBDDDD@DDFFF?FFCFIFFEFIHHFIHHHGEIFIE?=H9G=FHGIHIH/DIFBH=GHHA=?FIGEBHFIHI,-FHICGHDHHHIDHFHGGIHHH5BIHHHEFHEHFD+HHDGFHFGGHFBDEG?BGD@FG3GD*B?EE@EEE)GEEF;C?DEE?GG8;/F2;EE<GFFEG8GC:GGFE.*GEFEFECGFEEGF?A(:.FE*HEC0ECG<EG7*EEG::F*FC(EF?E)C?ED<A0C.E??6?
@antibody_259_multiplicity_12_copy_10-1
TGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATCCACCTTCAGTAGCTCCGACAAGCACTGGTTCCGCCAAGCTACAGGAAAAGGTCTGGAATGGGTCTCATCTATTGATACTGCTGGTGCCACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTACAGAGAAAATGCCAAGTATTCCTTGTATCTTCATATGAACAGCCTGAGATCCGT
+
??<???BBDDDB+DDDGFEFFGHHI8EHFHGICHHHIF?EAHHAF-,?HEHIICHHDIFHGHFHFIBADEFFHIHCIHEHH'FHC8HGII5FHG+-FCCHFH3DGHFF=HIHHFHHFCEF<FHHHHHE<34FF=G@GCFG.FGG8EGFG?;GF0GF*F3;G<GECEE6GB(((GG8CFG<G(9E.GA6EDACE6G*GE:FG;GG0E/EAHG?#)(*(A:EGE0EG*EEE(AC::CA)E*AEGGE(#E*?*
@antibody_259_multiplicity_12_copy_11-1
GAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTCTAGGTTAGACAATCAACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGGTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGGTGGAGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACCTATTCCAGACCTTTTCCG
+
?A???BB=D<B+BDDDFFFFFCIIEFCEHIIHIHHFBGGHHHHHHFHIHIG8;G.FICHF>G;IIHDA5HHHFEFIHIIFIFHIHHFHHI5IFBHFH/HHHDG=GH5DHHHHDDG.HHHFHHFD#DGGEBG3EA@*8BCG?(FEACE,BBF=88E8E?GGEFGGG8#*DA(EAE0EGEE>G@C*C#:G::GEGFEGGEG?GG(>E/HEFEGEH@G??*>E?/::GG1FE//E*0GE:G?*?:G:EEE(G)
@antibody_259_multiplicity_12_copy_12-1
CGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTCTAGGTTAGACGATCAACGAGCTGCTATACCATATGTTAATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAGTGAGTTCTTGGCATTTTCTCTGGACATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTATCAATAGATGAGACGCACTCCAGACCTTTTCCTGCCG
+
?????>B>=D<DD(DDAGGFFF>FHHHIHIIFHGIEHHGHHHGIHFHH+G>HACIHHHGFFFHIHH5FFH-H;GHHIFFIIGF=HFIF(EHFHFCG3EHFHHCHEHH@EHIEEFF+HDEHF:CDFEGFGFHFE=EG0*GEGGGCB:D:DG(GG@?DFG'DE#GG9CE?DEFCACFEE/GGGGGF*48F/98E80EAE0E'E?AGF/E?:C>/::G?B*0C;?6CCEG*GC*CGACEE.#GC:)GC(9(*?
@antibody_260_multiplicity_2_copy_1-1
GCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCAGGATTCACGTTCAGTAGCTACGACATGCACTGGGTCCGCCAAACTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGCAGGGCCGATTCACAATCTCCAGAGAAAATGCCAAGAACTCCTTGTTTCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTA
+
???A?>/B@DDADD@@FGFF.FIFEEICIF@HIHHHIH?-GIEIHF-.BFGCHFH+HHCGIFDIIIFHHHH-H5IAGICHFHI?5GAH6FB-HFIHFFFIID+FEHHHHHFDFDEGHFDHHEHFHH=?BF>=G@F1;@G**CBEEF;D=E?*G6EEGGG>B#C2;(;C>,C?CEG#A(CECEE;F:GEGFG?FACGAE?EEEG/AF/FFC?:/GCG0AE04CCGGGG:D:G;(GA?ED0A/CE:A80EEE
@antibody_260_multiplicity_2_copy_2-1
CGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACTAGTATGCATAGTAATAACCACTAATATCATAGTAATATGATCACGAATCACAGCTGTCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCCTTTGAAGAAACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTTTTACCAGCAGTACCAATAGCTGAGA
+
????=B?3<5DD5@@DEG>F,8HIHHIHHIF@@IIFI;FIAEGCFHAHFD0FEHFHEAFI+H,>HHFFIHF++IDFFFBHHDCIHHH8H7#HH+HFHDHH-CH.*HGFEHDHHFHH+FHHFGFEGDGFFFDFG*FGH=?BGE=GHGE(E=G.G@EGE9C:FFGCFE8FEC(EG:?G:FGEGEFGG9EEA(E)FCCCGE:E(:8GCCHE:E?6@**=<EGEFCEC(8)(G:EGCGGG?ECE?GGE*(.>E(
@antibody_261_multiplicity_4_copy_1-1
AACCACTACTATCATAGTAATATGATCACGAATCACAGCTGTCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGGTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATAATATGTGTCACCAGCAGTACCAATAGGTGAGACCCACTCCAGCCCTTTTCCTGTAGCTTGGCGGACGCAGTGCATGTCGTAGCTACTGAA
+
?????BBB<DDBBBDDFFBFGEH/HI.IIHFHFHFHFFAGDHHHIFFFHGIHHFHFCHFIDHHHF,CHFF*H-HCIIHEH-EGHHCEIIHICFHHHHIFIEFHE+HE*EHHEHD>GFEFE4EFF*EDFDFFF*@G+H=.BGGFF;GBF=G*A>EG?G.GAFEGFFGGEGGGGGEEGCGEEEEGF<E(;FGEDAC:*:)F8GE'E?CEE::?GH:E7GECEC(8GAC)ECGGCCG8G?GEE1*C.:0::GG
@antibody_261_multiplicity_4_copy_2-1
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACTACTATGCATAGTAATAACCACTACTATCATAGTAATATGATCACGAATCACAGCTGTCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGTTACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATAATATGCGTCACCAGCAGTACCAATAGCTGAGACCCA
+
?????BBBDDD<EDDBFGFAGEEFHHFHFCFIHIHFHC9HIIHII@CF-HGHIH+HFF?IHGHEFGH5HHHGHEFFFHHFCCACICIFHICDF*HHG6H5HGHDHHHBFEHGFHHFHGHFGHH+HDHEEGE9@+EIGH;CCGGGEGAEE'9(GG-GAGCFEGGGG;GG:(8EG0BCGE(?E8?E0AEC?G0GEGGE4EC?EEGEF:(EG(GC8:*?EEF#CGG6GFG*A<A2(<EECE?AG?(*E.A:E:
@antibody_261_multiplicity_4_copy_3-1
CTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTAACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGCGACACATATTATCCAGGCTCGGTGAAGGGCCGATTCACCGTCTCCAGAGAAAATGCCAAGCACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTTTAT
+
??=???BB?DDBBDDDFEFGFGFC+HIAIHFDAHIIIHHICHEGFAI.FF.-EFCE-.GIHHCIE5H>HF5HIECFGBFIHFIIHBCHDHHIGIHH+HHHIHDIDFEHHHG@4G*HHCGHHEHDDG+ECHHBG?@*FEGA;CEAGE/EFFEE,EGC/GFCGEEEGGEEACFEF:FEEG:?EFGE6EG<EFEAA:G:(EE?#CGEEE;>?CEG:CCA7CEF8;2EC0GCFEGF*ECE8E*E:ECC6*#?CE
@antibody_261_multiplicity_4_copy_4-1
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATATTATCCAGGCTCCGTGAAGGGCCGATTCACCGTCTCCAGAGAAAATGCCAAGACCTCCTTGTATCTTCAAATGAACATCCTGAGAGCCAGGGA
+
?????>BBA<D+DDD<@GFFFC-IFI0H8IGFBAAIFIHH@HHH8EHC7CHHFHHHEHDFGHHHHIF7IAH+HBHHFHIHHHC=8HIFF=HIHHGHHHHF*DFHFBGHHFFF+GG;EFFGFEFDH*GFHEHGFEF4E;HBFDGFGCGBFD*@GEEFEC?EG;EEE.E8?EDGG:EGEE8<G:EEG(AEAE)0GEEAE2EGE(GE9CCEGE#GHCCECF:GB;(:GEEAF8;C:0.AED6E:6A0E'G:E0
@antibody_262_multiplicity_2_copy_1-1
TGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGTTACAGGAAAAGGTTTGGAGTGGGTCTCAGCTATTGTACTGCTGGTGACACATACTATGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCTGAGAGCCGGCGACACGGCTGTGTATTACTGTGCAAAAGACATCCGTGATTCGTGATCATATTA
+
AA???>BBDDDDDDDDFF8GFFIFEHEHHHIHHHGEI=IHHIBDHI.FF=AIH=FIHHHFFH-IDGC#H5HEIIGHHHICH5CDCHAH?H=GF@FHHHHAHEFHDHA,F9D,AFDEHF=1BCFFEH?HEG;97FFDEGEGGFG8*AE#FF.GGEE@EE?GDC/EGGGCE?AEG?FGE;G:G(.FEE(0:;.EE:8E#*(E??::EG:646A(:CFG*G(@*/(E?6>?:?(EE6G?00D<?*?EC8CE*C
@antibody_262_multiplicity_2_copy_2-1
GACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACTAGTATGCATAGTAATAACACGACCATCAGAGTAATATGATCACGAATCACAGATGTCTCTTGCACAGTAATACACAGCCGTTTCCCCGGCTCTCAGCTGTGCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTACAATGGCTGACAC
+
?,???/BBBADBBDDDGFFCGEFHI8IBHHHHHC9IDIHH@HIGGGID-HFHHHGHHGHHCF/IH?IH+HD?E-HHHGIHIFFH<IGIFDGHHHGAHFIH.@HECE4HH,EHFHGFF,EHDHFHEH+)EHFE5EGCGG*FGDEC*)GE/?EC.*@E)BEE?8GCEEECEF(C*CF0EEFEG?GG?8?AEGGFGE0EAGGGE(?EC/EGECCCFA@/EEC/C?GC***AG*?A*E*CGGCC:(*.AA:*0G
@antibody_263_multiplicity_1_copy_1-1
TAACCACTACTATCATAGTAATATGATCACGAATCACAGCTGTCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGGCTGGATAGTATGTGTCACCAGCAGTACCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGCTACTGA
+
?????B+BDBBB@BD@FAF+AGFF>IHHAHHIIIDFIDHHH9HHFCIHEGHFF.HGIGB=IHIIHA;FFIIIIHHDIHIA5HHGHFIHI<HHHHHEHHHCHH:GCHH+FHBFEHHI=HG#HEHG3EHH;F3G??AEHHEDFEGHDGHEEFEE*B@6F?*GG6E,AGEAGGEDEECG<CCG+GC/6F;GG?FGC@GF0C*G?EAG:GEC;*??HFC0CF,C*G?C6<;?E?:*/EG?CEGGE68E)E'CC*
@antibody_264_multiplicity_1_copy_1-1
CTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATAATATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCAAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGACTGTGTATTACTGTGCAAGAGACAGCTGTGATTCGTGATCATATTACTAT
+
???,?>B-DDDDDBB?BCFCGFIHEBI8HHIFGHFAIICEEI7>DFDFHIHGGFCHG@IAIHFEFHFBHHFIHGIHIDAG5HIH=DFHFDHDIDHEIIGHGHF4EFHDHIHHHHEHHHFDHBFHE(DEHGHEFEFIGE?EDGC2FFGEECGDECCGCECACCG#GAGEF;=06E;G>1AEE:*(EC(G(A6AFGAD;A6#EC.F(?E;CHGG-('EC(CCBEG0E:EGEGG;:(*;<EEGCCEEEE:.GG
@antibody_265_multiplicity_1_copy_1-1
TGTCCCTTGGCCCCAGACATCATAAGCATCACTAGTATGGATAGTAATAACCACTACTATGAGAGTAATATGATCACGAATCACAGCTGTCTCTTGTACAGTAATACACAGGCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGAAATACCAATTGCGGAGACCCACTCCAG
+
?<<??<B>DDBB<D@B.FGFGFEHHAFIEHICHAHIDI9IHFDHCF-DHIHGFHBIIHHA>HFHHIH-HHIE55IEFIGDI-HFHIEHHIIHHCFG)7GHHE-HF)CHIH;HHHBGHFDDE9H+DEFDEH+CD6?G7EE44FHGE=ECEFF*GE.0GECCEEEGEGEE;0GAGG:AGEEEAAE6GF=G?E<G0GEEE:AG?4<0GCCG06CCE1ECG'B7EE(FEEC<'G:<*CC(*(G82AEEEA:CAE
@antibody_266_multiplicity_1_copy_1-1
ACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACTAGTATGCATAGTAATAACCACTACTATCATATTAATATGAGCACGAATCACAGGTGTCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGACACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCGTGGATAGTATGTGTCACCAACATTACTAATAGCTGGG
+
A??A?9BBDD<DDDBDFGGGFFHFCFHH#HIIIHIIHHGHHHHF@IFHHEG=HAFIGBFHHEGHIFGHIIDGGHIHHCFFHIGD-ICHAH=IIHHH+.FIIHFFFE,3GFF+DHDDHFH7(HHHFFFFF,FFG,*;E/?GEFGGF?,EFGFFGFEE?;;G?GDGGE0=EA6*(*GF?GAGG+EGF0A(?EGE?=E8FEC?GEA'E:EG/(G(*CFGE0GGEEC)**:GEE/E:CE#E?G#AG'C;EA((?
@antibody_267_multiplicity_1_copy_1-1
GACATCAAAAACCTCACTAGTATGCATAGTAATAACCACTACTATCATAGTAATATGATCACGAATCACAGCTGTCTCTTGCACAGTAATACACAGACGTGTCGACGGTTCTCAGGCTGTTCATTTGAAGATACAAGAAGTTCTTGGCATTTTCTCTGGAAATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTAGGTGTCACCAGCAGTACCAATACCTGAGACCCACTCCAGACCTTTCCCTGTAGC
+
?5,?5B>BEDDB-D?BCGGGFFIIHHIHFIE7,EI=H-IHHHIHH>9HIIHDHHACFIHHIIHIDHIIHHHFHH=AHCIH5HHHGIIHIHGHHDHHHHHFGFH.-HDH)@E9H?HD9F;*@FHGHFFFDE)GGGGGF.FFA+F3?EEC(EC<7;GGFEE(*EGGBFGGGEE(E=2GEE:E+EG9EG6CDFCE??CE#AEFG6GECGC-CEFE:EFGEG?,EGE*0/E0C?GCCE0(EE/6?(FEECE:C*
@antibody_268_multiplicity_1_copy_1-1
TTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCATCTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGGAGGGCCGATTCAACATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCGTCAAATGAACAGCTGAGAGCCGGGGACACGGCTGTCTATTA
+
5??A?BBBDDDBDD@DCGGAFGHH?HIIHHHIFIHHF@CAHIHFHHDIFI9.IHGIEFIIIHHDGFIIG5I--GFHAHHHHIHFG=FHHEHFHGHEHHAEH=EHHHFHECEH+HDF1GDFHHHGEF6B>CFGEGEIFGGG4+G9(;F0GGFGGFE@AFEEG)?AGF?EE'EF*AG-EE:ACG1;EEEGA(>?*EE':GEGG(EGAD(G):;C-AEE/:CC=EFA;?AC:'A1(./?E6;EAE6C*(88:E
@antibody_269_multiplicity_1_copy_1-1
CCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTAGTTACTAGTGGGACTCGATCCGGCAGCCCGCGGGGAAGGGACTGGAGTGGATTGGGCGTAACTATACCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCGGTGACCGCCGCAGACACGGCCGTGTATTACT
+
???,?BB<<EBDDDDDGGGFAFIHEHHBHIF+EI7IIH.9HGIEIHIIGHCHD7DGHIHEHIF.IFII=)IIFI<FGIEIHGHIHHFFH-HG(IHIFGHGGHEHHFE5FG*H0GHGEC#HDGEDGHA+E*FGGGGEB.EFFEEG3EDEFDDG*G:FFCG0CAG>6GECG;#EFE?G(E?E(EE*DGG:6E?EG?GG*CAGEACCGF?(CEEC@@CG/?(<G?GEEEEF8/EGC:AC*ECC?:)EECEF#E
@antibody_270_multiplicity_1_copy_1-1
TCCCTTGGCCCCAGTAGTCAAAGTACATATGAAAAGGCCGGCTATAATAACTCCCCGAACATATTAATTGCAATGGTACCGCACATTAATACACGGCCGTGTCCGCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGACTCGAGTCTTGAGGGAGGGGTTGTGGTTGGTGCTCCCACTCTAATAGATATACCCAATCCACTCCAGTCCCTTCCCTGGGGG
+
?????BB<DDDDBDDEGGG.CGIEH8CHHIHFFE=DIIFFHIHHHHHHHGHHEF+HFAG>I-GEEHH=GIF,HCIFIHIF?H@FIADEEHFEHIHIF88HHGHHHH=GE9HFG4HFC:HFH=HF'EFEEFDE0@2GH?CCCBGGCFEEG=6ECG2CCEGG:,??@B)?ECEGEAGG*?EGDEDGEE1G9GGA#*E>AEEG*-GECEEC#:ACHG:CCACE?>*??EEFA6FC:E6E?G:?/EG*E/E/C0
@antibody_271_multiplicity_1_copy_1-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCTCTGTCTCTGGTGGCTCCATCAGTAATTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGTAGTGGATTGGGTATATCTATTACAGTGGGTGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAATTCTCCCTGAAGCTGAGCACT
+
<????B-BDDDDDDDDGFGBFGI8CHCHFHIHGHIEGIIAHHIEFIHEDHFHGCHHHHFCFFHIIH7CFIFAHEFIA?EFHHICIHIHGEIIHHHFCHHHHIHFDCFFEHHHEH>DF,HHEHHHEFDFEHBBG#F;?*EEFEE,@FCFFBF(0EGE:?:E;EG,DE=EEG7=:EAC?E6GGG')AGEE8F0A:GCECE<(CC?E*E1A;=?:/@<C?G(CE0GG0?CE*GED:);?ECF(G18(CCA#AC
@antibody_272_multiplicity_1_copy_1-1
CCAGGGTCCCTTGGCCCCAGTAGTCAAAATACATATGAAAAGGCCGCCTATAATAACTCCCCGAACATAGTAATTGCAATGGTACCGCACAGTAATACACGGCCGTGTCCCCAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTGACTCGACTCATGAAGGAAGGGTTGTAGTTGGTGCTCCTACTCTAATAGATATACCCAATCCACTCAAGTCCCTTCCC
+
<????BBBDDD?DDDDFGFFDCF5HFAIIABIIIHEHHHEICFHIDGE@7IFDEFHHHHGHIFHI=HHHFIHHCCHGHIHHHIIIFHHIH8HGGDFH+I?GHH/IHHFGF#C9HA,EHGEFG((CBEGCDHG*FG#EDE(GEAGEEGGDF:GE:GFCAEEEECE,6EEE)EAEG?G?<EEGGE?(E'CGD)CGC((EEE*E:C6*E*?GE(GEE7E78((E,AECCE*/:1GCE)C<*':G(0AE?-GC0
@antibody_273_multiplicity_1_copy_1-1
CAGCCAGGGCGGTCCCTGAGACTCTCCTGTACAGCTTCTGGATTCACCTTTGGTGATTATGCTATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTAGGTTTCATTAGAAGCAAAGCTTATGGCGGGACAACAGAATACGCCGCGTCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCCAAAAGCATCGCCTATCTGCGAATGAACAGCCTGAAAACCGAGGACACAGCCGTGT
+
?,A?=BBBBDBDDDDBEFEF-GIIHEHHICIIDIEGGHIIAFGIHIDIHHFHFDHIGAHGFHEHGHIICIHF=AEH?HHH;;FGFIFH@IEGHHI#>IIEHHHHHIHHGEGHFH8HHFF4FHF)EF(FEHG?EE*BEF3(GFFEFG9E@FFGE@GGGGE?FCE;GEDC0EC.=*EGGEE*A<GGEEG??AE(F':ECE*E:DECE6AAGHC07:(EGG(2:E8(EAE*/GE?>?GGC:??8GCA.E0(C6
@antibody_274_multiplicity_1_copy_1-1
GTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCTGGCCAGAGTTGTAACCATAGCTGTATCCGTACCTGCACTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGGTCTTGGAATTGTCTCTGGAGATGGTGAATCGGACCTTCACAGAGTCTGCGTAGTATTTATTACCTCCATCATATGATATAACTGCCACCCACTCT
+
A??A?B<BDDDDBD-DDFFGFGH0EFHHHHDGAIFHIHDHIBHD=HAFIH-GEHHH9EEHIGIIGFGEIHIHIGII)AE)HEH@+>H=F+HDHHDIIHEHFDHDHHCHHFHGHDHHEFHHFF+HCDHCHA,EEFF=AGGHCFE:G?HAEG,,E5(GCG*C:6FEGCG(:F(EAEE:FEECEEC6EC')C*CE:1;#C((EF(:*EG;?EEE6<8@'E?)0BCFEE*E/.EGGE*G?(8EC(CE:E.:AC?
@antibody_275_multiplicity_15_copy_1-1
CTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGGACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATAGGATGGAAGTAATAAATACTACGCAGACACCGTGAAGGGTTGATTCACCATCTCCAGAGACAATTGCAAGAACAGGCTGTATCTGCAAATGAACATCCTGA
+
?A??,BBBBD@@DABB@GFGFFIHFHCHIIIHHEHIHDH?HHEHIH+IFFHHIHBECFI;CHHI+FHHHDIDIAIHHIHBFFIE?6HFGHFHF+HFFF=IHIAG@.CHHH8EEHGF,CHFGCA1CHEFBFFGEGDFGEFGEF*GFFBGG/AEBEFEA6=EEGC:EFG??E(F:*EGFGEEGG=;?GGE/(8FGEG??GEE?E?EEGACF)*EH@#<?GGCG/:EE:(*/EEC:))((AAECCCC(CG?<F
@antibody_275_multiplicity_15_copy_2-1
GACCGTGGTCCCTTTGCCCCAGACGTCCATGTATTAGTAGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGGCCTAATTTAAACACAGCAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTTACGGTGTCTGCGTAGTACTTATTACTTCCCTCATATGATACAAATGCCAC
+
????,7,BDBDDBDDDCG8CGGHIHICH.+HIFIDF.DIHHGHIEEFG.FH+CEII8.H?/EIFD@HEFHIH+FHEH+HHGGHHHHHIHB(HGI=H6HIFFHDFEHH*HFHEHG+HBFGHGGG@FGHGFG2GGDC*;H.*EGDEEE=EHGEFE:G0GGGEFGBD:EEAEEC*CFEG8EC6EGG(*G0(EGC?FGFGC:?(GE/:AE(E?CFGAEGCC(C/G(CEF:E8C(::E?C/)CE?*C8C10*E6E
@antibody_275_multiplicity_15_copy_3-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCTTGAAGGGCCGATTCACCATCTCCAGAGACAATTACAAGAACAGGCTGTATCTGGAAATGAACAGCC
+
?5???BBBDDDBD-BDGFFGGEECI6HEIHGHI@IH=FEHHC.HCE.IIFHHHIIH+GHICCFIEDHFHIAE(BHCGI;FDHAIH-GHHEHHGIHHCF=HCD)CFHFHHFEHDFH+FEH2GEH-EFGFHHD==DEF<GEGAGGE@FEGGDGEGFF9AEF?C*EECG4EEECGC:AEGGCG?:C*G/:8EGCG)GECEE):;C*EEA;E?EAEHGEE(#GEGAE(:.C(FC:**<EEE(>.EEFCEC<EC;
@antibody_275_multiplicity_15_copy_4-1
CTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACCGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGTTTAAATTAGGGCAGGTACG
+
?=A??BB@BDDDDBDDGCAFG/AHACFIIFHEHH9DHHHID@HHFDHFFHHCHHIIIEHHHG,E@5GHI+H-@EHGGDHIIG5HDIHDEE*IH,DI=HHIH<)HFHEHH@HHHHFHH28?E:>?=E7D;GBGGBG?G24GBGFGG=GFAGGE)GG;CGEEEFCCG:EG?FFEECECE?*G:GD;G?C8:GEGE.;E<GCEE.0:CEE)GEG6E@BAEGEGF<EAA('EG?:CCAE(.A**0(:E?E6*EG
@antibody_275_multiplicity_15_copy_5-1
GTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTATTAGTAGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTAATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCTCGGTGTCTGCGTAGTATTTATTTCTTCGATCATATGATATAAATGCC
+
?5???<B<DADEDBDDEFE6FFIEHIFHHIIIIHFFHHGHIIHFDGIGHDHCHFFFAHIHHHHFEHHIGCHF?DHFHHIGIFHHHAIIIIHHH>IHIHHFHFHIHFDDA=H2FFHDGGBFFH/,HHHGFF@EHHDEEFGEGEFA#DEE(F=EEAEE?E?G*E?'CEEG<?CGG.;GCFCDDE(GGEC5/E'80;8EGEA-'F*GG?E?*)GDEGCECGFEEFGF*(<GEE)EC/C?A4EC:C*(AEE(D?
@antibody_275_multiplicity_15_copy_6-1
TCCCTTTGCCCCAGACGTCCATGTATTAGTAGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAACTCTCAGGTTGTTCATTTGCAGCTACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAAGCGGCCCTTCATGGTGTCTGCGTAGTATTTATTACTTCCATCATATGATATAAATGCCACCCACTCTA
+
??,??BA9D?DDDD59CFFGFFAIFHABBHGHHGFIFHIDIHAHHCHHHBHGGHFHEGIGEF-IHEHAIHFHGGE5HIIH@HIHEFGHIF>CHA5HFHHFG,9IGF+CFHHFFH?H:GE**FBGGDE66*EF.FFFHFGDEEG#A(GDE;EFFEECGGE(GGEGE=EEG@GCGFC/F6ECAG((ECAC;GE*G6G?ACG:FEEEA(E126DC*ECE(G,;FE?EE=G0FE?CA*0G*G)8*CE10:G88(
@antibody_275_multiplicity_15_copy_7-1
AGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCAGAGAGCTGAGGACACGGCTGTGTATTATTGTGTTTAAATTAGGGCAG
+
?,?????B<-ED@DD<-FCFGFHAHEIH/HHFH/HHFIIGIIFBICDIHFCFIHGF-FI5@HFIH5FI.EF-BHC-IGIHI?IIIFEIIA(IHFHEGCDGFHHHEHHDDGH9HHHG+CFHEFH.HGEEGFGDDEHF@FGE=FEGBEECFG>.E.8DGEGE;EGE2G0BEGGFEBEGG(:E(CEEEGG<AFGEAG*EF6G<6E#F(EEGEHCE@84G(/-AG((:G*FE:E#A?#8?CG?/GGF0.()1//
@antibody_275_multiplicity_15_copy_8-1
TGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTAGGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGATACGGCTGTGTATTACTGTGTT
+
,?<??BBBBD@DDD@DFGFGG-6CFIIE/FH0+IIFHDI-H.IHI9EFIH9IH@+.IHEIAI+AHHGFIFFHFEFEFHHEFH=>I@BIIGH7FHDCHHHH+IDFEHHHCFHG@.H-AHH<EGBGFEH59FF<FHFGEBEGFECGE*GGGGG@E0)GE(*EEFG:FC*:EEGA6?8F?+E:GAC?CE<#EAE/*C?FGAGC(GG06GHC(?EGE187EC77GG?G:EE/)EE*EA8GA*:CA*?26E?G0C
@antibody_275_multiplicity_15_copy_9-1
TAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGTGTCTGCGTAGTATTTATTACTTCCATCATATGATACAAATGCCACCCACTCTAGCCCCTTACCTGGAGTCTGGCGGACCCAGTGCATT
+
?????B<BD@DDBDDDF8FGFEHE/.HHEHH7/EFFIGEFHI9IHIF,IIHGDCHECDIGIHHIHIDHEGIIF*HIIBII@HFFI?H6FHHD??AHIFFEHFCDF*CDBB@EHFHGGEH*#ED;EEHEGEGFGHG>H4E:CFE8==GGEEGEG8FCEFGC6E(GEG0E*EEC;0EC???GG6CF?6.GGG;'C>GG:)C<E/EG:1;ECEC?EG*(.8G'/0(EAGEE(*'E6ECAFG):?CE.AE0C(*
@antibody_275_multiplicity_15_copy_10-1
TCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCGTTAAGGGACGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGTTTAAGTTAGGGCAGGTAC
+
,=<?5BB?DD<DDBDBGAFF>EA+EHIIIIF9CHIEDIHIIHGHIIIH9GECHFC.I@IIAD.FHIHII5IHHDEHBDEDHHFG/HH.HG-IH<DF4HDIH.HHEHCF=FHH7?E?HHBFEDF-EGEEFFEEG##(G=E*F>GGDAG8;9FED:EGG*:CFEGEEGEEGGEE4CCEECEGEACGD(EA*GFFCD:G;EC:EGGFA?:*EHG:8@1EBG,CEG:/<C.E0CGFCECG*G(FE(*(?8EF.F
@antibody_275_multiplicity_15_copy_11-1
CCTTTGCCCCAGACGTCCATGTATTAGTAGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCTCGGTGTCTGCGTAGTATTTATAACTTCCATCATATGATATAAATGCCACCCACTCAAGC
+
??=??B/BB+5DDD?@GGFGF8HFAIIHHBHHHHIFE.IH.IIIH@9F5GBFHHHHHHFFIIIHHIIIIHF-HFIAH,HHHHI@FHI(GDFFAEIHDHHDHID3FCCHCHFHFFHHCHHGHD*:FHGGGE*DDCEFEFEFE/EGECGG*GE(7E8FEGE?CEEFGGC?EGGG(BGEEGCEEGFF?GCGGG(6EEG?E:E:8E::G0HEG::E*G@AGG8EG:G?GEECG:F.G*?E68:0ACECC/*?(:
@antibody_275_multiplicity_15_copy_12-1
ATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCATTTATATCATATGATGGAAGTAATAAATACTACGCAGACACCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTAATGTGTTTAAATTAGGGCACGTACGGATACAGCTATCGTTACAGCTCGGGCCTGAACTTT
+
<,???9BBD+D<DBDDFF>F-GHIIEHC?HHFH/,EAH>IHIIB>IHFCH.DHG'HHHHICDCHEC/FHAEEIDG75?GEIHGH7HDIA(HFDIAH7DIHFB=FFHFFHHHGFDCGHFFHF;EG)F@4G6H+C*EFFG:CGGGC@9G*EC()ECFEGGEE(EEAEGG8G6EE*CG?EGA/:C2EFG/EGE*G8E.EE*GC:A.?F*E<G#A0@EF*BGE8EE)G?0C):ACCGEFEEAGE?<GGGE'?CE
@antibody_275_multiplicity_15_copy_13-1
GACCGTGGTCCCTTTGCCCCAGACGTCCATGTATTAGTAGTAGTAGTAAATTTCAGGCACGAGCTGGAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGCCCCTTCACGGTGTCTGCGTAGTATTTATTACTTCCATCATATGATACAAATGCCAC
+
??,5??B5DD+D5BBDF>FFGGC/IFEFHHIIFIIIAIIIHIHHDICI8HG5HH=HIF-FIHFAHF(HBIHIICH4CHIDGFEB,GHIHHFHHHHD?HIEHH?HHHHIFGDHHG6H'HHHGEFD=EFDBFFH2GFGE@GGG/GGFGFFGFEE)GG;CBEEG)EGF8G8CE(;FGGBFF(EBEGCCEEG()CG.'GG6E(E:(GGGF?EC?*GH(:?EG4EGEE(EAGF(G?:(2:G(CAA#C;FCE/:C;
@antibody_275_multiplicity_15_copy_14-1
AGTAGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGTCTCTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGTGTCTGCGTAGTATTTATTACTTCCATCATATGATATAAATGCCACCGACTCTAGCCCCTCGCCTGGACCCTGGCGGACCC
+
??,??BB<BD5BDEDDF;GFFECHHEHHEHIBHIHIH58IIAFH?IGHIDDGGFCDHHIIFH,IGGICHICH,H@@FHIEI=HFG-H=HGIAC*+HGHH-H+HHHHHHEHD@H2FF:1FHFF*GF,E*HB2FCFEGDEGF?(G80CE=E..GE2F6:/:.B?GEG>C?E:GG;FG?/EEEEEE6E:?G?EGEFF:EGEGEGGC*EAAEGH;CCFE4((,=C(G<E6(EG'?EGFGC66:/.CED??F??G
@antibody_275_multiplicity_15_copy_15-1
AGTAGTAGTAAATTTCAGGCCCGAGCTGTAACGATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGTGTCTGCGTAGTATTTATTACTTCCATCATATGATATAAATGCCACCCACTCTAGCGCCTAGCCCGGAGCCTGGCGGACCCAGT
+
?????BBBDDDBD<DD7GCCF.HIHEFII@9HGHFEHIC-IIFFIIH.HIDI-IIHACHIFHHHFI+IICIH6E55DI?HIFHIEHHGHEFA+IIFIIDH=@FDFGEHFFFEHCD:HHFG?HG@HGFHFGFGH0HEFB0*FEEEGFEEE;<F8GG0EEG?=EG8FGEA;ECG<GC(C#EG8GE?FECAGCE9(EAEEG(FEAEG6*HE*CE:<:E)F'BE?(#AE?/1:1#GDEEEED?F-(*?8EA*E'
@antibody_276_multiplicity_1_copy_1-1
GTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATGCACAGTCGTGTCCTCAGCTCTCAGGCTGTTCCTTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGCAGTATTCATTACTTCCAACATATGCTATAACTGCCACCCACTCTATCCCATTGCCTGGAGTATGTCGGTCCCAGTGCATGAC
+
5?<?=BBBBBBED<5@FGCF-GFEHHHHHIFIIHAIEHIHIBHHDHHIFIDFIGHHCFBIFGH>II-CFIHE-EIEIHCEHFHHIFDAHF6=IHDHHE+6BHFC5CFIHHDF5(+*ED@?GCDF,FDGGDGH9?<@EF=?CEFEEFEGGE*EGC*GGCEEFEEGEG((C=?FFG/:EE.E06*GC/G?CE#8#E(E?*EF?GC(GE:C.?G:C)8'7-?EE?GEGG::'(*:#C<G.C:8':CA>EACGG
@antibody_277_multiplicity_1_copy_1-1
ACCCTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCGTAGCTGTATCCGTACCTGTCGTAATTTAAACACATTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGACTTGACTCAGGAGAAGGTGAATCGGCCCTTCACGGAGTCTGCGTTGTACTTATTACTTCCATCATATGATATAACCGCCACC
+
A???,7B7@DDBBBD,GFFFFEF?HHHEH;HHIFAIFA+HIIICAHCIEIDIAHIHCHIIHHHH#HHFHHIHEHIGH;FIIHH8FHHHFHF-GIHGH?HFHH=IH*FC<H=-FH>HGHE'GG+BGGGEGFGEDGEGGG7(FA,;:?HG:CGG6G.GEG;ACGFFG8EF#FFE'GG6(GG::F*?E66.GAC??0'4>EG>AEGACGEDECEG;G7G#?(GEA:*C:8GG/0:F/E:':GEGCC.?E*?**
@antibody_278_multiplicity_1_copy_1-1
CTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACAACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAACCGAGGACACGGCTGTGTATTACTGTGT
+
=??5?B<BDDB<DD5DFGGF+FHHIEHFHIDHCHIIDIH/G9CFIDIGAIIAFHHCIDHFAHAEEIAGIIHFIHHHIHD5GCDII-AHEHCFFFHHEHDDHHHHFDFFHHFFHHEHHFF+?GFF4BDE5FFGD@FGE*9EGFGFD;E4F+:GGEDGGFBG@GGE8CBECE*:0GGE(AEECFE:AG4;EC:GC*DECG:G?<*C2GH8;CGE;AGE<*GGE7G(:?EE:GEE.E*:E*C(C?EGGEE0ED
@antibody_279_multiplicity_3_copy_1-1
TAATTTAAAGACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCTGGCCCCTTGCCTGGAGCCTAGCGGACCCAGCGCATGCCATAGCTACTGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCCGGGA
+
,???A?BBD9DDDDDBFFGAC.HIHEHFEFDFIIHIBHIIHFHCDEHHHFH(FCI;GHGHIH,IHHIH=HHHIEICHFHFHFFDHEF<IHHIGHH/GHHHDGDDH=FEG@HEF)G=DHC@G,*AHHCEE+HGFAHDDEFGEDA-DG?FGEGEEGFDFGG;GGGE#GGC?E?GGEG:B0G0EEE(E=C<:<C9(CE(?EAE*ECG8A.EC#E*E=.:EECGG((G?E#E;???*G;:6AGEACF/G(?CC'
@antibody_279_multiplicity_3_copy_2-1
AGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCGCTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGGAGTTATATCATATGATGGAAGTAGTAAATACTACGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGTTTAAATTAGGGCAG
+
,5??=BBBDBBDDBAD,GC/EFICHHH>HAIHDHCGHIIF@EHHG+GGHHH6DFDI?I#HIIECFGHIFGEGH:CD;HHIEEIHHCGI-GH,FIDHEHHHE+=+=EDDII8ED+H'CEHDHED@DFHFDGDFGEFGGG.GG=,>?G?EC,F=E#DGECCG*FEG.6EG*FEGGE:2ECEGD?6G>EFGG0E(G.GG:CE?8??/GC:EGHE?/E@A<*::8G:((*G:CEEF(GG(A6C?*/E6G.E68'
@antibody_279_multiplicity_3_copy_3-1
AGTAGCTATGGCATGCGCTGGGTCCGCCAGGCTCCAGGCAAGGGGCTCGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACAAGGCTGTGGATTACTGTGTTTAAATTAGGGCAGAGACGGATACAGCTATGGTTACACCTCAGGCCT
+
,???,BBBDD<DD<D+EGFFGGH0IHFHEC>EHFHHIGHIFHHHHEH+IFFICHI'FFFHHHIEIFIHIHHCBDIIGHIG/EFEAFEHHHBFE-H?GHHEAFGEHFDAD@HDF+GGFH=CFDFHECHGHG;*CFEI;F6DGGF@G@G?1GEFA,EEBEE;CE=F@EED:GGGEE8@F(EG('E?**GAECE((GE?AAFE2EEE.E(GFEEFE8*E;((GCEGCAEGG*EC::*G?F(:CC'<-1AECCG
@antibody_280_multiplicity_12_copy_1-1
GTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTGTTTATAACTTCCATCATATGATATAACTGCCACCCACTCTCGCCCCTTGCCTGGAGC
+
<??A?><BBDDDD@BDGFCGGFFICBIEIHF/FI+DABHHHH..HEIGH8EHHHGHHG=HAFHGFHHGIEIHI#HHEG--HEHC)A#IH=HHHFEH?IE3EEH@DCHHHHHD2DF4EFH+FFH+H8HH3@*EEFEGGADE(HG0A?;FF/F<EE?DE6CFBD1G*EEGGGEGG?'8E8G6>EAG(E:EEEC((EG.6C(*?D(<G(C<8;CCHF>G?EC,7G.:C'?E?AEF'F*EGC**GCCE<GCEA/
@antibody_280_multiplicity_12_copy_2-1
GACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCCAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAATAATTATTACTTCCATCATATGATATAACTGCCACCCACTCTCGCCCACTGCCTGG
+
,?A==<BBBBDD5DDDFFFFFGHIIHHIIFHIIHCBIHHAIHHIA@HHGC-H8HHICEHAHG@HCEI*IG@I)HHAIHIEHI;HHHHH8HIHI8GCFECEHE@H-IHHFHCBGEHC=H*CBH(B/FEEGFGFHGDIG?GDG3EEEEGE@GGEGGFG@.B*F.EEGGEG6E;/EFE#?DEE??G*-EGAF<CCA)(?#E:/-C:E8GECA:(ED'EEEE(AGCG<CGECCGEE?G;CG(*::*'G*EAE?C
@antibody_280_multiplicity_12_copy_3-1
TGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCACTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCTTAGTATTTATTACTTCTATCATATGATATAACTGCCACCCACTCGCGCCCCT
+
?????BBBD?DDDDDDFFGF@GIFIFCAH/H=IGIHIEBHFIFDHAIIHHFHHF.HHCICEFE<I5HHEI?HIFIGHIFCHIIFEI=+BIDFFHHCHDHI=IHIFGFHEH?*H,F-#F4?FDFHH8HEEGEEGHE=EG8GGBGEC?FCFFE;*.HG;GCEGF(EEEG*CGG;:EGEGDGE:AG:CG1EFD6E98:GE(G*GF<6C.E?EEGFHE(AC1)<E:GGA0E-6E14?C?GD/60E0(EG(0A18
@antibody_280_multiplicity_12_copy_4-1
TGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCGAGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTTACCATCTCCAGAGACAACTCCAAGAACAGGCTGTATCTGCAAATGAACAG
+
???<A?B?DD@BDBDDGGFFGGII+IICEFCHHHHHIGIHIAIGGHIFHG0HEIGEIDG5HHHGDFA5H=HHDF5H-5AHHCEI=HBI-H+HEHCH6EHHF=HHFHFGHGDDHF?HDDHEHH-BFCGFFDEHE(FGF(EDEFFB;G1E3GG*FGA:0(GEB=EG=?FG?2>GGG/GE:CG+;GF*0G81EGCGC:1FG((*>GG6GHG6:E:CC(EE#FGEE<E/CEGCFGC.FA:F:6(CG:*A;E0:C
@antibody_280_multiplicity_12_copy_5-1
CCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCGGTAACCATAGCTGTATCCGTACCTGCCCTAACTTAAACAGAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTGTTGGAATTGTCTCGGGAGAAGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATTTATTACTTCCCTCATATGATATAACTGCCACCCACTCTCG
+
5????B?B<BDDDDD?EG.GGGE6IHIC/IIA@GHGIIE/CH+.=HCFGCFE.HF*9DC@5-DCGIHFHIFIHFIHC0)HEFIEIFF+HHAHHFH#DFFIEHHHDHFFHF>HH=DHFGH89HHGDFGF2*EEG=>9GFEE*FEGGFECBAEE8?,EGFGGGCBEEEGB0BG8,>#GGE?=GFEGGFAGCAG;F6G=EEEF(CG.EG*EC?G?*E;*?EGG(E/FG(*EEE?E6?GG?GEG:C6?6CCC6A
@antibody_280_multiplicity_12_copy_6-1
ACTCTCCTGTGCTGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCGAGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGAGAAGTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGTCTGTGTATTACTGTGTTTAAATTAGGGCAGGG
+
,????,BBB@D@-B<B?>FF;FHIBIIAHF@HAH/GHI.IDI0DBAHED>HEHG9HFII'EIHFHHI5HIIIH*-IAHCFHIHFFH=HHIHIIFFH8DHHBHHHHHHHD.:HIHDFGECDE*DEEGHFHEC2*G(FEGCGGEFG?GCGDE1GEC5*''EGEG(EF(1=GCGGGEF*E/G(EGG<?G?AGG>CG?GE?*G:CG*?CGC0G?6E<'GEG:(G8::*E8EG;C2G;:6F/E(*(0E:1E'.((
@antibody_280_multiplicity_12_copy_7-1
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGCGACTCGGCCCTTCACGGAGTCTGCGTAGTATTTCTTACTTCCATCATATGATATAACT
+
?????B?=D@DDBD-DE0GFGFHIB8FCEHHHEEFIIHIHHIF=GFIHFHE@DIIFIDHAIFHCH--GH)CEIGFFIFAC5FFEEDHDHEFGHAH>CHHHHH=HDGI6H=EHGGDHHH4EBFHHFFHG=FFGCGEECEF9EG-9EC(E@0GEEE@:/;G?FE4GCEEE(6GE*GFE9F*CGGGCC6EEAEG*6G*EEE8EF'8GGGC)ECCEAAGGECCG*<(::*FGE(AA(E:GEE#;:AGEGGCA?*
@antibody_280_multiplicity_12_copy_8-1
AGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCACTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAACCGCCACCCACTCTCGCCCCTTGCCTG
+
??A??BBBDDE@DE@?FFGFGFCIHIIHIIEHHCIFHH=EH=GH9HHHDGCCIFAF@/CI+FGHHF-AAAFHDIFEF5+HHCIHH-IH=BH?HBI?HIEH6HGEGHHHIHHFHF.FF+?GBHHG(GHFF?BGGG#DFFCE?G5*E;EH?EFEEE:E6*(G?@E.(EEE*F=?EAA1EG0FCG6G:?AACC.EEEFE(8A.GEAEGEFCCH:GEAGGE::0E?F?'C.(EC/E/C?.:/EF*GEE;EE.#*
@antibody_280_multiplicity_12_copy_9-1
AGACGTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTACAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATTTATTACTTCCATCATATTATATAACTGCCACCCACTCTCGCCCCTTGCCTG
+
??????BBB55D-DBD.GFEGCBHIAIEF0HHIFFGHC@IECGEIIIIHGDHHFDFGAHHCCFIGHF-IGICHFGHDFGIIHHH=HIHIHF=HI;DHGEHIDHHHCCHHHHFFF+F@H>6FFBAEDE-GGFGHDDFEEE=@EFFGG?HFC0;GBCCEGECE*/ECD)GGE8;GGGFE.FACGEA0GFFE:06?:EEEEEE9GG0EFH?GEE?C8EE*C?FECG(FEEA:A/C:(E(FC?E6.(E;E?A8E
@antibody_280_multiplicity_12_copy_10-1
GTCCATGTAGTAGTAGTAGTAGTAAATTTCAGGCCTGAGCTGTAACCATAGCTGTATCCGTACCTGACCTAATTTAAACACAGTAATACACAGACGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTTGTATGTATTACTTCCATCATATGATATAACTGCCACCCACTCTCGCTCCTTGACTGGAGC
+
?????BBBBDDDD-@DGFGFG@CFHFHIHFEICHEIHHEIDCFHCHF0IAFHDHIHIHHFIIFAHH#5EDIGFEDHHHHHH-F.HFHH)G*IFFAIIAIDFHHH=IFHH7HF?4FHFDEFHEF6GGHGGHHAGG*GFEGBEEFFE=E,EGE?A*C*FCGE@FF.DG(0?GCGB0EG?('GGE(6EA:AE#G#EE*4C.;EGEC?G(;/(;GGHG/C??G,?E**?4:G;CC:8(E*(G6*6/)*/0ECCC
@antibody_280_multiplicity_12_copy_11-1
TGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCACGGGGCGAGAGTGGGTGGCAGCTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAGTCCAAGAACAGGCTGTATCTGCAAATCAACAGCCTGAGAGCTGAGGACACGTCTGTGTA
+
??AAA9B<BBDBD?DD8GF?G>HIHC.7AIIHFIGDIFFDH9HEDIIEIGFIH-HECIFFHEHI-DCIHGAAHHFHHF-HIFHHGGIHEE+IHHIH.@GHHHHCECI)H+HGFD?HG+FHDFHHEHEE1H/GFGGG*GGFGEBDGEAEEGEGEEEGC.BE(C:E</E?(CGGG:AGEE?-CFGG6EEEE(#EC6:E<EG=/G:/(EHE48EEHEC003EF7EAEGE:0?0AC(EE(:CEAG?.F*C(8FE
@antibody_280_multiplicity_12_copy_12-1
TCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCGAGAGTGGGTGGCAGTTATATCATATGATGGAAGTTATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGATACAATTCCAAGAACAGGCTGTACCTTCAAATGAACAGCCTGAGAGCTGAGGACACGTCTGTGTATTA
+
A<=?=BBBD<D-DDD@G6;FAFHIHIAHICEIFGHHI=+GDIGHFII9I+F5FIIIH8GHEHHH?A9ID=FFIHADH7EH=HHGHHFEHI+#HHHHHHH2H5GHHHIGHD@HIHEGFHHBGHBDFG.EFGEDGH(GFHCD@E?@CEGGBFGGE;@<#BEE14GG0GFFG(/(E@?GG,E1GE*AG@EGE:?GA/FCGC:EE?F(E(HC/CEG.E@G*GEE2(CC0;(*F:G?DE?8E:EGG?E(*.G1*E
@antibody_281_multiplicity_3_copy_1-1
GTAGTTAATTTCAGGGCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGACTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGACTCGGCCCTTCACGGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAAGTGCCACCCACTCTAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTCCAT
+
?=?=?B<BDDD?<DDB>--/GEAHIFCFE8IBFFFHCHEI.II@HIFIIFIHH.?HFEIHFIIHDAFFHHCHFAH@IA'HHIGCIHHFIH9EHIII7DFHHHEBH8EHDEFHDHHBFHGFFGGDFGBGHFEG:GHGGAE*EHGGGGHEEEG3AECGAEE=:GGAEG6E9EEFEAEE.E(E0GFAE1<GFG(GG':CGAG-(CGEGA:GG:E*1@CECEC:EC4ACAGAFGCG:?C.FF*E*EG:(:(C-?
@antibody_281_multiplicity_3_copy_2-1
TCCATGTAGTAGTAGTAGTAGTTAATTTCAGGGCTGAGATGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGACTGTTCATTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGACTCTGCGTAGTATTTATTACTTCCATCATATGATATAAGTGCCACCCACTCTAGCCCCTTGCTTGGAGCC
+
????AB?5B-@?DB=BGCGFF8/IIHEBIEHH.GFIAH/HHEHFHHHFIEIFF+A?HFEHHICHFHHG@HIH+H=HFH+FIIHF)IGHEHD+HFHIIGF3DFHD+IHFHHHGHFHHEEFG5HGG@EG;H@@=F*EFHB*F;G>+C4GFEEEE@6CEE,EE?GFGG1EGCECECEEEFEC:+GF?G.GE6A*C1G?GGFF??6GEFDAC/FE8ECECE?,EE16G'CGG:E8EF.=DEE*FCF)0:CEG(G
@antibody_281_multiplicity_3_copy_3-1
TAGTAGTAGTAGTTAATTTCAGGGCTGAGCTGTAACCATAGCTGTATCCGTACCTGCCCTAATTTAAACACAGTAATACACAGCCGTGTCCTCAGCTCTCAGACTGTTCAGTTGCAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCAAGGAGTCTGCGTAGTATTTATTCCTTCCATCATTTGATATAAGTGCCACCCACTCTAGCCCCTTGCCTGGAGCCTGGCGGACC
+
?A?5?/B?BDDDDDDDGEGFA+BIFHHIH+HEIFFFFHHHHIG@GIHFCFHFFIEHHIHAIDFIHHCIGHH-HIBDIHH85GFFFHC8HHDH5HHHFHHHH7HE.6HHHD+HHFD?CFDHDFFE=/#FGFEDFEFFEAFAEF;@:EECGEA@6GEAGEGF:A(GEFE/G/CEGEFGG.?GFE8GAG2;C'GE?GCGEG*E(C.GGGEGG(GEE*C#GE:@E8((6A#G?)CACE:CC(AA*?.EAEE?>(
@antibody_282_multiplicity_1_copy_1-1
GCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGGAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGGGTGGGTGGCAGTTATATCTTATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCTTCTCCAGCGACAATTCCAAGAACAGGCTGTCTCTGCAAATGAACAGC
+
?5???BB?BD@BDB<DCCFG>FHIF8IF+AHIDDHICHEGGGHFHIII?FIDHFC9G-GGAIFFBIEFFGHHIH3HF-HHFGH=IICF)HIBHEHH?HCFEI@DGCHHDFFHHDHHDHEDGDEDFH?GGE8*DCBGE5GGEBEEE;EG8G+G.E2EEAA;EC?GFEG8EEG;GAGAE?7E,;C6FEG6G.ACEEC8/8AFE<'EEFH.**E0=7@(E0:C:E(E:A'?E?0?E0G:(G?*'08:<C;*EC
@antibody_283_multiplicity_1_copy_1-1
ACCCTCTCTGAATTATCCATGCACTGGGTGCGACAGGCTCCTGGAAAAGGGCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCTCAGAAGTTCCAGGGCAGAGTCCCCAGGACCGAGGACACATCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCAACAAAGCCGGCTTATCGTTCACGTGCATATTGTGGTGGTG
+
??<??B?BA9DBDD@D+CFBFEHHHIFFHBGGIHI/DDHGFIH.IIHI@A8GFG-CFFG9HIHFFFGHHI5IIHIIHHHIHIFDFFGHIIIGIFIEHEIFE+FDHF?HIHFHHH)CDF(;EHFDDEF0GFF0FGDECE(BEE,@D/EEEEGGCC?EGGFEC?EG8GCEECFGGG6>GEGC.ECC'E*GEGAG((G8(;ECEAAE:EH/6EE;@(E?EG70ED*EEGGE8D/G(CA9/:?;((E?(?FE:)
@antibody_284_multiplicity_1_copy_1-1
GTTGGTGCACAAGTACTGAATAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGGTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTGGCCTGCAACTTCTGTGCGTAGATGGTTTCACCATCTTCAGGATCAAAACCTCCCATCCACTCAAGCCCTTTTCCAGTAGCTGTCGCACA
+
??<??BBB@DDADDB,FFAEGFC;/IHFHIIHII-?HG0IAH.IIEIFI,HHHIHHHC:FCII+II>HFBFGHFFHHD<HDHAIHIHH6HIEHHEHHFC=HHHDHHHH@I=FHDEF?H#CGHFEGG+F=BGGGCHF@GCDGEGFG27G/76G,E?GCAEEE:??E;GE)@*GFGEEGEC(FEGG/*FEA9*GA?/GE.CEAEC4A(E?E(AAC::E<'7E7:CCEE?2EGF2C:?G:(:(*E?CGE::EA
@antibody_285_multiplicity_1_copy_1-1
CCTTGGCCCCAGGAGTCGAACCAGTTGGTGCACAAGTATTGAATAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTGCCCTGGAACTTCTGCGCGTAGATTGTTTCACCATCTTCAGGATCAAACCTCCCATCCACTCAAGCC
+
?=??5BBBDEDDDDDDF=CGFFCEHHEFIHHFIFII-IHHHGHEFIII-+HGHHHAFIHFHCHFHHCHFHD>5HFFHDFHDIDHHII+IHFFH-HDHIHIH,8HHG?GHFEIEFH+FH,EDEH+EFD1F7+;;;GIFHEDEGDGD:GGGG@;C*?GEEG8EGAG/8GF6A6E6ECEE@CE<EFEEGA?D?D0:GG?GE**(:E4E0EAC*GEEE<AEEE/(:::(8C(GE*(GF0E'G(?G(0EEA*:6G
@antibody_286_multiplicity_1_copy_1-1
ACCCGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGGTGCACAAGTATGAATAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTGACCGGGAACTTCTGTGCGTAGATTGTTTCACTATCTTCAGGATCTAAACCGCCCATCC
+
??,,5BBBDDDD-DAD@GG8CCHI,HAHHHHHFHHHHEEDHHHHFIHGHFHIHAIHH*9EGHHIHCEBGHF8B5HHIF-HHHHFHH+FH=H6IGIFHCH=HICH,IF*EFH;3FFH9FDGGHHFEGH2HF@FFEEFEGFGDEGEGCB*GEGEEE*G?((0E=F;E6G'(EFCGEGGG,GGEE?16A.CA0E(A::#?('?CFEA?E8;E**:EABGFC>4EG6**A*?C*E(FC?0*CAEEC(?(?>F(E
@antibody_287_multiplicity_1_copy_1-1
AGTTGGTGCACAAGTACTGAATAGCAATCACCACCACAACATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCCGTAGATGTGTCCTCGGTCATGGTGACTCTGCCCTGGAACTTCTGTGCGTAGATTGTTTCACCATCTTCAGGATCAAAATCTCCCATCCACTCAAGCCCTTCTCCAGGAGACTGTCGCA
+
=A<??B?7@5EBDD+DFFFGA/HIFEIFH5+IIADH5HHEHHHGBH7HIHG@H@I*FHFIHFHHG+CHGHH-EFGF-H--AHCHH8H:H?5GGIDIIFFFACFFHHHHFHHHFHFCHDDHEEBHCEG<G>F#EHEIGDFEBD0G@E(?GCG<F;)GEG0EGEEAEG?E?GGE?'AEECFAEEECGEAEACG?.CEE?G:EG/60/EEEGA*E*E(#:?CEGC'#GEE:EGGC)*E1E:GCE(6FE:FGE:
@antibody_288_multiplicity_1_copy_1-1
TGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGAACTGGGTACGACAGGCTCCTGGAAAAGGGCTTGAGTGGCTGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAGGACACATCTACAGACACAGCCTACATGGAGCTGAGCAGCGTGAGATCTGAGGACCCGGCCGTGTATTACTGTGCAACAGAGCCGGCGTATCGTTCAC
+
?,??=B/?BDBED@@DGGGFGGHEHFEHIFHIFEFHHFIIIEIHF>H@7FHIEFDHHFDHHIHCCIHICHHAIHICHFFHH?HIG-HEHIIEIHH=FDIHHHHHEGH8HCHGEHFHHC9D@5F5F6BHE?E@G=G@FGCEG@1CGF8FG?'*CE9GFCG*EC?DE1E=GGGG:G.8E;GBDGCGEEF:GE?E(EGEEEGEEE?FCCH'EH?0EFG:BEC@?GGAAF(-?GE#C(E(AE(0C?;:6:CE*/
@antibody_289_multiplicity_1_copy_1-1
AAGTACTGAATAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTGCCCTGAAACTTCTGTGCGTAGATTGTTTCACCATCTTCAGGATCAAAACATCCCATCCACTCAAGCCCTTTTCCAGGAGCATATCGCACCCAGTGCATG
+
<?5?<B/ABDDDDADDCFGF/CHFIH0HHIIIH+HIIHCFFHI?IHHA+HH.HCFHHFFGFFF-FIIFH+HIHH-HAHIAEHC=IHHHIDAFHHFIGDD-EII-FIHGHHHIEH6DFHHF=+HGFBG+EH3GG*GC*FGGCEFFEGGHFGEGG@EEE?EG:EF(EE@F86CEF5:=G8<E(EEGG0CCAGCEE4E6EGGG(<AFAE(?F:*FHEEGE0B/*GEE(:FE*EC.G#G?CGE:1G.0AG/8*C
@antibody_290_multiplicity_1_copy_1-1
TGTACAGTCTGGGGCTGAGGTGAAGAAGCCTAGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGACAGGATCCTGGAAAAGGGCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAATTCCAGGGCAGAGTCACCATGACCGAGGACACGTCTACAGACACAGCCTACATGGAGCTGAGCAGCTTGAGA
+
??A??BABDBEB@DDDFG>.GFHHF/IHFHH'DHFHIHFHIF.ADIIHI5HIHFFIFEHH-BHDHAIHIEFIHFIIEIHC#F7HIHHEHD:IFI;I.+HIEIHIEHHHHFHHHHCHFH*DH97E(@D,AHHEGGE;EBG6GEGFE'CGGD<FEA.EEEEFCE?:AFBG(0GFFEC:EF3C/A9EE<./EEG(:*:EGE<GE6ECGGECEF#G-7BECCG08E8AFA#E*:AEA*8:*GGEEGDE)*CCE?
@antibody_291_multiplicity_1_copy_1-1
CCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGTGACAGGCTCCTGGAAAAGGGCTTGCGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGGCACCATGTCCGAAGACACATCTACAGACACAGCCTTCATGGAGCTGAGCAGC
+
<????B5B-DDDD-BBGGG.FGAFII8IHAIIHHFIDGIE7HIHHAIFIHFFHHHGFIG-IFHH>@HEHFHHIFCHHAIFIFHHIH5FGHFGID)+FHEHIHFHDHFHHE@HHICGGDH6HEFGFFGH62G(HBG>G@GFE2B>1EGFGGGE;CCGG3F(;E*8GGBE6??ECEGE*E9GDGEEAGC?G8?6FA?C?E/CGA/?G'H'E'G0'@G?8:E7B'?4?EEE?G/?8:E0:C1(C*/CA(GE8C
@antibody_292_multiplicity_3_copy_1-1
AGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTACAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGACAGCTCCTGGAAAAGGGCCTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAAGACACATCTGCAGACACAGCCTACATGAACATGAGCAGCCTGAGATCTGAGGACACGGCCGTG
+
A????BBBDDDDD<DDGGCCCGAFHAHEHIHHFIHIG=HDHHIHHDEG9GHEEHH-IEEHCHEHHHFIH.BGH*ABDFHFIEHC8EDIHHHHEIEHHHHFHIIE#6GDF@GFFDGFFHF,E?HG.=FGGE:FD,HD:EFFF@,,EFEGE8HGBGECG8*GE;EG?C<CGG(E*/EEG8CA?C?E<GG<*(/E:ECC(EGGCGAE(G*G/D8C(C):C(DC*E.;:CF::E6EEE?ECACE(E4):::E:G
@antibody_292_multiplicity_3_copy_2-1
GTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCGTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGACAGCTCCTGTAAAAGGGCTTGAGTGGATGGGAGGTTTTGATACTGAAGATGGTGACACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAAGACACATCTGCAGACAGAGCCTACATGGACCTGAGCAGCCTGAGATCTGAGG
+
?????B??DD-DDD-BGGFCECHHIIHIIFDHHHF/FHF/FFIIH+DHIHIEIFIIDHHCI-HHH#HIHIIIEII-I>HIIHDHI=HBHGFHG6B(5HIHHHHIHF'HGHHEDH3=5GDH;GEFGFFGDFE(E*H@EH#GFGCGFD,G*CE<*GGGEDEGG6GA:GEEGEEE?GC(>DG@GCEG??EGE?EECAGE4D:G(GA?EG?#;6>/EG(G0EFG(?CCEC.G)?G*8:A'/F'?(:CE/CC::?
@antibody_292_multiplicity_3_copy_3-1
AATTATCCATGCACTGGGTGCGACAGCTCCTGGAAAAGGGCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCAACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAAGACACATCTACAGACACAGCCTACATGGACCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATAACTGTGCAACAGAGCCGGCTTATCGTTCACGTGCATATTGTGGTGGTGATTGCTATTCA
+
??=??B/BDDDDDBBDCFGF?FF-->HFIHFHHHCGIEIHIHHFHHFI7CFCHHCHIIIHHCDDHFHHHHEGIHIHHDHHG=H-I#HIIHHHHHHFDF+HIEFH8DHHGDDIF**E*G@H@GEHF;EGFEFEFHEGBHEGBFGFFGGFE:EEGGEE0G<E=G.GGEE*D)GFEEC?CCGGEEECE(GEG.;/G?(FGEG:EEGA??EFEEE::0EE7E?,EE6E(8?GG8*EG*):?E*/AE?EG/A-EG
@antibody_293_multiplicity_2_copy_1-1
AGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGAGACTCTAAGCTGGAATTTCTGTGCGTCGATTGTTTCACCATCTTCAGGATCAAGACCTCCCATCCACTCAAGCCCTGTTCCAGGAGCCTATCGAACCCAGTGCATGGGTAATTCAGTGAGGGTGTATCCGGAAACCTTGCAGGAGACCTTC
+
,??A<BBBD--BBDDDFF>GCGIH8HHIHHDH9GGCEEIDE.HHIEGEHHAIEIFFH-A8HFHHHII-CIDGIH#H-G5H,DHE?>HHAHHHCFHIFF#HDD*C#*(+F9HFEFHFFFBGD*FFE*EGEEEGGEGFEGGG#EECH?GEFGA(#GEEGG>?DEG1GGGAFE;F.E**GGEEGGEGE*<E)EGC*FE(ECA?GE**864((HEGE.EC8((:CGEEE?E6F(CFEEGGG*GGG?FECC.EC0
@antibody_293_multiplicity_2_copy_2-1
CAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTACCCTGGAATTTCTGTGCGTAGATTGTTTCACCATTTTCAGGATCAAAATCTCCCATCCACTCAAGCCCTTTTCCAGGACCCTGTCGCACCCAGTGCAGGGATAATTCAGTGAGGCTGTATCCGG
+
?=???B@BBDDDDDDBFCGFGGFHFHIFIIII-GFHCHGH.IIIGH=I/IG.IHGDFDHG5HF8IHHBEDHE@HAHGDHHA+H*I7EFFIHFHCGHHEH=GFFH*HCFHH+IHG(GHDH+CHEGHHCGBHHGDEEDHFGGDGG;EGG=3G@CEF.EECCGACEEFGGFEFEGEA6/8GA?FEE?<EGG(;FAEAG??G*GEEG:#(?1(ECF:**CEGBG874GC/6G(:GEGEGGG:.G(CE8EEF?E:
@antibody_294_multiplicity_1_copy_1-1
TAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGCCTGTGTCTGTAGATGTGTCCTCGGAAATGGTGACTCTGACCTGGAACTTCTGTGCGTAGATTGTTTCACCATCTTCAGGATCAAAACCTCCCATCCACTCAAGCCTTTTCCAGGAGTCTGTCGCAACCAGTGCATGGATAATTCAGT
+
???A?BBBDDDDDDD5FG?FFFBHBE,>IFIEIECHI/FIIFHH-FHH;I7HAD>EF@FGGDHFGIHGI=FIF,HFFF5GAA=FFDHIF6EHE(>HIHDHIHHFHEH+HHFH,G?FHHD@HFH?F9HE#=DHG(EED=EH1HG:EGEEGGEEEEG*FFEFGGFFG08:AE8CEGE>G1FE#A?CG0EEG*CFG8CF?EGE:/(G-E6(EHEE8(377EG)F?GEC:CGGAC0EC*E*:EE0AC?CEDE?C
@antibody_295_multiplicity_1_copy_1-1
TCCAGCTGATACAGTCTGGGGCTGAGGTGAAGAAGCGTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGAAAGGCTCCTGGAAAAGGGCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAAGGCAGAGTCACCATGACCGAGGACACATCGACAGACACTGGCTACATGGAGCTGAGCAG
+
?=???BB>+D@@BBDDGAFFGGH@EIIHHIHFAIIIIHAIEF/HHI.H-F>I@HIFHI@-HHFIHDIHIIF5EFHIEHHFIHC?FAHI+H+HFFH-HGHFFIHHF?HHHC,HHDHDEFDE4DBEGHFDE2GG*CFEE?6=E<GBEGEGBG?C2EGGAC*FDGEE*0GEA(EF:E(EEECGCE6E(G???A(F/E:6E-E(.?F?GFHCA?:GHA@'BE?E(?C/'E<EF(EG:C:::1EEC(CA?GAGCG
@antibody_296_multiplicity_1_copy_1-1
ATACTGAATAGCAGTCCCCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGGTCGTGGTGACTCTTTCCTGGAATTTCTGTGCGTAGATTGTTTCACCAATTTCAGGATCAACACCTCCCATCCACTCAAGCCCTCTTCCAGGAGCCTGTCGCACCGAGTGCATGGA
+
?????BA<?DDDEDDDGGFGCGHHHH-HI8>HIHCEHHFHBFFAA;II*HHDGEH+HHGHHHDHBFIHIDE-HHCHHAHHHFICHHDGFH-<DEHFHH.HHFHFIH=HIHFHBEHH*4EEHEEHG=EEGEHEGFGGE*EEGG2#CGGC*AFGF4GC@;FGEEEC=C:ECE.=E:=G76<:CG(*(GC?(.>EFF)#6:EEGFGEG*C/:E?EE@EE8/#:::G((G(86EG/AEE?F0C*GGEC:A8CC8
@antibody_297_multiplicity_1_copy_1-1
GCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGACAGGTTCCTGGAAAAGGTCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAGGTTCCAGGGCAGAGTCACCATGACCGCGGACACATCTACAGACCCAGTCGAGATGGATCTGAGCAGCCTA
+
?????B?BD<+@DDDB.EFFF?I>IIHIHIHGHECHCG@@H@FH*AH-FCFIEAI>9FIHFHI+IAG5HHC<HGHHHFH/H>IIEIIFEIIHHIHF3:GHHHHF@E3HHHHDHH=BG9FHHFFFE:HFBE9G7GCB<D*G:G:.FBAADG:CCFGGGG?(?CGC<:ECEF?EECF=E(E*GEC6@?G0286CE*FF:C6F/CCEG:#C:CE/8(<E?:ECBGG(GEG60((:AC*:E*G(C?0FAA?GE/
@antibody_298_multiplicity_1_copy_1-1
CACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGATGTGTCTGTAGATGTGTCCTGGGTCATGGTGACTCTGCCCTGGTACTTCTGTGGGTAGTTTGTTTCACCATCTTCAGGATCAAAACCTCCCATCCTCTCAAGCCCTTTTCCAGGAGCCGGTCGCACCCAGTGCATGGATAATTCAGTGAGGGTGTATCC
+
?=?<?BB?D-DBDDDDFFFGCFI-IHF>IFDFHHH-HFEFFIHIFHH-7EIEHIEFFHHFIHHGG=GIFHEHHIHIHDIHGIICHDHCIDHHICDGEHFHFHE'HIHDCHHHHHHF+GHHHDGGFHCGFGE8EG9.G+CGG?FG)EC-;1GGDEGGE*F>G4C8GE=EEEEEG??GGEG*FG)/CG'(GE?EGEGE.*AEE(6A?C68**:GH@GA7GC,EEEA?D1CEC0:E<EGFG0G'AEGEE:(EE
@antibody_299_multiplicity_2_copy_1-1
ACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGCCCTCAGATCTCAGGCTGCTCAGCTCCATGTAGGCTGTGTCTGTAGATGTGTCCTCGATCATGGTGACTCTGCCCTGGAAATTCTGTGCGTAGATTGTTTCACCATCTTCAGGATCAAAACTCCCATCCTCTAAAGTCCTTTTCCAGGAGCCTGTCGCACCCAGTGCATGGATAATTTAGTGAGGGTGTATCCGGAAACTTTGC
+
=????B=BDDDD-DDDGGFFFGIHFHHHHHFIIHHHHHDCCIHCGG-DCHHHDFFHI0EGHHFFFH,+FDCH+IHGEHHGFECHHHCHHG=E9FHGDHGHIHD#GIFHH?D6FFHB@HHHDHCEEHHFGD?GHEGEE?A7DE?G)G)>GG8.GCE0CCE6FGGF?E:EGDF:GG('G+:EGAFEF:F/EC;<<0GEF01EEGGEGGEFGFAG0/CG?;(GE:6(A1C6<EGGEECCC*:CGE?*G#(:8*
@antibody_299_multiplicity_2_copy_2-1
AGGAGTCGAACCAGTTGGTGCACAAGTAGTGAATAGCAATCACCACCACAATATGCACGTGAACGATAAGCCGGCTCTGTTGCACAGTAATACACGGCCGTGTCCTCAGATCTCGGGCTGCTCAGCTCCATTTAGGCTGTGTCTGTAGATGTGTCCTCGGTCATGGTGACTCTGCCCTGGAAATTCTGTGCGTAGATTGTTTCACCATATTCAGGATCAAAACTCCCATCCACTAAAGTCCTGTTCCAGG
+
<?A??B9BDDDDDEDBCGCFGFHEIFIAHCHHHFCFIEIIIGFIG==HIF=HIHIIIH)GIGCGHFHHHHGG5HFHIF?HHDFHHDHHIHDI7FFIH=HEH-HHH?FHGFFEHH,F(GCHDFHEH@CFDGH-GGGFGAEEGGGEFGGFE=EGFE:EEE;G?8(0GGGG:;AG*/CFGBCEE(?:CCF/GG*//.:(((G:;98??E*;#CFEC*FGCE,AC1CE:FE?GEE/GFC2AEA?.:(E?FC'?E
@antibody_300_multiplicity_1_copy_1-1
GTGTATGAACGGATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTAGACGTGTCTACTGATACGGTAACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTGTAATAGATGTAGCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTAGTAACTACTGATGGAGCCACTAGTGACAGTGCAGGTGAGGGACAGG
+
??,<?BBBBDD-DDDDGGFGFAIIEHCICIEIHEIHHHH.GH=IIIHIHIHG?HFF5HEEFG5IHIHFHCF@HH#HFHHCHDHHI+8IHFCIHDHHDFIIHF8EH8+DHHFDH9HH=IGGEHGA2FGDHGDE/EGIEG?;EFECGC,GBFEFEBGEGEGFB>4CEGC0EE?,<ECGGEG?8EGEGG?EC;?GCC:.?E:G6C)A6CA6G;C/FCGE<0:FBCEG'F(:?::CE>((G?0EEEGC0E0A(?
@antibody_301_multiplicity_233_copy_1-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGAG
+
?5???BB@D9D-<DDDGFACF+IHFHIHFB.FEFIIDFFIG@+HHHFFDGHHGFFHIDEFFFHHHHHIIIIFIIIHHEIIHGHDII7IBFFHH0DFHHEHHC.H4+DHE=G:G6EF)FF@HHGFHHHFGDAFEC@FCEBFEGG=G1GGE@6C.GGGGGEF:G?F*E?BGEGEBFE?GC:AEAEF:EF/C?GE**?/EECC0CGC6EH(G(?E@(@EE*E/?CFAE0C2F*EGCCAE/:E-:*EE/.:F6*
@antibody_301_multiplicity_233_copy_2-1
ATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGACAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGCGACGGGTTGAACGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTGCAGGCCCTTCCAAGCGGGCTGCCGGAACCAGC
+
?<?A?BBADBD<<5BDGFCF*FHI/IIBIHHFIDEEIIHGEEHFEH?DGFHGHDEH77I-HGFGHHHGHFIIHFDICF>HHH>GIGDIHC-DHGHF=GHHHHHF5HEDDFHH=,F+FG+'H1BFFHHFEGE@E(FEGGG6DG1EGEEB=EB.EEE:EEGGB<(G<EA/E6<GGADEG#G*E?29GGA;A:*EC/CEFGFAGG?G?GE6GD:AHAEE7'GE7(:E/F:GE(<E(EA;C)C?CEE?1?-??*
@antibody_301_multiplicity_233_copy_3-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTACGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCC
+
?5??,BB?@DDD?@DDCFFFBFEE.HHI+FIHHBFH+IIDHHIHIHGIFIHHAHHAGDAHH.DACHHCFFFI5FHI:@IGIH,=FHEI7FFHGHIHBHHHIDF.H8IHDHCBFCDH+GG:(+HFGG=GD*EBDGDGGCF:>GDF*FE,?*<?.*FGGGE-GGB<GE5FGFG6E;GEG8E-:GA?G**EGEGGE0.CG:0F'(GE:E6*GH6*ECBEEC?E/1CE;E1.G<GG=FACAEE<CG?8?GG*::
@antibody_301_multiplicity_233_copy_4-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGCTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGCCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTATCACTGC
+
?????-BBDD-DE@DEFGFFCCAFIHIIFAHIHIHEICIGBII@CH@HFH@HHD5HH-HCB?AHIH-HH,CI+=-CHCHCHIIHCIE-IID=(FIIIIHHIHH#*HCHH(HHHHD=GF@GEEGEGFEGF,EFH>FIGGGGGFEFEGG:B*GFEE/:1EGFEC?EEGEEE;BCGG-CFGE#G?ECGGEG:CEEGG8AEEG;G:EF/E2GEEGE(C-F?EEC1<:(2CAG0;0*CFGEC(C:E?(E(*C:F:
@antibody_301_multiplicity_233_copy_5-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTTACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGAGTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGGTACCATATCAGAAGACAGGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGT
+
5,?=?BBB@DD?<DDDGGCFGGCIH+IIHIHHI>IFHIFHGIIHGHFFHH-FGCE-CDIHBFH>GHF-GHHIHHF-EHFIEFFHHHHHIHH5=CCHHHHAFF,H.FIECEDFHGEFB;D:HH@H3EFGH?HEFHCFE@#FE@?EGEGHE/3EGBD*FGGE3G(FGAC?ECG6E6ECECC?EEFCG0EC*A0:96G(C?<(E:8>?FE(1*<EE(-?7EG:((C82A:EECEAEGE.EA/GCAC/CECE:?
@antibody_301_multiplicity_233_copy_6-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAAACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTTGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACGAGATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTG
+
=????B>BBBBDDDDD?EBDFGHI8CFFIHHCGCICH=IIGCGI)@H>FHFIFHIGIDHIIH5DHIFD5D5GFHFFHIH5HI-IHIGHDDH6HHEFHHHHIHAFDGHHEF+HD.HH*DGCFCDCHFGFED@D1EGDGEC?GD6AEG@E@GFF6GG'EEE#GFC**.CGEF8E*?GE<6GE(E:6E88:GE:GCEGCE:C?#E#*GGE/)CE.*G<E)CGG8.EEEC0?FEEF6EG*E?8EGGG(E0EGEC
@antibody_301_multiplicity_233_copy_7-1
TGCAGCTGCAGGAGTCGGGCCCCGGACTGGTGAAGCCTTCGTAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCTAGAGTCGAGTTACCATATCAGTAGTCACGTCTAACAAACAGTTCTCCCTGAAGCTCAGCTCTGT
+
??<??>B>BD<D5DDDFE?>GF+CFHHHHIIDC9HIEHIHF0HFHFFFHFFHIFHA@GHHEHIGIHE5-DHFEDHIHIFDFHIEDHFFBE-G+IIHFDIGGHHHHFHFF6HHHG=:DFFFHFHHEHGH4FDFC9D=F+F*;EG**.:CFEGE:FBEE'EFEG?GGE/EEGEG9EG;EGE:EAEG*#AE(G?EEEEE0E*FCEEE6CHFAA#(EEGGE8CE*G?E?G:CE??**#E8?D(F)(GFEEE?(0
@antibody_301_multiplicity_233_copy_8-1
GTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACACAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTAT
+
,?=A?BBBDDD@DDDDCF+GGFFCFHHHEFIF,DEFHI@HGHHIEEFGHFGHHIHIGFHHHH5HIE@G=D5GIIED=HHIIBGH+EHHHEEGIEDHHFDHHEDG@GHDBF:@GGHGHF;FHE(GGCEDFG,@+DG@GEE*GE=E9H3*E?E=EEGAGCEE/FF8GCCGGGGFC(;E(AEEE6E6FECEG..*GF:G6EE(ACFFE(<E?H*G(F.F?EB@ECAC;E<C8'CEA??*?EEECEECCG>(AF
@antibody_301_multiplicity_233_copy_9-1
GCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAACACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTGCCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTAATGGAATTCGTTCATACACCGGTATACTGGGAG
+
?<<?=>5BB@DD+D<<FFGFAGFH8FCIHIHCAHIFH,H=DCHC@HFHCE5EDFIFH-DDIHF=DFF(FA5HFHHGD5,FF5HHGHIDHCGHIHH=@@=GEC+HHH;9H=GDCDHGHHHF*D=H<H*DH<GDEGG@F*CE;GFD9E**EGEE@FCCECFEEEGG?G/GGCAG>)BCECC(A(EEFGG?:EGF.EEACF:?0E?AEEH:*:;A:F((E(;GE0EFG:0?(?E0'(CCE?GEE08#(:(C::
@antibody_301_multiplicity_233_copy_10-1
GTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCCCAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGCCTACTGATATGGTAACTCGACTCTTGAGGTACGGGCTGAAGGAGGAGCTCCCACTGTAATAAATGTACCCAATCCACTCCAGGCCCT
+
??,?5BBBD<5D@DDBGGGFGG+AC8HIFEHHIHD-EHHHHHFIE@EII@FH>FHEFFEHH+EHHHHIABHII5I5C?5-DFHFHFHCHIIFICIHHGHHHFHFGHGHHHHI+FEHH+HG*HH*4HGGEEG#HEEE/*4GFGGFB=E6?EGACGAEE.A(EG(EEEGEE(A:G8G:AC?EG+G?G2GC:*CG(D?C';(E>AE8EEAG*EC(F@@EC/,E7CC:)GE*0FEC1>EE(*E.G.0DAC8(E:
@antibody_301_multiplicity_233_copy_11-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGATCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCGCTGAAGCTGAGCTCTGTGACTGCCGCGGTCACGGCCGTGTATTACCGG
+
?????BBADBADDD7BCGGGGG8HFIFIEIGHHEI/CHG.IHHECHHFHEEGCF=GBFFGFI'=5IADGHEDAIHFH5HEFIHHFI8HFHIHFIHGIIHFGIHHH:)FBHHGHG@,FDFHHFG=FFFEEDG)CEF;EFFFEEB8,E<EFGEEB<EGF=A=E1>GEGG(EEF(((90CAF00?ECC8<8CECGEEF:EE:8<':?(ACCF8EGC7@G?E0F7CEG6C.E0?'A?8G?E:GACA?(EE(*?0
@antibody_301_multiplicity_233_copy_12-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGCCACGTCGAAGAAACAGTTCTCCATGAAGCTGAGCTCTGTGACTGCCGC
+
????,B@BBDDD?DDDGCFEGECH>?EFHHHIDHIE5?HFICB.IHHIIADHFFEGHGI?5H-E=HHAICGHFHIFDFE=HHHII*HHHFHH)HI=HFEFHHCIF,EHFHH+@F*?FFG,HEGH4F1F(E(F8AFEBG=GEGGGEGGGCE*C'FA0ACFAFFGGGEC;EEG/EFGGEFGGCG:AEDC'G8?EG<CGGF*A?(CGF?H<.F6CEAGCG?CEEF?C*E?GCA;GCGE:0CD::FF-8EC/*.
@antibody_301_multiplicity_233_copy_13-1
GACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTTAAGGAGGTGCTCCCACTGTAATAGATGTAGCCAATCCACTCCAGGCCCTTCCCAGCCGGCTGCCGG
+
?A?,<?BB@5BBD@DD.FFFFGFIHFHE6H=IHHIIIIFIIHEHIIIIGHE?FH.I-H@8FC+>HIIHHEHH-IAIH?IEH?F8HGIH5=IGEIH.HHHHH@?HIEHHFH*3HF@FH?DHD=EF#HFGECEDEEAEG*6>F:BEEE,EECCGEGEEF4B=CFEG:G:GG@8ECC*#G6CEEGB(EGE?GGEAE*1EG?EEEG:*>?*8CCE'@*(GGE8GBE<(GCEEFA?A:ECE(EGA/CCAEC?E/E
@antibody_301_multiplicity_233_copy_14-1
CTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTAGTGATATGGTAACTCGACTCTTGAGGGACGGGTAGAAGGAGGTGCTCCCACTGTAATAGATGTACCGAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAA
+
A????BBB-BDDDDDDGC?AE6H>CHHF;EF,IHHH>IGBECHHHGFFHHHIHCIHHGDIHGIHCGEEGHFHIIEHFHI5EHIIHIHHFIGCFFHHH=HDHEHHDCEHHDHDHH?GGH?4HFD=H6GGAFH+GGG=,,G)DFB?DEG*BG8*ED<EEG?FE:GE(EE.EE0'8C;EG(E6(F:E0C.EAAAGE6AEF(EAEFAE8E>)EH8EEA:FG?C7EG.:(CGECC0.:CGC62CG.ECE6GC*8*
@antibody_301_multiplicity_233_copy_15-1
CCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTATTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCT
+
5<???/7@BBDBD<BD;FFGCF->FF6IIFI.GDFIEGEHIIIDIEA.HHIHFIIHCIHAEGCHHHHIIIHHHGIHH7HEHH=CH+IHIHID-BIHHHHHGDEDHD)FEHH@FHE9HEHHHH;H+1GGFED:FFECGEGB?EEFDGG@8G4HE?GFBEEGGG0EEEGCGEE0,1GCGEE*CG**(GFAE:?E#C*CGGGGDCGEEF)ECEEGDE(EEFG;(:G(EGAEG:C?FA(A:**EFEE?AE(8C'
@antibody_301_multiplicity_233_copy_16-1
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTAAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCATCCCTCAAGAGTCGAGTTACCATCTCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTG
+
?????BBB6BDDDD5DFGAFG.=HFHIFFH-IHFGIFEHFHH+HD9EHIF=HFCGIHFBC?C-HHGHHHECEHCI'EAHCHHII)GIHI+IID(HHGFHCHHGFHFFBG=E;HE:HHHHGHGGBGDH@FEEC>GF0C,AG?FG<G0:G*GE*E*@BC;EHEG?GGGG8(8(<G#CF,EE6CG:)GCA?EG??GE4ED*GE:GF(G6FGE<*88;:7FECACGE??G(G(GA:E:;CA/A4AC?EGEGE??
@antibody_301_multiplicity_233_copy_17-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCTGTCCCTCAAGTGTCGAGTTACCATATCAGTAGAGACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCC
+
?????ABADDDDBDDDGFGGFAEHF7HIHH9IIHHE=/HHHBFIHIHHFEH7FIGHI8HGHHFHGIIH#HEHHHHFH<-IFH-HHHHGHFIF5F4HEI.EHEHDIFHFGHFHEFHH;EEHGEBHGDDHCEDGG?(FFF;8DF*G<GFB>,/GDAG,E.*GECE:EEG8?(AEEBCG6(6A.;?DE*E*2EGE(EGE0EFCE*)ACC:EC?GEE:*/?E:C;/.?EGGFEE:>E:E4E(F6=EF(*G/?C?
@antibody_301_multiplicity_233_copy_18-1
GTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCCTATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGACCTCTGTGACTGCCGCGGACACGGCCGTGTATTACT
+
?????=?BBDDDDE<BF@ACFCFH+A>HE5IHIHIHI=IDHGHGFHIIII/GCF7CGBHHDHE;C7H+BGDHIIBFH*DHIE5CHBFBF-IHHDHHEDHGH)BHHEIHEDCEFDFCFHEHHDEFF*CGC+CH+EFIGEF;GGED8*EEGGDG?GCGGEE*EG(F?EF*:?<'0FB=GGGEG:E/GGGFCCG/>GGECDEEGGEGE(6AG(.G:E#:DG((?G2EE(60CGF?EA:?CCEACG:FC:*/8*
@antibody_301_multiplicity_233_copy_19-1
TCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACATGGCCGTGTATTAGTGGAATTAGT
+
?=9??B/BDBD9BDBDCGBFGFHHIIHHHH7HIC5FH=D@GICHHH9IGDHBH)HGIC7HIAEHEF5IFEII>AHIHHICHFFHFA8FFB+EEE6HHAFIFFHHGEFBHDFHHHD<HEFDFFFHGFEEGGEB=@GFE@GEE@??HECGGG:ECFA2BFE0EGCE*6AEC:*GC?0CGD?E?C2E1CFC-:EE*G;/*EECFFA9*CEGGHE:@EGC0E(:FEGGC.(EEE.CCCEE(?C(:.6EG*:*E:
@antibody_301_multiplicity_233_copy_20-1
AGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGTTGACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCA
+
??5??-@B@EDDD@BBG9GGGG,HHIFHHIFGHF@=FGHHGBE+FHDAHI+GI,@FIG+GFEI>HICIFHHIIHIAEAEI5EFIFHFF+FHGHHHEHHE4FHIDHHFIHHH+3DIFHEHHGFDEBHGHF(H*GGDEFGEFECFEEF#D*G<GBE=EAGCGGBGG;??G(FEE(</EG/GGG8F2EGEGG*GGCFEE(GD*E*EE?E68G60E@GG(GCGEEFC)D*EEG6EA:<*C*:FGA(CGGAGE*G
@antibody_301_multiplicity_233_copy_21-1
GTACTAGTAGTAAGTACTAGAATTCTACTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACTCGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTATTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTAT
+
9=??,B?BDDDDDBDBGGCGGFFHFII+FIHHDD,EHFCHIIIG@HIIH9HEHAI.>H.HHH?IIABHFF#F?IHDHHC<HIFG?FHD;HHHDIHA0IHGDHHEHHH@DHDIHHFH*H=:FHHGHGHHFFEGCC7GGF(;EB:BGE=GEC+(AGG:EF0:@EGEG*CFGCG?E*EEEGE7/E:AEGE;EECG:AC(CGF6?EC'E)E?G0DGFE@?EGEAD,?EAGFGEC**:C*(EE?AGG?EEE*?EE
@antibody_301_multiplicity_233_copy_22-1
GTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGGTGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACCAGTGACAGTGCAGGTGAGGGACAGGGTCTCCGAAGGCTTCACCAGTCCTGGGCCCG
+
???,?BBA?D<DDDDAC0DFCGFIIIIGAHII7DIHII=BHDHDIHFAHHHIFIIEIHH-FHIGHIDHIEIHGHHGFBH5IE)DEIHAHEC<HAHH<HFI=EFHIC/EEHFCHFFCE)EIDF6:GGGGE9GFE<AEDBFFG2GGEE9GEEGF*GGGEEE0F@F,DGEG<8E:?C0FG?E:GCGG?EEG;6*GCG(GECEGE/2GD;E?E:C?EA7)/F(AG,??G?:EGGEC*E?C**GE?A(.G00*(6
@antibody_301_multiplicity_233_copy_23-1
GACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTACCTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATCGATGTACCCAATCCACTCCAGG
+
?????B>9DABBD?-DFGE>FGHHHI0CCH+I+IHGCHHIIHAHIBAD9FFGFI.8I8E@HEII5FDE+H=IFDGEFHHG-IIFI+HH=HII=IHCDIFDHH?4HHFBDHHDHHHGG@EHHDG2?EDEEGG*BG8*EE?FDGG9EEG?G8(GEFGE94(EGFE,EF0G;AEE;EFG6E(GE(F(FEEGEECEC)EGFEG')CE<(?*8G*0C.GCGC1E7G8E::?9**/*/EEAE*CGGE*;E(GEA*?
@antibody_301_multiplicity_233_copy_24-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTTCCTGAAGCTGAGCTCTGTGACTGCCGCGG
+
A????BBBDBBDBBDDGFFCFFHFFFIIHIFHI9EEHDHFHIIIDIG-G@D5GIGIDFHHF@FBCHFHH=IF-HAEHHF<HHAEHHDH/7HGDIHFG+,D=IHBHHFFFHGBEHFHEHGEHDH*BFEGFEHFEEGCBCFF4BGEHDCC3'GGAFGE:D?FG:CBF8EGEAEEED(EGCGGCFGECG:E;C?1EEC?G/?;CGG*AGE6<E.EA'BGGEC.*E:E?E*6G?C?:>AE:0GCG(::)E1G=E
@antibody_301_multiplicity_233_copy_25-1
ATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGTCCCTTCCCAGCGGGCTGCCGGATCCAGC
+
?=???BB<6BDDBD?DGCFGGFIIHEFBHEI7GHFIFEIFHHIHHIDFCHEIEDI)GDAIG>-IHFH'HHFAFDIIC@EFHHF@IDAFHEFIFFI7HH8FHFHIHFHHHCEFHHGHHG4EHFEEHEEF0F*F*FFG.EFFFG8EFF<EDAGDFCGEF?:GG;CGGGEGC:E(4EEFCE?GG;6EEG:?9A*'ECGAAA:GEGGEC?CG#FEG(GEEFGG(8((GCG6G:AEG:CCEG*EGG?FG6?C*:C
@antibody_301_multiplicity_233_copy_26-1
TGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGACGAGTTACCATATCAGTAGCTACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTACCGCGGACACGCCCGTGTATTACTGGAATTAGTTCATACACCG
+
?=<?ABBBDDDDDDDDFF/GFFCEFIIECIEH@GIIIHIH@IEIEIHIHHIII.CFHBH-8IHCEHCB>>HDII-AIH/GAIF<IHGHI.HIIH=C9EFCF5FE4FFI.FFCFHEEFH?EHIDGFEHFGCG-DBDEGGEGBG#FFC,@-?EG?GEFAECGG8(6CCE29GGEGG8E;<F?EA9E:GCEAGC2GD=AGGC)FAEE?E*EGHGC7*0AGE#:BC??#EEGC:G:EAG(1'C/F?D(CEA??A
@antibody_301_multiplicity_233_copy_27-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTAGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAATCCGTCTCTCAAGTGTCGAGTTACCATATCAGTAGACCGATCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGAGTGCCGCGGAC
+
?AA,?/B?DABD@-@DCF>FFFHH>FCIHHH0HH9=HIFG.HFDHHHIIHEFAI9DCE>HHHHFEHFIHHEHHHIE@HD;EHHGFHHHIHEHHI,HHFHFC#IHHH(HEDHHHE9C)HHHG7G@3G+G7G@DG=(EH)4CBGG1C,CCG8AE?GFCEF;FEC'@E(EE*GGAFGC*GFCGGE?/EGC8FEG;(GEEG96##(?EGFFEC8CAHFCCF(ECEEFEC>?ACCACCE:?C*0*:EA6C*E:*?
@antibody_301_multiplicity_233_copy_28-1
TGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTATCATAGACGTGTCTACTGATTTGGTAACTCGACTCTAGAGGGACGGGATGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGCTCCAGCT
+
?A???B?BDBADDDDD>BCCF?HF>B6E+IHFIAHAHIIED@@HIIFI>HCGHHIHII-IIHBHHIIGIIH-IIHII=HIH*GEHF5HF=GDHH-HGI+EHHFHH@HGDFFHFHC=EDHGEBH>H)GE#GGGE,F;@6FEE;EG8F+EGG?C';EG<;;;GG(CGEE:F:E<B*8EF;GE(:G(ACGEE*FEGGGGAC.*EF?'GCCEEC6EE7F(EEE@F?GE6FEE:GEGE(GAC?*8G9(C?FC/A8
@antibody_301_multiplicity_233_copy_29-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGAAGCACCTCCTTCAACCAGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTATAAGAAACAGTTCTCCCTGAAGCTGAGCTC
+
?=???BBBDB@DDBD-0G;FFFH6IE>FI>HFFDH0IEIHH'A+FH.FG?H,HF5HHAIGEGHHHFHHHGDCGFCI>DEHF5H;HHHAIHH=IFHHHEEGHGHDHH8+=FHFFCGHHC4HGGHG6FEHGFEF?.G2HH50CGEGG:GGDGE5EEGE#;EGGGE((B6GA?*EGECGG:G6(C?EG/6G?FE6E8:EE?EGEEEE?GE.2?;6EEEEEGC(E76;?A(GEEG???(E?CGCG0EEEA:A?G
@antibody_301_multiplicity_233_copy_30-1
ACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCTCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTATTAGACGTGTCTACTGATATGGTGACTCGACTCTTTAGGGACGGCTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCTATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGA
+
?????<BBDDBDDBDDGFGFFFHICCHH+HHHD/IICDHIIIHHF59EGIHIEEHGGF?GIHI5HHIIIHHHHFEIFFCIFIIHEHAH,EEIIDIH#IGIHCHCG,;HFEHHEHFGEGEEHGDGHDEHBGGG*F#EF2E*EBGGGACCGFFFB'E8@G'EFGAGCAAGCF(G(GEG1G@#E(FG(:*?**GGG/E?CG?GE?EE:?E?;H?G(*G(;G?@#28G:F6EECE<G<(*EEA(DFGEGEE6D*
@antibody_301_multiplicity_233_copy_31-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTAGAGTTACCATATCAGTAGACACGTCTAAGAAACACTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGAC
+
=??A5BBBBDD-DBDDF?-,GGABHHG,>@HFHIEHFIHHHHHGHH-FH.FFHGHE+-E>AIFHHHH3HCHDHFHF+HHHHAAHHHIHHAHI,CHHIDHFFHH=IEG'4EHHFHE=GCHEEFEEG,@GD+2GFGGF.EF:GD(@AEDGE:CGFFCEFE:(E?G=GFG*1E;GG</2ED(=EA:?(EGF/(FE?EG?;FAA<E;2GA=CG?ECE#GEEECEE:?(G=?..EC?;FD06GE*:AC(A?E*.:
@antibody_301_multiplicity_233_copy_32-1
TTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGATCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTTTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCGATCCAGGCCCTTCCCAGCGG
+
<?A??BBBBDBDD-D@CGGGCFIHCIHEHIIIGH+HDGFH+HFIHIIHHHH-/GHDF@H5IFIFAI@FEGIE-F<HB5GIH,IIHHAIHH+H5I+DHAH+HHEHHFE+FHIEHH@EFED?#DH.=HDHHGHFEBDBFFB;EBEB@FEGGGGG6F*AEC;E;8:ECEG*02>ECFGECCCC>?AA(CEEFG/G(?ECFAEGCFCGC:EGEH;G:E@:*)GGG'G(:?A*E'#:E?2:EE1?EC<(0E::E0
@antibody_301_multiplicity_233_copy_33-1
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTATCGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCC
+
?,<??>?>DDBBD<EDGGFFGCFHEIIFIHHHHIFI9HAI7FEIGEHF7BH.FAHHIFIIIHHHHIGHGHHHIIFFC9IEDHFHI'DIGCHFIEIHDFDH5HD2HHG,HFEI3HGHGHH=#FFHGFEHHGG*FH7EFFEC*GB2EG(9FGBF?GE(C1(CGFCCEEG?2;E6'G>EF?EC(G.>FF?4G?EE(G(EAGGE(EE(AGC/:0D:*EEG?G(:8CG:AG(GE(?EC*F')<*:CECC:0AE*C
@antibody_301_multiplicity_233_copy_34-1
GGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGTTGCTCCCACTGTAATAGATGTAACCAATCCACTCCAGGCCCGTC
+
=?A5AB??DABDDDD5GGGBGFIIHHAH@>-FFIGFIHHGIHDHAAHIAG+>5IIHF8FGCFIHFEIEIFHI5IGC-C4BH5EHIDHFFIHHEH4HIIIHDHHEGCGGFGH=GIHGCFHFEG4GE=ED+D?CGGFE2*GEFFF@EEGG)GEDEE*GED=FFCGE@EGCEGG:EEC41>G6'CEDGEAE(E?E'<??G<EA6EEE2'H<:HC::(F7E0FEE,?F?E*0(FC0?/GC/EG?E?EG?A/*E'
@antibody_301_multiplicity_233_copy_35-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGTTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCCAGAGCCGAGTTACCATATCACTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCAG
+
?=5??>B>DD-?@B-B8FGGFF+'IIIFICBEGEIIGHC-GDCHGDIHHHE>IE>H7ICIBFBHHAHIHH,CICHFFHI-EDBEHE-HEDHFHHIAIH@HDAHAFHGHEFHHHIHEDH#F?FHGDHHBE*GG@GGECECEH8@G661D*1G>FGG(GG?BG0*.GGE/CGFC,G2:(;E-AE?(C;(?/<E'AE,8EF?(E(AFGE(#FE*.0A/EE1GFBCFG2G(FE>G??:0:F1:CF?E(GGCC*A
@antibody_301_multiplicity_233_copy_36-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTTCTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCAAAGAGCTCAGCTTCAGGGAGAAGTCTTTCTTAGACGTGTCTACTAATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGGTCCCACTGTAATAGATGTACCCAAT
+
<<?A?BBBB?D@DD@DGGFGC;ICEFFFHFDIHGH?9EHFFHHCEHHCFA=HD-HGFCI+H-H-GG@HHII=FGEH@,IHBI@FIIIF@HFHHBHDHHHFHHG-@HHDHGH(FHFFHDH++DGHEE,2CGEHFHHGGF#F@GFGG*BFC;GCEE;GG?G80C,EC*C8FCGG<CF*C(GF:E0E(?CGEC*EG6?::EAG/0G?EEAGE8EGFGEF8*EFCGC?'GC6CG0E*/*EGCECE?CC:0;C:-
@antibody_301_multiplicity_233_copy_37-1
CTAGTAGTAAGTACTAGAATTCTAGTAGCTACCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATGGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAA
+
?????BB5BDB-ADDDF>FGCGHIEHFHIH/HFH-AFGDIIGI+DEIHFGHHBAGFIH-HF8EHHFHIHIHHFHHHIFFDI?I=EFHCDHIHHDCEHIEEH+HDHEHFHDHHFGHHHEHCHHHF2*HFH?HGAG;G*(AGBGEFECDEFAGF0EA;E;GECGEEEECEEECGEGE6;GEG<CEAGGEE(A0B6EGE5A:F(EEEC:HE:CECH:GG*AB.FCC#/CE;GG*'CEE*)AF:(AGGEEEG/0
@antibody_301_multiplicity_233_copy_38-1
CTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGTGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACGGCCGCGGACACGGGCGTGTATTACTGGAATCCGTTCATACACCGGTATAGTGGG
+
?????BB>D@BDDBADF+FACFAIFI;>HHIHICIHIHIHH=HHFHIHHGHIHIHAHIEFHAIGFH85DIHIIEGEIF#HIHHHHFIHEDIHFHEHFFHHDGGCHIGHFFFEE552F+GHDFFF=HDFC*,EFFFDE<+GFE@#EC/2CFGE8E?ACEGEEG80DGCG(EGFG0FECGEGEECE/EGE0F6EE?G*6:(8EGGE*E?CC(<GEEEE?C:C;A6GE((G:*0((*E*E)E8*G1EEF?(<E
@antibody_301_multiplicity_233_copy_39-1
TCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTCGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTGGGAGCTACTA
+
?5=??<BBDBBDDD-DFGFFFFHEIHHIBHFHHHGIH.FFFHIDGIIIHEHII9DIHIIIFDF+IHIGIEI@IHFFHDFCH-CH?GGIFFHHHDHF+HHH-H#(FFFHHH>?HEHHH=H=FGH*HGEHEDGEHGED8GBFFEGEGEEEFBF8GE;G?EEEGC6G8E;?EE(:GGFEC::/EG<CCC8E(GAG:DGA/(EEDEGCEE/(E?0::AEEGGBGEFGG:E??E**6EGE?AG?81CAA(00G)C
@antibody_301_multiplicity_233_copy_40-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTCCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAAAAGTTCTCCCTGAAGCGGAGCTC
+
?=??9BBBDADDDD-BGGFGFGHIEIE/HCFGFHDHHIFHD.I0HIFHIIGEHCCI+FIGHEI+'5GH.IDDI;EH)HEIHH?E+FB+H5HGFFGFHI6HHEHHF@EFHHDFFEHFHHFF()HEEEGHDGF0.EGEE(GEF3G*EFE;EGFEHEGEGFDAEGCEC0GG5G?GG:GCGAEE??2?G0FGG88<6EGEEFCGEEEEGA(GEE?*HC@FE/EA?GECAC(.:AGG1CC.(CGE/:G*E8G??C
@antibody_301_multiplicity_233_copy_41-1
ACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGCGCTCCCACTCTAATAGATGAACCCAATCCACTCCAGGTCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAG
+
??,??BBBDDDD?D@DFAGFCFIHFHHI/HHHHHGIHIFIHFHHCHHHHE9IIIGEFI7FHHIEEFEHDHHI+EHCIEIHHIHHIDIDCIHIHHCIHGH6?FI@HHEHHDFGDB29FHEGHHFEFGDEBHEEEEE=.GG*0DECEFEGEGEDF;G=G4E;.#EEC-EEGEE(G/ACFGCAE+F;;EC:E(CF(G;C)GG'CC(AEAH?2:EE<A'EGCFEC7AE0E*8E(8*C:C.E:CGC1CGEC?D*8
@antibody_301_multiplicity_233_copy_42-1
TGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCGGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAGCCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATTCACCGGTATAGTGGGAGCTACTAGAATTTA
+
??=?5?5-D@-@DBBDFCGG?GBEHIIA>IHHHIHH=HHIIH#HIFFHHCFHIHIFEHHFHDBB5HHBFGIEAI5=FGHIH=HHHH+IDHFIHH+IFH-HE#6FIAGEHDDEEHH+EH+FFFEE*EAEDB?FBCH@EEE1GGE:ED=GC?EGFG?FDE6FFA?GE=6(GE/ECEFGGGG?6C:GACEGGECE(EEEGEEE?E>E;(E8GEC*(EGA0C8(8EE:A0G?GC/18AGCAEE?:8C='AF.(*
@antibody_301_multiplicity_233_copy_43-1
CCGTGGTCCCTTTGCCCCAGACGTCCATGAAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCTTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGCTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACAGTAATAGATGTACCCAATCCACTCCAGGCC
+
????ABBBDDADDD<DFG;G@G;IEHHIE/HBIEHHCFCI@FHIDHGHHHHHGHHHACHFD5H.E5HGFIFGE=EHIHCGFHCIFIHH=CIFEHFHHA/I.GFEHHHFF-#HHCHD;FHCGHFHE*FH@FHB*DFF+E2EE4ECC?EEFDFA=A;EBFEE?EG?GCGGGGC?*GEC*0GFEEGFG6=4GGE.;CA(G:GE:?G?6CE:EEG**GFG-*,#GF*0:A8*E/EGAC:E'(GCCGEEEADGCE
@antibody_301_multiplicity_233_copy_44-1
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTTGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCGTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAATAAAAAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCG
+
?????BB<BADBDD?D8AFGCAFHFHHBIEGHIIHHHGH=HHGHFHIFHFDIGHHH-8IIFFHCE/IIGH5B?GHF-HHHI-HGHEEHFEHHHCIIDHIHE,HFGHHHCHECH(HEEH#GDFEHGEH+3HGE#GGEDF8EDEG1EEEGDEEF*GFGCEGEEFGEDF6FC??GG(G?CA.GFEEGE6EGGECC?;(FG6CACG6:G*D;AE/1:E'GGEGE::*DC.<C:GGEE*(C.CEC6GECDE?A?:
@antibody_301_multiplicity_233_copy_45-1
GTAGTAAGTACTAGAATTCTAGTAGCTCACACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGGGCTCCCACAGTAATAGATGTGACCAATCCACTCGAGGCCCTTTCCAGCGGGCTGCCGGATCCAGTTCCAGTATTAACTA
+
??9??B?B@DDD<DB@CF/EFFIIHFEH.HFH/GFHDHEGD@FFIHG8DHFH@EHHHIFHHHEH-HGEEHHGIIHHHEHII=HIFGHIG5H@HIIHGF-H5HDHH2HEFFDCFICHFHHHHF+GDHEGCFFDBGBIHGCDBEEGEGF*FEGEGGAAGG8:AGEEFFEEEG'GCEEGAA(#GGEGGG6GE?('*EEF?*CGGCG?(E??G??F@#E?GF8E.:E8G0(0:A-0G'C#CF;?0E6CEGGEE.
@antibody_301_multiplicity_233_copy_46-1
TATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAATGAGGTGCTCTCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACCAGTGACAGTGCAGGTGAG
+
?????B?BDDDDD@DDAGFF/G60FFBFFHIHHHE/AGHH?ICHA,.EIGHIDHIH.>+FHH=FGFFHHIEIIGFIGGDFIIDDHDIHFI6IHCDCGHHDG/=EGGEI+GEIFGDAH;H=(H+G<CHFGFGDG#FBEG@EEEE,;GAGG96G4:F?DEG?=GEGG;;A8DGF(EG:?(:<8?:?CGEGCC4E:EE(GG?*::G;FEC*EE?F'C*CBE?G.CA?:)?1GE:*(*?EEGG:C0/CE9*0'A
@antibody_301_multiplicity_233_copy_47-1
GCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCCATTACACTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTAGGAGCTACTAGAATTCTAG
+
,?<??B??DDBDDD5DGGFFGFH@HEHFIIFIEHAHIGIHFCFDIFHIDFFCH+EEDIH7H.I.H7HFHHIIHD-HHHHIA#,I+FDDDIF/IE=GFHHHFHHC=HHHGFGHFGGFHHG@G+CGDE@G<0FFHDG*.FGF0CCEGGGGGF(EF?A(EEFFEAAEE*EFF?AGEEAEE?ACGA(EE?E:FCG?F<FA??**EAG9):EEC*/CC04*CG<8?:C*C;CGEC(8'GA(/6EE:G0F*?GC:9
@antibody_301_multiplicity_233_copy_48-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACTCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACTGTTCTCCCTGAAGCTTAGCTCTGTCACT
+
A????BBBDDDDDDDDGGFCFFECFHBIHIHHGFIAIF@HIHDHH@FHIHHF/.GFHHDFHIIICI>IBDHIIHHHII@HHI5HIHCHDG8HE0HGIIG<=-4(HHGHHHFEGG.FBDDFGEDHE+EDHHE,HE.G?FEGB2?GFBEGEFC>GE;CEEFEE1EEEFBGAGFE(GEF:GEFEGGEE/G9FEG?ECG?680C/G01FEHGECE0AEE(EE7C9(FGAE:EGA0(::0*(**CCEE(?A*/*9
@antibody_301_multiplicity_233_copy_49-1
CAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACACTTGAGGGACGGGTTGAAGGAGGTGCTCCGACTGTAATAGATGTACCCAATCCACTCCAGGCCCTGCCCAGCGGGCTGCC
+
??A5?BB-DDDDBDDD?FFG;FIHFI;HHHHF@GGIIFIIIGHBECIFHHAHA7FGIG-FEHHFIBCIG+IFFFHHHH>EAE=EFHIE>IHFFFHFHID-I9FFFI?-GDEHFFHH+H>?GHF=CEFGDGGDGDGDCGEG:GEF?EEACFE*EG;GBFEEEEGAGFE/E(GGGCE(G(?:GE:?EC-'-EEE8EG'AE-(E(GAA?A<?EC0@EC(0E)::EGC?ECF8EGFEE6*(C>?:GCED*EECE
@antibody_301_multiplicity_233_copy_50-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTGGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCCAGAGTCGAGTTACCATATCGCTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGG
+
????=B<B<<D<BDD+/FCGGFEE.6FFIFH@@CIFI=DICI8GFIGFEHFEEHHFHIHFE?HFEGH;HI-HH=C+IHFDFHHHE=,IIHFEHHH/EFAHECHIEHIDGEFH7/GF@GE?DGF8F??GFDGGEDGG;G.F9EE@F<FGGG#2EE>6ECG=FF*=(G*9E3GGFC(CEE;CE;E<EFCA/AEG*E**E.;6:/GGE(?4EEE?H.ECG*G'CCGC.GEE(GG:*G:EGEFC:?(.CEE?EC
@antibody_301_multiplicity_233_copy_51-1
CCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGCTTCTTAGACGTCTCTACTGATATGGTAACTCGACTCTTGTGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACCAGTGACAGTGCAC
+
5?A??B5?BDBBB?-DFGFFEGEFIIEIIIHIHGD.7EFFAHHFHH@@HGHIDHCCHG@FEHFHIHI-IAFIHIFGHGHC+C=E+FGHIH7?CGIA,HCHHGHHFC,6HHEHHFHHHFFG*FGB#GE*EFHC2GGFGGFEEGCCEB::FEGG8EG8:B;EG.GGGEEFE;?/:ECEGEFE9E??(=C8EEFCFECE:G:G6EGA/?H(GEE08GC:8GBGE2:?EEG(E0FGEE:G/:G*(A:6?EAEE'
@antibody_301_multiplicity_233_copy_52-1
TCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAATTCGACTCTTGAGGGACGGGTTGATGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGTGCTGCCGAATCCAGCTCCAGTATTTACTACTGATGGAGCCACCAGTGACAGTGCA
+
?A?A?BB?@BBDD9DDFEFGGGBEFHFIHEHDFE>I?H@FIHIHHIF@AHH7HIEIFHH7+GEEHF=H+D=IH-GDIHF-GC=-AFIHAHHADIGIDHHDHHDGHHHHF=HHEH'FDH+FHGF#F.HGFF6EEDGC*F*EGGE2FEE#EEE@B,@G8;FGGG:@8*E;FEFEC<E0F61;GEE*EFGGGEEGCF*EGEGD?E#EGEHEE(FCE;E:)E,(:EGEAG?:E6EGEEEE=C1*C(E1:8A?GC
@antibody_301_multiplicity_233_copy_53-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACACGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTC
+
????,B@>D<DBD-<DFFAFGDICHIEIIIGGFIHGH9HFDEHIEHFHCGCIHA.EIEEI5HDFHIHD-FHDH-CIHHHI5HHIIHCI5GH@?IHHHFIIHG?EGEDCHH0#HHHGG+FGF@HF6EEHGDGEG*GDDHEBGEBED88G;EEFGEAGGEGEGGGGGE,6EECA:FGEGGE'E:EAEG<AE0GEGE?E6AGE#:(6GGFFG?FCCCG0B.C(:?C0(GG68EG8GGAGF6EECA..G(:<-G
@antibody_301_multiplicity_233_copy_54-1
GAGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAACTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGCCGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGATGGAGGTGCTCCCACTGTATTAGATGTACCCAA
+
?????B>BDDD<595DCGGC@FIHFHIIHIGIH+HIGHGIHFIHG+FHHAIIGHFHECHH@CHHCCGHIIFFCF-HFFEBHA-/HFI-HHHHHFEIHHHHHIIHE)FHFHHIHH+GEHGHFFGDH)DFGG/EG*@:+FGEEGECGEG:EF8G>G@8GEFECG)8G?AGG:CB#GEGAEGFA+EEGGFFDCCG:C((E?GEE;(E.E?C?:6E@G@:G*(@CA9EG:EEEE:1':E*(*C<;E*EE?'CC(
@antibody_301_multiplicity_233_copy_55-1
TCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCACTAGACACGTCTAAGAAACAGTTCTGCCTGAAGCTGAGCTCTGTGACTGCCGCGAACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAG
+
=,???<B?6<DBDDB@GFFFGFIFEFI8HIEIIIEII98+CIEIGH-CCHHIDHCG7IHHIHFIHHHHHHHIHIH=GHEHF@HHIH=IHHHHG3G4H;HFH@FFI?GFHH;EHHHHF*HBGEH?FDCAEGF@H*FI>8E6GEEG>DGFDEG,'F?EGEFCBCEAD:@EAFF@;:;CE#*GEGGEE:*EEGG(8EAEFE:.?'CE6E#EE)E:'EGEGG8EE8EGF(CCEGE*G.E(EEEAE?EE*C;(AC
@antibody_301_multiplicity_233_copy_56-1
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGAAGCTCCCACTATACCGGTGTATGAACGAATTTCAGTAATTCACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGTCGTGTCTACTTATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATAGACCCAATCCA
+
?????BBBDBDBDD5DFGFGGFHFFHGFE8IIIHC@.HHHAF@IABEH?HHI=CCFHHH-HHIGFAHFIFC*HEIIGCGHI-F*DHGIDE*I,IFF=IHIE+(*EHHH<EF*FH+GFFGHHGGHF:BG82GE9GEEFDBGFFG/EGF/BCG*GEGEF0BG;*?AGFGC(,:FGGGCFEE(G?.GGGCE*FA<GEEE?A(?C8*;0GEGC/G=C)0?(EG,?:?1G#E/?FCG(D.0CE*##*:?*AE/*E
@antibody_301_multiplicity_233_copy_57-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTAGATTGGGGACATCTATTACATTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATGAGCAGACACGTCTAAGAAACAGTTCTCCCTGAATCTGAGCTCTG
+
????ABBBDDD-DDD@GCCFGF>IHFHFHIH<HFGGIIIHIHHHFEIAG9GFHHEDIHHGHFH.HIGHIFEH*IFE@EGHFI57HFEHCI,HFHH8HEHGH+@HHG8+HGHAFHD/:FFDFF4HBHHGCGD)GEGF#GFGECHG)A*8GEEC?E;EE6BFGEGE.E:.CGGG6GG:6GAGEG?G?D?GEEEC;?(?G:C<*?6::)CA#FAEEE@G8EEG::;CE?GAE<EEEG#G(??(1FCEC(EEEA
@antibody_301_multiplicity_233_copy_58-1
GTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGCCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCGAAGAAACAGTTCTCCCTGAAGCTGAGCTTTGTGACTGCCGCGGACACGGCCGTGTATTACT
+
?????BBBDDDDDDEBGFGFGGEEHHE@IEEHAH=HHI@IHHGCHFFGIFHIA.?HHFHHHICHHEF5AH-IEG-HIGEHI5H3AHHI:FGHFHFIIH*?D1IGG+EFFGAFHHFHF=GGF@DHHGGGEGHGHH@EHEGE3*GGGDEDEB*(ECGC*G;EE::E6CG6GGE(GEGFGA6CE:C.E?CE*E*EG;:GE:/E.FE(?AF8EHEA-(CE?#;AE?/CE?C:EEGE?AEEGCGCAC(CCC:GCC
@antibody_301_multiplicity_233_copy_59-1
TGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTTCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGGCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTACAGGCCCTT
+
?<?AABB>DBD@DDDDFFGGFGHEH>HE-HHIHIHHHFIEHHG7-FIGHHFEHHHCICGIH>HE-FIHHHIFEFFEIEHHIAIGIHHIHCHFEGHFIH5HF.IHFEIEHHHGHH;HEHH9#FFD+=FHGGF?GEGBGGEEEE;EEBEG2>G1GCDGE(GAFAEEGBFF:A?GGC?:FF(GGGGF??EGA?0.EEECGA60ECGCG:EE#ECGEAEGF7F0CG:-CGDC:EEG9EA0G6GG(;FEEAECE?
@antibody_301_multiplicity_233_copy_60-1
GTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGTTGCTGCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATTCCGCTCCAGTATTAACTA
+
?????BBBD<BDDDDDFFFGFGIHFH-HFIHIHIFIHAHHE9H8IFHFIICGHA+=H-H+IDIFB5EICIGF-IH)F<FD5HHIHHIFHHFHHA@IDFHFFEHFEFFHFHHGEGF2EFE>HGHGHHF;EEFGGE5*GEFDAEGE:EFEG,FGGEEFE9GGECEBGFCF;)1DE.(FEF=CGG:ECF?GG0GDECGC8:2A:<GGAGEGEH>AFC(::?8/C,E(DCAFEE6'G*G:(?6E:C/**1;;CC
@antibody_301_multiplicity_233_copy_61-1
ATCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGTTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAACACCTCTTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTAGTACTGGAATTCG
+
,A5,5BBBD<DBDB5DCCGFFEEIIIEEA.ACICE.IHIHHH?GHBCIFIH,AIHIH5CI=F5-GE5EII-HFA5=EE=HAHHEHHEFHGDHHFHEHHHGHH:-HB@6FDHGIFHFHAHFG?DFF#G8GEFE#GFGGGGD#FGH3GE/*EFFEG;1GG=GBG?AEG0EEGGEEGEFE0GEEDA8AE??EE*GAA6G8<CF:?AG*GEE*AAEHFG:?7EGEEE/*G.:6E*AGA?(?'EC?16:(-C?:6
@antibody_301_multiplicity_233_copy_62-1
GACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATAGCAGTAGACACGTCTAAGAAACTGTTCTCCCTGAAGCTGAACTCTGTGACTGCCGCGGACACGGCCGTGTA
+
???AAB/BBBDDDBDDGFE--GIIFHIFHFHI.HIIIIIFFDCIHHHFBIFCHFA@>IHHFEHFHHFHG@)HFCHIIFE+DHC-?FCDEHIH(H7HAFGHHGFHH:HGF?GHHHH)@HDFGC@GHCE*GHFBE);<8HFE6BB(.((@GAGEEG?C:FCGE)/,*=?::GFA=(AA)AE#EAE0;GECCG?/GA9(EC:GA'0E(C(*GE*CHEE7C0E(-G.*<<0GF?F6?GGA?GC:CEEA;?EGC;
@antibody_301_multiplicity_233_copy_63-1
TGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGTTATGGTAACTCGACTCTTGAGGGCCGGGTTGAAGGAGGTGCGCCCACTGTAATAGATGTACCCAATCCACTCCACGCCCTTCCCAGCGGGCTGCCGGAA
+
,?A?9B?BDDDD?BD@CFGGFFB;HFHIHHIHIIFIHHIFFIIG9HHEAH@HCDHHHGHC/HIIFAI5HIF5HDHHHDIIH5H+FFHIIFCII+IECHFIHH#DIGHHHHHGHEGDGEDFGEFFEDHF;CFG#FHI3GGGGEEFG*GEC?(*FEE0GEFGG?FGGFGGEEGB(=)G?(?E=AFGGA(EGFEF#;EGG?EEGCGGFGF((.E:CC7:G7GEGACGE)EE?A8<'0:E/.F/8C?E(E(GG#
@antibody_301_multiplicity_233_copy_64-1
CGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCATCAGGGAGAACTGTTTGTTAGACGTGTCTACAGATATGGTAACTCGAATCTTGAGAGACGGGTTGAAGGAGGTGCTCCCACTTTAATGGATGTTCCCAATCCACTC
+
?????B-5DDEDDDDDGCFFG/>H.FFIFHH5BHIHHIHBHHIFIGIHHFAGGD?GHGFICI-FHIHDIFFHIFIIIHGHDHAHIEDHHHHIHHECG9FFFHHDDH==GHHHDHFB@HHHECHHGC=CEFFGEF*FC:GGGEF*E:@FGGEA;E?GGD?;(GGEC(:F8#EGE:G*A:F;6AEAGF?G8E'9CGEGGGE2G0-C?*CE<9GCECGC:0?CE?E0??(?6EC*EEC/E(G(:GAG:;?ECG
@antibody_301_multiplicity_233_copy_65-1
AGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGCCCCTCAAGAGTCGAGATACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTG
+
?,=?A?BB@DD@DADDGG+GGFHHI5HH,BHHDHH@IHHDFHFDH9HFIIBHEHFDH.HHCFDFAIH@HCF-HHEGH?IHI5GEHIHFIF>8HFHIF-(-DE8I+FFHFEGFF+H?HDFHFGHE+EBEEAEFFEFFG1DEEGGGGE,GGFEECDGCG(G8>=GGGECFEF0(E#GEE(EEE+G#DFA;F6CGC:F6E/G:GG<EG::E:E*GH(G<F>ECC#CG6:*GAG.;G?GGE.CGGEGEEF(A/C
@antibody_301_multiplicity_233_copy_66-1
GCACTGTCACTGGTGGATCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAACCTGAGCTCTGTGACTGCCGCGGACGCGGCCGTGTATTACTGCAATTCTTTCATACACCGGTATAGTGGGAG
+
<????>ABDDD@DDBD+F/F>AFIEIFAI8/IIHGHIH9HFHH=IIHIFHFGIHFCHHFFHFEHIHEIFFFHI?HI=HHGFAIEIFHG=HHIC=HCHH+A?FH)GHHHDH>HH:HGFF9GDHFF+,GGGGHH6G(FEGCGEEE?EEG*GGF:G;EG?AF0GF0*E1F/G(GCECE(GE*FCFG?GE:8GG?FECG:EE?CE;G*EE*C(6:CH/FGE(,A(?6EE(#:E<F6EE:::?G;C*GC8C?GEC
@antibody_301_multiplicity_233_copy_67-1
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATGGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTC
+
?9????<9<DBDD@ABFGF*EGFHIIIIFHFFIHICI.E,IHHFHIH?HE?I-GH-EEIH-BIIHI-HIEHHIFAHDIHIBHICDFDHH=CHE=H-IHHHIFHHHHE#GHHHHHHHBBFHDGGFGDFGHDEHG,GEG)EDHE2F?*FD@4CEG*6ECG@C/GAGG(CE*GG(?*FE/AGAE;G;<(GEG*(GG?FEA*?CG:C:?8ECEEG(HE=1F/GE8GC*68ED;*(:?CCEE:/:'(<GEE*AGG
@antibody_301_multiplicity_233_copy_68-1
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCCACTCTTGAGGGACCGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCC
+
??????>BDDBDDBDDGGFC0AFI/IH6FF>IAGHHHHHHE5F9F7HDIEGIFIHFHEG,HHIIIFHH-EEEFHFHH-IHEFHHEGC(HH+GEIFEEIIFDDHHI-EH;EEFHH@.FE0@+6GE*HFEHFG?GEGGE,EEDGG7G:<@E@EEC,GC*EG(2E;#GGG@(AGC:GE(GF>DGE#?FGEGACGEG(DF'?*(EGCGEGHEE/6EF7GD*E?C.8G(:CG:FG;CGE?CE8:??C*1E(EFE0
@antibody_301_multiplicity_233_copy_69-1
GCAGGAGTCCGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGTTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGCGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTATAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCC
+
??A??B>BD5DDDDDBCGGCGFEHEIHBIFFHDFIIF=HCCG@IFHAHF/H.H5HH)CIHHEEHHCHIE)-FFBFHIGFAHAC=DIID>IIHBEFHFHHHHH=EHF6HHFHFG+GHHF-1E+GFD/DGHHEGFF3E*=;#F(EB,72(F:0*>GEEGGAGGGEECF*CG=CE?GGA(GAE-CF?:AG/?2G:GEF<;GE6**E?(EE(C(EECCGEGEG7GFAG?8.E*FG0GCCG/8(E:E:E81A/(?
@antibody_301_multiplicity_233_copy_70-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTATGTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGTAGCAGGTGCTCCCACAGGAATAGATGTACCCAAG
+
??,?9BBBD<BDD?EDGC6GFCBIFHEHIFHHHHII7EEIFHHHHHEHIFEFHFDIIGHHI>DHH.HHEHGHFAFBHHHHI-5HHFFGIIDI=GHHHAGHIIFF:HGHFDFEEGHHHDDHCFGE*C7FEFEDFGGFFAEHE(CGE>FEE'BFEG(E;76EFEG?CEGGGDGCE??*E(EG(GEEGE0(G<EEGEG68E6.6/EECGEGG;GG1CC(0E(GGECE6:GA(*C66*GE(CCGGAF*(:*/(/
@antibody_301_multiplicity_233_copy_71-1
CTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGCGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTAAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATGGTGGG
+
?A?=?5BB+?DDDD@DFCFCEGHI>IEEIIGFHHHBHIHHAHDH?FGHH.HHIDH-CIEAHHFGFIH*IFHIIIH-E-HI5FH,HF5IFF(?5FHFEDFBH=AG+HGEHBBHGHHCAH3FE4GEFDGGFBH6D<FEG=GFDGFGFE;GEAEGC8CGE;FGEF*GGF9FGGE?G.;EECC9EG,(*CGDEEC*<DG.8(G*G??ECE;*(E;EE@EEGE8C0ECA1?C??AC>FG*:A?>A.E/E*GCG?E
@antibody_301_multiplicity_233_copy_72-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTCGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTAGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGA
+
????ABA?D@DDD?@DGEGGGCCIIFH/HHGHEIICFEHIGCHFFH,>IIIH99HIFDIIIFGDCFFHHIHI->EFIEGH?FHDGE>IH/IGFFHHH7BDIHD+HGFHHHFHD/=HEDGHDFDGHHDF,EG*?*,*EEFCD=@EADBEEGEGDFEAFGGGCFGEFGE?AAEEEG<F:EAGCFEGC?.2:GGEEE0AEEEG(:CE*E=;:E*EAFCG.E(@EGG:E*E6F?*GEC?E:E(C?*:FGGE*AE
@antibody_301_multiplicity_233_copy_73-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTACCACTATACCGATGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTGATTGATGTACCCAAT
+
?????B?<B@D-D@DDFEGGG;ACIH0FH>HIHAH+HI@I9HHHHFFFH7DEAFGIIGDHHIHF-CFH=HFC@=HIF=F+BHFEIIDIFGH#FCFFFHIGEDHFFFFHGHHHD?+CHD=EGGE:HGFDFEGGGED;GFGEDG>FG@GGEGA@FECECGGGDFF;:(B0FAE*.GE((EGEE:G:G6G6.E(ECFEEG*ECA?EC*:C.GCE?ECECEAEE.E;CC(.<*GGC/?(:EC?C(*GECA68GG
@antibody_301_multiplicity_233_copy_74-1
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCGTGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACTGAGCTCAGCTTCAGGAAGATCTGTTTCTTAGACGTTTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCC
+
?A???B??6DD<DDDDGFGAFB-IH>EFIBCH=,CH+HH8GHCI7.HIFH@HHAHFD>HBEIHFIIIIFHIHABHCCFCHIFFHHEIHFHIHHH+GHHFHGFHHHEHHH2FFFH*H=HGFFFB>ABFG60FFECB1F0G>;CFE;FEBE9G?F)CG?(EC1@GEE;F3AEAEG(**FEAAE9EC:G?C'GG/<GFG'CG?(<FG?G((A?A.E(CFGG:#G.*.GGGG:G:?6*;CG>C<E(A;((0(GA
@antibody_301_multiplicity_233_copy_75-1
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGTAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTTCCTGAAGCTGAGCTCTGTGACTGCCGCGGA
+
???5?BBBD9-BADBDEGFGGCAHHHHI-HIHIHIFFG8@H>GHIHFDH+CHCF+IIHHIEHHDEFHHIHHFH??HIHIHHB=HH?HFIFF>IIFCFIHDHFHFGH@FD<HHD.FH@@A*FF=FFFGHFE:=GGFBEGFGGEE;F9GGC8GGE(C4E(G*C4<8GGCCE(;EEGE?GE/?EG6?#ECEECEGEG.CECG9E.E6G<CGGE1DD@GCG?,@FE??CCG-(E<CG(EG:1E0EGE;:EG/()
@antibody_301_multiplicity_233_copy_76-1
TAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGGGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAATTCGTCTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACGCCAGGCCCTTCCCAACGGGCTGCCCGATCCAGCTCC
+
=????BBBDBDBD@DDFFFECGHHIHFHFIBHHHIFFH#IIIAGBI=HGHIHGHAE7GIGF=;-H-F-HFIHFI9HICCGIB?FHEHHHHE@HFCFFHF7#DHFDHHD+=HHDHD*;HHHF8,=FCFHGHHG?G@EE6FFBEEE@FECEEA*EC<'EFGCEG?GEE?:EGGGB?CE((GEC;EGEGG4EGE:FG(A;?EG>AEEE0:E6:?EC'E*GE8ACFE:EEEG*:E?EC*?E<.GCAA*A.0:E?
@antibody_301_multiplicity_233_copy_77-1
GTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCTGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAATAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCAAACACCGGTATAGTGGGAGCTACTAGAATTCTAGTACTTACTACTA
+
?=????B?6D<DDD<+E8CFGFFIH/HBI9CGFIHI@H=CHD:BHCB8DFHDI.@G8HH5HIG5HAIHHIIDC#F*CH5GIHHIIIFIH9+EIGFHHEFFEDHFD2FFHGHGEGFCFH@*H@EHGGFC#GFC3DGDE@G*GGF=E.EGGEGGGAGDGBFG8C??E(E)?D-.:F?EGFEF?CE*FDCFG6EGEG:8(G:?;?AC(E.GAEEE-9FGE:ECB;C':E6;CAEGF)<GEAE0.:G8CE*8(E
@antibody_301_multiplicity_233_copy_78-1
AGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTTTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGGCCTTCCCAGCGGGCTGCCGGAACCAGCACTA
+
,????B7B-D<-DDBBGCFCFGIFFII/HAHHHACBIEII+IIHFAHFFDHHIF-FFIF.6=HHDII+BHIBHHHIHGE@HIHHEIIHHFHIGGHHFHHHDHHHCFH(H,?GHHB@H@HGFFF*H=GDGEGHHFG=(E=GEDEECFF7GEGCG@CGD4;6E*0EEGFEDGE(?'EEE;FDFCGEF:E1AF?GGACC<8.E.EFAE?H?DEF:.EGGGC(98:0(EEC(GEEG:C<GG::?(*E-EC(E*(
@antibody_301_multiplicity_233_copy_79-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTGACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTG
+
????ABB=+DDDD+@DGFG.G//HCI?HEAHAHHGH.II/HFHCFI-CCID0+DHB@HHFIGHHIIFIIA-HGHHIHH5HHEHHHHIHFH=ECHI?HD>FFAHIHHHFEH@*?HHHFGFHDF;F@,FGDG9GG*FGFE>GDDGEDF?GCEFE;G0CGF0=E>GC?E:G6CGEFGG/E:GGGEC(EEAA;EEFFE/#:?GAEEGCCGE(.DGG9:(EFA/(GEEE?GEE6C(G8G>EGGE(AD(EG(AE?E
@antibody_301_multiplicity_233_copy_80-1
CCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGACCTCAGCTTCAGGGAGAACTGTTTCTCAGACGTGTCTACTGATATGGTCACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCGCTGTAATAGATGTACCCACTCCACTACAGGCCCTTCCCAGCGGGCT
+
????ABBBDD5BDBD5GGFCFF>FHHIHHHHDIIIIFHHIIIDI=HIIHC9IHBF8H@HFHEHHCHHH>EF5=HICFH;I,CIHFDH:FFGBH+IIHGFHHHHHFH7HFBHFEH8H#HHE=DFHDEGHH9FFHDEEHFBEG5'<G4GGGF@(HGGA?E81FFGE#A*GGAEFCEG?EG6CECCE:?GCGGEEE?;EE?EEE/>*E:?6(CEEH/.2CGE@G7(EC:>0C(E6/):E:E(:8EG5E*?:)*
@antibody_301_multiplicity_233_copy_81-1
TGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTACCACTATACCGGTGTATGAACGAATTCCAGTATTACAGGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTT
+
<???=BBBB-BBD5D-FFEGFGCHAHEIF.IHICI/IHHFIIHHI9HFH35F+D.@IEIDEIHC#HDIHIEEII-IIHCHID-IH8+GFIHHHGHHD6HHI)1HH;HHHHGH3GHGHG+.GGGEAFBEGH@FHCEGE*GBGC0GGGEFEEF4BEEE*GGFF:CFEGEGGA0FE:EEG:?CG'E.C.EEGE>EFE?:CG(?:6(GAEC?GFFEH@G;BCG<-.GGF:.:01C??E:E?G*:EG*A8GFE?E
@antibody_301_multiplicity_233_copy_82-1
ATACTGGAGCTGGATCCGGCAGCCCGCTGGGTAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGCTACCATATCAGTAGATACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGAGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTGGGAGCTACTAGAATCCTAGTACTTACTACTATTAC
+
?=???<BBD<9DDD5DFGGFFFIFCIHFEH@.IHHFHHFHHFDHIEFDI/HFGGIHDE-H.AHIH?FFHHIEICIIGDAFEIIHFHGH+HB6HH5FHFHGIHHIIHHFHIHBHHIAFFHF#HFGGF+F'G*HFGHFEG.CGGEEFEG3GEEGE4E?FFGFEGF=EEG(EGC;GGGECEEA:;AF@(G*FFG?EEE0:A6E?EG:AFFGAA6EEC@(D?-:*GEEC/FEC'AGC?/'0GEC>(0*CC*-G4
@antibody_301_multiplicity_233_copy_83-1
CCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTGTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCG
+
A??5?BBBB@D5DD-DGGE;GF@FHH-HFEIFHGFC7I(FAHFHFFHDAHF,FFF-IFHEHHHCIIF-IFFIIHHA?=FEIHEEDHFC75GHH,IHIEHHH+HGHEHHF=@EHFH5?+DC6GHGGHEG@0FG6DEGF8G5AGE9D=@E?EGB?G*(EEGGEAFEE:E?A=CE6GFE*G*?CGEEEEF:/D*EGG?A(GE?**G:GEE(EH=*EGF:ECCE(C?G?E:ACGEE(EGG?D((?:**6G<GAG
@antibody_301_multiplicity_233_copy_84-1
TGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGCCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACGAGTGACAGGGCAGGTGAGGGACAGGG
+
?9??=BBB@DDDDD5D9F@;9F-ICCEHHIFFI9IB8I>EFHIIBIHDHHEHDFFFGH-EHFHGFGHGFHHHDHHFGFH-AIHFE8HIHI>DDHHH@F@G@HBFGHHI8F)DFHGHHFFFDGGFEF?FHDH,A:EGG@F'FFA1DGG4CDEE*C8DGBGGEGGGG@EGE?G;G8AA(0EAE+GEC0G?CG*.FGGE:EEFGEGGE>:FAE/GF/C::CCE?EG*CGGEAAC;(C2EG?C:/E6'GE1.8E
@antibody_301_multiplicity_233_copy_85-1
GTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACGGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCACTTCCCAGCGGGCTGCCCGATCCAGCAC
+
??A??BBBD<D9D9D@FFFACCIH>AHGFHFHFFH-CIIHIFHHFDHHHFHIHHGHH-8CHFIIHFIHDHGBIDHFGG-DHICEHHIEH-HEFF?0HIH.HFDHHIH+FID@HFFE@FGHFBCHFEHEEGEH@GFGFEG/E*AEEGGF=EEFFGEC;EGECAEE(0CFE8G:;)EFGCCGGGEEG<G(GFE:(*G*8:GGAE(EEE?C(ECGE/CCBCC::,C:1=??C18GE:CAGGG#C>G:A?GG'?
@antibody_301_multiplicity_233_copy_86-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACCGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGAAACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGC
+
??=??BBBDDDDDDDBF>GCGCI7I>HHF6GIIHHH57GHIFEFEIHHIEHIFH,DHGH?HCIGHGDIHHFFIHHEGEIGHHF+FGECI*EHCDIIHCHDHCHHHF=EH+HDHCDCGFEGFG=GH;GGDFH?GF)E)8GF=FGGG@=EGE0BC?*BCG(FB#G*EGEE(EC;*A:GECBA(CE?EEE)CEFGEEG?EDGEG?G)E(H:A?EAF:FC#ACC/;:GG40CE0*ECGE6GEC:*/EG?C??('
@antibody_301_multiplicity_233_copy_87-1
CCGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCTTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGCCACGTCTAAGAAACAGTTCTCCGTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGT
+
?,A?=B?BD-DDDBDDCGFG/EICIIBHFHIIHI=IHFHFFI-BFIHGH>FHFFIA>IHFHHDDHF-AHHFIHG=IFIFIIHHF8HHCHEH?-IFHCFHHICHGHHF(HHIHFH7FBGHGHEHHDBFEFEBFFH9CGECE@CBFGD@:(HGGDFGEGE/E(B8EA?G2G<E'EGFEAGEAGEA?:?G6G*FGBGEE4EGGFDG>CEHGEC6D(CG:GGBFG1E?*<*8GG1EA/GGFEE?8((:CGC?E)
@antibody_301_multiplicity_233_copy_88-1
TGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTGTGGGACTGTCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCG
+
=A???BB@D-D@DBDDCGFCFCHHFHIH6CIFDG/IEHF9HHFF8H7EHHGII=HDHFHHHHIIC-IFH=HEIHHIHHDCFHBFIHHHDFCICCHFDHHHHE=H<HGHFHHHF9DEHHH8D+*FBGHEEFD8HEF+==GFGFEEGGGFGFG.FGEGEDC()F6G/G*?(GGGEECBC;(<GG?EEGE;?G??EC?F:A*<:(:FEE/(G6:G(ECEC*GF):/EEACGGE8*EAG10(6*4CG9.?(E?#
@antibody_301_multiplicity_233_copy_89-1
TCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTTCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCACTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACA
+
???A<BBB?DD@DBBDGFF>FFHIFIBI/A@FIIF7GFHHDHHHH@HHG-H7HBI,.-+;B?F>#HBF?H+EDH--IHHFHCGEFFEGFEHHFIHFHHHHHHCHHCHGHFHFGFH)HHF@DHGGHE7GBHFGGGFEHEHGGG@EDGE9G'C;G*GGEGEFG?EG(6<#E;GE6(.EGEEGEG(E(GEDG<8GEEEEGGEC(?(8?/E?F?4C@8*A/EG(',GCFA)E:E.:G0C::8E*DGC(*E?2?;
@antibody_301_multiplicity_233_copy_90-1
GAGTCGGGCCCAGGACTGGTGAAGCCTCCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGACTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTATCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTCCCGCGG
+
A????BBBDDD-DDB?FGFFCGHIIII/HB,HGH-/HIIGFIGIFH8HHHBHHIHFHFFGHFB-'C7G-IIFHEE5-FIHI+FHIIIHFF8IHD'HF8DG)9HHF6HFFHIFHEHGCHBF=DFHFFFHFGEFHBEDD=GGGG;E0/6CGBG*EEG1GE*EEE=EFEG*GEGEBG8C*?GGEE(6*G?(EAE*GGEECAE:GCG?C*FC?ECG8C0<CC?/G'8EGE:;/GC.?AAGC:>GGGG*?*?(CE
@antibody_301_multiplicity_233_copy_91-1
CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCT
+
?9???BBBDDB<DDDDFFFG-GICHEHHII,HIFEH9HIHEFHAIGHH-7F..DDGGHEFHEIHH@5HH5D,FIBFFIIFIEF-HHH=FIFI=FFHGHFDHHD*FFFHFD?EGFF?AHDFHGFH*HFFEHG*F)**EEGGFG>@EEDFEFADCFCCEGG/GE3EE9E4ECG?C8EGFGEAEGFGE*?;(8A(GCEDE0E:EECGF'HEGAGC:E@GEE/FGCGEG?6ECGG-C>*:>GG::EEC?.A1EE
@antibody_301_multiplicity_233_copy_92-1
TTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGCGGGACGGGTTCAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTCCGGATGGAGCCACCAG
+
5?A<=B<?DDDD@DDDGGCGGGIHH>F-IHFI9F/F7CHIIHGB@CI99AIHIIGG*IHHGIHHBHIDIFBIIH5-II=I@5H-IEHID8HHIHD=E8EDGGAF>DFICGHEGGEGHHG,)EGHH'-C4EEFGFH(GEH1GGEEEG:BGGCG:1F02GC=;GG*EG/C:*E3GGEBGGEEE(?F/(G:G:C(*;/E(:(:?CA:C*E:G:EC;*;A.1E'?.(C?1*A?-EEE*(*1C:.G*E01(C:/:
@antibody_301_multiplicity_233_copy_93-1
CCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTAGGTACATCTATTACAGTGTGAGCACCTCCTTCAACCCGTCCCACAAGAGTCGAGTTACCATAACAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACATGGCCGTGTATTACTGGTATTCCTTCATACACCGGTA
+
??5?A?B3DDD@EDDDGG@GG?HII/ICFIH=FHIFHIFEH=GH5IAIHDHFFBFFCDHHD+HHHGIEECHIEIFFIGDFHII<=FGFH*IH+HFH<DHFFEDHDG-;(DGHBFHDHDGEDFDD>FHCHGFD*G*CE.EEDG<EE(GABEFE*GG>EGEEE8GE(GGEG?G?<*GE*FGB:EG;EGC9EGE:/CF1?EE:GCC0E?HE(H(:C'C*G(:E'GF.AD:E8G'.?A:(G/EG'E/?EECCEG
@antibody_301_multiplicity_233_copy_94-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTTGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGACTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGAC
+
=??==BBBDBED9D@DGC-EGGHHEFEIGHGHHHIHGGDIHDGHIHEHHE0GDHDGIFGF?I=HHIE,FG,-HGIH5?FIFFFH+HD+=HGDHHHCG@DHHDHEHHHHHCHDG?HGHAGHH3?FG(G9=HHG;G;GE)FC@EEGEEEDF*BE7E,GEGGEEGEGEEE/EACGFGE?E+E60GF;CG(GEGE:FG(AEEC6)G(GGE.?EFCGF;/8.3.E-EGGE(:6EE?FE?EC-EGGC?E:EGCG-E
@antibody_301_multiplicity_233_copy_95-1
GGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGTACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAAAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCCGAAGCTGAGCACTGTGACTGCCGCGGACACGGCCGTGT
+
<?A??>?BBDDDDBDEGFGEGF,I>FCIFHHHHHFCIH/9GHHIIEHHHH.GC.FEFHBHFICHGGIE,*FGH-EGE5D>HDHIE/EHHGF-FHHH'H?+HGFFGHHHH;HGEGGHGHEEEGEGDBFD*FDG<GBFE8EDAEGF2ECGEF1GEEEFFGGGEAEG,GEEG(G<EGGEE7BGGDE;G4GE0GCF:)E?G(GG(G0EG'6A2E?((*:(::E@71/A8EF0EE*FE6?E8C*?0??6CE8E((
@antibody_301_multiplicity_233_copy_96-1
TAGACGTCGATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGACCGAATTCCAGTAATACACGGCCGTGTCCGCGACAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCGTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGTACGGGTTGAAGGAGGTGCTCCCACCGTAATAGATGTACCCAATCCACTCGAGGCCCTTCGCAGCGGGCTGCC
+
5????>BB-DDD@DBDFFA8FGHIHFFIICII/7EHEAEEHAIIIFFCHFD.AHIH-DHIFGHGH+IHAD#HFIHEEIGIFH-HFIFGAIEHF37I61HDEH*HHHIHGFHH?HFGHH(*HDF@EG6EGGF0EFG*CG#G?GGDGBGG1GGG?D*E19(GGFGBCFCEECEFAA,;E('FGGE88EG?GG8FE0.GGCEAG/-:C6C.8CG4:C@C01F'((EC/G?(?(?:-CCCE(EGCC.F*C:8E0
@antibody_301_multiplicity_233_copy_97-1
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGGACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGGAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTATTAGATGGACCCAATCCACTCC
+
5???5/>BDDBDDDD?FGGG8GIHIHEFHHHHDG7EHDI>/CII.HIHHHFHHDFF*HHHDFDFIEHFGHFHHEFH-FFH5IFH=H==FIHHEII@CHGHDHD,?HHBHDH+7DHBHHDDHHH+HH@+EFGGEHGFEFGEGFE)GB?G8E?GE,GCG6ECG::A3GGFEG:EEFEEGGC0AE(GEG;E*E(GG66G06EF'G?EEG(EFAE0(E(EE:?F'?EGCGGE(CC(?GC(GCEE)<F*.GFG00
@antibody_301_multiplicity_233_copy_98-1
AGGAGACGGTGACCGTGTTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGCAGGAGGTGCTCCTACTGTAATAAATGTACCCAAT
+
?<???-BBBBDBDDDD8-FFD?IBFIHFHEI=FHHDHCIIHGEE,II9IEH?FGEHFH>A.5DFHIHFAHDHIGIIFI+D>HFGAHCHFEHGFII3IHF=-HHI<HHFGHHHF*=GGED4G+F#+F.((E:,.G(>EGF*GCFCCG##7B0GCFGC8GC:@E=CC?EG6:GGEE?GC?GEEG?GE(?FGEG6:2EEA)EE:CCE*FEC)C(EA<C(?GF:CEAEGG?:(GG:?<(C.E(1*(GA;?CE6:
@antibody_301_multiplicity_233_copy_99-1
CTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGCACATCGATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGCGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCCCCCTGAAGCTGAGCTCTGTGACTGGCGCGGACACGGCCGTGTATTACTGGAAGTCCTTCATACACAGGTATAGTGGG
+
??A?=<>>D@BEDEDDFCFG8FIFCFHHFHHIAHGFIHHEHIDDH7-DDH>ECIHFFDIHHHGIFICAFHFCGHFEHFHI?HDEH#HIEHH,D-IHI<HEH=GDHHGFF*FFHGHCGF=H7GHEGHHGHF#GGEGEEEGGEBC3G8CEEEEF;C,G?GE:EEGA6GGE=FCF#FGGG0EEEG;F??EE=?FGGE8*C#EEE*AEG8EE?/6G*AEAE?((EEGE?*EG*?CFCGC>00*C::??E.GAAG
@antibody_301_multiplicity_233_copy_100-1
CAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCATGGAGAACTGTTTCTTAGACGTTTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCTTACCCACTCCAGGCCCTTCCCAGCGGGCTGCC
+
?????B<BD<DDDBDEF6FCGFCIHEGIHIG=DIIIHIE>@HHI.FIHFGH@IIIG@FFHFIIHHHFDHHFIFIHFCHIHBHH8HHHHA-HGIG-HCGHICAHH*GIDCHHEHFFDD+IE3FHH#HFAEE=FFH@FE>GG;F2G;E*EE*GFEFEEF?G0EGF;GGGE6E;A=?/CG6GC:E1GCGA*(:6E8GG0GEE(?G?E0C'(EHCFCEEGB'(A77/?-(C'E0(*(:E0EE0<CE/*:E(EE*
@antibody_301_multiplicity_233_copy_101-1
GTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGGGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAAGTCGACTCTTAAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGCGCGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGG
+
A?=5?BBBED?DDDBD>6FGF/CHHEEIAHH@HHDGHIGHHHFHGH8HHFFCGHHCHI5IHH-EADHH?5FIHHF>DGHII=-FHHHGHHFGCFHFHF=HFGH4BICFFHDE*DHH.E@H+FDCHHFFEGEGB#GEH2GE(*G*CEFDGG=GEE>EEG/GEEFGEE;EF(GF*FGC>EF8CG2GCAAG9CFFGCEC(FGFFGCGE<:GG'(:H2/?CC;EG(CGC*?CG:;E0GCE/ED(EE6EG?0?GA
@antibody_301_multiplicity_233_copy_102-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGCCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTTCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCGGAGCTCTGTGAC
+
AA???B9B?DDDD-DDFFFG/GEHHFHE-HGIHIGIFHHHDHEHH;E.HI.HHEEEHIHHF-H-IAIEHHII+<HHCIHIIHHHI+IHIHFEH=FGDBHHHHHHHFDHEHHDFFHFFH4EDFGHF*DG@2GGGEFEGGC?F9E8FBE:*EEB2@2FADEEE;C;EGEEGGFC.:EFE/GEFCGGEGE'A(EG:G)GGEAEE0*E?ECGFA?CH7BD/GEC',?8'A.G.CCEECC)8(G(?8C:A(GCG?
@antibody_301_multiplicity_233_copy_103-1
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTGCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACGTCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGCCTGCCGC
+
??A=ABBBD-D<DBD<FGGFDCFHHAFHI-DFGDHGHIIFIHGHIFHGDHIGHA#DEEICFCGHFIC5I-FIHIHHDF)GIIIH-IIEEIHH7IFGIHHHHIHCHEH6HHGHGFFGFEHHCFEDFHGEEDB/CHC2D*=0GGGEB?1GE.EGE(.*GGEC8FDCEFE'FF.EEGGF/+EE66CF6EF*A:CEGGGEECE<6EGEEGAEGH?(.GE;?C?EEF<EE::0EGAGC:D/*(G((:(.-F?A:G
@antibody_301_multiplicity_233_copy_104-1
GACCGTGGTCCCTTTGCCCCAGACGTCCATTTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTCGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGCGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGG
+
?=,??BB?BD<DDDDDFCGF.EIIICHA.F.FH0IIIFEFFF=DIHHEHHHH+GHHHFIHII-GI*FIFHDHIFIIIHAHFIGFFCD4H?HH5HI/HFICIDHIGHHFFH8HHGEAHFDEG+HGHHGGBGHAHG>EFHH,G0GGFCGDG;GE?EA/E0GFGFGGE*C.*C8GE6F0EEEAG;G)G81??GG6EG(6GC;(GC(?EFC(A(A::<=*CCBFB?(*:*::CC:?(;FC*:EC:*EC=.EGC/
@antibody_301_multiplicity_233_copy_105-1
GTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACACTTGAGGGTCGGGTTGAAGGAGGTGCCCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTA
+
?????A>-D@-?9DDD.GGGFFEFHEFCIIDGGII=F7>*E@AFHH:HEHFIDHEHIHIHFB8HAIIG+IGE=HHHCHGGGIFHHHHGFGBHHDHHCGDDGHGHE;FGHH*EHF2EBGHF.HEGBHEEFGF(E=FGB*B,GCDFGE*G*GE1GGG*GAECG8CDA(:E*EEGG(EEEFDEEGECGCCFEG6E/E0CE?(EGEEEF?/:)EFEEA)CGC:CCA:E(?*EE/;CG(2E;;G?'E*C*.*GE:
@antibody_301_multiplicity_233_copy_106-1
GACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTTACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGATACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAAGAGTTCTCCCTGAAGCTGACCTCTGTGACTGCCGCGGACAGGGCAGTGTA
+
A<A?ABBBDDDDDD-DGCGGGCFH/IH5I8EIDDEAIH,HEIF+FFGDHCIFFDIG0FHIGHHHIIHHHHFIHHIICFCHHA@IF-GGFIFIH*HHIEGH<IFHHEHIHHHC;H@FHG(EFEDEEG.D7FG@EBHBEG@?FHEGGECG>C=GFE8/?=CCG:EACEEG?G;GGEGE;1ECEE;80A?AEEFAG?E<G;;0*C/G.GD?*(FDE(EGB(:(E(AC;.G0?/;CEA?E?G*A'G*E'FC?GG
@antibody_301_multiplicity_233_copy_107-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTCCTTCCTGAAGCTTAGCTCTGTGACTGCTGCGGAC
+
??A?,?BBD@B-DDBDFFGGG?EF.F6HFHHI,HH.(H.HIFHFEI@IFIHC-HH5AHHHFGHFCEFCIGHIHFE=FFIHFGIFEHGGAD5HHHIIIF8IHHHHD8HGGHDHC@DFGHHHH,EGGDFFGFFFEEBGE*CHGEGGG8EEGE@GEEE=G/GEGC<?GE(;EB:?G*;E:F/*6AGE#CGGEFE<6GEG;E0FG?(GA:EEGEE/(EG((E'DCEGE??EE'EAG*AECE;0E(GG*CE/C?/
@antibody_301_multiplicity_233_copy_108-1
GGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCTACTCTTGAGGGACGGGTTGATGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCTAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCGGTATTAACTACTGATGGAGCCAACAATGAAAGTGCAGGTGAGGGACAG
+
?????BB?BB@A9@@DFEFF;GHIHHIHFCICHIIEHDHIHH=HID7FHFIHFFFIIEHDHHFEFCHIF-HIHHHH-H5H=ICGEHFBIIFGHHHIIEHFEFF;D(HDHHHHH4D4GGDFGG,=EG*E1GGE@BEEABGG2EGGF0GCG?GEG'ECGEGGCEAEGG#6.F.:AG*(G(CF<A6/?FC6?;)EGA:G8:G?G(C<GE?GEEEG(F'?CCCGEECE'EA6(?C#?(:>EC86:G*:E-E:C:
@antibody_301_multiplicity_233_copy_109-1
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGAGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAAAAGATGTACCCAATCCACTCC
+
???A?B<5DDDBDEBBGF0FFGIIHHIIHHGHFBFAHHCHIHIHH@IHHII;II9FH7DFHHIIHD5GHD5HIIAG+2)H#IHIIHEHIH5HBIHICHFHHGFHFH@FH@(H=HF2FHHEEHHFGFEH,GGGD@FFGG0EG22*GE6CEGGGEGBC?GAAE*;G?GE*EFECGEEE<E(ECGE*EGCGEF28GA0-/F6EDE*??E(E1(:EHFECE0:7GA?EFCGG>(EGEE9*::EA;'*6EFE<((
@antibody_301_multiplicity_233_copy_110-1
CCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTCCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGTACGGGTTGAGGGAGGTGCTCCCACTGTAATAGATGTACCCACTACACTCCAGGCCTCTCCCAGCGGGCTGC
+
<????B?BDDDBD?DBFF;-GFI/I@HCHHFICI9GHFIECGH>HFF@IGAHIIHH,FIHIDF--GGHHDHIHF5EHHFH-HFIGCHGHF>FHHGH.ICHAIHHEH==FGHF4EDFFH+.C>FHGHFGGGF*GEG,B#=FE,*EDD;G;=GECEB*DGG@FEACG:E0:EFFFGA08E#AEGF(A*.F#G)EAA.:EE?E<*C(GF0*:0AG*7'C;*:;(>'?E*E8EG'()?(#21)A>A?AE?((C9
@antibody_301_multiplicity_233_copy_111-1
CTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACCAATGACAGTGCAGGTGT
+
?,A???@BBBBBDDDDBCGCC6AIIFIEIEHEFHHAHI=A/GFIEFHGGHHHHHGF@FHIHEB-HHBHFDHGH+FIF5FIH5HFI=I+HHIEH?FHHH2AHHHFH.E,>HHHHFDHG8G?GGFEGHHFE,G8GDEEEGEEFDEEGF;EGGEDE+GCGGG?GECE'G,CGEGCGAGGG+>FGG/EGGGGFG*EEC<D??G0GGEG:CE9C'GCH*(F(GEGEEC:0EFC.EE*E:(GEE*:E*EC0E?6E*
@antibody_301_multiplicity_233_copy_112-1
GGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACTGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAAAC
+
?<,A=>BBDDDDBDDDAFG-FGHHH8EFFEGAHH5HHHFH?.IGHHAIB@IH-FEGGGIIIEIEH-IFGEIHFI/5HCIHFHFFEHIHDHH/-HFHHEC@H7HIHH(G(HFEHHH*FFHGDFGE39=GEEGHEFHEEGGEGDGF6EFE*EBCG.F(;GGE?EEF?E*FE(8CCG(ECE*E6CG*CE/ECG>EEG?GCCEGCE?GE??*(AE6FA::GAG@::(G/?ECG6C:GG.C1AE6G6?EEE(C/'
@antibody_301_multiplicity_233_copy_113-1
GAGACCCTGTCACTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGCCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACAATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCT
+
5?A555B-BDD-9ADDGFFGECHHIHBIH0HHHHIIHHI5?I=CIHHI7-HFDEICH55F@H?IFIH,HF5HCBHBHF-HGH=H8-II=IEDHF-.EH5H,@FDECF)HFH=CHHDHH?+HEDFGDF/HFGHGC@5EF59+GBBG8EFGGGF:(=GBG)@CG?::E?E.CG6?/C*;(G6FEGGE*GGGG6:GCA(GEE(*E4AEECGE:*AHG@A(:<G7C**GC.G2GG:?)E*E/(:?*E:**E*:*
@antibody_301_multiplicity_233_copy_114-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACGCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACT
+
?5???B?5DDBB<-DDGGFCGGHIIHHH8FIHHH;IAFIH-C?@CHHIGD7FIGCIIHF.CFHHIHH+IGHIHI>IFIHI5HC-FFIFCFFFHI@HGHHFCFFHDHHHFFFFDHFG=FHDHDGF@H8GFG;G,FFC;DGEGE*6>EFC+FFGGCE7=EGG?GEAE?EFEE?E(AE<GAEGG:GGE?*GGGE*G8BAC(**E?EEE6HECCDCEAB:EC,E?EE:G*E?.EAE*(?E6::EEG6A:EE*0G
@antibody_301_multiplicity_233_copy_115-1
ATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATTTGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGACCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCAACCA
+
<???,BB<D-ADDDDDFFFFFFFHI-FHHHIIFHIGHEHFEHI?EHHIFBF.HIGHIH.HFIHHHF@>HHGIFFIHBHHHHIHFI=IHIIFEII-GECHHH/HDFHIHCG@HFHDEHC.HBE;5D?FFE@E?B<EFGDBHGEGE;?G*EGGF?GGE6C9EEEFGG0EEEFEC6EGAFEA8C:GE4E:?GAGC'C:FEE?*CGCEA?H0G;??C2'EE8GEEE0E:A?G.EGCEA0*E*:E?C*GE*CC:C
@antibody_301_multiplicity_233_copy_116-1
CTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTGAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTTAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCTGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAAC
+
?A=?ABB>DDDDD@D-EFAFCGI+,C8HI>GH9HEIHHCHFIBAC?BGGEIHDHHDIHHIICHIHIIFH7HI5I5E5DHHHHEHG)-GHIFH/AHH=HCHHIHHIH)+HHHFFHDHHEDG@GECH*4HFDFCCD(B**BHGGE;GG(F5BEB(GEGGEGDGEF;GFEGFFGEEAEC4E6='EE(A*G8EEEE:?G((<GF(E;E*G*:E:CEH(E4/D?G:(CC<;C?EA.E0?:9??A(D(E?*?E1'*
@antibody_301_multiplicity_233_copy_117-1
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCAGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGATAACTGTTTCTTAGACGTGCCTACTGATATGGTAACTCCACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCC
+
????,BBBBDBB-DDDCFF@FGIHIIEIHHHHI.FIH-HIIIDIHIEIFI0IHIFFHHFG.IIIIDHFEEC5EFI-FDIH?,HH)IEIGHFHGEFFH.HHEHHHDHHH,GDAGH#GGDF@HHGE94GG<EEECE,EAF6BBEEG=EEGFG*EGG(GGFE'4/ECEEGF<((ECECEGGEEGE?E?AE6*:89?EEG:CECEEGG.AE*;*E6E*GGBC/CE?E*(<G:GCE?/E?:*G<?*.DE6CEE*G
@antibody_301_multiplicity_233_copy_118-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCACCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGATTAAGAAACAGTGCTTCCTGAAGCTGAGCTCTGTG
+
?=?A?BB>DDBDA5@-FGFGGEFFIHHHA;+HFFH-HECHCHGFHHFCGHBA7HHIC*HF9HIFIFFHHHDH?H@HEHIHF5IFHHFIHICHH1IGFFCIIFH,3HHFFH@HH;=FGFD;FFG(FGFH*FHH.F';EGEGEFE?GFFE<GEFE@FGG8GGGGGGCG(GFEF:?=C*G(E/G(FC?CA<E?<A/:?E6?AGG./6?E::EFAEH0#.E?B/EECFGG?*2E(*G0:8ECC:;GG0*G:E:E
@antibody_301_multiplicity_233_copy_119-1
TCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTATCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATAC
+
55A??BB3DDDDDBDB@FCECGE/IHFFHHFIHF9EEIFIHHH-@DEDIFG:EH@CEGH->IIHCI.FIFEF6HFD+HGI5IIFH>H,HA.H+IHDHHHHII9+HFDH?HHDHGGFHAFEEF1EFFFDBA-?;=AGFEEG??*GGFDEGGG;EGEGE4?GCAGEE:C0EGGG6GGGE:EC+?EE:0CG;EEEGE*CFCECAC?EA.C'?'AA@(GE0>?AGG(GC.?:DGE(?(CE.*EA-6G?9E*?.?
@antibody_301_multiplicity_233_copy_120-1
TGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAACCCACTCCAGGCCCTTCGCAGCGGG
+
????<B<>-BDDDDEAA?F-FGEFHFF>FHHIGFHHIIHICGHHDHHFHDFDCHHHIIIEHHD'-IHIHCIIHHGIFEDAHHFHE+HD(GHHBHHCH?CFEAEIHHHB6=EGHHE+HHDHEHEFFHGC8HFE0HEGGC1GEEE<:G?GFEF*B(EG'A83=GEAGH;E?AEFFGGGF/GCECCGC(GC?GEEF6GE6*6CAE60E*(<6HEF:7EE8C:DBG/8)(F8.(ECEGE4(EC4C8(G?ECE8G
@antibody_301_multiplicity_233_copy_121-1
GTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACT
+
<??=?//BDBEDDDDBGFFGFFEFFIHIFEAHIHHHHHHHIHIHIFHHIEHGHHI?HFIIH7GHHCF5IIHIEGFEIC=HGHDDG?F<HF.EFHIIHD-H.HGF-HHH=HHGFHHH,CIGF+HHFGHDH#H*FEEFE,EEG?8B:H;??;GG?GGGEF4EF*EAEGGG(ECGFE7GEA-GEGEFEAE:*EEGF;0:9-0:EE/?/<8EE<C0:(GG?C0C0G:G.A/>C:D0GEC()EEE*/G:0E:C8A
@antibody_301_multiplicity_233_copy_122-1
CAGGTGCAGCCGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGACACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCAACTCTTTCAACCCGTCCCTCAAGAGTAAAGTTACCATAGCAGTAGACACGTGTAAGAAACAGTTCTCCCTGAAGCTGAGCT
+
??A??B>B9--DDDDBGEFBGCIIFHICHIHIFHHI@HHDHIIHHH.FIHGHHGHAAFFHE8HHH,HIHE*F5I=HGA>FHH=G>HHEA-IG@G,HHHHDHHHIGHH-HHFGFG6FDHHEHHHHDHGGEE*D.FCFEHFDG:#@G1G(GEEEDBEF=CEFFE)G;ACEA/*/?*A'60('FDE0G:G(E?E?GF/(*EEAEFDGGGH'#H(EAEG8GE:A(GEGEGGFAE8*?E(9E'9EG:??#:CG)G
@antibody_301_multiplicity_233_copy_123-1
TGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAACTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGGGGGACGGGTTGAAGGAGGTGCTCCCATTGTAATAGATGTACCCAATCCACTCCAGGCCCTT
+
=??A?BBB69D@DD<DFCCFGFE8FCHCFIHHFHGIHFHHHEHGHII>5AHIHII.5HDFFIIHHFH4HDHCHFHEAHFCH);FI6FIHHFBHEIDHHEFHHHECBHEHHGFHGHHHBHFH;FFEFG'.HEGGG@*1GDGGG?GEGEA<CF*EBEGG?GG>?G,8G1?GE*EC??G>G;C:GEE;(E*>CGEEFEGFE1E::*EC?EF:H8CFE4(EF/(:.C'G0GEG)0.::EEE?CG6E<(CC*::6
@antibody_301_multiplicity_233_copy_124-1
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTGCTGATATGGTAACTCGACTCTTGAGGGACGGGTTACAGTAGGTGCTCCCACAGTAATAGATGTACCCAATCCA
+
???5?B?B7DDBDDDDGGGFGFHFH/IIFI+AHGDIGGHHFEII+GHHEHC+IHFHHAHI8H@H-FGFH5I-FHIFDHAH=FH5IIHH4EHAIHHI<DFHEEHH,HIDE?HFFFFFE@8EFGFEFEEFFGEH*DF0.EDDF?G?ECFGEGCGEGB(<EEGC/FDDAEEGGGE/FGF(EEE?GCGGFG)ADGGEE:(GFEFECAF0:C4E0E(0*G(GE,:8G)FC:GA)?8EGEA(G(0C/GE:(C:G8?
@antibody_301_multiplicity_233_copy_125-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTTCCGTGGACACGGCCGTGTATTACTGG
+
??A5?B?BDBB<?DDDFAFGGG+HIIAIHIIHFHH9BIHICI.FHG-BHFIHFIA?HEIG=HIFGHGHFIHHHHIH1IHHFHCHGFHCHHHHHHAICHHHH@DFHCHHBHFFDHAH4HHHGGFDCGDEDG,G*D@GE6EFG*?*GEGGDGE6D5DEGF,/E6GEE7BG?GE*GG1E?GEEF+F-:6F(GG/AG)GC:?AC9)E0GEH8E?G?AECEF:EE*F((G'A*:GCCG0EGGC*CG#G:C?(?EE
@antibody_301_multiplicity_233_copy_126-1
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGACACAGAGCTCAGCTTCAGGGAGAACTGTCGCTTAGACGTGTCTACTGATATGGTAACTCGACTCGTGAGGGAAGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCGGGCCC
+
A?,A?BBAA5@@DDDDFG6F?FFHHEEIBHH=DH.IFHFHHHHEIHIFFIHGHD7EFECH.IHDHHBIFFH-IEFIIDDED-HIEIDHCFFDE8GHHHHC<FD+HHHGH@H-CHHFF?DHFG*HGFGF?FGDGHDEEA.DEGEFFD7=EDG2##GFEF?F?GH6GAEEEFGGE?EAEFE80E?/E;G(G.F:.F?**'EEECEAE;E?(;E0FG:=*/?,:.:?GEAGE(E?A:F6CCCCG0EE**(/2?
@antibody_301_multiplicity_233_copy_127-1
TGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGCAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACGATATCAGTAGACACGTCTAAGAGACAGTTCTCCTTGAAGCTGAGCTCTTTGACTGC
+
?<??ABB>B@DBDDBDFFGFCGHCIFDIFHIIHHHHH9IIEHCHFHHHIFFBF-FFFHEHAEHI,FHGFFEHIGFD-I-#EFBHGH7I@FHEHF@HHHB,:FH+I+DIHEICH@HCHH9HEH;*=DGGHHG+DE1DEDCEFCFEEEF<EG*GE:GFEFECECEGGE>CGEGEGE(A*EEECEE(FEF88?EFE)EDEGGDCF/?>4E?G:#>FC@D(.E8B?'*?EC(ECC*:EAEG/(E?(*6C?ECCC
@antibody_301_multiplicity_233_copy_128-1
TAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGCATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTATTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCACACTGTAATAGATGTACCCAATCCACTCCACGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTAC
+
A??5?B?7D<-DDDDDGFGGFGHIHIIFICGIH+IIIDIFF(=HHIHEEHDHHIHFHGHHHAGAAG.IH-DI-FHHEGIH;>EHII6HHHEDIHF=DG3IGEIGHH;HB#FD<HI7H.HEH,GHH*H6E(*HDHEIFFGGFE6GA4G0;EE*F/GE3GEEGEE9E16?F*1BE=.FAGGEE?E:ACFE?A/6(F?EGCGEE(G(<(FE'E6DHFF::CFDGGEGE*CCCA**A*.E.G?.ADE??AEE(A
@antibody_301_multiplicity_233_copy_129-1
CCCAGACGTGCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGACTACTGATATAGTAAGTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTG
+
??=?AB?B@-DDD<DBGFFFFFCIHEFIHH=EFF/EFFIHFHAIIHDH@HCHFFGIHIIDH-GIFH5HHI5@HD5GIEBI5FHGH8GG-FHHFBGHHHFGFFH8HHGGIHF/;,FH=HE@E2HHCDFHGHECE#E0FGEFF/GG8BFAA,EF9?ECE-BC(FEEF#ECG1-E:GCA//EA8((??EFGE(4EFF*CFEGEFG?GGE<GGH;(H@@:G*,A/8*G(6?FG:CC:GC.EG*AE<CEEG(C)*
@antibody_301_multiplicity_233_copy_130-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGCACATCTATTACCGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGGGTCGAGTTAGCATATCTGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGAC
+
<????BB=DD@DDDDDFCGGGF-HHHIICFHFDEI-HHCFHF.-@HIHIHHH@HDI@+HFFFHHHHHEFHHI5HICFIIDHHIH@DHEDFHHHE6GIHHEEECFHAHD4GFH;FGDGCFHG=FFEFHE=GGEHGGG.E;:*FG:9EEGFGGC-=GEGGGGEECDE@BEGEGG:FGA:A6G?G:A/(GGFGG:E:E/CGF;CE*E?((CA6?E*E*8E'-@GGEA/8CE6<GEG(?:*AEAE10EE:(?:.
@antibody_301_multiplicity_233_copy_131-1
GCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCGGTGTATTACTGGAATTCGTTCAAACACCGGTGTAGTGGGAA
+
?=?<?B?@DDDDBBD-CFGFF-HIIFIGACDIGHAHGG77FIIH?FHE5HIGHFGHHF+IHCIIIIHFFHFHHCFHH,IHHIBEFHI?(I+H.IHIIDDE+H6HHFDFFD2>?DFFHDGH6GF=F*1ECDGDHGGGC68GD?GEED(CEFAFBGGGGGA*?(B:G;G9B*GF?G;F?=*GGAE:/C)GAAGEA?G:DFCGGAE.?GHE*HC'<.8AE:?GE;E(EC:/:E(*.E8AA**C)EC;EEE<*0
@antibody_301_multiplicity_233_copy_132-1
GAGGAGACGGTGACCGTGGTCCCGTTGCCCCAGACGTCCATGTAGTAGTACCAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACTAATTCCAGGAATACACGCCCGTGTCCGCGGCAGTCACAGAGTTCACCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTAGCCAA
+
=<???B<BDDDDB<BDFFFF>FH.HHHFC+IGC;IGIIEFF8IHCEHHIIF-FI.IHHFHHCDIE-F-IHFEHE+IHHHGH,GIIHIHFBG=FH.HHFHHI(#HE+GHH=E@?H+=EHHG*BHEHH'FDFDCFDHIDEGHE<9F(<GE*E8,GGEFGEC66EDGGCGAGE?CGC0GEG;EEAFC?888EE?G:FE8/ADG(G?G:CEGCHC*::CECEG/:1GCGCE*'8((*?G:GC1;AE?E((?AE:
@antibody_301_multiplicity_233_copy_133-1
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCGGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCACCCTGAAGCTGAGCTCTGTGA
+
?????BBBD@@DD5?DFFAF0EHHICECHEAH>G-FAI@.9FHHFHDI+FD/HHHHI#HHDICFEDHF=HGBAIIHH=FHGHH>FFHEFGIHFC)HFH8GHHHHGGC>HHH=DFDGHHHDEHHH*HEEGFHB6FGF=.GGFEGGG?EG:E;E@8DA6GFGEF*EAG:E*GAFE?ECE:@EEE<GEE8FEGEGEEEGEECEEFC.*.EE?H:G@CG(7*FE(?EE*:CE#'?EEFEGG:?:6E:C10E?9A
@antibody_301_multiplicity_233_copy_134-1
ACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGTGTCGAGTTACCATATCAGTAGTCACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCCGACACGGCAGCGTATTTTTGGAATTCGTTCATACACCGGTATAGTGGGAGCT
+
?????B53+BB@BDDEGE8FGGHI>CHFFIFEHIIEH+EHFHHHFHH.IHHHFFHGGEHIEA@I+5-H5EDFI-IAHHCGDIBHDH@H-IHF<HA=HCHIGIEE+EFHHHA<GEHH5HF;H@FHHF*GGGGBG,FGE*EBGFEBG8,,#E=GGEGG?GE(EA@BCG6GGE(E;CG:E#?EEECC046AGFCE(EGCE(8CE:*GE():(?FEH7(#?7?=GFG(CEA*EEC?GE8CE:EEEC:AF;A0CG
@antibody_301_multiplicity_233_copy_135-1
GAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCGTATCAGTAGTCACGTCTAAGAAACAGTTCTCCCTGAAGCTCAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTGGGAGCTACTAGCCTTCTAGTACTTACTACTAGTACTACAAC
+
??A,?BBBBDDBDDDD>CGCFGCFHEHHFI+IHIICIIHEHHHF-IF@?9FHIG0FHH=DG=AI.7>IIIDHFH)GHFHIFIGEGHHDBIGHIHHIHHIHHCD(IDFHG,FHH+DFGHGHH:EGGHGEGG)CGBCGEGE*G,HG1@=F?GE(GGGFGE0E;2G.C4GGGEGFEGEE.EA?EG?CE.1EE;*GAGGF(GEG?CEG?-EAEHE:E*E?3GGF.(ECGC:(?GGE:CEEE9)A0EEGGA:*:6
@antibody_301_multiplicity_233_copy_136-1
TGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAAGTGTTTCTTAGCCGTGTTTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTAAAGGAGGTGCTCCCACTGTAAAAGATGTACCCAATCCACTCCAG
+
A??AABB>DD<?DDDDFGE@GBEHHEHIHHIH9HH-HGDCIFFI-DHF7IGI=HFHI-GHHEFHIIHEFIGEEH?F-HH>H?IIHEGHFIF*EHH:HGF4GHFHHG8HDHH,HHHH9EFFEHFFFBG@G,C?HFHF9*BEG2EFGEE#GGE0EGF57CBGEE(C?GGC(:GG??E:FG:DGEECE;EFEGE(CECEE?.EEGCG:#(GG:AEH'/C:E:GCGG(A?E(EGE8F-*)*.(*??F:?(FEE*
@antibody_301_multiplicity_233_copy_137-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCCGCCCGCTGGGAAGGGCCAGGACTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTG
+
,,?,?B>BBBB-BDDBFAGGGFBHHFHFF.HG9IHHIHCCIHDEDHHHHHGGCHBHIHAFIHHIHDHFIIHHFH5HGHEFDHIFF,AEIEHHIGHHHD+H3HFFFFII=DEE#?HE@HG*CEGBGDGEFG*FEE#GGHGH?=D?C8EE.AEBE?EDECG(:GEEAEE8ED6GEE(GEEEEG((D;EGFGFG(ECE'(:6EE?C?GC;A*F/GF0C*E?GE0EEG*<G0C)F:?:C1EGEGEEFA':CEE?
@antibody_301_multiplicity_233_copy_138-1
CCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAATTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTAGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGC
+
,???A?BB-DBDBDDDBCGGFFIIEFICHFCHHHAHIIDIIHG@.FICHH.@IIIAEHFH5GFHCGFAGHAF?HGBIEFGIFHHFHIHFFHFHHAIEH?H<D=DHHFHHHDH?HGFFGCHHGCGFEGHHHF*;GC#EFGBE*2EGG5ECCBB-E*EGGEGF?GG(;GCGEF?EGGEEG/G?C:AG=)G.EGGGFEGGD?G0(*GGGC?GE;:(CE(FEGG?EE8C?/AGC8*C=G?:?E8**C*C0-?G*
@antibody_301_multiplicity_233_copy_139-1
TCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGTGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGAGCCACCAGT
+
????A5BBBDBBDDDD;8FG>GEEH/FH+FAHIGGIHCFI=HDID-FE9IDBHGFGGH;HCD?>HHI=HEIHIAHCB-HDIHFHDIDHHFEIHFICIIEHDCFDF>FGAHH7HDHH>+HHE+GHFG2EGE,HFE;GFEEGEBGBEF@FFGE.(?GEG,GEEGE'EEG*>CGGEF*:C?G3?C:?E:GE?E6FEEF0?E9E**AFFC'8FH?(;E@GG/C.GEGC?EEE:G:?(E1E41((*?*?(?;GCG
@antibody_301_multiplicity_233_copy_140-1
GTGGTCCCTCTGCCCCAGACGTCCATGTAATAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTACTCAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGCCGGGTTGAAGGAGGTGTTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCT
+
??,??B<?B-D@DDD<GFGGC>IHHIHHI/EGIFHGDIHHIFIGIEHHHHHIHHFFHI9F-FHIHFFID-G5FEHFHA-EHHEFDHHHHHBHAIHHE7HH=7HGFBHHEHC+GFEHC.GHHHG(GFG+FEFFE@@GE2GF+GGFE2EF:=F((D)GGGGE?C6GECE'ECFECE:GEFEFG6FGEGECEEGGG(EEA?EGE:A*EEH<<A(9EF1.EGC8?A.:AEFG*?EGE*G>EGE(:E6GC?)/:C
@antibody_301_multiplicity_233_copy_141-1
AGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGATCAGCTTCAGGGAGTCCTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGGAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACT
+
???<?BB>D<EDD@D?GFFGFFHIAFIFCHEI@IIHHHIEIIIEIHFIIHHCFD-FGHIHG6HHIGCH@IHIHHAHDHH@FFFHHFB=D)IH8FD+HFHIFFHC-*IEGHFHHHGF?HGEHF+HHDHGGEF4GEDGEB93GE*GDFDEE)G?EG2C;(/GEFG???/GE>GEGG?:EEE(FE=:EAEEAFEGDE.FG9ECCCG<A8CGG4(EF;G:EC(,:EGE1(C):*CEC?(GCCGAEG.A8(E#CF
@antibody_301_multiplicity_233_copy_142-1
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGAGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCC
+
5????<BB<@DDD?DDGFFFC>HHHIF6CBCFHHHIHFFHGEHIFGH.-=HDCCIHAFIFH.HIHBHBG5IIEGIHIHHIHFCIHCHHHH44HH3CIHFFHDDCH=HHHGHEHHDE+H.FF;G>HGEGFG7EGEFFEEC=HGEGGG?GFAE@D0E?GG#CE2GBEEG#G?:G<FF*EGG?:CEEDGG?FGE8'CECGCCGFEF(CC.(C(?ECG;GG3:E*GG*??C>G*2EFGE:AG:GGEC?CG:A*C
@antibody_301_multiplicity_233_copy_143-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCAAATCAGTAGACACGTCTACGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACT
+
?????/?BBDDDB<<BGGGGGFCECAFCFEFIIHEIHHG.+FHEGHHFGFDEIFH=GIEI@HI5E@IIHEIHHGIA/HHH*HIIDG-HFFHGIHHDHFDFHD@FH=HHH>EHHCG@GGH)(GFHD*CHEEE@FFFEF=7DCE0BFFECDDDE*GDBGEAB6FEGA8;GBACFGDGE9CGEG:#G*C:G*E<:<G(EG:E?EG(AA'HECE1:H17#EAGEG7G8(GF'/?:E:<.E<(:EEA*EE:E6EC
@antibody_301_multiplicity_233_copy_144-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCACATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGGAGCTGAGCTCTGTGACTGGCG
+
??9??BBBDDDD5D@DCGGFF-CIFC/FEHIHFIIIHIF.HIHHHIGIHCB-DFIHGIIHHHGIHGH2E<=+-HHHHEHFGHFH5EEHDDFHIHHHEFHHGHHGFFD=HHF>FHHG9=@EEF7DEGHF@EBG8GBFBEFGB=0G(GD8*EEE.EGECE/E(B?7:EFEGEC=EE(ECCGEG>G*GEE8;EF?G'C/C6ECEGE;CFHG8E?6(;:GGF)8?FC<FGA;0(FF(C*C;*?CFFEG.(E*FF
@antibody_301_multiplicity_233_copy_145-1
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTACTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCAAAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTAATGATATGGTGACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACGCAATCC
+
<??=?9BBBDD?@DBDG8AGGFI>IHA8IFH9IGEGHDII@HIE-CIHD9HIFH-C>ADIHI/FFFHIHHHH-HI5HII-IHIF=)HDBHDHHE8CHI0=GHHGFHHBGFDG*CH=CFEEDF+3H=DE*DFE/D*E*FFF;G==02CBEFFG?GG.G=EGE/EEDE*E6F0AE?EECG#GEEGFCGG?(A;ECE6G6;??#CEEF1<6G<0C'(8AF(FG?(?GEDEGG*:GC#A=.EC-*EC*EGCCG:
@antibody_301_multiplicity_233_copy_146-1
GTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGACTGGATTGGGTGCATCTATTACAGGGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTAGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGTAGCTGAGCTATGTGACTGCCGCGGAT
+
?A???/B?<D5D<DB?GF,GEGIH>-EC8IGHIHDEHHHIFHFFFHGEFH.HGI=HIFHIFAHDIIHHHIFHGHCIGHCIDDGH?HE-I-+ECHH+H.H,+HHGH+F?HG(IHFHH;HH3*HEBGHB@HGB)G.FD4HEGEEGD(EC8EA?EAEGGEG6EGCEEC0GE*ACEG;'GF@'?E:GGGEGAEGG??CFEEE:EGE?FG?EEEEG:HE.E:G-GG(/0CGG.C.FAE.:EAG8.C/?AGC4/A:
@antibody_301_multiplicity_233_copy_147-1
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGTACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACGCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACT
+
<??A,BBBE<DEDDD-GFGFFGEEIIIHI9HIHFIH@GC@H@?.HI9FFIIIHBAH-.DH@HHH-H5A.DDHFFHIDHFHHDGCFHHGH/EHH*FHHGIHHCE=GH(HHEFCGHF)FCFCDH++GEGEHG9GHEGEDGBH=F>GEEG1GAC3*C9GGG?GFCEFGC:1;E.C6?8FGGGF;6G<E(.A#A6FFECE(EE:/FE<(G(GFHE((E<CEAGEF,?CEF)FAE*EAEGCCGA:E6?FFE??.:
@antibody_301_multiplicity_233_copy_148-1
CCTGTGCCCCAGACGTCCATGTAGTAGTACGAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGAGCTCACACTGTAATAGATGTACCCAATCCACTCCAGGCCCTCCCCAG
+
,??,<B5?DDD@DDDBAE.FDFHHI@HII8/IHIIIFI.III#FHHHH8HAF?HH=IFIHHIHCHH+AH4IFIIHGHGDIDFCFCIH8GFIIFGAC,CFHDEH=DHH.6HHED;HF9BFFGEFHHG?GGFE2GD@1HG9*F,EG<5CBCGGG;CGG(0GGEAGCE8EEGEEEF*EG8G:EE(CGA?GCCE?(G<CECG:AEG(?GE:.ACE-C(GG?F?GCEGCG?-?<<E'8G>0?E:G*G(D('C=EG
@antibody_301_multiplicity_233_copy_149-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACAAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTTTTGAGGGACGGGTTGAAGGAGGTGCTCCCGCTGTAATAGAGGTACCCAAT
+
??5?,BBBDB<BDBDDFFFCGGFHFIHH/6IFII@IIHEHIFIHHFBCHHFFEHIHHHCHH-IGI/FHHHDGI?AHGFIDIEHD-HIHBADHBCE4DHHHD)EC>FHHHHHH7GH==HHDHH=9;E@E+H@CHEE3GDGF:FEA<BDC34E*,G;==CE?BGE@?GC;B0GEFAFGE0;F;GG?EGEG?//EGEG6E?A(C=C6E:*8A>GE7EGGECE(EGECCEE0'*1A?EE'(E1?*/)8G(*CAG
@antibody_301_multiplicity_233_copy_150-1
CGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCCAGAGTCGAGTTACCATATAAGTAGACAAGTCTAAGGAACAGTTCTCCCTGAAGCTGAGCTCTGTCACTGCCGCGGACAC
+
?<=??+BB?DBD9BB+FGA;GGFIHIH-@FHIHI+.IHG.FIIG>DGH.HHHH-H-IF/'HHHFHHFHFHHHHFAHHHFHC-FH5CHIHIIFHHHCH-HHHEHFHHBEEGHFGFDGG,F@HFFFDBGGCEG6FDFE'GFCAFGG03EF:*G*EDEGE;FGEE(@FEEFAC*E(GC/(GG8GE:C.F?FG(EEDEG::C#EG*0G#E'(AH8:CAEE7*?//(EEECGG(GCG#EF#:F(EE1'0EEEGF0
@antibody_301_multiplicity_233_copy_151-1
AGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAGTACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGAGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACGATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACAGGGCCGTG
+
?????BBBDDD<<@DDGGFGGCHHHHHIIIEFIHHEEHIIEH=FII.HHHFHHHFHD.GD-HGIFD7HH+HIHHFGHF5FIFIHCEFGFHHFHCDIFEGCF=B#HGFFHGHHIHHB*,GEHDGEFHDHDG8FHCFGG:;FGGEFFAGFCE*=GGECGGA7FCGFFEDEEE:CEF/:((GAEGECG8GE//FGEEE:('EEEG*4E6AE8<*F:E:*G*EG5AGE(?G*?EE(EG1:*C(:G**0E::C?(
@antibody_301_multiplicity_233_copy_152-1
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATCCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTAATGATATGGTAACTCGCCTCATGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATTTACCCAATCCACTCCAGGCC
+
,??=?BBBDD<DDDD@CFCEFGHHIHHBFFFGI@HFIHIHF9@EHHGI8HAHGH=G5HHGIIII=HDI>CGGEHHIDCIEIIIFHIIHHH=HH#GHHHGHHI==GH6H/H5HHHDFH;8FGB(=AEGG;DE#BE9GD?EE:FC+EEEEFE)CG*E*E?GEE:EGFGE*#3E6GG:CCFG1CGD:#G>E:*6F;GEGE/(E;CF(?#AFE?G/;A@:?EFEE'?(GGGA*'*?CG?GGGEC1CEA'/F:FE
@antibody_301_multiplicity_233_copy_153-1
GTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATATCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGACGGAGGTACTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCGAGCGGGCTGCCGGATC
+
????,>>5-D+DBD7<GGGFCFAFIHIFFH?1HIIHCIHCIHHDFHF>FDHHHH-FG+HIHIIEIHIIHGAH=HIHGDHIGEH?AHHHHEHEBHHIFFI=H@HIHHGFHADDFHFGEHEHDHDEFHEHCE.;FG;EEFGAG:EDGHGDGBC=?EEGE(FGEGGGE*D*F@AECGGCGGGG:6(CGE;?E'*/GG*C(EDFGG?<F;EE6CCAECGC7/FG/G(GG.?GEGECF*FC;C6C*E(E8G6?(*
@antibody_301_multiplicity_233_copy_154-1
CTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGGTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGTGGACACGGACGTGTATTACTGGAATTC
+
?=???BBBD-DDDDD<G@.GFFEIIHICF+IFDHHHHIII#IIHHFIHHIFBGHAECIHHIGIB-FHHFHGFHE5DHIHDHDFEIHH?HAHHHHHHIFBD=HHHHHIHGHHEIDGHHC,EEGHHDFF?HGE3E(GDFGGBEGFE0AEGEECG?@GEGEFG@/GF0F*GE'.(GFEGG#GCE:?FC/;?EG0G((E4FEG:E*;CFG?FG::>CC*GE?:::?.<AEC6?CA(CEA=CG.?*>ECGFCC/F
@antibody_301_multiplicity_233_copy_155-1
TGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTAACTGCCGCGGACACGGCCGTGTATTAATG
+
,??A?7-BDE-DDD-DFG8GFGBFCFCIFHAG.IGHIGHHGHD?EDIHAIHHHHII@?IHH+IHIFFHH7FAIHE>IAH+=GHIEHHGHH*DHIHGECD7DHD?DGD=H4>HGHGHCEEH+E5GDH@F6EGE1HEDEGE:GEGECECEGFEG'EFCEG#EAFGCFEF;;:C*G?E/GGEGC.FCECG*>GEEEEG;(EC:GG=E6FF(ECG(EEC7(::;*GGECGGCC?EA:*0AG(C?A;A*'(:(:C
@antibody_301_multiplicity_233_copy_156-1
GGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTATTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGATGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCAGATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCT
+
A??<?BBBDD<DDD?DFGGFDFHEFF+IIHHIF+A=HH:=HCHHIHGEHFIIHGABIBAIIIICIIEGHFHFHCIGIFHHIHGH7HIIH+IHIHIHHCEFHHH8+HGI>DGIH*HHGFHFFH;FF'D9?FEGEBGEGDE,F(+E*GEFAE8GA@BG@EGE?C:FE(=ECFE*FEEFC8CEEEDGGGE.CEEEGFCEFE(2AE:*?GHE(<?EHGEEE:G,G?EE.6:GG?*:(:?;/8(0C?G?8A0GF(
@antibody_301_multiplicity_233_copy_157-1
GAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGAGTGCCGCGGACACGGCCTTGTATTAATGGAATTCGTTCATACACCGGTATAGTGTGAGCTACTAGAATTCTAGTACTTACTACTAGTACTACTACATGGCCGTCTGGGGCAAAGGGACCACGGTCACCG
+
???=?-BBB<?D<DEDCG6;FG8FHHFHC;H0HDECDHIHIIFIFEHH8HHHFH=IEGHGH-H?DHEGH=IF5EDHHIBHGIFIHHH)+FHHF.HHHI+F;(HCEIHHHHHEH+BFFHFFD#@F,H@HHBDHBH>EGGEFG8*E;@'F;EBEEE*EC@E?EG?FFD?EAGC*GCE*EEGG.-;EE?4GEE9)ACF/G*F:G0<EEGH6CE#EE:3:C?8.#A6?G'CF*:(GA:E(2A0E-09G??/(F?
@antibody_301_multiplicity_233_copy_158-1
GGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCTGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAACTTCAGGGAGAACTGTCTCTTAGACGTGTCAACTGATAAGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATA
+
??,??BBBBDDDDDDDGGGF+FEFI>I+/HIFAI-IIHHFFFD+IHGHHGAHIF+IGIIHGHIHHIHHG5+IFDIEIFHHII@HFAHI+HGHFE>=CHHHHHGD6FG#HEGGEHEHH+GHF,EHEE+F?HAHGG@G0FGG*DDD*G*GGFFCF(B.ECEE?GE#EGGEEFEE*GG.E(GAEEFAE(C/A/FEGCEE:C:G8EA:CA?*A?A*H1CE7GEE*C:*GGE0?G(EC?G*F:/4CC:CEE1(E'
@antibody_301_multiplicity_233_copy_159-1
TGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGACGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGCATTACTGAAAGTCGTTCATACACCGATATAGTGGGAGCTAC
+
A?9=?BB?B<?DD<DDFGGCFGFFIEHHIIAIHE.GHIHIIIHHIDFHACHH@;/5FHHDHI6CA>HHIFHHCFHCHIIH@HFEHGF7DAFH8FIDHH*FHHD=2HEHHBFHHHAFDFGFGHDGEC#HG)DGGFGGE=E;DG0;FBF#GCEEAG?E*?EG?GEGDEGGE?((8/:GCGG8;CEE8G0;.E0AEF?G:/GGAGGEG0C?)?C;F0F((G:.EAC.0G*?#G;?E:'E?A*AGCEEECEEC(
@antibody_301_multiplicity_233_copy_160-1
GACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCGGTGTCCGCGGCAGTCACAGAGCTCTGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGGAACTCTACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCATTGTAATAGATGTACCCAATCCAC
+
5,??ABBBDDDBE?<DFFB>GGBHICHIFHIHHH/H-HBHGHIFH=E/HFAHFE=DFH-ICIFHFFCFIF-DI-HH@IHHFIEHBFIH=+HEII-FEDH@HHFGH+BIHHHDH+(HF#FF*/HHHHEB:9EGHG?GGDGGBE,*E,HG,EE0EC/E?EGCE;,EG??GE*EGEEG*FG)GEEG6G#F6CEE#FEDFGFEEG6CAGCCEAE?G.:0(:G9ECFE:A8*?(EGGF?:EGF6:?C:CGAC0?G
@antibody_301_multiplicity_233_copy_161-1
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCCTCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTAGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTACCTCAAGACTCGAGTTACCATCTCAGTCGACACGTCTAAGAAACAGTTCTCCCTGAAGATGAGCTCTGTG
+
,???ABB5D?DDDDDDFFGFFGIHHIHCHIAHFF>FFHF=IIIGHGFFICHDIGIHFHIIHIH.FHFHFHHCHHHE5+H#DFD@IDHEIHDHHHH,G*HHHF8DIHF.H6.#FD=EFHGFGH+DGGD;G#(EE6FEG7EF@EFFGG*CFFGCEGE8EGA@GAFCCCG?E=GFFECECEG/3ECEC.G(**?(A(CFA8*GC(E8E*F#EE-E@E@GE/GE88FE:8?EAACGA6**:G*GD1C)EGGA*G
@antibody_301_multiplicity_233_copy_162-1
CTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGTCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGATCTCTGTGACTGCCGTGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATA
+
?????A>BDB?D-DDDGGGGCEHI@FHFFHCFBH+IIDIHHIIHHHCFFCDHGIHHDEIH-AICHIBH=#-HI+EHHGI5HCHA8FHFHHIHIIIHH;=H;BH5CHHHEHH(HH@H1HDHGBFF2F,HF?GFDDGE=EDE1BEGGFG*E;G?DCFEGGCEG/0BCGGE@?/CEEAE?<EGCC.GFG=EEE(EE2'0(GF?6GEFC(;E<HEE:EC(EFE:BEG0GG:GG*1)GGF?'*/:#F(4CC81:G
@antibody_301_multiplicity_233_copy_163-1
CCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTTGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTGACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCGG
+
???<?BBB@DDDDEDDEGEFGFII8AFHIHICEHFH6EIE.HCIHHHIH+FGFFDGFHID>IFFFHIFIIHIHIIAHH-DHGHBHIHEHHHHHI@IH6FHI@HG+GHHDHHHBH=)GHDDFH28GB6EDFHCFEGG,EEC=DBD(EEF?FGFE*G;AGEEEEG6'EG*,?C?EEEE)+??F?G:AGCEFG:9C*?CE9EFCG)-EEEEF)GC@GFEE8BC7EEEE(/A:E6EE:G6(CGEEF:*E.GA;8
@antibody_301_multiplicity_233_copy_164-1
TCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAGCTGTTTCTTAGACGTCTCTACTGATATGGTAAGTCGACTCTTGAGGGACGGATTGAAGGAGGTGCTCCCATTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCC
+
?,?<?B=@BADDBD-B;GC-GGFIHHI;IHDCHHF9GHGHHI>.HAEI-GIIEDHIIH5HFEIIHE-AHFIFFIFC5H5=CIIGDHGAHHIIHIHG=HHHEGDHFHHFFHGGHG7<EFDH6@GH+FE?E+(GEBEIG>EC8(G*E*;GEEGFEEEF:'GE*GAE0EE(GGC(GA(EC:EGECE;G?G6?GFAE*GFFDFEC2ECCE)GGEGE'EG'GE07CGE6(C#F*EACG**AF/:EE0:EE0EE''
@antibody_301_multiplicity_233_copy_165-1
GTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTGACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTGCCACTGTAATAAATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCTGCTCCAGTATTAACTA
+
=??<5BBBDBBDBD<9FGFGG*FHIHHIBHHGCBHEHG>DIGI.E.>H-HHHHIFHE>GGH-IIBF5HIB#HHIHIIHH+G?HC#CHEEEHIEHHF.HDH+DGHCAHBH<CFDHGD?EFFGEEHH@E+,FH3GEG*FC@EEEGFEEGEGE*EGEEGEGGFEGGC<ECGGEAA,?#EGG*GC/A:EG(:GGG?EFEG?-F6F.CGAC?:AA(GDA*.?.?/):CE(0E?:CC(E*G(C6:(E<G6FG<0*E
@antibody_301_multiplicity_233_copy_166-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTAAACCCGTCCCTCAATAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTG
+
?<??,BB<DDDBDDDDGGGFGFIIIA8FH-H9D@IE/IFHHIHDFFHCDHH-IF,IF8C+>H5EIIHIIIFHH-I-FGDHAHH@BH-HHEHIIHCHHHHHH+@D.IEFFH=HFHHGFHCC2H9,FDHDHFGFFHGFH;8EGA3?*GGEF(GGGGGE7FF6AEFGEEEEFFGEG.E(GEEEE>DA/?G;*EBA/*>EEG9?E8FE<CE:G*GC@AGCFEEG:0:?:C*G?:1'C(CFA**?6*GCAE*:AG
@antibody_301_multiplicity_233_copy_167-1
GTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCAGCTCCAGTATTAACTACTGATGGACCCACCAGTGACAGTGCAGGTGAGGGACAGGGTCTCCGATGGCTTCACC
+
?????BBBDDBDDDDDCFFFFGFHHHA8HHB5CGFHDBG.=IIHGHEHCH.IGFF,=H;H=DHEHIHI,CI=IHIFHC5HH@HEH<EHHFBHHH5DHH<H/IH.HHGEHG4HHHHDHCHFF*DBGEEE@F2CFGDCEGEEEF.9D(D;??FG@G*)AEEE.EGEC,GGGEAA:CDECGFE+CE?AE?E(G10AGGFGEEG;(8CCE)GCHDE:(GEE::E(AF?;D0:;G6DG?*=*/8C(E06G*G?:.
@antibody_301_multiplicity_233_copy_168-1
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCGGCTGGGAAGGGGCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGACACAGTTCTCCCTGAAGCTGAGCTCTGTGACTG
+
?9???+B>DD@DDDD@FE>FGFC6H8HCI6GHCIFIIHDIFGC@*HEFIFHHHIHFIFHIFIFHIHHIFHHHCHICFAHEHEIEDHHD)C=F?G-+AHHGFGCHE.HHCE#HHH+HGG=FHC*HG,HHGGE9DFGFFEDGGDEECFEGBEE8GE0EE/E?GGC@C0G*E?GEEE6G6EGC:?E(FEE?F*EFGG(?(GAE:??GGCH'.EC?H(BEE()C.E:(C:?E8E?A*E>G10G:G?EF?*C2/C
@antibody_301_multiplicity_233_copy_169-1
AGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGTAACAGTTATCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGGATTACTGGAA
+
=?=??BBBBDBD@D?DFCGE+FHHIIHHF+HHHICDHHHIGIHHIIFD>CG?HAHH.FEFGII-H=DFHIF?H?HH-;IAEFD.HIHHG8II+IIH,CAH,GHHHHFHHFHHH4*E0HHFHHFHHEGHFGGFEFEI=HFGDEG;EGEFFE:EEEEA(8>E#G?CEFCEF(E(EA:*:FFG:GCECGGE(6/(*AAE*F:FFFG<.(??E*6GHEECCEGCE,DGA#ACEE;CA/FC01G#:/G:ECE:/E
@antibody_301_multiplicity_233_copy_170-1
AGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTTGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTGCATACACCGGTATAGTGGGAGCTACTAGAATTCTAGTACTTACT
+
??<?9>B3@DDDDDDDF-F.9CHIIHFC;>HIIII.'H9CHI-FHHIIHF+HHGHHC5HECFC>DIADHDFC)FHH5GHHHHGFACIFEHHG?HHFHHHGI#HHFDGGHBDFHHHHHHDCGHGGGB=FHG:GGGG=7CFGEGDCGCBFAEGGEEFCGGGGE.EBGBE*E:G:8?EGEGEGCEFG6C?(?;FG?A;?EFAAG;E0D**.GEG<:E:A8ECCG9C1EEC:CGEC.:EE=EF8?ECECG/E?E
@antibody_301_multiplicity_233_copy_171-1
TATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTAGACGTGTCTACTTATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCTGCTCCAGTATTAACTACTGATGGAGCCACCAGTGACAGTGCAGGTGAC
+
<<?=?BBBD+@@<DDBFFGGGGEFAI8HF>+HEHHIHHIFHIHHH-,IFIHEH.HHIHEFIEI5IH#HCI+HHHFFHFF#FDE-EIHDH7HHFFHF5H-DF.(CHFH@H6@DEFDGF9H8@EGFHCHHGH=CH=EFF9FE@GGEC*>F8*GCEEG@FF:EEBGEEB;/EGEFGAA0AEGEEFG(6E?GCCC*G?E?EGA8G#GE?:FEFE0?@GBCEEB,0G/G:G:GEE0CE-8(?(E0EGC(F(CAE*
@antibody_301_multiplicity_233_copy_172-1
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCGATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCACTG
+
=A??5BB<BBDDD@D?BCFFFFCHHEICIHI/GHIHFFHHI=FHE?HFFFIIH+FEDDH0HG=@DIHHEEF5FHHHHF5AHI-HIHIBHGDGIFHDDCHHGCHHHEFHHGHFFH=EF4FBFHGF5BGEEFGGGEGGG;EEFE1:C@EGC*#GGFEGG?@BG9?FFGEE6G.GA:#ECEEFEEEB1*?(?EA8FEGCE?GE?*EE:E?E*HAE@**C0ADC(GEECE60G2G::AGC*:6/0EGCEG*#:E
@antibody_301_multiplicity_233_copy_173-1
CCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGCTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTG
+
<=A<?BB?-DDDDDDDGCA6FAIEHGFIHHFIHFI9FHFFGHFIGEGBGHDIH?DCHH8DCG5IH-+>HFFIAHHH)EHGI#FH@HHHFIIHEIG<+GDHHHF+FDHFGFHFFEHFIHCEG=HH:E*=GBGGG<GCEDFGGED=GCFG.G;F-*E<CEC?G*GG;F*E,FEG?G(6?F(AE:*F;EGE?@G:CG'EE*;EGGC/GE<.=>C(CEFF:EBE->GC2G0EGA?E:GG/A0:FCEF*<CGD?:
@antibody_301_multiplicity_233_copy_174-1
GTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCCGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTATCCAATCCTCTCCA
+
=?5??<>BDD@DDDD5.GF8GGHHIFHIHHFIHGHFHHIHHC8FHHFHGIHFHFIHHHHEGIAIEHCHFBD-FEFI<HHHHDIDHIHEHFH.DHIGFAEHEGHHHDHHH?GGFFH*EFDHHH+;F#FH=HGEEG;CHG@GGGEB?@CEGEEFEEG*EE)GCG?GEC6E6CE(1G?A6EGG:EEE4EFGGFEAEG::;AGAE?CG:E:A?2?EE(:GC(ECF:GA/.E?CCG9G:.-)>C?CG(:(:0C:G
@antibody_301_multiplicity_233_copy_175-1
GTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGCCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTAATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTTTTACTGTAATAGATGAACCCAATCCACCCCAGGCCCT
+
,9??<B?BDDD<5DDDEFFFGFH>HIHIHIGHI9D?IGHHAAHCHFIIHFHGI7HG0=FHIHFIIH5H-HFBHCFFHCFFHIIG-G#<HFHHDCH9HHHHEDI,FEF6GHF.HEFHHFHFHG*=HFBGC,FFDEFGG*GDGCEFFGEEEEGE:GE.EGGGGAC:GGGE(GGG6CEGA.CGEA:E?FGGEEFCG6EE6E?8?>/CEE?(GEG?*)*AGG?AB/G?<A(C#?E<EGG?C8??(6E*:GC/EG
@antibody_301_multiplicity_233_copy_176-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCTTCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATGTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGCTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGG
+
???A<B?BB<DDDDDDG+CFGF;EIFCCFHHIIIIIH5HICBGHHICHIF9IHA9HGEHIHCHH'HGHH*GIAIGHIHFIAFHIHHH?=E.IGIFGHI8DIH36FHHEDDDFHHEDHHFH@FGGE@=H5B2*G<6BG#F(AGEGGGAEFFEG:>EEDFCEGEEGEE)CEECGEGGAE/GCGC@GEGD'EGEEA(C(ECC?/G:EE.H?:HE(:*'G(CGE?A?FCEG08:C?*F(EG(./GG06(1/*E*
@antibody_301_multiplicity_233_copy_177-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCAATTACCGTGGGAGCACGTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATAAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGT
+
???A?BB3D-DD-AD-AG/AGCC;FCIHFFFIBAHHHHHGHHIHHFHICHI>HACBFIHHFIHG5E5HHH=CCIHIFEHHIHHHIIHFIG=EFHHGIH@HGDHHDGHHHFEHD,ECH>FHFG?'DHFCGFGBGGG8CEG4(5GA;9E:B(*GF?G(8C@G)86GG**8EG?EG-G0;C?ECAC.E?0FECEFEFECGEECEG/E#)E9CHEG@1(GC0E7D:G/)EEG?6?(-CC*C:;)8*GC:(AE/0
@antibody_301_multiplicity_233_copy_178-1
GAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACATCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTCCCGCGGACACGGCCGTGTATTACTGG
+
???<?BB>DDBDD@D@CBFCFGIBHIIHHBHFHFHIII@HIHFGH,HIBE?ICI'IHHGEIIHFD?FAIFIHIEDHEIGG?HEFHEEF9HH-HEFIFH3FBIC8DFHGECIFHDHFG*HGHFGEH?EDHEG2EG?FDG=F2=2GEGD,G>GFFE/EEEGEGEEAEGGGF6EGAEFGC0GAAEG*1*EGEDAC((EEGE?EGGC0C:HG?H:EC:FE;ACGGG:'G'CGEGCCE(E6:E/EC?<*E0E(C9
@antibody_301_multiplicity_233_copy_179-1
GCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCAAAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGTCTCTTGAGGGAAGGGTTGAAGGAGGTGCTCCGACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGC
+
???5?BBBBDDEDB?BFF+FCCHFHHFHHII-HH=/HIIIHIIFC9HHHHBIIHEG@H-HHIHFHHFFHDED.CHDEE3I-DIIIAGIHHHGGFH=?CFHFHIFHGHCHH?H*#HH=EHHHFEDHCEHEGGGFFDE<)F(GGGGGGFG;EG*'CCGEGG(FEG?48GA:EA'A<G8(E6:(/<(CEG.CE0.:'A?66EAEGA(::6:E?CFCEGG?E,FC7GE6:*?CEE0E/0G??4.EE#6AF0GC:
@antibody_301_multiplicity_233_copy_180-1
CTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAAGAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATT
+
?<???B?BDBDDD@E?FGG0FCEIH8/IH(I/AGHIIIHHEDEIFEIICIIH/AHHCHHHHHHHIFHIFFHHHHGI5FHEFHIFIHC@CIIHHHHH=DFGHH3CHG@HII,EH+HGGHHHHGGEDBHEE@G10HDGEEEEEEG9EEG?EE*?:FEEGEGCEGDFGFE?:GFEEEF8(ECC(CE8.:EGEE?>AF#0CCAEC/<(E(8EEE/E(FG/(C/E*C#C8'EEA(?G/E'FE0C:FEGGAE)C:0
@antibody_301_multiplicity_233_copy_181-1
GAGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTATGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAATTCAACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATACGTGTACCCAA
+
<?=,?BBB?BDEDD@DG-GFGGBHIEAIEIIHC.HIHFIHHHHCAHAIH+EGIG=HHDH-AHHFH/E>FBHIIE?I-EIHECEDHF3FHIGHGI<>+FDFHIEFDFFEHD7HFEB;HDFE5H>FHCGHFHEAGFF9.,EGDEFGGGGF;E*AE;GCEEB/EFAAAGEC*G:CCG??G:GGEG<-4*CEEGE)C(AG'G:*EAC/?FA0G?/E@AFCC:.,(G0CGC?G?CG/(A::6EA1*EG?*EGCG*
@antibody_301_multiplicity_233_copy_182-1
CTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTTCTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGACGTACCCAATCCAGTCCAGGCCCTTCCCAGC
+
?9?=ABBBDDB<DDB5FGFCGG@6IFFAIFI-GHEFHD/I@F=HFFHHF/IFHIFHFHI?)IAFFFHHHIHHBIFGD,AH5'IIIFHE.HF/FHGHIDGG5ECDBGHFGH,HH(FHE=@EGFFH?HG8BAFDEGEFEB4G=;E/;1GE?4GGFEGGDE#EGEG@EEGGG-GG<C(CDGGE+GEG?CEF#EAF??)GF(EE.CC?GEF<CE'EEEB'(*E(F.E.AGG8GDF(*:?GG/1?G6(CE?CFC:
@antibody_301_multiplicity_233_copy_183-1
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTCGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATACCACTAGACACGTCGAAGGGACAGTTCTCTCTGAAGCTGAGCTCTGTGACTTCCGCTGACACGGCC
+
?5?5?<?BBDDDDDD-GFF>GGCEEHF-IIHIIFIEH99I./HIIDIHHEHF/-HEHIFHI5FIFC7IEAHECD>,GIHBDHHEHCHE6III5CHGFHFHI,IBD3CH+HHDFFG=GDEGDDGDEEGG>?E;AEDEEE@EE;G*FE;BFE(GGEAAG28:AEAE*E'E9?6ECGF*CGA8DC6?(CE(EF8GADAC0A*?E8'*6E/EECG(H#@GB'G(E/G0E:EFEE.;G.?.GCE?*CA'CGG*GG
@antibody_301_multiplicity_233_copy_184-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGACTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGCGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTCCCGCGG
+
?=?<?BB<BDDDE<BDG8.GFF/HCH>CFHHIIIIHHHHIHFHGF+FA7F9H-@ECHFF:A0I=+HHHHFH,HEG5EIDFEEIEGEHAHIDH,=I-IHHGHEGHHIHHHHC;B@FGFHH=H(HH9H**FGEE#HHFGFEGEFGFGCB?B.D@/C?<A@?GGF;GF9EEGGC<E?GAE:EG?G4A?AEEEGCEEEE:G6GE/?GEEE(8GE.8E:EGE/E<G(GCEDECEE-GGGECEEEE:GG#/?GGCC
@antibody_301_multiplicity_233_copy_185-1
AGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACTTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTAACCAATCCACTCCAGGCCCTTCCCAGCGGGCTTCCGGATCCAGCTCCAGTATTAACT
+
?A???B/BDBDDDDDBBCF8FFHHBHIEF>G,.9FFHGFEHI>HIIII7F0F:H>DFIGHIIH,IAFHHHIDHIIHIHGIDHFFEHHHF?HF,EF+FHHIGHCAG4HFHBE@HHF1D=HGDE4DFFD,DH*GFBH4DFE?GGDFFGFG*EEBGFEE=GEEGECEGBE6(.CGGFEEE8EEE:#EGEG/EEEC.(GGAC*AEC:E8F8GGFCE#C/G0/(EEE*EE(E*AFC(:ECACF:ACG*C?8CC?C
@antibody_301_multiplicity_233_copy_186-1
ACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCCTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCTACTCCAGGC
+
??5?,<-BBDBDBDDDF.C;CEIH-HFFEIFIHGHHHHHIFIHHFHF/HH@HH+FIGHAHHGHEIFIFIGECEIIHGDH-HIHHIEHF-HDH>IIIEIECFHFHHEE.G;=FIH+HBFDCAFHDFGDGGF',BEGGF,GA=HF;GF*8>CDDG?FD(#=FE=GGEEEAEEEFE;GCGGE.AGE:8:E::GGG-EEE8?(FGEC?GCFEA?GF<@(CEEEFCEEE?<?DEA?A*GFG;CEE'CC:GCFA8C
@antibody_301_multiplicity_233_copy_187-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCACCCCGCTGGGAAGGGCCTGGAGTAGATTGGGTACATCTATTACAGTGGGAGCCCCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGTCACGACTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTCAC
+
?A5??B9B+DDBDDB?FCGFGG>HICCIIIIHIIGHHHDHFI.IHF>IHIFFHFIHH.HH+FFIFHHIEHHHHHHCIH?HHGIEIIIHIH@IIGIDDFDHAH@HFHHFF#+IF*EEHDHHH)GGFFHGH@D;'EGE?GGEGGE?GGEG<EE#ECFGGFFGG**GEGCFE?AC;GE8G9GGEEG*GF(GCGGAGG?AGE0CGCG8?C?0E?0?#/BGGCG@:EE/C(C<EEFE0EGC9:E'EG:E*EE#8A
@antibody_301_multiplicity_233_copy_188-1
ACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATAAACGAATTCCAGTAATACACGGCCGTATCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGGGTCTTAGACGTGTCTACTGACATGGTAACTCGACTCTTGAGGGCCGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGC
+
?A?<?BB?DD@DDD<DGG8FFFF/HFHHFIGIIE9F7.HIIIHFHHHFHIHEECF-GIHIH5HHFI*FIHEHGI55HIGDHEH*GI-+HHIHHHE=HEGFIH@FHDFD:HFHD*HHHHHGFGEEDFFHHHDGGEBEFGFGF2FG6EF'DEFG,*CCFG?EGEEE#FGECEE4E**GEFGG:EG;E;E:.GGGC?DC#C0C(EEEEEC:A:6EE*G<?CDCBAAGEG?E?C/?/E*G?C.FE:?C?:GFGA
@antibody_301_multiplicity_233_copy_189-1
CTGCACTGTCACTGATGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGCGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTGAT
+
??AA?B=?D@DDBD-DFFFFF-AIIFHFFIHIEGHHDIII7IHFFHEHCH@HHDFHH=I-5GIEIHI-FIIFHHH3H=HHIIEHBHFHHFHHHH=HB8HH(HIHFHHIHGHHFIFGGHEED=C2GEGHEEEE0E=E?GE.E?GG>EEGCGAEGEFFGDFBG8GGEGCGGGGA.F;?6E6EEC*CGF9G6G1#(GGEG?CF8?.<*?E:(EEC0F(*D8GE*,E/(EEGG8E/CFAE0*G1ECE'?E*()(
@antibody_301_multiplicity_233_copy_190-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGATCCCACTATACCGGAGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTAAGCTTCAGGGAGAACTGTTTCTTAGACGTGACTACTGATATGGTAACTCGACTCTTGAGGGACGCGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAAT
+
??=5?B??B@@@DDDD?CFFGEIIHIH;HIHFHIF9IHFDIHFHAFFEHIHDBGCHDHHIHF=FEFG7=IEIFHHHI-IHIFH@IIHDIH.H+BIEHFFHEHHHEDDED:HDFGEFGAGFHG(GHH0FEEBG5GEE4GGEGFFDA#GG=ECGCCG?BGGG@GECGGGGEECE8HGC#F?:?E6E'GG?FE*(EECCE:C8FGEGGEAG?E(E@7;?.1EGGFGC?:'GCA.;:G:/AE(F?*AE8E/?(G
@antibody_301_multiplicity_233_copy_191-1
CGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACGGAGCTCAGCTTCAGTGAGAACTGTTTGTTAGACGTGTCTACTGATATGGTAACTCGACTCCTGCGGGACGGTTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTC
+
?????BBBDBBDBDDDGDAGGGCFC6FFFIIHHHCGEI0IEFHH5GAIHEHHIHIBHEHA>HIHIICEID-CHHHHCIHIC;HCIGFHH+HIHHHHHHHH7HHHHHFHFHHHICHHGEFEEECHHHEFGCBG9(EFFGE1G;GGDGE**8EDEFAEEG*@(A*6AEGGCAG:EGGGEEGEEA#0(?EE(EG*GG::C*2GA0*GG(FCEE.?(-C(B*EAEACE?EGGG*E8:G.8GGECCGGC(?E?A:
@antibody_301_multiplicity_233_copy_192-1
TCGGCCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCCGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCTTATCAGTAGACACGTCTAACAAACAGTTCTCCCTGAAGCTGAGCTCTGTGAGGGCCGCGGACA
+
?5??,?BBDDBDDBD?GCAGGGIAFHFIHHIGHG@HHHIFHF5FHIGHAHHIFF=H@GHIIFDGIF-GI#IGEIIIIFH+IDIFH==HHHHH6I-IE5FD5CHF3GFHH)HHDHCH,EHGHEB-DDHFDDGEEEGF+<EG=EGEE(EEC:8CECDGECEGF=C;F:GGCAFEGE(:EDEGEG<66E(G(CFFE6GC?F:E*G>GC?**GE(AE;EEGEC(.>EGCE:GAADC?G?G:C**:*CG?/E=F4
@antibody_301_multiplicity_233_copy_193-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACAGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCTGTCCCACAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAATAGTTCTCCCTGAAGCTGAGCTCTGTGAGTGTCGCGG
+
<<?A?BBBDDD5DD@DFGGAFGIHHIHIFHIHHHHIHIHIIC+FIBFAA,EHHCEEIHEFFDIIIGIFFFFFHFHFHIHH+HFH#H/IHFFHHEHGHHH@@CFHH?43=HH?FAHFHHEFDGDH*6EGGCH(EEG*EG3FEGGG(F?GFEC(CEGDFA:EE0E(EA*(18EE#EA(:EGG6AGEGGGF//@E:GEE?FFCGCGGG<H/GH)(:#E:GC'GE?EG;;EE*?*(F(GE;GG1E'6*'F:E:;
@antibody_301_multiplicity_233_copy_194-1
GGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTAAACCCGTCCCTCAAGAGGCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGGGCTCTGTGACTGCCGCGGACACGCCCGTGTATTACTGGAATTCGTTC
+
<A??ABBBDDDDDDBDFFFFFGHHEFAFH;GI0@CIIHGHGIH+HIHEF=HII.FBFHHCH+?H@EH?H-HDIFDHDHIHIGHIHI-IGHA=HEHHHFIEFHHF-H-EHHHFFFEHEEHH*+HGDGEH?E@F+G*6F.E@*CGEG3E8EC#ECG=FGFEG*GE0EE<6EECFG/:F:EGFGG;?GC(E1EE9?*?GEE(?2A*.C<HEGEAGEE7A08(<FCC/EG(<?(EC?EEG*CE(6*GEE*6(:8
@antibody_301_multiplicity_233_copy_195-1
CGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACAAGTCTAAGAAACAGTTCTCCCTGAAGCTGAGATCTGAGACTGCCGCGGACAC
+
???A?<>BBDDDDDDBGGGCF,HIHHHIH8DFHHDHHGFI@FII?HDIFC=IDHIHCGGHHH5+AEHHH5HHFHHHEHFH-GHD,GIDIF+G-8GCFDI*EHHHEFDHCGDD+HF2DED@HDGHE=*GEHGGFFE'GFF8@GDBFGCGAF;*GGGCGG9CGG*EEEED1:EA-GEGGGG*EG/EG'GGG46G.:AEEG(G/E::EG(AGHCCFE(EE(BC7E<;GEGDE(AEEE(8C(E<G-FEEG::'E
@antibody_301_multiplicity_233_copy_196-1
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGCTTCCGCGGCAGTCTCAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGTTGTACCCAACCCA
+
??A,5?BBDDDD-DDB0FEFCFIIHIFHIHCFC@FEGIHEHAIHHHIHEDEGI9FF/H.IFDDHFHIHGGIBHIIEGI)HAEE5FHHFFHFIHHG@CEHHHHHEHHH?HHHHHDHDHEGE#*BHFGHGHGEFFB(CHFEEBDE?FAEEF=GF?8EGGEEF?(CG?C8;*EGAG:EEE(:1;4GC>??*FGGGG:G6E(AEE:(ECE8GEA(GDG@G0EGGCEGA(EEEE*<<:?GE(.EECEC-CG(EC'
@antibody_301_multiplicity_233_copy_197-1
CGGGCCCAGGACTAGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCGAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACAC
+
,??,=BB?DD5BB5EDGGCC8FHC+FHHI8IIHHIIHHC@IDGEEF.DCDGDHAFHG-HD;G/I=IHHFIIF5EHFHHHII5CHDHHHH;IHH+HHIEFFBDHDGFHD1DCIEFHF6DDHECFHC@F@EHFF=DGFGEHGG=G5FEFFGGE<8.3C@FEGE:EGECE<GE(FEGG?AE'6CEAEECGG2EEFE*E:C*C?EC(:<GCE?CFE(0:EE:CEE0CC80EE:0(GE**GGDC8/?(6C:G0C?
@antibody_301_multiplicity_233_copy_198-1
AGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATAGCGGTGTATGAACGATTTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGGTGAAGGAGGTGCTCCCACTGCAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATCCTGCTCCA
+
<???=B9BD5D-ED?DFCFCFCIHHHIFHIDIG9EHHFGGGAGFHH.CHHF=HBHFIFHHF'FH5HFHIH,FIFHHIIIHFCH8FFGDHEH?EDIFIDIH.*EIF4HFHFBDH)E-FHDC:;EEECGCFG<FGEFBE=FEFGFDG(ECGFEGGGC=::EFGE>F*GGEGF#EEEGEECGE/CEG?G6C(E6#>AF?6EG1CGG(EFD<6?G>E@:*:CE:/E:A.(E:EEA6E:::*EC:0?D'EG**?E
@antibody_301_multiplicity_233_copy_199-1
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGAAGGTGCTCCCACTGTAATAGATGTACCCAAT
+
,????B>?DDD=DDADC8CFF>IHHHHFFFFG@IIHH=IH.HHHEIEGIGIFHHIAFFGHHI=IIIHH5H<=DHHHH4-HHI5=HIEIFHHCHH=FHHIHE,IHHH?GHBDE;EFHEGGGFEH+=+EHGEG4EGFCEGG@(7E8EHGGFEE6GE:.EE#A*GCEE*GGGF4GGF)?FG.CEEEC.EEE?EGA<?GEAFE=CF:<C;E66EEE@*.AEE,,0(CA;A1E2F(EC8'*CC:E8G?CGC*E1/
@antibody_301_multiplicity_233_copy_200-1
GGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTACGCGTCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTTTAATAGATGTACCCAATC
+
?A?=A<==DADBDDBAFCEF;.8FIF8@ICHH?FI=GIEIDCFIHHC@IGHIGHFF+FHIHDGHHEHIE(IGCCGIIHIHAHHHC-ACFH.+IHHGHGF=GEHHG+GFHGBH3HFDHGFEEFED,+GHF=(HEFF(F;ECFE<GEF*DEEFG).//6GGE('EEE?E<CGE0EFG(CGCGC6EC:FEAEE(EEE.6GEA?EGC*E?//;D(EEE7GBE<);?EG'F*G?A:'AE*.*6:?E:/A(;?A-E
@antibody_301_multiplicity_233_copy_201-1
GTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATTCCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTTGACGTGTCTACTGATATGGTAACTCGACTCTTGACGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAAATGTACCCAATCCACTCCA
+
<,=?,A-BBDDDBBDDGFAGGGHCHI+FHFIIFICFFC.HHHGIIFIHH+FHIIIFIIHHDGHHFHIHIIGHHIHHDHE+HHHFHHHHHFFHHIFEHE3GDG@HFHFHDHHHFF@@.HHGD@E50GEG*E@CHD;E9F*EDG@G<E*@AGGE*AE3(GG*E(BCCEGE/GGEE6AFEC#G;G?<0GC6G::A:EFE*E/6A(EG8(EEAEEEEGGEG=GFC11FEG?GCC(GCEGEEEC-?-E*(EFG)E
@antibody_301_multiplicity_233_copy_202-1
GACCGTGGTACCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATTCACTCCAAG
+
??<A?BBBD+DBBE-DGG8FFGFE8FHIIAIFHIFDHIHIIFECEE9D;AHHIIHIFFIAHHH?HHF-H.IHFDHHHIIH-HCIHIIIFH(IGH5,FF4.F,HHDFFHEDFEHGDDG==+H=HEG+E*EE1HEGGG>2FED0G:F<ECCED?FCECE*DGEEG*<EGCEEG#EG6?'EEA0+EGC8:G:EFF.EG?*EFE6EEFCG*CAFGEHCB:EE/G:GE?ACEC6C:?0'4EG:8:*.GGC:0:#;
@antibody_301_multiplicity_233_copy_203-1
GTCGGGCCCAGGACTGGTGTAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGATACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTGTGTGACTGCCGCGGAC
+
5?,??BBBBEB<BDDDCCF8FGHHHHHCIEIIHIHHHFHIFHIHGHDHHIHEHCHFIFHHHGGFF-IIFFHHBHDHFGFAF>FAECHBHCHEHEH=EH1H-HDCHGHIIC;EEFFGH.HECFGHHE(?H.G*H0BEE2EECFGF;ECGE8AFFGEE@EG?FEAEFE;?EFGGAFEE6GCE.EAGE(CGE;/AGC(EG;GEGEE??;HC::0?HC7CDE?8GCEFGE>GG0CGE0:.A*EE;E*8;:EG#/
@antibody_301_multiplicity_233_copy_204-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACAGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGTAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTATCATATCAGTAGACACGTCTAAGAAACAGTTCTGCCTGAAGCTGAGCTCTGT
+
?<?A=B?BDBBDDBDDGGGFFFFIIFAHFEG.GEIHIE>EHFIFHHEGEAHHH:HGGH;I(HIFHI-HD?HHGHBAAFHGHFBBHHH+HHIHEI+#H-H6BEHHI(H=FFG+HHBEGHE@GDGH@GH+GE:(GHFGHEGEGEEF@FGGEAG;EG0GE(GCEGD?G*(GEGA?CGGECGCG2C6E6;CF<<1F:E(.E(#.G?A?*?HC1?C=EE(GGCE7EFG#?(*(**.(?C?CG:)(EC;?6?:0G(
@antibody_301_multiplicity_233_copy_205-1
GAGACGGTGACCGTGGTCCCTTTGCCCCAAACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCTTGTCCGCGGCAGTCACAGAGATCAGCTTCCGGGAGAACTGTTTCTTAGACGTGTCTACTCATATGGTAACTCGACTCTTGAGGGACGGGTTGAATGAGGTGCTGCCACTATAATAGATGTACCCAATCC
+
5A=?ABBBB@@D5BDDGFFGFFIHICHIE-DFIFHIIFHEHH@HI-DHFIHICGFIHHIIH=EHGIHFE@HIIHFHHHHCG?5HHGHEDHC.HGHAFFHHH@GFHHBHGHH2HHHFEFHG,HGGEFHGHEEEFGGEG.8DG(EFH?0DFG(FFFE-<CG6G=EC0EGGEG?D'E.GG:CE'C>F/FG?.ECGG/;GE.G?*/G*GG*E*C:-HCG(:E?@;G:0(C/EE()E0GG(E(EGA'(?AG?ECG
@antibody_301_multiplicity_233_copy_206-1
GGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATAAGTAGTTAATACTGGAGCTGGATCCTGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGGTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACG
+
<??AABBBBDDBDBDBGFFGFGIIHIFHH/IIGFHFIHIFEFHCHAFFHHF4HEICACIHDIGHCD#5HIFIBICH@HCHFHHIHHCIICH8,DHDFHECHHCHHFHH+HFFDDF:HG8HHHHH+F+FDEGH+GGGCBED*)GDC?E@GE#EDGEEEEGFGEFGECEGF0:F6(.D;EF*/EEEE.GGEGFCEC?*GGGD(6;86?EAG?C(*4CE:CEG??:GFE(EC(0D0AF?FAFEG:E(A;EEG:
@antibody_301_multiplicity_233_copy_207-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCGTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACGATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACT
+
?????ABBDD9DBDBDFGGGFFIIHI/H/B9H.IFHCDIHH-FIHHGBFC?IHIHBHHHH(HE-HHGHHFFGFHF5FIDH5FHHDHIIFHHFFIFIFHHDEIHHH=H?+0H=FGHH=HFFF?HH*CHE6EGEEE7@EGDEHBFEGF6*EFE=GC<GE0CFE)1(E<=G6EE2G?EGGEGECAF;FG1?(E*EE8E'AG#ECEE?G:/FGH??;*E((E?,:AEFE;F)4FEE?:(8C/(C*<G??A?A6G
@antibody_301_multiplicity_233_copy_208-1
ATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGGACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACTTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGGAGCAGGTGCTCCCACTATAATAGATTTACCCAATCCACTCCAGGCCCTTACCAGCGGGCTGCCGGACCCAGC
+
??????B@BDDDB@B?FFCCFAI;;HEF.FEH5HFHHCI8HHIIIE.CHDFFFDFGHHHH'+G.GHHCIFEH-DHIHH5FHGHCHBHHIGEIGHIIHFAFHF.HHHHC>HGHDD?)FHFDDH:GF*G+EHE@DF'#8F?AEG?F(DFE??FE(GBEG*EAG/E?EE?G;E*E??A?E(FG>CB??EG6FCCEE(#:E<(FF*A)?F?GF*G*E:@GG9)EECA:CAC*ECGCC:CG*GGG*E(E(>C'CC
@antibody_301_multiplicity_233_copy_209-1
CTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGGAACAGTTCTCCCTGAAGCTGAGCTCTATGACTGCCGCGGAGACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATA
+
?=<A?B?BD@DDDDDDEGCCFFI5HHE8EHCHIFHHIIAHIIFHHI@HIE-BIICHHFHI5HHI?IG+HHHHHIE=IGIHHIIHI:CHHHHHH)HHI)HHHFFDEHEBDDHHCHG9HHGEF?+>?FH=FFH@HDED8GED+DCA8GDGF*C=<DCCG?EEGDGGG;:G'E?**EA:EF80FE?GGE?GGGCG;:E(CGGCE8DEFGH:E#?<CE:CBDB@?G6E0GEEEE*:GEGEAEG*E;?:*EGC4:
@antibody_301_multiplicity_233_copy_210-1
CCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACTCGGCCGTGTCCTCGGCAGTCACAGAGCTCAGCCTCAGGCAGAACTGGTTCTTAGACGTGTCTACGGATATGGTTACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTTCAGGCCCTTCCCAG
+
5????BBB@D@DDDBDFGFF6@HIHHI>IHH=BHIH9FFEEHIHDFHHAIDC-H=HGIHGGFHHIFD5HHF,@EHFHFIHEBIEI8IH-H+GIH5I+E-HHFH'HHFD#E)DFIGF3FH:)HFHFGHFH(EGEBG(G?AGEB:'BGEC?EE?D,>GF;EF;(EE?CE4EG#6366CGEF/(;@C?EC(F(FG(?E?E/C?GCC.EECC:;E;CGEGC.G:/E86#ECEG(*GAC(*6CCAG8F?6C6EE/
@antibody_301_multiplicity_233_copy_211-1
CTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGAATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTATGAATCAGTTCTCCGTGAAGCTGAGCACTATGACTGCCGCGGACACGGCCGTGTATT
+
????5BB7D5BDDDDDGGGCFGHI>I>IEHIAHFHHCFHHFIDEH=HHIGHFFFBHDDGGIGHFHEIIHGHIFIDCI)IIGHCI<FHFH+IHHGIEHHDFDIFHHHHHHHH8EH-FDFHHFGF45EEH?FCEFF*E?G@GEGGGGG@6E#33EE=F*EE??GEGEF=EEEE*CCG8A4?G2CGF)6C/F*AGG(GCE(.;CE?GG:);A?/CF*<G:FG(G?(G?G:-G???(E:((>:?E?(CC:?G->
@antibody_301_multiplicity_233_copy_212-1
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGCCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGGCGCCTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACT
+
<9???B?B<DD@DD<DGFGG0AH8>>H.HFHIHIDHIGFI.I0HHAIFHHEIHHIIIGIHIFFFEH5<+FI-D-HICGD)AHIIEHICFHHCCAHGHHHHIHHDHE8HHEHIHHHBFHEHF<HGDFB'9GG4EFDIGEGFGEFF;FGEE?E(CCGEG'E(GC1:GD5GGGEEC?<EG+:A?EAEG0;G2GGG>'1:C<(<0EGDG0*F9:0CHC0GEAEG=EFEEGG*:G??C:G?A)6E:?16G>*CFG
@antibody_301_multiplicity_233_copy_213-1
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGTATTGGGTACATCTATTACAGTGAGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTATACACGCCTAAGAAACAGTTCTCCCTGAAGCTTAGCTCTGGGAC
+
????AB?BDD@ADD-9FGGF8FC@FFFHHHFFIBDIIHGFFHHHDHIIGHFHEGHHI-FFHHHHHIHHG/IHHHHIAFHHD=CHHIDHIHIHEHF=H.HA=HIHEFHFHF<BFEH@B(G:GFHHD@+HBG=DE0:GEGBE@EFGFEGGEE)1?G)E#-E?GFECGF;AEEGGGEEEGEEC6EEAAEGAECEE18GGG/:CE*:CEF*E<E(C0EGC0FGG:C??E:<E?E*(E:C<*D#?8(G?CE(ECG
@antibody_301_multiplicity_233_copy_214-1
CTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATCCACCGGTATAGTGGGAGCTGCTAGAATTCTAGT
+
?????<7?B<DDDDDDFFAGG8IH>HCCFHFHHHIIHI,.?HIHFHAIEEIEFH)FHCHIIIGFHFDEFDFGIF-E5CEFGDHH-HDHIHGHHI@DFFHHHHDGBEHDF7HHEDHEHHHHHEFFEFGGHDEF=G6D*GFE(@ECE@FD<E6G*EED:?66EEFFAG*CFEGFGC,CEGFGCGFCC;GEE'F)ECFG?G?)E:GCEGH:EE(*CGCG*AEEB?E(GA(0::8GC*:/'.?EE?E8::2?EF
@antibody_301_multiplicity_233_copy_215-1
AAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTTGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTAGAGTTACCGTATCAGTAGCCACGTCTAAGGAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGTGGACACGGCCGTGTATTACTGGA
+
?<???B??DD<?BBA?-GF>FGECIEIHIHEFIIHHHI7FHCGIGH-GGHHIFHAC8IHIHIAHIHFFHFHBH>--H5HEH9E.IGD(FII6I,HHH8@FHHH?HHCHHHIFHDFHHHH4GG?GGHEEHFGEEEFD;G(GEHCDAG4GEG,AE?G20EE*)EEEG;F.(GGEGAG(6-(FG+(C?GECC*ECE*GC=EE?CEG9GG:((:EG@E@EEG/2(EECEC((:C?E.:G(80(:AE8GCEC:CE
@antibody_301_multiplicity_233_copy_216-1
TCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTAGTACAGTGGGAGCATCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGTAACAGTTCTCCCTGAAGCTGAACTCTGTGTCTGGCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACATCGGT
+
=?5??BBBDB@DBD-@FFGGFFB.;FFCIIF=GGHIF5H-GIHHHHIBDI>HGDHHH.HGI-HFFDFHE5HH+FGHIGHCFIIICHFIHAFHCIIHAFEFF+?FFH5E=HFGHEF+HHHFHB@?<?GDF+GH1GDEEEGFCB=;FE?EE-8EABEEECFGCEGEA?GGEEE#GE8E?C8FC?/FEE6/(G/C?(GE;GEGC(GCE/((C8EGCGE0DG:EE?(.AGFEE?E:?EE/EE0:(G:CE)E;G*
@antibody_301_multiplicity_233_copy_217-1
GCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGTTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCCTTCATACACCGGTATAGTGGGAG
+
9=?A,BB<D5DDD5D@E+FGBGFI8H@HIIH9DA.DHIFGIIFG#HHEH>,IHFIIH#FHI9ICCIFHHHBHHHDHEII?II5HEIH?I=IICHAFHHBFEE@IHFHADGEDGE+HEHIDHHD,FEE3HFEBHF?GHGH@ECEGFEG(AGC5FE;?(ECG@G<?CC*A<*EEB(E(EE*G?CG((.<(FE((C:;FE?.GAECFE/H:EH)G:#G;*:?GG?G:D/)8C0*GGEECEAF??G:EG:((C;
@antibody_301_multiplicity_233_copy_218-1
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGACTGGGTACATCTATTACAGTGGGAGTACCTCCTTCAACCCCTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCAAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCG
+
??55?>B>DD?<DDBDF>CGFFHFH+IAHEIF9=GHEBHIHI-CFF+5GAIIHGCFG-GCFGHFHIIH.HHHHHI+CI5H:*HIHHD-HHE?AHHHHGGHCDGH*FHCFHHFHFEFCFF*CG=EFG1C=F#DGE<GGH+BGGGGE0AFEGFGEG?*EAAEGAGFG6EF6E((EGG(G/EEG?AA0ECEGE?G#?EFC.CEFCE?=CA2E(EA@(FCE81CGC;GEGE6G6FEE?*)GA6ACGGG'E?C(E
@antibody_301_multiplicity_233_copy_219-1
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGCAGCTGAGCTCTGTGACTGCCGCGG
+
?????BBB,DDDBDDDGCGGFGCIFICHIIIGFF?IIHHIGHFHDIEA?7IHI-HDII-HHH9.ACIIHGH@I-ICICF-DDHDEGH=FHH8FI@G5IFHF<HF@HH8IH@D?HFFEHFGFDHHAHEDHG*DGGF,FA;F=CGC@DGEDACGE2GG*:,GG0?G(GGF:/CCCAFEEE?*FEG@EF1FG:EG?GFAGE/)GEC;G0HDE8E?HEEC?G::.'6CG(GGE'GCC<G?CFG.)CCG/8?C/E
@antibody_301_multiplicity_233_copy_220-1
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCTGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAAATGTTTCTTAGACGTGTCTACTGAGATGGTAACACGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACGCCAGGCC
+
<<A,??B5DDD?BD@<CFF>EFHFIEE;FHHHHHHII.IEIIFDHHEI=H,FFGHDHIFBFIH-GFIEFIGFHIHGFIFHHFIIIHDHHHI,GH5I(*CFIHHHHFB*DGGH+FHI@5GHGFH8CH*CHBFGHEEEGFE8B1*CEGCG#)EEEEGGBG8?(G.G?EE/?G<E*?GE8:C8;(GGCEFGAG(AE/?GEF*(F?EGECCFEHGG'FGC?E:EC:.:AA:09<6(EGG8<=(*:(*:EGF/C*
@antibody_301_multiplicity_233_copy_221-1
AGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATCTGGTAACTCGAGTCTTGAGGGACGGGTTGATAGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCG
+
,?5??BBB9DDBDDDDFF-GGFI?HIH/EAHFIIHHHCGH/AIHIHFCFFIAHHEFHIF-?AF5IIHH-AB5EAHAIIFEFDF-6HFIHHIHIDII5HF=HHC(HH@HHFHBHEDH.GGHFFFEGFEG-GHGE=G8(HGGEF*=GBH*GFGD?DG#G;GGGGFCGEE#E=GGGG6G:6G0GFE(/A(#EGGEEEGE:CEFEEFECGAE*?FG)@G7EG7;G/GEGF:*8(GGCEA(CGEE1CC:GAAEAE
@antibody_301_multiplicity_233_copy_222-1
CGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGGGCACCTCCTTCAACCCGTCCCTCAAGAGCCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTCAGATCTGTGACTGCCGCGGACAC
+
A?,?ABB<DBDD9DDBFF6GCGIICHEHII9ID>H?IBDHHIEHH.H5HI-IHHHHE,FEHGBIHH5FHEID@BHHCHIIFIH)HGH-HAEEHGDA<FGHHF6HGHGHFFGHEEH5HG=DGEFEHHF)?#GGEHEGG2F=EC*GFG(EE8G<ECEE:(EC(C6CCFC8G*BCBC?#>?CFC:G(ECEEC((CC6GGG;GE??(EE?E'E/E*@E.G*ECCEE(0EG(E6';C;?8*EG*?*FA?AE:C:G
@antibody_301_multiplicity_233_copy_223-1
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTTGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGAAGTACCCAATCCACTCCATGCCC
+
99???=BBED-D@DDDFGFCGBHHA68>IHI+H@FHEF)E9.HEHEBAAGF5H=HHAHI-DH-IHFF5HFFHF(-AEDEGHHHFHD@IIIIDHI=GFGH9HHHDHHFC@HHHFDDAFE;EE3G,2GFEB:F1*EEGEG8EEGEG,F/E*>GDAEECB(GE8DE:GG0>G?G?.:76G<EGCE?F6F0DGG(GCE1;E;DAD?EECGFA*C<C*E;:BAF8BF6GC?*-EEC0G4FA)CG.*0E0G(A8?:
@antibody_301_multiplicity_233_copy_224-1
GTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCCCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGATACGTCTAAGAAACAGTTCTCCCTGAAGCTAAGCTCTGTGACGGCCGCGAATACGGCCGTGTATTACT
+
?=????B<BDDDDD+5>AGFEF-IHEEIFHI=IFFDHHFID=HIHHIIIHG@DG5HHEHAIFDIHH5FEFEHGIFEHECHIHHADHI#=GB7IFIHI,IEFDHHDBCIFFGF3EFD=EDDHFEGHDEGDE:GFHFG4GGEBEGDGEFGGG=GDEE?GG/:A=GG8EG?EGGG?G6*@G(;F;(/FEAECCGGEFFGAE0GAGEEFGF.EF?A(@CGGGC@B:6/(G(?E0=(/*E'GA*E:A*<GC4ECE
@antibody_301_multiplicity_233_copy_225-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTAGCTCCATCTGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGAGTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACAGGTCTAACAAACAGTTCTCCCTGAAGCTGAGCTCTGT
+
?????B>BBDB-DDBBF;GCGGEFHIIHACIIIHF5FHHH9IHIHID/.+DIHGCFFCIGFIFCFHDH3IF@I-#F+DG1DHI+CCFHFF2HDFIHIBF-4HBHHBEHFHHHFHHGH3CEFD8GG*EF@GGCEG?@+E'ECG8GFGEFGF(C'6*F9CCC0)EEGGGGBGEEEEE?CGG?EGEE.EA<(EE6F?EE/CEC:/0GEE8.E1A:0(G:E?CE(7GFCECE.0*?:::*GA1AECEGEE.?*E
@antibody_301_multiplicity_233_copy_226-1
GACCGTGGTCCCTGTGCCCCAGACGTCTATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCCGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGTTGCTCCCACTGTACTAGATCTACGCAATCCACTCCCGG
+
?9=<?@?BDDDDD-DD;G6GFC.FACH/;HCIIFACHFIFFGAIGHHHGHFI-GEAHICHHFHHHIHGCHIGIIFFGCII#FI,IDCHAFDHHIEGH+IIHHFGHHH>+H9+@.-)DCFFGGDEGFGEFGE=EGF.GE?GDCGEDGEF,.8FGC(EGGGEEDFG@C#(G;GAEEGGCEECEF0A/6G*GGED?ACEFCEEEA*6GG*>CEF(AGBC*<E,2:CCE(*?AE/**6:(1?;E*.EC*.-/?E
@antibody_301_multiplicity_233_copy_227-1
GACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCCCGGCAGTCACAGAGCTCAGCTTCAGAGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCCAACCAG
+
?5?A?BBBDD9BD?D+?F>GECHH@HFI>HIGHGGEFDHF+HHHIEHIHHI/,HH@?I-DHIHBF-FHE5IEHHIHIHHHGHHH8GHDGHGIH<@,@HHFHHHFFH1FFH>HDHFEE,FHGHHE,HEAE@F7HDEDHEGDBG@EGFG?FC*ECGGCGAEAE=DEEGGEEEGGC.A=F:ECEEGGCE<:GGEC.GGEGE2C:(;E/EHGGA:?H*:?ECEEB0/C/(0*E<C'?FECAC?:(EE#E#:AA(
@antibody_301_multiplicity_233_copy_228-1
CCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGTAGTTAATACTGGAGCTGGAGCCGGCAGCCCGCTGGGATGGGCCTGGAGTGGATTGGGTACATATATTACAGCGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGGGGACACTGCCGTGTATTACTGGAATTCGTTCATACA
+
,,??,/?5<<DDDDBBGCGG/GHICHHEIICIIIH/II?AIH+F=EH9HF9HAHGFF7HE-HC-HH5HHCIHHIIIAH#H=5EDIHHEIDHIIHIHH+FDCBH+'HH@FHHG*=HHHFCHGHGFFFD?FFEGG@GG#GGEGG*GGGFGCGFGGCECGGEEEGE@8C.8;(EGGEGGEEEGC?G:ECEEA6:G.F0<.:C?;*?.E*H<ED6(H):CCG,G)<E0)GA00GCA'GCEGA)C)8CG:G>GEA
@antibody_301_multiplicity_233_copy_229-1
GTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCACGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGAAATGGTAACTCGACTCTTGAGGGGCGGGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATCCACTCCAGGCCCTTCCCAGCGGGCTGCCGGATC
+
?????BB9B@-DDD<E;>F>GGIHFACEIH/?FHHCFIEH>E?HCCHEEIFDHEHAFIFDHFFI>H-FHE'HH>FHEIIHHFIHHHH.H?E>HH#HF+.=E.HHAEGFCG4*HHGFFDF.EH@HF@FHAG+EGHDGBGEEEEECE1GGEE#GA;GGCEFE:G0GFDG(A?EFG((:/G2E?2AE?6AEE*?GGCFEGEE6G-GE.GH:G*E.8*EC:*:G/EE#(CCG10(/:GG?GFEEG?G.CCEEE(
@antibody_301_multiplicity_233_copy_230-1
GGAAACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTACTAGTAGTAAGTACTAGAATTCTAGTAGCTCCCACTATACCGGTGTATGAACGAATTCCAGTAATACACGGCCGTGTCCGCGGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGTTTCTTAGACGTGTCTACTGATATGGTAACTCGACTCTTGAGGGACGAGTTGAAGGAGGTGCTCCCACTGTAATAGATGTACCCAATC
+
??A,?BBBD@DDDDDDFFGCFAIHAFHHHHEFHCGF+IEG?CE.*CHFHGHFHGIHIFFHDHIHIEIICDEEFHFFH;HHHFICIHIHEFFG=DBIHAHHF=2HHFCFG((8FHDEHD;HGFFGGFGBGFH?F*HEE>GG?G,FGDGEE,EAEG(<EFDD@CEGCEAGG:G(*GEG?ECGEG6:G6CDGGG8:E0E/CEGEAGE;EEE:#CGHE7EFE:EC2GEE*?GCGF1:FGCAC.ECCE?0G0(CA
@antibody_301_multiplicity_233_copy_231-1
CTCCATCAGTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACACTGGGAGCACCTCCTTCAACCCGGCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCCTGTATTACTGGAATTCGTTCATACACCGGTATAGTGGGAGCTACGAGAATTCTAGT
+
=<???BB>D?DD?DD-GFFGEGIFIIHBHF/IHHFIFEIIGHIHDHHAEI-HHHIHHHHCIIIFFFCHHCH+HFHIC@-H)-=HI-GHHEHHAHIH,CCHFHH(CCHFEHHEH4:H=FEHH+EHGEFGFGEHE,HGBG8FG4GF=0ECFG4EGEEFGGEEFGC:GAG;8*GG6GEAG:EE0G(*>CG6C<E10(?*?:=C?/CCG*HG;C?A;ACEG?E@E?CE?GGE-.:A8EG1FE)*8?CCG*0E?(
@antibody_301_multiplicity_233_copy_232-1
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCACTAGTTAATACTGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACGATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTAAAGCTGAGCTCTGT
+
A??5,BBAD5DD@D@DGFGGCEFFIHFIIF;IEIIEHFHFGF?HAEF=HB,HFEDFHHEH0FHECHHH-AIGG5=HFHHIHHH>.7HHHHHHCD-FIH-IH+FD<GHF+GFHEDHEEE@+?GHEHHGGEGG=G=EGF@DFGGE83CEEFFEGEB:C8G<EFGGE36CGCGE:EGAF?G8GEEFGGG?0GEEDCCGEEAC(/G8EGDC8?E0G<GG;G/BEE01/E0E:C2:E/C?**G:?CA:G?00::D
@antibody_301_multiplicity_233_copy_233-1
TGGAGCTGGATCCGGCAGCCCGCTGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTCCTTCAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAAACAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGGAATTCGTTCATACACCGGTATAGTGGGTGCTACTAGAATTCTAGTACTTACTACTAGTACTACT
+
??=???BBBDDD-9BBFFFFGF=FFHEC9IHHHIHFA9FHHCIHEDAHHHBG=DHGH5HH/FGHCI5F-FIIHHHH-HHHFHEH-?-HCHHDB)IFI+H+FHHHEFHFDD@H,FB5FDHH*E*@EHFE(CEEGCD;GHEHBFFC8GEF6@E9EEC(EGDE8GGG.:1G8EGCAEGEA:9ECEE*1G.EGE/(A(GC8.<AF.G*EEEGFFC8A*;E*A8GG?#:?GEC*(GG/EGE;CE.:0;E:E:?*C
@antibody_302_multiplicity_1_copy_1-1
CTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAACTACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGACTGAGATCTGAGGACACGGCTGTGTATTACTTCGCGAGAGACAGCTGGCGCGCTATTAGCATTTTAGG
+
??<??BBBDB@DD-D@GFF-CFIIH>HH)F/HHD/E9HIIHCHHCHHI5EIEHIAHIHCI8DHHFHIGCIEI-IGDGD@HH4IFI(IIH=IIFHHHCFCFDGEDFHGH.HFGHDIGDHF*+EHEHE8;GDE#GGCAFG4FEEC2GBG#?A)AFGEFBGG/*A/G1C0F2;CEFFEE(BE<EEEAC4(FGGGG4GG<?G(C8C'G8EC:(HCEC'(G0*E,GE**EG?GG??/G?***C:*CFE(FF((GE
@antibody_303_multiplicity_1_copy_1-1
CAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGGCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAAGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAATTGAAGAGGC
+
?????<7BDBBDDDD</FCG9GHIFHFHIFHH.IEHIFHHHIFFFCGFHH@HGHHID.F-FIHGHICHCHFHHH<IIHFHAHFHF7HH?IHHIE)HCCHFIH@GHDFGHH?HEFGHGDEGCHD@DDHEEEGEE)GIBDE,?F*E=FCGGEE;EFCGGBCEG<G:<G8E6FEBCEGE??A:GGCEEFAE*EGGGG(0E:EFG9/<G*H*?4;;HEFCC1(CG(AFGC#CEE:EGAGECEEG(*6(E*A66C
@antibody_304_multiplicity_1_copy_1-1
GCCTCTGGATTCACCTTCAGTAGCTATGCGATGCACTGGATCCGCCAGACTCCAGGCAAGGGGCTGGAGTGGGTGGCAATTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTCTTACTGTACGAGAGACAGCTGGCGCGCTATTACATTGT
+
5=???B?BDBBDD@DD@FGCFGIFIH.IHE-IHHAHFGH#HIIEIF=9#IDGIAIHHIHGCHEHCFFHIIHHHFIHHIHHH(DHBAFI8IFEHHIH-EEHCHFHCEGHDDH4DHHF9<EA4GFGDEEEGGBGFGGG(BFBEEDGD8AE@EFCA8(EEEG?=;8GGGEG:?:FEEE(EGEGC:?F???GF?6'C?FA:??CEC6:*F;EEFE((GF?:*:,?A*GEG:(1EAE.E(6?:((.E*/EGC('F
@antibody_305_multiplicity_5_copy_1-1
GTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTAGCATTATATCAGATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACAGGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGCCACGGCTGTGTA
+
?????B9?DDDDBDDBFFFFFFFH+HEECHG8FHF=EGF@IIHBHGG>IIGDFHIFECHHI'HCHIEIFH+DHHFFCIF>IIFDHFH=HDHFDDHICHHHHHHAHEGHCHH1HCDHFHH.=EFEG,DHH0EEGEFEF9?G10GHC@FG:EGBGDFEEGEC(GGGAECGFEGGFGG((EG8GGCG:1CE*G*/GG)6EC6:*((FGGHG<E(:CC*EECBE?CG8CGA*?E;CE?:A1/:AG>E?GG2C:E
@antibody_305_multiplicity_5_copy_2-1
CTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTAGCATTATATCATATGATGGCAGTATTAAATACTACGCAGACTCCGTGAAGGGCCGATTCTCCATCTCCAGAGACACTTCCAAGAACACGCGGTATCTGCAAATGAACAGCCTGAGAGCTGAGGCCACGGCTGTGTATTACTGTGCGAGAGACAGCTGGCGCGCTATTAGCATTTTTGGACTGGGTATTA
+
?=?,ABBBBDD,BDDDFFGAGF-FHFIC>IHI.9IIIIH=HH>HHHEII9?HH@IAGIFHH;HHAHHIFF.IIAHGHIGH,HAHH-IEIEIHFHEH=IGHFHFEH5HF+EI,H=HG@GH.#HGEDHHEHEHD(EFGEE:EG;EFBCBE(:E(G;D?9CE4GEEGG*ECEFG?GCG8F;EFC6F?A6EEE;E?G*0G0E:EC*'>CGC86-GE:EGEGC0AFFEEGGA(EEE*EE?:EGAG(?C:/AG***
@antibody_305_multiplicity_5_copy_3-1
CCGGATATAATACCCACTCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGTGGCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAAGTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGGGTAGTATTTATTACTTCCATCATATGATATAATGCTACCCACTCCAGCCCGTTGCCTGGAGCCTGGCGGACCCAGTGCATAGCATAGCT
+
?A<??BB<DD-<DDA5GG>;6EHHHIHIHAIH69FHI-HHIHHGGIHFIHGIIIHGIFFHGF.HFF>EFHICHHHIGDFFIIFIIIFHFHFH;GFGHFHCDHFHC8HHE?=D+F6HFFHHB:GDFHGEEFFF=HEE.94ECAFDGGA?>G)E1FFFEE*)*EF=E/EF>F/EGGGFE6GF0G8:EGG;CG?DE'E8.?G?*'G*FGF?GE**E;@?7:EE8G/GGG()8G?:G<?E/6*-'26EAC*EGE
@antibody_305_multiplicity_5_copy_4-1
CCGGATATAATACCCGCTCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGTGGCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAAGTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGGGTAGTATTTATTACTTCCATCATATGATATAATGCTACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATAGCATAGCT
+
<???=BBB-DDDDDB-FCFGCGH7@IIEFIIHHHEH/IH9HFIF/@GFF.FGH(HIHF8AEIHIGIHHH-HCFGHGH=IIAEGIE-H8FHDHHIHDH.HH:FHGHFIFFHEH=HFFHDFC1GHHGE6FEH*FCG12=+EFGGC,FGEE1GF;FE(C*3GE#G.?F9CG=GE8FG;AFFGGFE(C6(G:5FF6EGCC'G?:EGAAGEEE?EC*/CC<C?CE.:GG.::.-E?FCE1?AG*GCCGE)A(CGC
@antibody_305_multiplicity_5_copy_5-1
ACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTATTCTGATCACTCCGGATATAATACCCACTCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGCGGCCTCAGCTCTCAGGCTGTTCATTTACAGATACAGCGTGTTCTTGGAAGTGTCACTGGAGATGGTGAATCGGCCCTTCAAAGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAATGCTACCCACTCCA
+
??A?,BB=DDBB+DD5-FF;@FIIF6HHCHGIGG?G>HH+HIEGIIHIHIIHEHHHH=C-HHI.'IG=H5>CIFHHECHH5HGFE.+@ADBHH-HH+FIHF.IFFHBHHHGHE#DG,DHBFH(D*H=+B6GF=G*FC?B2(GGDG=*GEG,GG.>GGCG:EFGECG;F*EG,@GD0GEGCB)?:0E*.GG?CE/*-G<G(FE/*CE:A.8GC:7EAEFCEEG*AG0CGA?(9*/?CEC(GFG?.**CEG.
@antibody_306_multiplicity_4_copy_1-1
CCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCGAGAGACAATTCCAAGAACACGCTGTATCTGCAAATCAACAGCCTGAGAGCTGAGGACACGGCAGTGTATTACTGTGCGAGAGACAC
+
=????BBBDDDBDDDDGGEFCCFI8HHE.FHEIIIHHFEID.EHG=EEIHH8H,IHGH@HIHIIHHFAIHACHFHBG;FFHAFFCEEHIFEHA=HHH6)HH@HFGHHIH4EFDHHF8@=#FEHGFFFDFFHDGGGAFE?EEEGGDG;E'BEEFC?AGGEECEG*EE@0*EEE.EAEAEGAGDGEG1GEGC/?GGACEEEE8/8>EDFG(F;G:7@)?7E:EGEEF(*?EE(GE66?E(?EEEC*G(.81G
@antibody_306_multiplicity_4_copy_2-1
CGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTAAAGGGCCGATTCACCATCTCCAGAGACAATTCCTAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTATG
+
?5???BB+/DEBD<DDFGFCFGFIBFI@HFGEHCHIH9IHIIIFIHIGHHHAG@IHHIH5ECFHFIHI-HGIFFFFBEIIIH5FH*#FIHFAIHIEHHCHCHHH4++DEIBDGDGFDGH=ECDDHBFGGGE*E2FE6FGEFGFB@CGEGEFAGGEF;9C)GG*CGFG(CFE(F8AGE+DCE4EA.:*?ACA??CE8/E:C?EE*GG(?GCEEEAGEE(,'CA:FG((GE8C(G)*GG*6GC(A8??((?*
@antibody_306_multiplicity_4_copy_3-1
CGGTGACCAGGGTGCCCTGGCCCCAGTGCTGGAAGTATTCTGATCACTCCAGATATAATAACCACTCCAAAAATGCTAATAGCGCGCCAGGTGTCTCTCGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCCGTTGATTTCCAGATACAGCGTGTTCTAGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCC
+
<?==?BBADB?DDDDDFGGGCCIF/AHH/>HEGHGIG@FIGHHEF8H7IG)AHHFHIBGIE-CHHHHBHI=?GHFII>IHHIIEHF-HHHHIHHHEGCGCBHEHEHGBHFHFFHH?DHHHDFGHDB>GEFHFBC@F#FGG<FBEE*FGGEF6(EGCE66*G1E(CGECEC>F0EAFE)ECE?EEFDGAE/CC:)CEG*(CC=9EGE?AEHG8:@GGGG?CGFG8G?GEAG8G6AC*(GCCE:F)EE(CC>
@antibody_306_multiplicity_4_copy_4-1
CTATTCTATGCACTGGGTCCGCCAGTCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTATCTGCAAATCAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTATGCGAGAGACACCTGGCGCGCTATTAGCATTTTTGGAGTGGTTATCATATCCTGG
+
??<=,BB3DDDB-BDD/FGC>GEHIHEIHHII>I+AGGCII?FIGDHGHGHIF-F@HHIC=H,CH-FBGGBFHHD5H-HHHFFIFH+-FIDGHEHGEIHHGH98EEB9FHHH=+HFHHF?HHGF4D,EDG=GEBGGF*H'GEGGFGEEE(EDG?GGE*BGFEE?FE6BE0CAF??A(FGEFA(EE(E/(GGG?E**(:CE?GG(*8A/G6EEDF@/FG:GE8E*EE0FGE?:?:?CCEEA(?2C8CE*?(
@antibody_307_multiplicity_1_copy_1-1
ATATAATTACCACTCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTACTTATTACTACCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGCCTGGCGGACCCAGTGCATAGCATAGCTACT
+
?<???BB=<DBBD9D<FCFEEFHCG,IHFHHHI-,GIHHI*ICHIIHFDDHGHDHDDHIHEFF=GFHDI>BIIFHIFFEHHI5FCHHGGH>HIHHFIFHHGHHFBBFGGH5AH@GHHDEEHF:GHH>HDGFGFCCGEFD#EE=3EGHE)CGGG*EFHFEAE=0=EC*G(CGDG/ECGEGGGGFEG??G(G<E6AGEEGEF?C:6EFEC?EC8C7GAC7BE/E6;(*#F(CC<*GCEE.8(EE66G*E?:.
@antibody_308_multiplicity_1_copy_1-1
GTGCTGGAAGTATTCTGATCACGCCGGATATAATAACCACTCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGGCTGTTCATTTCCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGACTGCGTAGTATTTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCTTTGCCTGGAGCCTG
+
???A?BB>DD?BB@-DGEFFFF@HIIHHIFHIIGHCAFFHCHIHHICFEHIHI/5IIHGI*@HIHG,HHFDIICHHCH-GFI?F+CDIHHHHIHHFIH)H.DHIFDHHHH@EGDHGFHFDGE+FHGHGDHFE;DEFFHBEFEG@FEG?EEE*GEEE>EEEA*GECA*G?AEGGA6EG(F?D:?:FGGG>AEEAD)FG/F.C:(:E6FC:CEEE(GCGGC77(FECG??(/AA?CE'EC?#)/EE0E:*AE
@antibody_309_multiplicity_1_copy_1-1
TCCAAAAATGCTAATAGCGCGCCAGCTGTCTCTCGCACAGTAATACACAGCCGTGTCCTCAGCTCTCAGTCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTATCTGGAGATGGTGAATCGGCCCTTCACGGAGTCTGCGTAGTATGTATTACTTCCATCATATGATATAACTGCCACCCACTCCAGCCCCTTGCCTGGAGGCTGGCGAATCCAGTGCATAGCATAGCTACTGAAGGTGAATCCA
+
9??5?<BBD@DBDDDDFGFFGFIIIIHFFHHHEEHHGHIIHHCEGHHIF@HFHFCHFHIHCHFFHIIAGIICFAGIHEHBFFH7HHHCFHIHCE.ICI=HH8HCDF3+HHC'DH4+FHCHF@FGFFFGFGEEGAF6FG8=FD?G2BGE2:EEC6AGGGECFGGE-EFE?GGG9*G?AGGCGC*<EA.A?EF(CEEE/=:A/.??66EDGC(GH*4EB;GEGEFA:?(?E:GG?4/C?E*<9.:84AFEEE
@antibody_310_multiplicity_2_copy_1-1
CCATTGTCCCTTGGCCCCGGACATCAAAAGCAACGTTATAGTAGTTCCAGTTATATATAGATTAATCCGCGGTTCGCACAGTAATACACAGCCGTGTCCTCAGTTCTCAGGCTGTTCATTTGCAGGTACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACTGAGTCTGCATTGTATTTATTACTTTCATAATACCGTAGAAATGCCACCCACTCCAGCCCCTTGTCTGGAGCCT
+
??<A,B5BD-@BBD@DEG+CFF>FIACCIIGHHHHH+HFHHHIIC7HGIHHFDHH@I,FHIHFHE,DEHHIF=HFEI<HHIFC8C/D87HHIFDHHDHIIFHEFHHHFHFBGHFH=FHCFF+FHD+FFGEE=BGFGED@9GEGGGEGBC:GG;CFEC=(;EECG?GFFAGG6CEG:#GEA(@8:EGE(.E;F8EECE?6G;((EE#HEG?GGE/*?(FB0CEGE;C0GG?F0?GF'GECE*CCEEE/ECC
@antibody_310_multiplicity_2_copy_2-1
GGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCAACGTTATAGTAGTTCCAGTTATATATAGATTAATCCGCGGTTCGCACATTAATACACAGCCGTGTCCTCAGTTCTCAGGCTGTTCATTTGCAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATGGGCCCTTCACGGAGTCTGCATAGTATTTATTACTTCCATCATACCGTATAAATGCCACCCACTCCAGCCCCTTGCCTGG
+
??<=?BBB<D-DEDDBFA@FFFHCCHFFEHFI-GIFIH.IH0HGHEHEFIHIFFAHIGIDDE5EH-HHHHHEHCHFGHHIFDIIH+FHHFHHHI-FIHIHCHIHHHCCDH2H4HGHHIDFE.C+HDEHHEF/GFGFD5GFGGD*GGFGGG=B*ECHFGGE0EFG2EEEFD*FACF4AEG=C+ECEGC;EAGFGEF(4ACGGEE6(???G6E;:7FG*:,EEGCEC<EEE/DCE6EEC*-?:EEC#C?*GA
